Citrus Sinensis ID: 017046
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 378 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.677 | 0.656 | 0.464 | 2e-63 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.759 | 0.313 | 0.376 | 2e-47 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.653 | 0.264 | 0.410 | 3e-43 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.653 | 0.185 | 0.402 | 2e-42 | |
| Q54I36 | 1338 | Dual specificity protein | no | no | 0.640 | 0.180 | 0.383 | 1e-40 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.682 | 0.223 | 0.373 | 3e-40 | |
| Q54XQ2 | 1125 | RGS domain-containing ser | no | no | 0.666 | 0.224 | 0.394 | 1e-39 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | no | 0.679 | 0.221 | 0.348 | 2e-39 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.685 | 0.315 | 0.381 | 5e-39 | |
| Q66HA1 | 850 | Mitogen-activated protein | yes | no | 0.648 | 0.288 | 0.361 | 9e-39 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 243 bits (620), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 124/267 (46%), Positives = 169/267 (63%), Gaps = 11/267 (4%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDE-RALLEGRFIREVNMMSRVKHD 118
LFIG+K GAH ++Y G Y R VA+K++ + +E RA LE +F EV ++SR+ H
Sbjct: 86 LFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVALLSRLFHP 145
Query: 119 NLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N+V+F+ ACK P + I+TE + +LR YL P L + L ALDI+R M+ LH+
Sbjct: 146 NIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHS 205
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
G+IHRDLK +NLLL D+ +K+ADFG + ET GTYRWMAPE+
Sbjct: 206 QGVIHRDLKSNNLLLN-DEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEMI------ 258
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 297
++K Y KVDVYSFGIVLWEL T LPF+GM+ +QAA+A A K+ RP LP P LA
Sbjct: 259 --KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALA 316
Query: 298 FIVQSCWVEDPNLRPSFSQIIRMLNAF 324
+++ CW E+P+ RP FS I+ +L +
Sbjct: 317 HLIKRCWSENPSKRPDFSNIVAVLEKY 343
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 190 bits (482), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 114/303 (37%), Positives = 176/303 (58%), Gaps = 16/303 (5%)
Query: 21 NQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG 80
NQ+ +G++ K S +VV+ S Q + + L I SK+GEG G VY+G +
Sbjct: 626 NQYNNQGNILKNSGSVVEPPS---QQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWR 682
Query: 81 DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELL 139
VAIK + + + L E R +E+ ++SR++H N+V + AC P + +TE L
Sbjct: 683 GSSVAIKQIKINEDVNNQVLEEFR--KELTILSRLRHPNIVLLMAACTAPPNLCFITEYL 740
Query: 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199
PG SL L S + K+++ + A+ IA+ M+ LH +G+IHRD+K NLLL + ++
Sbjct: 741 PGGSLYDALHS-KKIKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLD-EHMNV 798
Query: 200 KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259
K+ DFGL++ ++ + MT G+ WM+PEL GE Y KVDVY+FGI+LWE
Sbjct: 799 KICDFGLSKLKSKSTEMTKSIGSPIWMSPEL------LMGED--YTEKVDVYAFGIILWE 850
Query: 260 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
L T LP+ G+ ++Q A A K RP +P L+ ++Q+CW +DP RPSF++I+
Sbjct: 851 LGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEILN 910
Query: 320 MLN 322
+LN
Sbjct: 911 LLN 913
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (446), Expect = 3e-43, Method: Compositional matrix adjust.
Identities = 110/268 (41%), Positives = 160/268 (59%), Gaps = 21/268 (7%)
Query: 60 LFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
L I +IG G++G+VY + G + K L++ + AL E F EV +M R++H
Sbjct: 669 LVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSG--AALAE--FRSEVRIMRRLRHP 724
Query: 119 NLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLH 176
N+V FLGA + P + IVTE LP SL Y + RP + +D + ALD+A M+CLH
Sbjct: 725 NVVFFLGAVTRPPNLSIVTEFLPRGSL--YRILHRPKSHIDERRRIKMALDVAMGMNCLH 782
Query: 177 ANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-GTYRWMAPELYST 233
+ I+HRDLK NLL+ + ++K+ DFGL+R + T + + T GT WMAPE+
Sbjct: 783 TSTPTIVHRDLKTPNLLVD-NNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEV--- 838
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293
LR + N K DVYSFG++LWEL T RLP+ GM+ +Q A F++ R +P+++
Sbjct: 839 --LR---NEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELD 893
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIRML 321
P + I+ CW DPNLRPSF+Q+ +L
Sbjct: 894 PVVGRIILECWQTDPNLRPSFAQLTEVL 921
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 173 bits (439), Expect = 2e-42, Method: Composition-based stats.
Identities = 107/266 (40%), Positives = 147/266 (55%), Gaps = 19/266 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
I +IG+G KV +G + + VA+K LN +++ F EV ++ ++H NLV
Sbjct: 1075 IDKEIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMIQ-EFKAEVELLGSLQHPNLV 1133
Query: 122 KFLGACKDPLMVIVTELLPGMSLRKYLVSLRPN------KLDLHVALNFALDIARAMDCL 175
G +P M IV E LP +L + L+ +P+ KLD + L A DIAR M L
Sbjct: 1134 TCYGYSLNP-MCIVMEFLPSGNLFE-LIHSKPSEQQQSIKLDSTLILAIAFDIARGMQHL 1191
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT 235
H IIHRDLK NLL+ ++K+AD G+ARE + T+ MT GT W APE+
Sbjct: 1192 HTRNIIHRDLKSSNLLMD-KHFNIKIADLGIARETSFTQTMTT-IGTVAWTAPEI----- 1244
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295
LR + YN K DVYS+ IVL+ELLT P++G+ + A A K RP LP++ P+
Sbjct: 1245 LRH---ESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPDNCDPN 1301
Query: 296 LAFIVQSCWVEDPNLRPSFSQIIRML 321
+V CW EDPN RPSF +I L
Sbjct: 1302 WKKLVVWCWSEDPNKRPSFEEITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 167 bits (424), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 100/261 (38%), Positives = 151/261 (57%), Gaps = 19/261 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
I K+G G+ V+ G + VAIK+L S S++ +FI+EV+ + + H N+V
Sbjct: 1059 IVEKVGAGSFANVFLGIWNGYKVAIKILKNESISNDE-----KFIKEVSSLIKSHHPNVV 1113
Query: 122 KFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
F+GAC DP I TE L G SL L ++ KL+ + D++ M+ LH+ ++
Sbjct: 1114 TFMGACIDP-PCIFTEYLQGGSLYDVL-HIQKIKLNPLMMYKMIHDLSLGMEHLHSIQML 1171
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY-RWMAPELYSTVTLRQGE 240
HRDL N+LL + K++K+ADFGLA T+++ MT T RW +PEL +
Sbjct: 1172 HRDLTSKNILLD-EFKNIKIADFGLAT--TLSDDMTLSGITNPRWRSPELTKGLV----- 1223
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 300
YN KVDVYSFG+V++E+ T ++PFEG+ +A AAF++ RP +P D L ++
Sbjct: 1224 ---YNEKVDVYSFGLVVYEIYTGKIPFEGLDGTASAAKAAFENYRPAIPPDCPVSLRKLI 1280
Query: 301 QSCWVEDPNLRPSFSQIIRML 321
CW DP+ RPSF++I+ L
Sbjct: 1281 TKCWASDPSQRPSFTEILTEL 1301
|
Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 166 bits (419), Expect = 3e-40, Method: Composition-based stats.
Identities = 105/281 (37%), Positives = 149/281 (53%), Gaps = 23/281 (8%)
Query: 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREV 109
+R ++D + K+GEGA +V+EG + VAIK L DE E RFIREV
Sbjct: 843 EREYIIDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLK--IIGDEEQFKE-RFIREV 899
Query: 110 NMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPN------KLDLHVALN 163
+ + H N+V F+GAC P I+TE + G SL Y + PN K + L
Sbjct: 900 QNLKKGNHQNIVMFIGACYKP-ACIITEYMAGGSL--YNILHNPNSSTPKVKYSFPLVLK 956
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 223
A D+A + LH+ I+HRDL N+LL + ++K++DFGL+RE++ MT G
Sbjct: 957 MATDMALGLLHLHSITIVHRDLTSQNILLD-ELGNIKISDFGLSREKSREGSMTMTNGGI 1015
Query: 224 ---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
RW PEL + HY+ KVDVY F +V+WE+LT +PF + QA+ A
Sbjct: 1016 CNPRWRPPELTKNL-------GHYSEKVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVA 1068
Query: 281 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
+ RP +PE P+L ++ CW DPN RP F+ I+ L
Sbjct: 1069 YAGLRPPIPEYCDPELKLLLTQCWEADPNDRPPFTYIVNKL 1109
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54XQ2|RCKA_DICDI RGS domain-containing serine/threonine-protein kinase A OS=Dictyostelium discoideum GN=rckA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 164 bits (414), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 108/274 (39%), Positives = 149/274 (54%), Gaps = 22/274 (8%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125
I G+ G+VY G+Y + VAIKVL G L F REV +MS KHDNL + LG
Sbjct: 848 IASGSSGRVYNGQYKGKDVAIKVL--GPEVCVHFDL-NEFKREVALMSIFKHDNLARCLG 904
Query: 126 ACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 184
A + D +TE SL YL R N + L+FAL IAR M LH+ IIHRD
Sbjct: 905 AGQYDDKYFHLTEYCHNGSLFSYLRDQR-NNISFGQRLHFALGIARGMRYLHSMSIIHRD 963
Query: 185 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY 244
LK N+LLT K +K+ DFG +R MT GT WMAPE++++ T Y
Sbjct: 964 LKSMNILLTKRLK-IKIVDFGTSRVANKYN-MTTHVGTQAWMAPEIFTSRT--------Y 1013
Query: 245 NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCW 304
NKVDVYS+ I+L+E+ T + ++ +N+ K RP LP+D+ ++ I++ CW
Sbjct: 1014 TNKVDVYSYAIILFEIFTRKSAYDENANINIP-NMVMKGERPELPKDMQTSISNIIKKCW 1072
Query: 305 VEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPES 338
+ P+ RPSF +I+ L + ++ PSV S
Sbjct: 1073 QQKPSNRPSFIKIVAYLESIIY------PSVSNS 1100
|
Serine/threonine kinase involved in negative regulation of chemotaxis. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 163 bits (412), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 99/284 (34%), Positives = 146/284 (51%), Gaps = 27/284 (9%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
L I IG G KV+ G Y VAIK+ ++ + D+ + ++E + +KH+N
Sbjct: 142 LDIKEVIGSGGFCKVHRGYYDGEEVAIKIAHQ-TGEDDMQRMRDNVLQEAKLFWALKHEN 200
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+ G C + + +V E G SL + L K+ V +N+A+ IAR M+ LH
Sbjct: 201 IAALRGVCLNTKLCLVMEYARGGSLNRILA----GKIPPDVLVNWAIQIARGMNYLHNEA 256
Query: 180 ---IIHRDLKPDNLLLTP-------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 229
IIHRDLK N+L+ QK+LK+ DFGLARE T+ M+A GTY WM PE
Sbjct: 257 PMSIIHRDLKSSNVLIYEAIEGNHLQQKTLKITDFGLAREMYNTQRMSA-AGTYAWMPPE 315
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289
+ S T Y+ DV+S+G++LWEL+T P++G L AY A +P
Sbjct: 316 VISVST--------YSKFSDVWSYGVLLWELITGETPYKGFDPLSVAYGVAVNTLTLPIP 367
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL---FTLRP 330
+ +++SCW DP+ RP F +I++ L + FTL P
Sbjct: 368 KTCPETWGALMKSCWQTDPHKRPGFKEILKQLESIACSKFTLTP 411
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 162 bits (409), Expect = 5e-39, Method: Compositional matrix adjust.
Identities = 106/278 (38%), Positives = 157/278 (56%), Gaps = 19/278 (6%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
L I KIG G+ G V+ + VA+K+L ER F+REV +M R++H N
Sbjct: 551 LNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERV---NEFLREVAIMKRLRHPN 607
Query: 120 LVKFLGAC-KDPLMVIVTELLPGMSLRKYL-VSLRPNKLDLHVALNFALDIARAMDCLHA 177
+V F+GA + P + IVTE L SL + L S +LD L+ A D+A+ M+ LH
Sbjct: 608 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 667
Query: 178 NG--IIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMT-AETGTYRWMAPELYST 233
I+HRDLK NLL+ D+K ++K+ DFGL+R + T + + + GT WMAPE+
Sbjct: 668 RNPPIVHRDLKSPNLLV--DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV--- 722
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293
LR + N K DVYSFG++LWEL T + P+ ++ Q A FK R +P +++
Sbjct: 723 --LRD---EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 777
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331
P +A I++ CW +P RPSF+ I+ +L + + PP
Sbjct: 778 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 815
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q66HA1|M3K11_RAT Mitogen-activated protein kinase kinase kinase 11 OS=Rattus norvegicus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 161 bits (407), Expect = 9e-39, Method: Compositional matrix adjust.
Identities = 98/271 (36%), Positives = 140/271 (51%), Gaps = 26/271 (9%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIR-EVNMMSRVKHDNLVKFL 124
IG G GKVY G + +VA+K + DE + +R E + + + H N++
Sbjct: 124 IGIGGFGKVYRGSWRGELVAVKAARQ--DPDEDISVTAESVRQEARLFAMLAHPNIIALK 181
Query: 125 GAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG---I 180
C ++P + +V E G L + L R + HV +N+A+ IAR M LH +
Sbjct: 182 AVCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYLHCEALVPV 238
Query: 181 IHRDLKPDN-LLLTP------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
IHRDLK +N LLL P + K+LK+ DFGLARE T M+A GTY WMAPE+
Sbjct: 239 IHRDLKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKA 297
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293
T +G DV+SFG++LWELLT +P+ G+ L AY A +P
Sbjct: 298 STFSKGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLPIPSTCP 349
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
A ++ CW +DP+ RP F+ I++ L A
Sbjct: 350 EPFAQLMADCWAQDPHRRPDFASILQQLEAL 380
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 378 | ||||||
| 255584255 | 367 | protein kinase atn1, putative [Ricinus c | 0.965 | 0.994 | 0.832 | 0.0 | |
| 225439671 | 374 | PREDICTED: serine/threonine-protein kina | 0.986 | 0.997 | 0.802 | 1e-180 | |
| 297735553 | 337 | unnamed protein product [Vitis vinifera] | 0.886 | 0.994 | 0.851 | 1e-171 | |
| 356532165 | 370 | PREDICTED: serine/threonine-protein kina | 0.965 | 0.986 | 0.813 | 1e-171 | |
| 224139346 | 356 | predicted protein [Populus trichocarpa] | 0.910 | 0.966 | 0.814 | 1e-166 | |
| 449439809 | 373 | PREDICTED: serine/threonine-protein kina | 0.978 | 0.991 | 0.774 | 1e-165 | |
| 449521717 | 373 | PREDICTED: serine/threonine-protein kina | 0.978 | 0.991 | 0.774 | 1e-165 | |
| 388513773 | 360 | unknown [Medicago truncatula] | 0.896 | 0.941 | 0.818 | 1e-164 | |
| 357506575 | 363 | Protein kinase, putative [Medicago trunc | 0.907 | 0.944 | 0.823 | 1e-163 | |
| 217074000 | 360 | unknown [Medicago truncatula] | 0.896 | 0.941 | 0.824 | 1e-161 |
| >gi|255584255|ref|XP_002532865.1| protein kinase atn1, putative [Ricinus communis] gi|223527377|gb|EEF29519.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1665), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 314/377 (83%), Positives = 339/377 (89%), Gaps = 12/377 (3%)
Query: 1 MSCSNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAP-QLTIDRSLLVDPKL 59
MSCS+ NR GRE EQ SVE ++ + +NGS+TAP QL+ID +LLVDPKL
Sbjct: 1 MSCSSDNNNR-GRENEEQ---------SVEVQT-VITQNGSLTAPHQLSIDENLLVDPKL 49
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
LFIGSKIGEGAHGKVY+GRYGDRIVA+KVLNRGST +ERA LE RF REVNMMSRVKHDN
Sbjct: 50 LFIGSKIGEGAHGKVYQGRYGDRIVAVKVLNRGSTCEERAALENRFAREVNMMSRVKHDN 109
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
LVKF+GACK+PLMVIVTELLPGMSLRKYL+ +RPN+ DL +ALNFALDIARAMDCLHANG
Sbjct: 110 LVKFIGACKEPLMVIVTELLPGMSLRKYLIGIRPNQPDLRLALNFALDIARAMDCLHANG 169
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
IIHRDLKPDNLLLT +QKS+KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG
Sbjct: 170 IIHRDLKPDNLLLTANQKSVKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 229
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 299
EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK RP LPED SPDLAFI
Sbjct: 230 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKQERPSLPEDTSPDLAFI 289
Query: 300 VQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTEFSARAR 359
+QSCWVEDPNLRPSFSQIIRMLNAFLFTL PPS SVPES T+EAAA+SNG ++EFSARAR
Sbjct: 290 IQSCWVEDPNLRPSFSQIIRMLNAFLFTLSPPSTSVPESSTHEAAASSNGTVSEFSARAR 349
Query: 360 GKFAFLRQLFTAKRTKN 376
GKFAFLRQLFTAKR +N
Sbjct: 350 GKFAFLRQLFTAKRARN 366
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439671|ref|XP_002270753.1| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 637 bits (1642), Expect = e-180, Method: Compositional matrix adjust.
Identities = 304/379 (80%), Positives = 338/379 (89%), Gaps = 6/379 (1%)
Query: 1 MSCSNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLL 60
MSCS S G E+GE E++ ++R SVE + ++ +NGSI APQLTID +LLVDPKL+
Sbjct: 1 MSCSESN---TGGEQGEIEES--IIRNSVEVDPKSFTQNGSIMAPQLTIDENLLVDPKLI 55
Query: 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
FIGSK+GEGAHGKVYEGRYGD+IVAIKVL+RGSTS+ERA LEGRF REVNMMSRVKH+NL
Sbjct: 56 FIGSKVGEGAHGKVYEGRYGDQIVAIKVLHRGSTSEERAALEGRFAREVNMMSRVKHENL 115
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
VKF+GACKDPLMVIVTELLPGMSLRKYL S+RP ++D+HVAL+FALDIARAM+CLHANGI
Sbjct: 116 VKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPKRMDIHVALSFALDIARAMECLHANGI 175
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 240
IHRDLKPDNLLLT +QKS+KLADFGLAREE+VTEMMTAETGTYRWMAPELYSTVTLRQGE
Sbjct: 176 IHRDLKPDNLLLTANQKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGE 235
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 300
KKHYNNKVDVYSFGIV WELLTNR+PFEGMSNLQAAYAAAFK RP LPEDISPDLAFI+
Sbjct: 236 KKHYNNKVDVYSFGIVFWELLTNRMPFEGMSNLQAAYAAAFKQERPSLPEDISPDLAFII 295
Query: 301 QSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS-VPESDTNEAAATSNGAMTEFSARAR 359
QSCWVEDPN+RPSFSQIIRMLN F F + PP S + ESDTN AA +SNG MTE SAR R
Sbjct: 296 QSCWVEDPNMRPSFSQIIRMLNTFHFKVTPPPSSLLEESDTNGAAMSSNGTMTELSARTR 355
Query: 360 GKFAFLRQLFTAKRTKNLQ 378
GKF+FLRQLF AKRT+N Q
Sbjct: 356 GKFSFLRQLFAAKRTRNSQ 374
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297735553|emb|CBI18047.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1567), Expect = e-171, Method: Compositional matrix adjust.
Identities = 286/336 (85%), Positives = 311/336 (92%), Gaps = 1/336 (0%)
Query: 44 APQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEG 103
APQLTID +LLVDPKL+FIGSK+GEGAHGKVYEGRYGD+IVAIKVL+RGSTS+ERA LEG
Sbjct: 2 APQLTIDENLLVDPKLIFIGSKVGEGAHGKVYEGRYGDQIVAIKVLHRGSTSEERAALEG 61
Query: 104 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 163
RF REVNMMSRVKH+NLVKF+GACKDPLMVIVTELLPGMSLRKYL S+RP ++D+HVAL+
Sbjct: 62 RFAREVNMMSRVKHENLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPKRMDIHVALS 121
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 223
FALDIARAM+CLHANGIIHRDLKPDNLLLT +QKS+KLADFGLAREE+VTEMMTAETGTY
Sbjct: 122 FALDIARAMECLHANGIIHRDLKPDNLLLTANQKSVKLADFGLAREESVTEMMTAETGTY 181
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283
RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV WELLTNR+PFEGMSNLQAAYAAAFK
Sbjct: 182 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVFWELLTNRMPFEGMSNLQAAYAAAFKQ 241
Query: 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS-VPESDTNE 342
RP LPEDISPDLAFI+QSCWVEDPN+RPSFSQIIRMLN F F + PP S + ESDTN
Sbjct: 242 ERPSLPEDISPDLAFIIQSCWVEDPNMRPSFSQIIRMLNTFHFKVTPPPSSLLEESDTNG 301
Query: 343 AAATSNGAMTEFSARARGKFAFLRQLFTAKRTKNLQ 378
AA +SNG MTE SAR RGKF+FLRQLF AKRT+N Q
Sbjct: 302 AAMSSNGTMTELSARTRGKFSFLRQLFAAKRTRNSQ 337
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532165|ref|XP_003534644.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1562), Expect = e-171, Method: Compositional matrix adjust.
Identities = 300/369 (81%), Positives = 329/369 (89%), Gaps = 4/369 (1%)
Query: 10 RVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEG 69
R G+ EGE + + + GS E S++V +NGS+ + QLT+D +LLVDPKLLFIGSKIGEG
Sbjct: 4 REGKIEGEDRECEESVLGSTE--SKSVRENGSLASTQLTVDENLLVDPKLLFIGSKIGEG 61
Query: 70 AHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129
AHGKVYEGRYG++IVAIKVL+RGSTS+ERA LE RF REVNMMSRV HDNLVKF+GACKD
Sbjct: 62 AHGKVYEGRYGNKIVAIKVLHRGSTSEERASLENRFAREVNMMSRVHHDNLVKFIGACKD 121
Query: 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189
PLMVIVTELLPGMSLRKYL S+RP LDL VA+NFALDIARAMD LHANGIIHRDLKPDN
Sbjct: 122 PLMVIVTELLPGMSLRKYLTSIRPKLLDLDVAINFALDIARAMDWLHANGIIHRDLKPDN 181
Query: 190 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 249
LLLT DQKS+KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD
Sbjct: 182 LLLTADQKSVKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 241
Query: 250 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPN 309
VYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RPG+P+DISP+LAF++QSCWVEDPN
Sbjct: 242 VYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPGIPDDISPELAFVIQSCWVEDPN 301
Query: 310 LRPSFSQIIRMLNAFLFTLRPPSPSVPESDTN--EAAATSNGAMTEFSARARGKFAFLRQ 367
LRPSFSQIIRMLNAFLFTL PPSP +P N E A TSNG +TEFSAR RGKF FLRQ
Sbjct: 302 LRPSFSQIIRMLNAFLFTLSPPSPPLPVPPDNEPEVATTSNGTITEFSARNRGKFGFLRQ 361
Query: 368 LFTAKRTKN 376
LF++KRTKN
Sbjct: 362 LFSSKRTKN 370
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139346|ref|XP_002323067.1| predicted protein [Populus trichocarpa] gi|222867697|gb|EEF04828.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1521), Expect = e-166, Method: Compositional matrix adjust.
Identities = 289/355 (81%), Positives = 324/355 (91%), Gaps = 11/355 (3%)
Query: 26 RGSVE--KESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRI 83
RG VE ++ +V +NGSI D++LL+DPKLLFIG+KIGEGAHG+VY+GRYGD I
Sbjct: 7 RGGVEIYEQRTSVEENGSI-------DQNLLIDPKLLFIGNKIGEGAHGEVYKGRYGDLI 59
Query: 84 VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMS 143
VAIKVL+ G+TS+ERA LE RF REVNMMSRVKH+NLVKF+GACKDP MVIVTELLPGMS
Sbjct: 60 VAIKVLHPGTTSEERAALEDRFAREVNMMSRVKHENLVKFIGACKDPFMVIVTELLPGMS 119
Query: 144 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203
LRKYLVS+RP +LDL+VA+NFALD+ARAMDCLHANGIIHRDLKPDNLLLT +QKS+KLAD
Sbjct: 120 LRKYLVSIRPKQLDLYVAINFALDVARAMDCLHANGIIHRDLKPDNLLLTANQKSVKLAD 179
Query: 204 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 263
FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN
Sbjct: 180 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 239
Query: 264 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
R+PFEGMSNLQAAYAAAFK RP LPED+SPDLAFI+QSCWVEDPNLRPSF+QIIRMLNA
Sbjct: 240 RMPFEGMSNLQAAYAAAFKQERPALPEDVSPDLAFIMQSCWVEDPNLRPSFNQIIRMLNA 299
Query: 324 FLF--TLRPPSPSVPESDTNEAAATSNGAMTEFSARARGKFAFLRQLFTAKRTKN 376
FLF + P+PS+PESDTNEAA++SNG +TEFS+R RGKFAFLRQLFTAK+T+N
Sbjct: 300 FLFTLSPPSPTPSLPESDTNEAASSSNGTITEFSSRTRGKFAFLRQLFTAKKTRN 354
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439809|ref|XP_004137678.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1515), Expect = e-165, Method: Compositional matrix adjust.
Identities = 295/381 (77%), Positives = 327/381 (85%), Gaps = 11/381 (2%)
Query: 1 MSCSNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLL 60
MSC+ EKNR ++E VL + + V++NGSITA LTID +LLVDPKLL
Sbjct: 1 MSCN--EKNR---GVNDRETEHPVL---TKPHQKPVIQNGSITAQHLTIDNNLLVDPKLL 52
Query: 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
FIGSKIGEGAHGKVYEGRY + IVAIKVL+RGST +ERA LE RF REVNMMSRVKH+NL
Sbjct: 53 FIGSKIGEGAHGKVYEGRYRNEIVAIKVLHRGSTPEERAALESRFAREVNMMSRVKHENL 112
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
VKF+GACK+PLMVIVTELLPGMSLRKYL++ R +LD +A+NFALD+ARAMDCLHANGI
Sbjct: 113 VKFIGACKEPLMVIVTELLPGMSLRKYLMNNRKQQLDPRMAINFALDVARAMDCLHANGI 172
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 240
IHRDLKPDNLLLT +Q+S+KLADFGLAREE+VTEMMTAETGTYRWMAPELYSTVTLRQGE
Sbjct: 173 IHRDLKPDNLLLTANQRSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGE 232
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 300
KKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +P DISP+LAFIV
Sbjct: 233 KKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPSIPGDISPELAFIV 292
Query: 301 QSCWVEDPNLRPSFSQIIRMLNAFLFTL---RPPSPSVPESDTNEAAATSNGAMTEFSAR 357
QSCWVEDPN+RPSFSQIIRMLNA+LFTL SPS P+SDT E A TSN A+TEFS+R
Sbjct: 293 QSCWVEDPNMRPSFSQIIRMLNAYLFTLPPPSQSSPSSPKSDTTETATTSNSAITEFSSR 352
Query: 358 ARGKFAFLRQLFTAKRTKNLQ 378
ARGKF FLRQLF AKR KN Q
Sbjct: 353 ARGKFGFLRQLFAAKRAKNSQ 373
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449521717|ref|XP_004167876.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1513), Expect = e-165, Method: Compositional matrix adjust.
Identities = 295/381 (77%), Positives = 327/381 (85%), Gaps = 11/381 (2%)
Query: 1 MSCSNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLL 60
MSC+ EKNR ++E VL + + V++NGSITA LTID +LLVDPKLL
Sbjct: 1 MSCN--EKNR---GVNDRETEHPVL---TKPHQKPVIQNGSITAQHLTIDDNLLVDPKLL 52
Query: 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
FIGSKIGEGAHGKVYEGRY + IVAIKVL+RGST +ERA LE RF REVNMMSRVKH+NL
Sbjct: 53 FIGSKIGEGAHGKVYEGRYRNEIVAIKVLHRGSTPEERAALESRFAREVNMMSRVKHENL 112
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
VKF+GACK+PLMVIVTELLPGMSLRKYL++ R +LD +A+NFALD+ARAMDCLHANGI
Sbjct: 113 VKFIGACKEPLMVIVTELLPGMSLRKYLMNNRKQQLDPRMAINFALDVARAMDCLHANGI 172
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 240
IHRDLKPDNLLLT +Q+S+KLADFGLAREE+VTEMMTAETGTYRWMAPELYSTVTLRQGE
Sbjct: 173 IHRDLKPDNLLLTANQRSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGE 232
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 300
KKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +P DISP+LAFIV
Sbjct: 233 KKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPSIPGDISPELAFIV 292
Query: 301 QSCWVEDPNLRPSFSQIIRMLNAFLFTL---RPPSPSVPESDTNEAAATSNGAMTEFSAR 357
QSCWVEDPN+RPSFSQIIRMLNA+LFTL SPS P+SDT E A TSN A+TEFS+R
Sbjct: 293 QSCWVEDPNMRPSFSQIIRMLNAYLFTLPPPSQSSPSSPKSDTTETATTSNSAITEFSSR 352
Query: 358 ARGKFAFLRQLFTAKRTKNLQ 378
ARGKF FLRQLF AKR KN Q
Sbjct: 353 ARGKFGFLRQLFAAKRAKNSQ 373
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388513773|gb|AFK44948.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1504), Expect = e-164, Method: Compositional matrix adjust.
Identities = 280/342 (81%), Positives = 306/342 (89%), Gaps = 3/342 (0%)
Query: 34 RAVVKNGSIT-APQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRG 92
++V NGS+T Q TID +LLVDPKLLFIGSKIGEGAHGKVY+GRY D+IVAIKVL RG
Sbjct: 18 KSVRSNGSLTNTTQFTIDENLLVDPKLLFIGSKIGEGAHGKVYQGRYVDQIVAIKVLQRG 77
Query: 93 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLR 152
+TS+ERA LE RF REVNMMSRV HDNLVKF+GACKDPLMVIVTELLPGMSLRKYL S+R
Sbjct: 78 TTSEERASLENRFAREVNMMSRVHHDNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIR 137
Query: 153 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212
P LD+HVA+NFALDIARAMD LH NGIIHRDLKPDNLLLT +QKS+KLADFGLAREE+V
Sbjct: 138 PKPLDIHVAINFALDIARAMDWLHDNGIIHRDLKPDNLLLTANQKSVKLADFGLAREESV 197
Query: 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSN
Sbjct: 198 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSN 257
Query: 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332
LQAAYAAAFK RP +P+DISPDLAF++QSCWVEDPNLRPSFSQIIRMLN FLFTL P
Sbjct: 258 LQAAYAAAFKQERPKIPDDISPDLAFVIQSCWVEDPNLRPSFSQIIRMLNEFLFTLSPLF 317
Query: 333 PSVPESDTNEAAATS--NGAMTEFSARARGKFAFLRQLFTAK 372
P +PE D AAT+ NGA+TEFSAR +GKFAF RQLF++K
Sbjct: 318 PPLPEPDNEPKAATTSNNGAITEFSARNKGKFAFFRQLFSSK 359
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357506575|ref|XP_003623576.1| Protein kinase, putative [Medicago truncatula] gi|355498591|gb|AES79794.1| Protein kinase, putative [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 579 bits (1493), Expect = e-163, Method: Compositional matrix adjust.
Identities = 285/346 (82%), Positives = 311/346 (89%), Gaps = 3/346 (0%)
Query: 34 RAVVKNGSIT-APQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRG 92
++V NGS+T Q TID +LLVDPKLLFIGSKIGEGAHGKVY+GRY D+IVAIKVL RG
Sbjct: 18 KSVRSNGSLTNTTQFTIDENLLVDPKLLFIGSKIGEGAHGKVYQGRYVDQIVAIKVLQRG 77
Query: 93 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLR 152
+TS+ERA LE RF REVNMMSRV HDNLVKF+GACKDPLMVIVTELLPGMSLRKYL S+R
Sbjct: 78 TTSEERASLENRFAREVNMMSRVHHDNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIR 137
Query: 153 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212
P LD+HVA+NFALDIARAMD LH NGIIHRDLKPDNLLLT +QKS+KLADFGLAREE+V
Sbjct: 138 PKPLDIHVAINFALDIARAMDWLHDNGIIHRDLKPDNLLLTANQKSVKLADFGLAREESV 197
Query: 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSN
Sbjct: 198 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSN 257
Query: 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332
LQAAYAAAFK RP +P+DISPDLAF++QSCWVEDPNLRPSFSQIIRMLN FLFTL P S
Sbjct: 258 LQAAYAAAFKQERPKIPDDISPDLAFVIQSCWVEDPNLRPSFSQIIRMLNEFLFTLSPLS 317
Query: 333 PSVPESDTNEAAATS--NGAMTEFSARARGKFAFLRQLFTAKRTKN 376
P +PE D AAT+ NGA+TEFSAR +GKFAFLRQLF++KR KN
Sbjct: 318 PPLPEPDNEPKAATTSNNGAITEFSARNKGKFAFLRQLFSSKRIKN 363
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|217074000|gb|ACJ85360.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1477), Expect = e-161, Method: Compositional matrix adjust.
Identities = 282/342 (82%), Positives = 308/342 (90%), Gaps = 3/342 (0%)
Query: 34 RAVVKNGSIT-APQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRG 92
++V NGS+T Q TID +LLVDPKLLFIGSKIGEGAHGKVY+GRY D+IVAIKVL RG
Sbjct: 18 KSVRSNGSLTNTTQFTIDENLLVDPKLLFIGSKIGEGAHGKVYQGRYVDQIVAIKVLQRG 77
Query: 93 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLR 152
+TS+ERA LE RF REVNMMSRV HDNLVKF+GACKDPLMVIVTELLPGMSLRKYL S+R
Sbjct: 78 TTSEERASLENRFAREVNMMSRVHHDNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIR 137
Query: 153 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212
P LD+HVA+NFALDIARAMD LH NGIIHRDLKPDNLLLT +QKS+KLADFGLAREE+V
Sbjct: 138 PKPLDIHVAINFALDIARAMDWLHDNGIIHRDLKPDNLLLTANQKSVKLADFGLAREESV 197
Query: 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSN
Sbjct: 198 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSN 257
Query: 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332
LQAAYAAAFK RP +P+DISPDLAF++QSCWVEDPNLRPSFSQIIRMLN FLFTL P S
Sbjct: 258 LQAAYAAAFKQERPKIPDDISPDLAFVIQSCWVEDPNLRPSFSQIIRMLNEFLFTLSPLS 317
Query: 333 PSVPESDTNEAAATS--NGAMTEFSARARGKFAFLRQLFTAK 372
P +PE D AAT+ NGA+TEFSAR +GKFAFLRQLF++K
Sbjct: 318 PPLPEPDNEPKAATTSNNGAITEFSARNKGKFAFLRQLFSSK 359
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 378 | ||||||
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.862 | 0.978 | 0.763 | 3.1e-131 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.772 | 0.820 | 0.627 | 1.5e-97 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.738 | 0.790 | 0.646 | 5.9e-96 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.746 | 0.815 | 0.636 | 6.8e-95 | |
| TAIR|locus:2173674 | 405 | AT5G66710 [Arabidopsis thalian | 0.801 | 0.748 | 0.467 | 3.5e-68 | |
| TAIR|locus:2101689 | 377 | AT3G50720 [Arabidopsis thalian | 0.724 | 0.726 | 0.442 | 6.6e-58 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.687 | 0.632 | 0.431 | 1.1e-55 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.687 | 0.631 | 0.431 | 3.4e-54 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.701 | 0.504 | 0.388 | 5.1e-51 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.671 | 0.441 | 0.421 | 1.2e-47 |
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1287 (458.1 bits), Expect = 3.1e-131, P = 3.1e-131
Identities = 252/330 (76%), Positives = 278/330 (84%)
Query: 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIR 107
TI+ SLLVDPKLLFIGSKIGEGAHGKVY+GRYG +IVAIKV+NRGS D+++ LE RF+R
Sbjct: 6 TIEESLLVDPKLLFIGSKIGEGAHGKVYQGRYGRQIVAIKVVNRGSKPDQQSSLESRFVR 65
Query: 108 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
EVNMMSRV+H NLVKF+GACKDPLMVIVTELLPGMSLRKYL S+RP L L +AL+FALD
Sbjct: 66 EVNMMSRVQHHNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALD 125
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMA 227
IARA+ CLHANGIIHRDLKPDNLLLT + KS+KLADFGLAR YRWMA
Sbjct: 126 IARALHCLHANGIIHRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMA 185
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287
PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP
Sbjct: 186 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPV 245
Query: 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS-VPESDTNEAAAT 346
+PE ISP LAFIVQSCWVEDPN+RPSFSQIIR+LN FL TL PP P +PE+ TN T
Sbjct: 246 MPEGISPSLAFIVQSCWVEDPNMRPSFSQIIRLLNEFLLTLTPPPPQPLPETATNR---T 302
Query: 347 SNGAMTEFSARARGKFAFLRQLFTAKRTKN 376
+ A+TEFS R +GKFAF+RQLF AKR N
Sbjct: 303 NGRAITEFSIRPKGKFAFIRQLFAAKRNIN 332
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 969 (346.2 bits), Expect = 1.5e-97, P = 1.5e-97
Identities = 184/293 (62%), Positives = 229/293 (78%)
Query: 39 NGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDER 98
+G + + +D LVDP+ LF+G KIGEGAH KVYEG+Y ++ VAIK++ RG + +E
Sbjct: 5 SGFYSNEEFELDPKWLVDPRHLFVGPKIGEGAHAKVYEGKYRNQTVAIKIIKRGESPEEI 64
Query: 99 ALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL 158
A + RF RE+ M+S+V+H NLVKF+GACK+P+MVIVTELL G +LRKYLVSLRP +LD+
Sbjct: 65 AKRDNRFAREIAMLSKVQHKNLVKFIGACKEPMMVIVTELLLGGTLRKYLVSLRPKRLDI 124
Query: 159 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 218
+A+ FALDIARAM+CLH++GIIHRDLKP+NL+L+ D K++KLADFGLAR
Sbjct: 125 RLAVGFALDIARAMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTEMMTA 184
Query: 219 XXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
YRWMAPELYSTVTLRQGEKKHYN+KVD YSF IVLWEL+ N+LPFEGMSNLQAAYA
Sbjct: 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVLWELILNKLPFEGMSNLQAAYA 244
Query: 279 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331
AAFK+ RP ED+ DL IV SCW EDPN RP+F++II+ML +L T+ P
Sbjct: 245 AAFKNLRPSA-EDLPGDLEMIVTSCWKEDPNERPNFTEIIQMLLRYLTTVSAP 296
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 954 (340.9 bits), Expect = 5.9e-96, P = 5.9e-96
Identities = 181/280 (64%), Positives = 223/280 (79%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIRE 108
+D +VDP+ LF+G KIGEGAH K+YEG+Y ++ VAIK++ RG + +E A E RF RE
Sbjct: 15 LDPKWVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGESPEEIAKRESRFARE 74
Query: 109 VNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
V+M+SRV+H NLVKF+GACK+P+MVIVTELL G +LRKYLVSLRP LD+ VA+ +ALDI
Sbjct: 75 VSMLSRVQHKNLVKFIGACKEPIMVIVTELLLGGTLRKYLVSLRPGSLDIRVAVGYALDI 134
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAP 228
ARAM+CLH++G+IHRDLKP++L+LT D K++KLADFGLAR YRWMAP
Sbjct: 135 ARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEMMTAETGTYRWMAP 194
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288
ELYSTVTLR GEKKHYN+KVD YSF IVLWEL+ N+LPFEGMSNLQAAYAAAFK+ RP
Sbjct: 195 ELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSA 254
Query: 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328
+D+ DLA IV SCW EDPN RP+F++II+ML L T+
Sbjct: 255 -DDLPKDLAMIVTSCWKEDPNDRPNFTEIIQMLLRCLSTI 293
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 944 (337.4 bits), Expect = 6.8e-95, P = 6.8e-95
Identities = 180/283 (63%), Positives = 221/283 (78%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
+DP+LLF+G KIGEGAH KVYEG+Y ++ VAIK+++RG T +E A + RF+REV M+SR
Sbjct: 15 IDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGETPEEIAKRDSRFLREVEMLSR 74
Query: 115 VKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
V+H NLVKF+GACK+P+MVIVTELL G +LRKYL++LRP L+ VA+ FALDIAR M+C
Sbjct: 75 VQHKNLVKFIGACKEPVMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALDIARGMEC 134
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTV 234
LH++GIIHRDLKP+NLLLT D K++KLADFGLAR YRWMAPELYSTV
Sbjct: 135 LHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 194
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294
TLR GEKKHYN+KVD YSF IVLWELL N+LPFEGMSNLQAAYAAAFK+ RP E +
Sbjct: 195 TLRLGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ESLPE 253
Query: 295 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 337
+L IV SCW EDPN RP+F+ II +L +L + P ++P+
Sbjct: 254 ELGDIVTSCWNEDPNARPNFTHIIELLLNYLSKVGSPISAIPQ 296
|
|
| TAIR|locus:2173674 AT5G66710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 692 (248.7 bits), Expect = 3.5e-68, P = 3.5e-68
Identities = 144/308 (46%), Positives = 203/308 (65%)
Query: 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFI 106
TI+ LLVD K + IG IGEG+ VY G + + V++K+ TS +F
Sbjct: 59 TINTELLVDVKDISIGDFIGEGSSSTVYRGLFRRVVPVSVKIFQPKRTSALSIEQRKKFQ 118
Query: 107 REVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
REV ++S+ +H+N+V+F+GAC +P ++I+TEL+ G +L+K+++S+RP LDL ++++FAL
Sbjct: 119 REVLLLSKFRHENIVRFIGACIEPKLMIITELMEGNTLQKFMLSVRPKPLDLKLSISFAL 178
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWM 226
DIAR M+ L+ANGIIHRDLKP N+LLT DQK +KLADFGLAR YRWM
Sbjct: 179 DIARGMEFLNANGIIHRDLKPSNMLLTGDQKHVKLADFGLAREETKGFMTFEAGT-YRWM 237
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286
APEL+S TL GEKKHY++KVDVYSF IV WELLTN+ PF+G +N+ AYAA+ K+ RP
Sbjct: 238 APELFSYDTLEIGEKKHYDHKVDVYSFAIVFWELLTNKTPFKGKNNIFVAYAAS-KNQRP 296
Query: 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE-SDTNEAAA 345
+ E++ + I+QSCW E+P+ RP F +I L L +L + + S N A
Sbjct: 297 SV-ENLPEGVVSILQSCWAENPDARPEFKEITYSLTNLLRSLSSDTDATSSNSKANIATE 355
Query: 346 TSNGAMTE 353
S ++ +
Sbjct: 356 DSTSSLVQ 363
|
|
| TAIR|locus:2101689 AT3G50720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 595 (214.5 bits), Expect = 6.6e-58, P = 6.6e-58
Identities = 123/278 (44%), Positives = 179/278 (64%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIR 107
I R LL++PK + G IGEG + VY+GR + + VA+K++ G TS + +F +
Sbjct: 37 ISRELLLNPKDIMRGEMIGEGGNSIVYKGRLKNIVPVAVKIVQPGKTSAVSIQDKQQFQK 96
Query: 108 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
EV ++S +KH+N+V+F+GAC +P ++IVTEL+ G +L++++++ RP+ LDL V+L+FALD
Sbjct: 97 EVLVLSSMKHENIVRFVGACIEPQLMIVTELVRGGTLQRFMLNSRPSPLDLKVSLSFALD 156
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMA 227
I+RAM+ LH+ GIIHRDL P N+L+T D K +KLADFGLAR YRWMA
Sbjct: 157 ISRAMEYLHSKGIIHRDLNPRNVLVTGDMKHVKLADFGLAREKTLGGMTCEAGT-YRWMA 215
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287
PE+ S LR GEKKHY+ K+DVYSF ++ W LLTN+ PF + ++ Y + RP
Sbjct: 216 PEVCSREPLRIGEKKHYDQKIDVYSFALIFWSLLTNKTPFSEIPSISIPYFVN-QGKRPS 274
Query: 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
L +I ++ I++ CW D R F I L + L
Sbjct: 275 L-SNIPDEVVPILECCWAADSKTRLEFKDITISLESLL 311
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 574 (207.1 bits), Expect = 1.1e-55, P = 1.1e-55
Identities = 117/271 (43%), Positives = 171/271 (63%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERA-LLEGRFIREVNMMS 113
+D + L +G +GA GK+Y+G Y VAIK+L R S E+A +E +F +EV+M++
Sbjct: 125 IDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQQFQQEVSMLA 184
Query: 114 RVKHDNLVKFLGACKDPLM-VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+KH N+V+F+GAC+ P++ IVTE G S+R++L + + L +A+ ALD+AR M
Sbjct: 185 NLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 244
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYS 232
+H IHRDLK DNLL++ D KS+K+ADFG+AR YRWMAPE+
Sbjct: 245 AYVHGRNFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI- 302
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292
+ + YN KVDVYSFGIVLWEL+T LPF+ M+ +QAA+A + RP +P D
Sbjct: 303 -------QHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPNDC 355
Query: 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
P L+ I+ CW +P +RP F +++++L A
Sbjct: 356 LPVLSDIMTRCWDANPEVRPCFVEVVKLLEA 386
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 560 (202.2 bits), Expect = 3.4e-54, P = 3.4e-54
Identities = 117/271 (43%), Positives = 168/271 (61%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERA-LLEGRFIREVNMMS 113
+D + L +G +GA GK+Y G Y VAIK+L R ++ E+A LE +F +EV+M++
Sbjct: 126 IDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQFQQEVSMLA 185
Query: 114 RVKHDNLVKFLGACKDPLM-VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+KH N+V+F+GAC P++ IVTE G S+R++L + + L +A+ ALD+AR M
Sbjct: 186 FLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVARGM 245
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYS 232
+H IHRDLK DNLL++ D +S+K+ADFG+AR YRWMAPE+
Sbjct: 246 AYVHERNFIHRDLKSDNLLISAD-RSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI- 303
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292
+ + Y KVDVYSFGIVLWEL+T LPF+ M+ +QAA+A + RP +P D
Sbjct: 304 -------QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPADC 356
Query: 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
P L I+ CW DP +RP F++I+ +L A
Sbjct: 357 LPVLGEIMTRCWDADPEVRPCFAEIVNLLEA 387
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 530 (191.6 bits), Expect = 5.1e-51, P = 5.1e-51
Identities = 108/278 (38%), Positives = 164/278 (58%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERAL---LEGRFIREVNM 111
VD LF G K G + ++Y G+Y D+ VA+K++ D L LE +F +EV +
Sbjct: 202 VDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLGARLEKQFTKEVTL 261
Query: 112 MSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+SR+ H N++KF+GA KDP + ++T+ LP SLR +L L L + FA+DIAR
Sbjct: 262 LSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIAR 321
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL 230
M+ +H+ IIHRDLKP+N+L+ ++ LK+ADFG+A YRWMAPE+
Sbjct: 322 GMEYIHSRRIIHRDLKPENVLID-EEFHLKIADFGIACEEEYCDMLADDPGTYRWMAPEM 380
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 290
++K + K DVYSFG+VLWE++ +P+E M+ +QAA+A K+ RP +P
Sbjct: 381 I--------KRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPG 432
Query: 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328
D + +++ CW P+ RP F QI+++L F +L
Sbjct: 433 DCPVAMKALIEQCWSVAPDKRPEFWQIVKVLEQFAISL 470
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 1.2e-47, P = 1.2e-47
Identities = 113/268 (42%), Positives = 155/268 (57%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
++ K L G KI G++G +Y+G Y + VAIKVL + LE F +EV +M +
Sbjct: 285 INLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSD---LEKEFAQEVFIMRK 341
Query: 115 VKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
V+H N+V+F+GAC K P + IVTE +PG S+ YL + L A+DI + M
Sbjct: 342 VRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQK-GVFKLPTLFKVAIDICKGMS 400
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYST 233
LH N IIHRDLK NLL+ + + +K+ADFG+AR YRWMAPE+
Sbjct: 401 YLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVI-- 457
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293
E K Y++K DV+S+GIVLWELLT +LP+E M+ LQAA K RP +P++
Sbjct: 458 ------EHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTH 511
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIRML 321
P LA +++ W D RP FS+II L
Sbjct: 512 PKLAELLERLWEHDSTQRPDFSEIIEQL 539
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00037482001 | SubName- Full=Chromosome chr8 scaffold_88, whole genome shotgun sequence; (337 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 378 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-80 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-78 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-75 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-75 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-72 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-67 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-66 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-53 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-45 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-44 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-44 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-44 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-42 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-41 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-40 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-39 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-39 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-39 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-39 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-39 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-38 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-38 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-37 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-37 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-37 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-36 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-36 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-36 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-36 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-36 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-35 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-34 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-34 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-34 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-33 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-33 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-33 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-33 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-33 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-32 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-32 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-32 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-32 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-31 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-31 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-31 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-30 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-30 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-30 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-30 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-29 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-29 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-29 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-29 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-29 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-28 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-28 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-28 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-28 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-28 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-27 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-27 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-27 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-26 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-26 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-26 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-26 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-26 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-26 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-26 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-26 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-25 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-25 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-25 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-24 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-23 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-23 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-23 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-23 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-23 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-23 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-22 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-22 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-22 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-22 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-22 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-22 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-21 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-21 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-21 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-21 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-20 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-19 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-19 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-19 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-19 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-19 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-19 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-19 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-18 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-18 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-17 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-16 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-16 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-16 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-15 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-12 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-10 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-09 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-09 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 3e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-08 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 1e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-04 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 4e-04 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 5e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 8e-80
Identities = 99/272 (36%), Positives = 152/272 (55%), Gaps = 24/272 (8%)
Query: 60 LFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
L +G K+GEGA G+VY+G + VA+K L ++ + F+RE +M
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE----FLREARIMR 56
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ H N+VK LG C ++ ++IV E +PG L YL RP +L L L+FAL IAR M
Sbjct: 57 KLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG--TYRWMAPEL 230
+ L + IHRDL N L+ + +K++DFGL+R+ + + G RWMAPE
Sbjct: 117 EYLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE- 174
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLP 289
+L++G+ + +K DV+SFG++LWE+ T P+ GMSN + K R P
Sbjct: 175 ----SLKEGK---FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-VLEYLKKGYRLPKP 226
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
+ P+L ++ CW EDP RP+FS+++ +L
Sbjct: 227 PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 1e-78
Identities = 96/274 (35%), Positives = 149/274 (54%), Gaps = 29/274 (10%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRI------VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
L +G K+GEGA G+VY+G+ + VA+K L ++ + F+RE +M
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE----FLREARIMR 56
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFALDIAR 170
++ H N+VK LG C ++ + IV E + G L YL RP L ++ L+FAL IAR
Sbjct: 57 KLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIAR 113
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG--TYRWMAP 228
M+ L + IHRDL N L+ + +K++DFGL+R+ + G RWMAP
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAP 172
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG 287
E +L++G+ + +K DV+SFG++LWE+ T P+ GMSN + R
Sbjct: 173 E-----SLKEGK---FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLP 223
Query: 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
P + P+L ++ CW EDP RP+FS+++ +L
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 234 bits (599), Expect = 1e-75
Identities = 95/272 (34%), Positives = 145/272 (53%), Gaps = 28/272 (10%)
Query: 62 IGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV 115
+G K+GEGA G+VY+G + VA+K L G++ +ER F+ E ++M ++
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEERE----EFLEEASIMKKL 58
Query: 116 KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
H N+V+ LG C +PL IVTE +PG L +L KL L L AL IA+ M+
Sbjct: 59 SHPNIVRLLGVCTQGEPLY-IVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGME 116
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPEL 230
L + +HRDL N L+T + +K++DFGL+R+ + G +WMAPE
Sbjct: 117 YLESKNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLP 289
L+ G+ + +K DV+SFG++LWE+ T P+ GMSN + R P
Sbjct: 176 -----LKDGK---FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLELLEDGYRLPRP 226
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
E+ +L ++ CW DP RP+FS+++ L
Sbjct: 227 ENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 3e-75
Identities = 90/264 (34%), Positives = 137/264 (51%), Gaps = 20/264 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I K+GEG+ GKVY R ++VAIKV+ + +R R +RE+ ++ ++KH N
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE----RILREIKILKKLKHPN 58
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V+ +D + +V E G L L +L A + I A++ LH+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG--RLSEDEARFYLRQILSALEYLHSK 116
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
GI+HRDLKP+N+LL D +KLADFGLAR+ E +T GT +MAPE+
Sbjct: 117 GIVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL------ 169
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDL 296
K Y VD++S G++L+ELLT + PF G L + K P P DISP+
Sbjct: 170 --GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEA 227
Query: 297 AFIVQSCWVEDPNLRPSFSQIIRM 320
+++ V+DP R + + ++
Sbjct: 228 KDLIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 225 bits (577), Expect = 3e-72
Identities = 95/275 (34%), Positives = 147/275 (53%), Gaps = 33/275 (12%)
Query: 65 KIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
K+GEGA G+VY+G+ VA+K L ++ +ER F++E +M ++ H N
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD----FLKEARVMKKLGHPN 57
Query: 120 LVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP-------NKLDLHVALNFALDIAR 170
+V+ LG C ++PL +V E + G L YL RP + L L L+FA+ IA+
Sbjct: 58 VVRLLGVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMA 227
M+ L + +HRDL N L+ D +K++DFGL+R+ + +TG RWMA
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARP 286
PE +L+ G + +K DV+SFG++LWE+ T P+ G+SN + K R
Sbjct: 176 PE-----SLKDG---IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VLEYLRKGYRL 226
Query: 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
PE +L ++ SCW DP RP+FS+++ L
Sbjct: 227 PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 8e-67
Identities = 79/260 (30%), Positives = 122/260 (46%), Gaps = 49/260 (18%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+GEG G VY R + VAIK++ + +S +RE+ ++ ++ H N+VK
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL----EELLREIEILKKLNHPNIVKL 56
Query: 124 LGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
G +D + +V E G SL+ L KL L L I ++ LH+NGIIH
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-GTYRWMAPELYSTVTLRQGEK 241
RDLKP+N+LL D +KLADFGL++ T + + GT +MAPE+ K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL-------GK 168
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 301
+Y+ K D++S G++L+EL P+L +++
Sbjct: 169 GYYSEKSDIWSLGVILYEL---------------------------------PELKDLIR 195
Query: 302 SCWVEDPNLRPSFSQIIRML 321
+DP RPS +I+ L
Sbjct: 196 KMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 210 bits (538), Expect = 2e-66
Identities = 90/266 (33%), Positives = 142/266 (53%), Gaps = 24/266 (9%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ K+G G+ G VY+ ++ +IVA+K+L + E++ + RE+ ++ R+ H N
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK---RSEKSKKDQTARREIRILRRLSHPN 59
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V+ + A +D + +V E G L YL P L A AL I R ++ LH+N
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN 117
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLR 237
GIIHRDLKP+N+LL + +K+ADFGLA++ + +T GT +MAPE+ L
Sbjct: 118 GIIHRDLKPENILLDENG-VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV-----LL 171
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED------ 291
G Y KVDV+S G++L+ELLT + PF G N+ + P L D
Sbjct: 172 GG--NGYGPKVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSS 228
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQI 317
S + +++ C +DP+ RP+ +I
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 2e-53
Identities = 80/265 (30%), Positives = 125/265 (47%), Gaps = 27/265 (10%)
Query: 63 GSKIGEGAHGKVYEGRYGD--RIVAIKV--LNRGSTSDERALLEGRFIREVNMMSRVKHD 118
G +G G+ G VY D ++A+K L+ S + AL RE+ ++S ++H
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE-----REIRILSSLQHP 59
Query: 119 NLVKFLGACKDPLMV---IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
N+V++ G+ +D I E + G SL L KL V + I + L
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYL 117
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYS 232
H+NGI+HRD+K N+L+ D +KLADFG A+ + E + GT WMAPE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-- 174
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-YAAAFKHARPGLPED 291
+R E Y D++S G + E+ T + P+ + N AA Y P +PE
Sbjct: 175 ---IRGEE---YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH 228
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQ 316
+S + ++ C DP RP+ +
Sbjct: 229 LSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-45
Identities = 89/275 (32%), Positives = 144/275 (52%), Gaps = 28/275 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+DP L ++G G G V+ G++ G VAIK++ G+ S++ FI E +M
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD------FIEEAKVMM 54
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ H NLV+ G C K + IVTE + L YL R KL L+ D+ AM
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDMCSDVCEAM 113
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE 229
+ L +NG IHRDL N L+ + +K++DFGLAR + + T+ GT +W PE
Sbjct: 114 EYLESNGFIHRDLAARNCLVG-EDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPE 171
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA--YAAAFKHARP 286
++ +++K DV+SFG+++WE+ + ++P+E SN + +A ++ RP
Sbjct: 172 VFD--------YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRP 223
Query: 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
L ++ I+ SCW E P RP+F +++ L
Sbjct: 224 KL---APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 7e-45
Identities = 74/263 (28%), Positives = 133/263 (50%), Gaps = 21/263 (7%)
Query: 65 KIGEGAHGKVY--EGRYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
+IG+G+ GKVY + ++ +K ++ + ER + EV ++ ++ H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE----DALNEVKILKKLNHPNII 62
Query: 122 KFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDIARAMDCLHAN 178
K+ + ++ + IV E G L + + + L++ + + A+ LH+
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLR 237
I+HRD+KP N+ LT + +KL DFG+++ + ++ GT +++PEL
Sbjct: 123 KILHRDIKPQNIFLTSNGL-VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC------ 175
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 297
+ K YN K D++S G VL+EL T + PFEG + L+ A P +P S +L
Sbjct: 176 --QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-IPSQYSSELR 232
Query: 298 FIVQSCWVEDPNLRPSFSQIIRM 320
+V S +DP RPS +QI++
Sbjct: 233 NLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-44
Identities = 86/290 (29%), Positives = 141/290 (48%), Gaps = 40/290 (13%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI--------VAIKVLNRGSTSDERALLEGRFI 106
+ + + + ++G+G+ G VYEG + VAIK +N ++ ER +E F+
Sbjct: 3 LPREKITLIRELGQGSFGMVYEG-LAKGVVKGEPETRVAIKTVNENASMRER--IE--FL 57
Query: 107 REVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNK--------L 156
E ++M ++V+ LG P +V++ EL+ L+ YL S RP
Sbjct: 58 NEASVMKEFNCHHVVRLLGVVSTGQPTLVVM-ELMAKGDLKSYLRSRRPEAENNPGLGPP 116
Query: 157 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216
L + A +IA M L A +HRDL N ++ D ++K+ DFG+ R+ T+
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYY 175
Query: 217 TAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
RWMAPE +L+ G + K DV+SFG+VLWE+ T P++G+SN
Sbjct: 176 RKGGKGLLPVRWMAPE-----SLKDG---VFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227
Query: 273 LQA-AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
+ + H LPE+ L +++ CW +P +RP+F +I+ L
Sbjct: 228 EEVLKFVIDGGHLD--LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-44
Identities = 92/277 (33%), Positives = 144/277 (51%), Gaps = 26/277 (9%)
Query: 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
++ K L +G+ IG+G G V G Y + VA+K L ST+ + F+ E ++M
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQA------FLAEASVM 54
Query: 113 SRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+ ++H NLV+ LG +PL IVTE + SL YL S + L L FALD+
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLY-IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAP 228
M+ L +HRDL N+L++ + K++DFGLA+E + + ++G +W AP
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAP 168
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG 287
E LR +K ++ K DV+SFGI+LWE+ + R+P+ + L+ K R
Sbjct: 169 E-----ALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPHVEKGYRME 219
Query: 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
PE P++ +++ CW DP RP+F Q+ L
Sbjct: 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-44
Identities = 87/262 (33%), Positives = 136/262 (51%), Gaps = 25/262 (9%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I KIG+G G+VY+ R+ + VAIKV+ S + + I E+ ++ + KH N
Sbjct: 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI-----INEIQILKKCKHPN 58
Query: 120 LVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL-HVALNFALDIARAMDCLH 176
+VK+ G+ KD L IV E G SL+ L+ L +A ++ + ++ LH
Sbjct: 59 IVKYYGSYLKKDELW-IVMEFCSGGSLKD-LLKSTNQTLTESQIAY-VCKELLKGLEYLH 115
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
+NGIIHRD+K N+LLT D + +KL DFGL+ + + T+ GT WMAPE+ +
Sbjct: 116 SNGIIHRDIKAANILLTSDGE-VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN---- 170
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISP 294
K Y+ K D++S GI EL + P+ + ++A + A PGL PE S
Sbjct: 171 ----GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSD 225
Query: 295 DLAFIVQSCWVEDPNLRPSFSQ 316
+ ++ C ++P RP+ Q
Sbjct: 226 EFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 156 bits (393), Expect = 7e-44
Identities = 88/288 (30%), Positives = 139/288 (48%), Gaps = 25/288 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH-DNL 120
I K+GEG+ G+VY R ++VA+KVL + S + + RF+RE+ +++ + H N+
Sbjct: 4 ILRKLGEGSFGEVYLARD-RKLVALKVLAKKLESKSKEVE--RFLREIQILASLNHPPNI 60
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFALDIARAMDCLHAN 178
VK +D + +V E + G SL L + R L AL I A++ LH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE-------ETVTEMMTAETGTYRWMAPELY 231
GIIHRD+KP+N+LL D + +KL DFGLA+ ++ + + GT +MAPE+
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV- 179
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291
L + ++ D++S GI L+ELLT PFEG N A + K
Sbjct: 180 ----LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-ATSQTLKIILELPTPS 234
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESD 339
++ L+ + + S +++ L A R S S D
Sbjct: 235 LASPLSPSNP------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 83/275 (30%), Positives = 133/275 (48%), Gaps = 32/275 (11%)
Query: 56 DPKLLFI-GSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNM 111
DP+ L+ KIGEGA G+VY+ G VAIK + + E I E+ +
Sbjct: 16 DPRELYKNLEKIGEGASGEVYKATDRATGKE-VAIKKMRLRKQNKELI------INEILI 68
Query: 112 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
M KH N+V + + + +V E + G SL +++ +++ ++ +
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQIAYVCREVLQ 127
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPE 229
++ LH+ +IHRD+K DN+LL+ D S+KLADFG A + T + GT WMAPE
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289
+ +K Y KVD++S GI+ E+ P+ L+A + K G+P
Sbjct: 187 VIK--------RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK----GIP 234
Query: 290 -----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
E SP+ + C V+DP RPS ++++
Sbjct: 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 6e-41
Identities = 95/272 (34%), Positives = 135/272 (49%), Gaps = 35/272 (12%)
Query: 65 KIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
KIG+G G VY+G VA+K D + +F++E ++ + H N+VK
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR----KFLQEAEILKQYDHPNIVKL 57
Query: 124 LGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFALDIARAMDCLHANG 179
+G C K P+ IV EL+PG SL +L R K L V L +LD A M+ L +
Sbjct: 58 IGVCVQKQPIY-IVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT----YRWMAPELYSTVT 235
IHRDL N L+ + LK++DFG++REE + T G +W APE
Sbjct: 114 CIHRDLAARNCLVG-ENNVLKISDFGMSREEE-GGIYTVSDGLKQIPIKWTAPE-----A 166
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA--AYAAAFKHARPGL-PED 291
L G Y ++ DV+S+GI+LWE + P+ GMSN Q + ++ P L PE+
Sbjct: 167 LNYGR---YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEE 223
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
I ++ CW DP RPSFS+I L
Sbjct: 224 IYR----LMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 8e-40
Identities = 84/276 (30%), Positives = 125/276 (45%), Gaps = 41/276 (14%)
Query: 65 KIGEGAHGKVYEGRY----GDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
K+G+G+ G V G + G I VA+K L SD + F++E +M + H+N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD----IMDDFLKEAAIMHSLDHEN 57
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLD---LHVALNFALDIARAMDCLH 176
L++ G +++VTEL P SL L LR + L + ++A+ IA M L
Sbjct: 58 LIRLYGVVLTHPLMMVTELAPLGSL---LDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR----------WM 226
+ IHRDL N+LL D K +K+ DFGL R E Y W
Sbjct: 115 SKRFIHRDLAARNILLASDDK-VKIGDFGLMRALPQNEDH------YVMEEHLKVPFAWC 167
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 285
APE T T +++ DV+ FG+ LWE+ T P+ G+S Q + R
Sbjct: 168 APESLRTRT--------FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER 219
Query: 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
PE D+ ++ CW +P RP+F+ + L
Sbjct: 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 88/268 (32%), Positives = 138/268 (51%), Gaps = 40/268 (14%)
Query: 65 KIGEGAHGKVYEG---RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
K+G G +G+VYEG +Y VA+K L E + F++E +M +KH NLV
Sbjct: 13 KLGGGQYGEVYEGVWKKY-SLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 122 KFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ LG C ++P I+TE + +L YL +++ V L A I+ AM+ L
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--------YRWMAPE--L 230
IHRDL N L+ + +K+ADFGL+R +MT +T T +W APE
Sbjct: 126 IHRDLAARNCLVG-ENHLVKVADFGLSR------LMTGDTYTAHAGAKFPIKWTAPESLA 178
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAAAFKHARPGLP 289
Y+ ++ K DV++FG++LWE+ T + P+ G+ +L Y K R P
Sbjct: 179 YNK----------FSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKGYRMERP 227
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQI 317
E P + ++++CW +P+ RPSF++I
Sbjct: 228 EGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 90/269 (33%), Positives = 134/269 (49%), Gaps = 29/269 (10%)
Query: 65 KIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
K+G G G+V+ G + G VA+K L G+ S E F++E +M +++HD LV+
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA------FLQEAQIMKKLRHDKLVQL 66
Query: 124 LGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
C ++P+ IVTE + SL +L S KL L ++ A IA M L + I
Sbjct: 67 YAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYI 125
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYSTVTL 236
HRDL N+L+ + K+ADFGLAR E TA G +W APE Y T+
Sbjct: 126 HRDLAARNILVG-ENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295
K DV+SFGI+L E++T R+P+ GM+N + + P P + +
Sbjct: 184 ----------KSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP-RPPNCPEE 232
Query: 296 LAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
L ++ CW +DP RP+F + L +
Sbjct: 233 LYDLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 86/276 (31%), Positives = 138/276 (50%), Gaps = 26/276 (9%)
Query: 57 PKLLF-IGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
P+ F + K+G G G+V+EG + +R+ VAIK+L + L + F +EV + R
Sbjct: 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS-----DDLLKQQDFQKEVQALKR 58
Query: 115 VKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++H +L+ C +P+ I+TEL+ SL +L S L + ++ A +A M
Sbjct: 59 LRHKHLISLFAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGT-YRWMAPE 229
L IHRDL N+L+ + K+ADFGLAR +E V ++++ Y+W APE
Sbjct: 118 AYLEEQNSIHRDLAARNILVG-EDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPE 174
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL 288
S ++ K DV+SFGI+L+E+ T ++P+ GM+N Y R
Sbjct: 175 AAS--------HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HEVYDQITAGYRMPC 225
Query: 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
P ++ I+ CW +P RPSF + L+
Sbjct: 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 4e-39
Identities = 82/277 (29%), Positives = 137/277 (49%), Gaps = 27/277 (9%)
Query: 60 LFIGSKIGEGAHGKVYEGRY---GDRI---VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
L +G GA G VY+G + G+++ VAIKVL + +A E + E +M+
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKE--ILDEAYVMA 64
Query: 114 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
V H ++V+ LG C + ++T+L+P L Y+ + + N + LN+ + IA+ M
Sbjct: 65 SVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKGMS 123
Query: 174 CLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARE-ETVTEMMTAETGTY--RWMAPE 229
L ++HRDL N+L+ TP +K+ DFGLA+ + + AE G +WMA E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL 288
++ Y +K DV+S+G+ +WEL+T P+EG+ K R
Sbjct: 182 -----SILHRI---YTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQ 232
Query: 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
P + D+ ++ CW+ D RP+F ++I +
Sbjct: 233 PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-39
Identities = 90/285 (31%), Positives = 142/285 (49%), Gaps = 45/285 (15%)
Query: 66 IGEGAHGKVYEGRYGDRI--------VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
+G GA G+VYEG D + VA+K L +G+T E+ F++E ++MS H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK----EFLKEAHLMSNFNH 58
Query: 118 DNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNK-----LDLHVALNFALDIAR 170
N+VK LG C +P +I+ EL+ G L YL R + L L L+ LD+A+
Sbjct: 59 PNIVKLLGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKS----LKLADFGLAREETVTEMMTAETG---TY 223
L IHRDL N L++ +K+ DFGLAR+ ++ E
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282
RWMAPE +L G+ + + DV+SFG+++WE+LT + P+ ++N + +
Sbjct: 178 RWMAPE-----SLLDGK---FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV-----LQ 224
Query: 283 HARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
H G PE+ + ++ +CW +DP+ RP+F +I +L
Sbjct: 225 HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 90/275 (32%), Positives = 139/275 (50%), Gaps = 35/275 (12%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIR 107
IDR+ + +LL K+G G G+V+EG + + VA+K L G+ + F+
Sbjct: 3 IDRTSI---QLL---RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD------FLA 50
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
E +M +++H L++ C ++P + IVTEL+ SL +YL L L ++ A
Sbjct: 51 EAQIMKKLRHPKLIQLYAVCTLEEP-IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA 109
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--- 222
+A M L A IHRDL N+L+ + K+ADFGLAR ++ A G
Sbjct: 110 AQVASGMAYLEAQNYIHRDLAARNVLVG-ENNICKVADFGLAR-VIKEDIYEAREGAKFP 167
Query: 223 YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279
+W APE LY+ ++ K DV+SFGI+L E++T R+P+ GM+N +
Sbjct: 168 IKWTAPEAALYNRFSI----------KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
Query: 280 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 314
+ P P +L I+ CW EDP+ RP+F
Sbjct: 218 DQGYRMP-CPPGCPKELYDIMLDCWKEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 79/251 (31%), Positives = 125/251 (49%), Gaps = 21/251 (8%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G+G+ GKV R D ++ A+KVL + + + + E N++SR+ H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVE--HTLTERNILSRINHPFIVKL 58
Query: 124 LGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
A + + +V E PG L +L + A +A +I A++ LH+ GII+
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGE 240
RDLKP+N+LL +KL DFGLA+E +E T GT ++APE V L +G
Sbjct: 117 RDLKPENILLD-ADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPE----VLLGKG- 169
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 300
Y VD +S G++L+E+LT + PF + + Y PE +SP+ ++
Sbjct: 170 ---YGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIY-EKILKDPLRFPEFLSPEARDLI 224
Query: 301 QSCWVEDPNLR 311
+DP R
Sbjct: 225 SGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 80/267 (29%), Positives = 126/267 (47%), Gaps = 25/267 (9%)
Query: 63 GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
G+KIG G GKVY D ++A+K + D E+ ++ +KH NL
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIR---IQDNDPKTIKEIADEMKVLELLKHPNL 61
Query: 121 VKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
VK+ G + I E G +L + L R LD HV + L + + LH++G
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFG----LAREETVT-EMMTAETGTYRWMAPELYSTV 234
I+HRD+KP N+ L +KL DFG L T E + + GT +MAPE+
Sbjct: 120 IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI--- 175
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPE--D 291
G+ K + D++S G V+ E+ T + P+ + N Q + H +P +P+
Sbjct: 176 --TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQ 232
Query: 292 ISPD-LAFIVQSCWVEDPNLRPSFSQI 317
+SP+ F+ + C DP RP+ S++
Sbjct: 233 LSPEGKDFLDR-CLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 8e-38
Identities = 83/284 (29%), Positives = 137/284 (48%), Gaps = 31/284 (10%)
Query: 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY----GDRI-VAIKVLNRGSTSDERALLE 102
I R + +G IGEG G VY+G Y ++I VA+K ++ R
Sbjct: 2 EIQREDIT------LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVRE--- 52
Query: 103 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 162
+F++E +M + H ++VK +G + + IV EL P LR YL + LDL +
Sbjct: 53 -KFLQEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLI 110
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETG 221
++ ++ A+ L + +HRD+ N+L+ +PD +KL DFGL+R A G
Sbjct: 111 LYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD--CVKLGDFGLSRYLEDESYYKASKG 168
Query: 222 TY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278
+WMAPE ++ R+ + + DV+ FG+ +WE+L PF+G+ N
Sbjct: 169 KLPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIG 219
Query: 279 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322
R +P + P L ++ CW DP+ RP F+++ L+
Sbjct: 220 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 76/268 (28%), Positives = 125/268 (46%), Gaps = 30/268 (11%)
Query: 66 IGEGAHGKVYEGRY----GDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
+G G G V +G Y G + VA+K L + + A + F+RE ++M+++ H +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ----EHIAAGKKEFLREASVMAQLDHPCI 58
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
V+ +G CK +++V EL P L KYL R + A +A M L +
Sbjct: 59 VRLIGVCKGEPLMLVMELAPLGPLLKYLKK-RREIPVSDL-KELAHQVAMGMAYLESKHF 116
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETG---TYRWMAPEL--YSTV 234
+HRDL N+LL ++ K++DFG++R ++ A T +W APE Y
Sbjct: 117 VHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK- 174
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293
+++K DV+S+G+ LWE + P+ M + A R PE+
Sbjct: 175 ---------FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESGERLPRPEECP 224
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIRML 321
++ I+ SCW P RP+FS++
Sbjct: 225 QEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 6e-37
Identities = 87/275 (31%), Positives = 142/275 (51%), Gaps = 28/275 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
++P L ++G G G V+ G++ +I VAIK +N G+ S+E FI E +M
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED------FIEEAKVMM 54
Query: 114 RVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
++ H LV+ G C + PL IVTE + L YL R KL + L+ D+
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLY-IVTEFMENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEG 112
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPE 229
M+ L N IHRDL N L++ +K++DFG+ R E ++ + +W PE
Sbjct: 113 MEYLERNSFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPE 171
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQA--AYAAAFKHARP 286
+++ Y++K DV+SFG+++WE+ T ++PFE SN + + F+ RP
Sbjct: 172 VFNF--------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP 223
Query: 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
L S + ++ SCW E P RP+F++++R +
Sbjct: 224 KLA---SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 9e-37
Identities = 91/290 (31%), Positives = 133/290 (45%), Gaps = 43/290 (14%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREV 109
+DP + I IG G G+V GR + VAIK L GS+ +R F+ E
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL----DFLTEA 56
Query: 110 NMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFA 165
++M + H N+++ G P+M I+TE + SL K+L R N V +
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVM-IITEYMENGSLDKFL---RENDGKFTVGQLVGML 112
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY-- 223
IA M L +HRDL N+L+ + K++DFGL+R +E TY
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVC-KVSDFGLSRRLEDSE------ATYTT 165
Query: 224 -------RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275
RW APE + R + + DV+SFGIV+WE+++ P+ MSN Q
Sbjct: 166 KGGKIPIRWTAPE---AIAYR-----KFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QD 216
Query: 276 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
A R P D L ++ CW +D N RP+FSQI+ L+ +
Sbjct: 217 VIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-36
Identities = 84/293 (28%), Positives = 133/293 (45%), Gaps = 53/293 (18%)
Query: 64 SKIGEGAHGKVYEGRY---GDR---IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++GEG GKV RY GD VA+K LN R+ E RE+ ++ + H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE----REIEILRTLDH 65
Query: 118 DNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+N+VK+ G C+ P + ++ E LP SLR YL R ++L L F+ I + MD
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDY 124
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----------R 224
L + IHRDL N+L+ + +K++DFGLA+ ++ + Y
Sbjct: 125 LGSQRYIHRDLAARNILVESE-DLVKISDFGLAK------VLPEDKDYYYVKEPGESPIF 177
Query: 225 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----NRLPFEGMSNLQAAYAAA 280
W APE T +++ DV+SFG+ L+EL T ++ P +
Sbjct: 178 WYAPECLRTSK--------FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229
Query: 281 FKHAR--------PGLPE-DISPDLAF-IVQSCWVEDPNLRPSFSQIIRMLNA 323
R LP PD + +++ CW +P RPSF+ +I +++
Sbjct: 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 5e-36
Identities = 84/271 (30%), Positives = 139/271 (51%), Gaps = 24/271 (8%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
L++ + L +G IGEG G V +G Y + VA+K + T+ F+ E +M+
Sbjct: 2 LLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA-------FLEETAVMT 54
Query: 114 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
++ H NLV+ LG + IV EL+ +L +L + + + L F+LD+A M+
Sbjct: 55 KLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPELY 231
L + ++HRDL N+L++ D + K++DFGLAR M + +W APE
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVA-KVSDFGLAR----VGSMGVDNSKLPVKWTAPE-- 167
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290
L+ + +++K DV+S+G++LWE+ + R P+ MS L+ K R PE
Sbjct: 168 ---ALKHKK---FSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPPE 220
Query: 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
D+ ++ SCW +P RPSF ++ L
Sbjct: 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 6e-36
Identities = 83/269 (30%), Positives = 133/269 (49%), Gaps = 31/269 (11%)
Query: 63 GSKIGEGAHGKVYEGRYGDR--IVAIK---VLNRGSTSDER-ALLEGRFIREVNMMSRVK 116
G +G G+ G VYEG D A+K + + G T E LE +E+ ++S+++
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE----QEIALLSKLQ 60
Query: 117 HDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
H N+V++LG + D L I EL+PG SL K L V + I ++
Sbjct: 61 HPNIVQYLGTEREEDNLY-IFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEY 117
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
LH +HRD+K N+L+ + +KLADFG+A++ + G+ WMAPE V
Sbjct: 118 LHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE----V 172
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----PGLPE 290
+QG Y D++S G + E+ T + P+ S L+ AA FK R P +P+
Sbjct: 173 IAQQGG---YGLAADIWSLGCTVLEMATGKPPW---SQLEG-VAAVFKIGRSKELPPIPD 225
Query: 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+S + + C DP+LRP+ ++++
Sbjct: 226 HLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 7e-36
Identities = 76/222 (34%), Positives = 113/222 (50%), Gaps = 35/222 (15%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVL-----NRG--STSDERALLEGRFIREVNMMSRV 115
K+GEG +G VY+ R IVA+K + G ST+ +RE++++ +
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA----------LREISLLKEL 55
Query: 116 KHDNLVKFLG-ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
KH N+VK L + + +V E M L+KYL RP L ++ + + R +
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGT--YRWMAPELY 231
H++ I+HRDLKP N+L+ D LKLADFGLAR + T E T YR APE+
Sbjct: 114 CHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRTYTHEVVTLWYR--APEIL 170
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
G KHY+ VD++S G + E++T + F G S +
Sbjct: 171 ------LGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 8e-36
Identities = 95/314 (30%), Positives = 151/314 (48%), Gaps = 59/314 (18%)
Query: 45 PQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDE 97
P+ + R L +G +GEGA G+V + VA+K+L +T E
Sbjct: 5 PEWELPRDRLT------LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--E 56
Query: 98 RALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP- 153
+ L + + E+ MM + KH N++ LG C + PL V+V E +LR +L + RP
Sbjct: 57 KDLSD--LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPP 113
Query: 154 ----NKLDLHVA---------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
+ D ++FA +AR M+ L + IHRDL N+L+T D +K
Sbjct: 114 GEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMK 172
Query: 201 LADFGLAREETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIV 256
+ADFGLAR+ + T +WMAPE L+ V Y ++ DV+SFG++
Sbjct: 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVL 223
Query: 257 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLR 311
LWE+ T P+ G+ FK + G P++ + +L +++ CW E P+ R
Sbjct: 224 LWEIFTLGGSPYPGI-----PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQR 278
Query: 312 PSFSQIIRMLNAFL 325
P+F Q++ L+ L
Sbjct: 279 PTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 86/257 (33%), Positives = 136/257 (52%), Gaps = 26/257 (10%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125
IG+G G V G Y VA+K + +T+ F+ E ++M++++H NLV+ LG
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-------FLAEASVMTQLRHSNLVQLLG 66
Query: 126 AC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
+ + IVTE + SL YL S + L L F+LD+ AM+ L AN +HR
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 184 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPELYSTVTLRQGEK 241
DL N+L++ D + K++DFGL +E + T+ +TG +W APE LR+
Sbjct: 127 DLAARNVLVSEDNVA-KVSDFGLTKEASSTQ----DTGKLPVKWTAPE-----ALRE--- 173
Query: 242 KHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 300
K ++ K DV+SFGI+LWE+ + R+P+ + L+ K + P+ P + ++
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPVVYDVM 232
Query: 301 QSCWVEDPNLRPSFSQI 317
+ CW D RPSF Q+
Sbjct: 233 KQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-35
Identities = 89/272 (32%), Positives = 135/272 (49%), Gaps = 36/272 (13%)
Query: 65 KIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
K+G G G+V+ G Y G VAIK L +GS S E F+ E N+M +++H LV+
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA------FLAEANLMKQLQHPRLVRL 66
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
+ I+TE + SL +L + KL ++ ++ A IA M + IHR
Sbjct: 67 YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 184 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPEL--YSTVTLRQG 239
DL+ N+L++ + K+ADFGLAR E E + +W APE Y T T+
Sbjct: 127 DLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI--- 182
Query: 240 EKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS------NLQAAYAAAFKHARPGLPEDI 292
K DV+SFGI+L E++T R+P+ GM+ NL+ Y R P++
Sbjct: 183 -------KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-------RMPRPDNC 228
Query: 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
+L +++ CW E P RP+F + +L F
Sbjct: 229 PEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 85/265 (32%), Positives = 135/265 (50%), Gaps = 25/265 (9%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G IG GA G VY+G VAIK ++ E AL ++E++++ +KH N
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISL-EKIKEEALKS--IMQEIDLLKNLKHPN 60
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+VK++G+ + + I+ E SLR+ + + + + + + + LH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAPELYSTVTLR 237
G+IHRD+K N+L T D +KLADFG+A + V++ + GT WMAPE V
Sbjct: 119 GVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPE----VIEM 173
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA---RPGLPEDISP 294
G + D++S G + ELLT P+ +L AA F+ P LPE ISP
Sbjct: 174 SG----ASTASDIWSLGCTVIELLTGNPPY---YDLNPM-AALFRIVQDDHPPLPEGISP 225
Query: 295 DLAFIVQSCWVEDPNLRPSFSQIIR 319
+L + C+ +DPNLRP+ Q+++
Sbjct: 226 ELKDFLMQCFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 77/268 (28%), Positives = 137/268 (51%), Gaps = 34/268 (12%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD---NL 120
IG GA+G VY G++ R+VA+K++N + D+ + ++ REV ++S+++ N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ----REVALLSQLRQSQPPNI 64
Query: 121 VKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDIAR----AMDC 174
K+ G+ K P + I+ E G S+R + + + ++++ I R A+
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISV-----IIREVLVALKY 116
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYST 233
+H G+IHRD+K N+L+T +KL DFG+A + + GT WMAPE+ +
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT- 174
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED-I 292
E K+Y+ K D++S GI ++E+ T P+ + +A K P L ++
Sbjct: 175 ------EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDNGY 227
Query: 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRM 320
S L V +C E+P R S ++++
Sbjct: 228 SKLLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 8e-35
Identities = 81/268 (30%), Positives = 133/268 (49%), Gaps = 26/268 (9%)
Query: 63 GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRG----STSDERALLEGRFIREVNMMSRVK 116
G +G+GA G+VY D R +A+K + T E LE E+ ++ ++
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC----EIQLLKNLQ 62
Query: 117 HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
H+ +V++ G +D + I E +PG S++ L + L V + I ++ L
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYL 120
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETV---TEMMTAETGTYRWMAPELY 231
H+N I+HRD+K N+L ++KL DFG + R +T+ M + TGT WM+PE+
Sbjct: 121 HSNMIVHRDIKGANIL-RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291
S GE Y K DV+S G + E+LT + P+ + A + A + P LP
Sbjct: 180 S------GEG--YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSH 231
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+SPD ++ +VE+ RPS +++R
Sbjct: 232 VSPDARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 74/261 (28%), Positives = 127/261 (48%), Gaps = 24/261 (9%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG+G+ G+VY+ ++VAIKV++ DE + +E+ +S+ + + K
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDI----QQEIQFLSQCRSPYITK 63
Query: 123 FLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ G+ K + I+ E G S L +P KLD ++ ++ LH G I
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLLGLEYLHEEGKI 120
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
HRD+K N+LL+ ++ +KLADFG++ + T+++ T GT WMAPE+ ++Q
Sbjct: 121 HRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTF-VGTPFWMAPEV-----IKQS 173
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED-ISPDLAF 298
Y+ K D++S GI EL P + ++ + K+ P L + S
Sbjct: 174 G---YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNKFSKPFKD 229
Query: 299 IVQSCWVEDPNLRPSFSQIIR 319
V C +DP RPS ++++
Sbjct: 230 FVSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 87/275 (31%), Positives = 139/275 (50%), Gaps = 28/275 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ P L + +IG G G V+ G + R VAIK + G+ S+E FI E +M
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED------FIEEAQVMM 54
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ H LV+ G C + + +V E + L YL + R K L LD+ M
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGM 113
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE 229
L ++ +IHRDL N L+ +Q +K++DFG+ R + + T+ TGT +W +PE
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPE 171
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAA--YAAAFKHARP 286
++S Y++K DV+SFG+++WE+ + + P+E SN + A F+ +P
Sbjct: 172 VFSF--------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP 223
Query: 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
L S + ++Q CW E P RPSFS ++ L
Sbjct: 224 RL---ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 6e-34
Identities = 85/272 (31%), Positives = 132/272 (48%), Gaps = 28/272 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+DPK L ++G G G V G++ G VAIK++ GS S E FI E +M
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMM 54
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ H+ LV+ G C K + IVTE + L YL + L D+ M
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGM 113
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE 229
L + IHRDL N L+ DQ +K++DFGL+R + + T+ G+ RW PE
Sbjct: 114 AYLESKQFIHRDLAARNCLVD-DQGCVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPE 171
Query: 230 --LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 286
LYS +++K DV++FG+++WE+ + ++P+E +N + + R
Sbjct: 172 VLLYSK----------FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL-RL 220
Query: 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 318
P S + I+ SCW E RP+F Q++
Sbjct: 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 8e-34
Identities = 87/289 (30%), Positives = 130/289 (44%), Gaps = 52/289 (17%)
Query: 66 IGEGAHGKVYEGR------YGDR-IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+GEGA GKV+ G D+ +VA+K L +++D R F RE +++ +H+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK----DFEREAELLTNFQHE 68
Query: 119 NLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN------------KLDLHVALNF 164
N+VKF G C DP + +V E + L K+L S P+ +L L L
Sbjct: 69 NIVKFYGVCTEGDPPI-MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY- 223
A+ IA M L + +HRDL N L+ D +K+ DFG++R+ T+ T
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDL-VVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 224 --RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278
RWM PE +Y T DV+SFG+VLWE+ T + P+ G+SN +
Sbjct: 187 PIRWMPPESIMYRKFTTES----------DVWSFGVVLWEIFTYGKQPWYGLSNEE---- 232
Query: 279 AAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
+ G P ++ I+ CW DP R + I L
Sbjct: 233 -VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 94/280 (33%), Positives = 143/280 (51%), Gaps = 36/280 (12%)
Query: 60 LFIGSKIGEGAHGKVYEGR-YG----DRI--VAIKVLNRGSTSDERALLEGRFIREVNMM 112
L G +G GA GKV E YG D + VA+K+L + S ER L + E+ +M
Sbjct: 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL----MSELKIM 92
Query: 113 SRV-KHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
S + H+N+V LGAC P++VI TE L +L R + L L L+F+ +A
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVI-TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWM 226
+ M L + IHRDL N+LLT K +K+ DFGLAR+ + +WM
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 227 APE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGM---SNLQAAYAAAF 281
APE +++ V Y + DV+S+GI+LWE+ + P+ GM S +
Sbjct: 211 APESIFNCV---------YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY 261
Query: 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
+ A+P E ++ I+++CW DP RP+F QI++++
Sbjct: 262 RMAQP---EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 81/290 (27%), Positives = 128/290 (44%), Gaps = 47/290 (16%)
Query: 64 SKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
KIGEG +G VY+ R IVAIK + S+ + +RE+ ++ + H N++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE---GIPKTALREIKLLKELNHPNII 61
Query: 122 KFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
K L + + +V E + L K L+ R L + ++ + + + H++GI
Sbjct: 62 KLLDVFRHKGDLYLVFEFMD-TDLYK-LIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWM-APELYSTVTLRQ 238
+HRDLKP+NLL+ + LKLADFGLAR + T T RW APEL + +
Sbjct: 120 LHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPEL--LLGDKG 175
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEG------------------------MSNLQ 274
Y+ VD++S G + ELL+ R F G ++L
Sbjct: 176 -----YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230
Query: 275 AAYAAAFKH-ARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320
Y +F A LP+ + SP ++ DP+ R + Q +
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 83/269 (30%), Positives = 126/269 (46%), Gaps = 46/269 (17%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
K+GEG++G VY+ + ++VAIKV+ E I+E++++ + +VK
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE-------IIKEISILKQCDSPYIVK 62
Query: 123 FLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD---IA-------RA 171
+ G+ K+ + IV E S+ D+ N L IA +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVS-----------DIMKITNKTLTEEEIAAILYQTLKG 111
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
++ LH+N IHRD+K N+LL + KLADFG++ + M T GT WMAPE
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPE 169
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL- 288
V G YNNK D++S GI E+ + P+ + ++A + K P L
Sbjct: 170 ----VIQEIG----YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP-PTLS 220
Query: 289 -PEDISPDLAFIVQSCWVEDPNLRPSFSQ 316
PE SP+ V+ C V+DP RPS Q
Sbjct: 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 88/274 (32%), Positives = 136/274 (49%), Gaps = 42/274 (15%)
Query: 66 IGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFL 124
+G+G G+V++G D+ VA+K + L+ +F+ E ++ + H N+VK +
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE----LKIKFLSEARILKQYDHPNIVKLI 58
Query: 125 GAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFALDIARAMDCLHANGI 180
G C + P+ IV EL+PG +L LR K +L + FALD A M L +
Sbjct: 59 GVCTQRQPIY-IVMELVPGGD---FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----------RWMAPEL 230
IHRDL N L+ + LK++DFG++R+E + G Y +W APE
Sbjct: 115 IHRDLAARNCLVG-ENNVLKISDFGMSRQE--------DDGIYSSSGLKQIPIKWTAPE- 164
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLP 289
L G Y+++ DV+S+GI+LWE + P+ GM+N QA K R P
Sbjct: 165 ----ALNYGR---YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCP 216
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
+ D+ ++Q CW P RP FS++ + L A
Sbjct: 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 85/267 (31%), Positives = 136/267 (50%), Gaps = 25/267 (9%)
Query: 65 KIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
K+G G G+V+ G Y + VA+K L G+ S + F+ E N+M ++HD LV+
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA------FLEEANLMKTLQHDKLVRL 66
Query: 124 LGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
K+ + I+TE + SL +L S K+ L ++F+ IA M + IH
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 126
Query: 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPEL--YSTVTLRQ 238
RDL+ N+L++ + K+ADFGLAR E E + +W APE + + T+
Sbjct: 127 RDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI-- 183
Query: 239 GEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 297
K DV+SFGI+L+E++T ++P+ GMSN A + P E+ +L
Sbjct: 184 --------KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP-RMENCPDELY 234
Query: 298 FIVQSCWVEDPNLRPSFSQIIRMLNAF 324
I+++CW E RP+F + +L+ F
Sbjct: 235 DIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 8e-33
Identities = 75/275 (27%), Positives = 130/275 (47%), Gaps = 33/275 (12%)
Query: 66 IGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+G G G+V+ + G+ +V +K L T DE E F RE++M ++ H
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ--KTKDENLQSE--FRRELDMFRKLSHK 68
Query: 119 NLVKFLGAC--KDPLMVIVTELLPGMSLRKYLV-------SLRPNKLDLHVALNFALDIA 169
N+V+ LG C +P ++ E L+++L L+P L + IA
Sbjct: 69 NVVRLLGLCREAEP-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMA 227
MD L +HRDL N L++ Q+ +K++ L+++ +E + RW+A
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARP 286
PE +++ + ++ K DV+SFG+++WE+ T LPF G+S+ +
Sbjct: 187 PE-----AVQEDD---FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238
Query: 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
+PE L ++ CW +P RPSFS+++ L
Sbjct: 239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 85/280 (30%), Positives = 128/280 (45%), Gaps = 44/280 (15%)
Query: 66 IGEGAHGKVYEG-------RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+GEGA GKVY+G R VAIK L + + F +E +MS ++H
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ----EFRQEAELMSDLQHP 68
Query: 119 NLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK--------------LDLHVALN 163
N+V LG C K+ ++ E L L ++LV P+ LD L+
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAET 220
A+ IA M+ L ++ +HRDL N L+ + ++K++DFGL+R+ + + +
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVG-EGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 221 GTYRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAY 277
RWM PE LY T D++SFG+VLWE+ + L P+ G SN +
Sbjct: 188 LPVRWMPPEAILYGKFTTES----------DIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237
Query: 278 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 317
+ P PED + ++ CW E P RP F I
Sbjct: 238 MIRSRQLLPC-PEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 89/305 (29%), Positives = 147/305 (48%), Gaps = 58/305 (19%)
Query: 60 LFIGSKIGEGAHGKVYE-------GRYGDRIVAIKVLNRGSTSDE-RALLEGRFIREVNM 111
L +G +GEG GKV + GR G VA+K+L ++S E R LL E N+
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLS-----EFNL 56
Query: 112 MSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRP---------------- 153
+ +V H +++K GAC PL++IV G SLR +L R
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG-SLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 154 ------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207
L + ++FA I+R M L ++HRDL N+L+ + + +K++DFGL+
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA-EGRKMKISDFGLS 174
Query: 208 R---EETVTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 262
R EE + +WMA E L+ + Y + DV+SFG++LWE++T
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHI---------YTTQSDVWSFGVLLWEIVTL 225
Query: 263 NRLPFEGMS--NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320
P+ G++ L ++ RP E+ S ++ ++ +CW ++P+ RP+F+ I +
Sbjct: 226 GGNPYPGIAPERLFNLLKTGYRMERP---ENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282
Query: 321 LNAFL 325
L +
Sbjct: 283 LEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-32
Identities = 75/268 (27%), Positives = 128/268 (47%), Gaps = 31/268 (11%)
Query: 62 IGSKIGEGAHGKVYE-GRYGD-RIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVKHD 118
+ K+G+G++G VY+ R D + A+K ++ GS S ER + E+ +++ V H
Sbjct: 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE----DAVNEIRILASVNHP 59
Query: 119 NLVK----FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAM 172
N++ FL K + IV E P L K + + + + + + R +
Sbjct: 60 NIISYKEAFLDGNK---LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 173 DCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMT-AETGTYRWMAPEL 230
LH I+HRDLK N+LL D +K+ D G+++ + + M + GT +MAPE+
Sbjct: 117 QALHEQKILHRDLKSANILLVANDL--VKIGDLGISK--VLKKNMAKTQIGTPHYMAPEV 172
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 290
+ + Y+ K D++S G +L+E+ T PFE S +Q + P +P
Sbjct: 173 WK--------GRPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPP 223
Query: 291 DISPDLAFIVQSCWVEDPNLRPSFSQII 318
S DL ++S P LRP+ +I+
Sbjct: 224 IYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 85/269 (31%), Positives = 137/269 (50%), Gaps = 28/269 (10%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+IG G G+V+ GR + VA+K D L+ +F++E ++ + H N+V+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD----LKAKFLQEARILKQYSHPNIVR 57
Query: 123 FLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+G C K P+ IV EL+ G +L + P +L + + + A M+ L +
Sbjct: 58 LIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGP-RLKVKELIQMVENAAAGMEYLESKHC 115
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR-----WMAPELYSTVT 235
IHRDL N L+T ++ LK++DFG++REE + + A TG + W APE
Sbjct: 116 IHRDLAARNCLVT-EKNVLKISDFGMSREEE--DGVYASTGGMKQIPVKWTAPE-----A 167
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294
L G Y+++ DV+SFGI+LWE + +P+ +SN Q A + R PE
Sbjct: 168 LNYGR---YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPD 223
Query: 295 DLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
+ +++ CW DP RPSFS + + L +
Sbjct: 224 AVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 7e-32
Identities = 88/262 (33%), Positives = 129/262 (49%), Gaps = 26/262 (9%)
Query: 60 LFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
L + K+G G G+V+ G + G+ VA+K L G+ S E F+ E +M +++HD
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES------FLEEAQIMKKLRHD 61
Query: 119 NLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
LV+ + + IVTE + SL +L L L ++ A +A M +
Sbjct: 62 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYST 233
IHRDL+ N+L+ D K+ADFGLAR E TA G +W APE LY
Sbjct: 122 NYIHRDLRSANILVG-DGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGR 179
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDI 292
T+ K DV+SFGI+L EL+T R+P+ GM+N + + P P+D
Sbjct: 180 FTI----------KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP-CPQDC 228
Query: 293 SPDLAFIVQSCWVEDPNLRPSF 314
L ++ CW +DP RP+F
Sbjct: 229 PISLHELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 30/271 (11%)
Query: 65 KIGEGAHGKVYE-GRYGD-RIVAIKVLNRGS-TSDERALLEGRFIREVNMMSRVKHDNLV 121
IG+G+ G V + R D +I+ K ++ G+ T E+ L + EVN++ +KH N+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL----VSEVNILRELKHPNIV 62
Query: 122 KFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLH 176
++ D + IV E G L + + + + ++ + A+ H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 177 -----ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
N ++HRDLKP N+ L ++KL DFGLA+ + A+T GT +M+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPE 180
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289
+ Y+ K D++S G +++EL PF + LQ A R +P
Sbjct: 181 QLN--------HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR-IP 231
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320
S +L +++S DP+ RPS +++++
Sbjct: 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 80/267 (29%), Positives = 126/267 (47%), Gaps = 31/267 (11%)
Query: 66 IGEGAHGKVYEGR---YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
I +GA+G+V+ + GD I AIKV+ + + + + + E +++S+ + +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGD-IYAIKVIKKADMIRKNQV--DQVLTERDILSQAQSPYVVK 57
Query: 123 FLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ + +V E LPG L L ++ LD VA + +I A++ LH+NGII
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE---------TGTYRWMAPELYS 232
HRDLKPDN+L+ + LKL DFGL++ V + GT ++APE
Sbjct: 116 HRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE--- 171
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAFKHARPGLPE 290
V L QG ++ VD +S G +L+E L PF G + + K P E
Sbjct: 172 -VILGQG----HSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVE 225
Query: 291 DISPDLAFIVQSCWVEDPNLRPSFSQI 317
+S + ++ V DP R I
Sbjct: 226 -VSDEAIDLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 84/294 (28%), Positives = 129/294 (43%), Gaps = 44/294 (14%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY----GDRI---VAIKVLNRGSTSDERALLEGRFIR 107
V + + +G GA G+VYEG Y GD + VA+K L E F+
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL----PESCSEQDESDFLM 58
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-----KLDLHV 160
E +MS+ H N+V+ +G + P I+ EL+ G L+ +L RP L +
Sbjct: 59 EALIMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKD 117
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETVTE---- 214
L A D+A+ L N IHRD+ N LLT + K+ADFG+AR+
Sbjct: 118 LLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 215 ----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269
M+ +WM PE + + +K DV+SFG++LWE+ + +P+ G
Sbjct: 178 GGRAMLPI-----KWMPPEAFLDGI--------FTSKTDVWSFGVLLWEIFSLGYMPYPG 224
Query: 270 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
+N Q R P+ + I+ CW P RP+F+ I+ +
Sbjct: 225 RTN-QEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 69/255 (27%), Positives = 121/255 (47%), Gaps = 19/255 (7%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG+GA GKV + D ++ A+K +N+ ++ ++ + E ++ + H LV
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSV--RNVLNERRILQELNHPFLVNL 65
Query: 124 LGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
+ + M +V +LL G LR +L + K + +I A++ LH+ GIIH
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLALEYLHSKGIIH 123
Query: 183 RDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
RD+KPDN+LL D++ + + DF +A + T + T+ +GT +MAPE+
Sbjct: 124 RDIKPDNILL--DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR-------- 173
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPEDISPDLAFIV 300
+ Y+ VD +S G+ +E L + P+ G S ++ A + A P S + +
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233
Query: 301 QSCWVEDPNLRPSFS 315
DP R +
Sbjct: 234 NKLLERDPQKRLGDN 248
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 77/273 (28%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G+G+ G VY+ R+ +I A+K ++ + R L RE+ + +
Sbjct: 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL----RELKTLRSCESPY 60
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSL---RKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
+VK GA + IV E + G SL K + + L A I + +D L
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYL 115
Query: 176 HAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYS 232
H IIHRD+KP NLL+ +K+ADFG+++ E T+ + T GT +M+PE
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE--- 170
Query: 233 TVTLR-QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH----ARPG 287
R QGE Y+ D++S G+ L E + PF Q ++ + P
Sbjct: 171 ----RIQGE--SYSYAADIWSLGLTLLECALGKFPFL--PPGQPSFFELMQAICDGPPPS 222
Query: 288 LPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
LP + SP+ + +C +DP RPS +++++
Sbjct: 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 17/257 (6%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G GA G V+ + ++V IK + T DER + E ++ + H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQN----ECQVLKLLSHPNIIE 63
Query: 123 FLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ +D ++IV E PG +L +Y+ + LD L+F + I A+ +H I+
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
HRDLK N+LL + +K+ DFG+++ + GT +++PEL E
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC--------EG 175
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 301
K YN K D+++ G VL+EL + + FE +NL A + + SPDL ++
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKIMSGTFAPISDRYSPDLRQLIL 234
Query: 302 SCWVEDPNLRPSFSQII 318
S DP+ RP SQI+
Sbjct: 235 SMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 89/302 (29%), Positives = 142/302 (47%), Gaps = 59/302 (19%)
Query: 65 KIGEGAHGKVYEGRYGDRI-------VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++G+G+ G VYEG D I VA+K +N ++ ER F+ E ++M
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI----EFLNEASVMKGFTC 68
Query: 118 DNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD--------LHVALNFALDI 168
++V+ LG K ++V EL+ L+ YL SLRP + L + A +I
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR---- 224
A M L+A +HRDL N ++ D ++K+ DFG+ R+ ET YR
Sbjct: 129 ADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTRD-------IYETDYYRKGGK 180
Query: 225 ------WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 277
WMAPE +L+ G + D++SFG+VLWE+ + P++G+SN Q
Sbjct: 181 GLLPVRWMAPE-----SLKDGVFTTSS---DMWSFGVVLWEITSLAEQPYQGLSNEQV-- 230
Query: 278 AAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 333
K G P++ + +++ CW +P +RP+F +I+ +L L P P
Sbjct: 231 ---LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD---DLHPSFP 284
Query: 334 SV 335
V
Sbjct: 285 EV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-30
Identities = 87/296 (29%), Positives = 131/296 (44%), Gaps = 53/296 (17%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRI-----VAIKVLN-RGSTSDERALLEGRFIREVNMMS 113
L +G +GEG G V EG+ VA+K + T E +E F+ E M
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE---IEE-FLSEAACMK 56
Query: 114 RVKHDNLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLR----PNKLDLHVAL 162
H N++K +G C K P +++ + L +L+ R P KL L L
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222
F +DIA M+ L IHRDL N +L D + +ADFGL++ +G
Sbjct: 117 KFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT-VCVADFGLSK--------KIYSGD 167
Query: 223 Y-----------RWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269
Y +W+A E L V Y +K DV++FG+ +WE+ T + P+ G
Sbjct: 168 YYRQGRIAKMPVKWIAIESLADRV---------YTSKSDVWAFGVTMWEIATRGQTPYPG 218
Query: 270 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+ N + Y R PED +L ++ SCW DP RP+F+++ +L L
Sbjct: 219 VENHE-IYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-30
Identities = 83/295 (28%), Positives = 135/295 (45%), Gaps = 60/295 (20%)
Query: 66 IGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
IG+GA G+V++ R +VA+K+L +++D +A F RE +M+ H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA----DFQREAALMAEFDHP 68
Query: 119 NLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP------------------NKLDL 158
N+VK LG C P+ ++ + G L ++L P N L L
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYG-DLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 159 HVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216
L A +A M L +HRDL N L+ + +K+ADFGL+R +
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIYSADYY 186
Query: 217 TAETGTY---RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGM 270
A RWM PE Y+ Y + DV+++G+VLWE+ + + P+ GM
Sbjct: 187 KASENDAIPIRWMPPESIFYN----------RYTTESDVWAYGVVLWEIFSYGMQPYYGM 236
Query: 271 SNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
++ + Y + R G P++ +L +++ CW + P+ RPSF+ I R+L
Sbjct: 237 AHEEVIY-----YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-29
Identities = 83/268 (30%), Positives = 134/268 (50%), Gaps = 22/268 (8%)
Query: 63 GSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIRE-VNMMSRVKHDNL 120
G +G+GA+G VY G +++A+K + +++ A E ++E V+++ +KH N+
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 121 VKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V++LG C D + I E +PG S+ L P L V + I + LH N
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNC 122
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLARE-------ETVTEMMTAETGTYRWMAPELYS 232
++HRD+K +N++L P+ +KL DFG AR T + M+ + GT WMAPE+ +
Sbjct: 123 VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-AAFKHARPGLPED 291
+ Y K D++S G ++E+ T + P M L A + A + P LP+
Sbjct: 182 --------ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDS 233
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
S V SC D + RPS Q++R
Sbjct: 234 FSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 77/263 (29%), Positives = 125/263 (47%), Gaps = 23/263 (8%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G+G +G VY R +AIK + + + L E E+ + S +KH N+V++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE-----EIALHSYLKHRNIVQY 70
Query: 124 LGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF-ALDIARAMDCLHANGII 181
LG+ ++ I E +PG SL L S D + F I + LH N I+
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 182 HRDLKPDNLLLTPDQKSLKLADFG----LAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
HRD+K DN+L+ +K++DFG LA TE TGT ++MAPE+ +
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TGTLQYMAPEV-----ID 182
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-YAAAFKHARPGLPEDISPDL 296
+G + Y D++S G + E+ T + PF + QAA + P +PE +S +
Sbjct: 183 KGPRG-YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEA 241
Query: 297 AFIVQSCWVEDPNLRPSFSQIIR 319
+ C+ DP+ R S +++
Sbjct: 242 KNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 79/264 (29%), Positives = 125/264 (47%), Gaps = 26/264 (9%)
Query: 63 GSKIGEGAHGKVYEGR--YGDRIVAIKVLN--RGSTSDERALLEGRFIREVNMMSRVKHD 118
G ++G GA Y+ R ++A+K + R ++S++ ++E +E+ +M+R+ H
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVE-ALRKEIRLMARLNHP 63
Query: 119 NLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
++++ LGA C+D + E + G S+ L V +N+ + R + LH
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHE 121
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-----TGTYRWMAPELYS 232
N IIHRD+K NLL+ + L++ADFG A E GT +MAPE+
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV-- 179
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----PGL 288
LR GE+ Y DV+S G V+ E+ T + P+ A FK A P +
Sbjct: 180 ---LR-GEQ--YGRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSI 232
Query: 289 PEDISPDLAFIVQSCWVEDPNLRP 312
PE +SP L + C P RP
Sbjct: 233 PEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-29
Identities = 86/266 (32%), Positives = 128/266 (48%), Gaps = 24/266 (9%)
Query: 65 KIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
K+G+G G+V+ G + G VAIK L G+ E F++E +M +++HD LV
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA------FLQEAQIMKKLRHDKLVPL 66
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
+ + IVTE + SL +L L L ++ A IA M + IHR
Sbjct: 67 YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126
Query: 184 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPE--LYSTVTLRQG 239
DL+ N+L+ D K+ADFGLAR E + + +W APE LY T+
Sbjct: 127 DLRAANILVG-DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI--- 182
Query: 240 EKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298
K DV+SFGI+L EL+T R+P+ GM N + + P P+ L
Sbjct: 183 -------KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP-CPQGCPESLHE 234
Query: 299 IVQSCWVEDPNLRPSFSQIIRMLNAF 324
+++ CW +DP+ RP+F I L +
Sbjct: 235 LMKLCWKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
L ++G ++G G G V + + +I+A+K + + + +RE++++ +
Sbjct: 3 LEYLG-ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK----QILRELDILHKCN 57
Query: 117 HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
+V F GA + + I E + G SL K L ++ ++ + A+ + + + L
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYL 116
Query: 176 HAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
H IIHRD+KP N+L+ + +KL DFG++ + V + GT +MAPE
Sbjct: 117 HEKHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQ-LVNSLAKTFVGTSSYMAPE----- 169
Query: 235 TLR-QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF-------KHARP 286
R QG Y+ K D++S G+ L EL T R P+ F P
Sbjct: 170 --RIQGN--DYSVKSDIWSLGLSLIELATGRFPY---PPENDPPDGIFELLQYIVNEPPP 222
Query: 287 GLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQI 317
LP SPD V C ++DP RPS+ ++
Sbjct: 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 80/267 (29%), Positives = 136/267 (50%), Gaps = 23/267 (8%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I ++G+GA GKVY+ + A K++ S +E LE F+ E++++S KH N
Sbjct: 9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEE---LED-FMVEIDILSECKHPN 63
Query: 120 LVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSL-RP-NKLDLHVALNFALDIARAMDCLH 176
+V A + + I+ E G +L ++ L R + + L+ A++ LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE---ALNFLH 120
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTV 234
++ +IHRDLK N+LLT D +KLADFG++ + + + +T GT WMAPE+ +
Sbjct: 121 SHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNK-STLQKRDTFIGTPYWMAPEVVACE 178
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDI 292
T + Y+ K D++S GI L EL P ++ ++ K P L P
Sbjct: 179 TFKD---NPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-KSEPPTLDQPSKW 234
Query: 293 SPDLAFIVQSCWVEDPNLRPSFSQIIR 319
S ++SC V+DP+ RP+ +++++
Sbjct: 235 SSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 91/297 (30%), Positives = 147/297 (49%), Gaps = 47/297 (15%)
Query: 60 LFIGSKIGEGAHGKV-------YEGRYGDRI--VAIKVLNRGSTSDERALLEGRFIREVN 110
L +G +GEG G+V + +R+ VA+K+L +T + + L I E+
Sbjct: 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDL----ISEME 75
Query: 111 MMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRP-------------- 153
MM + KH N++ LGAC PL VIV E +LR+YL + RP
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPE 134
Query: 154 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213
+L ++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLAR+
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHI 193
Query: 214 EMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 268
+ T +WMAPE L+ + Y ++ DV+SFG++LWE+ T P+
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTLGGSPYP 244
Query: 269 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+ L
Sbjct: 245 GVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 19/260 (7%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
KIG+G+ G V++ R+ A+K ++ ER I E +++++ ++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE----EAIDEARVLAKLDSSYII 62
Query: 122 KFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
++ + + IV E L K L R L F + I + LH+ I
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI 122
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
+HRD+K NL L ++K+ D G+A+ T GT +++PEL
Sbjct: 123 LHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC-------- 173
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 299
E K YN K DV++ G+VL+E T + PF+ +N A + P + + S LA +
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFPPVSQMYSQQLAQL 232
Query: 300 VQSCWVEDPNLRPSFSQIIR 319
+ C +D RP Q++R
Sbjct: 233 IDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 8e-29
Identities = 98/310 (31%), Positives = 150/310 (48%), Gaps = 53/310 (17%)
Query: 53 LLVDPKL------LFIGSKIGEGAHGKVYE----GRYGDR-----IVAIKVLNRGSTSDE 97
L DPK L +G +GEG G+V G D+ VA+K+L +T +
Sbjct: 1 LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD 60
Query: 98 RALLEGRFIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPN 154
+ L + E+ MM + KH N++ LGAC PL V+V G +LR+YL + RP
Sbjct: 61 LSDL----VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKG-NLREYLRARRPP 115
Query: 155 KLDLHV--------ALNF------ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
+D L F A +AR M+ L + IHRDL N+L+T D +K
Sbjct: 116 GMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN-VMK 174
Query: 201 LADFGLAREETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIV 256
+ADFGLAR+ + T +WMAPE L+ V Y ++ DV+SFG++
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVL 225
Query: 257 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 315
LWE+ T P+ G+ ++ + + R P + + +L I++ CW P+ RP+F
Sbjct: 226 LWEIFTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFK 284
Query: 316 QIIRMLNAFL 325
Q++ L+ L
Sbjct: 285 QLVEDLDRVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-29
Identities = 68/282 (24%), Positives = 117/282 (41%), Gaps = 48/282 (17%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HD 118
G IGEG+ V + ++ AIK+L++ E+ E +++R+ H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK--VKYVKIEKEVLTRLNGHP 62
Query: 119 NLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDCLH 176
++K +D + V E P L +Y+ R LD +A +I A++ LH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET---------------- 220
+ GIIHRDLKP+N+LL D +K+ DFG A+ +
Sbjct: 120 SKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 221 -----GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--- 272
GT +++PEL + +K D+++ G +++++LT + PF G +
Sbjct: 179 FASFVGTAEYVSPELLN--------EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
Query: 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 314
Q + P + PD +++ V DP R
Sbjct: 231 FQKILKLEYS-----FPPNFPPDAKDLIEKLLVLDPQDRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 92/313 (29%), Positives = 137/313 (43%), Gaps = 60/313 (19%)
Query: 63 GSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
G K+GEG + VY+ R RIVAIK + G + + + +RE+ ++ +KH N+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 121 VKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFALDIARAMDCLHA 177
+ L + +V E + L K + + + L A ++ L R ++ LH+
Sbjct: 65 IGLLDVFGHKSNINLVFEFMET-DLEKVI---KDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWM-APEL-YSTV 234
N I+HRDLKP+NLL+ D LKLADFGLAR + MT + T RW APEL +
Sbjct: 121 NWILHRDLKPNNLLIASDGV-LKLADFGLARSFGSPNRKMTHQVVT-RWYRAPELLFGA- 177
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF-------------------------EG 269
+HY VD++S G + ELL R+PF G
Sbjct: 178 -------RHYGVGVDMWSVGCIFAELL-LRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 270 MSNLQAAYAAAFKHARPGLPED-----ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
+++L FK P P S D ++Q +PN R + Q L
Sbjct: 230 VTSLP--DYVEFKP-FPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ---ALEHP 283
Query: 325 LFTLRPPSPSVPE 337
F+ P P+ P
Sbjct: 284 YFSNDPA-PTPPS 295
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 75/274 (27%), Positives = 120/274 (43%), Gaps = 37/274 (13%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLN---RGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG GA VY + VAIK ++ ++ DE +EV MS+ H N
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE-------LRKEVQAMSQCNHPN 60
Query: 120 LVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDCLHA 177
+VK+ + + +V L G SL + S P LD + ++ + ++ LH+
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAET---GTYRWMAPELYS 232
NG IHRD+K N+LL D S+K+ADFG++ + GT WMAPE+
Sbjct: 121 NGQIHRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA--YAAAFKHARPGLPE 290
+ Y+ K D++SFGI EL T P+ S ++ P L
Sbjct: 180 -------QVHGYDFKADIWSFGITAIELATGAAPY---SKYPPMKVLMLTLQNDPPSLET 229
Query: 291 DISPDL---AF--IVQSCWVEDPNLRPSFSQIIR 319
+F ++ C +DP+ RP+ ++++
Sbjct: 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 90/268 (33%), Positives = 132/268 (49%), Gaps = 28/268 (10%)
Query: 65 KIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
K+G G G+V+ Y VA+K + GS S E F+ E N+M ++HD LVK
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA------FLAEANVMKTLQHDKLVKL 66
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
+ I+TE + SL +L S +K L ++F+ IA M + IHR
Sbjct: 67 HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 184 DLKPDNLLLTPDQKSL--KLADFGLAREETVTEMMTAETGTY--RWMAPEL--YSTVTLR 237
DL+ N+L++ SL K+ADFGLAR E E + +W APE + + T+
Sbjct: 127 DLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI- 182
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDL 296
K DV+SFGI+L E++T R+P+ GMSN + A + P PE+ +L
Sbjct: 183 ---------KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-RPENCPEEL 232
Query: 297 AFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
I+ CW P RP+F I +L+ F
Sbjct: 233 YNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 70/273 (25%), Positives = 134/273 (49%), Gaps = 26/273 (9%)
Query: 63 GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFI-----REVNMMSRV 115
G IG+G +G+VY ++A+K + +T R + + E+ + +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 116 KHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
H N+V++LG + I E +PG S+ L + + + F + +
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE----TVTEMMTAETGTYRWMAPEL 230
LH+ GI+HRDLK DNLL+ D K++DFG++++ + M+ + G+ WMAPE+
Sbjct: 124 LHSKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEV 181
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 290
+ + Y+ KVD++S G V+ E+ R P+ + A + K + P +P
Sbjct: 182 IHS------YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235
Query: 291 DISPDLAFI----VQSCWVEDPNLRPSFSQIIR 319
D+S +L+ + + +C+ +P+ RP+ ++++
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 85/267 (31%), Positives = 128/267 (47%), Gaps = 28/267 (10%)
Query: 65 KIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
K+G+G G+V+ G + G VAIK L G+ S E F++E +M +++H+ LV+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 66
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
+ + IVTE + SL +L L L ++ A IA M + +HR
Sbjct: 67 YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126
Query: 184 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPE--LYSTVTLRQG 239
DL+ N+L+ + K+ADFGLAR E + + +W APE LY T+
Sbjct: 127 DLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI--- 182
Query: 240 EKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298
K DV+SFGI+L EL T R+P+ GM N + + P P + L
Sbjct: 183 -------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHD 234
Query: 299 IVQSCWVEDPNLRPSFSQIIRMLNAFL 325
++ CW ++P RP+F L AFL
Sbjct: 235 LMCQCWRKEPEERPTF----EYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 91/280 (32%), Positives = 139/280 (49%), Gaps = 46/280 (16%)
Query: 65 KIGEGAHGKVYEGRYGDRI-------VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++G+G+ G VYEG + VAIK +N ++ ER F+ E ++M
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI----EFLNEASVMKEFNC 68
Query: 118 DNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLD--------LHVALNFALD 167
++V+ LG P +VI+ EL+ L+ YL SLRP + L + A +
Sbjct: 69 HHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG-----T 222
IA M L+AN +HRDL N ++ D ++K+ DFG+ R+ + E G
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRD--IYETDYYRKGGKGLLP 184
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281
RWM+PE +L+ G + DV+SFG+VLWE+ T P++GMSN Q
Sbjct: 185 VRWMSPE-----SLKDGV---FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM- 235
Query: 282 KHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSFSQII 318
GL + D PD+ F +++ CW +P +RPSF +II
Sbjct: 236 ---EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 96/301 (31%), Positives = 143/301 (47%), Gaps = 55/301 (18%)
Query: 60 LFIGSKIGEGAHGKVYEGR-YG------DRI--VAIKVLNRGSTSDERALLEGRFIREVN 110
L +G +GEG G+V YG D+ VA+K+L +T + A L I E+
Sbjct: 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADL----ISEME 69
Query: 111 MMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHV------- 160
+M + KH N++ LG C PL VIV E +LR++L + RP D
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 161 -ALNF------ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213
L+F A +AR M+ L + IHRDL N+L+T D +K+ADFGLAR
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN-VMKIADFGLARGVHDI 187
Query: 214 EMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 268
+ + +WMAPE L+ V Y ++ DV+SFGI++WE+ T P+
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGILMWEIFTLGGSPYP 238
Query: 269 GMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
G+ FK R G P + + +L +++ CW P RP+F Q++ L+
Sbjct: 239 GIP-----VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
Query: 325 L 325
L
Sbjct: 294 L 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-28
Identities = 86/286 (30%), Positives = 134/286 (46%), Gaps = 42/286 (14%)
Query: 65 KIGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
KIGEG+ G V + G R VA+K ++ R LL EV +M +H N+V
Sbjct: 26 KIGEGSTGIVCIATDKSTG-RQVAVKKMDL-RKQQRRELL----FNEVVIMRDYQHPNIV 79
Query: 122 KFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+ + D L V V E L G +L + R N+ + L +A+ LHA G
Sbjct: 80 EMYSSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQIATVCLAVL---KALSFLHAQG 135
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE---TGTYRWMAPELYSTVTL 236
+IHRD+K D++LLT D + +KL+DFG + V++ + GT WMAPE+ S
Sbjct: 136 VIHRDIKSDSILLTSDGR-VKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPEVIS---- 188
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLT------NRLPFEGMSNLQAAYAAAFKHARPGLPE 290
+ Y +VD++S GI++ E++ N P + M ++ K+
Sbjct: 189 ----RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKN-----LH 239
Query: 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 336
+SP L + V DP R + ++++ + FL PPS VP
Sbjct: 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN--HPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 80/287 (27%), Positives = 126/287 (43%), Gaps = 45/287 (15%)
Query: 66 IGEGAHGKVYEGRYG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+GEG GKV Y +VA+K L R + +E+N++ + H+N
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ----NTSGWKKEINILKTLYHEN 67
Query: 120 LVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+VK+ G C + + ++ E +P SLR YL +KL+L L FA I M LH
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLH 124
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRWMAPELY 231
+ IHRDL N+LL D + +K+ DFGLA+ E ++ + W A E
Sbjct: 125 SQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-WYAVECL 182
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-------RLPFEGMSNLQAAYAAAF--- 281
E K DV+SFG+ L+ELLT+ FE M +
Sbjct: 183 K-------ENKFSYAS-DVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234
Query: 282 ----KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
+ R P++ ++ ++++CW + RP+F +I +L
Sbjct: 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 74/262 (28%), Positives = 126/262 (48%), Gaps = 21/262 (8%)
Query: 66 IGEGAHGK--VYEGRYGDRIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVKHDNLVK 122
+G+GA G+ +Y D +V K +N S+ ER + E+ ++S ++H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA----LNEIVILSLLQHPNIIA 63
Query: 123 FLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ D ++I E G +L +V + + + L + I A+ +H GI+
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQG 239
HRD+K N+ LT +KL DFG+++ +E AET GT +M+PEL QG
Sbjct: 124 HRDIKTLNIFLTKAG-LIKLGDFGISKILG-SEYSMAETVVGTPYYMSPELC------QG 175
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 299
K YN K D+++ G VL+ELLT + F+ +N + + S +L +
Sbjct: 176 VK--YNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTPVVSVYSSELISL 232
Query: 300 VQSCWVEDPNLRPSFSQIIRML 321
V S +DP RP+ +++
Sbjct: 233 VHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 78/274 (28%), Positives = 133/274 (48%), Gaps = 38/274 (13%)
Query: 57 PKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
P+ + + +IG G +G VY+ R +VAIKV+ D+ +++ +E++M+
Sbjct: 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKL-EPGDDFEIIQ----QEISMLK 55
Query: 114 RVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIA-- 169
+H N+V + G+ + + IV E G SL+ Y V+ P IA
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ---------IAYV 106
Query: 170 -----RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GT 222
+ + LH G IHRD+K N+LLT + +KLADFG++ + T T + ++ GT
Sbjct: 107 CRETLKGLAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTAT-IAKRKSFIGT 164
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
WMAPE+ + V + G Y+ K D+++ GI EL + P + ++A + +
Sbjct: 165 PYWMAPEVAA-VERKGG----YDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS 219
Query: 283 HARPGLPED---ISPDLAFIVQSCWVEDPNLRPS 313
+ P +D SP ++ C +DP RP+
Sbjct: 220 NFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 87/295 (29%), Positives = 136/295 (46%), Gaps = 46/295 (15%)
Query: 59 LLFIGSKIGEGAHGKVYEGRY---GD---RIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
L FI ++G+G G V RY D +VA+K L + R F RE+ ++
Sbjct: 6 LKFI-QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR-----DFEREIEIL 59
Query: 113 SRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
++HDN+VK+ G C + +V E LP SLR YL R +LD L +A I
Sbjct: 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQIC 118
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYR 224
+ M+ L + +HRDL N+L+ + + +K+ DFGL + +E E+ +
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPIF- 176
Query: 225 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----NRLP----FEGMSNLQAA 276
W APE + E K ++ DV+SFG+VL+EL T + P M N +
Sbjct: 177 WYAPESLT-------ESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG 228
Query: 277 YAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
+ + R P ++ I++ CW DP+ RPSFS++ + A
Sbjct: 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 89/297 (29%), Positives = 145/297 (48%), Gaps = 47/297 (15%)
Query: 60 LFIGSKIGEGAHGKVYE----GRYGDR-----IVAIKVLNRGSTSDERALLEGRFIREVN 110
L +G +GEG G+V G D+ VA+K+L +T + + L + E+
Sbjct: 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEME 72
Query: 111 MMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
MM + KH N++ LGAC PL VIV G +LR+YL + RP ++ + D
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYDIARVPD 131
Query: 168 --------------IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213
+AR M+ L + IHRDL N+L+T + +K+ADFGLAR+
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNI 190
Query: 214 EMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 268
+ T +WMAPE L+ V Y ++ DV+SFG+++WE+ T P+
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTLGGSPYP 241
Query: 269 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+ L
Sbjct: 242 GIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 79/293 (26%), Positives = 127/293 (43%), Gaps = 48/293 (16%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +IGEGAHG V++ + VA+K + + +RE+ + +H
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN---QALREIKALQACQHPY 60
Query: 120 LVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+VK L V+V E +P L + L L ++ + + + +HAN
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPE-LYSTVT 235
GI+HRDLKP NLL++ D LK+ADFGLAR E + + + T + APE LY
Sbjct: 119 GIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG--- 174
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG------------------------MS 271
+ Y+ VD+++ G + ELL F G ++
Sbjct: 175 -----ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229
Query: 272 NLQAAYAAAFKHARPGLPEDISPDL---AF-IVQSCWVEDPNLRPSFSQIIRM 320
+L F ++P E+I PD A +++ V DP+ R S ++ +R
Sbjct: 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 86/282 (30%), Positives = 128/282 (45%), Gaps = 42/282 (14%)
Query: 66 IGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
IG+G G VY G D A+K LNR + +E +F++E +M H N+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE----QFLKEGIIMKDFSHPNV 58
Query: 121 VKFLGACKD----PLMVIVTELLPGM---SLRKYLVSLR--PNKLDLHVALNFALDIARA 171
+ LG C PL+V LP M LR ++ S P DL + F L +A+
Sbjct: 59 LSLLGICLPSEGSPLVV-----LPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKG 110
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGT-----YRW 225
M+ L + +HRDL N +L D+ ++K+ADFGLAR+ E + T +W
Sbjct: 111 MEYLASKKFVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285
MA E T + K DV+SFG++LWEL+T P + + R
Sbjct: 169 MALESLQTQK--------FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR 220
Query: 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327
PE L ++ SCW P +RP+FS+++ + T
Sbjct: 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 82/284 (28%), Positives = 128/284 (45%), Gaps = 31/284 (10%)
Query: 54 LVDPKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN 110
L DP +F + IGEG +GKVY+ R+ ++VAIK+++ +E E +R+ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 111 MMSRVKHDNLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVA 161
H N+ F GA D + +V EL G S+ + LR +L
Sbjct: 61 -----NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI 115
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT-AET 220
+ R + LH N +IHRD+K N+LLT +KL DFG++ + T
Sbjct: 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
GT WMAPE+ + + Y+ + DV+S GI EL + P M ++ A
Sbjct: 175 GTPYWMAPEV---IACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR----AL 227
Query: 281 FKHAR---PGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
FK R P L PE+ S + C +++ RP +++
Sbjct: 228 FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 81/263 (30%), Positives = 139/263 (52%), Gaps = 27/263 (10%)
Query: 66 IGEGAHGKVYEGRY---GDRI---VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G GA G VY+G + G+ + VAIK+LN T+ +A +E F+ E +M+ + H +
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNE--TTGPKANVE--FMDEALIMASMDHPH 70
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
LV+ LG C P + +VT+L+P L Y+ + N + + LN+ + IA+ M L
Sbjct: 71 LVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEERR 129
Query: 180 IIHRDLKPDNLLL-TPDQKSLKLADFGLAR-EETVTEMMTAETGTY--RWMAPELYSTVT 235
++HRDL N+L+ +P+ +K+ DFGLAR E + A+ G +WMA E
Sbjct: 130 LVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI---- 183
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294
+ + ++ DV+S+G+ +WEL+T P++G+ + K R P +
Sbjct: 184 ----HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTI 238
Query: 295 DLAFIVQSCWVEDPNLRPSFSQI 317
D+ ++ CW+ D + RP F ++
Sbjct: 239 DVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 88/287 (30%), Positives = 132/287 (45%), Gaps = 34/287 (11%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY---GDR--IVAIKVLNRGSTSDERALLEGRFIREV 109
+D + I IG G G+V GR G R VAIK L G T +R F+ E
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR----DFLSEA 56
Query: 110 NMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFA 165
++M + H N++ G P+M I+TE + +L +L R N V +
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSRPVM-IITEFMENGALDSFL---RQNDGQFTVIQLVGML 112
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETG- 221
IA M L +HRDL N+L+ + K++DFGL+R ++T T+ G
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGG 171
Query: 222 --TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278
RW APE + R+ + + DV+S+GIV+WE+++ P+ MSN Q
Sbjct: 172 KIPIRWTAPE---AIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIN 222
Query: 279 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
A + R P D L ++ CW +D N RP F QI+ L+ +
Sbjct: 223 AIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 73/270 (27%), Positives = 118/270 (43%), Gaps = 50/270 (18%)
Query: 82 RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLP 140
+VA+KVL ++ + R F++EV ++SR+ N+ + LG C DP + ++ E +
Sbjct: 47 VLVAVKVLRPDASDNARE----DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYME 102
Query: 141 GMSLRKYL-------VSLRPNKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLL 191
L ++L L N L + L A IA M L + +HRDL N L
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162
Query: 192 LTPDQKSLKLADFGLAREETVTEMMTAETGTY-----------RWMAPELYSTVTLRQGE 240
+ + +K+ADFG++R + Y RWMA E ++ G+
Sbjct: 163 VGKNYT-IKIADFGMSRN--------LYSSDYYRVQGRAPLPIRWMAWE-----SVLLGK 208
Query: 241 KKHYNNKVDVYSFGIVLWELLT--NRLPFEGMSNLQAAYAAAFKHARPGLPE-----DIS 293
+ K DV++FG+ LWE+LT P+E +++ Q A G
Sbjct: 209 ---FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNC 265
Query: 294 P-DLAFIVQSCWVEDPNLRPSFSQIIRMLN 322
P D+ ++ CW D RP+F +I L
Sbjct: 266 PKDIYELMLECWRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G G+ G+V R+ + A+K+L++ + + E ++ ++H LV
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK--QVEHVLNEKRILQSIRHPFLVNL 66
Query: 124 LGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
G+ +D + +V E +PG L +L + + VA +A + A++ LH+ I++
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPVARFYAAQVVLALEYLHSLDIVY 124
Query: 183 RDLKPDNLLLTPDQK-SLKLADFGLA-REETVTEMMTAETGTYRWMAPELYSTVTLRQGE 240
RDLKP+NLLL D +K+ DFG A R + T + GT ++APE + L +G
Sbjct: 125 RDLKPENLLL--DSDGYIKITDFGFAKRVKGRTYTL---CGTPEYLAPE----IILSKG- 174
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPF 267
Y VD ++ GI+++E+L PF
Sbjct: 175 ---YGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 80/283 (28%), Positives = 134/283 (47%), Gaps = 48/283 (16%)
Query: 68 EGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
EG G+++ G D V +K + ++ + LL ++E ++ + H N++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLL----LQESCLLYGLSHQNIL 71
Query: 122 KFLGAC---KDPLMVIVTELLPGMS---LRKYLVSLRPNKLDLHVALN------FALDIA 169
L C +P V L P M+ L+ +L R + + AL+ A+ IA
Sbjct: 72 PILHVCIEDGEPPFV----LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR---WM 226
M LH G+IH+D+ N ++ ++ +K+ D L+R+ + R WM
Sbjct: 128 CGMSYLHKRGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ-AAY-AAAFKH 283
A E +L K Y++ DV+SFG++LWEL+T + P+ + + AAY ++
Sbjct: 187 ALE-----SL---VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL 238
Query: 284 ARPGLPEDIS-PDLAFIVQS-CWVEDPNLRPSFSQIIRMLNAF 324
A+P I+ PD F V + CW DP RPSFSQ+++ L F
Sbjct: 239 AQP-----INCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 78/286 (27%), Positives = 137/286 (47%), Gaps = 40/286 (13%)
Query: 65 KIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
++GE A GK+Y+G ++VAIK L + + G F +E ++M+ + H
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQW----GEFQQEASLMAELHHP 67
Query: 119 NLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP---------------NKLDLHVAL 162
N+V LG ++ + ++ E L L ++L+ P + LD L
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222
+ A+ IA M+ L ++ +H+DL N+L+ +Q +K++D GL+RE + + +
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIG-EQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 223 Y---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYA 278
RWM PE + G+ +++ D++SFG+VLWE+ + L P+ G SN +
Sbjct: 187 LLPIRWMPPE-----AIMYGK---FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238
Query: 279 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
+ P ED P + ++ CW E P+ RP F I L ++
Sbjct: 239 VRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 78/296 (26%), Positives = 128/296 (43%), Gaps = 55/296 (18%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDER--ALLEGRFIREVNMMSRVKH 117
+ ++G+G G VY R + +VAIK + + S E L E + +R++N +H
Sbjct: 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----EH 57
Query: 118 DNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
N+VK D L V E + G +L + + + V + I + + +
Sbjct: 58 PNIVKLKEVFRENDELY-FVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWM-APELYS 232
H +G HRDLKP+NLL++ + +K+ADFGLARE + T T RW APE
Sbjct: 116 HKHGFFHRDLKPENLLVSGPE-VVKIADFGLARE--IRSRPPYTDYVST-RWYRAPE--- 168
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL--------------QAAYA 278
+ LR Y++ VD+++ G ++ EL T R F G S + + +
Sbjct: 169 -ILLRST---SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP 224
Query: 279 AAFKHAR---------PGLPED-----ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320
+K A SP+ +++ DP RP+ SQ ++
Sbjct: 225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 71/211 (33%), Positives = 111/211 (52%), Gaps = 16/211 (7%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG +G VY+ R IVA+K + R T DE + IRE++++ + H N+V+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEG--VPSTAIREISLLKELNHPNIVR 62
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
L + + +V E L + L+KY+ S LD + ++ + + + H++ ++
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ + +LKLADFGLAR V T E T + APE + L
Sbjct: 122 HRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE----ILLGS-- 174
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
+ Y+ VD++S G + E++ R F G S
Sbjct: 175 -RQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 73/228 (32%), Positives = 104/228 (45%), Gaps = 40/228 (17%)
Query: 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDE----RALLEGRFIREVNMMSRVKHDN 119
IG GA+G V R VAIK ++ D R L RE+ ++ ++H+N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-VFDDLIDAKRIL------REIKLLRHLRHEN 60
Query: 120 LVKFLGACKDPL------MVIVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAM 172
++ L + P + IVTEL+ L K + S P L D H+ F I R +
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQY-FLYQILRGL 116
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGT--YRWM 226
LH+ +IHRDLKP N+L+ + LK+ DFGLAR +E +T T YR
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR-- 173
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
APEL Y +D++S G + ELLT + F G +
Sbjct: 174 APELL-------LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 72/213 (33%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
S++GEGA G V + R I A+K + D L+ + +RE+ + K +V
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD----LQKQILRELEINKSCKSPYIV 62
Query: 122 KFLGACKDP---LMVIVTELLPGMSLRKYL--VSLRPNKLDLHVALNFALDIARAMDCLH 176
K+ GA D + I E G SL V R ++ V A + + + LH
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
+ IIHRD+KP N+LLT + +KL DFG++ E V + TGT +MAPE
Sbjct: 123 SRKIIHRDIKPSNILLT-RKGQVKLCDFGVS-GELVNSLAGTFTGTSFYMAPE------- 173
Query: 237 R-QGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
R QG K Y+ DV+S G+ L E+ NR PF
Sbjct: 174 RIQG--KPYSITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 73/265 (27%), Positives = 127/265 (47%), Gaps = 21/265 (7%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I KIG+G VY+ R+VA+K + D +A ++E++++ ++ H N
Sbjct: 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKA--RQDCLKEIDLLKQLDHPN 63
Query: 120 LVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLH 176
++K+L + ++ + IV EL L + + + K + + + + A++ +H
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTV 234
+ I+HRD+KP N+ +T +KL D GL R + ++ A + GT +M+PE
Sbjct: 124 SKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI--- 178
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHARPGLPEDI- 292
+ YN K D++S G +L+E+ + PF G NL + K P LP D
Sbjct: 179 -----HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHY 233
Query: 293 SPDLAFIVQSCWVEDPNLRPSFSQI 317
S +L +V C DP RP S +
Sbjct: 234 SEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 78/270 (28%), Positives = 132/270 (48%), Gaps = 24/270 (8%)
Query: 66 IGEGAHGKVYEGRY---GDRIVAIKVLNR-----GSTSDERALLEGRFIREVNMM-SRVK 116
+G GA G VY+ R G ++A+K +N G ER G + EV ++ +++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 117 HDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMD 173
H N+V++ ++ + IV +L+ G L ++ SL+ K N + + A+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 174 CLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
LH I+HRDL P+N++L D K + + DFGLA+++ +T+ GT + PE+
Sbjct: 128 YLHKEKRIVHRDLTPNNIMLGEDDK-VTITDFGLAKQKQPESKLTSVVGTILYSCPEIV- 185
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292
+ E Y K DV++FG +L+++ T + PF + L A P LPE +
Sbjct: 186 -----KNEP--YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-LPEGM 237
Query: 293 -SPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
S D+ ++ SC D RP Q+ M+
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-26
Identities = 81/280 (28%), Positives = 145/280 (51%), Gaps = 34/280 (12%)
Query: 63 GSKIGEGAHGKVYEGRYG--DRIVAIK--VLNRGSTSDE---RALLEGRFIREVNMMSRV 115
G+ IG G+ G VY G ++A+K L S S + R++L+ RE+ ++ +
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDA-LAREIALLKEL 63
Query: 116 KHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+H+N+V++LG+ D + I E +PG S+ L + + + NF I + ++
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNY 121
Query: 175 LHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGTYR--------W 225
LH GIIHRD+K N+L+ D K +K++DFG++++ + T T R W
Sbjct: 122 LHNRGIIHRDIKGANILV--DNKGGIKISDFGISKKLEANSLSTK-TNGARPSLQGSVFW 178
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285
MAPE+ ++ Y K D++S G ++ E+LT + PF + LQA + ++A
Sbjct: 179 MAPEVV--------KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENAS 229
Query: 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
P +P +IS + ++ + D N RP+ +++ + + FL
Sbjct: 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL--LKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 79/222 (35%), Positives = 113/222 (50%), Gaps = 30/222 (13%)
Query: 66 IGEGAHGKVY---EGRYGDRIVAIKVLN--RGSTSDERALLEGRFIREVNMMSRVKHDNL 120
IG GA G V+ + R G R+ K+ N + S +R RE+ M+ KHDN+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF------RELKMLCFFKHDNV 61
Query: 121 VKFLGACKDPL------MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+ L + P + +VTEL+ L K +VS +P D HV + F I R +
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSD-HVKV-FLYQILRGLKY 118
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYS 232
LH+ GI+HRD+KP NLL+ + LK+ DFGLAR E E MT E T + APE+
Sbjct: 119 LHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
+HY + VD++S G + ELL R+ F+ S +Q
Sbjct: 178 G-------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 75/227 (33%), Positives = 112/227 (49%), Gaps = 30/227 (13%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--- 116
++IGEGA+G VY+ R R VA+K + R S+E L +RE+ ++ +++
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLS--TLREIALLKQLESFE 59
Query: 117 HDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
H N+V+ L C P + +V E + L YL L + + R
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAP 228
+D LH++ I+HRDLKP N+L+T D + +K+ADFGLAR + +T+ T YR AP
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIYSFEMALTSVVVTLWYR--AP 175
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 274
E V L+ Y VD++S G + EL R P F G S
Sbjct: 176 E----VLLQS----SYATPVDMWSVGCIFAELF-RRRPLFRGTSEAD 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 80/269 (29%), Positives = 139/269 (51%), Gaps = 22/269 (8%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DP+ LF KIG+G+ G+V++G ++VAIK+++ DE ++ +E+ ++
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ----QEITVL 56
Query: 113 SRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
S+ + K+ G+ KD + I+ E L G S L L P LD +I +
Sbjct: 57 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILREILKG 113
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPEL 230
+D LH+ IHRD+K N+LL+ + +KLADFG+A + T T++ GT WMAPE+
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 290
++ Y++K D++S GI EL P + ++ + K+ P L
Sbjct: 173 I--------KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEG 223
Query: 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+ S L V++C ++P+ RP+ ++++
Sbjct: 224 NYSKPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 78/269 (28%), Positives = 136/269 (50%), Gaps = 22/269 (8%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DP+ LF +IG+G+ G+VY+G +VAIK+++ DE ++ +E+ ++
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ----QEITVL 56
Query: 113 SRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
S+ + ++ G+ K + I+ E L G S L L+P L+ +I +
Sbjct: 57 SQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILREILKG 113
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGTYRWMAPEL 230
+D LH+ IHRD+K N+LL+ +Q +KLADFG+A + T T++ GT WMAPE+
Sbjct: 114 LDYLHSERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 290
++ Y+ K D++S GI EL P + ++ + K++ P L
Sbjct: 173 I--------KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEG 223
Query: 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
S V++C +DP RP+ ++++
Sbjct: 224 QYSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 76/269 (28%), Positives = 136/269 (50%), Gaps = 37/269 (13%)
Query: 66 IGEGAHGKVYEGRY---GDRI---VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G GA G VY+G + G+++ VAIK L R +TS + + E +M+ V + +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPK---ANKEILDEAYVMASVDNPH 70
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+ + LG C + ++T+L+P L Y+ + N ++ LN+ + IA+ M+ L
Sbjct: 71 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAKGMNYLEERR 129
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---------RWMAPEL 230
++HRDL N+L+ Q +K+ DFGLA+ ++ A+ Y +WMA
Sbjct: 130 LVHRDLAARNVLVKTPQH-VKITDFGLAK------LLGADEKEYHAEGGKVPIKWMA--- 179
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLP 289
L + Y ++ DV+S+G+ +WEL+T P++G+ + + + K R P
Sbjct: 180 -----LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQP 233
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQII 318
+ D+ I+ CW+ D + RP F ++I
Sbjct: 234 PICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 90/291 (30%), Positives = 143/291 (49%), Gaps = 39/291 (13%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEGR--YGDRIVAIKVLN-RGSTSDERALLEGRFIREVNM 111
DP+ LF +IG G+ G VY R + +VAIK ++ G S+E+ I+EV
Sbjct: 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW---QDIIKEVRF 68
Query: 112 MSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
+ +++H N +++ G C ++ +V E Y + + L++H ++IA
Sbjct: 69 LQQLRHPNTIEYKG-CYLREHTAWLVME---------YCLGSASDILEVHKKPLQEVEIA 118
Query: 170 -------RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222
+ + LH++ IHRD+K N+LLT + ++KLADFG A ++ + GT
Sbjct: 119 AICHGALQGLAYLHSHERIHRDIKAGNILLT-EPGTVKLADFGSA---SLVSPANSFVGT 174
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
WMAPE V L E Y+ KVDV+S GI EL + P M+ + A Y A +
Sbjct: 175 PYWMAPE----VILAMDEG-QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-Q 228
Query: 283 HARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332
+ P L D S V SC + P RPS ++++ + F+ RPP+
Sbjct: 229 NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK--HRFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 22/221 (9%)
Query: 64 SKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
+GEGA+G V + R IVAIK S++ ++ +REV ++ +++H+N+V
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKF---KESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 122 KFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
A + + +V E + L L+ P L ++ + +A+ H++ I
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWM-APELYSTVTL 236
IHRD+KP+N+L++ LKL DFG AR + + Y RW APEL T
Sbjct: 122 IHRDIKPENILVSESGV-LKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLVGDT- 177
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
+Y VDV++ G ++ ELL F G S++ Y
Sbjct: 178 ------NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 74/261 (28%), Positives = 128/261 (49%), Gaps = 20/261 (7%)
Query: 65 KIGEGAHGKVY--EGRYGDRIVAIKVLN--RGSTSDERALLEGRFIREVNMMSRVKHDNL 120
KIGEG+ GK+Y + + IK ++ + ++ A +EV +++++KH N+
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK-----KEVILLAKMKHPNI 61
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V F + ++ + IV E G L K + R L++ + I+ + +H
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
I+HRD+K N+ L+ + KL DFG+AR+ E+ GT +++PE+
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC------- 174
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298
+ + YNNK D++S G VL+EL T + PFEG + Q + P P + S DL
Sbjct: 175 -QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISP-NFSRDLRS 232
Query: 299 IVQSCWVEDPNLRPSFSQIIR 319
++ + P RPS + I++
Sbjct: 233 LISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 20/260 (7%)
Query: 66 IGEGAHGKV--YEGRYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G+G++G+V R + IK LN R ++ ER E +E ++S++KH N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE----QEAQLLSQLKHPNIVA 63
Query: 123 FLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ + + D L+ IV G L L + L + + + + IA A+ LH I
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
+HRDLK N+ LT +K+ D G+AR E +M + GT +M+PEL+S
Sbjct: 124 LHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN------ 176
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 299
K YN K DV++ G ++E+ T + F ++ + + P +P+D SP+L +
Sbjct: 177 --KPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEGKLPPMPKDYSPELGEL 233
Query: 300 VQSCWVEDPNLRPSFSQIIR 319
+ + + P RPS I+R
Sbjct: 234 IATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 89/285 (31%), Positives = 135/285 (47%), Gaps = 43/285 (15%)
Query: 66 IGEGAHGKVYEGRY---GDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNL 120
IGEG G+V + R G R+ AIK + ++ D+ G E+ ++ ++ H N+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG----ELEVLCKLGHHPNI 70
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--------------LNFA 165
+ LGAC+ + + E P +L +L R + D A L+FA
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW 225
D+AR MD L IHRDL N+L+ + + K+ADFGL+R + V T RW
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVRW 189
Query: 226 MAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS--NLQAAYAAA 280
MA E YS Y DV+S+G++LWE+++ P+ GM+ L
Sbjct: 190 MAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239
Query: 281 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
++ +P +D DL ++ CW E P RPSF+QI+ LN L
Sbjct: 240 YRLEKPLNCDDEVYDL---MRQCWREKPYERPSFAQILVSLNRML 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 78/269 (28%), Positives = 136/269 (50%), Gaps = 22/269 (8%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DP+ LF +IG+G+ G+V++G ++VAIK+++ DE ++ +E+ ++
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ----QEITVL 56
Query: 113 SRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
S+ + K+ G+ K + I+ E L G S L LR D +I +
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA---LDLLRAGPFDEFQIATMLKEILKG 113
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPEL 230
+D LH+ IHRD+K N+LL+ +Q +KLADFG+A + T T++ GT WMAPE+
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 290
++ Y++K D++S GI EL P M ++ + K+ P L
Sbjct: 173 I--------QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTG 223
Query: 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+ S + +C +DP+ RP+ ++++
Sbjct: 224 EFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G G G+V + + +R A+K + + + + E ++ H +VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG--QQEHIFSEKEILEECNHPFIVKL 58
Query: 124 LGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
KD + ++ E G L L D + A + + A + LH GII+
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIY 116
Query: 183 RDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
RDLKP+NLLL D +KL DFG A++ + GT ++APE+
Sbjct: 117 RDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEII--------LN 166
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEG 269
K Y+ VD +S GI+L+ELLT R PF
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 71/228 (31%), Positives = 106/228 (46%), Gaps = 52/228 (22%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEG---RFIREVNMMSRVKHDN 119
+IGEG +G+VY+ R +VA+K + +E+ EG IRE+ ++ +++H N
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIR---MENEK---EGFPITAIREIKLLQKLRHPN 59
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLV------SLRPNKLDLHVALNFALD------ 167
+V+ L IVT G S+ Y+V L L + F
Sbjct: 60 IVR--------LKEIVTSKGKG-SI--YMVFEYMDHDL--TGLLDSPEVKFTESQIKCYM 106
Query: 168 --IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGT- 222
+ + LH+NGI+HRD+K N+L+ + LKLADFGLAR T T T
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVITL 165
Query: 223 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
YR PEL G + Y +VD++S G +L EL + F+G
Sbjct: 166 WYR--PPELL------LGATR-YGPEVDMWSVGCILAELFLGKPIFQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 91/280 (32%), Positives = 135/280 (48%), Gaps = 30/280 (10%)
Query: 65 KIGEGAHGKVY---EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
KIG+GA G VY + G VAIK +N ++ L+ I E+ +M KH N+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQE-VAIKQMNL-QQQPKKELI----INEILVMRENKHPNIV 79
Query: 122 KFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+L + D L V V E L G SL + +D + +A++ LH+N
Sbjct: 80 NYLDSYLVGDELWV-VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ 135
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQ 238
+IHRD+K DN+LL D S+KL DFG + T + + GT WMAPE+ VT
Sbjct: 136 VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV---VT--- 188
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDL 296
+K Y KVD++S GI+ E++ P+ + L+A Y A + P L PE +S
Sbjct: 189 --RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIF 245
Query: 297 AFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 336
+ C D R S ++++ + FL +P S P
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQ--HPFLKIAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 41/287 (14%)
Query: 66 IGEGAHGKVYEGRY---GDR---IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+GEG GKV RY GD VA+K L S + A L+ +E+ ++ + H+N
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK----KEIEILRNLYHEN 67
Query: 120 LVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+VK+ G C + + ++ E LP SL++YL NK++L L +A+ I + MD L
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLG 126
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAET---GTYRWMAPELYS 232
+ +HRDL N+L+ + + +K+ DFGL + ET E T + W APE
Sbjct: 127 SRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLT----------NRLPFEGMSNLQAAYAAAFK 282
+ K Y DV+SFG+ L+ELLT L G ++ Q +
Sbjct: 186 -------QSKFYIAS-DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237
Query: 283 HARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
G P + ++ +++ CW P+ R +F +I A L
Sbjct: 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 81/293 (27%), Positives = 137/293 (46%), Gaps = 56/293 (19%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+GEG++G V + ++ + +IVAIK + S++ +++ +RE+ M+ +++H+NLV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 123 FLGACK-DPLMVIVTELLPGM---SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+ + + +V E + L KY PN LD + I R ++ H++
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVT 235
IIHRD+KP+N+L++ +KL DFG AR T+ E+ T T + APEL
Sbjct: 120 NIIHRDIKPENILVSQS-GVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLV--- 173
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS-------------NLQAAYAAAFK 282
G+ K Y VD+++ G ++ E+LT F G S NL + F+
Sbjct: 174 ---GDTK-YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229
Query: 283 HARPG----LPE------------DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
LPE +S + + + C DP+ RPS SQ++
Sbjct: 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 73/213 (34%), Positives = 116/213 (54%), Gaps = 19/213 (8%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG +G VY+GR +IVA+K + R + +E + IRE++++ ++H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEG--VPSTAIREISLLKELQHPNIVC 63
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDCLHANGI 180
++ + ++ E L M L+KYL SL + +D + ++ I + + H+ +
Sbjct: 64 LQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122
Query: 181 IHRDLKPDNLLLTPDQKSL-KLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQ 238
+HRDLKP NLL+ D K + KLADFGLAR + + T E T + APE V L
Sbjct: 123 LHRDLKPQNLLI--DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPE----VLL-- 174
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
G + Y+ VD++S G + E+ T + F G S
Sbjct: 175 GSPR-YSTPVDIWSIGTIFAEMATKKPLFHGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 5e-24
Identities = 91/286 (31%), Positives = 133/286 (46%), Gaps = 34/286 (11%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY---GDR--IVAIKVLNRGSTSDERALLEGRFIREV 109
+D + I IG G G+V GR G R VAIK L G T +R F+ E
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRR----DFLSEA 56
Query: 110 NMMSRVKHDNLVKFLGA---CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNF 164
++M + H N++ G K P+M IVTE + SL +L R + V +
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSK-PVM-IVTEYMENGSLDAFL---RKHDGQFTVIQLVGM 111
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGT 222
IA M L G +HRDL N+L+ + K++DFGL+R E+ T G
Sbjct: 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 223 --YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279
RW APE + R+ + + DV+S+GIV+WE+++ P+ MSN Q A
Sbjct: 171 IPIRWTAPE---AIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKA 221
Query: 280 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+ R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 222 IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 7e-24
Identities = 79/268 (29%), Positives = 133/268 (49%), Gaps = 23/268 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +G+GA G+VY D R +A+K + S E + E+ ++ + H+
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 120 LVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+V++ G +DP+ + I E +PG S++ L S L +V + I + LH
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLH 123
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETV----TEMMTAETGTYRWMAPELY 231
+N I+HRD+K N+L ++KL DFG ++ +T+ T M + TGT WM+PE+
Sbjct: 124 SNMIVHRDIKGANIL-RDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TGTPYWMSPEVI 181
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291
S GE Y K D++S G + E+LT + P+ + A + A + P LP
Sbjct: 182 S------GEG--YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+S ++ +VE LRPS +++R
Sbjct: 234 VSDHCRDFLKRIFVE-AKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-23
Identities = 87/283 (30%), Positives = 137/283 (48%), Gaps = 36/283 (12%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG+ G V + ++VA+K ++ R LL EV +M +H+N+V+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDL-RKQQRRELL----FNEVVIMRDYQHENVVE 81
Query: 123 FLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ D L V++ E L G +L + R N+ + L + +A+ LHA G+
Sbjct: 82 MYNSYLVGDELWVVM-EFLEGGALTDIVTHTRMNEEQIAAV---CLAVLKALSVLHAQGV 137
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGL-AREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
IHRD+K D++LLT D + +KL+DFG A+ + GT WMAPEL S +
Sbjct: 138 IHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP---- 192
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP------EDIS 293
Y +VD++S GI++ E++ P+ L+ A K R LP +S
Sbjct: 193 ----YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIRDNLPPKLKNLHKVS 243
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 336
P L + V DP R + +++++ + FL PPS VP
Sbjct: 244 PSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-23
Identities = 79/273 (28%), Positives = 121/273 (44%), Gaps = 30/273 (10%)
Query: 66 IGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
IG G G+V+ G + VAIK L G T +R F+ E ++M + H N+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQ----DFLSEASIMGQFSHHNI 68
Query: 121 VKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV--ALNFALDIARAMDCLHA 177
++ G K +I+TE + +L KYL R + + + IA M L
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTY--RWMAPELYST 233
+HRDL N+L+ K++DFGL+R E+ T G RW APE +
Sbjct: 126 MNYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292
+ + + DV+SFGIV+WE+++ P+ MSN A R P D
Sbjct: 185 --------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPMDC 235
Query: 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+ ++ CW +D RP F I+ +L+ L
Sbjct: 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-23
Identities = 78/261 (29%), Positives = 131/261 (50%), Gaps = 19/261 (7%)
Query: 64 SKIGEGAHGK--VYEGRYGDRIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVKHDNL 120
KIGEG+ GK + + + + IK +N S ER E R +EV ++S +KH N+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE--ESR--KEVAVLSNMKHPNI 61
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V++ + ++ + IV + G L K + + R L++ + I A+ +H
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQ 238
I+HRD+K N+ LT D ++KL DFG+AR T E+ GT +++PE+
Sbjct: 122 ILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC------- 173
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298
E + YNNK D+++ G VL+E+ T + FE N++ + + P + S DL
Sbjct: 174 -ENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPPVSSHYSYDLRN 231
Query: 299 IVQSCWVEDPNLRPSFSQIIR 319
+V + +P RPS + I+
Sbjct: 232 LVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-23
Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG +G VY+ R + +A+K + R DE + IRE++++ ++H N+V+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEG--VPSTAIREISLLKEMQHGNIVR 65
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ + +V E L + L+K++ S + + + I R + H++ ++
Sbjct: 66 LQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ +LKLADFGLAR + T E T + APE+
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG------- 177
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
+HY+ VD++S G + E++ + F G S +
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210
|
Length = 294 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 3e-23
Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 17/218 (7%)
Query: 64 SKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
SKIGEG++G V++ R + +IVAIK + S++ +++ +RE+ M+ ++KH NLV
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIK---KFVESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 122 KFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ + + +V E L + + P + H+ +A++ H +
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYSTVTLRQG 239
IHRD+KP+N+L+T Q +KL DFG AR T + RW APEL T
Sbjct: 122 IHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT---- 176
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
Y VDV++ G V ELLT + + G S++ Y
Sbjct: 177 ---QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 4e-23
Identities = 71/264 (26%), Positives = 127/264 (48%), Gaps = 20/264 (7%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVL--NRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
+G GA+G V + R+ I+A+K + S +R L++ +++M S V V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMD----LDISMRS-VDCPYTV 63
Query: 122 KFLGAC-KDPLMVIVTELLPGMSLRKYL--VSLRPNKLDLHVALNFALDIARAMDCLHAN 178
F GA ++ + I E++ SL K+ V + + + A+ I +A++ LH+
Sbjct: 64 TFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122
Query: 179 -GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
+IHRD+KP N+L+ +KL DFG++ + T + G +MAPE +
Sbjct: 123 LSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINP---- 177
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED-ISPDL 296
+ +K Y+ K DV+S GI + EL T R P++ + P LP + SP+
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237
Query: 297 AFIVQSCWVEDPNLRPSFSQIIRM 320
V C ++ RP++ ++++
Sbjct: 238 QDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-23
Identities = 63/262 (24%), Positives = 117/262 (44%), Gaps = 24/262 (9%)
Query: 65 KIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
++G G G V +G Y ++ VA+K+L + L+ +RE N+M ++ + +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILK---NDNNDPALKDELLREANVMQQLDNPYI 58
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
V+ +G C+ ++V EL L K+L + + ++ M L
Sbjct: 59 VRMIGICEAESWMLVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNF 116
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT----YRWMAPELYSTVTL 236
+HRDL N+LL Q K++DFGL++ E +W APE +
Sbjct: 117 VHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK- 174
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295
+++K DV+SFG+++WE + + P++GM + R P+ P+
Sbjct: 175 -------FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QMIESGERMECPQRCPPE 226
Query: 296 LAFIVQSCWVEDPNLRPSFSQI 317
+ +++ CW + RP F+ +
Sbjct: 227 MYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 4e-23
Identities = 77/281 (27%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 66 IGEGAHGKVYEGRY---GDRI---VAIKVL-NRGSTSDERALLEGRFIREVNMMSRVKHD 118
+G G G V++G + GD I VAIK + +R + + + + M + H
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD-----HMLAMGSLDHA 69
Query: 119 NLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V+ LG C + +VT+L P SL ++ R + LD LN+ + IA+ M L +
Sbjct: 70 YIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKGMYYLEEH 128
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLA-------REETVTEMMTAETGTYRWMAPELY 231
++HR+L N+LL D +++ADFG+A ++ +E T +WMA E
Sbjct: 129 RMVHRNLAARNILLKSDSI-VQIADFGVADLLYPDDKKYFYSEHKTP----IKWMALE-- 181
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290
++ + Y ++ DV+S+G+ +WE+++ P+ GM K R P+
Sbjct: 182 -SILFGR-----YTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERLAQPQ 234
Query: 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331
+ D+ ++ CW+ D N+RP+F + + N F R P
Sbjct: 235 ICTIDVYMVMVKCWMIDENVRPTFKE---LANEFTRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 4e-23
Identities = 81/274 (29%), Positives = 123/274 (44%), Gaps = 25/274 (9%)
Query: 65 KIGEGAHGKVYEGRYGDRI----VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
+IG G GKV G + V +K L +T DE+ L F++EV + H N+
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL----FLQEVQPYRELNHPNV 57
Query: 121 VKFLGACKD--PLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCL 175
++ LG C + P + +V E P L+ YL S R V A ++A + L
Sbjct: 58 LQCLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTY--RWMAPELYS 232
H IH DL N LT D S+K+ D+GLA E+ + +T + RW+APEL
Sbjct: 117 HQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQA-AYAAA---FKHARPG 287
K K +++S G+ +WEL T P+ +S+ Q K +P
Sbjct: 176 IRGQDLLPKDQ-TKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234
Query: 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
L S ++Q CW+ DP RP+ ++ +L
Sbjct: 235 LDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-23
Identities = 67/226 (29%), Positives = 106/226 (46%), Gaps = 30/226 (13%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEG---RFIREVNMMSRVKHDN 119
KIGEG +GKVY+ R ++VA+K DE EG +RE++++ +
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALK--KTRLEMDE----EGIPPTALREISLLQMLSESI 61
Query: 120 -LVKFLGA------CKDPLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIA 169
+V+ L P + +V E L L+K++ S L +F +
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAP 228
+ + H +G++HRDLKP NLL+ + LK+AD GL R ++ + T E T + AP
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
E+ T HY+ VD++S G + E+ + F G S LQ
Sbjct: 181 EVLLGST-------HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 9e-23
Identities = 89/286 (31%), Positives = 133/286 (46%), Gaps = 45/286 (15%)
Query: 66 IGEGAHGKVYEG---RYGDRI-VAIKVLNR-GSTSDERALLEGRFIREVNMMSRV-KHDN 119
IGEG G+V + G ++ AIK+L S +D R F E+ ++ ++ H N
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR-----DFAGELEVLCKLGHHPN 64
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--------------LNF 164
++ LGAC++ + I E P +L +L R + D A L F
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR 224
A D+A M L IHRDL N+L+ + + K+ADFGL+R E V T R
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVG-ENLASKIADFGLSRGEEVYVKKTMGRLPVR 183
Query: 225 WMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281
WMA E YS Y K DV+SFG++LWE+++ P+ GM+ + Y
Sbjct: 184 WMAIESLNYSV----------YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLP 232
Query: 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII----RMLNA 323
+ R P + ++ +++ CW + P RP F+QI RML A
Sbjct: 233 QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 67/213 (31%), Positives = 111/213 (52%), Gaps = 16/213 (7%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG +G VY+ R +VA+K + R T E + IRE++++ + H N+VK
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEG--VPSTAIREISLLKELNHPNIVK 63
Query: 123 FLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
L + + +V E L L+K++ + + + L + ++ + + + H++ ++
Sbjct: 64 LLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ + +KLADFGLAR V T E T + APE+
Sbjct: 123 HRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC------ 175
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
K+Y+ VD++S G + E++T R F G S +
Sbjct: 176 -KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-22
Identities = 78/287 (27%), Positives = 129/287 (44%), Gaps = 39/287 (13%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRG--STSDERALLEGRFIREVNMMSR 114
+G +G+G G V E + + VA+K+L S+SD +E F+RE M
Sbjct: 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD----IE-EFLREAACMKE 57
Query: 115 VKHDNLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALN 163
H N++K +G + P+ +++ + L +L+ R P L L +
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---TAET 220
F +DIA M+ L + IHRDL N +L + ++ +ADFGL+++ + A
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 221 GTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278
+W+A E L V Y DV++FG+ +WE++T + P+ G+ N + Y
Sbjct: 177 LPVKWLALESLADNV---------YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-IYN 226
Query: 279 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
K R P D D+ ++ CW +P RPSF + L
Sbjct: 227 YLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-22
Identities = 79/289 (27%), Positives = 127/289 (43%), Gaps = 40/289 (13%)
Query: 60 LFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
L +G +GEG G V EG+ D I+ + V R+ +E F+ E M H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED-FLSEAVCMKEFDH 59
Query: 118 DNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALNFAL 166
N+++ +G C P V++ + L +L+ R P L + + F
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---------REETVTEMMT 217
DIA M+ L + IHRDL N +L + ++ +ADFGL+ R+ + +M
Sbjct: 120 DIASGMEYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKM-- 176
Query: 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276
+W+A E + + Y K DV+SFG+ +WE+ T + P+ G+ N +
Sbjct: 177 ----PVKWIAIESLA--------DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-I 223
Query: 277 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
Y + R P D L ++ SCW+ +P RPSF + L L
Sbjct: 224 YDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 82/283 (28%), Positives = 144/283 (50%), Gaps = 25/283 (8%)
Query: 56 DPKLLFIG-SKIGEGAHGKVY--EGRYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNM 111
DP+ +F+G +IG G+ G VY + + +VA+K ++ G ++E+ I+EV
Sbjct: 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKW---QDIIKEVKF 74
Query: 112 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIA 169
+ ++KH N +++ G K+ +V E G + V +P ++++ + AL
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL--- 131
Query: 170 RAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 228
+ + LH++ +IHRD+K N+LLT P Q +KLADFG A + + + GT WMAP
Sbjct: 132 QGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSA---SKSSPANSFVGTPYWMAP 186
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288
E+ + + +G+ Y+ KVDV+S GI EL + P M+ + A Y A +
Sbjct: 187 EV--ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ 241
Query: 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331
+ + V C + P RP+ ++++R + F+ RP
Sbjct: 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLR--HDFVRRDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 79/285 (27%), Positives = 129/285 (45%), Gaps = 42/285 (14%)
Query: 65 KIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++GEGA GKV+ + +VA+K L S S + F RE +++ ++H
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-----DFQREAELLTVLQH 66
Query: 118 DNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPN-------------KLDLHVALN 163
++V+F G C + +++V E + L ++L S P+ +L L L
Sbjct: 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 223
A IA M L + +HRDL N L+ +K+ DFG++R+ T+ T
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 224 ---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279
RWM PE ++ R+ + + D++SFG+VLWE+ T + P+ +SN +A
Sbjct: 186 LPIRWMPPE---SILYRK-----FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--IE 235
Query: 280 AFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
R P P++ I+Q CW +P R I L A
Sbjct: 236 CITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 33/282 (11%)
Query: 55 VDPKLLFIGSKIGEGAHGKV--YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
+ + L S +G G G V + ++A KV++ G+ S R + +RE+ +M
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK----QILRELQIM 57
Query: 113 SRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDIA 169
+ +V F GA + + + E + SL + P +++ +A+ +
Sbjct: 58 HECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLT 117
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 229
+ I+HRD+KP N+L+ + +KL DFG++ E + + GT +M+PE
Sbjct: 118 YLYNVHR---IMHRDIKPSNILVN-SRGQIKLCDFGVS-GELINSIADTFVGTSTYMSPE 172
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF---EGMSNLQAAYAAAF----- 281
QG K Y K DV+S GI + EL + PF + Q
Sbjct: 173 RI------QGGK--YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224
Query: 282 --KHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320
+ P LP D DL V +C ++DP RP+ Q+ M
Sbjct: 225 IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-22
Identities = 78/271 (28%), Positives = 133/271 (49%), Gaps = 29/271 (10%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVL----NRGSTSDERALLEGRFIREVNMMSRV 115
+G +G GA G+VY D R +A+K + + TS E LE E+ ++ +
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC----EIQLLKNL 61
Query: 116 KHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+HD +V++ G +DP + I E +PG S++ L + L +V + I + +
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGV 119
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAP 228
LH+N I+HRD+K N+L ++KL DFG ++ M + + TGT WM+P
Sbjct: 120 SYLHSNMIVHRDIKGANIL-RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288
E+ S GE Y K DV+S + E+LT + P+ + A + A + +P L
Sbjct: 179 EVIS------GEG--YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPML 230
Query: 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
P+ +S ++ +VE+ RP+ ++R
Sbjct: 231 PDGVSDACRDFLKQIFVEE-KRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-22
Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 40/277 (14%)
Query: 66 IGEGAHGKVYEGRY--------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
+G+G +Y+G + V+ + SD R L F ++MS++ H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA--FFETASLMSQLSH 60
Query: 118 DNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+LVK G C ++V E + L +L N + LH L+ A +A A+ L
Sbjct: 61 KHLVKLYGVCVRDENIMVEEYVKFGPLDVFL-HREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 178 NGIIHRDLKPDNLLLTPD------QKSLKLADFGLAREETVTEMMTAETGTYR-----WM 226
++H ++ N+L+ +KL+D G+ +T + R W+
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--------ITVLSREERVERIPWI 171
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 285
APE + + D +SFG L E+ +N P +S L ++ F +
Sbjct: 172 APECI------RNGQASLTIAADKWSFGTTLLEICSNGEEP---LSTLSSSEKERFYQDQ 222
Query: 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322
LP +LA ++ CW DP RPSF I+R LN
Sbjct: 223 HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGS--TSDERALLEGRFIREVNMMSRVKH 117
I +++G+G +G+V+ + D IVA+K + + +E + E ++++ K
Sbjct: 5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVR----HVLTERDILTTTKS 60
Query: 118 DNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+ LVK L A +D + + E +PG R L +L L A + ++ A+D LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH 118
Query: 177 ANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT 235
G IHRDLKP+N L+ D +KL DFGL++ + + G+ +MAPE+
Sbjct: 119 ELGYIHRDLKPENFLI--DASGHIKLTDFGLSKG--IVTYANSVVGSPDYMAPEVL---- 170
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
+G+ Y+ VD +S G +L+E L PF G S +
Sbjct: 171 --RGKG--YDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWE 208
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 3e-22
Identities = 79/270 (29%), Positives = 128/270 (47%), Gaps = 29/270 (10%)
Query: 63 GSKIGEGAHGKV---YEGRYGDRIVAIKVL---NRGSTSDERALLEGRFIREVNMMSRVK 116
G +G+GA G+V Y+ G + A +V TS E + LE E+ ++ ++
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC----EIQLLKNLQ 62
Query: 117 HDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
H+ +V++ G +D + I E +PG S++ L + L V + I M
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMS 120
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPE 229
LH+N I+HRD+K N+L ++KL DFG ++ M + + TGT WM+PE
Sbjct: 121 YLHSNMIVHRDIKGANIL-RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289
+ S GE Y K DV+S G + E+LT + P+ + A + A + P LP
Sbjct: 180 VIS------GEG--YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
IS + +VE + RPS +++R
Sbjct: 232 SHISEHARDFLGCIFVEARH-RPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 85/338 (25%), Positives = 140/338 (41%), Gaps = 84/338 (24%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDE-RALLE--------G 103
L +G +G GA GKV + R VA+K+L G+T+ E +AL+ G
Sbjct: 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG 68
Query: 104 RFIREVNMMSRV--------------KHDNLVKFLGA----------------------- 126
+ VN++ K NL +L +
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEG 128
Query: 127 CKDPLMVIV---TELLPGMSLRKYLVSLRPNK---------LDLHVALNFALDIARAMDC 174
K L + + G K L + ++ L L ++++ +AR M+
Sbjct: 129 KKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEF 188
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR----WMAPE- 229
L + IHRDL N+LL+ + +K+ DFGLAR+ + G R WMAPE
Sbjct: 189 LASRKCIHRDLAARNILLS-ENNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPES 246
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RPG 287
++ V Y + DV+SFG++LWE+ + P+ G+ + + K R
Sbjct: 247 IFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGV-QIDEEFCRRLKEGTRMR 296
Query: 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
PE +P++ I+ CW +P RP+FS+++ +L L
Sbjct: 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 75/223 (33%), Positives = 107/223 (47%), Gaps = 38/223 (17%)
Query: 64 SKIGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
S IGEGA+G V G + VAIK + + E R +RE+ ++ R KH+N+
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVK-VAIKKI----SPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 121 VKFLGACKDPL------MVIVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMD 173
+ L + P + IV EL+ L K + + L + H+ F I R +
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELME-TDLYKLI---KTQHLSNDHIQY-FLYQILRGLK 120
Query: 174 CLHANGIIHRDLKPDNLLL--TPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWM- 226
+H+ ++HRDLKP NLLL D LK+ DFGLAR E T +T T RW
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLTEYVAT-RWYR 176
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 177 APEIMLN-------SKGYTKAIDIWSVGCILAEMLSNRPLFPG 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 6e-22
Identities = 69/219 (31%), Positives = 112/219 (51%), Gaps = 30/219 (13%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLN----RGSTSDERALLEGRFIREVNMMSRVKHD 118
K+GEG + VY+G R IVA+K ++ G+ S IRE+++M +KH+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA--------IREISLMKELKHE 58
Query: 119 NLVKFLGA--CKDPLMVIVTELLPGMSLRKYL-VSLRPNKLDLHVALNFALDIARAMDCL 175
N+V+ ++ LM +V E + L+KY+ LD + +F + + +
Sbjct: 59 NIVRLHDVIHTENKLM-LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPE-LYST 233
H N ++HRDLKP NLL+ + LKLADFGLAR + + E T + AP+ L +
Sbjct: 117 HENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
T Y+ +D++S G ++ E++T R F G +N
Sbjct: 176 RT--------YSTSIDIWSVGCIMAEMITGRPLFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 7e-22
Identities = 79/271 (29%), Positives = 136/271 (50%), Gaps = 18/271 (6%)
Query: 55 VDPKLLF-IGSKIGEGAHGKVYEGRYGDR--IVAIKVLNRGSTSDERALLEGRFIREVNM 111
+DP ++ I ++G+GA GKVY+ + + + A KV+ T E L + ++ E+ +
Sbjct: 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELED--YMVEIEI 62
Query: 112 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
++ H +VK LGA D + I+ E PG ++ ++ L + + + +
Sbjct: 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLE 121
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPE 229
A+ LH+ IIHRDLK N+LLT D +KLADFG++ + T + + GT WMAPE
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL- 288
+ T++ Y+ K D++S GI L E+ P ++ ++ A K P L
Sbjct: 181 VVMCETMKDTP---YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLS 236
Query: 289 -PEDISPDLAFIVQSCWVEDPNLRPSFSQII 318
P S + +++ + P RPS +Q++
Sbjct: 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 8e-22
Identities = 75/266 (28%), Positives = 122/266 (45%), Gaps = 39/266 (14%)
Query: 66 IGEGAHGKVY-----EGRYGDRIVAIKVLNRGS----------TSDERALLEGRFIREVN 110
+G GA+GKV+ G ++ A+KVL + + T ER +LE +R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA--VRRCP 65
Query: 111 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
LV A + D + ++ + + G L +L + +I
Sbjct: 66 F--------LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIV 115
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMA 227
A+D LH GII+RD+K +N+LL + + L DFGL++E E A + GT +MA
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHAR 285
PE+ +R G H + VD +S G++ +ELLT PF +G N Q+ + ++
Sbjct: 175 PEV-----IRGGSGGH-DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK 228
Query: 286 PGLPEDISPDLAFIVQSCWVEDPNLR 311
P P+ +S + +Q +DP R
Sbjct: 229 PPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 58/172 (33%), Positives = 89/172 (51%), Gaps = 17/172 (9%)
Query: 156 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215
LD L+F+ +A+ M L + IHRDL N+LLT + + K+ DFGLAR+ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIR-NDS 268
Query: 216 MTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269
G R WMAPE +++ V Y + DV+S+GI+LWE+ + P+ G
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCV---------YTFESDVWSYGILLWEIFSLGSSPYPG 319
Query: 270 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
M Y + R PE ++ I++SCW DP RP+F QI++++
Sbjct: 320 MPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 77/264 (29%), Positives = 129/264 (48%), Gaps = 27/264 (10%)
Query: 66 IGEGAHGKVYEGRY---GDRI---VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G GA G VY+G + G+ + VAIKVL R +TS + + E +M+ V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKA---NKEILDEAYVMAGVGSPY 70
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+ + LG C + +VT+L+P L Y V +++ LN+ + IA+ M L
Sbjct: 71 VCRLLGICLTSTVQLVTQLMPYGCLLDY-VRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 180 IIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETG---TYRWMAPELYSTVT 235
++HRDL N+L+ +P+ +K+ DFGLAR + E G +WMA
Sbjct: 130 LVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEYHADGGKVPIKWMA-------- 179
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294
L + + ++ DV+S+G+ +WEL+T P++G+ + K R P +
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTI 238
Query: 295 DLAFIVQSCWVEDPNLRPSFSQII 318
D+ I+ CW+ D RP F +++
Sbjct: 239 DVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.3 bits (231), Expect = 2e-21
Identities = 93/302 (30%), Positives = 142/302 (47%), Gaps = 31/302 (10%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEGR---YGDRIVAIKVLNRGSTSDERALLEGRFIREVNM 111
DPK + KIG+GA G V+ G VAIK +N + + I E+ +
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQE-VAIKQINLQKQPKKELI-----INEILV 69
Query: 112 MSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
M +K+ N+V FL + D L V++ E L G SL + ++ + L
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVM-EYLAGGSLTDVVTETCMDEAQIAAVCRECL--- 125
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAP 228
+A++ LHAN +IHRD+K DN+LL S+KL DFG + T + + GT WMAP
Sbjct: 126 QALEFLHANQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288
E+ + +K Y KVD++S GI+ E++ P+ + L+A Y A + P L
Sbjct: 185 EVVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPEL 235
Query: 289 --PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAAT 346
PE +SP + C D R S ++++ + FL +P S P + A
Sbjct: 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKLAKPLSSLTPLILAAKEAMK 293
Query: 347 SN 348
SN
Sbjct: 294 SN 295
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 74/215 (34%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 66 IGEGAHGKV--YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G GA+G+V R VAIK L+R S A R RE+ ++ + H+N++
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHA---KRTYRELRLLKHMDHENVIGL 79
Query: 124 LGAC--KDPLM-----VIVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDCL 175
L L +VT L+ G L + + KL D H+ I R + +
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLM-GADLNNIV---KCQKLSDDHIQF-LVYQILRGLKYI 134
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-MAPELYSTV 234
H+ GIIHRDLKP N+ + D + LK+ DFGLAR + MT T RW APE +
Sbjct: 135 HSAGIIHRDLKPSNIAVNEDCE-LKILDFGLARH--TDDEMTGYVAT-RWYRAPE----I 186
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
L HYN VD++S G ++ ELLT + F G
Sbjct: 187 ML---NWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 59/178 (33%), Positives = 89/178 (50%), Gaps = 14/178 (7%)
Query: 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194
V E L G L ++ S + D A +A +I + LH GII+RDLK DN+LL
Sbjct: 74 VMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 195 DQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 253
D +K+ADFG+ +E E + GT ++APE+ +G+K YN VD +SF
Sbjct: 132 DGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL------KGQK--YNESVDWWSF 182
Query: 254 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 311
G++L+E+L + PF G + + + RP P IS + + + DP R
Sbjct: 183 GVLLYEMLIGQSPFHGEDEDELFD--SILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 86/284 (30%), Positives = 143/284 (50%), Gaps = 25/284 (8%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEGR--YGDRIVAIKVLN-RGSTSDERALLEGRFIREVNM 111
DP+ LF +IG G+ G VY R + +VAIK ++ G S+E+ I+EV
Sbjct: 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW---QDIIKEVKF 78
Query: 112 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIA 169
+ R+KH N +++ G ++ +V E G + V +P ++++ + AL
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL--- 135
Query: 170 RAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 228
+ + LH++ +IHRD+K N+LLT P Q +KLADFG A ++ + GT WMAP
Sbjct: 136 QGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSA---SIASPANSFVGTPYWMAP 190
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288
E+ + + +G+ Y+ KVDV+S GI EL + P M+ + A Y A +
Sbjct: 191 EV--ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ 245
Query: 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332
+ S V SC + P RP+ ++++ + F+ RP +
Sbjct: 246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM--FVLRERPET 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 4e-21
Identities = 88/284 (30%), Positives = 134/284 (47%), Gaps = 41/284 (14%)
Query: 66 IGEGAHGKVYEG---RYGDRI-VAIKVLNR-GSTSDERALLEGRFIREVNMMSRV-KHDN 119
IGEG G+V + + G R+ AIK + S D R F E+ ++ ++ H N
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-----DFAGELEVLCKLGHHPN 57
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--------------LNF 164
++ LGAC+ + + E P +L +L R + D A L+F
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR 224
A D+AR MD L IHRDL N+L+ + + K+ADFGL+R + V T R
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVR 176
Query: 225 WMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281
WMA E YS Y DV+S+G++LWE+++ P+ GM+ + Y
Sbjct: 177 WMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLP 225
Query: 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+ R P + ++ +++ CW E P RPSF+QI+ LN L
Sbjct: 226 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-21
Identities = 72/256 (28%), Positives = 104/256 (40%), Gaps = 30/256 (11%)
Query: 66 IGEGAHGKVYEGR---YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
I +GA G VY + GD AIKVL + S + + MM + + + K
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYF-AIKVL-KKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 123 FLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ KD L +V E L G + +L L A + ++ ++ LH GI
Sbjct: 62 LYYSFQSKDYLY-LVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 181 IHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
IHRD+KP+NLL+ DQ LKL DFGL+R GT ++APE
Sbjct: 119 IHRDIKPENLLI--DQTGHLKLTDFGLSR---NGLENKKFVGTPDYLAPETI-------- 165
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----ISPD 295
+ D +S G V++E L PF + A R PE+ SP+
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFH--AETPDAVFDNILSRRINWPEEVKEFCSPE 223
Query: 296 LAFIVQSCWVEDPNLR 311
++ DP R
Sbjct: 224 AVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 59/179 (32%), Positives = 93/179 (51%), Gaps = 23/179 (12%)
Query: 156 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215
LDL L F+ +A+ MD L + IHRD+ N+LLT D + K+ DFGLAR + + +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLAR-DIMNDS 266
Query: 216 MTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269
G R WMAPE ++ V Y + DV+S+GI+LWE+ + + P+ G
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCV---------YTVQSDVWSYGILLWEIFSLGKSPYPG 317
Query: 270 M---SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+ S ++ +RP P++ I++ CW +P RP+FSQI +++ L
Sbjct: 318 ILVNSKFYKMVKRGYQMSRPDFA---PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 6e-21
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG +G V++ + + IVA+K R D+ + +RE+ ++ +KH N+V+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
D + +V E L+KY S +D + +F + + + H++ ++
Sbjct: 64 LYDVLHSDKKLTLVFEYC-DQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVL 121
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ LKLADFGLAR + +AE T + P++ L
Sbjct: 122 HRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL---- 176
Query: 241 KKHYNNKVDVYSFGIVLWEL 260
Y+ +D++S G + EL
Sbjct: 177 ---YSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 79/288 (27%), Positives = 135/288 (46%), Gaps = 45/288 (15%)
Query: 65 KIGEGAHGKVYEGR------YGDR-IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++GEGA GKV+ D+ +VA+K L + + + F RE +++ ++H
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-----DFQREAELLTNLQH 66
Query: 118 DNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN--------------KLDLHVA 161
+++VKF G C DPL ++V E + L K+L + P+ +L L
Sbjct: 67 EHIVKFYGVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 221
L+ A IA M L + +HRDL N L+ +K+ DFG++R+ T+
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 222 TY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 277
T RWM PE ++ R+ + + DV+SFG++LWE+ T + P+ +SN +
Sbjct: 185 TMLPIRWMPPE---SIMYRK-----FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-- 234
Query: 278 AAAFKHARPGLPEDISPDLAF-IVQSCWVEDPNLRPSFSQIIRMLNAF 324
R + P + I+ CW +P R + +I ++L+A
Sbjct: 235 IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 75/266 (28%), Positives = 120/266 (45%), Gaps = 23/266 (8%)
Query: 66 IGEGAHGKVYE--GRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG+G +GKVY+ + + A+K+L+ S DE E ++ + H N+VKF
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP-----NHPNVVKF 84
Query: 124 LGA------CKDPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCL 175
G + +V EL G S+ + + L +LD + + L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTV 234
H N IIHRD+K +N+LLT + +KL DFG++ + T T + GT WMAPE+ +
Sbjct: 145 HNNRIIHRDVKGNNILLTT-EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV---I 200
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDI 292
Q Y+ + DV+S GI EL P M ++ + ++ P L PE
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP-RNPPPTLLHPEKW 259
Query: 293 SPDLAFIVQSCWVEDPNLRPSFSQII 318
+ C ++D RPS + ++
Sbjct: 260 CRSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 85/283 (30%), Positives = 132/283 (46%), Gaps = 36/283 (12%)
Query: 65 KIGEGAHGKV--YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG+ G V ++ + VA+K ++ R LL EV +M H+N+V
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDL-RKQQRRELL----FNEVVIMRDYHHENVVD 83
Query: 123 FLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ D L V V E L G +L + R N+ + L + RA+ LH G+
Sbjct: 84 MYNSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQIATV---CLSVLRALSYLHNQGV 139
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGL-AREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
IHRD+K D++LLT D + +KL+DFG A+ + GT WMAPE+ S +
Sbjct: 140 IHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP---- 194
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP------EDIS 293
Y +VD++S GI++ E++ P+ LQ A + R LP +S
Sbjct: 195 ----YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AMRRIRDNLPPRVKDSHKVS 245
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 336
L + V +P+ R + ++++ + FL PPS VP
Sbjct: 246 SVLRGFLDLMLVREPSQRATAQELLQ--HPFLKLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 2e-20
Identities = 89/301 (29%), Positives = 141/301 (46%), Gaps = 29/301 (9%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DPK + KIG+GA G VY + VAI+ +N + + I E+ +M
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-----INEILVM 71
Query: 113 SRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
K+ N+V +L + D L V++ E L G SL + ++ + L +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECL---Q 127
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPE 229
A++ LH+N +IHRD+K DN+LL D S+KL DFG + T + + GT WMAPE
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL- 288
+ + +K Y KVD++S GI+ E++ P+ + L+A Y A + P L
Sbjct: 187 VVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQ 237
Query: 289 -PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATS 347
PE +S + C D R S ++++ + FL +P S P + A +
Sbjct: 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIAKPLSSLTPLIAAAKEATKN 295
Query: 348 N 348
N
Sbjct: 296 N 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 2e-20
Identities = 89/289 (30%), Positives = 138/289 (47%), Gaps = 29/289 (10%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DPK + KIG+GA G VY + VAIK +N + + I E+ +M
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI-----INEILVM 70
Query: 113 SRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
K+ N+V +L + D L V++ E L G SL + ++ + L +
Sbjct: 71 RENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECL---Q 126
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPE 229
A+D LH+N +IHRD+K DN+LL D S+KL DFG + T + + GT WMAPE
Sbjct: 127 ALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL- 288
+ + +K Y KVD++S GI+ E++ P+ + L+A Y A + P L
Sbjct: 186 VVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQ 236
Query: 289 -PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 336
PE +S + C D + R S ++++ + FL +P S P
Sbjct: 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 2e-20
Identities = 79/279 (28%), Positives = 134/279 (48%), Gaps = 24/279 (8%)
Query: 54 LVDPKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN 110
L DP +F + +G G +G+VY+GR+ ++ AIKV++ T DE E +E+N
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDE----EEEIKQEIN 54
Query: 111 MMSRVKHD-NLVKFLGAC--KDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 162
M+ + H N+ + GA K+P + +V E S+ + + + N L
Sbjct: 55 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 114
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAET 220
+I R + LH + +IHRD+K N+LLT + +KL DFG++ + TV T
Sbjct: 115 YICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTF-I 172
Query: 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
GT WMAPE+ + + Y+ K D++S GI E+ P M ++A +
Sbjct: 173 GTPYWMAPEV---IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 229
Query: 281 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
A + S ++SC V++ + RP+ Q+++
Sbjct: 230 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 79/266 (29%), Positives = 137/266 (51%), Gaps = 21/266 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGDR--IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I ++G+GA GKVY+ + + + A KV++ T E L + ++ E+++++ H N
Sbjct: 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVID---TKSEEELED--YMVEIDILASCDHPN 63
Query: 120 LVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL-RP-NKLDLHVALNFALDIARAMDCLH 176
+VK L A + + I+ E G ++ ++ L RP + + V L+ A++ LH
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYLH 120
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVT 235
N IIHRDLK N+L T D +KLADFG++ + T T + + GT WMAPE+ V
Sbjct: 121 ENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV---VM 176
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDIS 293
+ + Y+ K DV+S GI L E+ P ++ ++ A K P L P S
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQPSRWS 235
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIR 319
+ ++ C ++ + R + +Q+++
Sbjct: 236 SEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 80/281 (28%), Positives = 130/281 (46%), Gaps = 44/281 (15%)
Query: 65 KIGEGAHGKVYEGR-YG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++GE GKVY+G +G + VAIK L + E L E F E M SR++H
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLRE-EFKHEAMMRSRLQH 67
Query: 118 DNLVKFLG-ACKDPLMVIVTELLPGMSLRKYLVSLRPN------------KLDLHVA--L 162
N+V LG K+ + ++ L ++LV P+ K L A +
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAE 219
+ IA M+ L ++ ++H+DL N+L+ D+ ++K++D GL RE + +M
Sbjct: 128 HIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-DKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 220 TGTYRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAA 276
RWM+PE +Y ++ D++S+G+VLWE+ + L P+ G SN
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDS----------DIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236
Query: 277 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 317
+ P P+D + ++ CW E P+ RP F I
Sbjct: 237 EMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 82/285 (28%), Positives = 136/285 (47%), Gaps = 26/285 (9%)
Query: 49 IDRSLLVDPKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRF 105
ID S L DP +F + +G G +G+VY+GR+ ++ AIKV++ T DE E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDE----EEEI 59
Query: 106 IREVNMMSRVKHD-NLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLRPNKLD 157
E+NM+ + H N+ + GA D + +V E S+ + + + N L
Sbjct: 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEM 215
+I R + LHA+ +IHRD+K N+LLT + +KL DFG++ + TV
Sbjct: 120 EDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRR 178
Query: 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275
T GT WMAPE+ + + Y+ + D++S GI E+ P M ++A
Sbjct: 179 NTF-IGTPYWMAPEV---IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234
Query: 276 AYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+ ++ P L + S ++ C V++ RPS Q+++
Sbjct: 235 LFLIP-RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 8e-20
Identities = 73/257 (28%), Positives = 118/257 (45%), Gaps = 32/257 (12%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSD----ERALLEGRFIREVNMMSRVKHDN 119
+G+G+ GKV D + A+KVL + E + E R + KH
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHPF 57
Query: 120 LVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
L + L +C KD L V E + G L ++ + D A +A +I + LH
Sbjct: 58 LTQ-LHSCFQTKDRLF-FVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH 113
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTV 234
GII+RDLK DN+LL + +K+ADFG+ + E + +T T GT ++APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSE-GHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEIL--- 168
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294
+ Y VD ++ G++L+E+L + PFEG + + R P +S
Sbjct: 169 ---SYQP--YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR--YPRWLSK 221
Query: 295 DLAFIVQSCWVEDPNLR 311
+ I++S ++P R
Sbjct: 222 EAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 9e-20
Identities = 73/223 (32%), Positives = 112/223 (50%), Gaps = 33/223 (14%)
Query: 64 SKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRF----IREVNMMSRVKH 117
++I EG +G VY R IVA+K L E+ EG F +RE+N++ +++H
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEK---EG-FPITSLREINILLKLQH 63
Query: 118 DNLVKF----LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
N+V +G+ D + +V E + L+ + +++ L V L + +
Sbjct: 64 PNIVTVKEVVVGSNLDKIY-MVMEYVE-HDLKSLMETMKQPFLQSEVK-CLMLQLLSGVA 120
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT--YRWMAPEL 230
LH N I+HRDLK NLLL ++ LK+ DFGLARE + + T T YR APEL
Sbjct: 121 HLHDNWILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYR--APEL 177
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
G K+ Y+ +D++S G + ELLT + F G S +
Sbjct: 178 L------LGAKE-YSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 80/283 (28%), Positives = 126/283 (44%), Gaps = 25/283 (8%)
Query: 47 LTID-RSLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDE--RALL 101
LTID + D L +IG G G+VY+ R+ ++A+K + R +E R L+
Sbjct: 3 LTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILM 62
Query: 102 EGRFIREVNMMSRVKHD--NLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL 158
+ +V + S HD +VK G D + I EL+ L K L ++ +
Sbjct: 63 D----LDVVLKS---HDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQ-GPIPE 113
Query: 159 HVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 217
+ + I +A+ L G+IHRD+KP N+LL ++KL DFG++ ++ T
Sbjct: 114 DILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKT 172
Query: 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
G +MAPE Y+ + DV+S GI L EL T + P++
Sbjct: 173 RSAGCAAYMAPERIDP----PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228
Query: 278 AAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQII 318
+ P LP E SPD V C +D RP + +++
Sbjct: 229 TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 81/294 (27%), Positives = 138/294 (46%), Gaps = 46/294 (15%)
Query: 65 KIGEGAHGKVYEGR------YGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++GEGA GKV+ D+I VA+K L S + + F RE +++ ++H
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK-----DFHREAELLTNLQH 66
Query: 118 DNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-----------KLDLHVALNF 164
+++VKF G C DPL ++V E + L K+L + P+ +L L+
Sbjct: 67 EHIVKFYGVCVEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY- 223
A IA M L + +HRDL N L+ + +K+ DFG++R+ T+ T
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 224 --RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280
RWM PE ++ R+ + + DV+S G+VLWE+ T + P+ +SN +
Sbjct: 185 PIRWMPPE---SIMYRK-----FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV--IEC 234
Query: 281 FKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 333
R P ++ ++ CW +P++R + I+ +++ L L SP
Sbjct: 235 ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLN----IKEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 75/224 (33%), Positives = 101/224 (45%), Gaps = 48/224 (21%)
Query: 66 IGEGAHGKV---YEGRYGDRIVAIKVLNR---GSTSDERALLEGRFIREVNMMSRVKHDN 119
IG GA G V Y+ G VAIK L+R T +RA RE+ +M V H N
Sbjct: 24 IGSGAQGIVCAAYDTVTGQN-VAIKKLSRPFQNVTHAKRAY------RELVLMKLVNHKN 76
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLHVALNFALDIAR----- 170
++ L P SL + YLV + +L + LD R
Sbjct: 77 IIGLLNV-----------FTPQKSLEEFQDVYLV-MELMDANLCQVIQMDLDHERMSYLL 124
Query: 171 -AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW 225
M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR + MMT T +
Sbjct: 125 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYY 183
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
APE V L G Y VD++S G ++ E++ + F G
Sbjct: 184 RAPE----VILGMG----YKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 28/197 (14%)
Query: 140 PGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 197
P + R L++ P + +DL + F+ +A M+ L + +HRDL N+L+ + K
Sbjct: 221 PERTRRDTLINESPALSYMDL---VGFSYQVANGMEFLASKNCVHRDLAARNVLIC-EGK 276
Query: 198 SLKLADFGLAREETVTEMMTAETGTY---RWMAPE-----LYSTVTLRQGEKKHYNNKVD 249
+K+ DFGLAR+ ++ T+ +WMAPE LY+T++ D
Sbjct: 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS-------------D 323
Query: 250 VYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDP 308
V+SFGI+LWE+ T P+ + + Y A + R P S ++ I+Q CW E
Sbjct: 324 VWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKF 383
Query: 309 NLRPSFSQIIRMLNAFL 325
+RP FSQ++ ++ L
Sbjct: 384 EIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 73/268 (27%), Positives = 129/268 (48%), Gaps = 43/268 (16%)
Query: 66 IGEGAHGKVY-----EGRYGDRIVAIKVLNRGS----------TSDERALLEGRFIREVN 110
+G GA+GKV+ G ++ A+KVL + + T ER +LE IR+
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE--HIRQSP 65
Query: 111 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS---LRPNKLDLHVALNFALD 167
+ + + D + ++ + + G L +L + ++ ++ +
Sbjct: 66 FLVTLHY-------AFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-----E 113
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRW 225
I A++ LH GII+RD+K +N+LL + + L DFGL++E E E + GT +
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEY 172
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKH 283
MAP++ +R G+ H + VD +S G++++ELLT PF +G N QA +
Sbjct: 173 MAPDI-----VRGGDGGH-DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK 226
Query: 284 ARPGLPEDISPDLAFIVQSCWVEDPNLR 311
+ P P+++S I+Q ++DP R
Sbjct: 227 SEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 75/228 (32%), Positives = 108/228 (47%), Gaps = 44/228 (19%)
Query: 64 SKIGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
S +G GA+G V ++ + G R VA+K L+R S A R RE+ ++ +KH+N+
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLR-VAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENV 78
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRK----YLVS----------LRPNKL-DLHVALNFA 165
+ L P SL + YLV+ ++ KL D HV
Sbjct: 79 IGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LI 126
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW 225
I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR + MT T +
Sbjct: 127 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARH--TDDEMTGYVATRWY 183
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
APE+ HYN VD++S G ++ ELLT R F G ++
Sbjct: 184 RAPEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 85/291 (29%), Positives = 128/291 (43%), Gaps = 51/291 (17%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+IGEG +G VY R IVA+K + +ER + +RE+ ++ ++H N+V+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALK---KVRMDNERDGIPISSLREITLLLNLRHPNIVE 70
Query: 123 FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN-------------FALDIA 169
E++ G L + + + DL L+ L +
Sbjct: 71 LK------------EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAP 228
R + LH N IIHRDLK NLLLT D+ LK+ADFGLAR + MT + T + AP
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288
EL T Y +D+++ G +L ELL ++ G S ++ P
Sbjct: 178 ELLLGCT-------TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN- 229
Query: 289 PEDISP---DLAFIVQSCWVEDP--NLRPSFSQI----IRMLNAFLFTLRP 330
E I P DL + + + P NL+ F + +R+LN FL P
Sbjct: 230 -ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLN-FLLMYDP 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 87/306 (28%), Positives = 142/306 (46%), Gaps = 42/306 (13%)
Query: 44 APQLTIDRSLLVDPKLL---FIGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDER 98
A ++ +D+ DP+ L +I KIGEG+ G V R + R VA+K+++ R
Sbjct: 9 ALRMVVDQG---DPRSLLENYI--KIGEGSTGIVCIAREKHSGRQVAVKMMDL-RKQQRR 62
Query: 99 ALLEGRFIREVNMMSRVKHDNLVK-FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLD 157
LL EV +M +H N+V+ + + ++ E L G +L + R N+
Sbjct: 63 ELL----FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQ 118
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-AREETVTEMM 216
+ L +A+ LH+ G+IHRD+K D++LLT D + +KL+DFG A+
Sbjct: 119 IATVCESVL---QALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKR 174
Query: 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276
+ GT WMAPE+ S + Y +VD++S GI++ E++ P+ S +Q
Sbjct: 175 KSLVGTPYWMAPEVIS--------RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-- 224
Query: 277 YAAAFKHARPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330
A K R P ISP L ++ +P R + +++ + FL
Sbjct: 225 ---AMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD--HPFLLQTGL 279
Query: 331 PSPSVP 336
P VP
Sbjct: 280 PECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 71/272 (26%), Positives = 123/272 (45%), Gaps = 33/272 (12%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLVK 122
IG GA G V + + I+A+K + ST DE+ + R + +++ +M +VK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIR--STVDEKE--QKRLLMDLDVVMRSSDCPYIVK 67
Query: 123 FLGA---------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
F GA C + LM I + KY+ + + + + A+ +A++
Sbjct: 68 FYGALFREGDCWICME-LMDISLDKF-----YKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 174 CLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
L IIHRD+KP N+LL ++KL DFG++ + + T + G +MAPE
Sbjct: 122 YLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 180
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292
R G Y+ + DV+S GI L+E+ T + P+ +++ K P L
Sbjct: 181 PSA-RDG----YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE 235
Query: 293 ----SPDLAFIVQSCWVEDPNLRPSFSQIIRM 320
SP + C ++D + RP + +++
Sbjct: 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 64/271 (23%), Positives = 133/271 (49%), Gaps = 24/271 (8%)
Query: 65 KIGEGAHGKVYEGRYGDRI----VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
++G G G V +G Y R VAIKVL + R +RE +M ++ + +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD----EMMREAEIMHQLDNPYI 57
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
V+ +G C+ +++V E+ G L K+L + +++ + + ++ M L
Sbjct: 58 VRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWMAPELYSTVTL 236
+HRDL N+LL +Q K++DFGL++ +++ + +A +W APE +
Sbjct: 117 VHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE---CINF 172
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295
R+ ++++ DV+S+GI +WE + + P++ M + + + R P + P+
Sbjct: 173 RK-----FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFIEQGKRLDCPAECPPE 226
Query: 296 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326
+ +++ CW+ RP+F+++ + + +
Sbjct: 227 MYALMKDCWIYKWEDRPNFAKVEERMRTYYY 257
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 69/222 (31%), Positives = 113/222 (50%), Gaps = 25/222 (11%)
Query: 64 SKIGEGAHGKVYEGR---YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---H 117
++IGEGA+GKV++ R G R VA+K + R T +E L IREV ++ ++ H
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLST--IREVAVLRHLETFEH 63
Query: 118 DNLVKFLGAC------KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
N+V+ C ++ + +V E + L YL + + + + R
Sbjct: 64 PNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
+D LH++ ++HRDLKP N+L+T + +KLADFGLAR + +T+ T + APE+
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMALTSVVVTLWYRAPEV- 180
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
L Q Y VD++S G + E+ + F G S++
Sbjct: 181 ----LLQSS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDV 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 59/267 (22%), Positives = 117/267 (43%), Gaps = 19/267 (7%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125
I E +Y+G + ++ V I+ + + L++ E+ + R+ +N++K G
Sbjct: 28 IKENDQNSIYKGIFNNKEVIIRTFKKFHK-GHKVLID-ITENEIKNLRRIDSNNILKIYG 85
Query: 126 ACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NG 179
D P + ++ E LR+ L + L L+ A+D + + L+
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN 143
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
+++L + L+T + K LK+ GL + + Y + ++ + +
Sbjct: 144 KPYKNLTSVSFLVTENYK-LKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIF---- 196
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 299
Y K D+YS G+VLWE+ T ++PFE ++ + K+ LP D ++ I
Sbjct: 197 --SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCI 254
Query: 300 VQSCWVEDPNLRPSFSQIIRMLNAFLF 326
V++C D RP+ +I+ L+ + F
Sbjct: 255 VEACTSHDSIKRPNIKEILYNLSLYKF 281
|
Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 4e-19
Identities = 83/283 (29%), Positives = 139/283 (49%), Gaps = 27/283 (9%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEGR--YGDRIVAIKVLN-RGSTSDERALLEGRFIREVNM 111
DP+ LF +IG G+ G VY R +VAIK ++ G S+E+ I+EV
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW---QDIIKEVRF 68
Query: 112 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIA 169
+ +++H N +++ G ++ +V E G + V +P ++++ + AL
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL--- 125
Query: 170 RAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 228
+ + LH++ +IHRD+K N+LL+ P +KL DFG A ++ GT WMAP
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSA---SIMAPANXFVGTPYWMAP 180
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288
E+ + + +G+ Y+ KVDV+S GI EL + P M+ + A Y A ++ P L
Sbjct: 181 EV--ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPAL 234
Query: 289 PED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330
S V SC + P RP+ +++ + F+ RP
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 6e-19
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G G G+V+ R + A+KV+ + E E ++ V H +++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ--EQHVHNEKRVLKEVSHPFIIRL 66
Query: 124 LGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
D + ++ E +PG L YL + + L +A +I A++ LH+ I++
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVY 124
Query: 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 242
RDLKP+N+LL + +KL DFG A++ + + GT ++APE+ + K
Sbjct: 125 RDLKPENILLDKE-GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVI--------QSK 173
Query: 243 HYNNKVDVYSFGIVLWELLTNRLPFEG 269
+N VD ++ GI+++E+L PF
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 6e-19
Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 17/264 (6%)
Query: 62 IGSKIGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ ++G+G+ G VY + + +KVL + + +E ++S++ H
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 120 LVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPN--KLDLHVALNFALDIARAMDCLH 176
+VKF + + I+TE G L L L+ L + + + + + +H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVT 235
I+HRDLK N+ L LK+ DFG++R + ++ T TGT +M+PE
Sbjct: 124 QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK--- 178
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295
QG Y++K D++S G +L+E+ FEG N + + P LPE S
Sbjct: 179 -HQG----YDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTPSLPETYSRQ 232
Query: 296 LAFIVQSCWVEDPNLRPSFSQIIR 319
L I+QS +DP+LRPS ++I+R
Sbjct: 233 LNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 7e-19
Identities = 76/268 (28%), Positives = 118/268 (44%), Gaps = 21/268 (7%)
Query: 65 KIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFL 124
+IG G GKV G +V+ + + +F+ E ++H NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 125 GACKDPL-MVIVTELLPGMSLRKYLVSLRPNKL---DLHVALNFALDIARAMDCLHANGI 180
G C + ++V E P L+ YL S R +L D A +IA + LH N
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF 121
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTV--- 234
IH DL N LLT D ++K+ D+GL+ + + + RW+APEL V
Sbjct: 122 IHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA-AYAA---AFKHARPGLP 289
L + K N V+S G+ +WEL P+ +S+ Q Y K +P L
Sbjct: 181 LLVVDQTKESN----VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK 236
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQI 317
+S ++Q CW++ P RPS ++
Sbjct: 237 LPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 85/339 (25%), Positives = 140/339 (41%), Gaps = 85/339 (25%)
Query: 60 LFIGSKIGEGAHGKVYEGR-YGD------RIVAIKVLNRGST-SDERALLE--------G 103
L +G +G GA GKV E +G VA+K+L G+T S+ +AL+ G
Sbjct: 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG 68
Query: 104 RFIREVNMMSRV--------------KHDNLVKFLGACKDPL------------------ 131
+ VN++ K+ NL FL A ++
Sbjct: 69 NHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMV 128
Query: 132 -MVIVTELLPGMSLRKYLVSLRPNK-----------------LDLHVALNFALDIARAMD 173
V + +P+ L + + ++ +AR M+
Sbjct: 129 EQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGME 188
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR----WMAPE 229
L + IHRDL N+LL+ + +K+ DFGLAR+ + G+ R WMAPE
Sbjct: 189 FLASRKCIHRDLAARNILLS-ENNVVKICDFGLARD-IYKDPDYVRKGSARLPLKWMAPE 246
Query: 230 -LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA-RP 286
++ V Y + DV+SFG++LWE+ + P+ G+ + + K R
Sbjct: 247 SIFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGV-QINEEFCQRLKDGTRM 296
Query: 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
PE+ +P++ I+ +CW DP RP+FS ++ +L L
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-19
Identities = 81/312 (25%), Positives = 132/312 (42%), Gaps = 66/312 (21%)
Query: 60 LFIGSKIGEGAHGKVY--------------------EGRYGDRIVAIKVLNRGSTSDERA 99
L K+GEG G+V+ +GR +VA+K+L + + R
Sbjct: 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR--PLLVAVKILRPDANKNARN 64
Query: 100 LLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNK-- 155
F++EV ++SR+K N+++ LG C +DPL ++TE + L ++L S +
Sbjct: 65 ----DFLKEVKILSRLKDPNIIRLLGVCVDEDPL-CMITEYMENGDLNQFLSSHHLDDKE 119
Query: 156 ---------------LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
+ L+ AL IA M L + +HRDL N L+ + ++K
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG-ENLTIK 178
Query: 201 LADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 257
+ADFG++R + + RWMA E + G+ + DV++FG+ L
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE-----CILMGK---FTTASDVWAFGVTL 230
Query: 258 WELLT--NRLPFEGMSNLQAAYAAA--FKHARP----GLPEDISPDLAFIVQSCWVEDPN 309
WE+L P+ +++ Q A F+ P L ++ CW D
Sbjct: 231 WEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCR 290
Query: 310 LRPSFSQIIRML 321
RPSFS I L
Sbjct: 291 ERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 66 IGEGAHGKVYEGR--YGDRIVAIK-VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G GA G V R + VAIK ++ ST +L R RE+ ++ ++H+N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFST----PVLAKRTYRELKLLKHLRHENIIS 73
Query: 123 FLGACKDPLMVI--VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
PL I VTELL G L + L S RP L+ F I R + +H+ G+
Sbjct: 74 LSDIFISPLEDIYFVTELL-GTDLHRLLTS-RP--LEKQFIQYFLYQILRGLKYVHSAGV 129
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 240
+HRDLKP N+L+ + LK+ DFGLAR + MT T + APE+ T
Sbjct: 130 VHRDLKPSNILIN-ENCDLKICDFGLARIQ--DPQMTGYVSTRYYRAPEIMLTW------ 180
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y+ +VD++S G + E+L + F G
Sbjct: 181 -QKYDVEVDIWSAGCIFAEMLEGKPLFPG 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 18/209 (8%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
K+GEG + V++GR + +VA+K + +E A IREV+++ +KH N+V
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTA--IREVSLLKNLKHANIVT 67
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ + +V E L L++YL + N + +H F + R + H I+
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ ++ LKLADFGLAR ++V T+ + E T + P++ T
Sbjct: 126 HRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST----- 179
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
Y+ +D++ G +L+E+ T R F G
Sbjct: 180 --EYSTPIDMWGVGCILYEMATGRPMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 33/218 (15%)
Query: 66 IGEGAHGKVYE-----GRYGDRIVAIKVL-------NRGSTSDERALLEGRFIREVNMMS 113
+G+G +GKV++ G +I A+KVL N+ T+ +A E N++
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA--------ERNILE 55
Query: 114 RVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
VKH +V + A + + ++ E L G L +L R A + +I+ A+
Sbjct: 56 AVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE--REGIFMEDTACFYLSEISLAL 113
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELY 231
+ LH GII+RDLKP+N+LL Q +KL DFGL +E +T GT +MAPE+
Sbjct: 114 EHLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
R G + VD +S G +++++LT PF
Sbjct: 173 M----RSG----HGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 75/256 (29%), Positives = 133/256 (51%), Gaps = 29/256 (11%)
Query: 66 IGEGAHGKVY-----EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
+G+G+ GKV+ G ++ A+KVL + + + R E ++++ V H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV---RTKMERDILAEVNHPFI 60
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYL---VSLRPNKLDLHVALNFALDIARAMDCLH 176
VK A + + ++ + L G L L V + ++A ++A A+D LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALDHLH 115
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVT 235
+ GII+RDLKP+N+LL ++ +KL DFGL++E E GT +MAPE V
Sbjct: 116 SLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE----VV 170
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295
R+G + D +SFG++++E+LT LPF+G + + K A+ G+P+ +SP+
Sbjct: 171 NRRG----HTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILK-AKLGMPQFLSPE 224
Query: 296 LAFIVQSCWVEDPNLR 311
++++ + +P R
Sbjct: 225 AQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEG---RFIREVNMMSRVKHDN 119
K+GEG++ VY+GR ++VA+K + E EG IRE +++ +KH N
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI---RLEHE----EGAPFTAIREASLLKDLKHAN 64
Query: 120 LVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V + +V E L L++Y+ L +H F + R + H
Sbjct: 65 IVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDD-CGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPE--LYSTVT 235
++HRDLKP NLL++ ++ LKLADFGLAR ++V ++ + E T + P+ L ST
Sbjct: 123 RVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST-- 179
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
Y+ +D++ G + +E+ T R F G ++++
Sbjct: 180 -------EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 70/219 (31%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 64 SKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---HD 118
++IG GA+G VY+ R + VA+K + R T+++ L +REV ++ R++ H
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLST--VREVALLKRLEAFDHP 62
Query: 119 NLVKFLGAC------KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
N+V+ + C ++ + +V E + LR YL + P L + R +
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
D LHAN I+HRDLKP+N+L+T +KLADFGLAR + +T T + APE+
Sbjct: 122 DFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLL 180
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
T Y VD++S G + E+ + F G S
Sbjct: 181 QST--------YATPVDMWSVGCIFAEMFRRKPLFCGNS 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 84/316 (26%), Positives = 139/316 (43%), Gaps = 78/316 (24%)
Query: 58 KLLFIGSKIGEGAHGKVY----EG--RYGDR------------IVAIKVLNRGSTSDERA 99
K L K+GEG G+V+ EG ++ D+ +VA+K+L + + R
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR- 63
Query: 100 LLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNK-- 155
F++E+ +MSR+K N+++ L C DPL +I TE + L ++L P +
Sbjct: 64 ---NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMI-TEYMENGDLNQFLSRHEPQEAA 119
Query: 156 -------LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
+ + A IA M L + +HRDL N L+ + ++K+ADFG++R
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY-TIKIADFGMSR 178
Query: 209 EETVTEMMTAETGTY-----------RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 257
+G Y RWM+ E ++ L + + DV++FG+ L
Sbjct: 179 --------NLYSGDYYRIQGRAVLPIRWMSWE---SILLGK-----FTTASDVWAFGVTL 222
Query: 258 WELLT--NRLPFEGMSNLQAAYAAA--FKHA-------RPGLPEDISPDLAF-IVQSCWV 305
WE+LT P+ +S+ Q F+ +P L PD + ++ SCW
Sbjct: 223 WEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPAL----CPDSLYKLMLSCWR 278
Query: 306 EDPNLRPSFSQIIRML 321
+ RPSF +I L
Sbjct: 279 RNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 84 VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFL--GACKDPLMVIVTELLPG 141
VAIK+L + +E RF RE + +R+ H N+V L G L+ V E +PG
Sbjct: 6 VAIKLLRTDAPEEEH--QRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63
Query: 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSL 199
+LR+ L + L L + A+ C H GI+HRDLKP N++++ +
Sbjct: 64 RTLREVLAADGALPAGETGRL--MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 200 KLADFGLAR-----EETVTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 251
K+ DFG+ + +T T GT + APE LR GE N+ D+Y
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-----QLR-GEPVTPNS--DLY 173
Query: 252 SFGIVLWELLTNRLPFEGMSNLQAAY 277
++G++ E LT + +G S + Y
Sbjct: 174 AWGLIFLECLTGQRVVQGASVAEILY 199
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 18/209 (8%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
K+GEG + VY+GR D +VA+K + +E A IREV+++ +KH N+V
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRL--EHEEGAPCTA--IREVSLLKDLKHANIVT 68
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ + +V E L L++YL N +++H F + R ++ H ++
Sbjct: 69 LHDIIHTEKSLTLVFEYL-DKDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVL 126
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ ++ LKLADFGLAR +++ T+ + E T + P++ T
Sbjct: 127 HRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST----- 180
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
Y+ ++D++ G + +E+ T R F G
Sbjct: 181 --DYSTQIDMWGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 77/242 (31%), Positives = 113/242 (46%), Gaps = 63/242 (26%)
Query: 62 IGSKIGEGAHGKVYEGRYGDR----IVAIK-VLN--RGSTSDERALLEGRFIREVNMMSR 114
I K+G+GA+G V++ DR +VA+K + + R +T +R E F++E+
Sbjct: 11 ILQKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG---- 64
Query: 115 VKHDNLVKFLG---ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL--NFALDI- 168
H N+VK L A D + +V E + + DLH + N D+
Sbjct: 65 -DHPNIVKLLNVIKAENDKDIYLVFEYM---------------ETDLHAVIRANILEDVH 108
Query: 169 --------ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR------EETVTE 214
+A+ +H+ +IHRDLKP N+LL D + +KLADFGLAR E
Sbjct: 109 KRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENP 167
Query: 215 MMTAETGTYRWM-APE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
++T T RW APE L ST Y VD++S G +L E+L + F G S
Sbjct: 168 VLTDYVAT-RWYRAPEILLGST---------RYTKGVDMWSVGCILGEMLLGKPLFPGTS 217
Query: 272 NL 273
L
Sbjct: 218 TL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-18
Identities = 74/269 (27%), Positives = 127/269 (47%), Gaps = 42/269 (15%)
Query: 66 IGEGAHGK--VYEGRYGDRIVAIKVL----NRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+GEG+ G+ + + D+ A+K + + + D R +E +++++KH N
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR--------KEAVLLAKMKHPN 59
Query: 120 LVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V F + + D + IV E G L + + R L + + + + +H
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
++HRD+K N+ LT + K +KL DFG AR T + A T GT ++ PE++
Sbjct: 120 RVLHRDIKSKNIFLTQNGK-VKLGDFGSARLLT-SPGAYACTYVGTPYYVPPEIW----- 172
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS--NL-----QAAYAAAFKHARPGLP 289
E YNNK D++S G +L+EL T + PF+ S NL Q +Y LP
Sbjct: 173 ---ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP--------LP 221
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQII 318
S +L +++ + +P RPS + I+
Sbjct: 222 SHYSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-18
Identities = 70/267 (26%), Positives = 123/267 (46%), Gaps = 19/267 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I KIG G +VY VA+K + D +A I+E++++ ++ H N
Sbjct: 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKA--RADCIKEIDLLKQLNHPN 63
Query: 120 LVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLH 176
++K+ + +D + IV EL L + + + K + + + + A++ +H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVT 235
+ ++HRD+KP N+ +T +KL D GL R + T + GT +M+PE
Sbjct: 124 SRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE------ 176
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHARPGLPED-IS 293
+ + YN K D++S G +L+E+ + PF G NL + + P LP D S
Sbjct: 177 --RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIRM 320
+L +V C DP RP + + +
Sbjct: 235 EELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 35/219 (15%)
Query: 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNL 120
KIGEG +V + + + AIK + + S E+ +RE+ + R+ H N+
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN----LREIQALRRLSPHPNI 60
Query: 121 VKFLGACKDPL---MVIVTELLPGMSL------RKYLVSLRPNKLDLHVALNFALDIARA 171
++ + D + +V EL+ M+L RK + ++ ++ + ++
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLP--EKRV-----KSYMYQLLKS 112
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APEL 230
+D +H NGI HRD+KP+N+L+ LKLADFG R T T RW APE
Sbjct: 113 LDHMHRNGIFHRDIKPENILI--KDDILKLADFGSCRGIYSKPPYTEYIST-RWYRAPE- 168
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
L G +Y K+D+++ G V +E+L+ F G
Sbjct: 169 ---CLLTDG---YYGPKMDIWAVGCVFFEILSLFPLFPG 201
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 38/236 (16%)
Query: 61 FIGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRF---------IREV 109
G+ +GEG +GKV + +IVAIK + S++ +RE+
Sbjct: 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 110 NMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
+M+ +KH+N++ + + + +V +++ L+K +V + + V L I
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKK-VVDRKIRLTESQVKC-ILLQI 128
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---------------EETVT 213
++ LH +HRDL P N+ + + K+ADFGLAR
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
E MT++ T + APEL L EK Y+ VD++S G + ELLT + F G
Sbjct: 188 EEMTSKVVTLWYRAPEL-----LMGAEK--YHFAVDMWSVGCIFAELLTGKPLFPG 236
|
Length = 335 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-18
Identities = 77/278 (27%), Positives = 124/278 (44%), Gaps = 37/278 (13%)
Query: 62 IGSKIGEGAHGKVYE--GRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I IG+G +GKV++ + A+K+L+ DE E ++ ++ H N
Sbjct: 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPN 76
Query: 120 LVKFLG-------ACKDPLMVI--------VTELLPGMSLRKYLVSLRPNKLDLHVALNF 164
+VKF G D L ++ VT+L+ G R + LH AL
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL-- 134
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTY 223
+ LH N IHRD+K +N+LLT + +KL DFG++ + T T + GT
Sbjct: 135 -----MGLQHLHVNKTIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 188
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283
WMAPE+ + Q Y+ + DV+S GI EL P + ++A + ++
Sbjct: 189 FWMAPEV---IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP-RN 244
Query: 284 ARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
P L PE S + ++ C +D RP+ S +++
Sbjct: 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 23/173 (13%)
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 221
L+F +AR M+ L + +HRDL N+LL K +K+ DFGLAR+ ++
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 222 TY---RWMAPE-----LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
T+ +WMAPE LY+T++ DV+S+GI+LWE+ + P+ GM
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLS-------------DVWSYGILLWEIFSLGGTPYPGMIV 345
Query: 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
Y R P+ + ++ I+ CW +P RPSF + ++ + L
Sbjct: 346 DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 74/225 (32%), Positives = 108/225 (48%), Gaps = 42/225 (18%)
Query: 66 IGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G GA+G V + R G + VAIK L R S+ L R RE+ ++ +KH+N++
Sbjct: 23 VGSGAYGTVCSALDRRTGAK-VAIKKLYRPFQSE---LFAKRAYRELRLLKHMKHENVIG 78
Query: 123 FLGACKDPLMVIVTELLPGMSLRK----YLVS----------LRPNKLDLHVALNFALDI 168
L P +SL + YLV ++ KL +
Sbjct: 79 LLDV-----------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM 127
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 228
+ + +HA GIIHRDLKP NL + D + LK+ DFGLAR +T +E MT T + AP
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR-QTDSE-MTGYVVTRWYRAP 184
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
E V L HY VD++S G ++ E+LT + F+G +L
Sbjct: 185 E----VILNW---MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 65/231 (28%), Positives = 115/231 (49%), Gaps = 20/231 (8%)
Query: 95 SDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP 153
+DER R E++ ++ H +VK K D ++++ E G L K +
Sbjct: 104 NDERQAAYAR--SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK 161
Query: 154 NKL---DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210
L + V L F I A+D +H+ ++HRDLK N+ L P +KL DFG +++
Sbjct: 162 EHLPFQEYEVGLLF-YQIVLALDEVHSRKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQY 219
Query: 211 TVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
+ + ++ ++ GT ++APEL+ E+K Y+ K D++S G++L+ELLT PF
Sbjct: 220 SDSVSLDVASSFCGTPYYLAPELW--------ERKRYSKKADMWSLGVILYELLTLHRPF 271
Query: 268 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 318
+G S + + P P +S + ++ ++P LRP+ Q++
Sbjct: 272 KGPSQREIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 72/237 (30%), Positives = 116/237 (48%), Gaps = 25/237 (10%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGST---SDERALLEGRFIREVNMMSRVKHDNL 120
IG GA G+V R+ ++ A+K+L++ SD E R ++M+ +
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER-----DIMAFANSPWV 105
Query: 121 VKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHAN 178
V+ A +D + +V E +PG L + + P K A + ++ A+D +H+
Sbjct: 106 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKW----AKFYTAEVVLALDAIHSM 161
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
G+IHRD+KPDN+LL LKLADFG + T M+ +T GT +++PE+ +
Sbjct: 162 GLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS--- 217
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPEDI 292
QG +Y + D +S G+ L+E+L PF S L Y+ H PED+
Sbjct: 218 -QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-LVGTYSKIMDHKNSLNFPEDV 272
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-17
Identities = 76/277 (27%), Positives = 121/277 (43%), Gaps = 41/277 (14%)
Query: 66 IGEGAHGKVYEG---RYGDRI------VAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
+G+G K+++G GD V +KVL+ R E F +MMS++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD----KSHRNYSES-FFEAASMMSQLS 57
Query: 117 HDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
H +LV G C + +MV E + SL YL N +++ L A +A A+
Sbjct: 58 HKHLVLNYGVCVCGDESIMV--QEYVKFGSLDTYL-KKNKNLINISWKLEVAKQLAWALH 114
Query: 174 CLHANGIIHRDLKPDNLLLT--PDQKS-----LKLADFGLAREETVTEMMTAETGTYRWM 226
L G+ H ++ N+LL D+K+ +KL+D G++ E++ W+
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI---PWV 171
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 285
PE ++ + D +SFG LWE+ + P +S L + F R
Sbjct: 172 PPECIE-------NPQNLSLAADKWSFGTTLWEIFSGGDKP---LSALDSQKKLQFYEDR 221
Query: 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322
LP +LA ++ C +P+ RPSF IIR LN
Sbjct: 222 HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 60/189 (31%), Positives = 96/189 (50%), Gaps = 14/189 (7%)
Query: 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 191
+ V E L G L ++ S +K DL A +A +I + LH+ GI++RDLK DN+L
Sbjct: 71 LFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL 128
Query: 192 LTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 250
L D +K+ADFG+ +E + + T GT ++APE+ G+K YN VD
Sbjct: 129 LDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL------LGQK--YNTSVDW 179
Query: 251 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 310
+SFG++L+E+L + PF G + + + P P ++ + I+ +V +P
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHD--EEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237
Query: 311 RPSFSQIIR 319
R IR
Sbjct: 238 RLGVKGDIR 246
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-17
Identities = 66/248 (26%), Positives = 111/248 (44%), Gaps = 23/248 (9%)
Query: 84 VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGM 142
VAI L R SD++ F+ E + + H N+V+ G + M+IVTE +
Sbjct: 36 VAIHTL-RAGCSDKQRR---GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNG 91
Query: 143 SLRKYLVSLRPNKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
+L +L R ++ L + +A M L G +H+ L +L+ D K
Sbjct: 92 ALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCK 147
Query: 201 LADFGLAREETVTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 258
++ F +E+ + T +G W APE ++ H+++ DV+SFGIV+W
Sbjct: 148 ISGFRRLQEDKSEAIYTTMSGKSPVLWAAPE-----AIQYH---HFSSASDVWSFGIVMW 199
Query: 259 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 317
E+++ P+ MS Q A R P + L ++ CW ++ RP FSQI
Sbjct: 200 EVMSYGERPYWDMSG-QDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258
Query: 318 IRMLNAFL 325
+L+ +
Sbjct: 259 HSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 68/222 (30%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 65 KIGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
IG GA+G V + R G + VAIK + A R +RE+ ++ KHDN++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKK-VAIKKIPHAFDVPTLA---KRTLRELKILRHFKHDNII 67
Query: 122 KFLGACKDPLM--------VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
A +D L V V L L + S +P L F + R +
Sbjct: 68 ----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP--LTEEHIRYFLYQLLRGLK 121
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-----ETVTEMMTAETGTYRWM-A 227
+H+ +IHRDLKP NLL+ D L++ DFG+AR MT T RW A
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RWYRA 179
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
PEL ++ Y +D++S G + E+L R F G
Sbjct: 180 PELLLSL-------PEYTTAIDMWSVGCIFAEMLGRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 18/209 (8%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
K+GEG + V++GR + +VA+K + +E A IREV+++ +KH N+V
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTA--IREVSLLKDLKHANIVT 68
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
D + +V E L L++Y+ N + +H F I R + H ++
Sbjct: 69 LHDIVHTDKSLTLVFEYL-DKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVL 126
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ ++ LKLADFGLAR ++V T+ + E T + P+ V L E
Sbjct: 127 HRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD----VLLGSSE 181
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
Y+ ++D++ G + +E+ + R F G
Sbjct: 182 ---YSTQIDMWGVGCIFFEMASGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 74/238 (31%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGST---SDERALLEGRFIREVNMMSRVKHDNL 120
IG GA G+V R+ ++ A+K+L++ SD E R I M+ + +
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI-----MAHANSEWI 105
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNFALDIARAMDCLHAN 178
V+ A +D + +V E +PG L V+L N + A + ++ A+D +H+
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDL----VNLMSNYDIPEKWARFYTAEVVLALDAIHSM 161
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
G IHRD+KPDN+LL LKLADFG + M+ +T GT +++PE V
Sbjct: 162 GFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE----VLK 216
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPEDIS 293
QG +Y + D +S G+ L+E+L PF S L Y+ H P+DI
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMDHKNSLTFPDDIE 273
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 7e-17
Identities = 81/306 (26%), Positives = 136/306 (44%), Gaps = 63/306 (20%)
Query: 60 LFIGSKIGEGAHGKVY----EG----------RYGDR--IVAIKVLNRGSTSDERALLEG 103
L + K+GEG G+V+ EG + + +VA+K+L T R
Sbjct: 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR----N 62
Query: 104 RFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 161
F++E+ +MSR+K+ N+++ LG C DPL ++TE + L ++L S R + A
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPL-CMITEYMENGDLNQFL-SQREIESTFTHA 120
Query: 162 -----------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210
L A+ IA M L + +HRDL N L+ + ++K+ADFG++R
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG-NHYTIKIADFGMSRNL 179
Query: 211 TVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL--LTNRL 265
+ + RWMA + ++ L + + DV++FG+ LWE+ L
Sbjct: 180 YSGDYYRIQGRAVLPIRWMA---WESILLGK-----FTTASDVWAFGVTLWEMFTLCKEQ 231
Query: 266 PFEGMSNLQAAYAAA----------FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 315
P+ +S+ Q + P P SP +++ CW D RP+F+
Sbjct: 232 PYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCP---SPVFKLMMR-CWSRDIKDRPTFN 287
Query: 316 QIIRML 321
+I L
Sbjct: 288 KIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 68/264 (25%), Positives = 118/264 (44%), Gaps = 21/264 (7%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRF---IREVNMMSRVKHDN 119
++G+G +G VY+ + +A+K + L E +F I E++++ +
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEI-------RLELDESKFNQIIMELDILHKAVSPY 60
Query: 120 LVKFLGA-CKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIARAMDCL-H 176
+V F GA + + + E + SL K Y + + V + + + L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
+ IIHRD+KP N+L+ +KL DFG++ V + G +MAPE +
Sbjct: 121 EHNIIHRDVKPTNVLVN-GNGQVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGP 178
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPEDISP 294
Q Y + DV+S G+ + E+ R P+ E +N+ A +A P LP S
Sbjct: 179 NQ--NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236
Query: 295 DLAFIVQSCWVEDPNLRPSFSQII 318
D V C + PN RP+++Q++
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 70/267 (26%), Positives = 126/267 (47%), Gaps = 19/267 (7%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I KIG G +VY + VA+K + D +A + ++E++++ ++ H N
Sbjct: 6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQD--CVKEIDLLKQLNHPN 63
Query: 120 LVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLH 176
++K+L + +D + IV EL L + + + K + + + + A++ +H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVT 235
+ ++HRD+KP N+ +T +KL D GL R + T + GT +M+PE
Sbjct: 124 SRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE------ 176
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHARPGLP-EDIS 293
+ + YN K D++S G +L+E+ + PF G NL + + P LP E S
Sbjct: 177 --RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIRM 320
L +V C DP+ RP + ++
Sbjct: 235 EKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 73/263 (27%), Positives = 131/263 (49%), Gaps = 24/263 (9%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
++G G +G VY+ R + + A+K++ + D+ +L++ +E+ M+ KH N+V
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKII-KLEPGDDFSLIQ----QEIFMVKECKHCNIVA 70
Query: 123 FLGA--CKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+ G+ ++ L I E G SL+ Y V+ ++L + L + + LH+ G
Sbjct: 71 YFGSYLSREKLW-ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---QGLAYLHSKG 126
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQ 238
+HRD+K N+LLT D +KLADFG+A + T T + GT WMAPE+ + V
Sbjct: 127 KMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV-AAVEKNG 184
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED---ISPD 295
G YN D+++ GI EL + P + ++A + + + +P +D S
Sbjct: 185 G----YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240
Query: 296 LAFIVQSCWVEDPNLRPSFSQII 318
V+ ++P RP+ +++
Sbjct: 241 FHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 72/243 (29%), Positives = 110/243 (45%), Gaps = 52/243 (21%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIK-VLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
I K+GEG G+VY+ R R+VA+K +L +E+ +RE+ ++ ++KH
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKHP 67
Query: 119 NLVKFLGACKDPLMVIVTELLPGMSLRK----YLVS---------LRPN---KLDLHVAL 162
N+V + M + P S RK Y+V+ L N KL
Sbjct: 68 NVVPLID------MAVER---PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK 118
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAET 220
+ L + ++ LH N I+HRD+K N+L+ +Q LK+ADFGLAR +
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 221 GT---Y------RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270
G Y RW PEL GE++ Y VD++ G V E+ T R +G
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLL------GERR-YTTAVDIWGIGCVFAEMFTRRPILQGK 230
Query: 271 SNL 273
S++
Sbjct: 231 SDI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 1e-16
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
K+GEG++ VY+G+ ++VA+KV+ E IRE +++ +KH N+V
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRL----QEEEGTPFTAIREASLLKGLKHANIVL 67
Query: 123 F--LGACKDPLMVIV----TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+ K+ L ++ T+L M K+ L P + L F + R + +H
Sbjct: 68 LHDIIHTKETLTLVFEYVHTDLCQYMD--KHPGGLHPENVKL-----FLFQLLRGLSYIH 120
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
I+HRDLKP NLL++ D LKLADFGLAR ++V + W P V L
Sbjct: 121 QRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP---PDVLL 176
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
E Y+ +D++ G + E++ F GM ++Q
Sbjct: 177 GSTE---YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 62/217 (28%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEG---RFIREVNMMSRVKHDN 119
K+GEG++ VY+G R ++VA+KV++ + EG IRE +++ +KH N
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTE-------EGVPFTAIREASLLKGLKHAN 64
Query: 120 LVKF--LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+V + K+ L + + L +Y++ P L + F + R + +H
Sbjct: 65 IVLLHDIIHTKETLTFVFEYM--HTDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHG 121
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTL 236
I+HRDLKP NLL++ LKLADFGLAR +++ ++ ++E T + P++ T
Sbjct: 122 QHILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT- 179
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
Y++ +D++ G + E+L + F G+S++
Sbjct: 180 ------DYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG GA+G V + + VAIK + + A R +RE+ ++ + H+N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAK---RTLREIKLLRHLDHENVI-- 67
Query: 124 LGACKDPLM----------VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
A KD + IV EL+ L + + S + D H F + R +
Sbjct: 68 --AIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDD-HCQY-FLYQLLRGLK 122
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYS 232
+H+ ++HRDLKP NLLL + LK+ DFGLAR + + MT T + APEL
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y +DV+S G + ELL + F G
Sbjct: 182 NCS-------EYTTAIDVWSVGCIFAELLGRKPLFPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 19/182 (10%)
Query: 151 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210
L L L + ++ +A+ M+ L + IHRDL N+LL+ + +K+ DFGLAR+
Sbjct: 171 LYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARD- 228
Query: 211 TVTEMMTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 264
+ G R WMAPE ++ V Y + DV+SFG++LWE+ +
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIFDRV---------YTIQSDVWSFGVLLWEIFSLGA 279
Query: 265 LPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
P+ G+ + + K R P+ +P++ + CW +P+ RP+FS+++ L
Sbjct: 280 SPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338
Query: 324 FL 325
L
Sbjct: 339 LL 340
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 82/284 (28%), Positives = 136/284 (47%), Gaps = 33/284 (11%)
Query: 61 FIGSKIGEGAHGKV-YEGRYGD-RIVAIKVLN-RGSTSDE--RALLEGRFIREVNMMSRV 115
+I +G GA G V R D A+KV++ G + + RA E + + S V
Sbjct: 35 WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIV 94
Query: 116 K-HDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVS-LRPNK-LDLHVALNFA 165
K H++ K KDP ++ +V + LR+ + S + N+ H A
Sbjct: 95 KCHEDFAK-----KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGT 222
+ + A+ +H+ +IHRD+K N+LL + +KL DFG ++ T ++ GT
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGT 208
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
++APE++ +K Y+ K D++S G++L+ELLT + PF+G N++
Sbjct: 209 PYYVAPEIW--------RRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLA 259
Query: 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326
LP ISP++ IV + DP RPS S+++ M LF
Sbjct: 260 GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303
|
Length = 496 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 63/232 (27%)
Query: 64 SKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGR---F----IREVNMMSR 114
+KIG+G G+V++ R +IVA+K + L+E F +RE+ ++
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALK----------KVLMENEKEGFPITALREIKILQL 67
Query: 115 VKHDNLVKFLGACKDPLMVIVTELLPGMSLRK--YLV---------SLRPNKLDLHVALN 163
+KH+N+V + C+ T+ P + YLV L NK +
Sbjct: 68 LKHENVVNLIEICR-------TKATPYNRYKGSFYLVFEFCEHDLAGLLSNK-----NVK 115
Query: 164 FAL-DIARAMDCL-------HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EE 210
F L +I + M L H N I+HRD+K N+L+T D LKLADFGLAR +
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKN 174
Query: 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
+ T T + PEL GE + Y +D++ G ++ E+ T
Sbjct: 175 SKPNRYTNRVVTLWYRPPELL------LGE-RDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 66 IGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G GA+G V Y+ R + VA+K L+R S A R RE+ ++ +KH+N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK-VAVKKLSRPFQSLIHAR---RTYRELRLLKHMKHENVIG 78
Query: 123 FLGACKDPLMVIVTELLPGMSLRK----YLVS----------LRPNKL-DLHVALNFALD 167
L P S+ YLV+ ++ KL D HV
Sbjct: 79 LLDV-----------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQ 126
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 227
+ R + +H+ GIIHRDLKP N+ + D + L++ DFGLAR+ + MT T + A
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQ--ADDEMTGYVATRWYRA 183
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
PE+ HYN VD++S G ++ ELL + F G
Sbjct: 184 PEIMLNWM-------HYNQTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFI---REVNMMSRVKHDNL 120
IG+G+ GKV ++ + A+KVL + + ++ E + I R V ++ VKH L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK---EQKHIMAERNV-LLKNVKHPFL 58
Query: 121 V--KFLGACKDPLMVIVT-----ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
V + D L ++ EL + + R A +A +IA A+
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR--------ARFYAAEIASALG 110
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYS 232
LH+ II+RDLKP+N+LL Q + L DFGL +E T+ GT ++APE+
Sbjct: 111 YLHSLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV-- 167
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
LR K+ Y+ VD + G VL+E+L PF
Sbjct: 168 ---LR---KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 75/267 (28%), Positives = 123/267 (46%), Gaps = 32/267 (11%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+IG GA G VY+ + R+ A+KV+ G+ D + + RE+ ++ V H N+VK
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDT---VRRQICREIEILRDVNHPNVVK 136
Query: 123 FLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
C D + ++ E + G SL ++ D+ A I + LH
Sbjct: 137 ----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV------ARQILSGIAYLHR 186
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTV 234
I+HRD+KP NLL+ K++K+ADFG++R + + M + GT +M+PE +T
Sbjct: 187 RHIVHRDIKPSNLLIN-SAKNVKIADFGVSR--ILAQTMDPCNSSVGTIAYMSPERINT- 242
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE-GMSNLQAAYAAAFKHAR-PGLPEDI 292
L G Y D++S G+ + E R PF G A+ A ++ P P
Sbjct: 243 DLNHGAYDGYAG--DIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA 300
Query: 293 SPDLAFIVQSCWVEDPNLRPSFSQIIR 319
S + + C +P R S Q+++
Sbjct: 301 SREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 64 SKIGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSD----ERALLEGRFIREVNMMSRVKH 117
+ +G G GKV E + + AIK L +G E + E R N +H
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN---SERH 61
Query: 118 DNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
LV + V V E G L ++ + + A+ +A + + LH
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDL---MMHIHTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVT 235
N I++RDLK DNLLL + +K+ADFGL +E T+ GT ++APE+ +
Sbjct: 119 ENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT--- 174
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y VD + G++++E+L PF G
Sbjct: 175 -----ETSYTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 69/236 (29%), Positives = 112/236 (47%), Gaps = 25/236 (10%)
Query: 66 IGEGAHGKV--YEGRYGDRIVAIKVLNRGST---SDERALLEGRFIREVNMMSRVKHDNL 120
IG GA G+V + ++ A+K+L++ SD E R ++M+ +
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER-----DIMAFANSPWV 105
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHAN 178
V+ A +D + +V E +PG L + + P K A + ++ A+D +H+
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW----ARFYTAEVVLALDAIHSM 161
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
G IHRD+KPDN+LL LKLADFG + M+ +T GT +++PE+ +
Sbjct: 162 GFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS--- 217
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPED 291
QG +Y + D +S G+ L+E+L PF S L Y+ H P+D
Sbjct: 218 -QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMNHKNSLTFPDD 271
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-16
Identities = 60/214 (28%), Positives = 109/214 (50%), Gaps = 15/214 (7%)
Query: 62 IGSKIGEGAHGKVY---EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+ S +G G G+V E GD I A+KV+ + + + F E +++S
Sbjct: 5 VKSLVGRGHFGEVQVVREKATGD-IYAMKVMKKSVLLAQETV--SFFEEERDILSISNSP 61
Query: 119 NLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+ + A +D + +V E PG L L++ ++ D +A + ++ A+ +H
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 178 NGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAE--TGTYRWMAPELYSTV 234
G +HRD+KP+N+L+ D+ +KLADFG A T +M+ ++ GT ++APE+ +
Sbjct: 121 MGYVHRDIKPENVLI--DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT-- 176
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
T+ K Y + D +S G++ +E++ R PF
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 77/332 (23%), Positives = 120/332 (36%), Gaps = 86/332 (25%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ IG GA G+V+ R ++ A+KVL + ++ +++ H
Sbjct: 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK---------------SDMIKRNQIAHVR 49
Query: 120 LVK-FLGACKDPLMV-------------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
+ L P +V +V E +PG L L+ R + A +
Sbjct: 50 AERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI--RKDVFPEETARFYI 107
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-------------REETV 212
++ A+D +H G IHRD+KPDN+L+ D +KLADFGL +
Sbjct: 108 AELVLALDSVHKLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 213 TEMMTAET-----------------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 255
GT ++APE V Y + D +S G+
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE----VLRGTP----YGLECDWWSLGV 218
Query: 256 VLWELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPED--ISPDLAFIVQSCWVEDPNLR- 311
+L+E+L PF LQ Y P D +SP+ ++ + DP R
Sbjct: 219 ILYEMLYGFPPFYS-DTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRL-LCDPEDRL 276
Query: 312 PSFSQIIRMLNAFLFT------LRPPSPSVPE 337
SF +I + F P VPE
Sbjct: 277 GSFEEIKS--HPFFKGIDWENLRETKPPFVPE 306
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 8e-16
Identities = 51/158 (32%), Positives = 84/158 (53%), Gaps = 12/158 (7%)
Query: 155 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214
+ DL+ A +A +I + LH+ GII+RDLK DN++L D +K+ADFG+ +E +
Sbjct: 92 RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGD 150
Query: 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
+ GT ++APE+ QG K Y VD +SFG++L+E+L + PF G +
Sbjct: 151 NRASTFCGTPDYIAPEIL------QGLK--YTFSVDWWSFGVLLYEMLIGQSPFHG--DD 200
Query: 274 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 311
+ + + P P I+ + I++ + DP R
Sbjct: 201 EDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 9e-16
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 66 IGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G GA+G V + R G++ VAIK L+R S+ + R RE+ ++ ++H+N++
Sbjct: 23 VGSGAYGSVCSAIDKRTGEK-VAIKKLSRPFQSE---IFAKRAYRELTLLKHMQHENVIG 78
Query: 123 ----FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
F A ++P M + L + + L + + +H+
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYM--QTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
GIIHRDLKP NL + D + LK+ DFGLAR MT T + APE V L
Sbjct: 137 GIIHRDLKPGNLAVNEDCE-LKILDFGLARHADAE--MTGYVVTRWYRAPE----VILNW 189
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
HYN VD++S G ++ E+LT + F+G
Sbjct: 190 ---MHYNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 34/278 (12%)
Query: 65 KIGEGAHGKV-----YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+IG G GKV Y R+V +K L ++S E + F+++ + ++H N
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVV-VKELKANASSKE----QNEFLQQGDPYRILQHPN 56
Query: 120 LVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL--NFALDIARAMDCLH 176
+++ LG C + + ++V E L+ YL + ++ + + L A +IA + +H
Sbjct: 57 ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYST 233
+ +H DL N LT D ++K+ D+G+ + + E RW+APEL
Sbjct: 117 KHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL--- 172
Query: 234 VTLRQG-----EKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNL----QAAYAAAFKH 283
V G E+ +N V++ G+ LWEL N P+ +S+ K
Sbjct: 173 VGEFHGGLITAEQTKPSN---VWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL 229
Query: 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
+P L S ++Q CW+ P R + ++ R+L
Sbjct: 230 FKPQLELPYSERWYEVLQFCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 73/263 (27%), Positives = 123/263 (46%), Gaps = 22/263 (8%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+IG G +G VY+ R + + AIKV+ D + + E+ MM KH N+V
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ-----EIIMMKDCKHSNIVA 70
Query: 123 FLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ G+ +D L I E G SL+ P + +A + + + + LH+ G
Sbjct: 71 YFGSYLRRDKLW-ICMEFCGGGSLQDIYHVTGPLS-ESQIAY-VSRETLQGLYYLHSKGK 127
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQG 239
+HRD+K N+LLT D +KLADFG++ + T T + GT WMAPE+ +
Sbjct: 128 MHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV-----E 181
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED---ISPDL 296
K YN D+++ GI EL + P + ++A + + +P +D S
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241
Query: 297 AFIVQSCWVEDPNLRPSFSQIIR 319
V+ ++P RP+ ++++
Sbjct: 242 HHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 70/219 (31%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG GA G V +R VAIK L+R + A R RE+ +M V H N++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVNHKNIIGL 88
Query: 124 LGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHVALNFALDIAR------AMDC 174
L P SL ++ + + +L + LD R M C
Sbjct: 89 LNV-----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC 137
Query: 175 ----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 230
LH+ GIIHRDLKP N+++ D +LK+ DFGLAR + MMT T + APE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE- 195
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
V L G Y VD++S G ++ E++ + F G
Sbjct: 196 ---VILGMG----YKENVDIWSVGCIMGEMIKGGVLFPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 73/265 (27%), Positives = 124/265 (46%), Gaps = 38/265 (14%)
Query: 66 IGEGAHGKVY-----EGRYGDRIVAIKVLNRGS----------TSDERALLEGRFIREVN 110
+G GA+GKV+ G ++ A+KVL + + T ER +LE +R+
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE--HVRQSP 65
Query: 111 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+ + + F K + ++ + + G + +L R N + V ++ +I
Sbjct: 66 FLVTLHY----AFQTEAK---LHLILDYVSGGEMFTHLYQ-RDNFSEDEVRF-YSGEIIL 116
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAP 228
A++ LH GI++RD+K +N+LL + + L DFGL++E E + GT +MAP
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARP 286
E+ +G+ H VD +S GI+++ELLT PF EG N Q+ + P
Sbjct: 176 EII------RGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP 228
Query: 287 GLPEDISPDLAFIVQSCWVEDPNLR 311
P I P+ ++ +DP R
Sbjct: 229 PFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 75/221 (33%), Positives = 103/221 (46%), Gaps = 42/221 (19%)
Query: 66 IGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG GA G V Y+ DR VAIK L+R + A R RE+ +M V H N++
Sbjct: 25 IGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVNHKNIIS 80
Query: 123 FLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLHVALNFALDIAR------AM 172
L P SL + YLV + +L + LD R M
Sbjct: 81 LLNV-----------FTPQKSLEEFQDVYLV-MELMDANLCQVIQMELDHERMSYLLYQM 128
Query: 173 DC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 228
C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR + MMT T + AP
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
E V L G Y VD++S G ++ E++ +++ F G
Sbjct: 188 E----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G+G G+V + ++ A K L++ + E + E ++ +V +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG--EQMALNEKKILEKVSSRFIVSL 58
Query: 124 LGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
A KD L +++T L+ G L+ ++ ++ A+ +A I ++ LH I+
Sbjct: 59 AYAFETKDDLCLVMT-LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
+RDLKP+N+LL D +++++D GLA E + + GT +MAPE+ +
Sbjct: 118 YRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL--------QG 168
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPF 267
+ Y+ VD ++ G L+E++ R PF
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-15
Identities = 70/258 (27%), Positives = 114/258 (44%), Gaps = 30/258 (11%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G G G VY+ + RI+A+KV+ T + L+ + + E+ ++ + ++ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE----LQKQIMSELEILYKCDSPYIIGF 64
Query: 124 LGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
GA + + I TE + G SL Y K+ HV A+ + + + L + I+H
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILH 118
Query: 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 242
RD+KP N+L+ + +KL DFG++ + V + GT +MAPE S GE+
Sbjct: 119 RDVKPSNMLVN-TRGQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPERIS------GEQ- 169
Query: 243 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA------AAFKHARPGLPE-DISPD 295
Y DV+S GI EL R P+ + Q + P LP S
Sbjct: 170 -YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK 228
Query: 296 LAFIVQSCWVEDPNLRPS 313
+ C + P RP+
Sbjct: 229 FVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 45/115 (39%), Positives = 62/115 (53%), Gaps = 25/115 (21%)
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---------------EETVTEM 215
A++ LH GI+HRDLKPDNLL+T +KL DFGL++ E+ E
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 216 MTAET-GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ + GT ++APE V LRQG Y VD ++ GI+L+E L +PF G
Sbjct: 172 LDKQVCGTPEYIAPE----VILRQG----YGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 52/181 (28%), Positives = 83/181 (45%), Gaps = 27/181 (14%)
Query: 84 VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGM 142
V +K+ +G+T L+E ++ VN H ++++ + +V LP
Sbjct: 94 VVLKIGQKGTT-----LIEAMLLQNVN------HPSVIRMKDTLVSGAITCMV---LPHY 139
Query: 143 S--LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
S L YL + R L + AL I + LHA IIHRD+K +N+ + D +
Sbjct: 140 SSDLYTYL-TKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN-DVDQVC 197
Query: 201 LADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260
+ D G A+ V GT APE+ + + YN+K D++S GIVL+E+
Sbjct: 198 IGDLGAAQFPVVAPAFLGLAGTVETNAPEVLA--------RDKYNSKADIWSAGIVLFEM 249
Query: 261 L 261
L
Sbjct: 250 L 250
|
Length = 357 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 71/268 (26%), Positives = 123/268 (45%), Gaps = 24/268 (8%)
Query: 10 RVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEG 69
++ E+E++ + G E E + + + I+RS KL G+ IG G
Sbjct: 30 MNDKKLDEEERSHNNNAGEDEDEEKMIDND---------INRSPNKSYKL---GNIIGNG 77
Query: 70 AHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127
+ G VYE D VAIK + + R LL + + +N++ + F
Sbjct: 78 SFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137
Query: 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN--FALDIARAMDCLHANGIIHRDL 185
K+ + +V E +P ++ KY+ N L + L ++ + RA+ +H+ I HRDL
Sbjct: 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDL 196
Query: 186 KPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 245
KP NLL+ P+ +LKL DFG A+ + + + + APEL T +Y
Sbjct: 197 KPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT-------NYT 249
Query: 246 NKVDVYSFGIVLWELLTNRLPFEGMSNL 273
+D++S G ++ E++ F G S++
Sbjct: 250 THIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 35/223 (15%)
Query: 65 KIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVK-HDNLVK 122
++G+GA+G V R + V + T+ + +L R +RE+ ++ + H N+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 123 FLGACKDPLMVIVT----------ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
M IV E L L + + S +P D H +F I +
Sbjct: 67 LYD------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT-DAHFQ-SFIYQILCGL 118
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRWM- 226
+H+ ++HRDLKP NLL+ D + LK+ DFGLAR MT T RW
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLARGFSENPGENAGFMTEYVAT-RWYR 176
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
APE+ + + Y +DV+S G +L ELL + F+G
Sbjct: 177 APEIMLSF-------QSYTKAIDVWSVGCILAELLGRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 66 IGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G G++G V+ D+ VA+K + +D +++ +RE+ ++ R+ HDN+VK
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHA--LREIKIIRRLDHDNIVKV 67
Query: 124 ---LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN-----------FALDIA 169
LG L V L L + + DL L F +
Sbjct: 68 YEVLGPSGSDLTEDVGSL---TELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL 124
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR------EETVTEMMTAETGTY 223
R + +H+ ++HRDLKP N+ + + LK+ DFGLAR T Y
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
R +P L + +Y +D+++ G + E+LT + F G L+
Sbjct: 185 R--SPRLLLSPN-------NYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 67/225 (29%), Positives = 110/225 (48%), Gaps = 42/225 (18%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG G++ KV E + RI A+KV+ + +D+ +++ + KH F
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDE---------DIDWVQTEKH----VF 49
Query: 124 LGACKDPLMV-------------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
A P +V V E + G L ++ R KL A ++ +I+
Sbjct: 50 ETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISL 107
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPE 229
A++ LH GII+RDLK DN+LL + +KL D+G+ +E T+ GT ++APE
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPE 166
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE--GMSN 272
+ LR GE Y VD ++ G++++E++ R PF+ GMS+
Sbjct: 167 I-----LR-GED--YGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 60/241 (24%), Positives = 98/241 (40%), Gaps = 58/241 (24%)
Query: 61 FIGSKIGEGAHGKVYEGR----YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
G IG G +G+VY+ + + AIK ++ + RE+ ++ +K
Sbjct: 4 IEG-CIGRGTYGRVYKAKRKNGKDGKEYAIKKFK--GDKEQYTGISQSACREIALLRELK 60
Query: 117 HDNLVKFLGACKDPLMVIVTELLPGMSL-----------------RKYLVSLRPN--KLD 157
H+N+V + V + + L + VS+ P+ K
Sbjct: 61 HENVVSLVE-------VFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAR------ 208
L LN + LH+N ++HRDLKP N+L+ P++ +K+ D GLAR
Sbjct: 114 LWQILN-------GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
+ T YR APEL +HY +D+++ G + ELLT F+
Sbjct: 167 KPLADLDPVVVTIWYR--APELLLGA-------RHYTKAIDIWAIGCIFAELLTLEPIFK 217
Query: 269 G 269
G
Sbjct: 218 G 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 14/150 (9%)
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 221
+ +I A+D LH+ I++RDLK +NL+L D +K+ DFGL + E +T+ T +T G
Sbjct: 100 YGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCK-EGITDAATMKTFCG 157
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281
T ++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 158 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209
Query: 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 311
+ + P +S D ++ ++DPN R
Sbjct: 210 EDIK--FPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+GEGA+G V + R+ + IVAIK + S+E ++ +RE+ M+ +K +N+V+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIK---KFKDSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 124 LGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
A + + +V E + L L+ PN + ++ + +A+ H N I+H
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123
Query: 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 242
RD+KP+NLL++ + LKL DFG AR ++E A Y +A Y + L G
Sbjct: 124 RDIKPENLLISHND-VLKLCDFGFAR--NLSEGSNANYTEY--VATRWYRSPELLLGAP- 177
Query: 243 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
Y VD++S G +L EL + F G S +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRG----STSDERALLEGRFIREVNMMSRVKHDN 119
+G+G+ GKV R R+ A+KVL + E + E R + ++R H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILS----LAR-NHPF 57
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
L + + P + V E + G L ++ R + D A +A +I A+ LH
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDK 115
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLR 237
GII+RDLK DN+LL + KLADFG+ +E T+ GT ++APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHC-KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL------ 168
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
++ Y VD ++ G++L+E+L PFE
Sbjct: 169 --QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 39/137 (28%), Positives = 78/137 (56%), Gaps = 9/137 (6%)
Query: 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 191
+ +V L+ G L+ ++ ++ L++ ++++ I + LH+ I++RD+KP+N+L
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127
Query: 192 LTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 251
L DQ + +L+D GLA E + +T GT +MAPE+ +++ Y+ VD +
Sbjct: 128 LD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL--------KEEPYSYPVDWF 178
Query: 252 SFGIVLWELLTNRLPFE 268
+ G ++E++ R PF+
Sbjct: 179 AMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 40/112 (35%), Positives = 67/112 (59%), Gaps = 12/112 (10%)
Query: 160 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 219
A+ +A +IA + LH+ GII+RDLK DN++L + +K+ADFG+ +E + T
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKEN-IFGGKTTR 159
Query: 220 T--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
T GT ++APE+ + + Y VD ++FG++L+E+L + PF+G
Sbjct: 160 TFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 26/211 (12%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLV- 121
IG+G+ GKV R+ ++ A+KVL + + ++ E + E N ++ VKH LV
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE--EKHIMSERNVLLKNVKHPFLVG 60
Query: 122 -KFLGACKDPLMVIVTELLPG---MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
F D L ++ + G L++ L P A +A +IA A+ LH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR------ARFYAAEIASALGYLHS 114
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTL 236
I++RDLKP+N+LL Q + L DFGL +E T+ GT ++APE+
Sbjct: 115 LNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL----- 168
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
K+ Y+ VD + G VL+E+L PF
Sbjct: 169 ---HKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 42/228 (18%)
Query: 64 SKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
+IGEG +G+VY+ R +VA+K + +E+ IRE+ ++ ++ H N+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 122 KFLGACKDPLMVIVTELLPGMSLRK-----YLV---------SLRPNKL----DLHVALN 163
L IVT+ + +K YLV L + L + H+ +
Sbjct: 70 N--------LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-S 120
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETG 221
F + ++ H +HRD+K N+LL ++ +KLADFGLAR + T +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
T + PEL GE++ Y +DV+S G +L EL T + F+
Sbjct: 180 TLWYRPPELL------LGEER-YGPAIDVWSCGCILGELFTKKPIFQA 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G+G G+V + R ++ A K LN+ +R EG + E ++++V +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMV-EKRILAKVHSRFIVSL 58
Query: 124 LGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLHANG 179
A K L +++T ++ G LR ++ ++ A + I ++ LH
Sbjct: 59 AYAFQTKTDLCLVMT-IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT-AETGTYRWMAPELYSTVTLRQ 238
II+RDLKP+N+LL + +++++D GLA E + T GT +MAPEL Q
Sbjct: 118 IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL------Q 170
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
GE+ Y+ VD ++ G+ L+E++ R PF
Sbjct: 171 GEE--YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 72/226 (31%), Positives = 102/226 (45%), Gaps = 44/226 (19%)
Query: 66 IGEGAHGKVYEGRYGDRI----VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
IG GA G V D + VA+K L+R + A R RE+ ++ V H N++
Sbjct: 29 IGSGAQGIVCAAF--DTVLGINVAVKKLSRPFQNQTHA---KRAYRELVLLKCVNHKNII 83
Query: 122 KFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLHVALNFALDIAR------A 171
L P SL + YLV + +L ++ LD R
Sbjct: 84 SLLNV-----------FTPQKSLEEFQDVYLV-MELMDANLCQVIHMELDHERMSYLLYQ 131
Query: 172 MDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 227
M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR MMT T + A
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRA 190
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
PE V L G Y VD++S G ++ EL+ + F+G ++
Sbjct: 191 PE----VILGMG----YKENVDIWSVGCIMGELVKGSVIFQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 28/213 (13%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSD----ERALLEGRFIREVNMMSRVKHDN 119
+G+G+ GKV E + D + AIKVL + + + E R + ++ KH
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRIL----ALAA-KHPF 57
Query: 120 LVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
L L C KD L V E + G L + R K D + +A ++ A+ LH
Sbjct: 58 LTA-LHCCFQTKDRLF-FVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLH 113
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVT 235
+G+I+RDLK DN+LL + KLADFG+ +E + + T GT ++APE+
Sbjct: 114 RHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL---- 168
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
++ Y VD ++ G++++E++ + PFE
Sbjct: 169 ----QELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 41/111 (36%), Positives = 70/111 (63%), Gaps = 12/111 (10%)
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 220
A+ +A +IA + LH+ GII+RDLK DN++L + +K+ADFG+ + E + + +T +T
Sbjct: 103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCK-ENMWDGVTTKT 160
Query: 221 --GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
GT ++APE+ + + Y VD ++FG++L+E+L + PFEG
Sbjct: 161 FCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 36/106 (33%), Positives = 61/106 (57%), Gaps = 12/106 (11%)
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 221
+ +I A+ LH+ +++RDLK +NL+L D +K+ DFGL +E +++ T +T G
Sbjct: 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEG-ISDGATMKTFCG 157
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
T ++APE+ E Y VD + G+V++E++ RLPF
Sbjct: 158 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG+G G+VY+ R D RI A+KVL++ ++ + I E N++ R D F
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEV--AHTIGERNILVRTLLDE-SPF 57
Query: 124 LGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+ K D + +VT+ + G L +L + + A + ++ A++ LH
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
I++RDLKP+N+LL + L DFGL++ +T+ T T GT ++APE V L
Sbjct: 116 DIVYRDLKPENILLDAT-GHIALCDFGLSKAN-LTDNKTTNTFCGTTEYLAPE----VLL 169
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
++K Y VD +S G++++E+ PF
Sbjct: 170 ---DEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 39/111 (35%), Positives = 68/111 (61%), Gaps = 12/111 (10%)
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 220
A+ +A +I+ + LH GII+RDLK DN++L + +K+ADFG+ +E V + +T T
Sbjct: 103 AVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMV-DGVTTRT 160
Query: 221 --GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
GT ++APE+ + + Y VD +++G++L+E+L + PF+G
Sbjct: 161 FCGTPDYIAPEIIAY--------QPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 62 IGSKIGEGAHGKVYEGRYGDR--IVAIKVLNRGST----SDERALLEGRFIRE------V 109
+G +G G+ G+V ++ AIK L + + E + E V
Sbjct: 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 110 NMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
NMM + +N V FL E + G L +L + VA + ++
Sbjct: 82 NMMCSFQDENRVYFL-----------LEFVVGGELFTHLRK--AGRFPNDVAKFYHAELV 128
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGTYRWMAP 228
A + LH+ II+RDLKP+NLLL D K +K+ DFG A++ V + GT ++AP
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLL--DNKGHVKVTDFGFAKK--VPDRTFTLCGTPEYLAP 184
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
E+ + K + VD ++ G++L+E + PF
Sbjct: 185 EVI--------QSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 40/219 (18%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG G++ KV R D+I A+KV+ + D+ +++ + KH F
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDE---------DIDWVQTEKH----VF 49
Query: 124 LGACKDPLMV-------------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
A +P +V +V E + G L ++ R KL A +A +I
Sbjct: 50 EQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICI 107
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPE 229
A++ LH GII+RDLK DN+LL D +KL D+G+ +E T+ GT ++APE
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPE 166
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
+ +GE+ Y VD ++ G++++E++ R PF+
Sbjct: 167 IL------RGEE--YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 57/247 (23%), Positives = 105/247 (42%), Gaps = 45/247 (18%)
Query: 65 KIGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G+G G+V+ + ++ A+KVL++ + +E+ ++ + H L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDHPFLPT 65
Query: 123 FLGACKDPLMVI-VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ + + V + PG L + L L VA +A ++ A++ LH GI+
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLA----------------------REETVTEMMTAE 219
+RDLKP+N+LL + L+DF L+ +E + E
Sbjct: 126 YRDLKPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 220 T--------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
GT ++APE+ S + + VD ++ GI+L+E+L PF+G S
Sbjct: 185 PSFRSNSFVGTEEYIAPEVIS--------GDGHGSAVDWWTLGILLYEMLYGTTPFKG-S 235
Query: 272 NLQAAYA 278
N ++
Sbjct: 236 NRDETFS 242
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 69/258 (26%), Positives = 124/258 (48%), Gaps = 25/258 (9%)
Query: 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG G++ KV R +RI A+KV+ + +D+ + E ++ + + +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDI--DWVQTEKHVFEQASNHPFLVG 60
Query: 124 LGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
L +C + + V E + G L ++ R KL A ++ +I+ A++ LH GII
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGII 118
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGE 240
+RDLK DN+LL + +KL D+G+ +E T+ GT ++APE+ +GE
Sbjct: 119 YRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL------RGE 171
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFE--GMS-----NLQAAYAAAFKHARPGLPEDIS 293
Y VD ++ G++++E++ R PF+ G S N + + +P +S
Sbjct: 172 D--YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229
Query: 294 PDLAFIVQSCWVEDPNLR 311
A +++S +DP R
Sbjct: 230 VKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRG---STSDERALLEGRFIREVNMMSRVKHDNL 120
IG+G+ GKV + R D RI A+K + + S S+ L R ++++V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAER-----TVLAQVNCPFI 55
Query: 121 V--KFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
V KF + L +V + G L +L R + DL A + ++ A++ LH
Sbjct: 56 VPLKFSFQSPEKLY-LVLAFINGGELFHHL--QREGRFDLSRARFYTAELLCALENLHKF 112
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVTLR 237
+I+RDLKP+N+LL Q + L DFGL + + GT ++APEL
Sbjct: 113 NVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-- 169
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
Y VD ++ G++L+E+LT PF
Sbjct: 170 ------YTKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 42/150 (28%), Positives = 77/150 (51%), Gaps = 14/150 (9%)
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 221
+ +I A++ LH+ +++RD+K +NL+L D +K+ DFGL + E +++ T +T G
Sbjct: 100 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCK-EGISDGATMKTFCG 157
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281
T ++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 158 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 209
Query: 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 311
+ R P +SP+ ++ +DP R
Sbjct: 210 EEIR--FPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLVK 122
IG+G+ GKV + + + A+KVL + + + + + E N ++ VKH LV
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE--QKHIMAERNVLLKNVKHPFLVG 60
Query: 123 FLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ + + V + + G L +L R A +A +IA A+ LH+ I+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGE 240
+RDLKP+N+LL Q + L DFGL +E ++ T GT ++APE+ +R
Sbjct: 119 YRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV-----IR--- 169
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPF 267
K+ Y+N VD + G VL+E+L PF
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLVK 122
IG+G+ GKV + A+KVL + + ++ + + E N ++ +KH LV
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE--QNHIMAERNVLLKNLKHPFLVG 60
Query: 123 FLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ + + V + + G L +L R A +A ++A A+ LH+ II
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGE 240
+RDLKP+N+LL Q + L DFGL +E E T+ GT ++APE+ LR
Sbjct: 119 YRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV-----LR--- 169
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPF 267
K+ Y+ VD + G VL+E+L PF
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 47/231 (20%)
Query: 62 IGSKIGEGAHGKV---YEGRYGDRIVAIKVLNR--GSTSDERALLEGRFIREVNMMSRVK 116
I IG+G++G V + G++ VAIK +N SD R +RE+ ++ ++
Sbjct: 4 IQEVIGKGSYGVVCSAIDTHTGEK-VAIKKINDVFEHVSDAT-----RILREIKLLRLLR 57
Query: 117 HDNLVKFLGACKDPLMVIVTELLPG--MSLRKYLVSLRPNKLDLHVALN----------- 163
H ++V+ I +LP + V + DLH +
Sbjct: 58 HPDIVE-----------IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQ 106
Query: 164 -FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAE 219
F + RA+ +H + HRDLKP N+L D K LK+ DFGLAR +T T + +
Sbjct: 107 FFLYQLLRALKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTD 165
Query: 220 TGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
RW APEL + + Y +D++S G + E+LT + F G
Sbjct: 166 YVATRWYRAPELCGSFFSK------YTPAIDIWSIGCIFAEVLTGKPLFPG 210
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 32/158 (20%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
I GA GKVY GR + ++ A+KV+ + ++ NM+ +V+ +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINK------------NMVHQVQAER--DA 57
Query: 124 LGACKDPLMV-------------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
L K P +V +V E L G ++ L D +A+ + ++A
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVAL 115
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
A+D LH +GIIHRDLKPDN+L++ ++ +KL DFGL++
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 62/234 (26%), Positives = 95/234 (40%), Gaps = 40/234 (17%)
Query: 105 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 163
F ++MS+V H +L G C + ++V E + L V LR K + VA
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD---VCLRKEKGRVPVAWK 119
Query: 164 F--ALDIARAMDCLHANGIIHRDLKPDNLLLT------PDQKSLKLADFG-----LAREE 210
A +A A+ L ++H ++ N+LL +KL+D G L+REE
Sbjct: 120 ITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE 179
Query: 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270
V + W+APE + D +SFG L E+ F+G
Sbjct: 180 RVERI--------PWIAPECVPGGN-------SLSTAADKWSFGTTLLEIC-----FDGE 219
Query: 271 SNLQAAYAAA---FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
L+ + F + LPE +LA ++ C +P RPSF I+R L
Sbjct: 220 VPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 40/233 (17%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG+G G+VY R VA+K + R S+ LL+ RF+RE + + + H +V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSEN-PLLKKRFLREAKIAADLIHPGIVP 66
Query: 123 FLGACKDPLMVIVT-ELLPGMSLRKYLVSLRPN---KLDLHVA------LNFALDIARAM 172
C D V T + G +L+ L S+ +L L+ I +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 173 DCLHANGIIHRDLKPDNLLL---------------TPDQKSLKLADFGLAREETVTEMMT 217
+ +H+ G++HRDLKPDN+LL + L D + MT
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 218 AE---TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
GT +MAPE L + D+Y+ G++L+++LT P+
Sbjct: 187 IPGKIVGTPDYMAPE-----RLLGVPA---SESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 41/142 (28%), Positives = 75/142 (52%), Gaps = 10/142 (7%)
Query: 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 187
KD L +++T L+ G L+ ++ ++ D A+ +A +I ++ LH I++RDLKP
Sbjct: 72 KDALCLVLT-LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKP 130
Query: 188 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 247
+N+LL D ++++D GLA E E + GT +MAPE+ + + Y
Sbjct: 131 ENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV--------KNERYTFS 181
Query: 248 VDVYSFGIVLWELLTNRLPFEG 269
D + G +++E++ + PF
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 52/208 (25%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G+G G+V + R ++ A K L + + E + E ++ +V +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKG--ESMALNEKQILEKVNSQFVVNL 65
Query: 124 LGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
A KD L +++T ++ G L+ ++ ++ + AL +A +I ++ LH +
Sbjct: 66 AYAYETKDALCLVLT-IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
+RDLKP+N+LL D ++++D GLA + E + GT +MAPE+ +
Sbjct: 125 YRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-------- 175
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y D + G +++E++ + PF G
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 7e-12
Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERAL--LEGRFI-----REVNMMSRV 115
G K+G G +G VY+ + D G E AL +EG I RE+ ++ +
Sbjct: 6 GCKVGRGTYGHVYKAKRKD----------GKDEKEYALKQIEGTGISMSACREIALLREL 55
Query: 116 KHDNLVK----FLGACKDPLMVIVT----ELLPGMSL-RKYLVSLRPNKLDLHVALNFAL 166
KH N++ FL + ++ +L + R + +P +L + +
Sbjct: 56 KHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLY 115
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAREETVTEMMTAETG-- 221
I + LHAN ++HRDLKP N+L+ P++ +K+AD G AR A+
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 222 --TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
T+ + APEL +HY +D+++ G + ELLT+ F
Sbjct: 176 VVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G+G G+V + R ++ A K L + + E + E ++ +V +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--ESMALNEKQILEKVNSRFVVSL 65
Query: 124 LGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
A KD L +++T L+ G L+ ++ + + A+ +A +I ++ LH I+
Sbjct: 66 AYAYETKDALCLVLT-LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
+RDLKP+N+LL D ++++D GLA + + GT +MAPE+ +
Sbjct: 125 YRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--------KN 175
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFE 268
+ Y D ++ G +L+E++ + PF+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 164 FALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 220
+ +I A+D LH+ +++RDLK +NL+L D +K+ DFGL +E + + T +T
Sbjct: 100 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKE-GIKDGATMKTFC 157
Query: 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
GT ++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 158 GTPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209
Query: 281 FKHARPGLPEDISPDLAFIVQSCWVEDPNLR 311
+ R P +SP+ ++ +DP R
Sbjct: 210 MEEIR--FPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 62/272 (22%), Positives = 109/272 (40%), Gaps = 39/272 (14%)
Query: 14 EEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLF-IGSKIGEGAHG 72
E G+ + H ++ES + + + T ++ + I S + G+ G
Sbjct: 47 ELGDSDDVTHATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEG 106
Query: 73 KVYE-GRYGD---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128
+V+ ++GD + V +K + G T RE++++ + H ++ + A +
Sbjct: 107 EVFVCTKHGDEQRKKVIVKAVTGGKTPG----------REIDILKTISHRAIINLIHAYR 156
Query: 129 DPLMVIVTELLPGMSLRKYLVSL-----RPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
V M + KY L R L L A+ + A+ LH GIIHR
Sbjct: 157 WKSTVC-------MVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHR 209
Query: 184 DLKPDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTYRWMAPELYSTVTLRQGE 240
D+K +N+ L + ++ L DFG A T +GT +PEL +
Sbjct: 210 DVKTENIFLDEPENAV-LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP----- 263
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
Y K D++S G+VL+E+ + G
Sbjct: 264 ---YCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292
|
Length = 392 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 4e-11
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERAL--LEGRFI-----REVNMMSRV 115
G K+G G +G VY+ + D G + AL +EG I RE+ ++ +
Sbjct: 6 GCKVGRGTYGHVYKAKRKD----------GKDDRDYALKQIEGTGISMSACREIALLREL 55
Query: 116 KHDNLVK----FLGACKDPLMVIVT----ELLPGMSL-RKYLVSLRPNKLDLHVALNFAL 166
KH N++ FL + ++ +L + R + +P +L + +
Sbjct: 56 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 115
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAREETVTEMMTAETG-- 221
I + LHAN ++HRDLKP N+L+ P++ +K+AD G AR A+
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 222 --TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
T+ + APEL +HY +D+++ G + ELLT+ F
Sbjct: 176 VVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 68/243 (27%), Positives = 111/243 (45%), Gaps = 56/243 (23%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL--V 121
IG GA G+V + D + A+K+L + ++ + R R++ V+ D+L V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI----LVEADSLWVV 64
Query: 122 KFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
K + +D L + ++ E LPG + L ++ + L + + A+D +H G
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLA-------REE-------------TVTEMMT--- 217
IHRD+KPDNLLL + +KL+DFGL R E T M +
Sbjct: 123 IHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 218 AET-------------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 264
AET GT ++APE++ ++ G YN D +S G++++E+L
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGVIMYEMLIGY 233
Query: 265 LPF 267
PF
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDER----ALLEGRFIREVNMMSRVKHDN 119
+G+G G+V + R ++ A K L + + AL E R + +VN V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS--- 64
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+ + KD L +++T ++ G L+ ++ ++ D A+ +A ++ ++ L
Sbjct: 65 -LAYAYETKDALCLVLT-IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER 122
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
I++RDLKP+N+LL D+ ++++D GLA + E + GT +MAPE+
Sbjct: 123 IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI------NN 175
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPF 267
EK Y D + G +++E++ + PF
Sbjct: 176 EK--YTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 66/317 (20%), Positives = 114/317 (35%), Gaps = 83/317 (26%)
Query: 83 IVAIKVLNRGSTSDER------ALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVT 136
+V +++ + + ++E ++ F R N+M+ +L +++
Sbjct: 27 LVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLW--------VIS 78
Query: 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD- 195
+ S L + P + + N R ++ LH NG IHR++K ++L++ D
Sbjct: 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG 138
Query: 196 -------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 248
L G + + V + T W++PEL LRQ + YN K
Sbjct: 139 LVSLSGLSHLYSLVRNG-QKAKVVYDFPQFSTSVLPWLSPEL-----LRQ-DLYGYNVKS 191
Query: 249 DVYSFGIVLWELLTNRLPFEGMSNLQAA------------YAAAF-------KHARPGL- 288
D+YS GI EL T R+PF+ M Q F K+++ G+
Sbjct: 192 DIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVD 251
Query: 289 -------------------------PEDISPDLAFIVQSCWVEDPNLRPS---------F 314
+ SP +V+ C +DP RPS F
Sbjct: 252 SGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311
Query: 315 SQIIRMLNAFLFTLRPP 331
Q+ + +L PP
Sbjct: 312 KQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 73/320 (22%), Positives = 126/320 (39%), Gaps = 61/320 (19%)
Query: 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
IG + + + + + +VA+K +N S S E L +E+ +++H N++
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKL---LQQEIITSRQLQHPNIL 62
Query: 122 KFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL-DIARAMDCLHANG 179
++ + + +V+ L+ S L + P L +A+ F L D+ A+D +H+ G
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILKDVLNALDYIHSKG 121
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLA--------REETVTEMMTAETGTYRWMAPELY 231
IHR +K ++LL+ D K L+ + R+ V + + W++PE+
Sbjct: 122 FIHRSVKASHILLSGDGKV-VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV- 179
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ----------------- 274
L+Q + YN K D+YS GI EL +PF+ M Q
Sbjct: 180 ----LQQ-NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234
Query: 275 ---------AAYAAAFKHARPGLPEDI------SPDLAFIVQSCWVEDPNLRPSFSQI-- 317
+ ++ +H D S V+ C DP RPS SQ+
Sbjct: 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294
Query: 318 ------IRMLNAFLFTLRPP 331
+ N L L P
Sbjct: 295 HSFFKQCKRRNTSLLDLLKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 8e-11
Identities = 60/241 (24%), Positives = 106/241 (43%), Gaps = 43/241 (17%)
Query: 65 KIGEGAHGKVY---EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
KIG G G+V+ R + + RG E++ L + EVN+M +KH N+V
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQL----VIEVNVMRELKHKNIV 75
Query: 122 K----FLGACKDPLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCL 175
+ FL L +++ E L + + K++ H ++ + A+
Sbjct: 76 RYIDRFLNKANQKLYILM-EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 176 H-----ANG--IIHRDLKPDNLLLTPDQKSL----------------KLADFGLAREETV 212
H NG ++HRDLKP N+ L+ + + K+ DFGL++ +
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
M + GT + +PEL E K Y++K D+++ G +++EL + + PF +N
Sbjct: 195 ESMAHSCVGTPYYWSPELLLH------ETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248
Query: 273 L 273
Sbjct: 249 F 249
|
Length = 1021 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 67/261 (25%), Positives = 119/261 (45%), Gaps = 36/261 (13%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG G G+VY R D ++ A+K L++ ++ E + E M+S V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVS------- 52
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN------------FALDIARA 171
G C P +V ++ +++ L N DLH L+ +A +I
Sbjct: 53 TGDC--PFIVCMSYAFHTPDKLSFILDLM-NGGDLHYHLSQHGVFSEAEMRFYAAEIILG 109
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
++ +H +++RDLKP N+LL + ++++D GLA + + + A GT+ +MAPE+
Sbjct: 110 LEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEV- 166
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM-SNLQAAYAAAFKHARPGLPE 290
L++G Y++ D +S G +L++LL PF + + LP+
Sbjct: 167 ----LQKGVA--YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 220
Query: 291 DISPDLAFIVQSCWVEDPNLR 311
SP+L +++ D N R
Sbjct: 221 SFSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 66 IGEGAHGKV--YEGRYGDRIVAIKVLN------RGSTS---DERALLEGRFIREVNMMSR 114
IG GA G+V + + ++ A+K+LN R T+ +ER +L R + +
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68
Query: 115 VKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
D +L V + G L L+S ++L +A + ++ A+D
Sbjct: 69 AFQDENNLYL----------VMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVLAIDS 117
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFG--LAREETVTEMMTAETGTYRWMAPELYS 232
+H G +HRD+KPDN+LL ++LADFG L T GT +++PE+
Sbjct: 118 VHQLGYVHRDIKPDNVLLDK-NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
+ + K Y + D +S G+ ++E+L PF
Sbjct: 177 AM---EDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 57/222 (25%), Positives = 105/222 (47%), Gaps = 11/222 (4%)
Query: 66 IGEGAHGKV--YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG GA G+V + + D++ A+K+LN+ R R+V + + + +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
++ L +++ + G L L+S ++L +A + ++ A+D +H +HR
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLT--LLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR 126
Query: 184 DLKPDNLLLTPDQKSLKLADFG--LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
D+KPDN+L+ + ++LADFG L E T + GT +++PE+ + + K
Sbjct: 127 DIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM---EDGK 182
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283
Y + D +S G+ ++E+L PF S L Y H
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNH 223
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 60/237 (25%), Positives = 111/237 (46%), Gaps = 22/237 (9%)
Query: 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
S++G G G V + ++ I+A K+++ + + + + IRE+ ++ +V
Sbjct: 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHL----EIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 122 KFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL-HANG 179
F GA D + I E + G SL + L + ++ + ++ + R + L +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE +
Sbjct: 125 IMHRDVKPSNILVN-SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPE--------RL 174
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPEDISP 294
+ HY+ + D++S G+ L EL R P L+A + G P ISP
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 66 IGEGAHGKVYEGRYGDR---IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G G+ G+V Y + VAIK + ++ + E +++ + H V
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQV--DHVFSERKILNYINHPFCVN 95
Query: 123 FLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDCLHANGI 180
G+ KD + +V E + G ++ LR NK V +A I + L + I
Sbjct: 96 LYGSFKDESYLYLVLEFVIG---GEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNI 152
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
++RDLKP+NLLL D +K+ DFG A+ +T T + GT ++APE+ V
Sbjct: 153 VYRDLKPENLLLDKD-GFIKMTDFGFAKVVDTRTYTL---CGTPEYIAPEILLNVG---- 204
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPF 267
+ D ++ GI ++E+L PF
Sbjct: 205 ----HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 64/253 (25%), Positives = 114/253 (45%), Gaps = 33/253 (13%)
Query: 66 IGEGAHGKV--YEGRYGDRIVAIKVLN------RGSTS---DERALLEGRFIREVNMMSR 114
IG GA G+V + ++ +RI A+K+LN R T+ +ER +L + + +
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 115 VKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
D + + +V + G L L+S ++L +A + ++ A+
Sbjct: 69 AFQD----------ENYLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFG--LAREETVTEMMTAETGTYRWMAPELYS 232
+H +HRD+KPDN+LL + ++LADFG L + T + GT +++PE+
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----PGL 288
+ G+ Y + D +S G+ ++E+L PF S L Y H P
Sbjct: 177 AMEDGMGK---YGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHEERFQFPSH 232
Query: 289 PEDISPDLAFIVQ 301
D+S + ++Q
Sbjct: 233 ITDVSEEAKDLIQ 245
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 67/259 (25%), Positives = 105/259 (40%), Gaps = 51/259 (19%)
Query: 84 VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGM 142
V +KVL+ A E +MM +V H ++V G C +D ++V E +
Sbjct: 35 VILKVLDPSHRDISLAFFET-----ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89
Query: 143 SL-----RKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 197
L RK V P K A +A A+ L ++H ++ N+LL +
Sbjct: 90 PLDLFMHRKSDVLTTPWKF------KVAKQLASALSYLEDKDLVHGNVCTKNILLAREGI 143
Query: 198 S------LKLADFG-----LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNN 246
+KL+D G L+R+E V + W+APE + K+ +
Sbjct: 144 DGECGPFIKLSDPGIPITVLSRQECVERI--------PWIAPECVE-------DSKNLSI 188
Query: 247 KVDVYSFGIVLWELLTN-RLPFEG--MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 303
D +SFG LWE+ N +P + ++ + Y P E LA ++ C
Sbjct: 189 AADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKE-----LADLMTHC 243
Query: 304 WVEDPNLRPSFSQIIRMLN 322
DPN RP F I+R +N
Sbjct: 244 MNYDPNQRPFFRAIMRDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 63/251 (25%), Positives = 104/251 (41%), Gaps = 69/251 (27%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLN------RGSTSDERALLEGRFIREVNMMSRVKH 117
IG GA G+V + D I A+K L + + RA E ++++ +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRA--------ERDILAEADN 60
Query: 118 DNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+VK + +D + ++ E LPG + L+ + + + + A+D +H
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIH 118
Query: 177 ANGIIHRDLKPDNLLLTPDQKS-LKLADFGL-----------------------AREETV 212
G IHRD+KPDNLLL D K +KL+DFGL +
Sbjct: 119 KLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 213 TEMMT---AET-------------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256
M + AET GT ++APE++ + YN + D +S G++
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL--------QTGYNKECDWWSLGVI 228
Query: 257 LWELLTNRLPF 267
++E+L PF
Sbjct: 229 MYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 35/216 (16%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG G G+VY R D ++ A+K L++ ++ E + E M+S V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVS------- 52
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN------------FALDIARA 171
G C P +V +T +++ L N DLH L+ +A +I
Sbjct: 53 TGDC--PFIVCMTYAFHTPDKLCFILDLM-NGGDLHYHLSQHGVFSEKEMRFYATEIILG 109
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
++ +H +++RDLKP N+LL + ++++D GLA + + + A GT+ +MAPE+
Sbjct: 110 LEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEV- 166
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
L++G Y++ D +S G +L++LL PF
Sbjct: 167 ----LQKGTA--YDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 67/244 (27%), Positives = 108/244 (44%), Gaps = 58/244 (23%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--LV 121
IG GA G+V + D I A+K+L + ++ + R R++ V+ D +V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI----LVEADGAWVV 64
Query: 122 KFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
K + +D + ++ E LPG + L ++ + L + + A+D +H G
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 181 IHRDLKPDNLLLTPDQKS-LKLADFGLA-------REE----------------TVTEMM 216
IHRD+KPDNLLL D K +KL+DFGL R E +
Sbjct: 123 IHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 217 TAET-------------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 263
AET GT ++APE++ ++ G YN D +S G++++E+L
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGVIMYEMLIG 232
Query: 264 RLPF 267
PF
Sbjct: 233 YPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 66/257 (25%), Positives = 107/257 (41%), Gaps = 72/257 (28%)
Query: 64 SKIGEGAHGKVYEGRYGD--RIVAIK------VLNRGSTSDERALLEGRFIREVNMMSRV 115
IG GA G+V R D + A+K VL R + +A E ++++
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA--------ERDILAEA 58
Query: 116 KHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
++ +VK + +D + V + +PG + L+ L + DL A + ++ A++
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL--ARFYIAELTCAIES 116
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGL------------------ARE------E 210
+H G IHRD+KPDN+L+ D +KL DFGL R+ E
Sbjct: 117 VHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 211 TVTEMMTAE--------------------TGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 250
+E+ GT ++APE V LR G Y D
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPE----VLLRTG----YTQLCDW 227
Query: 251 YSFGIVLWELLTNRLPF 267
+S G++L+E+L + PF
Sbjct: 228 WSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 45/155 (29%), Positives = 65/155 (41%), Gaps = 28/155 (18%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTS------DERALLEGRFIREVNMMSRVKHDN 119
I GA ++Y G + IK R DER + R RE +MSR +
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKW--RIPKRYRHPELDER-IRRERTRREARIMSRAR--- 57
Query: 120 LVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
K V IV E + G L+ + S +L+L + +I R +
Sbjct: 58 --KAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGMEELEL------SREIGRLVG 109
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
LH+ GIIH DL N++L+ + + L DFGLA
Sbjct: 110 KLHSAGIIHGDLTTSNMILSGGK--IYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 3e-09
Identities = 40/156 (25%), Positives = 60/156 (38%), Gaps = 33/156 (21%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTS------DERALLEGRFIREVNMMSRVKHDN 119
I +GA +Y G + IK R S DER E R E ++SR +
Sbjct: 2 IAKGAEAIIYLGDFLGLKAVIKE--RVPKSYRHPELDERIRRE-RTRNEARLLSRARK-- 56
Query: 120 LVKFLGACK------DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
G DP IV E + G L+ + + + + + +
Sbjct: 57 ----AGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVI-----EEGNDELLREIGRLVGK-- 105
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
LH GI+H DL N+++ D+ L L DFGL +
Sbjct: 106 --LHKAGIVHGDLTTSNIIVRDDK--LYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 33/115 (28%), Positives = 51/115 (44%), Gaps = 12/115 (10%)
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE QG
Sbjct: 121 IMHRDVKPSNILVNSRGE-IKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------QG 172
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294
HY + D++S G+ L E+ R P A F S
Sbjct: 173 T--HYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESH 223
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 64 SKIGEGAHGKVYE--GRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
S++G G G V++ + I+A K+++ + + + + IRE+ ++ +V
Sbjct: 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHL----EIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 122 KFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL-HANG 179
F GA D + I E + G SL + L + ++ + ++ + + + L +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE QG
Sbjct: 125 IMHRDVKPSNILVN-SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------QG 176
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLP 266
HY+ + D++S G+ L E+ R P
Sbjct: 177 --THYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 35/149 (23%), Positives = 60/149 (40%), Gaps = 17/149 (11%)
Query: 65 KIGEGAHGKVYEGRYGDRIVAIKV----LNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
I +GA +Y + +K R DE+ L R RE ++++ + +
Sbjct: 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEK-LRRERTRREARILAKAREAGV 61
Query: 121 -VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V + +IV E + G L+ L RP+ ++ R + LH G
Sbjct: 62 PVPIVYDVDPDNGLIVMEYIEGELLKDALEEARPD---------LLREVGRLVGKLHKAG 112
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
I+H DL N++L+ + + DFGL
Sbjct: 113 IVHGDLTTSNIILSGGR--IYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 65/266 (24%), Positives = 112/266 (42%), Gaps = 77/266 (28%)
Query: 60 LFIGSK-IGEGAHGKVYEGRYGDR--IVAIK------VLNRGSTSDERALLEGRFIREVN 110
+F+ K +G GA G+V D + A+K VLNR + +A E +
Sbjct: 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKA--------ERD 53
Query: 111 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
+++ ++ +VK + +D + V + +PG + L+ R +A + ++
Sbjct: 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMEVFPEVLARFYIAELT 111
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA------------------REET 211
A++ +H G IHRD+KPDN+L+ D +KL DFGL R+++
Sbjct: 112 LAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS 170
Query: 212 VT---------------EMMTAE---------------TGTYRWMAPELYSTVTLRQGEK 241
+ + T E GT ++APE V LR+G
Sbjct: 171 MEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE----VLLRKG-- 224
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPF 267
Y D +S G++L+E+L + PF
Sbjct: 225 --YTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 29/114 (25%), Positives = 53/114 (46%), Gaps = 11/114 (9%)
Query: 155 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214
KL + A++ LH + IIH D+K +N+L + + L D+GL +
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164
Query: 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
GT + +PE + + +Y+ D ++ G++ +ELLT + PF+
Sbjct: 165 CY---DGTLDYFSPE--------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 17/138 (12%)
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 223
+A ++ A+D LH GI+ RDL P+N+LL D+ ++L F E V + E
Sbjct: 90 WAAEMVVALDALHREGIVCRDLNPNNILLD-DRGHIQLTYFSRWSE--VEDSCDGEAVEN 146
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283
+ APE+ G D +S G +L+ELLT G + ++ + H
Sbjct: 147 MYCAPEV--------GGISEETEACDWWSLGAILFELLT------GKTLVECHPSGINTH 192
Query: 284 ARPGLPEDISPDLAFIVQ 301
+PE +S + ++Q
Sbjct: 193 TTLNIPEWVSEEARSLLQ 210
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 26/154 (16%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG+GA G+V + D +I A+K L + + L + R+V ++ +V
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV--LAESDSPWVVSL 66
Query: 124 LGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR--------AMDC 174
+ +D + ++ E LPG L L+ K D F+ D+ R A++
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDT-----FSEDVTRFYMAECVLAIEA 116
Query: 175 LHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLA 207
+H G IHRD+KPDN+L+ D+ +KL+DFGL+
Sbjct: 117 VHKLGFIHRDIKPDNILI--DRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 18/40 (45%), Positives = 26/40 (65%)
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207
I A+D LH+ GI+HRD+KP N++ + S K+ D G A
Sbjct: 264 ILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 40/120 (33%), Positives = 57/120 (47%), Gaps = 15/120 (12%)
Query: 144 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLA 202
L YL R L L A + A+D +H GIIHRD+K +N+L+ P+ + L
Sbjct: 246 LYTYL-GARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLG 302
Query: 203 DFG---LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259
DFG AR T GT APE+ + G+ Y VD++S G+V++E
Sbjct: 303 DFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA------GDP--YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 46/191 (24%), Positives = 76/191 (39%), Gaps = 59/191 (30%)
Query: 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 191
+ V + +PG + L+ + DL A + ++ A++ +H G IHRD+KPDN+L
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIFPEDL--ARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133
Query: 192 LTPDQKSLKLADFGLA------------------REETVTEMMTAE-------------- 219
+ D +KL DFGL R++++
Sbjct: 134 IDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 220 ----------------TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 263
GT ++APE V LR G Y D +S G++L+E+L
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPE----VLLRTG----YTQLCDWWSVGVILYEMLVG 244
Query: 264 RLPFEGMSNLQ 274
+ PF + L+
Sbjct: 245 QPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 63/252 (25%), Positives = 112/252 (44%), Gaps = 49/252 (19%)
Query: 108 EVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL---RPNKLDLHVALN 163
E+ M +++H N+VK +G C+ + ++ E + G +L + L +L R K+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKI------- 785
Query: 164 FALDIARAMDCLHAN---GIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAE 219
A+ IA+A+ LH ++ +L P+ +++ D+ L+L+ GL +T + +A
Sbjct: 786 -AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA- 843
Query: 220 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ----- 274
++APE E K K D+Y FG++L ELLT + P + +
Sbjct: 844 -----YVAPETR--------ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVE 890
Query: 275 -AAYAAAFKH----ARPGLPEDISPDLAFIVQS------CWVEDPNLRPSFSQIIRMLNA 323
A Y + H P + D+S + IV+ C DP RP + +++ L +
Sbjct: 891 WARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
Query: 324 FLFTLRPPSPSV 335
R S V
Sbjct: 951 ---ASRSSSSCV 959
|
Length = 968 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 28/183 (15%)
Query: 84 VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLP--G 141
V IK RG T+ E +L R +N H ++++ G + +LP
Sbjct: 120 VVIKAGQRGGTATEAHIL-----RAIN------HPSIIQLKGTFTYNKFTCL--ILPRYK 166
Query: 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 201
L YL + R + + L + RA+ LH N IIHRD+K +N+ + + L
Sbjct: 167 TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-HPGDVCL 223
Query: 202 ADFGLA--REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259
DFG A + GT APEL + + Y VD++S GIVL+E
Sbjct: 224 GDFGAACFPVDINANKYYGWAGTIATNAPELLA--------RDPYGPAVDIWSAGIVLFE 275
Query: 260 LLT 262
+ T
Sbjct: 276 MAT 278
|
Length = 391 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 60/267 (22%), Positives = 94/267 (35%), Gaps = 81/267 (30%)
Query: 125 GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 184
G+ KD +I T + GMS +L +A + +A+D +H G +HR
Sbjct: 84 GSAKD---LICTHFMDGMS-------------ELAIAY-ILQGVLKALDYIHHMGYVHRS 126
Query: 185 LKPDNLLLTPDQK--------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
+K ++L++ D K +L + + G R V + W++PE+
Sbjct: 127 VKASHILISVDGKVYLSGLRSNLSMINHG-QRLRVVHDFPKYSVKVLPWLSPEVL----- 180
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA--------------------- 275
Q + Y+ K D+YS GI EL +PF+ M Q
Sbjct: 181 -QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239
Query: 276 ---------------AYAAAFKHARPGLPED--------ISPDLAFIVQSCWVEDPNLRP 312
+ RP E SP V+ C +P+ RP
Sbjct: 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP 299
Query: 313 SFSQIIRMLNAFLFTL--RPPSPSVPE 337
S S +LN F R S ++PE
Sbjct: 300 SAST---LLNHSFFKQIKRRASEALPE 323
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 40/105 (38%), Positives = 54/105 (51%), Gaps = 18/105 (17%)
Query: 60 LFIGSKIGEGAHGKVYEGR-YGD------RIVAIKVLNRGSTSDE-RALLEGRFIREVNM 111
L +G +G GA G+V E +G R VA+K+L G+T E RAL+ E+ +
Sbjct: 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS-----ELKI 63
Query: 112 MSRVKHD-NLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLR 152
+ + H N+V LGAC PLMVIV E +L YL S R
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSNYLRSKR 107
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 41/157 (26%), Positives = 56/157 (35%), Gaps = 30/157 (19%)
Query: 63 GSKIGEGAHGKVYEGRYGDRIVAIKV----LNRGSTSDERALLEGRFIREVNMMSRVKHD 118
IG+GA + +G Y R IK R DER E R E ++S +
Sbjct: 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTE-RTRAEARLLSEARR- 395
Query: 119 NLVKFLGACK------DPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
G DP IV E + G L+ L +
Sbjct: 396 -----AGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVL----------EGNPELVRKVGEI 440
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
+ LH GI+H DL N ++ D+ L L DFGL +
Sbjct: 441 VAKLHKAGIVHGDLTTSNFIVRDDR--LYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 24/66 (36%), Positives = 40/66 (60%), Gaps = 1/66 (1%)
Query: 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 201
M+ +K ++ +K D++V + + LH GI+HRD+KP+NLL+T D + +K+
Sbjct: 292 MAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ-VKI 350
Query: 202 ADFGLA 207
DFG A
Sbjct: 351 IDFGAA 356
|
Length = 507 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 33/88 (37%), Positives = 49/88 (55%), Gaps = 15/88 (17%)
Query: 60 LFIGSKIGEGAHGKVYEGR-YG----DRI--VAIKVLNRGSTSDERALLEGRFIREVNMM 112
L G +G GA GKV E +G D + VA+K+L + +DER L + E+ ++
Sbjct: 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREAL----MSELKIL 95
Query: 113 SRV-KHDNLVKFLGACKD--PLMVIVTE 137
S + +H N+V LGAC P++VI TE
Sbjct: 96 SHLGQHKNIVNLLGACTHGGPVLVI-TE 122
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 32/114 (28%), Positives = 42/114 (36%), Gaps = 15/114 (13%)
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
HR K N+LLT D LKL + + Y +MAPE+ + +
Sbjct: 34 HRQAKSGNILLTWD-GLLKLDGSVAFKTPE-----QSRPDPY-FMAPEVIQGQSYTE--- 83
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295
K D+YS GI L+E L LP+ L A P D S
Sbjct: 84 -----KADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNL 132
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 4e-04
Identities = 41/195 (21%), Positives = 70/195 (35%), Gaps = 57/195 (29%)
Query: 34 RAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNR- 91
+VK G + + +G++IG G VY VA+K +R
Sbjct: 8 HTLVKRGVVES-----------------LGNQIGVGKESDVYLALDPDGNPVALK-FHRL 49
Query: 92 GSTSDERALLEGRFIREVNMMSRVKHDNLV-----------KFLGACKD-------PL-- 131
G TS + + R+ + KH + + L A + P+
Sbjct: 50 GRTSFRKV----KRKRDY--LGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPIDW 103
Query: 132 --MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189
+V E + G+ L + V P ++ L L + + GIIH DL N
Sbjct: 104 NRHAVVMEYIDGVELYRVRVLEDPEEV-LDEILEEIVKAYKH-------GIIHGDLSEFN 155
Query: 190 LLLTPDQKSLKLADF 204
+L+ D+K + D+
Sbjct: 156 ILVDDDEKIY-IIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 5e-04
Identities = 19/74 (25%), Positives = 27/74 (36%), Gaps = 10/74 (13%)
Query: 145 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN----------GIIHRDLKPDNLLLTP 194
R L+ L VA +A + L A ++H DL P NLL+ P
Sbjct: 122 RLKLLRQLAAALRRLVAAELLDRLAELWERLLAALLALLPALPLVLVHGDLHPGNLLVDP 181
Query: 195 DQKSLKLADFGLAR 208
+ + DF A
Sbjct: 182 GGRVTGVIDFEDAG 195
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 45/157 (28%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEG-------RYGDRIVAIKVLNRGSTSDER 98
QL D + + L +G +G GA G+V E VA+K+L + S E+
Sbjct: 25 QLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEK 84
Query: 99 ALLEGRFIREVNMMSRV-KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKL 156
L + E+ +MS + H N+V LGAC K + I+TE L Y L NK
Sbjct: 85 QAL----MSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDY---LHRNK- 136
Query: 157 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 193
H L + LD R L + G + ++ L
Sbjct: 137 --HTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLG 171
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 7e-04
Identities = 28/154 (18%), Positives = 52/154 (33%), Gaps = 23/154 (14%)
Query: 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDN 119
+ G +VY D +K+ REV ++ + +
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKG-------ADREREVAILQLLARKGL 53
Query: 120 LV-KFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
V K L + D ++ E + G +L + + + + +A + LH
Sbjct: 54 PVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAE---------QLAELLAKLHQ 104
Query: 178 ---NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
+ H DL P N+L+ K L + D+ A
Sbjct: 105 LPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 40/109 (36%), Positives = 54/109 (49%), Gaps = 13/109 (11%)
Query: 60 LFIGSKIGEGAHGKVYEGR-YG-DRI-----VAIKVLNRGSTSDERALLEGRFIREVNMM 112
L +G +G GA GKV EG YG R VA+K+L + S E+ L + E+ +M
Sbjct: 39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQAL----MSELKIM 94
Query: 113 SRV-KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH 159
+ + H N+V LGAC K + I+TE L YL R N L H
Sbjct: 95 THLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRH 143
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 39.0 bits (92), Expect = 0.002
Identities = 33/154 (21%), Positives = 55/154 (35%), Gaps = 21/154 (13%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-RIVAIKV--LNRGSTSDERALLEGRFIREVN-----MMS 113
+G IG G VY GD VA+K+ R S + G + +S
Sbjct: 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLS 60
Query: 114 RVK----HDNLVKFLGA---CKDPLM----VIVTELLPGMSLRKYLVSLRPNKLDLHVAL 162
R+ NL + A P+ V+V E + G + + D
Sbjct: 61 RLWAEKEFRNLKRLYEAGVPVPKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELY 120
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ 196
+ L++ R + G++H DL N+L+ +
Sbjct: 121 DQILELMRKL--YREAGLVHGDLSEYNILVDDGK 152
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 51/176 (28%), Positives = 70/176 (39%), Gaps = 21/176 (11%)
Query: 42 ITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGR-YG------DRIVAIKVLNRGST 94
I QL D L G +G GA GKV E YG VA+K+L +
Sbjct: 19 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH 78
Query: 95 SDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK--DPLMVIVTELLPG---MSLRKYL 148
ER L + E+ ++S + H N+V LGAC P +VI G LR+
Sbjct: 79 LTEREAL----MSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKR 134
Query: 149 VSLRPNKLDLH--VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202
S K + H AL L R M C N + D+KP + P + + +
Sbjct: 135 DSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYM--DMKPGVSYVVPTKADKRRS 188
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 378 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.25 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.23 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.22 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.1 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.04 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.01 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.96 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.73 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.72 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.68 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.45 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.39 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.32 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.27 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.19 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.16 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.1 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.02 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.95 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.93 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.83 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.75 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.68 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.63 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.58 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.58 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.53 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.52 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.36 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.31 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.3 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.29 | |
| PLN02236 | 344 | choline kinase | 97.25 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.78 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.75 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.72 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.48 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.08 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.96 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.93 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.69 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.36 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.33 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.24 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.15 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.81 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.4 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-54 Score=395.80 Aligned_cols=271 Identities=45% Similarity=0.796 Sum_probs=241.1
Q ss_pred cccccCCcceeecceeecccceEEEEEEECCee-EEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
..+.++...+.+.+.||+|+||+||+|.+.++. ||||++......... ...|.+|+.+|.+++|||||+|+|++.+
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES---RKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH---HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456677777888889999999999999999988 999999876655544 4579999999999999999999999987
Q ss_pred C--CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeecCCCCcEEEcCCCCceeEecccc
Q 017046 130 P--LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 130 ~--~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~g-ivH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
+ .+++||||+++|+|.+++.......+++..++.++.||+.||.|||+++ ||||||||+|||++.+..++||+|||+
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 6 4899999999999999998754678999999999999999999999999 999999999999996654799999999
Q ss_pred ccccccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017046 207 AREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 207 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
++..... ...+...||+.|||||++... ...|+.++||||||+++|||+||..||.+....+........+.+
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~------~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGE------KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR 264 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCC------CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC
Confidence 9876554 344457899999999999741 367999999999999999999999999999997778888889999
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
+.+|..+++.+..++..||..||..||++.+++..|+.+......
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999999999999988776554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-54 Score=381.08 Aligned_cols=254 Identities=30% Similarity=0.478 Sum_probs=222.7
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCC--e
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL--M 132 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--~ 132 (378)
..+++.++.||+|..|+||+++++ ++.+|+|++....... ..+++.+|+++++.++||+||.++|.|.++. .
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~----~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPA----LQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHH----HHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 346778899999999999999885 7999999995544433 3356899999999999999999999996543 8
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.|+||||+||||.+++... +.+++.....++.+++.||.|||+ ++||||||||+||||+..|. |||||||.+....
T Consensus 154 sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe-VKicDFGVS~~lv 230 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE-VKICDFGVSGILV 230 (364)
T ss_pred EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC-EEeccccccHHhh
Confidence 8999999999999999863 679999999999999999999995 99999999999999997665 9999999998765
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCC----ChHHHHHHHHHhcCCCC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM----SNLQAAYAAAFKHARPG 287 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~~~~~~~~~~ 287 (378)
.. ...+.+||..|||||.+.+ ..|+.++||||||++++|+.+|+.||... ...-+++..+.....|.
T Consensus 231 nS-~a~tfvGT~~YMsPERi~g--------~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~ 301 (364)
T KOG0581|consen 231 NS-IANTFVGTSAYMSPERISG--------ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR 301 (364)
T ss_pred hh-hcccccccccccChhhhcC--------CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC
Confidence 55 6678899999999999975 78999999999999999999999999763 34566677778889999
Q ss_pred CCCC-ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 288 LPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 288 ~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
+|.. +|+++++|+..||++||.+|||+.|+++ +.++...
T Consensus 302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~--Hpfi~~~ 341 (364)
T KOG0581|consen 302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ--HPFIKKF 341 (364)
T ss_pred CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc--CHHHhhc
Confidence 9997 9999999999999999999999999999 5555543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-55 Score=390.75 Aligned_cols=263 Identities=27% Similarity=0.394 Sum_probs=219.0
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHH--HHHHHHHHHHHHHhhccCCCeeeEEeeEecC-C
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERA--LLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 131 (378)
.+.|.+.+.||+|+||.|-+|.. +++.||||++++........ .....+.+|+++|++|+|||||+++++|..+ .
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45688899999999999999965 57999999998866554321 1122357999999999999999999999765 6
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC--CCceeEeccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLARE 209 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~--~~~vkl~Dfg~a~~ 209 (378)
.|+||||++||+|.+.+-. .+.+.+.....+++|++.|+.|||++||+||||||+|||+..+ ...+||+|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 6999999999999999876 4568888889999999999999999999999999999999754 23599999999999
Q ss_pred cccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
......+.+.||||.|.|||++.... ...+..++|+|||||+||-+++|.+||.+........+.+..+.-...|
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg-----~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKG-----VEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred cccceehhhhcCCccccChhheecCC-----eecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 88888999999999999999997621 1233458999999999999999999998876655455555544433332
Q ss_pred ---CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 290 ---EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 290 ---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
..++.+..+||.+||..||++|||+.++|+ ++|+...
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~--hpW~~~~ 443 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALN--HPWFKDA 443 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc--Chhhhcc
Confidence 458899999999999999999999999999 5555543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=390.81 Aligned_cols=251 Identities=29% Similarity=0.475 Sum_probs=219.5
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
..|..++.||+|||+.||.++. +|+.||+|++.+........ .+++.+||++.+.|+|||||+++++|+|. +.|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~--reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQ--REKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcch--HHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 6799999999999999999986 68999999998755444332 35688999999999999999999999986 7899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-c
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-T 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~-~ 213 (378)
|.|+|..++|..+++. ...+++.+++.++.||+.||.|||+++|+|||||..|+|++.+. +|||+|||+|..... .
T Consensus 96 vLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-NVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-cEEecccceeeeecCcc
Confidence 9999999999999984 56899999999999999999999999999999999999999554 599999999987653 3
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
+...+.||||-|+|||++.. ...+..+||||+||+||.||.|++||+...- .+.+.. ++.....+|..++
T Consensus 173 Erk~TlCGTPNYIAPEVl~k--------~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-kety~~-Ik~~~Y~~P~~ls 242 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNK--------SGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-KETYNK-IKLNEYSMPSHLS 242 (592)
T ss_pred cccceecCCCcccChhHhcc--------CCCCCchhhhhhhhHHHhhhhCCCCcccchH-HHHHHH-HHhcCcccccccC
Confidence 66778899999999999974 6678999999999999999999999987543 343433 3455667888999
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
.++.+||.++|..||.+|||+++|+. +.++
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~--h~Ff 272 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLD--HPFF 272 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc--CHhh
Confidence 99999999999999999999999998 5555
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-53 Score=374.41 Aligned_cols=252 Identities=31% Similarity=0.472 Sum_probs=218.3
Q ss_pred ccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 130 (378)
.+.+++|.+++.||+|+||+||.++. +++.||+|++++.......+ .+....|..+|.+++||+||+++..|+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e--~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKE--VRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhh--HHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 35678999999999999999999876 56899999999877766533 34688999999999999999999999875
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
.+|+|+||+.||.|...|+. .+.+++..+..|+.+|+.||.|||++|||||||||+|||++.+| +++|+|||+++..
T Consensus 99 kLylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-HIKLTDFGLCKED 175 (357)
T ss_pred eEEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cEEEeccccchhc
Confidence 89999999999999999985 57899999999999999999999999999999999999999665 5999999999854
Q ss_pred c-cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 211 T-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 211 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
- ......+.|||+.|||||++.. ..|+.++|+||||+++|+|++|.+||.+.+. ...++.+.....+..|
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~--------~gy~~~vDWWsLGillYeML~G~pPF~~~~~-~~~~~~I~~~k~~~~p 246 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLG--------KGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-KKMYDKILKGKLPLPP 246 (357)
T ss_pred ccCCCccccccCCccccChHHHhc--------CCCCcccchHhHHHHHHHHhhCCCCCcCccH-HHHHHHHhcCcCCCCC
Confidence 3 3345566799999999999975 6899999999999999999999999998664 4445555555556677
Q ss_pred CCChHHHHHHHHHccccCCCCCC----CHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRP----SFSQIIR 319 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rp----s~~~ll~ 319 (378)
..++.+++++++++|..||++|. ++.++.+
T Consensus 247 ~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 247 GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 77999999999999999999995 5666655
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=366.94 Aligned_cols=250 Identities=30% Similarity=0.490 Sum_probs=213.5
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
..+|.+.++||+|+||+||+|+++ +..||||.+......... .+....|+.+|+.++|||||.+++++++ ++.|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~---~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKL---VELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHH---HHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 356888999999999999999874 689999999876543332 2457799999999999999999999975 4789
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC-C----CceeEecccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD-Q----KSLKLADFGLAR 208 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~-~----~~vkl~Dfg~a~ 208 (378)
+|||||.||+|.+++.. .+.+++..++.++.||+.||++||+++||||||||.|||++.. + -.+||+|||+|+
T Consensus 86 lVMEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999987 3589999999999999999999999999999999999999853 2 359999999999
Q ss_pred ccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH-hcCCCC
Q 017046 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF-KHARPG 287 (378)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~ 287 (378)
.........+.||++.|||||++.. ..|+.|+|+||+|+|+|+|++|+.||...+..+....... ....+.
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~--------~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~ 235 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMS--------QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV 235 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHh--------ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc
Confidence 9888888889999999999999964 7899999999999999999999999998776554443322 233445
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
++..++..+.+++...+..+|.+|-+..+.+.
T Consensus 236 ~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 236 LPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred hhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 55667778889999999999999988777665
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-51 Score=377.79 Aligned_cols=262 Identities=35% Similarity=0.607 Sum_probs=229.5
Q ss_pred ccccccCCcceeecceeecccceEEEEEEECCe-eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDR-IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
...+.++.+.+.+++.||+|-||+||+|.+.+. .||+|.++...... ..|.+|+++|++|+|+|||+++++|.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~------~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP------EAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh------hHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 445667778888999999999999999999886 99999998865443 35889999999999999999999997
Q ss_pred cC-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 129 DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 129 ~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
.+ .++|||||++.|+|.++|....+..+...+.+.++.||++|++||+++++|||||.++||||+.+. .+||+|||+|
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-~vKIsDFGLA 350 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-VVKISDFGLA 350 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc-eEEEcccccc
Confidence 65 599999999999999999976667899999999999999999999999999999999999999554 6999999999
Q ss_pred cccccccc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 208 REETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 208 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
+....... .....-...|+|||.+.. ..++.++||||||++||||+| |+.||.++++. +....+..+.
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~--------~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-ev~~~le~Gy 421 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNY--------GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-EVLELLERGY 421 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhh--------CCcccccceeehhhhHHHHhccCCCCCCCCCHH-HHHHHHhccC
Confidence 95333322 223344568999999975 789999999999999999999 99999998884 4566778899
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+.+-|..+|+++.++|..||..+|++|||++.+...|+.+...
T Consensus 422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 9999999999999999999999999999999999988887654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-52 Score=354.89 Aligned_cols=251 Identities=28% Similarity=0.478 Sum_probs=211.8
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEe-eE-ecCC-e
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG-AC-KDPL-M 132 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~-~~-~~~~-~ 132 (378)
.+|.|.++||.|+||+||+++. ++..||.|.+..+..... .......|+.+|++|+|||||++++ .+ .+.. +
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k---~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAK---ARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHH---HHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 4689999999999999999976 688999999875443322 2345789999999999999999998 44 3444 8
Q ss_pred EEEEeccCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CC--CeeecCCCCcEEEcCCCCceeEecccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHA--NG--IIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~--~g--ivH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
+||||||.+|+|..+++..+. ..+++..+|+++.|++.||.++|+ .. |+||||||.||+++.+| .|||+|||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL 174 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGL 174 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchh
Confidence 899999999999999976543 459999999999999999999999 44 99999999999999655 599999999
Q ss_pred ccccccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017046 207 AREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 207 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
++..+.. ....+.+|||.||+||.+.. ..|++++||||+||++|||+.-..||.+. +...+...+..+.-
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~--------~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHE--------SGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKIEQGDY 245 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhc--------CCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHHHcCCC
Confidence 9875443 34567799999999999965 88999999999999999999999999987 55666666777777
Q ss_pred CCCC-CCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 286 PGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 286 ~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
+++| +.+|.++..+|..|+..||..||+...++..+
T Consensus 246 ~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 246 PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 7787 67999999999999999999999854444433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=373.45 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=217.1
Q ss_pred ccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP 130 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 130 (378)
.-.+.+|..++.||.|+|++|++|+. +++.||||++.+.....+.. .+-+..|-.+|.+| .||+|++|+..|+|.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~K--vkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKK--VKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcc--cchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 34567899999999999999999976 57899999998876655543 23467888899999 899999999999876
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
.+|+|+||+++|+|.++|.. .+.+++..++.+++||+.||+|||++|||||||||+|||++.++. ++|+|||.|+.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh-ikITDFGsAK~ 223 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH-IKITDFGSAKI 223 (604)
T ss_pred cceEEEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc-EEEeecccccc
Confidence 79999999999999999986 478999999999999999999999999999999999999997765 99999999975
Q ss_pred cccccc--------------cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHH
Q 017046 210 ETVTEM--------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (378)
Q Consensus 210 ~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 275 (378)
...... ...++||..|.+||++.. ...++.+|||+||||||+|+.|.+||.+.++. .
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--------~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-l 294 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--------SPAGPSSDLWALGCILYQMLAGQPPFRAANEY-L 294 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcC--------CCCCcccchHHHHHHHHHHhcCCCCCccccHH-H
Confidence 332211 145789999999999975 77899999999999999999999999987653 3
Q ss_pred HHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 276 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.++.+ ......+|+++++.+.+|++++|..||.+|+|..+|-+|
T Consensus 295 iFqkI-~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 295 IFQKI-QALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHH-HHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 33333 345667899999999999999999999999999999884
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=361.40 Aligned_cols=252 Identities=27% Similarity=0.490 Sum_probs=212.6
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE--ecC-C
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDP-L 131 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~--~~~-~ 131 (378)
...|..++.||+|+||+||++... ++..|||.+....... .+.+.+|+.+|++++|||||+++|.. .+. .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-----SESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-----HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 455778899999999999999875 5899999987763332 23477999999999999999999964 233 5
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
++++|||+++|+|.+++....+ .+++..+..+.+||++||+|||++||+|+||||+|||++..++.+||+|||++....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 8899999999999999998554 899999999999999999999999999999999999999734459999999988655
Q ss_pred c----ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCC
Q 017046 212 V----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHARP 286 (378)
Q Consensus 212 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~ 286 (378)
. ........||+.|||||++.. +.....++|||||||++.||+||+.||.. .......+........|
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~-------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P 242 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRN-------GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP 242 (313)
T ss_pred cccccccccccccCCccccCchhhcC-------CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC
Confidence 2 222345689999999999963 12233599999999999999999999987 44455556666666678
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
.+|..+|+++++|+.+|+..||..|||+.++|++.
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 99999999999999999999999999999999943
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=364.34 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=221.1
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEecC--C
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP--L 131 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~--~ 131 (378)
-++|.++++||.|+||.||+|+. .++.||||.+++....-+.. .-+||++.|++|+ |||||++.+++.|. .
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~----~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC----MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH----HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 46799999999999999999975 57899999999877664433 2469999999998 99999999998654 6
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
+++||||+ ..+|+++++.. ...+++..+..|++||+.||+|+|.+|+.|||+||+|||+... ..+||+|||+|+...
T Consensus 85 L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~-~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN-DVIKIADFGLAREVR 161 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-ceeEecccccccccc
Confidence 89999999 56999999884 7889999999999999999999999999999999999999843 459999999999988
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC----
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG---- 287 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---- 287 (378)
.....+..+.|..|+|||++.. ...|+.+.|+|++|||++|+.+-++.|+|.++.++++.+...-..|.
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLr-------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLR-------SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cCCCcchhhhcccccchHHhhh-------ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 8888889999999999999874 47899999999999999999999999999999988887754333331
Q ss_pred -------------C-----------CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 288 -------------L-----------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 288 -------------~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+ -..++.++.+||.+||.+||.+|||+.++++ ..++..
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~--~pffq~ 296 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ--HPFFQV 296 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc--Cccccc
Confidence 1 1247789999999999999999999999999 445443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=339.44 Aligned_cols=239 Identities=28% Similarity=0.423 Sum_probs=211.6
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
..++|.+++.||.|+||+|.+++. ++..+|+|++.+......++ .+...+|..+|+.+.||+++++++.+.|. ++
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQ--veH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQ--VEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHH--HHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence 346788999999999999999976 57899999998877665544 34678999999999999999999999775 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||++||.|..+++. .+.+++..++.+++||+.||+|||+.+|++|||||+|||+|.+|. +||+|||+|+....
T Consensus 120 ymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~-iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH-IKITDFGFAKRVSG 196 (355)
T ss_pred EEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc-EEEEeccceEEecC
Confidence 999999999999999986 468999999999999999999999999999999999999997765 99999999987554
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
. +.+.||||.|+|||++.. ..+..++|+||||+++|||+.|.+||.+.+. ...+..+. .....+|..+
T Consensus 197 r--T~TlCGTPeYLAPEii~s--------k~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~-~~~v~fP~~f 264 (355)
T KOG0616|consen 197 R--TWTLCGTPEYLAPEIIQS--------KGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKIL-EGKVKFPSYF 264 (355)
T ss_pred c--EEEecCCccccChHHhhc--------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHH-hCcccCCccc
Confidence 4 567799999999999965 7899999999999999999999999998777 44555443 4566789999
Q ss_pred hHHHHHHHHHccccCCCCC
Q 017046 293 SPDLAFIVQSCWVEDPNLR 311 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~R 311 (378)
++++++|+.++|+.|-.+|
T Consensus 265 s~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 265 SSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CHHHHHHHHHHHhhhhHhh
Confidence 9999999999999999999
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=364.02 Aligned_cols=258 Identities=29% Similarity=0.521 Sum_probs=218.9
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec-CC
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-PL 131 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~ 131 (378)
....|.+++.||+|+||+|+.|.+ +++.||+|++.+...........+.+.+|+.+++.++ ||||+++++++.. ..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456799999999999999999976 5799999987765332111123345679999999998 9999999999964 46
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc-
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE- 210 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~- 210 (378)
.++||||+.||+|.+++.. .+.+.+..+..++.|++.|++|||++||+||||||+|||++.+.+.+||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 8999999999999999987 5689999999999999999999999999999999999999976356999999999877
Q ss_pred ccccccccCcCcccccccccccccccccccccc-C-CCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH-Y-NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
.......+.+||+.|+|||++.+ .. | +.++||||+|++||.|++|..||.+.+. ...+.. .......+
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~--------~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-~~l~~k-i~~~~~~~ 242 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSG--------KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-PNLYRK-IRKGEFKI 242 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCC--------CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-HHHHHH-HhcCCccC
Confidence 46667788899999999999976 22 4 5899999999999999999999998443 333433 55667778
Q ss_pred CCCC-hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 289 PEDI-SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 289 ~~~~-~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
|..+ ++++..|+.+||..||..|+|+.++++ +.++..
T Consensus 243 p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~--h~w~~~ 280 (370)
T KOG0583|consen 243 PSYLLSPEARSLIEKMLVPDPSTRITLLEILE--HPWFQK 280 (370)
T ss_pred CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh--Chhhcc
Confidence 8888 999999999999999999999999995 666654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=341.81 Aligned_cols=249 Identities=30% Similarity=0.437 Sum_probs=209.4
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 134 (378)
+.|+.+.++|+|+||.||+.++ +|+.||||++........ +.+-.++|+++|++++|||+|.++.+|. ...+++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~---VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPV---VKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHH---HHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence 3577889999999999999976 579999999976554333 3345789999999999999999999995 458899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc-cc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VT 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-~~ 213 (378)
|+|||+..-|. -+.. .+++++.+.+..+++|++.|+.|+|++++|||||||+||||+.++ .+||||||+|+... .+
T Consensus 79 VFE~~dhTvL~-eLe~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 79 VFEYCDHTVLH-ELER-YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLCDFGFARTLSAPG 155 (396)
T ss_pred EeeecchHHHH-HHHh-ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-cEEeccchhhHhhcCCc
Confidence 99999775454 4544 467899999999999999999999999999999999999999665 59999999999776 66
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC-------
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP------- 286 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------- 286 (378)
...+..+-|..|+|||++.+ ..+|+..+||||+||++.||++|.+.|++.++.+.++.+...-...
T Consensus 156 d~YTDYVATRWYRaPELLvG-------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVG-------DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred chhhhhhhhhhccChhhhcc-------cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 66778899999999999976 3689999999999999999999999999999988887654321111
Q ss_pred -----C-----CC------------CCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 287 -----G-----LP------------EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 287 -----~-----~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
- +| +.++..+.+|+++||..||++|++-++++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0 11 235667899999999999999999999987
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=365.48 Aligned_cols=252 Identities=32% Similarity=0.499 Sum_probs=219.5
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE-ecCCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~~~~~l 134 (378)
..|....+||+|+.|.||.|+. +++.||||.+......... .+++|+.+|+..+|+|||++++.| .++.+|+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~ke-----LilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKE-----LLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchh-----hhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 3477778999999999999976 4688999999887766543 478999999999999999999987 4668999
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||++||+|.+.+.. ..+++.++..++++++.||+|||.+||+|||||.+|||++.++. +||+|||++.......
T Consensus 348 VMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~-vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS-VKLTDFGFCAQISEEQ 423 (550)
T ss_pred EEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc-EEEeeeeeeecccccc
Confidence 9999999999999976 45999999999999999999999999999999999999997765 9999999998765544
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCCCCCC
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLPEDI 292 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 292 (378)
...+.+|||.|||||++.. ..|+++.||||||++++||+-|.+||-..+...+++.+...+. ....++.+
T Consensus 424 ~KR~TmVGTPYWMAPEVvtr--------k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~kl 495 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTR--------KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKL 495 (550)
T ss_pred CccccccCCCCccchhhhhh--------cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCcccc
Confidence 5567899999999999964 8899999999999999999999999998888887777655433 23456789
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
|+.+++|+.+||..|+.+|+++.++|+ +.++...
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~--HpFl~~a 529 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLE--HPFLKMA 529 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhc--Chhhhhc
Confidence 999999999999999999999999999 5666443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=355.22 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=210.2
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-C
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 131 (378)
+..++|.+++.||+|+||.||+++. +|..+|+|++++..-....+. +.++.|-.+|....+|+||+++..|+|. +
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv--~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQV--EHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhH--HHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 4567899999999999999999965 689999999988655444332 4578899999999999999999999876 8
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
+||||||++||++..+|.. .+.+++..++.|+.+++.|+..||..|+|||||||+|+|||..|+ +||+||||+....
T Consensus 216 LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH-iKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH-IKLSDFGLSTGLD 292 (550)
T ss_pred eEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC-Eeeccccccchhh
Confidence 9999999999999999975 578999999999999999999999999999999999999997765 9999999985210
Q ss_pred c-------------------------c-----------------------cccccCcCcccccccccccccccccccccc
Q 017046 212 V-------------------------T-----------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKH 243 (378)
Q Consensus 212 ~-------------------------~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 243 (378)
. . ......+|||.|+|||++.+ ..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--------kg 364 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--------KG 364 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--------CC
Confidence 0 0 00112369999999999976 66
Q ss_pred CCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC--CCChHHHHHHHHHccccCCCCCC---CHHHHH
Q 017046 244 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRP---SFSQII 318 (378)
Q Consensus 244 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll 318 (378)
|+...|+|||||||||||.|.+||.+.+..+....+..-.....+| ..+++++.+||.+||. ||.+|. ++.||-
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 9999999999999999999999999877755443333222233444 3578999999999999 999997 588887
Q ss_pred HHHHhhh
Q 017046 319 RMLNAFL 325 (378)
Q Consensus 319 ~~l~~~~ 325 (378)
+ ++++
T Consensus 444 ~--HPfF 448 (550)
T KOG0605|consen 444 K--HPFF 448 (550)
T ss_pred c--CCcc
Confidence 7 4444
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=352.32 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=210.8
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---CC
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PL 131 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~ 131 (378)
...|..+++||+|.||.||+|++ +++.||+|.+..+....... ....+||.||++|+||||++|.+...+ +.
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~---~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFP---ITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcch---HHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 35588899999999999999987 57889999998766443322 235699999999999999999998754 37
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
+|+|+|||++ +|.-++.. ..-.|++.++..|+.||+.||+|+|++||+|||||.+|||||.+| .+||+|||+|+...
T Consensus 193 iYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-VLKIADFGLARFYT 269 (560)
T ss_pred EEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-CEEeccccceeecc
Confidence 8999999966 88888865 445799999999999999999999999999999999999999555 59999999999544
Q ss_pred cc--cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC---
Q 017046 212 VT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--- 286 (378)
Q Consensus 212 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--- 286 (378)
.. ...+..+.|..|.|||++.+ ...|+.++|+||.||||.||+.|++.|++.++.+.+-.+......|
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG-------~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLG-------ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred CCCCcccccceEEeeccChHHhcC-------CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 33 34677889999999999987 3689999999999999999999999999988866655443221111
Q ss_pred -----CCC-------------------CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 287 -----GLP-------------------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 287 -----~~~-------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
.+| ..++....+|+..+|..||.+|.|+.++++ ..+|
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~--seyF 403 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ--SEYF 403 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc--Cccc
Confidence 111 246778899999999999999999999988 6666
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=343.93 Aligned_cols=257 Identities=30% Similarity=0.501 Sum_probs=219.0
Q ss_pred cccccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
..+..+.+.|.+..+||.|..++||+|+. .++.||||++..+....+. +.+.+|++.|+.++||||++++..|.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~l----d~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDL----DALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhH----HHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 35667889999999999999999999987 5799999999987776653 35889999999999999999999985
Q ss_pred -cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 129 -DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 129 -~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
+..+|+||.|+.+||+.+++...-...+++..+..+.++++.||.|||.+|.||||||+.||||+.+|. |||+|||.+
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~-VkLadFgvs 173 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT-VKLADFGVS 173 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc-EEEcCceee
Confidence 568999999999999999999888888999999999999999999999999999999999999997765 999999986
Q ss_pred ccccccc----cc-ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 017046 208 REETVTE----MM-TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (378)
Q Consensus 208 ~~~~~~~----~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 282 (378)
....... .. ...+||++|||||++.- +...|+.++||||||++..||.+|..||..+.....+.... .
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q------~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-q 246 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ------QLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-Q 246 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhh------cccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-c
Confidence 5322211 11 56689999999999643 34779999999999999999999999999988766555443 3
Q ss_pred cCCC-----CCC----CCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 283 HARP-----GLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 283 ~~~~-----~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+.+| .++ ..++..++.++..||.+||.+|||++++++
T Consensus 247 n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 247 NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 3333 111 236678999999999999999999999999
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=362.32 Aligned_cols=255 Identities=28% Similarity=0.459 Sum_probs=220.7
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
-|++++.||+|+.|.|-+|++ +|+.+|||++.+....... ....+.+||-+|+.+.||||+++++++++. ++|+|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s--~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSS--QPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccc--cccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 488999999999999999987 6899999999876322111 123577999999999999999999999765 89999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
.||++||.|.+++.. .+.+++.++.++++||+.|+.|+|..+|+|||+||+|+|++..+. +||+|||+|.....+..
T Consensus 91 lEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n-IKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN-IKIADFGMASLEVPGKL 167 (786)
T ss_pred EEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC-EeeeccceeecccCCcc
Confidence 999999999999986 578999999999999999999999999999999999999997666 99999999999888888
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHH
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (378)
..+.||+|.|.|||++.+. ...+.++||||.|+|||.||+|+.||++.+ ...++.. .......+|..+|++
T Consensus 168 LeTSCGSPHYA~PEIV~G~-------pYdG~~sDVWSCGVILfALLtG~LPFdDdN-ir~LLlK-V~~G~f~MPs~Is~e 238 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGR-------PYDGRPSDVWSCGVILFALLTGKLPFDDDN-IRVLLLK-VQRGVFEMPSNISSE 238 (786)
T ss_pred ccccCCCcccCCchhhcCC-------CCCCCccccchhHHHHHHHHhCCCCCCCcc-HHHHHHH-HHcCcccCCCcCCHH
Confidence 8999999999999999872 334689999999999999999999999644 3444433 345667788999999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 296 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 296 l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
+++||.+||..||.+|.|.++|++ +.++....
T Consensus 239 aQdLLr~ml~VDp~~RiT~~eI~k--HP~l~g~~ 270 (786)
T KOG0588|consen 239 AQDLLRRMLDVDPSTRITTEEILK--HPFLSGYT 270 (786)
T ss_pred HHHHHHHHhccCccccccHHHHhh--CchhhcCC
Confidence 999999999999999999999999 45554433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=354.33 Aligned_cols=260 Identities=31% Similarity=0.573 Sum_probs=211.4
Q ss_pred ccCCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEe
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLG 125 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~ 125 (378)
.+..++|.+.+.||+|+||.||+|.+ .++.||||++........ ...+.+|+.++..+ +||||+++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~ 78 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASE----HKALMSELKILIHIGNHLNVVNLLG 78 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHH----HHHHHHHHHHHHHhccCcceeeEEe
Confidence 45567899999999999999999964 236799999875443322 23588999999999 8999999999
Q ss_pred eEec--CCeEEEEeccCCCCHHHHHhhhC---------------------------------------------------
Q 017046 126 ACKD--PLMVIVTELLPGMSLRKYLVSLR--------------------------------------------------- 152 (378)
Q Consensus 126 ~~~~--~~~~lv~e~~~~~sL~~~l~~~~--------------------------------------------------- 152 (378)
++.+ ...+++|||+++|+|.+++....
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 8854 35789999999999999987532
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc---ccccCc
Q 017046 153 ---------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAET 220 (378)
Q Consensus 153 ---------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~ 220 (378)
...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+++...... ......
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCC
Confidence 12477888999999999999999999999999999999999655 59999999987532211 112234
Q ss_pred CccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHH
Q 017046 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 299 (378)
Q Consensus 221 gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 299 (378)
+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+................+..+..+++++.++
T Consensus 238 ~~~~y~aPE~~~~--------~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 309 (338)
T cd05102 238 LPLKWMAPESIFD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRI 309 (338)
T ss_pred CCccccCcHHhhc--------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 5678999998854 568899999999999999997 9999987655444444444555566677899999999
Q ss_pred HHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 300 VQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 300 i~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
+.+||..||.+|||+.++++.|+.++.
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=321.74 Aligned_cols=261 Identities=28% Similarity=0.408 Sum_probs=217.0
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
..|...++||+|.||.||+|++ +++.||||+++.....+.. .....+||+.|+.++|+||+.++++|.+ ..+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi---~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI---NRTALREIKLLQELKHPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc---cHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence 3577889999999999999987 5799999999876554322 2346799999999999999999999954 57889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
|+||++ .+|...++. ....++..++..|+.+++.||+|||++.|+||||||.|+|++.+|. +||+|||+++......
T Consensus 79 VfEfm~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~-lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 79 VFEFMP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ-LKIADFGLARFFGSPN 155 (318)
T ss_pred EEEecc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc-EEeecccchhccCCCC
Confidence 999994 599999987 4567999999999999999999999999999999999999997765 9999999999765544
Q ss_pred cc-ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC---C--
Q 017046 215 MM-TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG---L-- 288 (378)
Q Consensus 215 ~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---~-- 288 (378)
.. ...+-|..|+|||++.+ ...|+...|+||.|||+.||+.|.+-|+|.++.+.+..+......|. +
T Consensus 156 ~~~~~~V~TRWYRAPELLfG-------sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFG-------SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred cccccceeeeeccChHHhcc-------chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence 33 33378999999999987 47899999999999999999999999999998777665443322221 1
Q ss_pred ---------------------CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 017046 289 ---------------------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 333 (378)
Q Consensus 289 ---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 333 (378)
-...+.++.+|+.+||..||.+|.|+.|+++ +.++.+.+.+.+
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~--~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK--HPYFKSLPLPTP 292 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc--chhhhcCCCCCC
Confidence 1235677899999999999999999999999 778877555443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=360.95 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=215.3
Q ss_pred ccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP 130 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 130 (378)
.+.-++|.++++||+|+||+|+++.. +++.+|||+++++....+.+. +..+.|.+|+... +||.+++++.+|+..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~V--e~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEV--ESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccH--HHHHHHHHHHHHhccCCeEeecccccccC
Confidence 45667899999999999999999976 468999999999887655443 3467788888777 599999999999754
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
++|+||||+.||++..+.. .+.+++..+..|+++|+.||.|||++|||+||||.+|||+|.+|. +||+|||+++.
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh-~kiADFGlcKe 517 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH-VKIADFGLCKE 517 (694)
T ss_pred CeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc-EEecccccccc
Confidence 8999999999999554433 468999999999999999999999999999999999999998876 99999999987
Q ss_pred cc-cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 210 ET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 210 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
.- .+..+.+.||||.|||||++.. ..|+.++|+|||||+|||||.|..||.+.+. ++.+ ..+....+.+
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e--------~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-ee~F-dsI~~d~~~y 587 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTE--------QSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-EEVF-DSIVNDEVRY 587 (694)
T ss_pred cCCCCCccccccCChhhcChhhhcc--------CcccchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHH-HHHhcCCCCC
Confidence 54 6667889999999999999965 8899999999999999999999999998665 3333 3445677888
Q ss_pred CCCChHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 319 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~ 319 (378)
|..+|.+..++++++|.++|.+|.. +.+|.+
T Consensus 588 P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~ 623 (694)
T KOG0694|consen 588 PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK 623 (694)
T ss_pred CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh
Confidence 9999999999999999999999974 566655
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=357.15 Aligned_cols=267 Identities=34% Similarity=0.615 Sum_probs=224.8
Q ss_pred ccccccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
.+.|.+..+.+.++..||+|.||+||+|+|.| .||||+++......+. .+.|++|+.++++-+|.||+-|.|++..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~q---lqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQ---LQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHH---HHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 36788888999999999999999999999987 7999999988877763 3569999999999999999999999988
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+.+.||+.+|+|.+|+.++.-. ..+|+......|+.|++.|+.|||.++|||||||..||++..+ .+|||+|||++..
T Consensus 460 p~~AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatv 537 (678)
T KOG0193|consen 460 PPLAIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATV 537 (678)
T ss_pred CceeeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceee
Confidence 8889999999999999999763 4689999999999999999999999999999999999999955 5699999999864
Q ss_pred cc---cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CC
Q 017046 210 ET---VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH-AR 285 (378)
Q Consensus 210 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~ 285 (378)
.. .........|...|||||+++. .+..+|++.+||||||+++|||++|..||......+.++. +-.+ ..
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRm-----qd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm-VGrG~l~ 611 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRM-----QDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM-VGRGYLM 611 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhh-----cccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-ecccccC
Confidence 32 2223344568889999999974 2468999999999999999999999999994443333222 2222 11
Q ss_pred C---CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 286 P---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 286 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
+ ....+++.++++|+..||..++++||.+.+|+..|..++..+
T Consensus 612 pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 612 PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 2 233567889999999999999999999999999888887753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-48 Score=354.85 Aligned_cols=246 Identities=31% Similarity=0.511 Sum_probs=211.5
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
++|.+.+.||+|+||.||+|+.+ .+.||+|.+.+.......- +.+.+|+++++.++|||||.++++|+. .++++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l---~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKEL---KNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHH---HHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 46888899999999999999765 5899999998766554322 347899999999999999999999975 48999
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
|+||+.| +|..++.. .+.++++.+..++.+++.||.|||+.+|+|||+||.|||++.+ +++|+||||+|+.++...
T Consensus 79 Vte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNT 154 (808)
T ss_pred Eehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-CceeechhhhhhhcccCc
Confidence 9999976 99999986 5789999999999999999999999999999999999999955 469999999999876554
Q ss_pred c-cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 215 M-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 215 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
. .+...|||.|||||++.+ .+|+..+|.||||||+|||+.|++||-..+-.+ +.. .+...+...|...+
T Consensus 155 ~vltsikGtPlYmAPElv~e--------~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~-Lv~-~I~~d~v~~p~~~S 224 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEE--------QPYDHTSDLWSLGCILYELYVGQPPFYARSITQ-LVK-SILKDPVKPPSTAS 224 (808)
T ss_pred eeeeeccCcccccCHHHHcC--------CCccchhhHHHHHHHHHHHhcCCCCchHHHHHH-HHH-HHhcCCCCCccccc
Confidence 3 345679999999999864 889999999999999999999999997644322 222 33455666778899
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.++.+|+..+|.+||..|.|+.+++.|
T Consensus 225 ~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 225 SSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 999999999999999999999999983
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=335.96 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=217.4
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe---cC---C
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK---DP---L 131 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~---~~---~ 131 (378)
|.-.+.+|+|+||.||.|+. +++.||||....+..-.. +|+++|+.+.|||||+++.+|. +. +
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn---------rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN---------RELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc---------HHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 66678999999999999976 468999999877665432 7999999999999999988773 12 3
Q ss_pred eEEEEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
..+||||++ .+|...++.. ....++.-.+.-+.+||++||+|||+.||+||||||.|+|+|.+.+.+||||||.|+.
T Consensus 97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 459999995 4999988742 2457888999999999999999999999999999999999999988999999999998
Q ss_pred cccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC---
Q 017046 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--- 286 (378)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--- 286 (378)
...++...+...|..|+|||++.+. ..|+.+.||||.||++.||+.|++-|.|.+..+.+..++.....|
T Consensus 176 L~~~epniSYicSRyYRaPELifga-------~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 176 LVKGEPNISYICSRYYRAPELIFGA-------TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred eccCCCceeEEEeccccCHHHHcCc-------cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 8888888888999999999999873 689999999999999999999999999988766655443222111
Q ss_pred -------C-----------------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCCCCCC
Q 017046 287 -------G-----------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 336 (378)
Q Consensus 287 -------~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~ 336 (378)
. +....++++.+|+.++|..+|.+|.++.+++. +.++..++.+....|
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~--h~fFdelr~~~~~l~ 320 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA--HPFFDELRDPNTKLP 320 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc--chhhHHhhCcCccCc
Confidence 0 23457899999999999999999999999998 788888887754443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=343.27 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=203.8
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHH-----H----HHHHHHHHHHHHHhhccCCCeeeEEe
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER-----A----LLEGRFIREVNMMSRVKHDNLVKFLG 125 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~-----~----~~~~~~~~E~~~l~~l~hp~iv~l~~ 125 (378)
...|++++.||+|.||.|-+|+. .++.||||++.+....... . .-.++..+||.+|++|+|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 35699999999999999999987 4789999999764432210 0 01246889999999999999999999
Q ss_pred eEecC---CeEEEEeccCCCCHHHHHhhhCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeE
Q 017046 126 ACKDP---LMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 201 (378)
Q Consensus 126 ~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~~-l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl 201 (378)
+..|+ .+|+|+|||..|.+...= .... +++.+++.|+++++.||+|||.+|||||||||+|+||+.+| +|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g-~VKI 251 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG-TVKI 251 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-cEEe
Confidence 98654 799999999988875422 2234 89999999999999999999999999999999999999765 6999
Q ss_pred ecccccccc------ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHH
Q 017046 202 ADFGLAREE------TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (378)
Q Consensus 202 ~Dfg~a~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 275 (378)
+|||.+... +........+|||.|+|||++.... .....+.+.||||+|++||.|+.|..||.+.....
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~----~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~- 326 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN----SFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE- 326 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC----CccccchhhhhhhhhhhHHHhhhccCCcccchHHH-
Confidence 999998743 2222233468999999999986521 12345678999999999999999999998765533
Q ss_pred HHHHHHhcCCCCCCCC--ChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 276 AYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 276 ~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
++.. +.+.+..+|.. +.+++++||++||.+||+.|.+..+|..|.+
T Consensus 327 l~~K-Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 327 LFDK-IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHH-HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 3333 33455556654 7899999999999999999999999977543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=337.93 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=217.1
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
.+|.+.+.||+|.||+|-+|.. .|+.||||.++++...++...+ ++.+||+||+.|+||||+.++.+|+.. ..+|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlv--hIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLV--HIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHH--HHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 5689999999999999999965 5899999999998887776653 689999999999999999999999754 7899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||..+|.|++|+.. .+.+++.+++.+++||++|+.|+|.++++|||||.+|||+|.++ ++||+|||++.......
T Consensus 131 vMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-NIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-Ceeeeccchhhhhcccc
Confidence 9999999999999987 46799999999999999999999999999999999999999665 59999999999888888
Q ss_pred ccccCcCccccccccccccccccccccccC-CCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
...++||+|.|.+||++++ .+| ++.+|.||||++||.|+.|.+||++.+.... ...+..+.- ..+.-+
T Consensus 208 fLqTFCGSPLYASPEIvNG--------~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l-vrQIs~GaY--rEP~~P 276 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNG--------TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL-VRQISRGAY--REPETP 276 (668)
T ss_pred HHHHhcCCcccCCccccCC--------CCCCCCccchhhHHHHHHHHhhcccccCCchHHHH-HHHhhcccc--cCCCCC
Confidence 8899999999999999976 344 6789999999999999999999998765333 333322221 123356
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
.++.-||++||..||++|.|+.++..+++-.
T Consensus 277 SdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 277 SDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred chHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 6788899999999999999999999987543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=317.27 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=220.8
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
..++|.+++.||+|.||.||.|+.. +-.||+|++.+..... ......+.+|+++-+.|+||||++++++|.|. ..
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~--~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK--TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH--hcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 3467999999999999999999874 5789999998765332 23345688999999999999999999999876 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
|+++||..+|+|...+...+...+++..+..++.|++.||.|+|..+|+||||||+|+|++..+. +||+|||.+....
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~-lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAP- 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC-eeccCCCceeecC-
Confidence 99999999999999999767778999999999999999999999999999999999999997765 9999999987755
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
.....+.|||..|.+||...+ ..++..+|+|++|++.||++.|.+||.... ..+.++. +...+..+|..+
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~--------~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkr-I~k~~~~~p~~i 245 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEG--------RGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKR-IRKVDLKFPSTI 245 (281)
T ss_pred CCCceeeecccccCCHhhcCC--------CCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHH-HHHccccCCccc
Confidence 445567899999999999865 778999999999999999999999999876 3444444 345667788999
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
+.++.++|.+|+..+|.+|.+..+++++.+
T Consensus 246 s~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 246 SGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 999999999999999999999999999643
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=335.10 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=208.7
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-----CCeEEEEec
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-----PLMVIVTEL 138 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~~~lv~e~ 138 (378)
..||+|++|.||+|.++++.||||+++....... ...+.|.+|+.+|.+++||||+++++++.+ ...++||||
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHK--VLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccH--HHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5789999999999999999999999976543322 123468899999999999999999998865 367899999
Q ss_pred cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEeccccccccccccccc
Q 017046 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 217 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~ 217 (378)
+++|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+|||++.++ .+||+|||++....... .
T Consensus 104 ~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~~--~ 178 (283)
T PHA02988 104 CTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSPP--F 178 (283)
T ss_pred CCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcccc--c
Confidence 999999999976 35689999999999999999999984 999999999999999665 59999999987543322 2
Q ss_pred cCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHH
Q 017046 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 297 (378)
Q Consensus 218 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 297 (378)
...++..|+|||++.. ....++.++|||||||++|+|++|..||.+.+..+...........+.+|..+++++.
T Consensus 179 ~~~~~~~y~aPE~~~~------~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 252 (283)
T PHA02988 179 KNVNFMVYFSYKMLND------IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIK 252 (283)
T ss_pred cccCcccccCHHHhhh------ccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHH
Confidence 4568899999999853 1256889999999999999999999999987654433333334556677778999999
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 298 FIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 298 ~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
+++.+||+.||.+|||+.++++.|+.+..
T Consensus 253 ~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 253 CIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999987643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=363.87 Aligned_cols=263 Identities=29% Similarity=0.550 Sum_probs=224.3
Q ss_pred cccCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEe
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 125 (378)
..+...+....++||+|+||+||+|+.. ...||||.++.....+.+ ..|.+|++++..++|||||+|+|
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~----~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQAR----QDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHH----HHHHHHHHHHHhccCCCeEEEEE
Confidence 3455667778899999999999999763 368999999987766443 46999999999999999999999
Q ss_pred eEec-CCeEEEEeccCCCCHHHHHhhhCCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEE
Q 017046 126 ACKD-PLMVIVTELLPGMSLRKYLVSLRPN------------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 192 (378)
Q Consensus 126 ~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~------------~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill 192 (378)
+|.+ +.+++|+||+..|+|.++|....+. .++..+.+.|+.|||.|+.||-++.+|||||..+|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 9965 4788999999999999999764321 27888999999999999999999999999999999999
Q ss_pred cCCCCceeEeccccccccccccccc---cCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCC
Q 017046 193 TPDQKSLKLADFGLAREETVTEMMT---AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 268 (378)
Q Consensus 193 ~~~~~~vkl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 268 (378)
. ++..|||+|||+++.....+... ...-..+|||||.+.. +.|+.++||||+||+|||+++ |..||.
T Consensus 637 g-e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--------~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 637 G-ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--------GKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred c-cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--------CcccchhhhhhhhhhhhhhhccccCccc
Confidence 9 55679999999998654333222 2244679999999976 889999999999999999999 999999
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 269 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
+.++.+.+... ..+...+.|+++|.++.+||..||+.+|.+||++++|-..|+.+...-+
T Consensus 708 glSn~EVIe~i-~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 708 GLSNQEVIECI-RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ccchHHHHHHH-HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 99986655544 4455588999999999999999999999999999999999998876643
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=333.35 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=217.0
Q ss_pred cccCCcceeecceeecccceEEEEEEECC--eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-c
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-D 129 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~ 129 (378)
..+....|++++.||+|.-|+||+++..+ ..+|+|++.+........ ..+...|-+||+.++||.++.+|..|+ +
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkK--l~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKK--LKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhH--HHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 44566778999999999999999999865 799999998876655433 346778999999999999999999996 5
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
.+.|++||||+||+|..+++.+....+++..++.|+++++.||+|||..|||+|||||+||||..+|+ |.|+||.++..
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH-IMLsDFDLS~~ 228 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH-IMLSDFDLSLR 228 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc-EEeeecccccc
Confidence 58899999999999999999888888999999999999999999999999999999999999997765 99999998641
Q ss_pred cc----------------------------------c-c----------------------cccccCcCccccccccccc
Q 017046 210 ET----------------------------------V-T----------------------EMMTAETGTYRWMAPELYS 232 (378)
Q Consensus 210 ~~----------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~ 232 (378)
.. . . ......+||..|.|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 00 0 0 0112347999999999997
Q ss_pred cccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCC
Q 017046 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP 312 (378)
Q Consensus 233 ~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 312 (378)
+ ...+.++|+|+||+++|||+.|..||.|.++.+....++.+.....-...++..+++||+++|.+||.+|.
T Consensus 309 G--------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 309 G--------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred c--------CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 6 56788999999999999999999999999988877777655444333346889999999999999999998
Q ss_pred C----HHHHHH
Q 017046 313 S----FSQIIR 319 (378)
Q Consensus 313 s----~~~ll~ 319 (378)
. +.||-+
T Consensus 381 g~~rGA~eIK~ 391 (459)
T KOG0610|consen 381 GSKRGAAEIKR 391 (459)
T ss_pred ccccchHHhhc
Confidence 7 888877
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=336.63 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=205.3
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|.+.+.||+|+||+||++.. +++.||+|.+......... ....+.+|+.+++.++|+||+++++.+.+ ...++||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhh--hHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 67789999999999999976 5789999998764432211 12357899999999999999999998864 4788999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccc
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~ 216 (378)
||+++|+|.+++.......+++..+..++.|++.||+|||+.||+||||||+|||++.++ .++|+|||++.........
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-HIRISDLGLAVQIPEGETV 158 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcCCCCee
Confidence 999999999888654445789999999999999999999999999999999999998655 5999999998765433334
Q ss_pred ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCCCCCCChH
Q 017046 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ--AAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 294 (378)
....|++.|+|||++.. ..++.++|||||||++|+|++|..||.+..... .............++..+++
T Consensus 159 ~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 230 (285)
T cd05631 159 RGRVGTVGYMAPEVINN--------EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSE 230 (285)
T ss_pred cCCCCCCCccCHhhhcC--------CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCH
Confidence 45679999999999864 578899999999999999999999998654321 22222233444556778999
Q ss_pred HHHHHHHHccccCCCCCCC-----HHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPS-----FSQIIRM 320 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps-----~~~ll~~ 320 (378)
++.+|+.+||..||.+||+ +++++++
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 231 DAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999999997 8899883
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=352.25 Aligned_cols=255 Identities=29% Similarity=0.532 Sum_probs=218.8
Q ss_pred cccccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-c
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-D 129 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~ 129 (378)
+.|.+.++...-+.-||+|+-|.||+|+..++.||||+++.-+ ..+|+=|++|+||||+.|.|+|. .
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk------------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK------------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh------------hhhHHHHHhccCcceeeEeeeecCC
Confidence 3455555555566789999999999999999999999875311 25678899999999999999995 5
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+.++||||||..|-|..+|+. .+.+.......|..+|+.|+.|||.+.|||||||.-||||+.+. .|||+|||-++.
T Consensus 185 PcyCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e 261 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDFGTSKE 261 (904)
T ss_pred ceeEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEeccccchHh
Confidence 688999999999999999986 56799999999999999999999999999999999999999665 599999999988
Q ss_pred cccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
.......-.++||..|||||++.. .+.+.++|||||||+|||||||..||.+....-.++-.-.......+|
T Consensus 262 ~~~~STkMSFaGTVaWMAPEvIrn--------ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP 333 (904)
T KOG4721|consen 262 LSDKSTKMSFAGTVAWMAPEVIRN--------EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP 333 (904)
T ss_pred hhhhhhhhhhhhhHhhhCHHHhhc--------CCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc
Confidence 776666677899999999999975 788999999999999999999999998755433333333344566788
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
..+|+.++-|++.||.-.|..||++.+++.||+-+-+.+
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 899999999999999999999999999999998765544
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=324.04 Aligned_cols=258 Identities=28% Similarity=0.359 Sum_probs=214.5
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---CCe
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLM 132 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~~ 132 (378)
+.|.++..|++|+||.||+|++ +++.||+|.++.+....-... .-++||.+|.+++|||||.+..+... +..
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI---tsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI---TSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc---hhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 5688999999999999999987 479999999987664332221 35799999999999999999887643 368
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
|+|||||+. +|..++... ...+...++..++.|++.||+|||.+.|+||||||+|+|++..|. +||+|||+|+..+.
T Consensus 153 y~VMe~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~-lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI-LKIADFGLAREYGS 229 (419)
T ss_pred eeeHHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc-EEecccchhhhhcC
Confidence 999999966 999999875 478999999999999999999999999999999999999996665 99999999997654
Q ss_pred c-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC-----
Q 017046 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP----- 286 (378)
Q Consensus 213 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 286 (378)
. ...+..+.|..|+|||++.+ ...|+.+.|+||+|||+.||+++.+.|.|.+..+.+..+...-..|
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG-------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLG-------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred CcccCcceEEEeeecCHHHhcC-------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 4 34566788999999999987 3689999999999999999999999999988877666553222111
Q ss_pred ------------------------CCCCC-ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 287 ------------------------GLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 287 ------------------------~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
.|+.. ++....+|+..+|..||.+|.|+.+.|+ +.++...+-
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e~P~ 369 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRETPL 369 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--ccccccCCC
Confidence 11111 5677889999999999999999999999 677766443
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=344.65 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=221.3
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CC-eE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PL-MV 133 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~-~~ 133 (378)
+.|..++++|+|+||.++..+++ +..|++|.+.......... .....|+.++++++|||||.+.+.|.+ +. .+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r---~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER---RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh---HHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 46888999999999999987664 6789999988766554332 246799999999999999999999954 44 88
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
|||+||+||+|.+.+...++..++++.+..|+.|++.|+.|||+..|+|||||+.||+++.++. |+|+|||+|+.....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~-VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK-VKLGDFGLAKILNPE 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc-eeecchhhhhhcCCc
Confidence 9999999999999999877778999999999999999999999999999999999999998876 899999999988777
Q ss_pred c-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
. ...+.+||+.|++||++.+ .+|..++|||||||++|||++-+++|.+.+- ..+...+....-.++|..+
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d--------~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-~~Li~ki~~~~~~Plp~~y 230 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSD--------IPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-SELILKINRGLYSPLPSMY 230 (426)
T ss_pred hhhhheecCCCcccCHHHhCC--------CCCCccCcchhhcchHHHHHhcccccCccch-HHHHHHHhhccCCCCCccc
Confidence 6 7778899999999999965 7899999999999999999999999987654 4445555566677889999
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
+.+++.+|..||..+|..||++.+++..
T Consensus 231 s~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 231 SSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 9999999999999999999999999995
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=345.16 Aligned_cols=248 Identities=30% Similarity=0.473 Sum_probs=214.8
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
....|.....||+|+||.||+|.+ +++.||+|++..+...++.+ .+.+|+.+|..++++||.++|+.+-. ..+
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIe----diqqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIE----DIQQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhH----HHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence 345677789999999999999987 46899999998877766543 47799999999999999999998855 478
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
+++||||.||++.+.+.. ...+++..+..++++++.||.|||.++.+|||||+.|||+..++ .+||+|||.+.....
T Consensus 87 wiiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-DVKLADFGVAGQLTN 163 (467)
T ss_pred HHHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-cEEEEecceeeeeec
Confidence 899999999999999975 34458999999999999999999999999999999999999774 599999999876544
Q ss_pred cc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 017046 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291 (378)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (378)
.. ...+.+|||.|||||++.. ..|+.++||||||+++|||++|.+||.+..... ....+.+..+|.+...
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~--------~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-vlflIpk~~PP~L~~~ 234 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQ--------SGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-VLFLIPKSAPPRLDGD 234 (467)
T ss_pred hhhccccccccccccchhhhcc--------ccccchhhhhhhhHHHHHHhcCCCCCcccCcce-EEEeccCCCCCccccc
Confidence 33 3377899999999999964 689999999999999999999999999877733 2334456677777788
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+++.+++|+..||.+||+.||+|.++++
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 9999999999999999999999999998
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=345.57 Aligned_cols=270 Identities=31% Similarity=0.533 Sum_probs=228.2
Q ss_pred ccccccCCcceeecceeecccceEEEEEEEC--C----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeE
Q 017046 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG--D----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123 (378)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l 123 (378)
...|.+..++..+.++||+|+||+||+|+.. + ..||+|..+........ ....|++|+++|+.++|||||++
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~--~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKE--QIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHH--HHHHHHHHHHHHHhCCCCCEEEE
Confidence 3457777788888899999999999999763 1 23899998863322222 23469999999999999999999
Q ss_pred EeeEecC-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEe
Q 017046 124 LGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (378)
Q Consensus 124 ~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~ 202 (378)
+|++.+. .+++|||+|.||+|.++|.... ..++..+...++.+.+.||+|||+++++||||..+|+|++.++ .+||+
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-~vKIS 304 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-VVKIS 304 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-eEEeC
Confidence 9998654 6889999999999999998743 3699999999999999999999999999999999999999544 48999
Q ss_pred ccccccccccccccc-cCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017046 203 DFGLAREETVTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (378)
Q Consensus 203 Dfg~a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~ 280 (378)
|||+++......... ...-...|+|||.+.. ..|+.++|||||||++||+++ |..||.+....+......
T Consensus 305 DFGLs~~~~~~~~~~~~~klPirWLAPEtl~~--------~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~ 376 (474)
T KOG0194|consen 305 DFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT--------GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV 376 (474)
T ss_pred ccccccCCcceeeccccccCcceecChhhhcc--------CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH
Confidence 999998755222222 2235578999999965 689999999999999999999 889999999877666666
Q ss_pred HhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 281 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 281 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
..+.+...|...+.++..++..||..+|++|||+.++.+.|..+.....++
T Consensus 377 ~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 377 KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 778888899999999999999999999999999999999999998887764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=345.22 Aligned_cols=264 Identities=32% Similarity=0.500 Sum_probs=212.8
Q ss_pred ccccccccCCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCC
Q 017046 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDN 119 (378)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~ 119 (378)
..+-.+.+...+|.+.+.||+|+||.||+|++ .+..||||+++....... ...+.+|+.++..+ +|||
T Consensus 25 ~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~----~~~~~~Ei~il~~l~~Hpn 100 (375)
T cd05104 25 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTE----REALMSELKVLSYLGNHIN 100 (375)
T ss_pred CCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHH----HHHHHHHHHHHHHhcCCcc
Confidence 33344556667899999999999999999864 246899999975443332 23578999999999 8999
Q ss_pred eeeEEeeEecC-CeEEEEeccCCCCHHHHHhhhC----------------------------------------------
Q 017046 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR---------------------------------------------- 152 (378)
Q Consensus 120 iv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~---------------------------------------------- 152 (378)
|+++++++.++ ..++||||+++|+|.+++....
T Consensus 101 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 180 (375)
T cd05104 101 IVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVP 180 (375)
T ss_pred eeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccc
Confidence 99999998654 7889999999999999986522
Q ss_pred ---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 153 ---------------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 153 ---------------------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
...+++..+..++.||+.||.|||+.|++||||||+|||++.+ ..+||+|||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~DfG 259 (375)
T cd05104 181 TKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFG 259 (375)
T ss_pred cccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEEEecCc
Confidence 1247888899999999999999999999999999999999954 459999999
Q ss_pred cccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017046 206 LAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 206 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 281 (378)
++........ .....++..|+|||++.. ..++.++|||||||++|+|++ |..||.+............
T Consensus 260 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~ 331 (375)
T cd05104 260 LARDIRNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK 331 (375)
T ss_pred cceeccCcccccccCCCCCCcceeChhHhcC--------CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH
Confidence 9875432221 112234567999999854 568899999999999999998 8999987765555555555
Q ss_pred hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
....+..+...+.++.+|+.+||..||.+|||+.++++.|+..
T Consensus 332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 5555566677889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=340.49 Aligned_cols=242 Identities=24% Similarity=0.395 Sum_probs=200.2
Q ss_pred ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccC
Q 017046 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLP 140 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~ 140 (378)
+.||+|+||.||+++. +++.||||++......... ...++.+|+.+++.++||||+++++.+.+ ...++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKD--EVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhH--HHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 3689999999999976 4689999999764322211 12357789999999999999999998865 47889999999
Q ss_pred CCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc-cccccccC
Q 017046 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAE 219 (378)
Q Consensus 141 ~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~~ 219 (378)
+++|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+|||++.++ .+||+|||++.... ........
T Consensus 79 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 79 GGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCCCcccce
Confidence 9999999875 45789999999999999999999999999999999999999665 59999999987532 22223445
Q ss_pred cCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHH
Q 017046 220 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 299 (378)
Q Consensus 220 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 299 (378)
+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+... .... .......+|..+++++.+|
T Consensus 156 ~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~-~~~~~~~~p~~~~~~~~~l 225 (323)
T cd05571 156 CGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFEL-ILMEEIRFPRTLSPEAKSL 225 (323)
T ss_pred ecCccccChhhhcC--------CCCCccccCcccchhhhhhhcCCCCCCCCCHHH-HHHH-HHcCCCCCCCCCCHHHHHH
Confidence 79999999999864 568899999999999999999999998755432 2222 2344567788899999999
Q ss_pred HHHccccCCCCCC-----CHHHHHHH
Q 017046 300 VQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 300 i~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
|.+||..||.+|| ++.+++++
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 226 LAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 9999999999999 89999883
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=350.09 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=204.0
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec----
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---- 129 (378)
....|.+++.||+|+||.||+|.. .++.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---------YKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---------hHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 446799999999999999999987 468999998865322 13479999999999999999887632
Q ss_pred -----CCeEEEEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEe
Q 017046 130 -----PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (378)
Q Consensus 130 -----~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~ 202 (378)
..+++||||++ ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++..+||+
T Consensus 135 ~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 13668999996 4787776532 345699999999999999999999999999999999999998766679999
Q ss_pred ccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 017046 203 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (378)
Q Consensus 203 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 282 (378)
|||+++............||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.............
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLG-------ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 9999986554444445678999999998754 246889999999999999999999999887654443332211
Q ss_pred cC---------------------------CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 283 HA---------------------------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 283 ~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
.. ...+|...++++.+||.+||..||.+|||+.++++ +.++..+..+
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~--hp~f~~~~~~ 360 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA--DPFFDDLRDP 360 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC--ChhHHhhhcc
Confidence 10 01134457889999999999999999999999998 5666655543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=339.92 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=206.4
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
....|.+.+.||+|+||.||++++. ++.||+|++........ .....+.+|+.+++.++||||+++++++.+ +..
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM--KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhh--hhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 4567999999999999999999874 68899999875432211 122458899999999999999999999865 478
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+.|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 94 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-CEEEeeccCceEcCC
Confidence 899999999999999875 35789999999999999999999999999999999999999665 599999999875432
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
. .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .+... ......+|..+
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i-~~~~~~~p~~~ 238 (329)
T PTZ00263 171 R--TFTLCGTPEYLAPEVIQS--------KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-IYEKI-LAGRLKFPNWF 238 (329)
T ss_pred C--cceecCChhhcCHHHHcC--------CCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-HHHHH-hcCCcCCCCCC
Confidence 2 234579999999999864 567889999999999999999999998766533 23332 23456677889
Q ss_pred hHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPS-----FSQIIRM 320 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 320 (378)
+..+.+|+.+||..||.+||+ +.+++.+
T Consensus 239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999999999999986 7888874
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=342.95 Aligned_cols=261 Identities=31% Similarity=0.520 Sum_probs=211.3
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeE
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKF 123 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l 123 (378)
.+.....+|.+++.||+|+||.||++++. +..||+|+++....... ...+.+|+.+++.+ +||||+++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~il~~l~~h~nIv~~ 107 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE----REALMSELKILSHLGQHKNIVNL 107 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHH----HHHHHHHHHHHHhhccCCceeeE
Confidence 44566778999999999999999998752 24799999976544332 23578999999999 89999999
Q ss_pred EeeEec-CCeEEEEeccCCCCHHHHHhhhC--------------------------------------------------
Q 017046 124 LGACKD-PLMVIVTELLPGMSLRKYLVSLR-------------------------------------------------- 152 (378)
Q Consensus 124 ~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-------------------------------------------------- 152 (378)
++++.+ +..++||||+++|+|.+++....
T Consensus 108 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (374)
T cd05106 108 LGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV 187 (374)
T ss_pred eeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence 999865 47889999999999999985421
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 153 ------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 153 ------------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
...+++..++.++.||+.||.|||++|++||||||+|||++.+ ..++|+|||++.......
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDS 266 (374)
T ss_pred cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEeeceeeeeccCCc
Confidence 1247888999999999999999999999999999999999954 469999999987543221
Q ss_pred c---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 215 M---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 215 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
. .....++..|+|||++.. ..++.++|||||||++|+|++ |..||..................+..+.
T Consensus 267 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 338 (374)
T cd05106 267 NYVVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPD 338 (374)
T ss_pred ceeeccCCCCccceeCHHHhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCC
Confidence 1 112234567999998854 568899999999999999997 9999987655444444444445556667
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
..++++.+++.+||+.||.+|||+.++++.|+.++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 78999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=335.32 Aligned_cols=245 Identities=25% Similarity=0.385 Sum_probs=204.2
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
+|.+.+.||+|+||.||+++.. ++.||+|++......... ....+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK--QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhH--HHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 5888999999999999999875 789999998754322111 224578999999999999999999988654 78899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
|||+++++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+|||++.++ .+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 80 MEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEEecCcchhccCC--
Confidence 999999999999975 35689999999999999999999999999999999999999655 5999999998754322
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHH
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (378)
.....|++.|+|||++.. ..++.++|||||||++|+|++|..||.+..... .+... ......+|..+++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-~~~~i-~~~~~~~~~~~~~~ 224 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS--------KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-IYEKI-LAGKLEFPRHLDLY 224 (291)
T ss_pred cccccCChhhcCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HhCCcCCCccCCHH
Confidence 234578999999999854 567889999999999999999999998766533 23332 33456677888999
Q ss_pred HHHHHHHccccCCCCCCC-----HHHHHHH
Q 017046 296 LAFIVQSCWVEDPNLRPS-----FSQIIRM 320 (378)
Q Consensus 296 l~~li~~~l~~dp~~Rps-----~~~ll~~ 320 (378)
+.+|+.+||..||.+||+ +.+++++
T Consensus 225 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 225 AKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 999999999999999995 9999884
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=322.76 Aligned_cols=262 Identities=28% Similarity=0.408 Sum_probs=213.3
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--- 129 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--- 129 (378)
.....|...+.||+|+||.|+.+.+ +++.||||++........ ..++..+|+++|+.++|+||+.+++.+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~---~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQI---DAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchH---HHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 3445566678999999999999876 579999999875444332 34578899999999999999999998743
Q ss_pred ---CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 130 ---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 130 ---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
...|+|+|++ +.+|.+.++. +..++...+..+++|++.||.|+|+.||+||||||.|+|++.+.. +||+|||+
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~-lKI~DFGL 171 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD-LKICDFGL 171 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC-EEeccccc
Confidence 2579999999 6799999986 345999999999999999999999999999999999999996654 99999999
Q ss_pred cccccc---ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017046 207 AREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 207 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 283 (378)
|+..+. ...++..+.|..|.|||++.. ...|+.+.||||+|||+.||++|++.|.|.+....+..+...-
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~-------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLN-------SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL 244 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhc-------cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence 997653 555677889999999999865 4789999999999999999999999999866544333221111
Q ss_pred C---------------------CCCC--------CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 284 A---------------------RPGL--------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 284 ~---------------------~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
. .+.. -++.++.+.+|+.+||..||.+|+|++|.++ +.++..+..+.
T Consensus 245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~--hPYl~~~hdp~ 320 (359)
T KOG0660|consen 245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA--HPYLAPYHDPE 320 (359)
T ss_pred CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc--ChhhhhhcCCc
Confidence 1 1111 1367889999999999999999999999999 66776665444
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=324.58 Aligned_cols=255 Identities=26% Similarity=0.462 Sum_probs=209.3
Q ss_pred cCCcceeecceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
++.+.|.+.+.||+|+||.||+|.+. +..||+|.++....... ...+.+|+.++..++||||+++++.+..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ----RRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHH----HHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 34567899999999999999999752 46899999986544322 2358899999999999999999998864
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++ .++++|||.+.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l~dfg~~~ 155 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQ 155 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEECCCcccc
Confidence 4789999999999999998763 35789999999999999999999999999999999999999655 59999999876
Q ss_pred cccccccc--ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017046 209 EETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 209 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
........ ....++..|+|||.+.. ..++.++|||||||++|++++ |..||.+..... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-~~~~~~~~~~ 226 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQY--------HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-VIKAVEDGFR 226 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhh--------CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHHHHCCCC
Confidence 53222111 12345678999998854 678899999999999999875 999998766543 3334444455
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
...+..++..+.+++..||+.+|.+||++.++++.|..+
T Consensus 227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 567788999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=337.14 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=202.1
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
.|.+.+.||+|+||.||+|+.. ++.||||++......... ....+.+|+.++..++||||+++++++.++ ..++|
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLN--EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhh--HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 5889999999999999999874 689999999764322211 224578999999999999999999998654 78899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
|||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..... .
T Consensus 80 ~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 80 MEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-HIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEEeCcCCccccc--c
Confidence 999999999999975 35689999999999999999999999999999999999999665 599999999875433 2
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC---CCCCC---
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA---RPGLP--- 289 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---~~~~~--- 289 (378)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.......... .+...
T Consensus 155 ~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 226 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRG--------KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPR 226 (333)
T ss_pred cCCcccCccccChhHhcC--------CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccc
Confidence 345579999999999864 5788999999999999999999999987655333222211111 11111
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
..+++++.+++.+||..+|.+||++.+++++
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 2468999999999999999999999999984
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=329.63 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=197.2
Q ss_pred ceeecceeecccceEEEEEEE---CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc---cCCCeeeEEeeEe----
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACK---- 128 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~---- 128 (378)
+|.+.+.||+|+||+||+|++ .++.||+|++.......... ..+.+|+.+++.+ +||||+++++++.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCch---HHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 688899999999999999976 35789999987644332211 2355677766665 6999999999874
Q ss_pred --cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 129 --DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 129 --~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
+...++||||+. ++|.+++.......+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~ 156 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGL 156 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccccc
Confidence 235889999995 6999999775556799999999999999999999999999999999999999665 599999999
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
+.............|++.|+|||.+.. ..++.++|||||||++|+|++|.+||.+....+...........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~ 228 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 228 (290)
T ss_pred eEeccCCcccccccccccccChHHHhC--------CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 976554444455678999999999854 567889999999999999999999998876644433322111000
Q ss_pred -------------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 287 -------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 287 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+...++..+.+|+.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 011346788899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=336.91 Aligned_cols=250 Identities=22% Similarity=0.347 Sum_probs=206.8
Q ss_pred ccCCcceeecceeecccceEEEEEEECC---eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGD---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 130 (378)
.+..+.|.+.+.||+|+||.||+|.+.+ ..||+|++......... ....+.+|+.+++.++||||+++++++.++
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQK--QVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhh--hHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 3456789999999999999999997532 57999998754322211 224578999999999999999999999654
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
..++||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++..
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~ikL~DFG~a~~ 180 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGFAKV 180 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEecCCCCee
Confidence 68899999999999999975 35689999999999999999999999999999999999998655 599999999875
Q ss_pred cccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+... .+... ......+|
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~i-~~~~~~~p 248 (340)
T PTZ00426 181 VDTR--TYTLCGTPEYIAPEILLN--------VGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-IYQKI-LEGIIYFP 248 (340)
T ss_pred cCCC--cceecCChhhcCHHHHhC--------CCCCccccccchhhHHHHHhcCCCCCCCCCHHH-HHHHH-hcCCCCCC
Confidence 4322 234579999999999864 567889999999999999999999998766533 23332 33445677
Q ss_pred CCChHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
..+++.+.+++++||+.||.+|+ ++++++++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 88999999999999999999995 89999884
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=330.47 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=201.5
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
...+|.+.+.||+|+||.||+|+. +++.||+|++........ ...+.+|+.+++.++||||+++++++.++ ..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT----PFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc----chhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence 356799999999999999999987 468999999875433221 12467899999999999999999998654 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+ +++|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 79 ~lv~e~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 79 TLVFEYV-HTDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLADFGLARAKSV 155 (303)
T ss_pred EEEEECC-CcCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECCCCcceeccC
Confidence 8999999 4688888765 345689999999999999999999999999999999999999655 599999999864332
Q ss_pred c-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CC----
Q 017046 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-RP---- 286 (378)
Q Consensus 213 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~---- 286 (378)
. .......+++.|+|||++.+ ...++.++|||||||++|+|++|..||.+..+............ .+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLG-------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228 (303)
T ss_pred CCccCCCCcccCCCCChHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence 2 22334578999999998753 24578899999999999999999999987655433332221100 00
Q ss_pred --------C---------CC---------CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 287 --------G---------LP---------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 287 --------~---------~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
. .+ ...++++.+|+.+||+.||.+|||+.++++ +.++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~--h~~f~~~ 294 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS--HEYFSDL 294 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc--CcccccC
Confidence 0 00 124567899999999999999999999998 6666554
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=325.80 Aligned_cols=254 Identities=31% Similarity=0.553 Sum_probs=209.7
Q ss_pred CcceeecceeecccceEEEEEEECC-------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
.++|.+.+.||+|+||.||+|...+ ..||+|.+....... ....|.+|+.++..++||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK----VQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHH----HHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 4578889999999999999997632 569999987544322 23458899999999999999999999864
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~ 194 (378)
...+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 478899999999999999975322 45888999999999999999999999999999999999996
Q ss_pred CCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCC
Q 017046 195 DQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270 (378)
Q Consensus 195 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 270 (378)
++ .++|+|||++....... ......+++.|+|||.+.. ..++.++|||||||++|+|++ |..||.+.
T Consensus 160 ~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 160 GL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--------GKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred CC-cEEECCCcceeeccccccccccCCCcccccccCHHHhcc--------CcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 55 59999999987532221 2233456788999998754 567889999999999999998 99999876
Q ss_pred ChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 271 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
... .....+.....+..+..+++++.+|+.+||+.||.+||++.+++++|+++
T Consensus 231 ~~~-~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 231 SNQ-EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred CHH-HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 653 34444555556667788999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=333.83 Aligned_cols=242 Identities=26% Similarity=0.423 Sum_probs=199.7
Q ss_pred ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccC
Q 017046 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLP 140 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~ 140 (378)
+.||+|+||.||+++. .++.||+|++......... ....+.+|+.+++.++||||+++++.+.+ ...++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKD--EVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 3689999999999976 4689999999764332221 12457899999999999999999998865 47889999999
Q ss_pred CCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-ccccccC
Q 017046 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAE 219 (378)
Q Consensus 141 ~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 219 (378)
+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .......
T Consensus 79 ~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 79 GGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcccccccc
Confidence 9999988865 35689999999999999999999999999999999999999655 599999999875322 2223345
Q ss_pred cCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHH
Q 017046 220 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 299 (378)
Q Consensus 220 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 299 (378)
+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+..... ... ........+|..+++++.+|
T Consensus 156 ~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-~~~-~~~~~~~~~p~~~~~~~~~l 225 (328)
T cd05593 156 CGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFE-LILMEDIKFPRTLSADAKSL 225 (328)
T ss_pred cCCcCccChhhhcC--------CCCCccCCccccchHHHHHhhCCCCCCCCCHHH-HHH-HhccCCccCCCCCCHHHHHH
Confidence 79999999999854 567899999999999999999999998755432 222 22334556788899999999
Q ss_pred HHHccccCCCCCC-----CHHHHHHH
Q 017046 300 VQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 300 i~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
+.+||..||.+|| ++.+++++
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 226 LSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 9999999999997 89999884
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=338.55 Aligned_cols=265 Identities=31% Similarity=0.508 Sum_probs=215.1
Q ss_pred cccccccCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCe
Q 017046 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNL 120 (378)
Q Consensus 49 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i 120 (378)
.+..+.++...|.+++.||+|+||.||+|.+. ...||||++........ ...+.+|+.++..+. ||||
T Consensus 28 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~----~~~~~~Ei~~l~~l~~HpnI 103 (400)
T cd05105 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSE----KQALMSELKIMTHLGPHLNI 103 (400)
T ss_pred CCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHH----HHHHHHHHHHHHhcCCCCCe
Confidence 34456677888999999999999999999753 24699999976543322 235889999999996 9999
Q ss_pred eeEEeeEec-CCeEEEEeccCCCCHHHHHhhhC-----------------------------------------------
Q 017046 121 VKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR----------------------------------------------- 152 (378)
Q Consensus 121 v~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~----------------------------------------------- 152 (378)
+++++++.+ +..++||||+++|+|.+++....
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (400)
T cd05105 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQA 183 (400)
T ss_pred eeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccc
Confidence 999999965 47899999999999999886531
Q ss_pred -----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecC
Q 017046 153 -----------------------------------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDL 185 (378)
Q Consensus 153 -----------------------------------------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~di 185 (378)
...+++..+..++.|++.||.|||+.|++|+||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~di 263 (400)
T cd05105 184 DTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDL 263 (400)
T ss_pred cccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 124778888999999999999999999999999
Q ss_pred CCCcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh
Q 017046 186 KPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262 (378)
Q Consensus 186 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~ 262 (378)
||+|||++.++ .+||+|||++....... ......+++.|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 264 kp~Nill~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ellt 334 (400)
T cd05105 264 AARNVLLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD--------NLYTTLSDVWSYGILLWEIFS 334 (400)
T ss_pred ChHhEEEeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC--------CCCCchhhHHHHHHHHHHHHH
Confidence 99999999654 59999999987532221 1122346678999998854 567889999999999999997
Q ss_pred -CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 263 -NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 263 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
|..||..................+..+..++.++.+++.+||..||.+|||+.++.+.|..++.
T Consensus 335 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 335 LGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred CCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 9999987655444455555555666777899999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=338.80 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=199.0
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
.|.+++.||+|+||+||+|+. +++.||||++......... ....+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~--~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRN--QVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhH--HHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 578899999999999999987 4679999999764432222 124688999999999999999999998654 78899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc--
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-- 213 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-- 213 (378)
|||++||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++......
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 80 MDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-CEEEeeCcCCcccccccc
Confidence 999999999999875 35689999999999999999999999999999999999999655 5999999987421100
Q ss_pred ----------------------------------------------cccccCcCccccccccccccccccccccccCCCc
Q 017046 214 ----------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 247 (378)
Q Consensus 214 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 247 (378)
......+||+.|+|||++.. ..++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~ 228 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--------KGYTQL 228 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--------CCCCCc
Confidence 01123479999999999864 568899
Q ss_pred ccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC--CChHHHHHHHHHcc--ccCCCCCCCHHHHHHH
Q 017046 248 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCW--VEDPNLRPSFSQIIRM 320 (378)
Q Consensus 248 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l--~~dp~~Rps~~~ll~~ 320 (378)
+|||||||++|+|++|..||....................+|. .+++++.+||.+|+ ..+|..||++.+++++
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999999999999987665444333332222333333 58899999999844 5566669999999983
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=333.45 Aligned_cols=261 Identities=31% Similarity=0.559 Sum_probs=211.0
Q ss_pred cccCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEE
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFL 124 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~ 124 (378)
|.+..+.|++.+.||+|+||.||+|... ++.||+|++........ ...+..|+.++.++ +||||++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~----~~~~~~E~~~~~~l~~h~niv~~~ 77 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE----YKALMTELKILIHIGHHLNVVNLL 77 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHH----HHHHHHHHHHHHhhccCcchhhee
Confidence 3455668999999999999999998642 36899999875443322 23477899999999 899999999
Q ss_pred eeEec--CCeEEEEeccCCCCHHHHHhhhCC-------------------------------------------------
Q 017046 125 GACKD--PLMVIVTELLPGMSLRKYLVSLRP------------------------------------------------- 153 (378)
Q Consensus 125 ~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~------------------------------------------------- 153 (378)
+++.. ...+++|||+++++|.+++.....
T Consensus 78 ~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (337)
T cd05054 78 GACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE 157 (337)
T ss_pred eeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence 98753 467899999999999999864321
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc---ccccCc
Q 017046 154 ----------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAET 220 (378)
Q Consensus 154 ----------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~ 220 (378)
..+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||++....... ......
T Consensus 158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCC
Confidence 2578999999999999999999999999999999999999655 59999999997542221 112234
Q ss_pred CccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHH
Q 017046 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 299 (378)
Q Consensus 221 gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 299 (378)
++..|+|||++.. ..++.++|||||||++|+|++ |..||.+....+...........+..+...++++.++
T Consensus 237 ~~~~y~aPE~~~~--------~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 308 (337)
T cd05054 237 LPLKWMAPESIFD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSI 308 (337)
T ss_pred CCccccCcHHhcC--------CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHH
Confidence 5678999998854 678899999999999999998 9999987554444444444455556677789999999
Q ss_pred HHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 300 VQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 300 i~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
+.+||+.+|.+||++.+++++|..++.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=328.67 Aligned_cols=258 Identities=27% Similarity=0.501 Sum_probs=211.6
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCe----eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDR----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+...+|.+.+.||+|+||.||+|++ .++ .||+|+++....... ..++.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 3456799999999999999999976 233 489999875433222 235889999999999999999999998
Q ss_pred cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
....++++||+++|+|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||++.
T Consensus 80 ~~~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~ 157 (316)
T cd05108 80 TSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAK 157 (316)
T ss_pred CCCceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEccccccc
Confidence 87888999999999999999763 34688999999999999999999999999999999999998655 59999999997
Q ss_pred ccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 209 EETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 209 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
....... .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~ 228 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGE 228 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhcc--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhCCC
Confidence 5433222 122234668999998854 668899999999999999997 99999876543 3344444555
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
....+..++.++.+++.+||..+|.+||++.+++..+......
T Consensus 229 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 229 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 5566777899999999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=332.59 Aligned_cols=242 Identities=24% Similarity=0.402 Sum_probs=198.6
Q ss_pred ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccC
Q 017046 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLP 140 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~ 140 (378)
+.||+|+||.||+++. .+..||+|++......... ....+.+|+.+++.++||||+++++.+.+ ...++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhH--HHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 3689999999999986 4689999999764322211 12357789999999999999999998865 47889999999
Q ss_pred CCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-ccccccC
Q 017046 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAE 219 (378)
Q Consensus 141 ~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 219 (378)
+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..... .......
T Consensus 79 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 79 GGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCCccccc
Confidence 9999988865 35689999999999999999999999999999999999999665 599999999875322 2222345
Q ss_pred cCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHH
Q 017046 220 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 299 (378)
Q Consensus 220 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 299 (378)
.|++.|+|||.+.. ..++.++|||||||++|+|++|..||.+.+.... .... ......+|..+++++.++
T Consensus 156 ~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~~-~~~~~~~p~~~~~~~~~l 225 (323)
T cd05595 156 CGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELI-LMEEIRFPRTLSPEAKSL 225 (323)
T ss_pred cCCcCcCCcccccC--------CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHH-hcCCCCCCCCCCHHHHHH
Confidence 79999999999854 5678999999999999999999999987654332 2222 234456778899999999
Q ss_pred HHHccccCCCCCC-----CHHHHHHH
Q 017046 300 VQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 300 i~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
+.+||..||.+|| ++.+++++
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 226 LAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 9999999999998 89999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=319.16 Aligned_cols=255 Identities=31% Similarity=0.514 Sum_probs=211.0
Q ss_pred cCCcceeecceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV 133 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 133 (378)
+....|++.++||+|+||.||+|++.+ ..||+|++....... ..+.+|+++++.++||||+++++.+.+...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~------~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCH------HHHHHHHHHHHhCCCCCcceEEEEECCCCcE
Confidence 455679999999999999999998754 579999987644322 2578999999999999999999988777889
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||.+......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCceeecccc
Confidence 999999999999999764455689999999999999999999999999999999999999655 5999999998754322
Q ss_pred ccc--ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 214 EMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 214 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
... ....++..|+|||.... ..++.++||||||+++|+|++ |..||.+..... .............+.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~ 226 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRMPCPP 226 (262)
T ss_pred ccccccCCcccceecCHhHhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-HHHHHhcCCCCCCcc
Confidence 211 12345678999998754 568899999999999999999 889998765533 333333444445566
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
.++..+.+++.+||+.+|.+||++.++++.|+.++
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 78999999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=325.20 Aligned_cols=250 Identities=22% Similarity=0.358 Sum_probs=205.3
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|++.+.||+|+||+||++.. +++.||+|++......... ....+.+|+.+++.++||||+++++.+.+ ...++||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhh--hHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 77889999999999999986 4689999998764432221 12357789999999999999999998864 4789999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccc
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~ 216 (378)
||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-HIRISDLGLAVEIPEGETI 158 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-CEEEeeCCCceecCCCCcc
Confidence 999999999988764445799999999999999999999999999999999999999554 5999999998765433333
Q ss_pred ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHH--HHHHHhcCCCCCCCCChH
Q 017046 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA--YAAAFKHARPGLPEDISP 294 (378)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 294 (378)
....|++.|+|||++.. ..++.++||||+||++|+|++|..||.+....... ...........++..+++
T Consensus 159 ~~~~~~~~y~aPE~~~~--------~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd05605 159 RGRVGTVGYMAPEVVKN--------ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSE 230 (285)
T ss_pred ccccCCCCccCcHHhcC--------CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCH
Confidence 44578999999999854 56788999999999999999999999875542211 122233444556677999
Q ss_pred HHHHHHHHccccCCCCCC-----CHHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
.+.+|+.+||..||.+|| ++.+++++
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 999999999999999999 89999884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=332.57 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=217.4
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEecC-Ce
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-LM 132 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~-~~ 132 (378)
...|.+.+.||.|.||.||+++. +++.+|+|++.+....... ....+.+|+.+|+++. |||||.+++.|++. ..
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~--~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE--DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc--cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 45699999999999999999976 4789999999887665432 1235789999999998 99999999999865 68
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC---CceeEeccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---KSLKLADFGLARE 209 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~---~~vkl~Dfg~a~~ 209 (378)
++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+.... ..+|++|||++..
T Consensus 112 ~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 8999999999999999874 399999999999999999999999999999999999996542 3699999999998
Q ss_pred cccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC--CCC
Q 017046 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--RPG 287 (378)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~ 287 (378)
..........+||+.|+|||++.. ..|+..+||||+|+++|.|++|.+||.+.+............. ...
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~--------~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~ 260 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGG--------RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSE 260 (382)
T ss_pred ccCCceEeeecCCccccCchhhcC--------CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCC
Confidence 777667788899999999999964 6899999999999999999999999999886555543332222 112
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.-+.++..+.+++..||..||..|+|+.++++| .|+..
T Consensus 261 ~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H--pWi~~ 298 (382)
T KOG0032|consen 261 PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH--PWIKS 298 (382)
T ss_pred CccccCHHHHHHHHHhcccCcccCCCHHHHhcC--ccccC
Confidence 224579999999999999999999999999995 55443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=325.69 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=198.8
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
+-+.|.+.+.||.|+||.||+|+. +++.||+|+++........ ..+.+|+.+++.++||||+++++++.+. ..
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP----CTAIREVSLLKNLKHANIVTLHDIIHTERCL 78 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcc----hhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 446799999999999999999976 4689999998754432221 2467899999999999999999998654 68
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+++ +|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 79 ~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~~ 155 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSV 155 (288)
T ss_pred EEEEeCCCc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEECcCcceeeccC
Confidence 899999965 99998865 345689999999999999999999999999999999999999665 599999999875332
Q ss_pred c-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-------
Q 017046 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA------- 284 (378)
Q Consensus 213 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------- 284 (378)
. .......+++.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+..........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVLLG-------STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228 (288)
T ss_pred CCccccCceecccccChHHhcC-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 2 12234568899999998753 24578899999999999999999999987665433322211000
Q ss_pred -------------CC--------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 285 -------------RP--------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 285 -------------~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.+ .....+++++.+|+.+||..||.+|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0112467889999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=330.63 Aligned_cols=239 Identities=26% Similarity=0.393 Sum_probs=196.7
Q ss_pred eecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccCCC
Q 017046 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGM 142 (378)
Q Consensus 66 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 142 (378)
||+|+||.||+++.. ++.||+|++......... ....+.+|+.++..++||||+++++++.+ ...++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRS--EVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 699999999999874 678999998753322111 12457899999999999999999998865 4789999999999
Q ss_pred CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-ccccccCcC
Q 017046 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETG 221 (378)
Q Consensus 143 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~g 221 (378)
+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||++..... .......+|
T Consensus 79 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 79 ELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCccccccC
Confidence 99999875 35699999999999999999999999999999999999999665 599999999875322 222334579
Q ss_pred ccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 017046 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 301 (378)
Q Consensus 222 t~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 301 (378)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ..... ......++..+++++.+++.
T Consensus 156 t~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~li~ 225 (312)
T cd05585 156 TPEYLAPELLLG--------HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-MYRKI-LQEPLRFPDGFDRDAKDLLI 225 (312)
T ss_pred CcccCCHHHHcC--------CCCCCccceechhHHHHHHHhCCCCcCCCCHHH-HHHHH-HcCCCCCCCcCCHHHHHHHH
Confidence 999999999864 568899999999999999999999998765433 33332 34456778889999999999
Q ss_pred HccccCCCCCCC---HHHHHH
Q 017046 302 SCWVEDPNLRPS---FSQIIR 319 (378)
Q Consensus 302 ~~l~~dp~~Rps---~~~ll~ 319 (378)
+||..||.+||+ +.+++.
T Consensus 226 ~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 226 GLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHcCCCHHHcCCCCCHHHHHc
Confidence 999999999975 667766
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=325.62 Aligned_cols=253 Identities=30% Similarity=0.523 Sum_probs=199.6
Q ss_pred CcceeecceeecccceEEEEEEEC------------------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCC
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG------------------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 118 (378)
...|.+.++||+|+||.||++.+. +..||+|++........ ...|.+|+.++..++||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNA----RNDFLKEVKILSRLKDP 79 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHH----HHHHHHHHHHHhhcCCC
Confidence 457889999999999999999742 24699999876543222 24688999999999999
Q ss_pred CeeeEEeeEec-CCeEEEEeccCCCCHHHHHhhhC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 017046 119 NLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR-----------------PNKLDLHVALNFALDIARAMDCLHANGI 180 (378)
Q Consensus 119 ~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~~l~~lH~~gi 180 (378)
||+++++++.+ ...++||||+.+++|.+++.... ...+++..++.++.||+.||.|||+.||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999864 47899999999999999986521 1246778899999999999999999999
Q ss_pred eeecCCCCcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHH
Q 017046 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 257 (378)
Q Consensus 181 vH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 257 (378)
+||||||+|||++.++ .+||+|||++....... ......++..|+|||++.. ..++.++||||||+++
T Consensus 160 vH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l 230 (304)
T cd05096 160 VHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--------GKFTTASDVWAFGVTL 230 (304)
T ss_pred cccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--------CCCCchhhhHHHHHHH
Confidence 9999999999999655 59999999987543221 1223345788999998854 5688999999999999
Q ss_pred HHHHh--CCCCCCCCChHHHHHHHH--H----hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 258 WELLT--NRLPFEGMSNLQAAYAAA--F----KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 258 ~~ll~--g~~pf~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
|+|++ +..||.+........... . .......+..++..+.+++.+||..||.+|||+.++.+.|+
T Consensus 231 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 231 WEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 99986 667887765433222111 1 11122345678899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=338.47 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=200.3
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
++|.+.+.||+|+||+||+++. +++.||||++......... ....+.+|+.++..++||||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKE--QVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 3688999999999999999987 4689999999754322111 224577899999999999999999998755 7889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||++.......
T Consensus 79 v~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 79 IMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEeecccceeccccc
Confidence 9999999999999875 35699999999999999999999999999999999999999665 59999999986422110
Q ss_pred ---------------------------------------ccccCcCccccccccccccccccccccccCCCcccchhhhH
Q 017046 215 ---------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 255 (378)
Q Consensus 215 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~ 255 (378)
.....+||+.|+|||++.. ..++.++|||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~ 227 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--------TGYNKECDWWSLGV 227 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--------CCCCCeeeeecchh
Confidence 0112469999999999854 56889999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC--CChHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 017046 256 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRPS---FSQIIRM 320 (378)
Q Consensus 256 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 320 (378)
++|+|++|..||.+.+................+|. .+++++.+||.+|+. +|.+|++ +.+++++
T Consensus 228 il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999999999987765443333222122223333 478999999999996 9999997 9999883
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=338.64 Aligned_cols=248 Identities=26% Similarity=0.405 Sum_probs=203.4
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
+|.+.+.||+|+||+||+++.. ++.||||++........ .....+.+|+.++..++||||+++++++.++ ..++|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKR--NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhc--cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 6889999999999999999875 78999999975432221 1124578999999999999999999988654 78999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEeecCCCCccCcccCc
Confidence 9999999999999763 6799999999999999999999999999999999999999665 59999999987543322
Q ss_pred -----------------------------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCC
Q 017046 215 -----------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 265 (378)
Q Consensus 215 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~ 265 (378)
......||+.|+|||++.. ..++.++|||||||++|+|++|..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--------TPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcC--------CCCCCceeeEecchhhhhhccCCC
Confidence 2234578999999999865 578899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCC--CChHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 017046 266 PFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRPS-FSQIIRM 320 (378)
Q Consensus 266 pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~ 320 (378)
||.+..................+|. .+++++.+||.+||. ||.+||+ +.+++++
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9988765443333322112223333 369999999999997 9999999 9999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=343.82 Aligned_cols=248 Identities=30% Similarity=0.524 Sum_probs=211.4
Q ss_pred eeecccceEEEEEEECC--eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeEEEEeccCC
Q 017046 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPG 141 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv~e~~~~ 141 (378)
.||+|.||+||.|++.+ ...|||.+......... -+..||.+-++|+|.|||+++|.+. ++++-|.||.++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~Q-----PLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQ-----PLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhc-----cHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 69999999999998754 57889988654443322 3678999999999999999999985 4577799999999
Q ss_pred CCHHHHHhhhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc-cccccccc
Q 017046 142 MSLRKYLVSLRPNKL--DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE-TVTEMMTA 218 (378)
Q Consensus 142 ~sL~~~l~~~~~~~l--~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~-~~~~~~~~ 218 (378)
|+|.+++.. +.+++ .+..+..+..||++||.|||++.|||||||-+||||+.-.+.+||+|||-++.. .....+.+
T Consensus 657 GSLSsLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CcHHHHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 999999987 55677 788999999999999999999999999999999999988888999999988753 34444567
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHH-HHhcCCCCCCCCChHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA-AFKHARPGLPEDISPDLA 297 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~ 297 (378)
+.||..|||||++... ...|+.++|||||||++.||.||++||-.....+..+.. -.-...|++|..++.+++
T Consensus 736 FTGTLQYMAPEvIDqG------~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak 809 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQG------PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAK 809 (1226)
T ss_pred cccchhhhChHhhccC------CcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHH
Confidence 7899999999999653 267899999999999999999999999877665555443 345668889999999999
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 298 FIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 298 ~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
++|.+|+.+||.+||++.++++ ..++.
T Consensus 810 ~FilrcFepd~~~R~sA~~LL~--DpFlq 836 (1226)
T KOG4279|consen 810 NFILRCFEPDPCDRPSAKDLLQ--DPFLQ 836 (1226)
T ss_pred HHHHHHcCCCcccCccHHHhcc--Ccccc
Confidence 9999999999999999999998 55553
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=336.95 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=205.1
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-C
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 131 (378)
+..+.|.+.+.||+|+||.||+++.. ++.||+|++......... ....+.+|+.+++.++||||+++++++.++ .
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRS--DSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh--hHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 45678999999999999999999874 689999999753221111 123477899999999999999999988765 6
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~~~~ 193 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEEEEeccceeecc
Confidence 8899999999999998865 4588999999999999999999999999999999999999665 59999999987543
Q ss_pred ccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh-cCCCCC
Q 017046 212 VTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGL 288 (378)
Q Consensus 212 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~ 288 (378)
... ......||+.|+|||++... .....++.++|||||||++|+|++|..||.+...... +..+.. .....+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~~~~~ 268 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YSKIMDHKNSLTF 268 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccC----CCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-HHHHHcCCCcCCC
Confidence 322 22345799999999998541 1124578899999999999999999999987665433 333322 223344
Q ss_pred CC--CChHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 017046 289 PE--DISPDLAFIVQSCWVEDPNL--RPSFSQIIRM 320 (378)
Q Consensus 289 ~~--~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 320 (378)
|. .++.++.+||.+||..+|.+ |+|+.+++++
T Consensus 269 ~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 269 PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 44 57999999999999999987 9999999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=317.01 Aligned_cols=246 Identities=26% Similarity=0.524 Sum_probs=204.8
Q ss_pred eeecccceEEEEEEE----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCeEEEEeccC
Q 017046 65 KIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLP 140 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~lv~e~~~ 140 (378)
+||+|+||.||+|.+ ++..+|+|+++....... ....+.+|+.+++.++||||+++++++.+...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPA---LKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHH---HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCC
Confidence 589999999999864 358899999875543222 2346889999999999999999999998888899999999
Q ss_pred CCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc----c
Q 017046 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----M 216 (378)
Q Consensus 141 ~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~ 216 (378)
+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||.||+++.++ .++|+|||++........ .
T Consensus 79 ~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCccccccCCCCCeeeec
Confidence 9999999875 35689999999999999999999999999999999999999654 599999999875432221 1
Q ss_pred ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHH
Q 017046 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295 (378)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (378)
....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.... ...........+..|..++++
T Consensus 156 ~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 226 (257)
T cd05116 156 THGKWPVKWYAPECMNY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVTQMIESGERMECPQRCPPE 226 (257)
T ss_pred CCCCCCccccCHhHhcc--------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHCCCCCCCCCCCCHH
Confidence 22234578999998753 567889999999999999998 99999876553 344445555667788889999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 296 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 296 l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
+.++|.+||+.||.+||++.+|.+.|..++
T Consensus 227 l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 227 MYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred HHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=332.65 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=202.4
Q ss_pred ceeecceeecccceEEEEEEE-----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-CC
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PL 131 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~ 131 (378)
+|.+.+.||+|+||.||+++. .++.||+|++........ ......+..|+.++..+ +||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQK-AKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhh-hhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 478899999999999999875 468899999875432221 12234578899999999 59999999998865 46
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCcCCcccc
Confidence 8899999999999999875 35689999999999999999999999999999999999999665 59999999987532
Q ss_pred cc--cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCC
Q 017046 212 VT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFKHARPG 287 (378)
Q Consensus 212 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~ 287 (378)
.. .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||..... .............+.
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRG-------KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP 229 (332)
T ss_pred ccCCCccccccCCccccCHHHhcC-------CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC
Confidence 22 12234579999999999854 13467899999999999999999999964321 122233333445667
Q ss_pred CCCCChHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
++..+++.+.+++.+||..||.+|| ++.+++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 230 FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 7788999999999999999999999 78888873
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=318.09 Aligned_cols=255 Identities=32% Similarity=0.576 Sum_probs=211.8
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCC
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPL 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~ 131 (378)
+....|.+.+.||+|+||.||+|... ++.||+|++...... ...+.+|+.+++.++||||+++++++. +..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME------VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 76 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH------HHHHHHHHHHHHhCCCCChhheEEEEcCCCC
Confidence 45567888999999999999999764 688999998753221 135789999999999999999999885 457
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.+++|||+++++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~ 155 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT 155 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeCCCccccccc
Confidence 88999999999999999775556789999999999999999999999999999999999998655 59999999987543
Q ss_pred ccccc--ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 212 VTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 212 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
..... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+... ............+..
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~ 226 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKGYRMER 226 (263)
T ss_pred cceeeccCCCCCccccCCHHHhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCCCCC
Confidence 32211 11234567999998754 567889999999999999998 9999987544 444555555566777
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
+..++.++.+++.+||..+|.+|||+.++++.|+.++
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 8889999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=337.64 Aligned_cols=258 Identities=32% Similarity=0.590 Sum_probs=224.2
Q ss_pred ccCCcceeecceeecccceEEEEEEECC------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
.+..+...+.+.||.|-||.||+|.+++ -.||||..+.+...+.. +.|+.|.-+|+.++|||||+++|+|
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~t----ekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDT----EKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhH----HHHHHHHHHHHhCCCcchhheeeee
Confidence 3455556677899999999999998743 36999999988777664 3699999999999999999999999
Q ss_pred ecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
.+...+||||.++-|.|+.+++.+ ...++......+++||..||+|||+..+|||||..+|||+.+... |||+|||++
T Consensus 461 ~e~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C-VKLaDFGLS 538 (974)
T KOG4257|consen 461 VEQPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC-VKLADFGLS 538 (974)
T ss_pred eccceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce-eeecccchh
Confidence 999999999999999999999874 467999999999999999999999999999999999999997765 999999999
Q ss_pred cccccccccccC--cCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 208 REETVTEMMTAE--TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 208 ~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
+........... .-...|||||.++. ..++.++|||.||+.|||++. |..||.+..+.+. .-.+..+.
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINf--------RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-I~~iEnGe 609 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINF--------RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-IGHIENGE 609 (974)
T ss_pred hhccccchhhccccccceeecCccccch--------hcccchhhHHHHHHHHHHHHHhcCCccccccccce-EEEecCCC
Confidence 876555443333 34567999999965 789999999999999999998 9999999877443 33445788
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
+++.|+.||+.+..|+.+||+.+|.+||.+.++...|...+.
T Consensus 610 RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 610 RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999998887765
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=330.10 Aligned_cols=243 Identities=27% Similarity=0.420 Sum_probs=199.1
Q ss_pred ceeecccceEEEEEEE-----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEe
Q 017046 64 SKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTE 137 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e 137 (378)
+.||+|+||.||+++. .++.||+|++......... .....+..|+.+++.++||||+++++.+.+ +..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~-~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQ-KDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhh-hhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 5799999999999875 4678999999764322111 122357789999999999999999998865 47899999
Q ss_pred ccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-cccc
Q 017046 138 LLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMM 216 (378)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~ 216 (378)
|+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..... ....
T Consensus 81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEeeCcCCeecccCCCcc
Confidence 9999999999875 35688999999999999999999999999999999999999665 599999999864322 2223
Q ss_pred ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHH
Q 017046 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDL 296 (378)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 296 (378)
....|++.|+|||++.. ..++.++|||||||++|+|++|..||.+...... .... ......+|..+++++
T Consensus 158 ~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-~~~~-~~~~~~~~~~~~~~~ 227 (323)
T cd05584 158 HTFCGTIEYMAPEILMR--------SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-IDKI-LKGKLNLPPYLTPEA 227 (323)
T ss_pred cccCCCccccChhhccC--------CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-HHHH-HcCCCCCCCCCCHHH
Confidence 34579999999999864 5578899999999999999999999987665433 2222 234556788899999
Q ss_pred HHHHHHccccCCCCCC-----CHHHHHHH
Q 017046 297 AFIVQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 297 ~~li~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
.+++.+||..||.+|| ++.+++++
T Consensus 228 ~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 228 RDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 9999999999999999 89998884
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=317.04 Aligned_cols=255 Identities=32% Similarity=0.537 Sum_probs=209.5
Q ss_pred ccCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CC
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PL 131 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 131 (378)
.+..++|++.++||+|+||.||+|... +..||+|.+...... .+.+.+|+.+++.++||||+++++.+.+ ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS------VQAFLEEANLMKTLQHDKLVRLYAVVTKEEP 75 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh------HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 356678999999999999999999864 467999987653322 2358899999999999999999998864 46
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.+++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 154 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIE 154 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-cEEECCCccceecC
Confidence 78999999999999999775556789999999999999999999999999999999999999655 59999999997543
Q ss_pred cccc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 212 VTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 212 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
.... .....++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+..... .............
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~ 225 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-VMSALQRGYRMPR 225 (261)
T ss_pred CCceeccCCCccceecCCHHHhcc--------CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-HHHHHHcCCCCCC
Confidence 2221 122345678999998854 567889999999999999998 999998765533 3333334444555
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
+..++.++.+++.+||..+|++||+++++++.|+.+
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 567899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=338.26 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=197.5
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
+|.+++.||+|+||+||+++. +++.||||++........ .....+.+|+++++.++||||+++++++.++ ..++|
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKK--DQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHh--HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 688899999999999999976 568999999865332211 1234678999999999999999999999755 78999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEeecccccccccccc
Confidence 999999999999875 35689999999999999999999999999999999999999655 59999999985211000
Q ss_pred -----------------------------------------------ccccCcCccccccccccccccccccccccCCCc
Q 017046 215 -----------------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 247 (378)
Q Consensus 215 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 247 (378)
.....+||+.|+|||++.. ..++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~ 228 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--------QGYGQE 228 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--------CCCCCc
Confidence 0012469999999999854 568899
Q ss_pred ccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC--CChHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 017046 248 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLR---PSFSQIIRM 320 (378)
Q Consensus 248 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~ 320 (378)
+|||||||++|+|++|..||.+..................+|. .++.++.+||.+||. +|.+| +++.+++++
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999999999999999987665333222221122333443 478999999999997 77665 599999984
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=328.55 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=198.1
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHH---hhccCCCeeeEEeeEecC-CeE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM---SRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
|.+.+.||+|+||.||++.+ +++.||||+++........ ....+.+|+.++ +.++||||+++++++.++ ..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD--EVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 56789999999999999987 4689999999764322211 123466666554 566899999999998654 789
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc-c
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-V 212 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-~ 212 (378)
+||||++|++|..++.. ..+++..+..++.||+.||.|||+.|++||||||+|||++.++ .+||+|||++.... .
T Consensus 79 lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCC
Confidence 99999999999988753 5799999999999999999999999999999999999999665 59999999986432 2
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
.......+|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..... .. .......+|..+
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~-~~-i~~~~~~~p~~~ 224 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTE--------TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF-DS-IVNDEVRYPRFL 224 (324)
T ss_pred CCcccccccCccccCHhHhcC--------CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH-HH-HHhCCCCCCCCC
Confidence 222345579999999999864 56788999999999999999999999876653332 22 233445677889
Q ss_pred hHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
++++.+++.+||..||.+|| ++.+++++
T Consensus 225 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 225 SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 99999999999999999999 57888774
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=334.92 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=197.7
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
++|.+.+.||+|+||+||+++. +++.||||++........ .....+.+|+.++..++||||+++++.+.+. ..++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK--EQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh--hHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 3688899999999999999977 468999999975432221 1224578899999999999999999998765 7889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 79 IMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-CEEEeeccCcccccccc
Confidence 9999999999999975 35799999999999999999999999999999999999999665 59999999986432110
Q ss_pred ------------------------------------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHH
Q 017046 215 ------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 258 (378)
Q Consensus 215 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 258 (378)
.....+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--------TGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--------CCCCCchhhhhhHHHHH
Confidence 0123479999999999864 56889999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC--CChHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 017046 259 ELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWV--EDPNLRPSFSQIIRM 320 (378)
Q Consensus 259 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~--~dp~~Rps~~~ll~~ 320 (378)
+|++|..||.+..................+|. .+++++.+++.+++. .++..||++.+++++
T Consensus 228 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 228 EMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99999999987665433322222122333443 478899999998664 223356899999984
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=316.22 Aligned_cols=252 Identities=29% Similarity=0.485 Sum_probs=210.3
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|.+.+.||+|++|.||.+.. .++.||+|.+...............+.+|+.++++++||||+++++++.+ ...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999976 46899999987654433222223468899999999999999999999865 47889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
+|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceeccccc
Confidence 9999999999999876 34689999999999999999999999999999999999999655 59999999986432211
Q ss_pred cc----ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 215 MM----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 215 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
.. ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..............+.++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPS 230 (263)
T ss_pred cccccccCCCcCccccCcceecc--------CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCc
Confidence 11 23467889999999865 4588999999999999999999999988766655555555556667888
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.++.++.+++.+||..+|.+|||+.+++++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 231 HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 899999999999999999999999999884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=316.01 Aligned_cols=251 Identities=33% Similarity=0.571 Sum_probs=209.3
Q ss_pred ccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe--cCC
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK--DPL 131 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~ 131 (378)
.++.+.|.+.+.||+|+||.||++...+..||+|.++.... ...+.+|+.+++.++|+|++++++++. +..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch-------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 35567889999999999999999999999999999865432 134789999999999999999998763 346
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.+++|||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~ 153 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS 153 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCCccceecc
Confidence 88999999999999999875555689999999999999999999999999999999999999655 59999999987543
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
... ....++..|+|||++.. ..++.++|||||||++|+|++ |..||..... ............+..+.
T Consensus 154 ~~~--~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~ 222 (256)
T cd05082 154 STQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYKMDAPD 222 (256)
T ss_pred ccC--CCCccceeecCHHHHcc--------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcCCCCCCCC
Confidence 222 23345668999998754 567889999999999999997 9999986543 33333344455566777
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
.+++.+.+++.+||..+|.+|||+.++++.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=330.61 Aligned_cols=247 Identities=28% Similarity=0.377 Sum_probs=195.6
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 130 (378)
.++|.+.+.||+|+||.||++++ .++.||+|++......... ..++.+|+.+++.++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH---AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhH---HHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 46799999999999999999976 4689999998765433221 24577999999999999999999988432
Q ss_pred ---CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 131 ---~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a 170 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA 170 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCCc
Confidence 36899999954 6766664 2488999999999999999999999999999999999999665 5999999999
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH------
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF------ 281 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~------ 281 (378)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..........
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 76544444455678999999999864 5688899999999999999999999987654322111100
Q ss_pred --------------hcCCCC--------------------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 282 --------------KHARPG--------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 282 --------------~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
....+. .....++++.+||.+||..||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000111 111245778999999999999999999999994
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=327.16 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=201.0
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
..++|.+.+.||+|+||.||++++. +..||+|++....... ...++.+|+++++.++||||+++++++.+ +..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPA----IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHH----HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 4567999999999999999999874 6789999987643322 23468899999999999999999998854 578
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .++|+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 155 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI 155 (331)
T ss_pred EEEeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccccc
Confidence 999999999999999976 34689999999999999999999986 699999999999999665 59999999987543
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHH---------------
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA--------------- 276 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--------------- 276 (378)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 156 ~~-~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (331)
T cd06649 156 DS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEP 226 (331)
T ss_pred cc-ccccCCCCcCcCCHhHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCc
Confidence 22 2344578999999999864 56889999999999999999999999754432110
Q ss_pred ------------------------------HHHHHhcCCCCCC-CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 277 ------------------------------YAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 277 ------------------------------~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.........+..+ ..+++++.+||.+||..||++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0001111122222 2478899999999999999999999999994
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=315.20 Aligned_cols=246 Identities=24% Similarity=0.550 Sum_probs=204.0
Q ss_pred eeecccceEEEEEEEC----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCeEEEEeccC
Q 017046 65 KIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLP 140 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~lv~e~~~ 140 (378)
.||+|+||.||+|.+. +..||+|++....... ..+.+.+|+.+++.++||||+++++++..+..++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~----~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKS----VRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChH----HHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCC
Confidence 4899999999999763 3569999987653322 2346889999999999999999999998788999999999
Q ss_pred CCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc----c
Q 017046 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----M 216 (378)
Q Consensus 141 ~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~----~ 216 (378)
+++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++........ .
T Consensus 78 ~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 78 GGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceecc
Confidence 9999999875 345789999999999999999999999999999999999998554 599999999874322211 1
Q ss_pred ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHH
Q 017046 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295 (378)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (378)
....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.... ...........+.++..++++
T Consensus 156 ~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 226 (257)
T cd05115 156 SAGKWPLKWYAPECINF--------RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-EVMSFIEQGKRLDCPAECPPE 226 (257)
T ss_pred CCCCCCcccCCHHHHcc--------CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHHCCCCCCCCCCCCHH
Confidence 12233578999998753 567889999999999999996 99999876653 344455556667788889999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 296 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 296 l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
+.+++.+||..+|.+||++.++.+.|+.++
T Consensus 227 l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=336.41 Aligned_cols=247 Identities=23% Similarity=0.386 Sum_probs=198.4
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
.|.+++.||+|+||+||+|+. .++.||+|++........ .....+.+|+.+++.++||||+++++.+.++ ..++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~--~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLR--NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhH--HHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 578899999999999999987 468899999875332211 1234688999999999999999999998654 78999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc---
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV--- 212 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~--- 212 (378)
|||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 80 MDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEeECCCCcccccccc
Confidence 999999999999875 35689999999999999999999999999999999999999665 599999999742100
Q ss_pred ---------------------------------------------ccccccCcCccccccccccccccccccccccCCCc
Q 017046 213 ---------------------------------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 247 (378)
Q Consensus 213 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 247 (378)
.......+||+.|+|||++.. ..++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~ 228 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--------TGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--------CCCCCe
Confidence 000123468999999999864 568899
Q ss_pred ccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC--CCChHHHHHHHHHccccCCCCCCC---HHHHHH
Q 017046 248 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPS---FSQIIR 319 (378)
Q Consensus 248 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~ 319 (378)
+|||||||++|+|++|..||.+.+................+| ..+++++.++|.+|+ .+|.+|++ +.++++
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999999999999998876654444433222233333 457899999999976 59999987 888887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=329.82 Aligned_cols=244 Identities=26% Similarity=0.409 Sum_probs=198.0
Q ss_pred ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-CeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~~lv~e~~ 139 (378)
+.||+|+||.||++++ .++.||+|+++........ ....+..|..++..+ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~--~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDE--DIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 3689999999999987 4689999999865432221 123577899999988 799999999998654 789999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc-cccccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE-TVTEMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~-~~~~~~~~ 218 (378)
+|++|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++... ........
T Consensus 79 ~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 79 SGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEECcCccccccccCCCcccc
Confidence 99999988865 35799999999999999999999999999999999999999665 5999999998642 22223345
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC-------hHHHHHHHHHhcCCCCCCCC
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS-------NLQAAYAAAFKHARPGLPED 291 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~ 291 (378)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ................+|..
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 227 (329)
T cd05588 156 FCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS 227 (329)
T ss_pred ccCCccccCHHHHcC--------CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCC
Confidence 679999999999864 568889999999999999999999996321 11122223334455667888
Q ss_pred ChHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPS------FSQIIRM 320 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps------~~~ll~~ 320 (378)
++.++.+++.+||..||.+||+ +.+++++
T Consensus 228 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 228 LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999999999999987 6788773
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=323.35 Aligned_cols=247 Identities=27% Similarity=0.379 Sum_probs=196.8
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||+|+||.||++++. ++.||+|++........ ....+.+|+.+++.++||||+++++++.+ +..++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE---VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccccc---chhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 5889999999999999999874 68899999876543222 12457899999999999999999998854 578999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||++++.+..+.. ....+++..++.++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccCccccccccc
Confidence 99998877665443 245799999999999999999999999999999999999999665 59999999987643221
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC---------
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--------- 284 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------- 284 (378)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.............
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLG--------APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred ccccccccccccCCcHHHcC--------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 2234468999999999854 5678899999999999999999999987665443322111000
Q ss_pred ---CC-----C-------------CCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 285 ---RP-----G-------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 285 ---~~-----~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+ . ....++.++.+|+.+||..||.+|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 0 01236788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=319.54 Aligned_cols=247 Identities=36% Similarity=0.678 Sum_probs=201.5
Q ss_pred eecceeecccceEEEEEEEC------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 61 FIGSKIGEGAHGKVYEGRYG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 61 ~~~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
.+.+.||.|.||.||+|.+. +..|+||+++....... .+.|.+|++.+++++||||+++++++.+ +..+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEE----EEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHH----HHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccccc----ceeeeeccccccccccccccccccccccccccc
Confidence 35678999999999999886 57899999966443332 2468899999999999999999999974 4689
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV- 212 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~- 212 (378)
+||||+++|+|.+++.......+++..+..++.|++.||.|||+++++|+||+++||+++.++ .+||+|||++.....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccc
Confidence 999999999999999985457899999999999999999999999999999999999999655 699999999876521
Q ss_pred --ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 213 --TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 213 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
............|+|||.+.. ..++.++||||||+++|||++ |..||.+... ............+..+
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~ 227 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKD--------GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EEIIEKLKQGQRLPIP 227 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHH--------SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HHHHHHHHTTEETTSB
T ss_pred ccccccccccccccccccccccc--------cccccccccccccccccccccccccccccccc-ccccccccccccceec
Confidence 122233457789999999865 558999999999999999999 7899988755 4444455666777788
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
..++..+.+++..||..+|.+|||+.++++.|
T Consensus 228 ~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 88999999999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=314.62 Aligned_cols=262 Identities=30% Similarity=0.462 Sum_probs=212.0
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCC-eeeEEeeEec-C--
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN-LVKFLGACKD-P-- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~l~~~~~~-~-- 130 (378)
...|..+++||+|+||+||+|+. +|+.||+|++......+- .-....+|+.+++.++|+| |+.+++++.. .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG---~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG---VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC---CCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 34577788899999999999976 578999999987655211 1123569999999999999 9999998853 2
Q ss_pred ----CeEEEEeccCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecc
Q 017046 131 ----LMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 131 ----~~~lv~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Df 204 (378)
.+++|+||+ ..+|.+++..... ..++...+..+++||+.||+|||++||+||||||.||||+++| .+||+||
T Consensus 87 ~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-~lKlaDF 164 (323)
T KOG0594|consen 87 RGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-VLKLADF 164 (323)
T ss_pred cccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-cEeeecc
Confidence 578999999 5699999988543 4688899999999999999999999999999999999999755 5999999
Q ss_pred ccccccccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017046 205 GLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 205 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 283 (378)
|+|+....+ ...+..++|..|.|||++.+ ...|+...||||+|||++||+++++.|.+.++.+.+..+...-
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlG-------s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l 237 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLG-------STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL 237 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcC-------CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence 999876633 33567789999999999987 2469999999999999999999999999999877766654333
Q ss_pred CCCC---CC-------------------------CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 284 ARPG---LP-------------------------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 284 ~~~~---~~-------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
..|. +| ...+++..+++.+||+.+|.+|.|+...++ +.++...+...
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~--h~yf~~~~~~~ 312 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT--HPYFSELPEKS 312 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc--Chhhcccccch
Confidence 2221 11 112347889999999999999999999998 55665554433
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=334.20 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=203.7
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-C
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 131 (378)
.....|.+.+.||+|+||.||+++.. ++.||+|++.+....... ....+.+|+.+++.++||||+++++.+.++ .
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRS--DSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhh--hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 45578999999999999999999874 688999998753222111 123477899999999999999999998654 7
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-HLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEEecccceecc
Confidence 8999999999999999865 3589999999999999999999999999999999999999665 59999999987643
Q ss_pred ccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 212 VTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 212 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
... .....+||+.|+|||++... +....++.++|||||||++|+|++|..||.+.+................+|
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p 269 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP 269 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhcc----CCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC
Confidence 222 12355799999999998641 112347889999999999999999999998766544433333333334455
Q ss_pred C--CChHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 017046 290 E--DISPDLAFIVQSCWVEDPNL--RPSFSQIIRM 320 (378)
Q Consensus 290 ~--~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 320 (378)
. .++..+.+++..||..++.+ |+++.+++++
T Consensus 270 ~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 270 EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 4 46899999999999855543 8899999994
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=315.18 Aligned_cols=253 Identities=32% Similarity=0.538 Sum_probs=211.2
Q ss_pred cCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV 133 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 133 (378)
+..+.|.+.++||+|+||.||+|... ++.||+|.+....... ..+.+|+.++++++||||+++++.+.+...+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP------EAFLAEANLMKQLQHPRLVRLYAVVTQEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH------HHHHHHHHHHHhcCCcCeeeEEEEEccCCcE
Confidence 44567899999999999999999864 5889999987654432 2578999999999999999999998777899
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
++|||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcceeecCCC
Confidence 999999999999998765556789999999999999999999999999999999999999655 5999999998654322
Q ss_pred cc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 214 EM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 214 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
.. .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.... ..............+.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~ 226 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-EVIQNLERGYRMPRPD 226 (260)
T ss_pred CcccccCCcccccccCHHHhcc--------CCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHHcCCCCCCCC
Confidence 11 122345678999998854 567889999999999999999 99999876653 3333344455556677
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
..+.++.+++.+||..+|.+|||+++++..|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=309.42 Aligned_cols=250 Identities=25% Similarity=0.376 Sum_probs=208.1
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 133 (378)
.+.|.+-+.||+|.|+.||+..+ +|+.+|+|++........ -.+++.+|+.|.+.|+||||+++.+.+. +...|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~---~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc---cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 45688889999999999998644 678899988765444332 1235789999999999999999999885 56889
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC--CCCceeEeccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAREET 211 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~--~~~~vkl~Dfg~a~~~~ 211 (378)
+|+|++.|++|..-|... .-.++..+-.+++||+++|.|+|.+||||||+||+|+|+-+ .+..+||+|||+|...+
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999987666542 45788999999999999999999999999999999999953 34469999999999888
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC---CCCC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA---RPGL 288 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---~~~~ 288 (378)
.+.......|||.|||||++.. .+|+..+|||+-|+|||-|+.|.+||.+.+. ..+++.+..+. ++..
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrk--------dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye~I~~g~yd~~~~~ 235 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYEQIKAGAYDYPSPE 235 (355)
T ss_pred CccccccccCCCcccCHHHhhc--------CCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhccccCCCCcc
Confidence 7777778899999999999964 7899999999999999999999999998554 44454444322 2222
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
-+.++++.++|+++||..||.+|.|+.|.|++
T Consensus 236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 236 WDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 35689999999999999999999999999884
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=314.09 Aligned_cols=249 Identities=32% Similarity=0.588 Sum_probs=204.6
Q ss_pred CCcceeecceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
+.+.|.+.+.||+|+||.||++.+.+ ..+|+|.+....... ..+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE------EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY 75 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccH------HHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence 45678899999999999999998764 589999876543322 347889999999999999999998864 4788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 76 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 76 IVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-eEEECCCCCccccCCC
Confidence 999999999999998753 34689999999999999999999999999999999999999554 5999999998754322
Q ss_pred cc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 214 EM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 214 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
.. .....++..|+|||.+.. ..++.++||||||+++|+|++ |+.||....... ..........+..|.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~ 224 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNF--------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-VVEMISRGFRLYRPK 224 (256)
T ss_pred ceeccCCCCCchhhCChhhccc--------CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCCCCCCC
Confidence 21 122245568999999854 567889999999999999999 999998766533 334444455556677
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
..+.++.+++.+||..+|.+|||+.++++.|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 7889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=338.23 Aligned_cols=249 Identities=22% Similarity=0.356 Sum_probs=198.5
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
++|++++.||+|+||.||+++. +++.||||++........ .....+.+|+.+++.++||||+++++.+.+ +..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMR--NQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhh--hhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 3688999999999999999986 468999999865322111 112457899999999999999999999865 47889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc--
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-- 212 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~-- 212 (378)
||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 79 v~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 79 VMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEEEEeCCCCccccccc
Confidence 9999999999999975 35689999999999999999999999999999999999999665 599999999742100
Q ss_pred ------------------------------------------ccccccCcCccccccccccccccccccccccCCCcccc
Q 017046 213 ------------------------------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 250 (378)
Q Consensus 213 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Di 250 (378)
.......+||+.|+|||++.. ..++.++||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di 227 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--------TGYTQLCDW 227 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--------CCCCcceee
Confidence 000113479999999999864 567899999
Q ss_pred hhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC--CCChHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 017046 251 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRP---SFSQIIRM 320 (378)
Q Consensus 251 wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~ 320 (378)
|||||++|+|++|..||.+..................++ ..+++++.++|.+|+ .+|.+|+ ++.+++++
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999999999998876544333322211222222 368899999999976 5999999 89999984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=315.04 Aligned_cols=253 Identities=32% Similarity=0.523 Sum_probs=210.1
Q ss_pred cCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV 133 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 133 (378)
+..++|.+.++||+|+||.||++... +..||+|.+....... ..+.+|+.++++++||||+++++.+.+...+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~------~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP------ESFLEEAQIMKKLRHDKLVQLYAVVSEEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH------HHHHHHHHHHHhcCCCceEEEEeEECCCCcE
Confidence 44567899999999999999999864 4679999987654432 2488999999999999999999998777889
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.+ ..++|+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeeccCc
Confidence 99999999999999976555668999999999999999999999999999999999999955 45999999998754322
Q ss_pred cc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 214 EM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 214 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
.. .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+..... ..........+..+.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~ 226 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-VLEQVERGYRMPCPQ 226 (260)
T ss_pred ccccccCCCCCccccChHHHhc--------CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCCC
Confidence 21 112235567999998754 567889999999999999999 899998766543 334444455566777
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
..+..+.+++.+||..+|.+|||+.++.+.|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 889999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=342.31 Aligned_cols=247 Identities=23% Similarity=0.399 Sum_probs=203.5
Q ss_pred cceeecceeecccceEEEEEEEC---CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG---DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
..|.+.+.||+|+||.||+|... ++.||+|.+....... ...+.+|+.+++.++||||+++++++.+ +..+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~-----~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQ-----AAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHH-----HHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 44999999999999999999753 5678888765432211 2347789999999999999999999864 5789
Q ss_pred EEEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
+||||++||+|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~ 220 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYS 220 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCceecC
Confidence 999999999999988642 234689999999999999999999999999999999999999665 59999999997543
Q ss_pred ccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 212 VTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 212 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
... .....+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.... .............+
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-~~~~~~~~~~~~~~ 291 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWER--------KRYSKKADMWSLGVILYELLTLHRPFKGPSQR-EIMQQVLYGKYDPF 291 (478)
T ss_pred CccccccccccCCCccccCHhHhCC--------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCC
Confidence 221 2334579999999998854 56889999999999999999999999876553 33444444455566
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+..+++++.++|.+||..||.+||++.+++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 7789999999999999999999999999876
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=314.71 Aligned_cols=254 Identities=32% Similarity=0.540 Sum_probs=208.7
Q ss_pred CCcceeecceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 129 (378)
++.+|.+.+.||+|+||.||+|.+. ...||+|.+........ ...|.+|+.+++.++||||+++++.+.+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ----RLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHH----HHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 4567889999999999999999873 35799999876543322 2458899999999999999999998854
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
...+++|||+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~ 155 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRR 155 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEECccchhhc
Confidence 4788999999999999999763 34789999999999999999999999999999999999999655 599999999876
Q ss_pred cccc-c--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017046 210 ETVT-E--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 210 ~~~~-~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
.... . ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||....... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-~~~~~~~~~~ 226 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-VIKAVEDGYR 226 (266)
T ss_pred ccccccceeccCCCCCccccChhhhcc--------CCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-HHHHHHcCCC
Confidence 5311 1 1112344678999998854 567889999999999999998 999998766533 3344444445
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
...+..++..+.+++.+||+.+|.+||++.+++++|..+
T Consensus 227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 566678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=342.60 Aligned_cols=252 Identities=28% Similarity=0.442 Sum_probs=208.8
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC---
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 130 (378)
...+|.+.+.||+|+||+||+++. +++.||||++......... ..++.+|+.++..++|+||++++..+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~---~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEAD---KNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHH---HHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 456899999999999999999976 5789999999765543322 23578999999999999999988766321
Q ss_pred ------CeEEEEeccCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEe
Q 017046 131 ------LMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (378)
Q Consensus 131 ------~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~ 202 (378)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vkL~ 185 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKLG 185 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEEEE
Confidence 2579999999999999986532 34689999999999999999999999999999999999999665 59999
Q ss_pred cccccccccc---ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHH
Q 017046 203 DFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (378)
Q Consensus 203 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 279 (378)
|||+++.... .......+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+... ......
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-~~~~~~ 256 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR--------KPYSKKADMFSLGVLLYELLTLKRPFDGENM-EEVMHK 256 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHH
Confidence 9999875332 122334579999999999864 5688999999999999999999999987654 344444
Q ss_pred HHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 280 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 280 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
........++..+++++.+++.+||..||.+||++.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 45555666788899999999999999999999999999874
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=328.43 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=198.5
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec------C
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------P 130 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------~ 130 (378)
+|.+.+.||+|+||.||+|+. +++.||||++......... ..++.+|+.+++.++||||+++++++.. .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD---ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchh---HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 478899999999999999986 4689999998753322211 2357899999999999999999988742 2
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 78 ~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~ 153 (338)
T cd07859 78 DIYVVFELM-ESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVA 153 (338)
T ss_pred eEEEEEecC-CCCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccCcccccc
Confidence 478999999 5699998875 35699999999999999999999999999999999999999665 5999999998753
Q ss_pred cccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHH-------
Q 017046 211 TVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA------- 279 (378)
Q Consensus 211 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~------- 279 (378)
.... ......|++.|+|||++.. ....++.++|||||||++|+|++|+.||.+..........
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 227 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGS------FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP 227 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhc------cccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 2211 1234578999999998753 1246788999999999999999999999875532211100
Q ss_pred ---------------HHh----cCCCC---CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 280 ---------------AFK----HARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 280 ---------------~~~----~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
... ..... ....+++++.+++.+||..||.+|||+.++++ +.++.....
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~--hp~f~~~~~ 298 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA--DPYFKGLAK 298 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc--CchhhhcCc
Confidence 000 00000 01246788999999999999999999999999 566655433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=314.29 Aligned_cols=253 Identities=32% Similarity=0.523 Sum_probs=209.1
Q ss_pred cCCcceeecceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV 133 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 133 (378)
+....|.+...||+|+||.||++...+ ..+|+|.+...... ...+.+|+.+++.++|||++++++++.+...+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM------PEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc------HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcE
Confidence 344668899999999999999998754 57999987654332 13578999999999999999999998877889
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
++|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccceEccCC
Confidence 999999999999999765555689999999999999999999999999999999999999655 5999999998754322
Q ss_pred cc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 214 EM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 214 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
.. .....++..|+|||.... ..++.++||||||+++|+|++ |..||.+..... ..........+..+.
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~ 226 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-VLEQVERGYRMPCPQ 226 (260)
T ss_pred cccccCCCccchhhCCHHHhcc--------CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCc
Confidence 21 122345678999998754 567889999999999999999 999998766543 334444445556677
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
..+..+.+++.+||..||.+||++.++++.|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=330.54 Aligned_cols=242 Identities=25% Similarity=0.405 Sum_probs=198.7
Q ss_pred ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccC
Q 017046 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLP 140 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~ 140 (378)
+.||+|+||.||+++. +++.||+|++......... ...++..|++++..++||||+++++++.+ ...++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~--~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD--EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 3689999999999976 5689999999764332211 12357789999999999999999998865 47899999999
Q ss_pred CCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCceeEeccccccccc-ccccccc
Q 017046 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTA 218 (378)
Q Consensus 141 ~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 218 (378)
+++|.+++.. ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.... .......
T Consensus 79 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 79 GGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCccccc
Confidence 9999988865 3568999999999999999999997 7999999999999999665 59999999986432 2222334
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 298 (378)
..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .... .......+|..+++++.+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-~~~~-i~~~~~~~p~~~~~~~~~ 225 (325)
T cd05594 156 FCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFEL-ILMEEIRFPRTLSPEAKS 225 (325)
T ss_pred ccCCcccCCHHHHcc--------CCCCCccccccccceeeeeccCCCCCCCCCHHH-HHHH-HhcCCCCCCCCCCHHHHH
Confidence 579999999999854 568899999999999999999999998765432 2222 234455677889999999
Q ss_pred HHHHccccCCCCCC-----CHHHHHHH
Q 017046 299 IVQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 299 li~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
++.+||..||.+|+ ++.+++++
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 226 LLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 99999999999996 89999884
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=326.53 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=222.2
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
..|.+.+.||+|.|+.|-+|++ +|+.||||++.+.+.... ....+.+|++.|+.++|||||++|.+.... .+|+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~---st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL---STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh---hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 4588889999999999999975 899999999987665443 235688999999999999999999998544 7999
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
|+|.=++|+|.+||.. ....+.++.+.+|+.||+.|+.|+|...+|||||||+||++-..-+-|||+|||++.....+.
T Consensus 95 iLELGD~GDl~DyImK-He~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMK-HEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEecCCchHHHHHHh-hhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999999987 356799999999999999999999999999999999999887666679999999998888888
Q ss_pred ccccCcCccccccccccccccccccccccC-CCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
...+.||+..|-|||++.+ ..| .+++||||||+|||.|++|++||+..++.+.+-.+. .....+|..++
T Consensus 174 kL~TsCGSLAYSAPEILLG--------DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm--DCKYtvPshvS 243 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLG--------DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM--DCKYTVPSHVS 243 (864)
T ss_pred hhhcccchhhccCchhhhc--------CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh--cccccCchhhh
Confidence 8889999999999999986 344 468899999999999999999999877766554432 34556788999
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
.++++||..||..||.+|.+.++|.. ..|+....
T Consensus 244 ~eCrdLI~sMLvRdPkkRAslEeI~s--~~Wlq~~D 277 (864)
T KOG4717|consen 244 KECRDLIQSMLVRDPKKRASLEEIVS--TSWLQAGD 277 (864)
T ss_pred HHHHHHHHHHHhcCchhhccHHHHhc--cccccCCC
Confidence 99999999999999999999999988 55655543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=302.56 Aligned_cols=265 Identities=23% Similarity=0.353 Sum_probs=209.6
Q ss_pred ccccccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
...+.++.++|+|.+.||.|||+.||+++. +++.||+|++.-....+. +..++|++..++++|||+++++++.
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~-----e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDI-----EEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHH-----HHHHHHHHHHHhhCCcchHHHHHHH
Confidence 345668899999999999999999999874 678999999876553222 3578999999999999999998876
Q ss_pred e----c--CCeEEEEeccCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCcEEEcCCCC
Q 017046 128 K----D--PLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQK 197 (378)
Q Consensus 128 ~----~--~~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~g--ivH~dikp~Nill~~~~~ 197 (378)
. | ...|++++|+..|+|.+.+...+ +..+++.++++|+.+|++||.+||+.. +.||||||.|||++.++
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~- 166 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG- 166 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-
Confidence 2 2 25899999999999999997643 346999999999999999999999998 99999999999999655
Q ss_pred ceeEecccccccccccc----------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCC
Q 017046 198 SLKLADFGLAREETVTE----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267 (378)
Q Consensus 198 ~vkl~Dfg~a~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 267 (378)
.++|.|||.+......- .......|..|+|||++.... ....+.++|||||||++|+|+.|..||
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~-----~~ti~ertDIWSLGCtLYa~mf~~sPf 241 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS-----HCTITERTDIWSLGCTLYAMMFGESPF 241 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheeccc-----CcccccccchhhhhHHHHHHHHcCCcc
Confidence 59999999987532211 122335788999999987522 356789999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCCCC--CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 268 EGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
+..............+....+| ..+|..+.++++.||+.||.+||++.+++..++.+.
T Consensus 242 e~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 242 ERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred hHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 6322111111111122222333 348999999999999999999999999999988764
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=331.46 Aligned_cols=266 Identities=32% Similarity=0.529 Sum_probs=216.5
Q ss_pred cccccccccCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CC
Q 017046 47 LTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HD 118 (378)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp 118 (378)
+..+..+.+..+.|.+++.||+|+||.||+|++. +..||+|+++....... ...+.+|+.++.++. ||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~----~~~~~~E~~~l~~l~~H~ 101 (401)
T cd05107 26 LPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE----KQALMSELKIMSHLGPHL 101 (401)
T ss_pred CCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH----HHHHHHHHHHHHhcCCCC
Confidence 3344457778888999999999999999999853 35799999976543332 235889999999997 99
Q ss_pred CeeeEEeeEec-CCeEEEEeccCCCCHHHHHhhhCC--------------------------------------------
Q 017046 119 NLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRP-------------------------------------------- 153 (378)
Q Consensus 119 ~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-------------------------------------------- 153 (378)
||+++++++.+ +..++||||+.+|+|.+++.....
T Consensus 102 niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (401)
T cd05107 102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDM 181 (401)
T ss_pred CeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccccc
Confidence 99999999865 478999999999999999965321
Q ss_pred ----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 017046 154 ----------------------------------------------------NKLDLHVALNFALDIARAMDCLHANGII 181 (378)
Q Consensus 154 ----------------------------------------------------~~l~~~~~~~i~~qi~~~l~~lH~~giv 181 (378)
..+++..++.++.|++.||.|||+.|++
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 261 (401)
T cd05107 182 SKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV 261 (401)
T ss_pred CCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcC
Confidence 1366778889999999999999999999
Q ss_pred eecCCCCcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHH
Q 017046 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 258 (378)
Q Consensus 182 H~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 258 (378)
||||||+|||++.+ ..++|+|||++....... ......+++.|+|||.+.. ..++.++||||||+++|
T Consensus 262 Hrdlkp~NiLl~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGvil~ 332 (401)
T cd05107 262 HRDLAARNVLICEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--------NLYTTLSDVWSFGILLW 332 (401)
T ss_pred cccCCcceEEEeCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--------CCCCcHhHHHHHHHHHH
Confidence 99999999999954 469999999987532211 1122356788999998854 56788999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 259 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 259 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
+|++ |..||......+...........+..|..++.++.+++.+||..+|..||++.++++.|+.++
T Consensus 333 e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 333 EIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 9998 899998766555555555556666777889999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=351.82 Aligned_cols=261 Identities=22% Similarity=0.392 Sum_probs=208.9
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---C
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---P 130 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~ 130 (378)
....|.+++.||+|+||+||++++. +..||+|++......... ...|..|+.+++.|+||||++++++|.+ .
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~---~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE---KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHH---HHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3457999999999999999999874 578999998765443322 2468899999999999999999998843 3
Q ss_pred CeEEEEeccCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CCeeecCCCCcEEEcCC------
Q 017046 131 LMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHAN-------GIIHRDLKPDNLLLTPD------ 195 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~-------givH~dikp~Nill~~~------ 195 (378)
.+++||||+++++|.++|.... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 5889999999999999987532 35699999999999999999999985 49999999999999632
Q ss_pred ----------CCceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCC
Q 017046 196 ----------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 265 (378)
Q Consensus 196 ----------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~ 265 (378)
...+||+|||++.............||+.|+|||++.. ....++.++||||||||||+|++|..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~g------e~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH------ETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhc------cCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 22489999999976554444455679999999998854 22457889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 266 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 266 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
||.................... ....+.++.+||..||..+|.+||++.+++. ..++...
T Consensus 242 PF~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~--h~~ik~i 301 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLG--YQIIKNV 301 (1021)
T ss_pred CCCcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc--cHHHhhc
Confidence 9987666555544433322222 2457899999999999999999999999997 3444433
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=316.29 Aligned_cols=258 Identities=28% Similarity=0.508 Sum_probs=210.6
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCe----eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDR----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+...+|.+.+.||+|+||+||+|++ +++ .||+|++........ ...+.+|+.+++.++||||+++++++.
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA----NKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHH----HHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 4567889999999999999999976 333 589999876544332 235889999999999999999999998
Q ss_pred cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
....+++|||+++|+|.+++... ...+++..++.++.|++.||.|||+.|++||||||+|||++.++ .+||+|||++.
T Consensus 80 ~~~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~ 157 (279)
T cd05109 80 TSTVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLAR 157 (279)
T ss_pred CCCcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCcee
Confidence 87888999999999999998752 35689999999999999999999999999999999999998555 59999999987
Q ss_pred ccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 209 EETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 209 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
....... .....+++.|+|||.+.. ..++.++|||||||++|||++ |..||..... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~ 228 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILH--------RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-REIPDLLEKGE 228 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCC
Confidence 5432221 112234678999998854 568889999999999999998 9999976554 33334444455
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.+..+..++.++.+++.+||..||..||++.++++.|..+...
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 5566677899999999999999999999999999988776443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=316.56 Aligned_cols=256 Identities=27% Similarity=0.462 Sum_probs=207.5
Q ss_pred CCcceeecceeecccceEEEEEEE--CCe----eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDR----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
...+|.+.+.||+|+||+||+|.+ .++ .+++|.+....... ....+..|+.++..++||||+++++++.+
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~~~~~l~~l~h~~iv~~~~~~~~ 80 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQ----TFQEITDHMLAMGSLDHAYIVRLLGICPG 80 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchH----HHHHHHHHHHHHhcCCCCCcceEEEEECC
Confidence 446788899999999999999987 333 47778775432211 12357788889999999999999999877
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
...++++||+++|+|.+++.. ....+++..+..++.|++.||.|||+.|++|+||||+|||++.++ .+||+|||+++.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-~~kl~Dfg~~~~ 158 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS-IVQIADFGVADL 158 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEEcCCcccee
Confidence 788899999999999999976 345789999999999999999999999999999999999999554 599999999875
Q ss_pred ccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017046 210 ETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 210 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
..... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~ 229 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILF--------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLLEKGER 229 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhcc--------CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCc
Confidence 32221 1223456778999998854 568899999999999999998 9999987654 333333444555
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
+..+..++.++..++.+||..||..|||+.++++.|..+..
T Consensus 230 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 56666788899999999999999999999999998887664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=334.68 Aligned_cols=248 Identities=28% Similarity=0.420 Sum_probs=210.9
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv 135 (378)
.|.-++.||.|+||.||-|++ +.+.||||.+.......... ...++.|+..|++++|||+|.+.|+|- +...|+|
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EK--WqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK--WQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHH--HHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 366678999999999999986 56899999987654433221 236899999999999999999999984 5578899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
|||| -|+-.|++.-. ..++.+.++..|+.+.+.||+|||+++.||||||..|||++..| .|||+|||.|.... .
T Consensus 105 MEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~---P 178 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSASIMA---P 178 (948)
T ss_pred HHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccchhhcC---c
Confidence 9999 55888888663 36799999999999999999999999999999999999999554 59999999986544 4
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC-CCChH
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISP 294 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 294 (378)
.++++|||.|||||++... +.+.|+-++||||||++..||...++|+.+++....+|.+.. +..|.++ ..+|.
T Consensus 179 AnsFvGTPywMAPEVILAM-----DEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ-NesPtLqs~eWS~ 252 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPTLQSNEWSD 252 (948)
T ss_pred hhcccCCccccchhHheec-----cccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-cCCCCCCCchhHH
Confidence 4678999999999999764 468899999999999999999999999999988777776654 4444444 46999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.+.+|+..||.+-|.+|||.++++++
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 99999999999999999999998884
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=326.47 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=199.9
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCC-CeeeEEeeEec-CCeEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKD-PLMVI 134 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~l~~~~~~-~~~~l 134 (378)
+|.+.+.||+|+||.||+|+.. ++.||||++......... ....+..|+.++..+.|+ +|+.+++++.+ +..++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDD--DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 4788899999999999999875 578999999764322211 123577899999999765 57788888864 47899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc-cc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VT 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-~~ 213 (378)
||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.... ..
T Consensus 79 v~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEEeecCcceecCCCC
Confidence 9999999999998875 35689999999999999999999999999999999999999665 59999999986432 22
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...... .... ......+|..++
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-~~~i-~~~~~~~~~~~~ 225 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-FQSI-MEHNVSYPKSLS 225 (324)
T ss_pred CceeeecCCccccChhhhcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHH-HcCCCCCCCCCC
Confidence 22334579999999999864 5678899999999999999999999987665333 3222 345566788899
Q ss_pred HHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPSF-----SQIIRM 320 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 320 (378)
.++.+++.+||..||.+|++. .+++++
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 226 KEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999999999999975 677663
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=327.34 Aligned_cols=241 Identities=29% Similarity=0.436 Sum_probs=196.5
Q ss_pred ceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-CeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~~lv~e~~ 139 (378)
+.||+|+||.||+++.. ++.||+|++......... ....+..|..++..+ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDD--DVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhcc--HHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 36899999999999874 678999998754322111 123467888888876 699999999998654 788999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc-ccccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 218 (378)
++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++ .++|+|||++.... .......
T Consensus 79 ~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 79 NGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCCCcccc
Confidence 99999998875 35699999999999999999999999999999999999999665 59999999987532 2223344
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 298 (378)
..||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+... ..... ......+|..++.++.+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i-~~~~~~~~~~~~~~~~~ 225 (320)
T cd05590 156 FCGTPDYIAPEILQE--------MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAI-LNDEVVYPTWLSQDAVD 225 (320)
T ss_pred cccCccccCHHHHcC--------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-HHHHH-hcCCCCCCCCCCHHHHH
Confidence 579999999999854 567889999999999999999999998766533 23322 34455667789999999
Q ss_pred HHHHccccCCCCCCCH------HHHHH
Q 017046 299 IVQSCWVEDPNLRPSF------SQIIR 319 (378)
Q Consensus 299 li~~~l~~dp~~Rps~------~~ll~ 319 (378)
++.+||..||.+||++ +++++
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 226 ILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred HHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 9999999999999998 77776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=319.72 Aligned_cols=255 Identities=28% Similarity=0.478 Sum_probs=208.1
Q ss_pred CCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+...|.+.++||+|+||.||+|... +..||||++....... ....+.+|+.++..++||||+++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 78 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP----LREEFKHEAMMRSRLQHPNIVCLLGVVT 78 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHH----HHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 3456888999999999999999763 3689999997544322 2345889999999999999999999986
Q ss_pred c-CCeEEEEeccCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEc
Q 017046 129 D-PLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 193 (378)
Q Consensus 129 ~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~ 193 (378)
+ ...++++||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 5 46889999999999999985311 13478889999999999999999999999999999999998
Q ss_pred CCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCC
Q 017046 194 PDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269 (378)
Q Consensus 194 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~ 269 (378)
.++ .+||+|||+++...... ......+++.|+|||.+.. ..++.++|||||||++|+|++ |..||.+
T Consensus 159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--------GKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhc--------CCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 554 59999999987543222 1223356778999998854 567889999999999999998 8889987
Q ss_pred CChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 270 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
... ...............+..++.++.+++..||+.+|.+||++.+++..|+.+
T Consensus 230 ~~~-~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 230 YSN-QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred CCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 655 344555555556667788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=316.01 Aligned_cols=254 Identities=31% Similarity=0.568 Sum_probs=205.7
Q ss_pred cCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
+..++|++.+.||+|+||.||+|.+. +..||+|++........ ...+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~e~~~l~~l~~~~iv~~~~~~ 78 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE----RIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHH----HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 45677999999999999999998753 35799998865332221 23588999999999999999999998
Q ss_pred ec-CCeEEEEeccCCCCHHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCc
Q 017046 128 KD-PLMVIVTELLPGMSLRKYLVSLRP--------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (378)
Q Consensus 128 ~~-~~~~lv~e~~~~~sL~~~l~~~~~--------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~ 198 (378)
.+ ...++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~-~ 157 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-T 157 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC-C
Confidence 65 478899999999999999875322 2357788899999999999999999999999999999999655 5
Q ss_pred eeEeccccccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHH
Q 017046 199 LKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (378)
Q Consensus 199 vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 274 (378)
++|+|||++........ .....+++.|+|||.+.. ..++.++|||||||++|+|++ |..||.+... .
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~ 228 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-E 228 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc--------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-H
Confidence 99999999864322211 112345778999998854 567889999999999999999 7899987654 3
Q ss_pred HHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 275 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
...........+..+..++..+.+++.+||+.||.+|||+.++++.|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 229 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 444444455556677889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=316.76 Aligned_cols=254 Identities=30% Similarity=0.533 Sum_probs=207.3
Q ss_pred CcceeecceeecccceEEEEEEE------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 129 (378)
.+.|.+.+.||+|+||.||+|.. .+..||+|.+........ ...+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ----WGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHH----HHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 35688889999999999999974 347899999875443322 2357899999999999999999998865
Q ss_pred CCeEEEEeccCCCCHHHHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLR---------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~---------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~ 194 (378)
...+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 47889999999999999985322 124788899999999999999999999999999999999996
Q ss_pred CCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCC
Q 017046 195 DQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270 (378)
Q Consensus 195 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 270 (378)
++ .+||+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.
T Consensus 160 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 160 QL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--------GKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred CC-cEEeccccccccccCCcceecccCCCccceecChHHhcc--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 55 59999999987542221 1223345678999998854 567889999999999999998 99999876
Q ss_pred ChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 271 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
.. ............+..+..+++.+.+++.+||..||.+||++.+++++|..+
T Consensus 231 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 231 SN-QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred CH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 54 344445555555667788999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=323.11 Aligned_cols=241 Identities=29% Similarity=0.458 Sum_probs=194.5
Q ss_pred ceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-CCeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PLMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e~~ 139 (378)
+.||+|+||.||+|+.. ++.||+|+++......... ...+..|..++..+ +||||+++++++.+ ...++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD--VECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhh--HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 36999999999999874 5789999998643222111 12345666666654 89999999998865 4788999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-cccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~ 218 (378)
+||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..... ......
T Consensus 79 ~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 79 NGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCCCcccc
Confidence 99999998875 35699999999999999999999999999999999999999665 599999999875322 223345
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 298 (378)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...... ... .....+.+|..++.++.+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-~~~-i~~~~~~~~~~~~~~~~~ 225 (316)
T cd05592 156 FCGTPDYIAPEILKG--------QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-FDS-ILNDRPHFPRWISKEAKD 225 (316)
T ss_pred ccCCccccCHHHHcC--------CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHcCCCCCCCCCCHHHHH
Confidence 579999999999864 5688999999999999999999999987665332 222 334566778889999999
Q ss_pred HHHHccccCCCCCCCHH-HHHH
Q 017046 299 IVQSCWVEDPNLRPSFS-QIIR 319 (378)
Q Consensus 299 li~~~l~~dp~~Rps~~-~ll~ 319 (378)
++.+||..||.+||++. ++++
T Consensus 226 ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 226 CLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHc
Confidence 99999999999999865 5655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=327.58 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=202.1
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
....|.++++||+|+||.||++++. ++.||||++....... ....+.+|+++++.++|+||+++++++.+ +..
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT----VRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHH----HHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 4466888999999999999999874 6899999986544322 23468899999999999999999999864 478
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+++++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 148 ~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 148 QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQ 220 (353)
T ss_pred EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEcccccceeccc
Confidence 899999999998652 2356778889999999999999999999999999999999655 599999999875432
Q ss_pred c-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCCCC
Q 017046 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS--NLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 213 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~ 289 (378)
. .......||..|+|||.+.... ......+.++|||||||++|+|++|+.||.... ..............+..+
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 297 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDL---NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAP 297 (353)
T ss_pred ccccccccccCccccCcccccccc---ccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCC
Confidence 2 1223457899999999874311 012334568999999999999999999997432 222222333344455667
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
..++.++.+||.+||..||.+|||+.++++ +.++..
T Consensus 298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~--hp~~~~ 333 (353)
T PLN00034 298 ATASREFRHFISCCLQREPAKRWSAMQLLQ--HPFILR 333 (353)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhc--Cccccc
Confidence 789999999999999999999999999999 455544
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=350.50 Aligned_cols=260 Identities=34% Similarity=0.597 Sum_probs=220.6
Q ss_pred cCCcceeecceeecccceEEEEEEECC-------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
+..+..++.+.||+|.||.||.|...+ ..||||.+++.....+. ..|++|..+|+.++|||||+++|++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~----~~Fl~Ea~~m~~f~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEV----SDFLKEALLMSKFDHPNIVSLIGVC 764 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHH----HHHHHHHHHHhcCCCcceeeEEEee
Confidence 557778899999999999999997632 35999999877665543 3699999999999999999999999
Q ss_pred ecC-CeEEEEeccCCCCHHHHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeE
Q 017046 128 KDP-LMVIVTELLPGMSLRKYLVSLR-----PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 201 (378)
Q Consensus 128 ~~~-~~~lv~e~~~~~sL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl 201 (378)
-+. ..+|++|||+||+|..+|+..+ ...++..+.+.++.||+.|+.||+++++|||||..+|+|++.. ..|||
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VKI 843 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVKI 843 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEEE
Confidence 654 6789999999999999998853 3458999999999999999999999999999999999999955 56999
Q ss_pred ecccccccccccccccc---CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHH
Q 017046 202 ADFGLAREETVTEMMTA---ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 277 (378)
Q Consensus 202 ~Dfg~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 277 (378)
+|||+|+.......... ..-...|||||.+.. ..++.++|||||||+|||+++ |..||.+.++.+. .
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--------~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~ 914 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--------GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-L 914 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhh--------cccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-H
Confidence 99999994333222111 133468999999964 789999999999999999999 9999999888554 4
Q ss_pred HHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 278 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
.....+.+...|..++..+.++|..||+.+|++||++..+++.+..+....
T Consensus 915 ~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 915 LDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 445556699999999999999999999999999999999999888777554
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=326.42 Aligned_cols=258 Identities=36% Similarity=0.558 Sum_probs=202.0
Q ss_pred cCCcceeecceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC--C
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--L 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~ 131 (378)
...+.|.-...||+|+||.||+|...+ ..||||.+........ ..|.+|+.++.+++|||+|+|+|+|.+. .
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~-----~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~ 146 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGE-----REFLNEVEILSRLRHPNLVKLLGYCLEGGEH 146 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcch-----hHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence 344566667899999999999999876 8999998876555421 2499999999999999999999999755 3
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG---IIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~g---ivH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
.+||+||+++|+|.+++.......++|..+++|+.++|.||+|||+.. ||||||||+|||+|.+ ...||+|||+|+
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAK 225 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcc
Confidence 899999999999999998733228899999999999999999999964 9999999999999955 459999999997
Q ss_pred cccc-ccccccC-cCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC-----hHHHHHHH--
Q 017046 209 EETV-TEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS-----NLQAAYAA-- 279 (378)
Q Consensus 209 ~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~~-- 279 (378)
.... ....... .||.+|+|||.+.. +..+.++||||||++|+||++|+.+.+... ........
T Consensus 226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~--------g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 226 LGPEGDTSVSTTVMGTFGYLAPEYAST--------GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCCccccceeeecCCCCccCChhhhcc--------CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 6544 3332233 89999999999854 678999999999999999999998876432 11111111
Q ss_pred ----HHhcCCCCCC-CCCh--H---HHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 280 ----AFKHARPGLP-EDIS--P---DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 280 ----~~~~~~~~~~-~~~~--~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
......+.+. ...+ . .+..+..+|++.+|..||++.+|++.|.....
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 1112222332 2233 2 25678899999999999999999998855443
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=313.33 Aligned_cols=249 Identities=33% Similarity=0.588 Sum_probs=209.1
Q ss_pred cCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCeEE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI 134 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~l 134 (378)
+..++|.+.+.||+|+||.||++...++.||+|.+..... ...+.+|+.+++.++||||+++++.+.+...++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~-------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT-------AQAFLEETAVMTKLHHKNLVRLLGVILHNGLYI 75 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch-------HHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEE
Confidence 4557799999999999999999999999999999865322 135789999999999999999999998778899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
+|||+.+++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccceecccc-
Confidence 99999999999999875555689999999999999999999999999999999999999665 5999999998653322
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
......+..|+|||.+.. ..++.++|+||||+++|+|++ |..||...... ...........+..+..++
T Consensus 154 -~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 223 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKH--------KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-EVKECVEKGYRMEPPEGCP 223 (254)
T ss_pred -CCCCCCCceecCHHHhcc--------CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-HHHHHHhCCCCCCCCCcCC
Confidence 122344568999998754 567889999999999999998 99999876553 3334444445555667789
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
..+.+++.+||..+|..||++.++++.|+
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 99999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=311.11 Aligned_cols=251 Identities=35% Similarity=0.604 Sum_probs=211.6
Q ss_pred cCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMV 133 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 133 (378)
+..+.|.+.+.||.|+||.||++...++.||+|.+..... ...++.+|+.+++.++|+||+++++.+. +...+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 4567788999999999999999999999999999976543 1246889999999999999999999886 45789
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQG 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-CEEEcccccccccccc
Confidence 999999999999999875445799999999999999999999999999999999999999655 5999999999765322
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
.. ....+..|+|||.+.. ..++.++||||||+++|+|++ |..||..... ...............+..+
T Consensus 156 ~~--~~~~~~~~~ape~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05039 156 QD--SGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPHVEKGYRMEAPEGC 224 (256)
T ss_pred cc--cCCCcccccCchhhcC--------CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHhcCCCCCCccCC
Confidence 22 3345667999998754 567889999999999999997 9999986654 3344444445556677788
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
++++.+++.+||..+|.+|||+.++++.|..
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 9999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=318.54 Aligned_cols=260 Identities=32% Similarity=0.531 Sum_probs=211.4
Q ss_pred ccccCCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeE
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKF 123 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l 123 (378)
.+.+...+|.+.+.||+|+||.||++.. .+..||+|+++....... ...+.+|+.+++++ +||||+++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE----REALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHH----HHHHHHHHHHHHhccCCCCcceE
Confidence 3445566799999999999999999864 235799999876543322 24588999999999 79999999
Q ss_pred EeeEec-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEe
Q 017046 124 LGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (378)
Q Consensus 124 ~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~ 202 (378)
++.+.+ +..+++|||+.+++|.+++.......+++.++..++.|++.||.|||+.|++|+||||+|||++.++ .++|+
T Consensus 105 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~ 183 (302)
T cd05055 105 LGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKIC 183 (302)
T ss_pred EEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-eEEEC
Confidence 998864 4789999999999999999764444589999999999999999999999999999999999998554 59999
Q ss_pred cccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHH
Q 017046 203 DFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278 (378)
Q Consensus 203 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 278 (378)
|||++....... ......++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.........
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~ 255 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhcc--------CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH
Confidence 999987533221 1122345678999998854 567889999999999999998 9999987665444444
Q ss_pred HHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 279 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
.......+..+...++++.+++.+||..+|++|||+.++++.|.++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 4444445556667889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=344.49 Aligned_cols=261 Identities=23% Similarity=0.375 Sum_probs=211.3
Q ss_pred ccccccccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEE
Q 017046 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFL 124 (378)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~ 124 (378)
.......+....++|.+.|.+|||+.||+|... +..||+|.+....... ...+.+||.+|+.|+ |+|||.++
T Consensus 27 ~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~-----L~~v~~EI~~MK~L~gh~nIV~yi 101 (738)
T KOG1989|consen 27 FVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEA-----LNAVKREIDIMKLLSGHKNIVSYI 101 (738)
T ss_pred CCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHH-----HHHHHHHHHHHHHhcCCCceeeEe
Confidence 344556677888999999999999999999874 3799999987652222 134789999999996 99999999
Q ss_pred eeE-e----c---CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCcEEEcC
Q 017046 125 GAC-K----D---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTP 194 (378)
Q Consensus 125 ~~~-~----~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~g--ivH~dikp~Nill~~ 194 (378)
+.. . + -..+|+||||.||.|-|++.......|++.++++|++|+++|+++||... |||||||-+||||+.
T Consensus 102 dss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~ 181 (738)
T KOG1989|consen 102 DSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA 181 (738)
T ss_pred ccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC
Confidence 933 1 1 14679999999999999998766777999999999999999999999998 999999999999996
Q ss_pred CCCceeEecccccccccccccc----------ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCC
Q 017046 195 DQKSLKLADFGLAREETVTEMM----------TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 264 (378)
Q Consensus 195 ~~~~vkl~Dfg~a~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~ 264 (378)
++ .+||||||.+......... -....|+.|+|||.+.-+. +.+.+.|+|||+|||+||-||...
T Consensus 182 ~g-~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlys-----g~pI~eKsDIWALGclLYkLCy~t 255 (738)
T KOG1989|consen 182 DG-NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYS-----GLPIGEKSDIWALGCLLYKLCYFT 255 (738)
T ss_pred CC-CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhc-----CCCCcchhHHHHHHHHHHHHHHhC
Confidence 66 5999999998753322210 1124789999999987543 578899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCC--CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 265 LPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 265 ~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
.||++.... .+ ......+| +.++..+.+||..||+.||.+||++-|++..+..+.
T Consensus 256 ~PFe~sg~l----aI--lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 256 TPFEESGKL----AI--LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred CCcCcCcce----eE--EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 999875331 11 22233333 468999999999999999999999999999886665
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=329.50 Aligned_cols=255 Identities=25% Similarity=0.349 Sum_probs=203.2
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
++|.+.+.||+|+||+||+++. .++.||+|+++....... .....+.+|+.+++.++||||+++++.+.+. ..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQ--ETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhh--hHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 3588899999999999999986 468999999986433211 1234578899999999999999999988654 6889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||+++++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 79 VMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANK 156 (330)
T ss_pred EECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-CEEeccCCCCeECCCCC
Confidence 99999999999999763 35799999999999999999999999999999999999999665 59999999987543222
Q ss_pred --ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC--C
Q 017046 215 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--E 290 (378)
Q Consensus 215 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~ 290 (378)
......||+.|+|||++...... ....++.++|||||||++|+|++|..||....................+| .
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGD--GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP 234 (330)
T ss_pred ceeeecccCCccccCHHHhcccccc--ccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCC
Confidence 12234789999999998642111 13567889999999999999999999998766544333222222222333 3
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+++++.+|+..||. +|.+|||+.++++
T Consensus 235 ~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 235 KVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 578999999999998 9999999999987
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=328.50 Aligned_cols=240 Identities=29% Similarity=0.472 Sum_probs=196.7
Q ss_pred ceeecccceEEEEEEE-----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEEEe
Q 017046 64 SKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTE 137 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv~e 137 (378)
+.||+|+||.||+++. .++.||+|++........ ...++..|++++++++||||+++++++.++ ..++|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR---DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 5799999999998864 468999999976432211 123567899999999999999999998654 7889999
Q ss_pred ccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-ccc
Q 017046 138 LLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMM 216 (378)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~ 216 (378)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++...... ...
T Consensus 79 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 79 FLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCCCce
Confidence 9999999999865 35689999999999999999999999999999999999999665 5999999998754333 223
Q ss_pred ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHH
Q 017046 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDL 296 (378)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 296 (378)
....|++.|+|||.+.. ..++.++|||||||++|+|++|+.||.+......... . ......+|..+++++
T Consensus 156 ~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~-i-~~~~~~~p~~~~~~~ 225 (318)
T cd05582 156 YSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM-I-LKAKLGMPQFLSPEA 225 (318)
T ss_pred ecccCChhhcCHHHHcC--------CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH-H-HcCCCCCCCCCCHHH
Confidence 34578999999999854 5678899999999999999999999987665433322 2 234456778899999
Q ss_pred HHHHHHccccCCCCCCC-----HHHHHH
Q 017046 297 AFIVQSCWVEDPNLRPS-----FSQIIR 319 (378)
Q Consensus 297 ~~li~~~l~~dp~~Rps-----~~~ll~ 319 (378)
.+++.+||+.||.+||+ +.+++.
T Consensus 226 ~~li~~~l~~~P~~R~~a~~~~~~~~~~ 253 (318)
T cd05582 226 QSLLRALFKRNPANRLGAGPDGVEEIKR 253 (318)
T ss_pred HHHHHHHhhcCHhHcCCCCCCCHHHHhC
Confidence 99999999999999999 455554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=325.15 Aligned_cols=246 Identities=25% Similarity=0.394 Sum_probs=200.0
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-CCeEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~l 134 (378)
+|.+.+.||+|+||.||+++.. ++.||||++.......... ...+..|..++..+ +||+|+.+++++.+ +..++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD--VECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH--HHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 4778899999999999999874 5789999998644322211 23466788888777 58999999998865 47889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-c
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-T 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~-~ 213 (378)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..... .
T Consensus 79 v~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCC
Confidence 9999999999998875 35689999999999999999999999999999999999999665 599999999875322 2
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
......+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+...... ...+ ......+|..++
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~~~i-~~~~~~~p~~~s 225 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQSI-MEHNVAYPKSMS 225 (323)
T ss_pred CccccCCCChhhcCHHHhcC--------CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH-HHHH-HhCCCCCCCcCC
Confidence 22335579999999999864 6688999999999999999999999987665333 3322 234556778899
Q ss_pred HHHHHHHHHccccCCCCCCCH-----HHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPSF-----SQIIR 319 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~-----~~ll~ 319 (378)
.++.+++.+||+.||.+|++. .++++
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 226 KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred HHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 999999999999999999974 66665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=312.42 Aligned_cols=249 Identities=31% Similarity=0.550 Sum_probs=204.7
Q ss_pred CCcceeecceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
+.++|.+.+.||+|+||.||.+++.+ ..+|+|.+....... ..+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE------DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY 75 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccH------HHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence 46779999999999999999998765 469999887543322 3488999999999999999999998644 678
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
++|||+.+++|.+++... ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++......
T Consensus 76 lv~e~~~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 76 IVTEYMSNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDD 153 (256)
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccceecCCC
Confidence 999999999999998763 33689999999999999999999999999999999999999655 5999999998753322
Q ss_pred ccc--ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 214 EMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 214 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
... ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...... ...........+..+.
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~ 224 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLY--------SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-ETVEKVSQGLRLYRPH 224 (256)
T ss_pred ceeecCCCccChhhCCHHHHhc--------CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHhcCCCCCCCC
Confidence 211 12235578999998854 567889999999999999998 99999876543 3334444455555667
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
..+..+.+++.+||..+|.+||++.++++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 7889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=318.95 Aligned_cols=262 Identities=32% Similarity=0.588 Sum_probs=212.4
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC---------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCee
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLV 121 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv 121 (378)
.+.+....|.+++.||+|+||.||++++. ...+|+|.+........ ...+.+|+.+++.+ +||||+
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD----LSDLISEMEMMKMIGKHKNII 87 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHH----HHHHHHHHHHHHHhcCCCCEe
Confidence 34455678999999999999999999753 24699999976533222 23578899999999 799999
Q ss_pred eEEeeEec-CCeEEEEeccCCCCHHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCC
Q 017046 122 KFLGACKD-PLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLK 186 (378)
Q Consensus 122 ~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dik 186 (378)
++++++.+ ...++||||+.+++|.+++..... ..+++..++.++.|++.||+|||+.|++|||||
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 167 (307)
T cd05098 88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167 (307)
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 99998864 478899999999999999976322 348889999999999999999999999999999
Q ss_pred CCcEEEcCCCCceeEeccccccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-
Q 017046 187 PDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 262 (378)
Q Consensus 187 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~- 262 (378)
|+||+++.++ .++|+|||++........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 168 p~Nill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 168 ARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred HHheEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhcc--------CCCCcHHHHHHHHHHHHHHHcC
Confidence 9999999665 599999999865432211 112234568999998854 567889999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 263 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 263 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
|..||.+... ...............+..++.++.+++.+||..+|.+|||+.++++.|..++..
T Consensus 239 g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 239 GGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred CCCCCCcCCH-HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 8899976543 444444455555677788999999999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=317.88 Aligned_cols=259 Identities=31% Similarity=0.520 Sum_probs=208.0
Q ss_pred cceeecceeecccceEEEEEEECC----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-CC
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYGD----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PL 131 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~ 131 (378)
++|.+.+.||+|+||.||+|...+ ..+++|.++....... ...+.+|+.++.++ +||||+++++++.+ ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND----HRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHH----HHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 468889999999999999997643 2478888764332222 23588999999999 79999999999864 46
Q ss_pred eEEEEeccCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC
Q 017046 132 MVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 197 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~ 197 (378)
.+++|||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||++.++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~- 156 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL- 156 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC-
Confidence 889999999999999996532 13488899999999999999999999999999999999998654
Q ss_pred ceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHH
Q 017046 198 SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276 (378)
Q Consensus 198 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 276 (378)
.+||+|||++..............+..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.... ..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-~~ 227 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY--------SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-EL 227 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HH
Confidence 599999999864322211122233557999998754 567889999999999999997 99999876553 33
Q ss_pred HHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 277 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
.........+..+..++.++.+|+.+||..+|.+|||+.++++.|..++...+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 228 YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 444444555667778999999999999999999999999999999988866543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=318.35 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=203.2
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|.+.+.||+|+||.||++.. +++.||+|.+......... ....+..|+.+++.++|++|+.+++.+.+ ...++||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchH--HHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 66778999999999999977 4689999998754333221 12346789999999999999999998864 4788999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccc
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~ 216 (378)
||++|++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.........
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCCccc
Confidence 999999999998765555799999999999999999999999999999999999999665 4999999998754433333
Q ss_pred ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCCCCCCChH
Q 017046 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ--AAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 294 (378)
....|+..|+|||++.. ..++.++||||||+++|+|++|..||....... .............++..+++
T Consensus 159 ~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd05630 159 KGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSP 230 (285)
T ss_pred cCCCCCccccChHHHcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCH
Confidence 44578999999999864 568899999999999999999999998644311 11222222333456677899
Q ss_pred HHHHHHHHccccCCCCCCC-----HHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPS-----FSQIIR 319 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps-----~~~ll~ 319 (378)
++.+|+..||+.||.+||| +.++++
T Consensus 231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 231 DARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 9999999999999999999 899998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=325.49 Aligned_cols=242 Identities=26% Similarity=0.391 Sum_probs=197.3
Q ss_pred ceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-CeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~~lv~e~~ 139 (378)
+.||+|+||.||+|+.. ++.||+|++......... ....+..|..++..+ +||||+++++++.++ ..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDD--DVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhh--HHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 36899999999999874 578999998764322111 123467888888876 799999999999654 788999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc-ccccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 218 (378)
++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.... .......
T Consensus 79 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 79 NGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCCccccc
Confidence 99999998875 35689999999999999999999999999999999999999665 59999999987432 2222344
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 298 (378)
..|++.|+|||++.. ..++.++|||||||++|+|++|..||.+.+.... .... ......+|..++.++.+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~~~i-~~~~~~~p~~~~~~~~~ 225 (321)
T cd05591 156 FCGTPDYIAPEILQE--------LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-FESI-LHDDVLYPVWLSKEAVS 225 (321)
T ss_pred cccCccccCHHHHcC--------CCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-HHHH-HcCCCCCCCCCCHHHHH
Confidence 578999999998854 5688999999999999999999999987665333 3332 23445567778999999
Q ss_pred HHHHccccCCCCCC-------CHHHHHHH
Q 017046 299 IVQSCWVEDPNLRP-------SFSQIIRM 320 (378)
Q Consensus 299 li~~~l~~dp~~Rp-------s~~~ll~~ 320 (378)
++.+||..||.+|| ++.+++++
T Consensus 226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 99999999999999 88899874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=325.78 Aligned_cols=244 Identities=27% Similarity=0.426 Sum_probs=196.2
Q ss_pred ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-CCeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PLMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e~~ 139 (378)
+.||+|+||.||+++. +++.||+|+++......... ...+..|+.++..+ +||||+++++++.+ ...++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDED--IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhH--HHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 3699999999999987 46789999998654322211 23477888888877 79999999998865 4789999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc-ccccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 218 (378)
++++|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.... .......
T Consensus 79 ~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 79 NGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCCCcccc
Confidence 99999988865 35799999999999999999999999999999999999999665 59999999987532 2222344
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC-------hHHHHHHHHHhcCCCCCCCC
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS-------NLQAAYAAAFKHARPGLPED 291 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~ 291 (378)
..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ................+|..
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 227 (329)
T cd05618 156 FCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 227 (329)
T ss_pred ccCCccccCHHHHcC--------CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCC
Confidence 579999999999864 567889999999999999999999995211 11112222333455668888
Q ss_pred ChHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPS------FSQIIRM 320 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps------~~~ll~~ 320 (378)
++..+.+++.+||..||.+||+ +.+++++
T Consensus 228 ~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 228 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999999999999998 5787773
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=326.23 Aligned_cols=261 Identities=30% Similarity=0.549 Sum_probs=209.4
Q ss_pred ccCCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEe
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLG 125 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~ 125 (378)
....++|.+.+.||+|+||.||+|.+ .++.||||+++....... ...+.+|+.++.++ +||||+++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~ 78 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE----HRALMSELKILIHIGHHLNVVNLLG 78 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHH----HHHHHHHHHHHHhccCCccHhhhcc
Confidence 34567899999999999999999974 357899999976543322 23578999999999 7899999999
Q ss_pred eEec--CCeEEEEeccCCCCHHHHHhhhCC--------------------------------------------------
Q 017046 126 ACKD--PLMVIVTELLPGMSLRKYLVSLRP-------------------------------------------------- 153 (378)
Q Consensus 126 ~~~~--~~~~lv~e~~~~~sL~~~l~~~~~-------------------------------------------------- 153 (378)
++.. ...+++|||+++|+|.+++.....
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (343)
T cd05103 79 ACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSL 158 (343)
T ss_pred eeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcc
Confidence 8753 367899999999999999865221
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc---c
Q 017046 154 ---------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---M 215 (378)
Q Consensus 154 ---------------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~ 215 (378)
..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++....... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 159 SDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred ccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhh
Confidence 2367788899999999999999999999999999999999554 59999999987532211 1
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
.....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+...................|...++
T Consensus 238 ~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (343)
T cd05103 238 KGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 309 (343)
T ss_pred cCCCCCCcceECcHHhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCH
Confidence 112345678999998854 567889999999999999997 99999876544444444445555666777889
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
++.+++..||+.+|.+|||+.+++++|..++..
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=330.40 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=203.0
Q ss_pred cccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 130 (378)
..+..+.|.+.+.||+|+||.||++++. ++.||+|++......... ....+.+|+.+++.++||||+++++.+.++
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~--~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS--DSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhH--HHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 3345678999999999999999999874 689999998653222111 123477899999999999999999998654
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
..++||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~ 191 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMK 191 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCceeE
Confidence 78899999999999999865 4589999999999999999999999999999999999999665 599999999875
Q ss_pred ccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh-cCCC
Q 017046 210 ETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARP 286 (378)
Q Consensus 210 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~ 286 (378)
..... .....+||+.|+|||++... .....++.++|||||||++|+|++|..||.+.+.... +..+.. ....
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~~~~ 266 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YSKIMNHKNSL 266 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhcc----CCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCcc
Confidence 43322 12345799999999998641 1123478899999999999999999999987665333 333322 2223
Q ss_pred CCC--CCChHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 017046 287 GLP--EDISPDLAFIVQSCWVEDPNL--RPSFSQIIRML 321 (378)
Q Consensus 287 ~~~--~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~l 321 (378)
.+| ..++..+.++|..||..++.+ |+++.+++++.
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 267 TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 333 368999999999999844433 78999999854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=316.65 Aligned_cols=252 Identities=31% Similarity=0.551 Sum_probs=206.6
Q ss_pred CcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
...|.+.+.||+|+||.||+|+.. ++.||+|.++....... ...+.+|+++++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA----RKDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHH----HHHHHHHHHHHHhcCCCCchheeeEEec
Confidence 456888899999999999999753 36899999876544322 2468899999999999999999998864
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLR------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ 196 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~ 196 (378)
...+++|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 47899999999999999997532 23478899999999999999999999999999999999999665
Q ss_pred CceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCCh
Q 017046 197 KSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272 (378)
Q Consensus 197 ~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 272 (378)
.++|+|||++....... ......+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+...
T Consensus 160 -~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 160 -VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred -eEEECCcccceecccCcceecCCCCcccceecChhhhcc--------CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 59999999986432211 1223345778999999864 668889999999999999998 9999987655
Q ss_pred HHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
.. .............+..++..+.+++.+||..||.+||++.++++.|+
T Consensus 231 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 231 EE-VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 33 33444445555566789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=319.06 Aligned_cols=260 Identities=32% Similarity=0.523 Sum_probs=206.2
Q ss_pred cCCcceeecceeecccceEEEEEEEC--Ce--eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DR--IVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD 129 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 129 (378)
+...+|.+.+.||+|+||.||+|.+. +. .+|+|.++...... ....+.+|+.++.++ +||||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD----DHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHH----HHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 34567889999999999999999863 33 46777765433222 124578999999999 89999999999864
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~ 194 (378)
...++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 47899999999999999997532 135789999999999999999999999999999999999996
Q ss_pred CCCceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChH
Q 017046 195 DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273 (378)
Q Consensus 195 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 273 (378)
++ .++|+|||++.............++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+....
T Consensus 160 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 230 (303)
T cd05088 160 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230 (303)
T ss_pred CC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhc--------cCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence 65 599999999864322222222234667999998754 557889999999999999998 99999866543
Q ss_pred HHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 274 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
..............+..+++++.+++.+||..+|.+||++.++++.|...+...
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 231 -ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred -HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 333333334445566678899999999999999999999999999998776553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=317.16 Aligned_cols=243 Identities=21% Similarity=0.348 Sum_probs=192.2
Q ss_pred eecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEEEeccCCC
Q 017046 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGM 142 (378)
Q Consensus 66 lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv~e~~~~~ 142 (378)
||+|+||.||+++. .++.||+|.+......... ....+..|+++++.++||||+++++.+.++ ..++||||++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~--~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKS--GEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcch--hhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 69999999999976 4789999998653322111 112356799999999999999999988654 788999999999
Q ss_pred CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccccccCcCc
Q 017046 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222 (378)
Q Consensus 143 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt 222 (378)
+|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.............|+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCceeeccCCC
Confidence 999988765555689999999999999999999999999999999999999655 5999999998765443333445789
Q ss_pred cccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCCCCCChHHHHHH
Q 017046 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ---AAYAAAFKHARPGLPEDISPDLAFI 299 (378)
Q Consensus 223 ~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~l 299 (378)
..|+|||++.. ..++.++|||||||++|+|++|..||.+..... .................+++++.+|
T Consensus 158 ~~y~aPE~~~~--------~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (277)
T cd05607 158 NGYMAPEILKE--------EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDI 229 (277)
T ss_pred CCccCHHHHcc--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHH
Confidence 99999999864 558899999999999999999999997643321 1122222212222224689999999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 017046 300 VQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 300 i~~~l~~dp~~Rps~~~ll~ 319 (378)
+.+||+.||.+||++.++++
T Consensus 230 i~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 230 CRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHhccCHhhCCCCccchh
Confidence 99999999999999966543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=310.30 Aligned_cols=254 Identities=33% Similarity=0.535 Sum_probs=207.8
Q ss_pred cCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
+..+.|.+.+.||+|+||.||+|... ++.||+|.++..... ...+.+|+.++++++||||+++++++.+ ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD------PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc------HHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence 34567899999999999999999864 478999998754332 1347899999999999999999998864 478
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.....
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~ 155 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKE 155 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence 8999999999999999765445789999999999999999999999999999999999999665 499999999875432
Q ss_pred cccc--ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 213 TEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 213 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
.... .....+..|+|||.+.. ..++.++||||||+++|+|++ |+.||.+..... .............+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~ 226 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALY--------NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQVDQGYRMPCP 226 (261)
T ss_pred CcccccCCCcCceeccCcccccc--------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCC
Confidence 2111 11123457999998754 567889999999999999999 999998766533 33344444455566
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
..++..+.+++.+||..+|.+||++.++++.|+.+
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 77899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=315.45 Aligned_cols=260 Identities=32% Similarity=0.588 Sum_probs=212.1
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeE
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKF 123 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l 123 (378)
.+.++..+|.+.+.||+|+||.||++... ...+|+|.+........ ...+.+|+.++..+ +||||+++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD----LSDLVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHH----HHHHHHHHHHHHhhcCCCCeeeE
Confidence 45566778999999999999999999763 26799999876543322 23588999999999 79999999
Q ss_pred EeeEec-CCeEEEEeccCCCCHHHHHhhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 017046 124 LGACKD-PLMVIVTELLPGMSLRKYLVSL--------------RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 188 (378)
Q Consensus 124 ~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~ 188 (378)
++++.+ +..+++|||+++++|.+++... ....+++..++.++.|++.||.|||+.||+||||||+
T Consensus 82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 161 (293)
T cd05053 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR 161 (293)
T ss_pred EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccccee
Confidence 998864 4789999999999999998652 2346889999999999999999999999999999999
Q ss_pred cEEEcCCCCceeEeccccccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CC
Q 017046 189 NLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 264 (378)
Q Consensus 189 Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~ 264 (378)
||+++.++ .++|+|||++........ .....++..|+|||.+.. ..++.++|||||||++|+|++ |.
T Consensus 162 Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~ 232 (293)
T cd05053 162 NVLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLLWEIFTLGG 232 (293)
T ss_pred eEEEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc--------CCcCcccceeehhhHHHHHhcCCC
Confidence 99999654 599999999875432211 122234567999998754 567889999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 265 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 265 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
.||.+... ............+..+..++.++.+|+.+||..||.+|||+.++++.|..++
T Consensus 233 ~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 233 SPYPGIPV-EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 99987654 3444445555556677788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=324.61 Aligned_cols=268 Identities=25% Similarity=0.391 Sum_probs=210.2
Q ss_pred cccccCCcceeecceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeE-
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC- 127 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~- 127 (378)
..+.++...|.++++||+||.+.||++...+ +.||+|.+........ ...-|..|+..|.+| .|.+||+++++-
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~q---tl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQ---TLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHH---HHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 3456788899999999999999999998764 6788887655443332 224589999999999 499999999987
Q ss_pred ecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
.|+++|+||||= ..+|..+|.. +...++...+..|+.|++.|+.++|.+||||.||||.|+|+. .| .+||+|||+|
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k-~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG-~LKLIDFGIA 506 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKK-KKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KG-RLKLIDFGIA 506 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-ee-eEEeeeechh
Confidence 577999999986 4599999987 334455458899999999999999999999999999999998 44 4999999999
Q ss_pred ccccccc---ccccCcCcccccccccccccccccc---ccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017046 208 REETVTE---MMTAETGTYRWMAPELYSTVTLRQG---EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 208 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 281 (378)
....... .....+||+.||+||.+........ .....+.++||||||||||+|+.|++||....+....+..+.
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~ 586 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT 586 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence 7644332 2345689999999999976543311 133478899999999999999999999987665554444443
Q ss_pred hc-CCCCCCCCChHH-HHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 282 KH-ARPGLPEDISPD-LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 282 ~~-~~~~~~~~~~~~-l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.. ...++|..-+.. +.++++.||.+||.+|||..++|+ +.++..
T Consensus 587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq--hpFl~~ 632 (677)
T KOG0596|consen 587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ--HPFLQI 632 (677)
T ss_pred CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc--Cccccc
Confidence 33 233555544444 999999999999999999999999 444443
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=314.92 Aligned_cols=257 Identities=27% Similarity=0.515 Sum_probs=209.0
Q ss_pred CCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+..+|.+.+.||.|+||.||++.. .+..+|+|.+...... ....+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN-----ARKDFHREAELLTNLQHEHIVKFYGVCV 77 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 456789999999999999999974 2356899988653321 1235889999999999999999999986
Q ss_pred c-CCeEEEEeccCCCCHHHHHhhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC
Q 017046 129 D-PLMVIVTELLPGMSLRKYLVSLR-----------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ 196 (378)
Q Consensus 129 ~-~~~~lv~e~~~~~sL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~ 196 (378)
+ ...+++|||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||+++.++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 4 47899999999999999987532 13489999999999999999999999999999999999999665
Q ss_pred CceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCCh
Q 017046 197 KSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272 (378)
Q Consensus 197 ~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 272 (378)
.++|+|||++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 158 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 158 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228 (288)
T ss_pred -cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 59999999987543221 1123345778999998854 567889999999999999998 9999987654
Q ss_pred HHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.. .............+..++.++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 229 ~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 229 NE-VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 33 3344444455566677899999999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=313.56 Aligned_cols=254 Identities=31% Similarity=0.568 Sum_probs=208.0
Q ss_pred cCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
+..++|.+.+.||+|+||.||+|... +..||+|.+........ ...+.+|+.++..++||||+++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE----RIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHH----HHHHHHHHHHHHhCCCCceeEEEEEE
Confidence 45678999999999999999998764 26799999865443222 23588999999999999999999998
Q ss_pred ec-CCeEEEEeccCCCCHHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCc
Q 017046 128 KD-PLMVIVTELLPGMSLRKYLVSLRP--------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (378)
Q Consensus 128 ~~-~~~~lv~e~~~~~sL~~~l~~~~~--------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~ 198 (378)
.+ ...++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~-~ 157 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-T 157 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC-C
Confidence 64 478999999999999999865321 2468889999999999999999999999999999999999665 5
Q ss_pred eeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHH
Q 017046 199 LKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (378)
Q Consensus 199 vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 274 (378)
+||+|||+++...... ......++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 229 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE 229 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhc--------CCCCcccchHHHHHHHHHhhccCCCCCccCCHHH
Confidence 9999999987533221 1223456788999998753 567889999999999999998 999998766533
Q ss_pred HHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 275 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
..........+..|..++.++.+++.+||..+|.+|||+.++++.|+
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 230 -VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 34444455566778889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=323.47 Aligned_cols=241 Identities=27% Similarity=0.419 Sum_probs=194.8
Q ss_pred ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-CCeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PLMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e~~ 139 (378)
+.||+|+||.||++++ +++.||+|+++........ ....+..|..++..+ +||||+++++++.+ ...++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDD--DVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcc--hHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 4699999999999987 4678999999764321111 112456777777765 89999999999865 4788999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc-ccccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 218 (378)
.+++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .++|+|||++.... .......
T Consensus 79 ~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 79 NGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCCCceec
Confidence 99999998875 35689999999999999999999999999999999999999665 59999999986432 1222345
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 298 (378)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .... .....+.+|..++.++.+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~ 225 (316)
T cd05620 156 FCGTPDYIAPEILQG--------LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-LFES-IRVDTPHYPRWITKESKD 225 (316)
T ss_pred cCCCcCccCHHHHcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHH-HHhCCCCCCCCCCHHHHH
Confidence 579999999999864 568899999999999999999999998765432 2322 234456677789999999
Q ss_pred HHHHccccCCCCCCCH-HHHHH
Q 017046 299 IVQSCWVEDPNLRPSF-SQIIR 319 (378)
Q Consensus 299 li~~~l~~dp~~Rps~-~~ll~ 319 (378)
++.+||..||.+||++ .++++
T Consensus 226 li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 226 ILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHc
Confidence 9999999999999997 46664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=329.81 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=195.6
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CC
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PL 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 131 (378)
+....|.+.+.||+|+||.||++.+ +++.||+|.... ..+.+|+++++.++||||+++++++.. ..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 3456799999999999999999987 468999996432 236789999999999999999998864 46
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++|||++ +++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 158 ~~lv~e~~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~ 233 (391)
T PHA03212 158 TCLILPRY-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPV 233 (391)
T ss_pred eEEEEecC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-CEEEEeCCcccccc
Confidence 78999999 5789888865 35689999999999999999999999999999999999999665 49999999986422
Q ss_pred c--ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh------HHHHHHHH---
Q 017046 212 V--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN------LQAAYAAA--- 280 (378)
Q Consensus 212 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~--- 280 (378)
. ........||+.|+|||++.. ..++.++|||||||++|+|++|..||..... .......+
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLAR--------DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred cccccccccccCccCCCChhhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 1 122234579999999999854 5688999999999999999999987643221 00000000
Q ss_pred -----------------------Hhc-C-CCC-CC-----CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 281 -----------------------FKH-A-RPG-LP-----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 281 -----------------------~~~-~-~~~-~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
... . .+. .+ ..++.++.+||.+||+.||.+|||+.++++ +.++..+.
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~--hp~f~~~~ 383 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD--FAAFQDIP 383 (391)
T ss_pred hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc--ChhhccCC
Confidence 000 0 000 00 134678999999999999999999999998 66776654
Q ss_pred CC
Q 017046 330 PP 331 (378)
Q Consensus 330 ~~ 331 (378)
.+
T Consensus 384 ~~ 385 (391)
T PHA03212 384 DP 385 (391)
T ss_pred CC
Confidence 43
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=315.45 Aligned_cols=257 Identities=28% Similarity=0.514 Sum_probs=209.3
Q ss_pred CCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+..+|.+.+.||+|+||.||+++.. ...+++|.+....... ...+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-----RKDFQREAELLTNLQHEHIVKFYGVCG 77 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHH-----HHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 3456888999999999999999742 3568888876533322 235789999999999999999999986
Q ss_pred c-CCeEEEEeccCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEc
Q 017046 129 D-PLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 193 (378)
Q Consensus 129 ~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~ 193 (378)
+ ...++||||+++++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 5 47899999999999999997532 13488999999999999999999999999999999999999
Q ss_pred CCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCC
Q 017046 194 PDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269 (378)
Q Consensus 194 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~ 269 (378)
.++ .++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||..
T Consensus 158 ~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t~g~~p~~~ 228 (291)
T cd05094 158 ANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSFGVILWEIFTYGKQPWFQ 228 (291)
T ss_pred cCC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 665 59999999987543221 1223456788999998854 567889999999999999998 9999977
Q ss_pred CChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 270 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
..... ..........+..+..++..+.+++.+||+.+|.+|||+.++++.|..+...
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 229 LSNTE-VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCHHH-HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 65533 3344444555556677899999999999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=340.37 Aligned_cols=259 Identities=31% Similarity=0.527 Sum_probs=226.0
Q ss_pred ccCCcceeecceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
.+++...+|.+.||.|.||+||.|+.+ ...||||.++.....+.+ ..|+.|+.||-++.||||++|.|+..
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekqr----rdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQR----RDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHH----hhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 467788899999999999999999873 468999999987776544 46999999999999999999999997
Q ss_pred cC-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 129 DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 129 ~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
.. ...||+|||++|+|..+|+.+ .+.+...+..-+++.|+.|+.||-++|+|||||..+||||+. +..+|++|||++
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~-DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs-nLvCKVsDFGLS 778 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQN-DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS-NLVCKVSDFGLS 778 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhc-CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc-ceEEEeccccce
Confidence 65 566999999999999999884 467999999999999999999999999999999999999995 456999999999
Q ss_pred ccccccc-c-ccc--CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 017046 208 REETVTE-M-MTA--ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (378)
Q Consensus 208 ~~~~~~~-~-~~~--~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 282 (378)
+...... . .++ ..-..+|.|||.+.. ..++.++||||+|++|||.++ |..||.++++ ++....+..
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~--------RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~ 849 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQ 849 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhh--------cccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHh
Confidence 8543222 1 111 123468999999975 789999999999999999887 9999999998 556777788
Q ss_pred cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+.+.+-|.++|..+..|+..||++|-.+||.+.+|+..|++++..
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 899999999999999999999999999999999999999999854
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=322.64 Aligned_cols=254 Identities=24% Similarity=0.413 Sum_probs=202.1
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
..++|.+.++||.|+||.||++.+. +..+|+|++....... ....+.+|+++++.++||||+++++++.+ +..
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA----IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHH----HHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence 4567999999999999999999874 6789999887653322 23458899999999999999999999864 478
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+|||++.++ .+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~ 155 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI 155 (333)
T ss_pred EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhh
Confidence 999999999999999975 34689999999999999999999985 799999999999999665 49999999986532
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHH---------------
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA--------------- 276 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--------------- 276 (378)
. .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (333)
T cd06650 156 D-SMANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE 226 (333)
T ss_pred h-hccccCCCCccccCHHHhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccc
Confidence 2 22234578999999999854 56788999999999999999999999754321110
Q ss_pred ----------------------------HHHHHhcCCCCCCC-CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 277 ----------------------------YAAAFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 277 ----------------------------~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.........+.++. .++.++.+|+.+||+.||.+|||+.++++ +.++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~--h~~~~~ 304 (333)
T cd06650 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV--HAFIKR 304 (333)
T ss_pred cCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh--CHHHhc
Confidence 01111122222222 36788999999999999999999999988 455543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=311.79 Aligned_cols=251 Identities=29% Similarity=0.532 Sum_probs=202.1
Q ss_pred eecceeecccceEEEEEEECC----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-------
Q 017046 61 FIGSKIGEGAHGKVYEGRYGD----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------- 129 (378)
Q Consensus 61 ~~~~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------- 129 (378)
.+++.||+|+||.||+|+..+ ..||+|.++........ ...+.+|+.+++.++||||+++++.+..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE---MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHH---HHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 467889999999999998743 36899988765433322 2458899999999999999999987632
Q ss_pred CCeEEEEeccCCCCHHHHHhhh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSL----RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
...+++|||+.+++|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg 157 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFG 157 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-CEEECCCC
Confidence 2468999999999999987432 223588999999999999999999999999999999999998655 59999999
Q ss_pred cccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017046 206 LAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 206 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 281 (378)
++........ .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~ 228 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLAD--------RVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDYLR 228 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccC--------CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHH
Confidence 9876432221 122245678999998854 567889999999999999999 8999987654 34444455
Q ss_pred hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
....+..+..++..+.+++.+||..||.+|||+.++++.|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 5555566778899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=315.34 Aligned_cols=255 Identities=29% Similarity=0.563 Sum_probs=206.8
Q ss_pred ceeecceeecccceEEEEEEECC-------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-C
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-P 130 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 130 (378)
+|.+.+.||+|+||.||+|.... ..+++|.+........ ...+.+|+.+++.++||||+++++.+.+ .
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE----LRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHH----HHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 36778899999999999997632 5689998876544322 2358899999999999999999998854 4
Q ss_pred CeEEEEeccCCCCHHHHHhhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 017046 131 LMVIVTELLPGMSLRKYLVSLR----------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 188 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~ 188 (378)
..+++|||+.+++|.+++.... ...+++..++.++.|++.||.|||+.|++||||||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 7889999999999999986522 134788999999999999999999999999999999
Q ss_pred cEEEcCCCCceeEeccccccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CC
Q 017046 189 NLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 264 (378)
Q Consensus 189 Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~ 264 (378)
|||++.++ .++|+|||++........ .....++..|+|||.+.. ..++.++||||||+++|+|++ |.
T Consensus 157 nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~~l~el~t~g~ 227 (290)
T cd05045 157 NVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD--------HIYTTQSDVWSFGVLLWEIVTLGG 227 (290)
T ss_pred eEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHcc--------CCcchHhHHHHHHHHHHHHHhcCC
Confidence 99998554 699999999874322211 122345678999998754 567889999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 265 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 265 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.||.+... ...............+..++.++.+++..||+.+|.+||++.++++.|+.++..
T Consensus 228 ~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 228 NPYPGIAP-ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCCCCCH-HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 99987654 344444445555666778999999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=326.53 Aligned_cols=247 Identities=29% Similarity=0.375 Sum_probs=196.6
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 129 (378)
.++|.+.+.||+|+||.||++.. .++.||||++......... ...+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH---AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchh---HHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 46799999999999999999986 4688999998764433222 2357789999999999999999987743
Q ss_pred --CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 130 --~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
...++||||++ ++|.+++.. .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a 173 (364)
T cd07875 100 EFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA 173 (364)
T ss_pred ccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCCCc
Confidence 24689999995 578777753 488999999999999999999999999999999999999665 5999999999
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc----
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH---- 283 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---- 283 (378)
.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+............
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhC--------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 86554444455678999999999864 568889999999999999999999998766543322211100
Q ss_pred ----------------CCCC--------------------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 284 ----------------ARPG--------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 284 ----------------~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
..+. .....+.++.+||.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 011234678999999999999999999999993
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=323.38 Aligned_cols=242 Identities=27% Similarity=0.422 Sum_probs=197.7
Q ss_pred ceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-CeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~~lv~e~~ 139 (378)
+.||+|+||+||++++. ++.||+|+++........ ....+..|..++..+ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDD--DVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhh--HHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 36999999999999874 578999999864322211 123467888888888 699999999988654 788999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-cccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~ 218 (378)
+|++|..++.. ...+++..+..++.|++.||.|||+.|++||||||+|||++.++ .++|+|||++..... ......
T Consensus 79 ~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 79 NGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCCCcccc
Confidence 99999998875 35799999999999999999999999999999999999999665 599999999864222 222234
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 298 (378)
.+|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.... ... .......+|..++.++.+
T Consensus 156 ~~g~~~y~aPE~~~~--------~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~-~~~-i~~~~~~~~~~~~~~~~~ 225 (318)
T cd05570 156 FCGTPDYIAPEILSY--------QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL-FQS-ILEDEVRYPRWLSKEAKS 225 (318)
T ss_pred eecCccccCHHHhcC--------CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH-HHH-HHcCCCCCCCcCCHHHHH
Confidence 578999999999864 5688999999999999999999999987654332 222 234455677789999999
Q ss_pred HHHHccccCCCCCCCH-----HHHHHH
Q 017046 299 IVQSCWVEDPNLRPSF-----SQIIRM 320 (378)
Q Consensus 299 li~~~l~~dp~~Rps~-----~~ll~~ 320 (378)
||.+||..||.+|||+ .+++++
T Consensus 226 li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 226 ILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999999 888873
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=319.04 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=202.2
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~ 132 (378)
+.+.|.+.++||+|+||.||+|+. .++.||+|.+......... ..+.+|+.+++.++||||+++++++. ++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP----CTAIREVSLLKDLKHANIVTLHDIVHTDKSL 79 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcc----hhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence 346799999999999999999976 4678999998765433221 24678999999999999999999986 4578
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++.....
T Consensus 80 ~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSV 156 (309)
T ss_pred EEEEeCCCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECccccceecCC
Confidence 999999964 88888765 235689999999999999999999999999999999999999655 599999999875332
Q ss_pred cc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc--------
Q 017046 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH-------- 283 (378)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-------- 283 (378)
.. ......+++.|+|||.+.+ ...++.++|||||||++|+|++|..||.+.+..+.........
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 157 PTKTYSNEVVTLWYRPPDVLLG-------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred CccccccccccccccCCHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 22 2234467899999998753 2457889999999999999999999998765433222111100
Q ss_pred ------------CCC--------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 284 ------------ARP--------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 284 ------------~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
..+ .....+++++.+|+.+||..||.+|||+.++++ +.++..+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~~~ 294 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK--HAYFRSLGT 294 (309)
T ss_pred hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc--Chhhhhccc
Confidence 000 011347889999999999999999999999998 556655443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=310.99 Aligned_cols=252 Identities=31% Similarity=0.564 Sum_probs=205.3
Q ss_pred eeecceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC----
Q 017046 60 LFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 130 (378)
|.+++.||+|+||.||.|... +..||+|.++........ ...+.+|+.+++.++||||+++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE---IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHH---HHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 467889999999999999763 267999998764433221 23588999999999999999999987432
Q ss_pred ---CeEEEEeccCCCCHHHHHhhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEec
Q 017046 131 ---LMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (378)
Q Consensus 131 ---~~~lv~e~~~~~sL~~~l~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~D 203 (378)
..+++|||+++++|..++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~d 156 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVAD 156 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-eEEECC
Confidence 3689999999999999885532 23689999999999999999999999999999999999999654 599999
Q ss_pred cccccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017046 204 FGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (378)
Q Consensus 204 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 279 (378)
||+++....... .....++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.... .....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-~~~~~ 227 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-EIYDY 227 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhccc--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH
Confidence 999875432221 112235678999998753 567889999999999999999 89999876653 44455
Q ss_pred HHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 280 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 280 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
......+..+..++.++.+++.+||..||.+|||+.++++.|..+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 555666777888999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=312.58 Aligned_cols=252 Identities=32% Similarity=0.549 Sum_probs=209.5
Q ss_pred CcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
..+|.+.++||.|+||.||+|... +..+|+|++....... ...+..|+.+++.++||||+++++++.+. ..++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK-----QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh-----HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 456889999999999999999875 5789999987543322 23478999999999999999999988654 7889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDV 158 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEEccccchhhcCCcc
Confidence 99999999999999875566789999999999999999999999999999999999999655 59999999986543221
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+....+ ..........+..+..+
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~--------~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 229 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASH--------GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-VYDQITAGYRMPCPAKC 229 (261)
T ss_pred ccccCCCCceEecCHHHHcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-HHHHHHhCCcCCCCCCC
Confidence 1123345678999998754 567889999999999999998 899998766433 34444455566677889
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
++++.+++.+||..||.+|||+.++++.|+.
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 230 PQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=323.58 Aligned_cols=241 Identities=27% Similarity=0.403 Sum_probs=193.0
Q ss_pred ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHH-HHhhccCCCeeeEEeeEec-CCeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLVKFLGACKD-PLMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~ 139 (378)
+.||+|+||+||+|+. +++.||+|++.......... ...+..|.. +++.++||||+++++.+.+ ...++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE--QKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhH--HHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 3689999999999987 47899999987543222111 123455544 5678899999999998865 4788999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-cccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~ 218 (378)
++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..... ......
T Consensus 79 ~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 79 NGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCCCcccc
Confidence 99999998875 45789999999999999999999999999999999999999665 599999999865322 222334
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 298 (378)
.+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+.. ..+.... .....++..+++++.+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~i~-~~~~~~~~~~~~~~~~ 225 (323)
T cd05575 156 FCGTPEYLAPEVLRK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-EMYDNIL-NKPLRLKPNISVSARH 225 (323)
T ss_pred ccCChhhcChhhhcC--------CCCCccccccccchhhhhhhcCCCCCCCCCHH-HHHHHHH-cCCCCCCCCCCHHHHH
Confidence 579999999999854 56889999999999999999999999876543 3333332 3345566778999999
Q ss_pred HHHHccccCCCCCCCH----HHHHH
Q 017046 299 IVQSCWVEDPNLRPSF----SQIIR 319 (378)
Q Consensus 299 li~~~l~~dp~~Rps~----~~ll~ 319 (378)
++.+||+.||.+||++ .++++
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~il~ 250 (323)
T cd05575 226 LLEGLLQKDRTKRLGAKDDFLEIKN 250 (323)
T ss_pred HHHHHhhcCHHhCCCCCCCHHHHHc
Confidence 9999999999999987 46655
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=314.75 Aligned_cols=249 Identities=21% Similarity=0.352 Sum_probs=202.8
Q ss_pred eeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|+..+.||+|+||+||++... ++.||+|.+......... ....+.+|+.+++.++|+||+.+.+.+.+ +..+++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRK--GESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhh--HHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 567788999999999999874 689999998764332221 12346789999999999999999988854 4788999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccc
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~ 216 (378)
||+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-HIRISDLGLAVKIPEGESI 158 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEEecCCcceecCCCCcc
Confidence 999999999988764455799999999999999999999999999999999999999665 5999999998654433333
Q ss_pred ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHH--HHHHhcCCCCCCCCChH
Q 017046 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY--AAAFKHARPGLPEDISP 294 (378)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 294 (378)
....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+........ ..........++..++.
T Consensus 159 ~~~~g~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd05632 159 RGRVGTVGYMAPEVLNN--------QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSE 230 (285)
T ss_pred cCCCCCcCccChHHhcC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCH
Confidence 45578999999999854 568889999999999999999999998765432221 12223334456677899
Q ss_pred HHHHHHHHccccCCCCCCC-----HHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPS-----FSQIIR 319 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps-----~~~ll~ 319 (378)
++.+|+..||..||.+||+ +.+++.
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 231 EAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 9999999999999999999 778877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=322.80 Aligned_cols=244 Identities=27% Similarity=0.412 Sum_probs=197.2
Q ss_pred ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-CCeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PLMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e~~ 139 (378)
+.||+|+||+||+++. .++.||+|++......... ....+.+|+.++.++ +||||+.+++++.+ ...++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDE--DIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 3699999999999986 4688999999865433222 123577899999888 69999999998865 4788999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc-ccccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 218 (378)
+|++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... .......
T Consensus 79 ~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 79 NGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCCCceec
Confidence 99999988865 35799999999999999999999999999999999999999665 49999999987422 2223345
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCCCCCCCh
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS-----NLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ................+|..++
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 227 (327)
T cd05617 156 FCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLS 227 (327)
T ss_pred ccCCcccCCHHHHCC--------CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCC
Confidence 679999999999864 678899999999999999999999996321 1122222333344556788899
Q ss_pred HHHHHHHHHccccCCCCCCC------HHHHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPS------FSQIIRM 320 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps------~~~ll~~ 320 (378)
..+.+++.+||..||.+|++ +.+++++
T Consensus 228 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 228 VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 99999999999999999997 4677763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=316.05 Aligned_cols=249 Identities=29% Similarity=0.409 Sum_probs=194.4
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc---cCCCeeeEEeeEec----
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACKD---- 129 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~---- 129 (378)
.|.+.+.||+|+||+||+|++ +++.||+|.++......... ..+.+|+.+++.+ +||||+++++++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP---LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCc---hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 378889999999999999987 46889999987543222111 1244666666655 79999999998753
Q ss_pred --CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 130 --~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
...+++|||+. ++|.+++.......+++..+..++.|++.||.|||+.|++||||||+|||++.++ .+||+|||++
T Consensus 78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~dfg~~ 155 (288)
T cd07863 78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLA 155 (288)
T ss_pred CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccCcc
Confidence 24789999996 5899988765555699999999999999999999999999999999999999665 5999999998
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC---
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--- 284 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--- 284 (378)
.............++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+...............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227 (288)
T ss_pred ccccCcccCCCccccccccCchHhhC--------CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence 76544433445578999999998854 5688999999999999999999999987655433322211100
Q ss_pred CC----------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 285 RP----------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 285 ~~----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.. .+...++..+.+++.+||+.||.+|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0113467889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=310.59 Aligned_cols=256 Identities=29% Similarity=0.552 Sum_probs=210.9
Q ss_pred CCcceeecceeecccceEEEEEEECC-----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 130 (378)
....|.+.+.||+|+||.||+|.+.+ ..||||.......... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 79 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV----REKFLQEAYIMRQFDHPHIVKLIGVITEN 79 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHH----HHHHHHHHHHHHhCCCCchhceeEEEcCC
Confidence 45668889999999999999997632 3689998865543222 24688999999999999999999999888
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~ 157 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYL 157 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-CeEEccCceeeec
Confidence 889999999999999999763 34689999999999999999999999999999999999999655 5999999998754
Q ss_pred ccccc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 211 TVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 211 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
..... .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~~~~~~~~ 228 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-IGRIENGERLP 228 (270)
T ss_pred ccccceecCCCCccccccChhhhcc--------CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHcCCcCC
Confidence 33221 112234567999998754 567889999999999999996 9999987765433 33444555666
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.+..++..+.+++.+||..+|.+|||+.++++.|..+..
T Consensus 229 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 778899999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=307.86 Aligned_cols=244 Identities=32% Similarity=0.586 Sum_probs=198.3
Q ss_pred ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccC
Q 017046 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLP 140 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~ 140 (378)
+.||+|+||.||+|+. .++.||+|.+....... ....+.+|+++++.++||||+++++++.+ ...++||||+.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD----LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHH----HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 3689999999999977 57889999886543322 22468899999999999999999999865 46889999999
Q ss_pred CCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccc---c
Q 017046 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---T 217 (378)
Q Consensus 141 ~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~ 217 (378)
+++|.+++.. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++......... .
T Consensus 77 ~~~L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 77 GGDFLTFLRT-EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEEECccccCcccccccccccCC
Confidence 9999999875 234689999999999999999999999999999999999999655 5999999998753322111 1
Q ss_pred cCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHH
Q 017046 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDL 296 (378)
Q Consensus 218 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 296 (378)
....+..|+|||.+.. ..++.++||||||+++|+|++ |..||....... .............+..++..+
T Consensus 155 ~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 225 (252)
T cd05084 155 MKQIPVKWTAPEALNY--------GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-TREAIEQGVRLPCPELCPDAV 225 (252)
T ss_pred CCCCceeecCchhhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-HHHHHHcCCCCCCcccCCHHH
Confidence 1123457999998854 567889999999999999998 999997665533 333444455566777889999
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 297 AFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 297 ~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
.+++.+||..+|.+|||+.++++.|.
T Consensus 226 ~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 226 YRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=312.45 Aligned_cols=253 Identities=31% Similarity=0.566 Sum_probs=205.8
Q ss_pred CcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
.+.|.+.+.||+|+||.||+|.+. +..||+|.+........ ...|.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD----ESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 456889999999999999999874 36789998765443322 2358899999999999999999998754
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC--CceeE
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKL 201 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~--~~vkl 201 (378)
...++||||++|++|.+++..... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ ..+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 477899999999999999976432 2589999999999999999999999999999999999998543 35899
Q ss_pred eccccccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHH
Q 017046 202 ADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 277 (378)
Q Consensus 202 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 277 (378)
+|||++........ ......+..|+|||++.. ..++.++|||||||++|+|++ |..||.+... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-~~~~ 231 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD--------GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVM 231 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhc--------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHH
Confidence 99999875422111 112233567999999854 568899999999999999997 9999987654 3344
Q ss_pred HHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 278 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
...........+..++..+.+++.+||..+|.+|||+.+++++|.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 455555566777889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=316.61 Aligned_cols=264 Identities=30% Similarity=0.569 Sum_probs=212.9
Q ss_pred cccccCCcceeecceeecccceEEEEEEEC---------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCe
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNL 120 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i 120 (378)
..+.....+|.+.+.||+|+||.||+++.. ...||+|.++....... ...+..|+.+++.+ +||||
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~E~~~l~~l~~h~~i 80 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD----LADLISEMELMKLIGKHKNI 80 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHH----HHHHHHHHHHHHhccCCCCe
Confidence 344556678999999999999999998752 35799999876443322 23578999999999 69999
Q ss_pred eeEEeeEecC-CeEEEEeccCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecC
Q 017046 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDL 185 (378)
Q Consensus 121 v~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~di 185 (378)
+++++++.+. ..+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++|+||
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dl 160 (314)
T cd05099 81 INLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDL 160 (314)
T ss_pred eeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence 9999988654 6889999999999999997632 134888999999999999999999999999999
Q ss_pred CCCcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh
Q 017046 186 KPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262 (378)
Q Consensus 186 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~ 262 (378)
||+|||++.++ .+||+|||+++...... ......++..|+|||.+.. ..++.++||||||+++|+|++
T Consensus 161 kp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~~ 231 (314)
T cd05099 161 AARNVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGILMWEIFT 231 (314)
T ss_pred cceeEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHcc--------CCcCccchhhHHHHHHHHHHh
Confidence 99999999665 59999999997543211 1122234567999998854 568889999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 263 -NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 263 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
|..||.+... ...............+..++.++.+++.+||..+|.+|||+.++++.|..+....
T Consensus 232 ~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 232 LGGSPYPGIPV-EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred CCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 8999987654 3444444455555667788999999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=329.05 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=197.0
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
+|.+.+.||+|+||.||+++. +++.||||++........ .....+..|+.++..++||||+++++.+.++ ..++|
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK--EQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhh--hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 578899999999999999987 468999999975322111 1234678899999999999999999998754 78999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++ .++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEeeccCCcccccccc
Confidence 999999999999875 35689999999999999999999999999999999999999665 59999999986321110
Q ss_pred -----------------------------------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHH
Q 017046 215 -----------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259 (378)
Q Consensus 215 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ 259 (378)
.....+||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilye 228 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--------TGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--------CCCCCcceeccccceeee
Confidence 0123479999999999864 668899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCCCC--CChHHHHHHHHHccccCCCCCCC---HHHHHH
Q 017046 260 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRPS---FSQIIR 319 (378)
Q Consensus 260 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps---~~~ll~ 319 (378)
|++|..||.+..................+|. .+++++.++|.+|+. ||.+|++ +.++++
T Consensus 229 l~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 229 MLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred cccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 9999999987665443322222122233443 378999999999774 9999984 778877
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=308.84 Aligned_cols=249 Identities=33% Similarity=0.597 Sum_probs=204.1
Q ss_pred CCcceeecceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
+..+|.+.+.||+|+||.||++.+.+ ..+|+|++....... ..+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE------DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF 75 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH------HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE
Confidence 45678899999999999999998754 579999986543322 247789999999999999999998864 4788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||++|++|.+++... ...+++..++.++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 76 IVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDD 153 (256)
T ss_pred EEEecCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-cEEECCcccceecccc
Confidence 999999999999998763 34789999999999999999999999999999999999999655 5999999998754322
Q ss_pred ccc--ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 214 EMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 214 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
... ....++..|+|||.+.. ..++.++||||||+++|+|++ |..||......+ .............+.
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~ 224 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDY--------SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVESVSAGYRLYRPK 224 (256)
T ss_pred cccccCCCCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-HHHHHHcCCcCCCCC
Confidence 111 11223457999998854 567889999999999999999 899998765533 344444455566677
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
.++.++.+++.+||..+|.+|||+.++++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 8999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=307.71 Aligned_cols=245 Identities=29% Similarity=0.520 Sum_probs=202.7
Q ss_pred ceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCeEEEEec
Q 017046 64 SKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTEL 138 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~lv~e~ 138 (378)
++||+|+||.||+|.+. +..||+|.+....... ....+.+|+.+++.+.||||+++++++.....++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA----GKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchH----HHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEe
Confidence 46999999999999763 2679999987655431 23468899999999999999999999887788999999
Q ss_pred cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccc--
Q 017046 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-- 216 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~-- 216 (378)
+++++|.+++... ..+++..+..++.|++.||.|||..|++|+||||+|||++.++ .+||+|||++.........
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEeccccccceeecCCcccc
Confidence 9999999999763 3689999999999999999999999999999999999999665 5999999998754322211
Q ss_pred --ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 217 --TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 217 --~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
....++..|+|||.+.. ..++.++||||||+++|+|++ |..||...... ..............+..++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 224 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--------GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLESGERLPRPEECP 224 (257)
T ss_pred cccCccccccccCHHHhcC--------CCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHHcCCcCCCCCCCC
Confidence 11223467999998854 568889999999999999998 99999876653 3444444555556777899
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
..+.+++.+||..+|.+||++.++++.|...
T Consensus 225 ~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 225 QEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 9999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=308.48 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=205.5
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||.|+||.||++.. +++.||+|.++....... .+.+.+|+.+++.++||||+++++.+.+ ...+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA----VEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHH----HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 477889999999999999976 478999999875443222 2357789999999999999999998865 478999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEEEcccCcceeeccccc
Confidence 9999999999998765556789999999999999999999999999999999999998655 59999999987543322
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
......+++.|+|||++.. ..++.++|+||||+++|+|++|..||...+... ............++..++.
T Consensus 156 ~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 226 (255)
T cd08219 156 YACTYVGTPYYVPPEIWEN--------MPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-LILKVCQGSYKPLPSHYSY 226 (255)
T ss_pred ccccccCCccccCHHHHcc--------CCcCchhhhhhhchhheehhhccCCCCCCCHHH-HHHHHhcCCCCCCCcccCH
Confidence 2234568889999998854 567889999999999999999999998755433 3333444555567778999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+.+++.+||..||.+|||+.+++.
T Consensus 227 ~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 227 ELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred HHHHHHHHHHhCCcccCCCHHHHhh
Confidence 9999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=315.27 Aligned_cols=261 Identities=30% Similarity=0.577 Sum_probs=211.7
Q ss_pred cccCCcceeecceeecccceEEEEEEEC---------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeee
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVK 122 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~ 122 (378)
+.+...+|.+.+.||+|+||.||+++.. +..||+|.+........ ...+.+|+.+++.+ +||||++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD----LSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHH----HHHHHHHHHHHHhhccCCCchh
Confidence 3456778999999999999999999741 24799998875433222 23588999999999 8999999
Q ss_pred EEeeEec-CCeEEEEeccCCCCHHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCC
Q 017046 123 FLGACKD-PLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 187 (378)
Q Consensus 123 l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp 187 (378)
+++.+.+ ...+++|||+.+++|.+++..... ..+++..+..++.|++.||.|||++|++||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 9998865 478899999999999999976322 3478888999999999999999999999999999
Q ss_pred CcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-C
Q 017046 188 DNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 263 (378)
Q Consensus 188 ~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g 263 (378)
+||+++.++ .+||+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |
T Consensus 166 ~Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g 236 (304)
T cd05101 166 RNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEIFTLG 236 (304)
T ss_pred ceEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhcc--------CCCCchhhHHHHHHHHHHHHcCC
Confidence 999998554 59999999987543221 1223345678999998854 567889999999999999998 8
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 264 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 264 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
..||.+... ...............+..++.++.+++.+||..+|.+|||+.++++.|..++..
T Consensus 237 ~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 237 GSPYPGIPV-EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CCCcccCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 899987654 444444445555566778999999999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=321.30 Aligned_cols=241 Identities=29% Similarity=0.466 Sum_probs=194.1
Q ss_pred ceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-CeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~~lv~e~~ 139 (378)
+.||+|+||+||+|++. ++.||||+++......... ...+..|..++..+ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD--VECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcch--HHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 36999999999999874 5789999997643211111 12356777777764 899999999998654 788999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-ccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~ 218 (378)
+||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...... .....
T Consensus 79 ~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 79 NGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCCCceee
Confidence 99999999875 35689999999999999999999999999999999999999665 5999999998643221 22234
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 298 (378)
..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+... ..... ....+.+|..++.++.+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-~~~~i-~~~~~~~~~~~~~~~~~ 225 (316)
T cd05619 156 FCGTPDYIAPEILLG--------QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-LFQSI-RMDNPCYPRWLTREAKD 225 (316)
T ss_pred ecCCccccCHHHHcC--------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HhCCCCCCccCCHHHHH
Confidence 578999999999854 568899999999999999999999998766433 23222 33445667779999999
Q ss_pred HHHHccccCCCCCCCHH-HHHH
Q 017046 299 IVQSCWVEDPNLRPSFS-QIIR 319 (378)
Q Consensus 299 li~~~l~~dp~~Rps~~-~ll~ 319 (378)
++.+||..||.+||++. ++++
T Consensus 226 li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 226 ILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHhccCHhhcCCChHHHHc
Confidence 99999999999999996 6655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=309.02 Aligned_cols=254 Identities=31% Similarity=0.522 Sum_probs=206.3
Q ss_pred CCcceeecceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 129 (378)
+..+|.+.+.||+|+||.||+|+.. +..+|+|.++....... ...+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ----RRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHH----HHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4567899999999999999999762 24799999876443322 2458899999999999999999998854
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
...++||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+|||++.++ .++|+|||++..
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l~dfg~~~~ 155 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRV 155 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEeCCCCcccc
Confidence 4788999999999999999763 35689999999999999999999999999999999999998655 599999999875
Q ss_pred cccccc----cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 210 ETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 210 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
...... .....++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+....+ .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-~~~~~~~~~ 226 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-VIKAIEEGY 226 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhcc--------CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-HHHHHhCCC
Confidence 432211 112233568999998854 568889999999999999886 999998765433 333334444
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
....+..+++.+.+++.+||+.+|.+||++.++++.|..+
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 5555667899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=312.46 Aligned_cols=258 Identities=29% Similarity=0.554 Sum_probs=207.9
Q ss_pred ccCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEee
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 126 (378)
.+..++|.+.+.||+|+||.||+|... +..||+|.+........ ...+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~ 77 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE----RIEFLNEASVMKGFTCHHVVRLLGV 77 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHH----HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 456778999999999999999998653 34799998865433222 2357899999999999999999998
Q ss_pred Eec-CCeEEEEeccCCCCHHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC
Q 017046 127 CKD-PLMVIVTELLPGMSLRKYLVSLRP--------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 197 (378)
Q Consensus 127 ~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~ 197 (378)
+.+ ...++||||+++|+|.+++..... ..++...+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~- 156 (288)
T cd05061 78 VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF- 156 (288)
T ss_pred EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC-
Confidence 864 478999999999999999975321 2356778899999999999999999999999999999999655
Q ss_pred ceeEeccccccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChH
Q 017046 198 SLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273 (378)
Q Consensus 198 ~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 273 (378)
.++|+|||+++....... .....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+...
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~- 227 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN- 227 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhcc--------CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 599999999874322211 122245678999998754 567889999999999999998 7899987654
Q ss_pred HHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 274 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
............+..+..+++.+.+++.+||+.||.+|||+.++++.|...+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 228 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 3344444455556667788999999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=324.33 Aligned_cols=248 Identities=29% Similarity=0.374 Sum_probs=196.6
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC---
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 130 (378)
-.++|.+.+.||+|+||.||++.. .++.||||++......... ..++.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH---AKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHH---HHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 346799999999999999999976 4689999998765433222 23577899999999999999999987432
Q ss_pred ----CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 131 ----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 131 ----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCcc
Confidence 46899999965 67776643 588999999999999999999999999999999999999665 599999999
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc---
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH--- 283 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--- 283 (378)
+.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..............
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 986554444455678999999999864 568889999999999999999999998765433221111000
Q ss_pred -----------------CC--------------------CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 284 -----------------AR--------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 284 -----------------~~--------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.. ...+...+.++.+||.+||..||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 00112245678999999999999999999999994
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=314.07 Aligned_cols=244 Identities=24% Similarity=0.377 Sum_probs=194.8
Q ss_pred eecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccCCC
Q 017046 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGM 142 (378)
Q Consensus 66 lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 142 (378)
||+|+||+||++.+ +++.||+|++......... ....+..|+.+++.++||||+++.+++.+ ...++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRK--GYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhH--HHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 69999999999976 4689999998764332221 12357789999999999999999998865 4688999999999
Q ss_pred CHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-ccccC
Q 017046 143 SLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAE 219 (378)
Q Consensus 143 sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~ 219 (378)
+|.+++... ....+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++....... .....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcccccc
Confidence 999887542 234689999999999999999999999999999999999998654 59999999986533222 22345
Q ss_pred cCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHH--HHHHHhcCCCCCCCCChHHHH
Q 017046 220 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA--YAAAFKHARPGLPEDISPDLA 297 (378)
Q Consensus 220 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~ 297 (378)
.|++.|+|||.+.+ ..++.++|||||||++|+|++|..||......... ...........++..+++++.
T Consensus 158 ~g~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (280)
T cd05608 158 AGTPGFMAPELLQG--------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASK 229 (280)
T ss_pred CCCcCccCHHHhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHH
Confidence 78999999999864 56788999999999999999999999764432111 111122234456677999999
Q ss_pred HHHHHccccCCCCCC-----CHHHHHHH
Q 017046 298 FIVQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 298 ~li~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
+++.+||+.||.+|| ++++++++
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 999999999999999 78888883
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=306.20 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=207.6
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||+|+||.||++.. +++.|++|.+......... ...+.+|+.+++.++||||+++++.+.+ +..++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE---REEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHH---HHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence 367788999999999999987 4689999998754333222 2468899999999999999999998864 478999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccc
Confidence 9999999999999875556799999999999999999999999999999999999999665 49999999987543222
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
......+++.|+|||++.. ..++.++|+||||+++|+|++|..||..... ............+.++..++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08529 157 FANTIVGTPYYLSPELCED--------KPYNEKSDVWALGVVLYECCTGKHPFDANNQ-GALILKIIRGVFPPVSQMYSQ 227 (256)
T ss_pred hhhccccCccccCHHHhcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCCccccCH
Confidence 2234468889999998864 5678899999999999999999999987664 333444455556667778899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
++.+++.+||+.+|++||++.+++++
T Consensus 228 ~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 228 QLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHHHccCCcccCcCHHHHhhC
Confidence 99999999999999999999999873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=322.22 Aligned_cols=238 Identities=27% Similarity=0.401 Sum_probs=190.0
Q ss_pred ceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHH-HHHhhccCCCeeeEEeeEec-CCeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREV-NMMSRVKHDNLVKFLGACKD-PLMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~ 139 (378)
+.||+|+||+||++++. ++.||+|++.......... ...+..|. .+++.++||||+++++++.+ +..++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE--EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhH--HHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 36999999999999874 5789999987533221111 12344444 45677899999999998864 4789999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc-ccccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 218 (378)
++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.... .......
T Consensus 79 ~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 79 NGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCCCCccc
Confidence 99999999875 35688999999999999999999999999999999999999665 59999999987432 2222345
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 298 (378)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .+.... .....++..++.++.+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~-~~~~~~~~~~~~~~~~ 225 (325)
T cd05602 156 FCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNIL-NKPLQLKPNITNSARH 225 (325)
T ss_pred ccCCccccCHHHHcC--------CCCCCccccccccHHHHHHhcCCCCCCCCCHHH-HHHHHH-hCCcCCCCCCCHHHHH
Confidence 579999999999864 568889999999999999999999998765533 233322 2344566789999999
Q ss_pred HHHHccccCCCCCCCHHH
Q 017046 299 IVQSCWVEDPNLRPSFSQ 316 (378)
Q Consensus 299 li~~~l~~dp~~Rps~~~ 316 (378)
++.+||+.||.+||++.+
T Consensus 226 li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 226 LLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHcccCHHHCCCCCC
Confidence 999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=317.09 Aligned_cols=263 Identities=31% Similarity=0.571 Sum_probs=212.4
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC---------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCee
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLV 121 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv 121 (378)
.+.+...+|.+++.||+|+||.||++++. +..||+|.+........ ...+.+|+.+++++ +||||+
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~~h~~iv 81 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD----LSDLVSEMEMMKMIGKHKNII 81 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHH----HHHHHHHHHHHHhhcCCCCee
Confidence 45566678999999999999999999752 23689998875433222 23588999999999 799999
Q ss_pred eEEeeEec-CCeEEEEeccCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCC
Q 017046 122 KFLGACKD-PLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 186 (378)
Q Consensus 122 ~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dik 186 (378)
++++.+.+ ...+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++|||||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlk 161 (334)
T cd05100 82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA 161 (334)
T ss_pred eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 99999864 46889999999999999997532 1347888999999999999999999999999999
Q ss_pred CCcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-
Q 017046 187 PDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 262 (378)
Q Consensus 187 p~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~- 262 (378)
|+|||++.++ .+||+|||+++...... ......++..|+|||++.. ..++.++||||||+++|+|++
T Consensus 162 p~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 162 ARNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred cceEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhcc--------CCcCchhhhHHHHHHHHHHHhc
Confidence 9999999655 59999999987543221 1122334567999998854 567889999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 263 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 263 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
|..||.+... ...............+..++.++.+++.+||..+|.+|||+.++++.|..+....
T Consensus 233 g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 233 GGSPYPGIPV-EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred CCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 8899987654 4444444455556677788999999999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=306.60 Aligned_cols=253 Identities=33% Similarity=0.550 Sum_probs=209.7
Q ss_pred cCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
+..+.|.+.+.||+|+||.||+|... +..||||.+....... ..+.+|+.+++.++||||+++++.+.+ ...
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP------EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCH------HHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 45678999999999999999999865 4679999987644332 347899999999999999999999865 578
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
+++|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~ 155 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLIED 155 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEEECccccceeccc
Confidence 9999999999999999875556799999999999999999999999999999999999999665 599999999875432
Q ss_pred ccc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 213 TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 213 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
... ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.... ..............+
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~ 226 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANY--------GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVERGYRMPRP 226 (261)
T ss_pred hhhhhhhccCCCccccCHHHhcc--------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCC
Confidence 111 112234568999998854 567889999999999999998 99999876653 334444445555667
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
...+.++.+++.+||..+|.+||++.++++.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 7789999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=318.26 Aligned_cols=237 Identities=27% Similarity=0.376 Sum_probs=190.6
Q ss_pred ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHH-HHhhccCCCeeeEEeeEec-CCeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLVKFLGACKD-PLMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~ 139 (378)
+.||+|+||.||++++ .++.||+|++......... ....+..|.. +++.++||||+++++.+.+ +..++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKK--EQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhh--HHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 3699999999999987 4688999998754322211 1233555554 5788899999999998865 4788999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc-ccccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 218 (378)
+|++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.... .......
T Consensus 79 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 79 NGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCCCcccc
Confidence 99999988865 35689999999999999999999999999999999999999665 59999999987532 2222344
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 298 (378)
..|++.|+|||.+.. ..++.++|||||||++|+|++|..||.+.+.. ...... ......+|...+.++.+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i-~~~~~~~~~~~~~~~~~ 225 (321)
T cd05603 156 FCGTPEYLAPEVLRK--------EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-QMYDNI-LHKPLQLPGGKTVAACD 225 (321)
T ss_pred ccCCcccCCHHHhcC--------CCCCCcCcccccchhhhhhhcCCCCCCCCCHH-HHHHHH-hcCCCCCCCCCCHHHHH
Confidence 578999999999854 56888999999999999999999999876543 333333 33456677788999999
Q ss_pred HHHHccccCCCCCCCHH
Q 017046 299 IVQSCWVEDPNLRPSFS 315 (378)
Q Consensus 299 li~~~l~~dp~~Rps~~ 315 (378)
++.+||+.||.+||++.
T Consensus 226 li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 226 LLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHccCCHhhcCCCC
Confidence 99999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=306.01 Aligned_cols=253 Identities=34% Similarity=0.543 Sum_probs=208.0
Q ss_pred cCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV 133 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 133 (378)
+..+.|.+.+.||+|+||.||++... +..+|+|.+...... ...+.+|+.+++.++|+||+++++.+.+...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS------VEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhH------HHHHHHHHHHHHhcCCCCcceEEEEEcCCCeE
Confidence 45678999999999999999999864 467999988653221 23588999999999999999999998778889
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcceeeccCC
Confidence 999999999999999875556688999999999999999999999999999999999998654 5999999998653322
Q ss_pred cc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 214 EM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 214 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
.. .....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+... .............+.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~ 226 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRMPRPE 226 (260)
T ss_pred CcccccCCcccccccCHhHhcc--------CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHhCCCCCCCcc
Confidence 11 122245567999998854 567889999999999999998 999998765533 233333444455567
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
..+.++.+++.+||..+|.+||++.++++.|+.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=310.02 Aligned_cols=250 Identities=30% Similarity=0.506 Sum_probs=198.4
Q ss_pred ceeecceeecccceEEEEEEE------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--- 129 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--- 129 (378)
.|.+.+.||+|+||+||++.. .+..||+|++........ ...+.+|+++++.++||||+++++++.+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQN----TSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHH----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 347889999999999988653 357899999876533221 2457899999999999999999998753
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
...+++|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+|||++.++ .++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~ 156 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKA 156 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeecccccc
Confidence 257899999999999999875 4599999999999999999999999999999999999999654 599999999875
Q ss_pred cccccc----cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH-----------
Q 017046 210 ETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ----------- 274 (378)
Q Consensus 210 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------- 274 (378)
...... .....++..|+|||.+.. ..++.++||||||+++|+|++|..||.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKE--------NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM 228 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcc--------cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccccc
Confidence 432211 122345667999998754 567889999999999999999999986433210
Q ss_pred ---HHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 275 ---AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 275 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
..............+..++.++.+++..||+.+|.+|||+.++++.|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred chhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111122233345667889999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=311.07 Aligned_cols=252 Identities=30% Similarity=0.538 Sum_probs=204.3
Q ss_pred CCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+.++|.+.++||+|+||.||++.. .+..+|+|.+...... ....+.+|+++++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES-----ARQDFQREAELLTVLQHQHIVRFYGVCT 77 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHH-----HHHHHHHHHHHHhcCCCCCCceEEEEEe
Confidence 456788889999999999999864 2457899987643321 1235889999999999999999999886
Q ss_pred cC-CeEEEEeccCCCCHHHHHhhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC
Q 017046 129 DP-LMVIVTELLPGMSLRKYLVSLRP-------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194 (378)
Q Consensus 129 ~~-~~~lv~e~~~~~sL~~~l~~~~~-------------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~ 194 (378)
+. ..+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+.|++|+||||+|||++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 54 67899999999999999876432 34789999999999999999999999999999999999996
Q ss_pred CCCceeEeccccccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCC
Q 017046 195 DQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270 (378)
Q Consensus 195 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 270 (378)
++ .++|+|||++........ .....+++.|+|||.+.. ..++.++|||||||++|+|++ |..||...
T Consensus 158 ~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 158 GL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred CC-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc--------CCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 54 599999999864432211 122235678999998854 567889999999999999998 99999776
Q ss_pred ChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 271 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
..... ............+..+++.+.+++.+||..||.+||++.++++.|.
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 229 SNTEA-IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CHHHH-HHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 65433 3334445555667789999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.51 Aligned_cols=250 Identities=28% Similarity=0.411 Sum_probs=209.4
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv 135 (378)
+|.+.+.||+|+||.||++.. .++.+|+|.+......... ...+.+|+.+++.++||||+++++.+. ++..++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE---RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHH---HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence 477889999999999999876 5688999998765433222 246889999999999999999999875 4578899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++..++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999999998755566899999999999999999999999999999999999986666689999999986554444
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHH
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (378)
.....++..|+|||.+.. ..++.++||||||+++|+|++|..||.+.+... ............++..++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd08220 158 AYTVVGTPCYISPELCEG--------KPYNQKSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMSGTFAPISDRYSPD 228 (256)
T ss_pred ccccccCCcccCchhccC--------CCCCcccchHHHHHHHHHHHhCCCCcccCchHH-HHHHHHhcCCCCCCCCcCHH
Confidence 445578889999998854 557889999999999999999999998765433 33334444555677789999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 017046 296 LAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 296 l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
+.+++.+||..+|.+|||+.+++++
T Consensus 229 l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 229 LRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHHccCChhhCCCHHHHhhC
Confidence 9999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.53 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=204.4
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
.+|.+.+.||+|+||.||+|+. +++.||||.+......... ....+.+|+.+++.++||||+++++.+.+ +..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK--ARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHH--HHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 4688999999999999999986 5789999988653332222 23458899999999999999999998864 47889
Q ss_pred EEeccCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
+|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~~ 158 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccceeccc
Confidence 999999999999886432 34589999999999999999999999999999999999999665 499999999875432
Q ss_pred cc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCC-C
Q 017046 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGL-P 289 (378)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~-~ 289 (378)
.. ......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||..... .............+.. +
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT 230 (267)
T ss_pred hhHHHhcCCCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCCh
Confidence 22 1234468889999998854 5578899999999999999999999965432 2222233222233333 3
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
..++..+.+++.+||..+|.+||++.++++.++.+
T Consensus 231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 45778999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=319.80 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=198.6
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
++|.+.+.||+|+||+||+++.. ++.||+|++.+...... .....+.+|+.++..++||||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKR--AETACFREERDVLVNGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhh--hhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence 36889999999999999999874 68999999875322111 1224578899999999999999999988654 7899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||++|++|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 79 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 79 VMDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADG 156 (331)
T ss_pred EEecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEEEECCceeecCCCC
Confidence 9999999999999975 245789999999999999999999999999999999999998665 59999999986543222
Q ss_pred c--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC---
Q 017046 215 M--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--- 289 (378)
Q Consensus 215 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 289 (378)
. .....||+.|+|||++.... .....++.++|||||||++|+|++|+.||.+....+.............++
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CccccceeccccccCHHHHhhcc---ccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCcc
Confidence 1 22346899999999985311 012457889999999999999999999998765544333322222222222
Q ss_pred CCChHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPN--LRPSFSQIIRM 320 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~--~Rps~~~ll~~ 320 (378)
..++.++.+++.+||..++. .|+++.+++++
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 34789999999998865443 37899999984
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=308.67 Aligned_cols=258 Identities=25% Similarity=0.455 Sum_probs=210.1
Q ss_pred cCCcceeecceeecccceEEEEEEEC------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
++.+.|.+.+.||+|+||.||+|.+. +..|++|.+........ ...+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ----VTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 45678999999999999999999864 47899998875433222 245789999999999999999999875
Q ss_pred c--CCeEEEEeccCCCCHHHHHhhhCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCcee
Q 017046 129 D--PLMVIVTELLPGMSLRKYLVSLRP------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200 (378)
Q Consensus 129 ~--~~~~lv~e~~~~~sL~~~l~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vk 200 (378)
+ ...+++++|+.+++|.+++..... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .+|
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~k 157 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-QVK 157 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-cEE
Confidence 4 468899999999999999876432 4589999999999999999999999999999999999998654 599
Q ss_pred Eeccccccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHH
Q 017046 201 LADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276 (378)
Q Consensus 201 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 276 (378)
|+|||+++....... .....++..|+|||.+.. ..++.++|||||||++|++++ |..||..... ...
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~ 228 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN--------KEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEM 228 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc--------CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HHH
Confidence 999999875322211 122345678999998854 567889999999999999999 9999987654 334
Q ss_pred HHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 277 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.........+..+..+++++.+++.+||..+|++|||+.++++.|..+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 229 AAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 44444444555566789999999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=318.77 Aligned_cols=245 Identities=24% Similarity=0.392 Sum_probs=197.1
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec-CCeEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~~~lv 135 (378)
|...+.||+|+||+||+++. +++.||+|++......... ....+..|..++..+. |++|+++++++.+ +..++|
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD--DVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 56778999999999999987 4689999999764322211 1234678888888885 5778888888865 478899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-c
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-~ 214 (378)
|||++||+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++ .++|+|||++...... .
T Consensus 80 ~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 80 MEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCCc
Confidence 999999999999875 35699999999999999999999999999999999999999665 5999999998753222 2
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+...... .... ......+|..++.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-~~~i-~~~~~~~p~~~~~ 226 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-FQSI-MEHNVSYPKSLSK 226 (323)
T ss_pred cccCccCCccccCHHHHcC--------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHH-HhCCCCCCccCCH
Confidence 2234568999999999864 5688999999999999999999999987665333 3322 2344567788999
Q ss_pred HHHHHHHHccccCCCCCCCH-----HHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPSF-----SQIIR 319 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~-----~~ll~ 319 (378)
++.+++.+||..+|.+|++. .++++
T Consensus 227 ~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05615 227 EAVSICKGLMTKHPSKRLGCGPEGERDIRE 256 (323)
T ss_pred HHHHHHHHHcccCHhhCCCCCCCCHHHHhc
Confidence 99999999999999999973 55655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=305.68 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=212.3
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~ 132 (378)
.-++|..++.||+|.||+|-+++. +++.||||+++++......+. +.-+.|-++|+..+||.+..+...|+ ...+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEV--AHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEV--AHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHh--hhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 345678889999999999999876 579999999998776654443 34678999999999999999887776 4589
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc-c
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE-T 211 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~-~ 211 (378)
|+||||+.||.|.-.+.. ...+++..++.+..+|+.||.|||+++||.||||.+|+|+|.+|+ +||+|||+++.. .
T Consensus 244 CFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH-IKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH-IKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc-eEeeecccchhccc
Confidence 999999999999877764 567999999999999999999999999999999999999998876 999999999864 4
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (378)
.+..+.+.||||.|.|||++.. ..|+.++|+|.+|++||||++|+.||..... +.++.. +......+|..
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleD--------nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~kLFeL-Il~ed~kFPr~ 390 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLED--------NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EKLFEL-ILMEDLKFPRT 390 (516)
T ss_pred ccceeccccCChhhcCchhhcc--------ccccceeehhhhhHHHHHHHhccCcccccch-hHHHHH-HHhhhccCCcc
Confidence 4556678899999999999965 7899999999999999999999999986554 333333 33456678999
Q ss_pred ChHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 017046 292 ISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 319 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~ 319 (378)
++++++.|+..+|.+||.+|. .+.++.+
T Consensus 391 ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 999999999999999999995 4666665
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.58 Aligned_cols=250 Identities=29% Similarity=0.474 Sum_probs=204.5
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---CCe
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLM 132 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~~ 132 (378)
-+|.+.+.||+|+||.||++.. .+..||+|++...............+.+|+.+++.++||||+++++.+.+ ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3678889999999999999976 46899999987654333222233468899999999999999999998754 357
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCCcccccc
Confidence 899999999999999875 34589999999999999999999999999999999999999655 599999999864322
Q ss_pred c----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 213 T----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 213 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
. .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||..................+.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--------EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQL 230 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--------CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCC
Confidence 1 11123457889999998854 56788999999999999999999999877665555554444556677
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+..+++.+.+++ .||..+|.+||+++++++
T Consensus 231 ~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 231 PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 778889999999 677789999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=307.27 Aligned_cols=253 Identities=29% Similarity=0.510 Sum_probs=204.0
Q ss_pred CcceeecceeecccceEEEEEEEC--C---eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-C
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--D---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-P 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 130 (378)
...|.+.+.||+|+||.||+|... + ..||||++........ ...|..|+.+++.++||||+++++++.+ .
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ----RRDFLSEASIMGQFDHPNIIHLEGVVTKSR 78 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHH----HHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence 456889999999999999999864 2 3699999876433222 2468899999999999999999999865 4
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||+++++|.+++.. ..+.+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~~ 156 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFL 156 (269)
T ss_pred ceEEEEecCCCCcHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-cEEECCCcccccc
Confidence 67899999999999999876 345689999999999999999999999999999999999998554 5999999988643
Q ss_pred cccccc----cc--CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 017046 211 TVTEMM----TA--ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 211 ~~~~~~----~~--~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 283 (378)
...... .. ...+..|+|||.+.. ..++.++|||||||++|+|++ |..||....... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-~~~~i~~~ 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VINAIEQD 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--------CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-HHHHHHcC
Confidence 221111 11 112457999998854 567889999999999999886 999998765433 33333344
Q ss_pred CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
.....+..++..+.+++..||..+|.+||++.+++..|+.+
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 45555677899999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=310.02 Aligned_cols=254 Identities=28% Similarity=0.489 Sum_probs=201.4
Q ss_pred CcceeecceeecccceEEEEEEE------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 129 (378)
.+.|++.+.||+|+||.||+++. .+..||+|.++....... ...+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHH----HHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 45678899999999999999874 357899999875433222 2458899999999999999999998864
Q ss_pred --CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 130 --~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
...++||||++|++|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~ 156 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLT 156 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCccc
Confidence 3578999999999999998653 34689999999999999999999999999999999999998655 5999999998
Q ss_pred ccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC------------
Q 017046 208 REETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS------------ 271 (378)
Q Consensus 208 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------------ 271 (378)
....... ......++..|+|||.+.. ..++.++||||||+++|+|+++..|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQ--------SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG 228 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhcc--------CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccc
Confidence 7543221 1123456778999998754 567889999999999999999876643211
Q ss_pred --hHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 272 --NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 272 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
.................+..++..+.+|+.+||+.+|.+|||+.++++.|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 229 QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111122222334445667899999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=317.87 Aligned_cols=256 Identities=22% Similarity=0.342 Sum_probs=200.2
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
++|.+.+.||+|+||+||+++.. ++.||+|++.+...... .....+..|+.++..++|+||+++++.+.+. ..++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR--AETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHh--hHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 36888999999999999999874 57899999865322111 1223477899999999999999999988654 7889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||+++|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 79 v~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 79 VMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEeecchheecccCC
Confidence 99999999999999763 35689999999999999999999999999999999999999655 59999999986432221
Q ss_pred --ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC---
Q 017046 215 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--- 289 (378)
Q Consensus 215 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 289 (378)
......||+.|+|||++.... .....++.++|||||||++|+|++|+.||.+.+................+|
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAME---DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233 (332)
T ss_pred cceecccccCccccCHHHHhccc---cCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcc
Confidence 122357999999999985311 012457889999999999999999999998776544433333222222333
Q ss_pred CCChHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNL--RPSFSQIIRM 320 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 320 (378)
..+++++.+|+.+||..++.+ |+++.+++++
T Consensus 234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 457999999999999665444 6899999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=307.26 Aligned_cols=251 Identities=29% Similarity=0.481 Sum_probs=203.2
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---CCe
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLM 132 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~~ 132 (378)
.+|.+.+.||+|+||.||.+.. ++..||||.+...............+.+|+.+++.++||||+++++++.+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5688999999999999999986 46889999886543322222223468899999999999999999998864 257
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCcccccccc
Confidence 7999999999999998752 4588999999999999999999999999999999999999655 599999999874321
Q ss_pred c----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 213 T----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 213 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
. .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||..................+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVL 230 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--------CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCC
Confidence 1 11223468889999998854 45788999999999999999999999876655554444434445566
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
|..++..+.+++.+||. +|.+||++++++++
T Consensus 231 ~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 231 PPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 77788899999999995 99999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=322.26 Aligned_cols=255 Identities=28% Similarity=0.407 Sum_probs=199.6
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 129 (378)
++.|.+.+.||+|+||.||++.. +++.||||++........ ....+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLI---HARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhH---HHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 56799999999999999999976 467899999875432221 12357789999999999999999987742
Q ss_pred --CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 130 --~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
...+++|+++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~ 165 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLA 165 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-CEEEcCCccc
Confidence 2468999988 8899888753 5699999999999999999999999999999999999999665 5999999998
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc----
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH---- 283 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---- 283 (378)
...... .....||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+..............
T Consensus 166 ~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 166 RQADDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred eecCCC--cCCccccccccCchHhcC-------CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 764332 234578999999998853 2457889999999999999999999998755433222111000
Q ss_pred -----------------CCCCCC--------CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 284 -----------------ARPGLP--------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 284 -----------------~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
..+..+ ...++.+.+|+.+||..||.+|||+.++++ +.++.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~--hp~~~~~~~ 306 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA--HPYFSQYHD 306 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CcchhccCC
Confidence 001111 235677899999999999999999999998 566655443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.41 Aligned_cols=246 Identities=31% Similarity=0.547 Sum_probs=203.0
Q ss_pred ceeecccceEEEEEEECC-----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCeEEEEec
Q 017046 64 SKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTEL 138 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~lv~e~ 138 (378)
+.||+|+||.||+|.+.. ..||||.+...... .....+.+|+.++++++||||+++++.+.+...+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEe
Confidence 368999999999997632 36999999876554 223568899999999999999999999877788999999
Q ss_pred cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc----
Q 017046 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---- 214 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~---- 214 (378)
+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEecccccccccccccccee
Confidence 9999999999874435689999999999999999999999999999999999999665 59999999987543321
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
......++..|+|||.+.. ..++.++|||||||++|+|++ |..||...+..+..............+..++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRT--------RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACP 227 (257)
T ss_pred cccCCCCCceecCHHHhcc--------cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCC
Confidence 1123456788999998754 567889999999999999998 9999987666544333333444455666788
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
..+.+++.+||..+|.+|||+.++++.|.
T Consensus 228 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 228 QDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=324.92 Aligned_cols=247 Identities=32% Similarity=0.462 Sum_probs=195.3
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC------C
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP------L 131 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~ 131 (378)
|.+.+.||+|+||.||++.. .++.||||++........ ...++.+|+.+++.++||||+++++++.+. .
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV---SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH---HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 67789999999999999986 578999999865432221 124688999999999999999999988643 5
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.++ .+||+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence 789999995 688888764 45799999999999999999999999999999999999999655 59999999987543
Q ss_pred cc--cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH--------
Q 017046 212 VT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF-------- 281 (378)
Q Consensus 212 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-------- 281 (378)
.. .......+++.|+|||.+.+ ...++.++|||||||++|+|++|+.||.+.+..........
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMG-------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcC-------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 22 12233467889999998864 23578899999999999999999999987654332221110
Q ss_pred --------------h-cCC-C------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 282 --------------K-HAR-P------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 282 --------------~-~~~-~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
. ... + .+....++++.+||.+||..||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 000 0 1234467899999999999999999999999983
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=298.04 Aligned_cols=256 Identities=22% Similarity=0.366 Sum_probs=207.6
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCc---hHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-C
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTS---DERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-L 131 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~ 131 (378)
.|.-.+.||.|..++|-+..+ ++..+|+|++...... .....+.+.-.+|+.+|+++ .||+|+.+.++++.+ +
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 455667899999999987754 5788899987653322 22233345567899999998 699999999999755 7
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++|+|.++.|.|.|++.+ .-.+++.....+++|+++|++|||.++||||||||+|||++ ++.+++|+|||+++...
T Consensus 98 ~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld-dn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD-DNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec-cccceEEeccceeeccC
Confidence 7899999999999999987 45799999999999999999999999999999999999999 45569999999999988
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHH---HhcCCCCC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA---FKHARPGL 288 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---~~~~~~~~ 288 (378)
.++.....||||+|.|||.+.+.-. .+...|+...|+|++|+|||.|+.|.+||.......-+..+. .....+++
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~--e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMY--ENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecc--cCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 8888888999999999999876322 224568889999999999999999999997543322111111 11222222
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.+++.+.++||.+||+.||.+|.|++|+|++
T Consensus 253 -adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 253 -ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 4688999999999999999999999999994
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=330.31 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=191.0
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc------CCCeeeEEeeE
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK------HDNLVKFLGAC 127 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~l~~~~ 127 (378)
...+|.+.+.||+|+||+||+|.+ .++.||||+++...... ..+..|+++++.++ |++++.+++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~------~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYT------RDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhH------HHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 346799999999999999999976 46889999996532211 12445666666554 45688888888
Q ss_pred ec--CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCC-------
Q 017046 128 KD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQK------- 197 (378)
Q Consensus 128 ~~--~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~------- 197 (378)
.. .+.++||+++ |++|.+++.. .+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccc
Confidence 64 3688999998 7899998875 3579999999999999999999998 59999999999999985542
Q ss_pred --------ceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCC
Q 017046 198 --------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (378)
Q Consensus 198 --------~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 269 (378)
.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~--------~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLG--------LGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhc--------CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 489999998764322 2345689999999999865 6788999999999999999999999987
Q ss_pred CChHHHHHHHHHhcC-------------------------CCCCC---------------CCChHHHHHHHHHccccCCC
Q 017046 270 MSNLQAAYAAAFKHA-------------------------RPGLP---------------EDISPDLAFIVQSCWVEDPN 309 (378)
Q Consensus 270 ~~~~~~~~~~~~~~~-------------------------~~~~~---------------~~~~~~l~~li~~~l~~dp~ 309 (378)
....+.......... .+... ...++.+.+||.+||..||.
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 665433221111000 00000 01135577999999999999
Q ss_pred CCCCHHHHHHHHHhhhhcc
Q 017046 310 LRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 310 ~Rps~~~ll~~l~~~~~~~ 328 (378)
+|||+.|+++ +.++...
T Consensus 428 ~R~ta~e~L~--Hp~~~~~ 444 (467)
T PTZ00284 428 KRLNARQMTT--HPYVLKY 444 (467)
T ss_pred hCCCHHHHhc--Ccccccc
Confidence 9999999999 4555443
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=306.76 Aligned_cols=247 Identities=33% Similarity=0.575 Sum_probs=197.8
Q ss_pred eeecccceEEEEEEECC----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-CCeEEEEec
Q 017046 65 KIGEGAHGKVYEGRYGD----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PLMVIVTEL 138 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e~ 138 (378)
.||+|+||.||+|+..+ ..+++|.++....... ...+.+|+.++.++ +||||+++++++.. ...+++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD----HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHH----HHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 58999999999998743 3578888875333222 23578999999999 79999999999864 478899999
Q ss_pred cCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecc
Q 017046 139 LPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 139 ~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Df 204 (378)
+++++|.+++.... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .+||+||
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~kl~df 156 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADF 156 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eEEECCC
Confidence 99999999987532 12478999999999999999999999999999999999999654 5999999
Q ss_pred ccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 017046 205 GLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 205 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 283 (378)
|++..............+..|+|||++.. ..++.++||||||+++|+|++ |..||.+... ..........
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~ 227 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG 227 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHcc--------CCCCchhhHHHHHHHHHHHHcCCCCCccccCH-HHHHHHHhCC
Confidence 99864322211122234567999998754 567889999999999999997 9999977554 3334444444
Q ss_pred CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
.....+..++.++.+++.+||..+|.+|||+.+++..|..++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 455566778899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=305.94 Aligned_cols=248 Identities=29% Similarity=0.551 Sum_probs=204.5
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchH----HHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDE----RALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
|.+.+.||+|+||.||+|.. .++.||+|.+........ .....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 66788999999999999976 468899998876544322 22233568899999999999999999998864 478
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-CEEecccCCCccccc
Confidence 899999999999999976 35689999999999999999999999999999999999998655 599999999875432
Q ss_pred cc-------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017046 213 TE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 213 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
.. ......|+..|+|||.+.. ..++.++|+|||||++|+|++|..||.+........ .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~ 229 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ--------TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENAS 229 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc--------CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH-HHhccCC
Confidence 11 1122357889999998854 567889999999999999999999998766544333 3334556
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+.++..++..+.+++.+||+.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 6778889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=308.51 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=202.9
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-----
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD----- 129 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~----- 129 (378)
..|.+.+.||+|+||.||+|+. .++.||+|++....... ..+..|+.++..+ +||||+++++.+.+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~------~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE------EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccH------HHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 4577889999999999999987 46899999987543322 2477899999998 79999999998853
Q ss_pred --CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 130 --~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
...+++|||+.+++|.+++.......+++..+..++.|++.||+|||++||+|+||||+||+++.++ .++|+|||++
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~ 158 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVS 158 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCc
Confidence 3578999999999999999875556799999999999999999999999999999999999999665 5999999998
Q ss_pred cccccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017046 208 REETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 208 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
...... .......|++.|+|||++.... .....++.++|||||||++|+|++|..||...................
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 235 (272)
T ss_pred eecccccccCCcccccccccCHhHhcccc---CcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC
Confidence 754322 2233457889999999885311 012467889999999999999999999998766544443333223333
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
..+..++.++.+|+.+||..+|.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 344568899999999999999999999999987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=305.42 Aligned_cols=250 Identities=31% Similarity=0.526 Sum_probs=204.2
Q ss_pred ceeecceeecccceEEEEEEE-CCeeEEEEEeecCCCch-HHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
+|++.+.||+|+||+||+|.. +++.+|+|.+....... ........+.+|+.+++.++|+||+++++++.+. ..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367889999999999999976 56889999987544322 1222234688999999999999999999998654 78899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc---
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV--- 212 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~--- 212 (378)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-eEEeccchhhHhhhhccc
Confidence 999999999999975 34689999999999999999999999999999999999999655 599999999864321
Q ss_pred ----ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh-cCCCC
Q 017046 213 ----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPG 287 (378)
Q Consensus 213 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~ 287 (378)
........++..|+|||.+.. ..++.++|+||||+++|+|++|..||............... ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINE--------SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229 (265)
T ss_pred cccccccccccCCCccccChhhhcC--------CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC
Confidence 112233468889999999864 55788999999999999999999999876654443333222 34456
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
++..++.++.+++.+||..+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 77789999999999999999999999999987
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=306.72 Aligned_cols=258 Identities=29% Similarity=0.517 Sum_probs=211.8
Q ss_pred cCCcceeecceeecccceEEEEEEEC--C----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--D----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
++...|.+.+.||+|+||.||+|... + ..||+|.+....... ....+.+|+.++..++||||+++++++.
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK----ANKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHH----HHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 34567899999999999999999763 2 368999887655422 2245889999999999999999999998
Q ss_pred cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
....+++|||+++++|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++.
T Consensus 80 ~~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~dfg~~~ 157 (279)
T cd05057 80 SSQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLAK 157 (279)
T ss_pred cCceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCCcccc
Confidence 88899999999999999998763 34689999999999999999999999999999999999998655 59999999987
Q ss_pred cccccccc---ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 209 EETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 209 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
........ ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~ 228 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILH--------RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VEIPDLLEKGE 228 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhc--------CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHHhCCC
Confidence 54322211 11223568999998753 567889999999999999998 9999987654 33444444555
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
....+..++.++.+++.+||..+|..||++.++++.|..+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 5666777889999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=304.08 Aligned_cols=245 Identities=36% Similarity=0.640 Sum_probs=206.3
Q ss_pred ceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEe
Q 017046 64 SKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTE 137 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e 137 (378)
+.||+|+||.||++... +..|++|++....... ....+.+|+.+++.++|+||+++++++.+ ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 36899999999999875 6789999997655443 23468899999999999999999998865 47889999
Q ss_pred ccCCCCHHHHHhhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 138 LLPGMSLRKYLVSLR-------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 138 ~~~~~sL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
|+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~ 155 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDV 155 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-cEEEccccccccc
Confidence 999999999998632 36799999999999999999999999999999999999999665 5999999999765
Q ss_pred ccc---cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017046 211 TVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 211 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
... .......++..|+|||.+.. ..++.++||||||+++|+|++ |..||..... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~ 226 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKD--------GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRKGYRL 226 (262)
T ss_pred ccccccccccCCCcCccccCHHHhcc--------CCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCC
Confidence 433 22234467889999998754 467889999999999999999 6999988754 3444455556667
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
..+..++.++.+++.+||..+|.+|||+.+++++|+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 778889999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=322.83 Aligned_cols=259 Identities=32% Similarity=0.554 Sum_probs=226.7
Q ss_pred cccccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+.|.++..+.....+||-|.||.||.|.|+ .-.||||.++.+.-. .+.|+.|+.+|+.++|||+|+++|+|.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe------veEFLkEAAvMKeikHpNLVqLLGVCT 333 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME------VEEFLKEAAVMKEIKHPNLVQLLGVCT 333 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh------HHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence 467788888889999999999999999986 478999999765433 246999999999999999999999996
Q ss_pred -cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 129 -DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 129 -~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
+..+|||+|||..|+|.+||.......++.-..+.++.||..|+.||..+++|||||..+|+||. +++.||++|||++
T Consensus 334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg-EnhiVKvADFGLs 412 (1157)
T KOG4278|consen 334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHIVKVADFGLS 412 (1157)
T ss_pred cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc-ccceEEeeccchh
Confidence 56899999999999999999987667788888899999999999999999999999999999999 4566999999999
Q ss_pred cccccccccccC---cCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 017046 208 REETVTEMMTAE---TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 208 ~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 283 (378)
+.+..... +.. .-...|.|||.+.. ..++.++|||+||++|||+.| |-.||.+.+. ...|....++
T Consensus 413 RlMtgDTY-TAHAGAKFPIKWTAPEsLAy--------NtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-SqVY~LLEkg 482 (1157)
T KOG4278|consen 413 RLMTGDTY-TAHAGAKFPIKWTAPESLAY--------NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYGLLEKG 482 (1157)
T ss_pred hhhcCCce-ecccCccCcccccCcccccc--------cccccchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHhcc
Confidence 87654322 222 23568999999876 678999999999999999998 8999998654 5667788889
Q ss_pred CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.+..-|+.|++.+..|++.||+++|.+||++.++-+.++.++.
T Consensus 483 yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 483 YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 9999999999999999999999999999999999999988873
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=309.64 Aligned_cols=253 Identities=29% Similarity=0.512 Sum_probs=201.8
Q ss_pred CcceeecceeecccceEEEEEEECC------------------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCC
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYGD------------------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 118 (378)
.++|.+.+.||+|+||.||++...+ ..||+|.+........ ...+.+|+++++.++||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~----~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA----REDFLKEVKILSRLSDP 79 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHH----HHHHHHHHHHHHhcCCC
Confidence 4578899999999999999987532 4689999876544322 24688999999999999
Q ss_pred CeeeEEeeEec-CCeEEEEeccCCCCHHHHHhhhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 017046 119 NLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR---------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 188 (378)
Q Consensus 119 ~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~---------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~ 188 (378)
||+++++++.+ +..+++|||+.+++|.+++.... ...+++..++.++.|++.||+|||+.|++|+||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999998865 57899999999999999987633 126899999999999999999999999999999999
Q ss_pred cEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh--C
Q 017046 189 NLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--N 263 (378)
Q Consensus 189 Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~--g 263 (378)
||+++.++ .++|+|||++....... ......+++.|+|||.+.. ..++.++|||||||++|+|++ |
T Consensus 160 Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~~~~~ 230 (296)
T cd05051 160 NCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--------GKFTTKSDVWAFGVTLWEILTLCR 230 (296)
T ss_pred ceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--------CCCCccchhhhhHHHHHHHHhcCC
Confidence 99999664 59999999987532221 2223456778999998754 568899999999999999998 7
Q ss_pred CCCCCCCChHHHHHHHHHh------cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 264 RLPFEGMSNLQAAYAAAFK------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 264 ~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
..||............... ......+..++.++.+++.+||+.||.+|||+.++++.|.
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 231 EQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 7888766543332222111 1112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=302.85 Aligned_cols=249 Identities=29% Similarity=0.445 Sum_probs=205.0
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe--cCCeEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK--DPLMVI 134 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~~~l 134 (378)
.|++.+.||+|+||.||++.. .++.||+|.+......... ...+.+|+.+++.++|||++++++.+. +...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRE---RKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHH---HHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence 378899999999999999976 4678999998754433222 235788999999999999999998875 335789
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
+|||+++++|.+++.......+++.++..++.|++.||++||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQC 156 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEecccceEEecccC
Confidence 99999999999999875556799999999999999999999999999999999999999655 5999999998654322
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
.......+++.|+|||.+.. ..++.++||||||+++|+|++|..||...+... ..........+..+..++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 227 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSN--------KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-LVYRIIEGKLPPMPKDYS 227 (257)
T ss_pred CccccccCCcCccChhHhcC--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCCCCCccccC
Confidence 22234468899999998854 567889999999999999999999998655433 333344445556677899
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
+++.+++.+||+.+|.+|||+.+++++
T Consensus 228 ~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 228 PELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=319.46 Aligned_cols=237 Identities=28% Similarity=0.393 Sum_probs=190.1
Q ss_pred ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHH-HHhhccCCCeeeEEeeEec-CCeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLVKFLGACKD-PLMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~ 139 (378)
+.||+|+||+||+++. +++.||+|++.......... ...+..|.. +++.++||||+++++.+.+ +..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE--QKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH--HHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 3689999999999986 46899999997543222111 223555554 4677899999999998864 5789999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc-ccccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 218 (378)
.|++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.... .......
T Consensus 79 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 79 NGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCCCCccc
Confidence 99999988865 45799999999999999999999999999999999999999665 59999999987432 2223345
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 298 (378)
.+|++.|+|||++.. ..++.++|||||||++|+|++|..||.+.+... ...... .....++...+..+.+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~ 225 (325)
T cd05604 156 FCGTPEYLAPEVIRK--------QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-MYDNIL-HKPLVLRPGASLTAWS 225 (325)
T ss_pred ccCChhhCCHHHHcC--------CCCCCcCccccccceehhhhcCCCCCCCCCHHH-HHHHHH-cCCccCCCCCCHHHHH
Confidence 579999999999864 567889999999999999999999998765433 333333 2344556678999999
Q ss_pred HHHHccccCCCCCCCHH
Q 017046 299 IVQSCWVEDPNLRPSFS 315 (378)
Q Consensus 299 li~~~l~~dp~~Rps~~ 315 (378)
++.+||..+|.+||++.
T Consensus 226 ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 226 ILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHhccCHHhcCCCC
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=316.34 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=199.4
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
++|.+.+.||+|+||+||+++.. ++.||+|++........ .....+.+|+.++..++|+||+++++++.+ +..++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKR--AETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 36889999999999999999874 57899999875322111 122357789999999999999999999865 47889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||++||+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 79 v~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 79 VMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCC
Confidence 99999999999999763 35789999999999999999999999999999999999999665 59999999987543322
Q ss_pred c--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC---
Q 017046 215 M--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--- 289 (378)
Q Consensus 215 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 289 (378)
. .....|++.|+|||++..... ....++.++|||||||++|+|++|+.||.+..................+|
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMED---GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred ceeeccccCCcccCCHHHHhcccc---CCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcc
Confidence 1 123479999999998854210 11357889999999999999999999998766544333333222233333
Q ss_pred CCChHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNL--RPSFSQIIRM 320 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 320 (378)
..++.++.+++.+||..++.+ |+++.+++++
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 346899999999999866544 4688888874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=312.17 Aligned_cols=252 Identities=31% Similarity=0.443 Sum_probs=205.0
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
..+|.+.+.||+|+||.||+|+. .++.||+|.+........ ..+.+|+.+++.+.||||+++++.+.+ ...+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~-----~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-----ELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchH-----HHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 35789999999999999999986 468999999876554332 347899999999999999999998854 5789
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||+++++|.+++.. ..+++.++..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPE 169 (296)
T ss_pred EeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccchhcccc
Confidence 99999999999999864 4588999999999999999999999999999999999998655 5999999998753322
Q ss_pred c-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCCCCC
Q 017046 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLPED 291 (378)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~ 291 (378)
. ......+++.|+|||.+.. ..++.++|||||||++|+|++|..||................. ....+..
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (296)
T ss_pred ccccCcccCCccccCHHHHcC--------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence 1 1233478899999998854 5578899999999999999999999987665444333222111 2234566
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
++..+.+++.+||..+|.+|||+.++++ ..++..
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~--~~~~~~ 275 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKI 275 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhh--Chhhhc
Confidence 8899999999999999999999999998 444444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=340.73 Aligned_cols=259 Identities=26% Similarity=0.407 Sum_probs=203.6
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
.+|.+.++||+|+||.||+|.+ +++.||+|++........ ....++.+|+++++.++||||+++++++.+ +..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e--~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP--LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCH--HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 4689999999999999999987 468999999876443222 234578999999999999999999999865 47889
Q ss_pred EEeccCCCCHHHHHhhhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 135 VTELLPGMSLRKYLVSLR---------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~---------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
+|||++|++|.+++.... ...++...++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-~vKLiDFG 158 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDWG 158 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-CEEEEecC
Confidence 999999999999986421 12356677899999999999999999999999999999999665 49999999
Q ss_pred cccccccc-------------------cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCC
Q 017046 206 LAREETVT-------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 266 (378)
Q Consensus 206 ~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p 266 (378)
++...... ......+||+.|+|||.+.+ ..++.++|||||||++|+|++|..|
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--------~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--------VPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--------CCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 98754110 00112468999999998854 5678999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCCC--CCCChHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhhhcc
Q 017046 267 FEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTL 328 (378)
Q Consensus 267 f~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~~~~~~ 328 (378)
|.............. ...... ...+++.+.+++.+||..||.+|| +++++++.|..++...
T Consensus 231 F~~~~~~ki~~~~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 231 YRRKKGRKISYRDVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred CCCcchhhhhhhhhc-cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 987544322222111 111111 135788999999999999999996 6778888888876543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=326.67 Aligned_cols=257 Identities=30% Similarity=0.521 Sum_probs=222.8
Q ss_pred cccccccCCcceeecceeecccceEEEEEEECC-----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeE
Q 017046 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123 (378)
Q Consensus 49 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l 123 (378)
.+..-+|..+...+.++||+|.||.|++|.|+. -.||||+++.+.... ....|++|+.+|.+|+|||+++|
T Consensus 101 ~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~----~mddflrEas~M~~L~H~hliRL 176 (1039)
T KOG0199|consen 101 IDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA----IMDDFLREASHMLKLQHPHLIRL 176 (1039)
T ss_pred CCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch----hHHHHHHHHHHHHhccCcceeEE
Confidence 344566777888899999999999999998853 479999999877654 23579999999999999999999
Q ss_pred EeeEecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEec
Q 017046 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (378)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~D 203 (378)
||+..+....+|||.++.|+|.+.|.......|.......|+.||+.|+.||.++++|||||..+|+|+-.. ..|||+|
T Consensus 177 yGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI~D 255 (1039)
T KOG0199|consen 177 YGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKICD 255 (1039)
T ss_pred eeeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeeeec
Confidence 999998888999999999999999988666789999999999999999999999999999999999999864 4699999
Q ss_pred ccccccccccccccc----CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHH
Q 017046 204 FGLAREETVTEMMTA----ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278 (378)
Q Consensus 204 fg~a~~~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 278 (378)
||+.+.....+.... ..-...|+|||.+.. ..++.++|||++||+||||++ |..||.+....+.+.
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh--------~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~- 326 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH--------RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK- 326 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhcc--------ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH-
Confidence 999986554443322 234568999999964 789999999999999999999 899999988755444
Q ss_pred HHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 279 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+..+.+..-|..++.++.++++.||..+|.+|||+..|.+
T Consensus 327 ~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 327 NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 44478888889999999999999999999999999999975
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=307.97 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=199.5
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
..+|.+.+.||+|+||.||+|+. .++.||+|++........ ..+.+|+.+++.++||||+++++.+.+ ...+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~-----~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-----SLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchH-----HHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence 45689999999999999999986 468899999875433221 247789999999999999999998854 4788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++......
T Consensus 83 iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 83 ICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITAT 159 (267)
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccceeeccc
Confidence 99999999999998865 35689999999999999999999999999999999999998665 4999999998754322
Q ss_pred c-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC---CCC
Q 017046 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP---GLP 289 (378)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~~~ 289 (378)
. ......+++.|+|||.+... ....++.++|+|||||++|+|++|..||..................+ ..+
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVE-----KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234 (267)
T ss_pred ccccCccccCccccCHhHcccc-----cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccc
Confidence 1 12344688899999987431 12446789999999999999999999997654433222111111111 122
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
..++..+.+++.+||..+|.+|||+++++++|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 35788999999999999999999999998854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=320.84 Aligned_cols=249 Identities=27% Similarity=0.339 Sum_probs=204.4
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-C-----CCeeeEEeeEec-
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-H-----DNLVKFLGACKD- 129 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----p~iv~l~~~~~~- 129 (378)
+|.|.+.||+|+||.|.++.+ +++.||||+++....-.. +-..|+.+|..|+ | -|||+++++|..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~------Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLR------QAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHH------HHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 688999999999999999976 579999999988665443 2457899999886 3 479999999965
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC-CCCceeEecccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP-DQKSLKLADFGLAR 208 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~-~~~~vkl~Dfg~a~ 208 (378)
+++|||+|.+ ..+|+++++.++..+++...++.++.||+.||.+||+.||||+||||+||||.. +...|||+|||++.
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 5899999999 679999999988889999999999999999999999999999999999999953 33369999999998
Q ss_pred ccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--
Q 017046 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-- 286 (378)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-- 286 (378)
.....-. ..+.+..|+|||++.+ .+|+.+.||||||||++||++|.+.|.|.+..+.+..+......|
T Consensus 340 ~~~q~vy--tYiQSRfYRAPEVILG--------lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 340 FESQRVY--TYIQSRFYRAPEVILG--------LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred ccCCcce--eeeeccccccchhhcc--------CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 7554433 6678889999999987 789999999999999999999999999988766554432111110
Q ss_pred ------------------------------------------------CCCC-----------CChHHHHHHHHHccccC
Q 017046 287 ------------------------------------------------GLPE-----------DISPDLAFIVQSCWVED 307 (378)
Q Consensus 287 ------------------------------------------------~~~~-----------~~~~~l~~li~~~l~~d 307 (378)
..|. .-...+.+++++||.+|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 0110 01134789999999999
Q ss_pred CCCCCCHHHHHHHHHhhhh
Q 017046 308 PNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 308 p~~Rps~~~ll~~l~~~~~ 326 (378)
|..|+|+.+.++ +.++.
T Consensus 490 P~~R~tp~qal~--Hpfl~ 506 (586)
T KOG0667|consen 490 PAERITPAQALN--HPFLT 506 (586)
T ss_pred chhcCCHHHHhc--Ccccc
Confidence 999999999999 44543
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=303.46 Aligned_cols=250 Identities=26% Similarity=0.498 Sum_probs=206.5
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|...+.||+|+||.||+|.. .++.|++|.+...............+.+|+.+++.++||||+++++.+.+ ...+++|
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 56678899999999999987 46899999987654332222223468899999999999999999998865 4788999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccc
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~ 216 (378)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++.........
T Consensus 82 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 82 ELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccceeccccccc
Confidence 99999999999975 34588999999999999999999999999999999999999665 5999999998764443333
Q ss_pred ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHH
Q 017046 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDL 296 (378)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 296 (378)
....++..|+|||.+.. ...++.++|+||||+++|+|++|..||..................+.++..+++++
T Consensus 159 ~~~~~~~~y~~pe~~~~-------~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQ-------QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA 231 (258)
T ss_pred cccCCCcceeCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHH
Confidence 45578899999998754 12378899999999999999999999987665444444433345566777899999
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 017046 297 AFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 297 ~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+++.+||..+|.+||++.+++.
T Consensus 232 ~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 232 KDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHHhhcCcccCcCHHHHhc
Confidence 99999999999999999999987
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=308.67 Aligned_cols=261 Identities=29% Similarity=0.467 Sum_probs=205.7
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCC
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPL 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~ 131 (378)
...+.|+++++||+|+||.||+|+.. +..|++|++....... ...+.+|+.+++.++||||+++++.+. +..
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYMVEIEILATCNHPYIVKLLGAFYWDGK 83 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHH-----HHHHHHHHHHHHhCCCCcEeeeEEEEEeCCe
Confidence 34567999999999999999999874 6889999987543221 235788999999999999999999875 457
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||+++++|..++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~ 161 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNV 161 (292)
T ss_pred EEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-CEEEccCccceecc
Confidence 89999999999998887653 35689999999999999999999999999999999999998554 59999999886432
Q ss_pred cc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--CC
Q 017046 212 VT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GL 288 (378)
Q Consensus 212 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~ 288 (378)
.. .......+++.|+|||.+..... ....++.++|||||||++|+|++|..||......... ........+ ..
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~ 237 (292)
T cd06644 162 KTLQRRDSFIGTPYWMAPEVVMCETM---KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-LKIAKSEPPTLSQ 237 (292)
T ss_pred ccccccceecCCccccCceeeccccc---cCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH-HHHhcCCCccCCC
Confidence 21 12234467889999998853111 1245788999999999999999999999876543322 222222222 23
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
+..++.++.+++.+||..+|.+||++.++++ +.++..+
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~ 275 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLE--HPFVSSV 275 (292)
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHhc--Ccccccc
Confidence 4568889999999999999999999999988 4554443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=301.23 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=205.3
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
.|.+.+.||.|+||.||.++. .++.+++|.+......... ..++.+|+.++++++|+||+++++++.+. ..+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE---RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhH---HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence 377889999999999988765 4688999998755433322 23578999999999999999999998654 67899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEEECcCcceEEcccccc
Confidence 9999999999999875456789999999999999999999999999999999999999655 59999999987543322
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+. ............+..++.
T Consensus 157 ~~~~~~~~~~y~ape~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08221 157 MAETVVGTPYYMSPELCQG--------VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL-VVKIVQGNYTPVVSVYSS 227 (256)
T ss_pred cccccCCCccccCHhhcCC--------CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcCCCCCCccccCH
Confidence 2334578999999998854 4577899999999999999999999987554333 333344444455567899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
++.+++.+||..+|.+||++.+++++
T Consensus 228 ~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 228 ELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhhC
Confidence 99999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=307.62 Aligned_cols=254 Identities=32% Similarity=0.472 Sum_probs=207.5
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|.+.+.||.|+||.||+|.. .++.|++|.+........ ..+.+|+.+++.++||||+++++.+.+ ...++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK-----ELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchH-----HHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 5699999999999999999975 578999999876443322 357899999999999999999998864 47889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
|+||+.+++|..++.. ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccchhccccc
Confidence 9999999999998864 4689999999999999999999999999999999999999655 59999999987533222
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCCCCCCC
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH-ARPGLPEDI 292 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~ 292 (378)
......++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.+............ .....+..+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241 (296)
T ss_pred ccCCCcCCCccccCcchhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccC
Confidence 1233468889999998854 557889999999999999999999998876644433322211 122345678
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
++.+.+++.+||..||.+|||+.+++. +.++....+
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~--~~~~~~~~~ 277 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKLAKP 277 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhh--ChHhhhccc
Confidence 899999999999999999999999998 666655444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=320.42 Aligned_cols=240 Identities=26% Similarity=0.409 Sum_probs=189.9
Q ss_pred eecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc---cCCCeeeEEeeEecC-CeEEEEecc
Q 017046 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACKDP-LMVIVTELL 139 (378)
Q Consensus 66 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~~-~~~lv~e~~ 139 (378)
||+|+||+||+|+.. ++.||+|++.......... ...+..|..++..+ +||||+.+++.+.+. ..++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKE--VAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhH--HHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 699999999999874 6899999987533222211 12355666776655 699999999988654 789999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-cccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~ 218 (378)
++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||++..... ......
T Consensus 79 ~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 79 SGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred CCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCCCCccC
Confidence 99999998875 45799999999999999999999999999999999999999665 599999999865322 222345
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC-CCChHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLA 297 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 297 (378)
.+||+.|+|||.+.. ...++.++|||||||++|+|++|..||.+....+ .+..... ....++ ..+++++.
T Consensus 156 ~~gt~~y~aPE~~~~-------~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-~~~~i~~-~~~~~~~~~~~~~~~ 226 (330)
T cd05586 156 FCGTTEYLAPEVLLD-------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-MYRNIAF-GKVRFPKNVLSDEGR 226 (330)
T ss_pred ccCCccccCHHHHcC-------CCCCCCccceeccccEEEEeccCCCCCCCCCHHH-HHHHHHc-CCCCCCCccCCHHHH
Confidence 679999999998853 2347889999999999999999999998765433 3333322 223333 34789999
Q ss_pred HHHHHccccCCCCCC----CHHHHHH
Q 017046 298 FIVQSCWVEDPNLRP----SFSQIIR 319 (378)
Q Consensus 298 ~li~~~l~~dp~~Rp----s~~~ll~ 319 (378)
+++.+||..||.+|| ++.++++
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 999999999999998 6788877
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=308.01 Aligned_cols=253 Identities=30% Similarity=0.521 Sum_probs=204.3
Q ss_pred CCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+..+|.+.+.||+|+||.||++.. .+..||+|++........ ...+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~ei~~l~~l~h~~iv~~~~~~~ 78 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM----QADFQREAALMAEFDHPNIVKLLGVCA 78 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHH----HHHHHHHHHHHHhcCCCchheEEEEEc
Confidence 446788999999999999999976 357899999875443222 245889999999999999999999886
Q ss_pred c-CCeEEEEeccCCCCHHHHHhhhCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCC
Q 017046 129 D-PLMVIVTELLPGMSLRKYLVSLRP--------------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 187 (378)
Q Consensus 129 ~-~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp 187 (378)
+ ...+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+.|++||||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 5 478999999999999999974321 2478888999999999999999999999999999
Q ss_pred CcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-C
Q 017046 188 DNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 263 (378)
Q Consensus 188 ~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g 263 (378)
+||+++.++ .++|+|||++....... .......+..|+|||.+.. ..++.++|||||||++|+|++ |
T Consensus 159 ~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~~~ 229 (288)
T cd05050 159 RNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWEIFSYG 229 (288)
T ss_pred hheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhc--------CCCCchhHHHHHHHHHHHHHhCC
Confidence 999998665 59999999986432221 1122234667999998754 568889999999999999997 8
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 264 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 264 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
..||.+....+ .............+..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus 230 ~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 230 MQPYYGMAHEE-VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCCCCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 88998766533 33344444444566778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=299.71 Aligned_cols=243 Identities=32% Similarity=0.579 Sum_probs=198.9
Q ss_pred eeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccCCC
Q 017046 65 KIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGM 142 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 142 (378)
.||+|+||.||+|... +..||+|.+........ ...+.+|+.+++.++||||+++++.+.+ ...++||||++++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQEL----KIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHH----HHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 6899999999999764 57899999876543322 2358899999999999999999999865 4788999999999
Q ss_pred CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccc--ccCc
Q 017046 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM--TAET 220 (378)
Q Consensus 143 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~ 220 (378)
+|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......... ....
T Consensus 78 ~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 78 DFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEEECCCccceeccccccccCCCCC
Confidence 999988653 35689999999999999999999999999999999999998655 5999999998643222111 1223
Q ss_pred CccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHH
Q 017046 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 299 (378)
Q Consensus 221 gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 299 (378)
++..|+|||++.. ..++.++||||||+++|+|++ |..||.+..... .............+..++..+.++
T Consensus 156 ~~~~y~aPE~~~~--------~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l 226 (250)
T cd05085 156 IPIKWTAPEALNY--------GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-AREQVEKGYRMSCPQKCPDDVYKV 226 (250)
T ss_pred CcccccCHHHhcc--------CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHH
Confidence 4567999998854 567889999999999999998 999998765533 333444555566677899999999
Q ss_pred HHHccccCCCCCCCHHHHHHHHH
Q 017046 300 VQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 300 i~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
+.+||..+|.+||++.++++.|.
T Consensus 227 i~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 227 MQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHcccCcccCCCHHHHHHHhc
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=302.13 Aligned_cols=248 Identities=30% Similarity=0.525 Sum_probs=197.5
Q ss_pred ceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe--cCCeEEEE
Q 017046 64 SKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVT 136 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~~~lv~ 136 (378)
+.||+|+||.||+|... ...||+|.+........ ...+.+|+.+++.++||||+++++.+. +...+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE----VEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHH----HHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 36899999999999752 25799998764332222 235789999999999999999999764 44678999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc--
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-- 214 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-- 214 (378)
||+.+++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+|||++.++ .+||+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 77 PYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYY 154 (262)
T ss_pred ecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCccccccccCCcce
Confidence 999999999998753 34567888899999999999999999999999999999999655 59999999986432211
Q ss_pred ---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 215 ---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 215 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
......++..|+|||.+.. ..++.++|||||||++|+|++ |.+||..... ............+..+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 225 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-FDITVYLLQGRRLLQPE 225 (262)
T ss_pred eecccccCcCCccccChhHhcc--------CccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHhcCCCCCCCC
Confidence 1112345678999998754 567889999999999999999 5667776544 33444445555566667
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.++..+.+++..||..+|.+||++.++++.|..++.
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 788999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=300.95 Aligned_cols=249 Identities=32% Similarity=0.583 Sum_probs=203.3
Q ss_pred CCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
++..|.+.+.||.|+||.||++.+. +..+|+|.+....... ..+.+|+++++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE------EDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC 75 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH------HHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence 4567888999999999999999875 6789999987544432 247899999999999999999999864 4788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
++|||+++++|.+++.. ....+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 76 LVFEFMEHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEEEcCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-eEEECCCcceeecccC
Confidence 99999999999999875 234689999999999999999999999999999999999998554 5999999998653322
Q ss_pred cc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 214 EM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 214 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
.. .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||..... ...............+.
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~ 224 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSF--------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETINAGFRLYKPR 224 (256)
T ss_pred cccccCCCccchhhcCHhHhcc--------CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHhCCCCCCCCC
Confidence 11 112234568999998854 567889999999999999998 9999986554 33333434444545566
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
..+..+.+|+.+||..+|.+|||+.++++.|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 6889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=302.79 Aligned_cols=254 Identities=29% Similarity=0.507 Sum_probs=204.9
Q ss_pred CCcceeecceeecccceEEEEEEEC--C---eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--D---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 129 (378)
....|...+.||+|+||.||+|+.. + ..+|+|.+........ ...+..|+++++.++||||+++.+++.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ----RQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHH----HHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 3456788899999999999999863 2 3799998876443322 2358899999999999999999999864
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
...++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~ 156 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRV 156 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-cEEECCCcccee
Confidence 478999999999999999875 335789999999999999999999999999999999999999654 599999999865
Q ss_pred cccccc----cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 210 ETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 210 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
...... ......+..|+|||.+.. ..++.++|||||||++|+|++ |..||...... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-~~~~~i~~~~ 227 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-EVMKAINDGF 227 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhc--------CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHHHhcCC
Confidence 432211 111223457999998854 567889999999999999997 99999876553 3334444444
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
....+..++.++.+++.+||..+|.+||++.++++.|..+
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 5555667899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=305.70 Aligned_cols=253 Identities=30% Similarity=0.498 Sum_probs=198.5
Q ss_pred CcceeecceeecccceEEEEEEE------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe--
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-- 128 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-- 128 (378)
...|++.+.||+|+||.||++.. .+..||+|.+....... ...+.+|+++++.++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH-----LRDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHH-----HHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 35688899999999999999874 35789999987543221 235889999999999999999999763
Q ss_pred -cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 129 -DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 129 -~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
....++||||+++++|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~ 155 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFGLT 155 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCCccc
Confidence 23678999999999999999753 34689999999999999999999999999999999999999665 5999999998
Q ss_pred cccccccc----cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH---------
Q 017046 208 REETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ--------- 274 (378)
Q Consensus 208 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------- 274 (378)
........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|..|+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ 227 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhcc--------CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccc
Confidence 75432211 112233456999998854 567889999999999999999877754322110
Q ss_pred ------HHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 275 ------AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 275 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
..............+..++.++.+|+.+||..+|.+|||+.++++.|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 01111222333445567889999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=308.22 Aligned_cols=247 Identities=33% Similarity=0.579 Sum_probs=198.5
Q ss_pred eeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv~ 136 (378)
|++++.||+|+||+||+++.. ++.||+|++.......... ....+|+.++++++||||+++++++. +...+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~---~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEER---EENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHH---HHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccccc---chhhhhhhccccccccccccccccccccccccccc
Confidence 778899999999999999985 4689999998765544332 23456999999999999999999986 45788999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc-cccccc
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEM 215 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~-~~~~~~ 215 (378)
||+.+++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||++.. ......
T Consensus 78 ~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 78 EYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG-EVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS-EEEESSGTTTEESTSTTSE
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccc
Confidence 99999999999983 35789999999999999999999999999999999999999554 599999999875 223334
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHH--HHHHHHh-cCCC--CCCC
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA--AYAAAFK-HARP--GLPE 290 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~-~~~~--~~~~ 290 (378)
.....++..|+|||++.. ...++.++||||||+++|+|++|..||........ ....... .... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQ-------GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR 227 (260)
T ss_dssp BSSSSSSGGGSCHHHHTT-------TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT
T ss_pred cccccccccccccccccc-------cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccc
Confidence 456678999999999851 26788999999999999999999999987632111 1111111 1111 1112
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
..+.++.+++..||+.||.+|||+.++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23589999999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=301.38 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=206.5
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
..|.+.+.||+|+||.||+|.. +++.||+|.++........ ...++.+|+.++++++|+||+++++.+.+ +..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~--~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK--ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchh--hHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4688899999999999999987 4789999988753332222 13468899999999999999999998864 47889
Q ss_pred EEeccCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
+|||+++++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~~ 158 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceeeeccC
Confidence 999999999999986532 34589999999999999999999999999999999999999665 599999999865332
Q ss_pred cc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCCC
Q 017046 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~ 290 (378)
.. ......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||..... .............+..+.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPA 230 (267)
T ss_pred CCcccceecCCccccCHHHhcc--------CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCCh
Confidence 21 1233468889999998754 5678899999999999999999999965432 222333333344444554
Q ss_pred -CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 291 -DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 291 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
.++.++.+++.+||..+|.+|||+.++++.|..+
T Consensus 231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 6888999999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=354.23 Aligned_cols=250 Identities=27% Similarity=0.403 Sum_probs=213.5
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv~ 136 (378)
+.-+..||.|.||.||-+.. +|+..|+|-++-.... ...-..+.+|+.++..++|||+|+++|+-. .+..+|.|
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 55677899999999999875 6788999987654333 122235779999999999999999999864 44778999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc---
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT--- 213 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~--- 213 (378)
|||+||+|.+++.. ++..++.....+..|++.|++|||++|||||||||.||+++.+| .+|++|||.|......
T Consensus 1314 EyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCchhc
Confidence 99999999999975 45677888889999999999999999999999999999999666 6999999999754322
Q ss_pred --cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 017046 214 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291 (378)
Q Consensus 214 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (378)
.......||+.|||||++.+.. ......++|||||||++.||+||+.||...++...++..+-.+..|.+|..
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~-----~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ 1465 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTK-----GKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER 1465 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccc-----cCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh
Confidence 2234568999999999998732 234466899999999999999999999999988888888889999999999
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
++++-++||.+||..||..|.++.|++++
T Consensus 1466 ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 99999999999999999999999999883
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=319.78 Aligned_cols=247 Identities=23% Similarity=0.360 Sum_probs=193.7
Q ss_pred CcceeecceeecccceEEEEEEEC----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CC
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PL 131 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 131 (378)
...|.+++.||+|+||.||++... +..||+|.+.... ...+|+.+++.++||||+++++.+.. ..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----------~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----------TPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----------cHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 456999999999999999998653 4679999886432 14589999999999999999998864 47
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.+++||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++....
T Consensus 161 ~~lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~ 236 (392)
T PHA03207 161 VCMVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLD 236 (392)
T ss_pred EEEEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccccccC
Confidence 88999999 5688888843 46799999999999999999999999999999999999999665 59999999986543
Q ss_pred cccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH---HHHHHHH-----
Q 017046 212 VTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL---QAAYAAA----- 280 (378)
Q Consensus 212 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~----- 280 (378)
.... .....||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.... .......
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~ 308 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLAL--------DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV 308 (392)
T ss_pred cccccccccccccccCccCHhHhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence 2221 224579999999999864 56889999999999999999999999764321 1111000
Q ss_pred --------------------HhcCCCCC--C-----CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 281 --------------------FKHARPGL--P-----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 281 --------------------~~~~~~~~--~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
....++.+ + ..++.++.++|.+||..||.+|||+.+++. +.++..
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~--~p~f~~ 380 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS--LPLFTK 380 (392)
T ss_pred CccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh--Cchhhc
Confidence 00001111 1 235678899999999999999999999999 455544
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=310.08 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=202.6
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
.|.+.+.||+|+||.||++... ++.||+|.+......... ....+..|+++++.++||||+++++.+.+ ...++|
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRN--KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHH--HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 5888899999999999999874 689999999875544322 23468899999999999999999998865 468899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||+.|++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-CEEEeecchhhccccccc
Confidence 9999999999999765556799999999999999999999999999999999999999665 59999999876432111
Q ss_pred -----------------------------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCC
Q 017046 215 -----------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 265 (378)
Q Consensus 215 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~ 265 (378)
......|+..|+|||.+.+ ..++.++||||||+++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--------DGHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--------CCCCchHHHHHHHHHHHHHhhCCC
Confidence 1112367889999999864 557889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCC--CChHHHHHHHHHccccCCCCCCC----HHHHHH
Q 017046 266 PFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRPS----FSQIIR 319 (378)
Q Consensus 266 pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 319 (378)
||.+............ ....++. ..+.++.+++.+||..||.+||| +.+++.
T Consensus 231 pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 231 PFKGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCchHHHHHHHhc--CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 9987765444333332 2223333 37899999999999999999999 888888
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=306.93 Aligned_cols=253 Identities=27% Similarity=0.475 Sum_probs=198.6
Q ss_pred CcceeecceeecccceEEEEEEECC----------------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCe
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYGD----------------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 120 (378)
..+|.+.+.||+|+||.||+++..+ ..||+|.+........ ...|.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA----RNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHH----HHHHHHHHHHHHhCCCCCc
Confidence 4578899999999999999986532 3589999876543322 2358899999999999999
Q ss_pred eeEEeeEec-CCeEEEEeccCCCCHHHHHhhhCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCc
Q 017046 121 VKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRP----------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189 (378)
Q Consensus 121 v~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~----------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~N 189 (378)
+++++++.. ...++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 999999854 578899999999999999864210 136888999999999999999999999999999999
Q ss_pred EEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh--CC
Q 017046 190 LLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--NR 264 (378)
Q Consensus 190 ill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~--g~ 264 (378)
|+++.++ .+||+|||++....... ......++..|+|||.+.. ..++.++|||||||++|+|++ |.
T Consensus 160 ill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~~l~el~~~~~~ 230 (295)
T cd05097 160 CLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTLWEMFTLCKE 230 (295)
T ss_pred EEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhcc--------CCcCchhhHHHHHHHHHHHHHcCCC
Confidence 9999654 59999999986532221 1122345678999998754 567899999999999999988 67
Q ss_pred CCCCCCChHHHHHHHHH------hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 265 LPFEGMSNLQAAYAAAF------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 265 ~pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
.||.............. .......+..+++.+.+|+.+||+.||.+|||+.++++.|.
T Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 231 QPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 88877654332221111 11122345568899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=326.50 Aligned_cols=251 Identities=28% Similarity=0.482 Sum_probs=210.2
Q ss_pred ceeecceeecccceEEEEEEECC--eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE-ecCCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~~~~~lv 135 (378)
.|.|+..||.|+||.||+|...+ -..|-|++....... .+.++-||.||..+.||+||.+++.| .++.++++
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEE-----LEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEE-----LEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhH-----HhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 46788999999999999997654 345666664332221 24588999999999999999999865 67789999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc-ccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTE 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~-~~~~~ 214 (378)
.|||.||....++... +..+.+.++.-+++|++.||.|||+++|||||||..|||++-+|. ++|+|||.+.. .....
T Consensus 108 iEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd-irLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD-IRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc-EeeecccccccchhHHh
Confidence 9999999998888763 578999999999999999999999999999999999999998876 99999998754 33334
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC--CCCCC
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDI 292 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~ 292 (378)
...+++|||.|||||+..+-++. ..+|++++||||||++|.+|.-+.+|-...+....+..+. +..+|. -|..+
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~K---D~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia-KSePPTLlqPS~W 261 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFK---DQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLLQPSHW 261 (1187)
T ss_pred hhccccCCcccccchheeecccc---CCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh-hcCCCcccCcchh
Confidence 55678999999999999886653 4789999999999999999999999998887766555543 333333 36779
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
+..+.+++.+||.+||..||++.+++++
T Consensus 262 s~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 262 SRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 9999999999999999999999999984
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=303.50 Aligned_cols=256 Identities=24% Similarity=0.414 Sum_probs=204.0
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
..|.+.+.||+|+||.||+++. +++.||||.+......... ....+.+|+.+++.++||||+++++.+.+ +..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK--ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHH--HHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 3577889999999999999985 5789999988754332222 23468899999999999999999998854 57889
Q ss_pred EEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 135 VTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
+|||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~ 158 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEECcchhhhcccc
Confidence 99999999999988642 234689999999999999999999999999999999999999655 599999999865432
Q ss_pred cc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCC-C
Q 017046 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAAFKHARPGL-P 289 (378)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~-~ 289 (378)
.. ......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.... ............+.. +
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS 230 (267)
T ss_pred CCcccccccCCcCccCHHHhcC--------CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCc
Confidence 22 1233468889999998854 56788999999999999999999999754432 222222222222322 3
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
..++..+.+++.+||..+|.+|||+.++++.+..+
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 45888999999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=309.05 Aligned_cols=258 Identities=29% Similarity=0.539 Sum_probs=208.4
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCe----eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDR----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+....|++.+.||+|+||.||+|.+ .++ .||+|.+........ ...+.+|+.+++.++||||+++++.+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA----NVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHH----HHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 3456788889999999999999976 333 578898865443222 235789999999999999999999998
Q ss_pred cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
....++++||+++|+|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus 80 ~~~~~~v~e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~ 157 (303)
T cd05110 80 SPTIQLVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDFGLAR 157 (303)
T ss_pred CCCceeeehhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-ceEEccccccc
Confidence 7778899999999999999876 334689999999999999999999999999999999999998555 59999999997
Q ss_pred ccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 209 EETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 209 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
....... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~ 228 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHY--------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLLEKGE 228 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhcc--------CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHCCC
Confidence 5432221 122345678999998754 568889999999999999997 9999987543 33333344444
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
....+..++.++.+++..||..+|++||++.++++.|..+...
T Consensus 229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 5555667889999999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=300.99 Aligned_cols=249 Identities=25% Similarity=0.424 Sum_probs=207.1
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---CCeE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMV 133 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~~~ 133 (378)
+|.+.+.||.|+||.||++.. .++.||+|++......... ..++..|+++++.++||||+++++.+.+ ...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE---KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHH---HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 477889999999999999976 4688999998765443322 2468899999999999999999997743 3578
Q ss_pred EEEeccCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 134 IVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLH-----ANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH-----~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
++|||+++++|.+++.... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~ 156 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGL 156 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEecccc
Confidence 9999999999999987632 357899999999999999999999 89999999999999999654 599999999
Q ss_pred ccccccccc-cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017046 207 AREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 207 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
+........ .....+++.|+|||.+.. ..++.++|+||||+++|+|++|..||.... .............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~ 227 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNH--------MSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLASKIKEGKF 227 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcC--------CCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHHHHHhcCCC
Confidence 876543332 334578999999999854 557889999999999999999999998765 3444455555556
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
+.++..++.++.+++.+||..+|.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 67788899999999999999999999999999883
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=303.13 Aligned_cols=254 Identities=27% Similarity=0.527 Sum_probs=203.1
Q ss_pred CCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
..++|.+.+.||.|+||.||+|+.. .+.|++|.+....... ....+.+|++++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 78 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDEN----LQSEFRRELDMFRKLSHKNVVRLLGLCR 78 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchH----HHHHHHHHHHHHHhcCCcceeeeEEEEC
Confidence 3467888999999999999999853 3679999886543321 2245889999999999999999999986
Q ss_pred c-CCeEEEEeccCCCCHHHHHhhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCcee
Q 017046 129 D-PLMVIVTELLPGMSLRKYLVSLRP-------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200 (378)
Q Consensus 129 ~-~~~~lv~e~~~~~sL~~~l~~~~~-------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vk 200 (378)
+ ...++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~ 157 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-EVK 157 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-cEE
Confidence 5 478999999999999999976442 1589999999999999999999999999999999999999665 499
Q ss_pred Eecccccccccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHH
Q 017046 201 LADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 277 (378)
Q Consensus 201 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 277 (378)
|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+........
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~ 229 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE--------DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN 229 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH
Confidence 99999986432211 1223356778999998754 456789999999999999998 889997765543333
Q ss_pred HHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 278 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
...........+..++..+.+++.+||..+|.+|||+.++++.|.
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 322222233445678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.57 Aligned_cols=251 Identities=29% Similarity=0.445 Sum_probs=202.5
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
.+.|.+.+.||.|+||.||++.. .++.+++|++....... ...+.+|+.+++.++||||+++++.+.+ ...+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD-----FEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhh-----HHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence 35788999999999999999986 45789999997654332 2357899999999999999999998854 4788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
++|||+.+++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 77 l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccchhhhhh
Confidence 999999999999998763 25799999999999999999999999999999999999999665 4999999998754332
Q ss_pred c-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC---CCC
Q 017046 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP---GLP 289 (378)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~~~ 289 (378)
. ......++..|+|||.+... ....++.++|+||||+++|+|++|..||.+................+ ..+
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~-----~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVE-----RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDK 229 (262)
T ss_pred hhccccccCCccccCchhhccc-----ccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccch
Confidence 2 22344688899999987541 01267889999999999999999999998766544444332221111 223
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
..++.++.+++.+||..+|..|||+.+++.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 456788999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=344.08 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=217.9
Q ss_pred ccccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
.+-+..++|.|++.||+|+||.|.+++. +++.||+|++++..-.... ....|..|-.+|..-+.+.|++++..|+|
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~--~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRA--ETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhch--hHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4557788999999999999999999987 4689999999763222111 12358889999999999999999999987
Q ss_pred C-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 ~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
+ ++|+||||++||+|-.++... ..+++..+++|+..|+.||..||+.|+|||||||+|||+|..|+ +||+|||.+-
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH-ikLADFGsCl 223 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH-IKLADFGSCL 223 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc-EeeccchhHH
Confidence 6 899999999999999999863 37999999999999999999999999999999999999997765 9999999987
Q ss_pred cccccc--ccccCcCcccccccccccccccccccc-ccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017046 209 EETVTE--MMTAETGTYRWMAPELYSTVTLRQGEK-KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 209 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
...... .....+|||.|++||++.. ++.+ +.|+...|+||+||++|||+.|..||...+-.+..-.+......
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs----~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQS----QGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHh----hcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 655333 2345689999999999976 3344 78999999999999999999999999876655554455555556
Q ss_pred CCCC--CCChHHHHHHHHHccccCCCCCCC---HHHHHHHHHhhh
Q 017046 286 PGLP--EDISPDLAFIVQSCWVEDPNLRPS---FSQIIRMLNAFL 325 (378)
Q Consensus 286 ~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~l~~~~ 325 (378)
..|| ..+|.++++||.+++. +|..|.. ++++-. +++|
T Consensus 300 l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~--HpFF 341 (1317)
T KOG0612|consen 300 LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN--HPFF 341 (1317)
T ss_pred cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh--Cccc
Confidence 6777 5699999999999876 7888887 999977 4454
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=312.96 Aligned_cols=247 Identities=21% Similarity=0.354 Sum_probs=192.1
Q ss_pred ecceeecc--cceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 62 IGSKIGEG--AHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 62 ~~~~lG~G--~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
++++||+| +|++||+++. +++.||+|.+......... ...+.+|+.+++.++||||+++++++.+ +..++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEM---VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHH---HHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 45789999 7899999876 4689999998765443322 2357789999999999999999998854 5788999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc---
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT--- 213 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~--- 213 (378)
||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++ .++++||+........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhcccccccc
Confidence 999999999999765455699999999999999999999999999999999999999665 5999999865322111
Q ss_pred -----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--
Q 017046 214 -----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-- 286 (378)
Q Consensus 214 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-- 286 (378)
.......++..|+|||++.. ....++.++|||||||++|+|++|..||.............. ...+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhc------ccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-CCcccc
Confidence 01122356778999999853 124578899999999999999999999986554332222111 1000
Q ss_pred -------------------------------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 287 -------------------------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 287 -------------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.....+++++.+|+.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 011235678999999999999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=306.22 Aligned_cols=254 Identities=27% Similarity=0.428 Sum_probs=201.9
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEe----
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK---- 128 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~---- 128 (378)
....|++.+.||.|+||.||+|+. .++.||+|++...... ...+..|+.++.++ +||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE------EEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH------HHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 446788899999999999999987 4689999998653221 13477899999998 7999999999873
Q ss_pred ---cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 129 ---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 129 ---~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
....+++|||+.+++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg 166 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFG 166 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCc
Confidence 23678999999999999999876666789999999999999999999999999999999999999665 59999999
Q ss_pred cccccccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017046 206 LAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 206 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
++...... .......|++.|+|||.+.... .....++.++|+|||||++|+|++|..||.................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~---~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 243 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCccc---CcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC
Confidence 98654321 1223456889999999875310 1135678899999999999999999999987655444333222222
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
....+..++.++.++|.+||..||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 22233468899999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=290.92 Aligned_cols=268 Identities=26% Similarity=0.467 Sum_probs=222.2
Q ss_pred cccccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeE
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGAC 127 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~ 127 (378)
+....+.+.+..+..||+|+-|.||+.+.. +...|||.+.......+. ++++..+.++...+ .|+||+.+|+|
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~----kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEEN----KRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHH----HHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 445567777888899999999999999874 689999999875554433 47889998887775 99999999999
Q ss_pred e-cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 128 K-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 128 ~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
. +...++.||.+ +..+..++.. ..+++++..+-++...++.||.||-++ ||+|||+||+|||+|..| .+||||||
T Consensus 161 i~n~dV~IcMelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFG 237 (391)
T KOG0983|consen 161 ITNTDVFICMELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFG 237 (391)
T ss_pred eeCchHHHHHHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeeccc
Confidence 5 44677889988 5567777765 346799999999999999999999875 899999999999999554 59999999
Q ss_pred cccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017046 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
++.........+...|.+.|||||.+... +...|+.++||||||++++||.||..||.+....-+....+....+
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERidp~-----~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP 312 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERIDPP-----DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP 312 (391)
T ss_pred ccceeecccccccccCCccccCccccCCC-----CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC
Confidence 99877666666677899999999999763 2467999999999999999999999999987666666677777777
Q ss_pred CCCCC--CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 286 PGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 286 ~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
|.++. .+|+++.+|+..||.+|+.+||.+.++++ +.++...++..
T Consensus 313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~--h~Fi~~ye~a~ 359 (391)
T KOG0983|consen 313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE--HPFIKRYETAE 359 (391)
T ss_pred CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc--Ccceeecchhh
Confidence 77765 48999999999999999999999999999 55555444433
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=305.67 Aligned_cols=245 Identities=27% Similarity=0.426 Sum_probs=204.3
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
.|.+.+.||+|+||.||++.+ .++.||+|++......... ....+.+|++++++++||||+++++.+.++ ..++|
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK--QVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 588899999999999999987 4689999998754332211 234688999999999999999999998654 78899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEeeCCCccccCCC--
Confidence 999999999999976 35799999999999999999999999999999999999999665 5999999998764433
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHH
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (378)
.....+++.|+|||.+.. ...+.++||||||+++|+|++|..||...... ...... ......+|..++..
T Consensus 155 ~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~-~~~~~~~~~~~~~~ 224 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS--------KGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKI-LEGKVRFPSFFSPD 224 (290)
T ss_pred CCCCCCCccccChhhhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH-hcCCccCCccCCHH
Confidence 334578899999998854 45778999999999999999999999876632 223222 24456677888999
Q ss_pred HHHHHHHccccCCCCCC-----CHHHHHHH
Q 017046 296 LAFIVQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 296 l~~li~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
+.+++.+||..||.+|+ ++.+++++
T Consensus 225 l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 225 AKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 99999999999999999 88888873
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=303.59 Aligned_cols=244 Identities=30% Similarity=0.478 Sum_probs=203.3
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||.|+||.||+|+. .++.||+|++......... ..+.+|+.+++.++||||+++++.+.+ ...++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI----EDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHH----HHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence 577889999999999999987 4689999998765432221 347799999999999999999998854 478899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-c
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-~ 214 (378)
+||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...... .
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEcccccceeeccccc
Confidence 999999999999875 3789999999999999999999999999999999999999655 5999999998765433 2
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC-Ch
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED-IS 293 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~ 293 (378)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........ .........+.++.. ++
T Consensus 154 ~~~~~~~~~~y~~PE~~~~--------~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 224 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQ--------SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-LFLIPKNNPPSLEGNKFS 224 (274)
T ss_pred ccccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-HHHhhhcCCCCCcccccC
Confidence 2334568889999999864 4588999999999999999999999987654332 333334445555555 88
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.++.+++.+||..+|++|||++++++
T Consensus 225 ~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 225 KPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 99999999999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=299.55 Aligned_cols=251 Identities=28% Similarity=0.474 Sum_probs=206.3
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC---Ce
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---LM 132 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---~~ 132 (378)
.+|.+.+.||+|+||.||+|+. ++..||+|.+...............+.+|+.+++.++||||+++++.+.+. .+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5688999999999999999986 468999998865432222222334688999999999999999999988543 47
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcccccccccc
Confidence 899999999999999875 24588999999999999999999999999999999999999655 599999999875322
Q ss_pred c----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 213 T----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 213 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
. .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..................+.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--------EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPML 230 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCC
Confidence 1 11123468889999998854 45788999999999999999999999887666655555545556778
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
|..+++.+.+++.+||. +|..||++.+++.+
T Consensus 231 p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 231 PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 88999999999999999 57999999998874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=308.50 Aligned_cols=257 Identities=32% Similarity=0.453 Sum_probs=207.3
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|.+.+.||+|+||.||++.. .++.||+|.+........ +.+.+|+.+++.++||||+++++.+.+ ...++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK-----ELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchH-----HHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 5789999999999999999986 478999999876444332 347899999999999999999998864 47889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+|||++.++ .++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQ 169 (297)
T ss_pred eecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEECcCccceEccCCc
Confidence 9999999999999864 4589999999999999999999999999999999999999655 59999999986543222
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh-cCCCCCCCCC
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDI 292 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 292 (378)
......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||.+............. ......+..+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241 (297)
T ss_pred cCcCcccCCccccCHHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcccc
Confidence 1233468889999998854 56788999999999999999999999775543332222211 1122345668
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 333 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 333 (378)
+..+.+++.+||..+|.+||++.++++ +.++....+...
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~~~~~~~ 280 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLKLAKPLSS 280 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc--Cchhcccccccc
Confidence 899999999999999999999999999 566665544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=303.28 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=199.2
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
.+.|.+.+.||+|+||.||+|+. .++.||+|+++...... ...+.+|+.+++.++||||+++++.+.+ +..+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-----FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 35788899999999999999987 46899999987543322 1246789999999999999999998854 5788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
++|||+++++|.+++.. .+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 83 ICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITAT 159 (267)
T ss_pred EEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCc
Confidence 99999999999999875 35789999999999999999999999999999999999999665 4999999998643322
Q ss_pred -cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC-C--C
Q 017046 214 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG-L--P 289 (378)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~--~ 289 (378)
.......|+..|+|||.+... ....++.++|+|||||++|+|++|..||..................+. + .
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVE-----RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK 234 (267)
T ss_pred ccccccccCcccccChhhhccc-----cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccccc
Confidence 122344789999999987421 124578899999999999999999999976554333332222221111 1 1
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
..++..+.+++.+||..+|.+|||+.+++++
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 2477889999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.95 Aligned_cols=252 Identities=28% Similarity=0.431 Sum_probs=200.7
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|++.+.||+|+||.||++... +..+++|.+....... ...+.+|+++++.++||||+++++.+.+ ...++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE-----LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHH-----HHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 34678899999999999999874 5788888885433211 2357889999999999999999998854 47889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
||||+++++|..++.. ....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 80 LIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEccccccccccccc
Confidence 9999999999988765 335789999999999999999999999999999999999998655 5999999998653221
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh-cCCCCCCCCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDI 292 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 292 (378)
.......+++.|+|||++.... .....++.++|||||||++|+|++|..||............... ......+..+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 234 (282)
T ss_pred cccccccccccccCHhhccccC---CCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCcccc
Confidence 1223456889999999875311 12355788999999999999999999999876654433333221 1122345668
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+.++.+++.+||..||.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 899999999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=305.35 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=205.5
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
.+.|.+.+.||.|+||.||++.. .+..||+|+........ ...+.+|+.+++.++||||+++++.+.+ ...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE-----LEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHH-----HHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence 35688999999999999999987 46889999987543221 2358899999999999999999998864 4788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 79 ILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKST 156 (280)
T ss_pred EEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEEccCccchhhccc
Confidence 999999999999998763 35699999999999999999999999999999999999999655 5999999987643222
Q ss_pred -cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--CCCC
Q 017046 214 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPE 290 (378)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~ 290 (378)
.......+++.|+|||.+.... .....++.++|+||||+++|+|++|..||.+........ .......+ ..+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACET---FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL-KILKSEPPTLDQPS 232 (280)
T ss_pred ccccceeecchhhcCHHHHhhcc---cCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH-HHhcCCCCCcCCcc
Confidence 1223446889999999875311 112457789999999999999999999998766544332 22333222 2355
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.++.++.+++.+||..+|.+||++.++++ +.++.
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~ 266 (280)
T cd06611 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLK--HPFVS 266 (280)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHhc--Chhhc
Confidence 78899999999999999999999999988 44443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=304.87 Aligned_cols=250 Identities=29% Similarity=0.433 Sum_probs=196.2
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||+|+||.||+|+. ++..||+|++........ ....+.+|+.+++.++||||+++++.+.+ ...++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG---VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC---chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence 477889999999999999987 468999999865432221 12347789999999999999999999864 578999
Q ss_pred EeccCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
|||+. ++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPV 155 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEECcccceeecCCCc
Confidence 99996 689888865333 5689999999999999999999999999999999999999665 59999999986533221
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC---------
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--------- 284 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------- 284 (378)
......+++.|+|||.+.+ ...++.++|||||||++|+|++|+.||.+...............
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLG-------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred ccccCCcccccccChHHhcC-------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence 1223467889999998753 23467899999999999999999999987655433322111000
Q ss_pred ----------C--------CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 285 ----------R--------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 285 ----------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
. ......+++++.++|.+||..||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 01123478899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=306.79 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=200.8
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
..+.|.+.+.||.|+||.||+|+. +++.||+|.+......... ..+.+|+.+++.++||||+++++++.+ ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAP----CTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCch----hHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence 456799999999999999999976 4688999998754433221 246789999999999999999999865 478
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~ 156 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSI 156 (301)
T ss_pred EEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEECcCcchhccCC
Confidence 89999996 5899888753 45689999999999999999999999999999999999999665 599999999875332
Q ss_pred cc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc--------
Q 017046 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH-------- 283 (378)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-------- 283 (378)
.. ......+++.|+|||.+.+ ...++.++|||||||++|+|++|.+||.+.+............
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 229 (301)
T cd07873 157 PTKTYSNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229 (301)
T ss_pred CCCcccccceeecccCcHHHhC-------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc
Confidence 22 2233467889999998753 2457789999999999999999999998765432221111000
Q ss_pred ------------CCCC--------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 284 ------------ARPG--------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 284 ------------~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
..+. ....+++++.+||.+||..||.+|||+.++++ +.++..+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~--h~~f~~~ 292 (301)
T cd07873 230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK--HPYFHCL 292 (301)
T ss_pred hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc--Ccccccc
Confidence 0000 11357888999999999999999999999998 4455443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=304.70 Aligned_cols=253 Identities=28% Similarity=0.503 Sum_probs=197.6
Q ss_pred CcceeecceeecccceEEEEEEEC------------------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCC
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG------------------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 118 (378)
.++|++.+.||+|+||.||++.+. ...||+|++........ ...+.+|+.+++.++||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~----~~~~~~E~~~l~~l~~~ 79 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNA----RNDFLKEIKIMSRLKDP 79 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHH----HHHHHHHHHHHHhCCCC
Confidence 356899999999999999998542 24689999875533222 23588999999999999
Q ss_pred CeeeEEeeEec-CCeEEEEeccCCCCHHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 017046 119 NLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRP---------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 188 (378)
Q Consensus 119 ~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~---------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~ 188 (378)
||+++++++.+ ...+++|||+.+++|.+++..... ..+++..+..++.|++.||+|||+.|++|+||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~ 159 (296)
T cd05095 80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159 (296)
T ss_pred CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 99999998864 478899999999999999876321 23677889999999999999999999999999999
Q ss_pred cEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh--C
Q 017046 189 NLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--N 263 (378)
Q Consensus 189 Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~--g 263 (378)
|||++.++ .++|+|||++....... ......++..|++||.... ..++.++|||||||++|+|++ |
T Consensus 160 Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~DiwSlG~~l~el~~~~~ 230 (296)
T cd05095 160 NCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--------GKFTTASDVWAFGVTLWEILTLCK 230 (296)
T ss_pred eEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--------CCccchhhhhHHHHHHHHHHHhCC
Confidence 99998654 59999999987532221 1122234678999997754 568899999999999999998 7
Q ss_pred CCCCCCCChHHHHHHHH--H----hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 264 RLPFEGMSNLQAAYAAA--F----KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 264 ~~pf~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
..||...+......... . .......+..+++.+.+|+.+||..||.+||++.++++.|.
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 231 EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 78997655433221110 0 11122334568899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=316.20 Aligned_cols=243 Identities=25% Similarity=0.385 Sum_probs=188.3
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CC
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PL 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 131 (378)
.....|.+.+.||+|+||.||+|+.. ++.||+|+..... ...|+.+++.++||||+++++++.+ ..
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-----------~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-----------TLIEAMLLQNVNHPSVIRMKDTLVSGAI 131 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-----------cHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence 34456999999999999999999875 4689999754321 3468999999999999999998865 46
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||+ .++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++....
T Consensus 132 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~ 208 (357)
T PHA03209 132 TCMVLPHY-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPV 208 (357)
T ss_pred eEEEEEcc-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCccccccc
Confidence 78999999 5688888865 345799999999999999999999999999999999999999665 49999999987544
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCC-CCCCCChH---------HHHHHHHH
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNL---------QAAYAAAF 281 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~-pf~~~~~~---------~~~~~~~~ 281 (378)
.........||+.|+|||++.. ..++.++|||||||++|+|+++.. +|...... ........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~ 280 (357)
T PHA03209 209 VAPAFLGLAGTVETNAPEVLAR--------DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280 (357)
T ss_pred cCcccccccccccccCCeecCC--------CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence 3333345578999999999864 568899999999999999998544 44432111 00000000
Q ss_pred --hcCCCCCC------------------------------CCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 282 --KHARPGLP------------------------------EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 282 --~~~~~~~~------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
......++ ..++.++.+||.+||+.||.+|||+.++++
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00011111 135667788999999999999999999998
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=303.16 Aligned_cols=242 Identities=27% Similarity=0.469 Sum_probs=194.4
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||+|+||.||+|++ +++.||+|++........ ...+.+|+.++++++||||+++++.+.+ ...++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVEL----QKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHH----HHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 567788999999999999986 568899999876533222 2358899999999999999999998864 477899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
|||+++++|..+ ..+++..+..++.|++.||.|||+.|++|+||||+|||++.++ .++|+|||++...... .
T Consensus 78 ~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~-~ 149 (279)
T cd06619 78 TEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNS-I 149 (279)
T ss_pred EecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCcceecccc-c
Confidence 999999998654 2478889999999999999999999999999999999999665 4999999998754322 2
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH------HHHHHHHhcCCCCCC
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ------AAYAAAFKHARPGLP 289 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~~ 289 (378)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||....... ...........+..+
T Consensus 150 ~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISG--------EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP 221 (279)
T ss_pred ccCCCCChhhcCceeecC--------CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC
Confidence 334578999999999864 567889999999999999999999996532211 111222222223332
Q ss_pred -CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 290 -EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 290 -~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
...++++.+++.+||..+|.+||++.+++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 3478899999999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=298.01 Aligned_cols=249 Identities=29% Similarity=0.426 Sum_probs=206.2
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||+|+||.||.++. .++.||+|.+......... ...+.+|+.+++.++||||+++++.+.+ ...++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE---REESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHH---HHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence 478889999999999999876 4689999998754332221 2357899999999999999999999865 478899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||+.+++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchh
Confidence 9999999999998765555689999999999999999999999999999999999998655 59999999987543322
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ...........+..+..++.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08218 157 LARTCIGTPYYLSPEICEN--------RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-NLVLKIIRGSYPPVSSHYSY 227 (256)
T ss_pred hhhhccCCccccCHHHhCC--------CCCCCccchhHHHHHHHHHHcCCCCccCCCHH-HHHHHHhcCCCCCCcccCCH
Confidence 1223457889999998854 56788999999999999999999999865543 33444455666667788999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
++.+++.+||..+|.+||++.+++++
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 228 DLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 99999999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=298.24 Aligned_cols=247 Identities=38% Similarity=0.704 Sum_probs=204.0
Q ss_pred eecceeecccceEEEEEEECC------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 61 FIGSKIGEGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 61 ~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
.+.+.||.|+||.||+++..+ ..||+|++........ ...+..|+.++..++||||+++++.+.+ ...+
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQ----IEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHH----HHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 456889999999999998754 7899999976544322 2358899999999999999999998865 5788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceecccc
Confidence 999999999999999764433399999999999999999999999999999999999999655 5999999998754433
Q ss_pred cccc--cCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 214 EMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 214 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
.... ...+++.|+|||.+.. ..++.++||||||+++|+|++ |..||..... ...............+.
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~ 227 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKD--------GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-EEVLEYLKKGYRLPKPE 227 (258)
T ss_pred cccccccCCCcccccChHHhcc--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcCCCCCCCC
Confidence 2211 1236789999998743 567889999999999999998 8899987544 44444555556667777
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
.++.++.+++.+||..+|.+|||+.++++.|
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 228 NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 8999999999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=299.36 Aligned_cols=252 Identities=29% Similarity=0.461 Sum_probs=191.3
Q ss_pred ceeecccceEEEEEEEC----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEEEec
Q 017046 64 SKIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTEL 138 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv~e~ 138 (378)
+.||+|+||.||+|... +..+|+|.++....... ...+.+|+.+++.++||||+++++.+.+. ..++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE----QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH----HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 36899999999999753 35799998876543322 23588999999999999999999988654 67899999
Q ss_pred cCCCCHHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 139 LPGMSLRKYLVSLRP---NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
+++++|.+++..... ...++..+..++.|++.||+|||+.|++|+||||+||+++.+ ..++|+|||++........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccccccCcce
Confidence 999999999975332 245677888999999999999999999999999999999965 4599999999864332211
Q ss_pred ---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHh----cCCCC
Q 017046 216 ---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK----HARPG 287 (378)
Q Consensus 216 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~----~~~~~ 287 (378)
.....++..|+|||++...... .....++.++||||||+++|+|++ |..||......+........ ...+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGN-LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eecCCCcCCcccccCHhHhcccccc-ccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 1234567889999988531100 001246789999999999999996 99999876654433222111 11223
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
+....++.+.+++..|| .+|++|||+.+|+..|.
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 33457788999999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=302.23 Aligned_cols=245 Identities=35% Similarity=0.636 Sum_probs=197.8
Q ss_pred eeecccceEEEEEEECC--------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 65 KIGEGAHGKVYEGRYGD--------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
.||+|+||.||+|+..+ ..+|+|.+........ ...+.+|+.+++.++||||+++++++.+ ...+++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE----KKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhh----HHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 58999999999997643 5799998865432222 2358899999999999999999998864 478999
Q ss_pred EeccCCCCHHHHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC----CceeEecccc
Q 017046 136 TELLPGMSLRKYLVSLR-----PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ----KSLKLADFGL 206 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~----~~vkl~Dfg~ 206 (378)
|||+++++|.+++.... ...+++..++.++.|++.||.|||+.+++|+||||+||+++.++ ..++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999999997532 23478899999999999999999999999999999999998654 1599999999
Q ss_pred ccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 017046 207 AREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (378)
Q Consensus 207 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 282 (378)
+........ .....++..|+|||.+.. ..++.++|||||||++|+|++ |..||....... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~ 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD--------GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHVTA 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHcc--------CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-HHHHHhc
Confidence 865432211 122345678999998854 567899999999999999998 999998765533 3333334
Q ss_pred cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
......+..++..+.+++.+||..+|.+||++.++++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 4455666788999999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=301.33 Aligned_cols=250 Identities=27% Similarity=0.488 Sum_probs=203.4
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCch-HHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
|.+.+.||+|+||.||++.. +++.||+|++....... ........+.+|+.+++.++||||+++++.+.++ ..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 67788999999999999976 57899999987544322 1222345788999999999999999999998654 68899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++..++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 82 VEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 999999999999875 34689999999999999999999999999999999999998666669999999986543221
Q ss_pred ----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCC
Q 017046 215 ----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL---QAAYAAAFKHARPG 287 (378)
Q Consensus 215 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~ 287 (378)
......++..|+|||.+.. ..++.++|+||||+++|+|++|..||...... ............+.
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRG--------EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231 (268)
T ss_pred cCCccccccccccceeCHhHhcc--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCC
Confidence 1123467889999998854 56788999999999999999999999754321 22222222344566
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
++..+++++.+++.+||..+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 232 IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 77788999999999999999999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=307.16 Aligned_cols=245 Identities=24% Similarity=0.402 Sum_probs=196.4
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||+|+||.||++.+. +..+|+|.+....... ...++.+|++++++++||||+++++.+.+ +..++|
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPA----IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHH----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence 5888999999999999999874 6789999887543322 23458899999999999999999998864 578999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
|||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.++ .++|+|||++......
T Consensus 78 ~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 78 MEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS- 153 (308)
T ss_pred eeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccccc-
Confidence 9999999999999753 568999999999999999999998 5999999999999999655 5999999998654222
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHH---------------
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA--------------- 279 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~--------------- 279 (378)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...... .....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 154 MANSFVGTRSYMSPERLQG--------THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred ccccCCCCcCccChhHhcC--------CCCCccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcc
Confidence 2234578899999998754 55788999999999999999999999654321 11111
Q ss_pred ---------------------HHhcCCCCCCC-CChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 280 ---------------------AFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 280 ---------------------~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
......+..|. .++.++.+++.+||..+|++|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111222222 367889999999999999999999999994
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=311.51 Aligned_cols=256 Identities=22% Similarity=0.341 Sum_probs=216.2
Q ss_pred cccCCcceeecceeecccceEEEEE--EECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 129 (378)
..+..+.|...+.||+||||.||-. +.+|+.||.|.+.+.......- +...+.|-++|.+++.+.||.+-..|+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~g--e~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKG--ETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhh--hHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 3456677888899999999999965 4578999999886644332221 2346789999999999999999877765
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+.+++||..|.||+|.-.|.......+++..+..|+++|+.||++||..+||.||+||+|||+|..| +++|+|+|+|..
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-hvRISDLGLAve 336 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-HVRISDLGLAVE 336 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC-CeEeeccceEEe
Confidence 4799999999999999988887777899999999999999999999999999999999999999554 599999999999
Q ss_pred cccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCC
Q 017046 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA--AYAAAFKHARPG 287 (378)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~ 287 (378)
...+......+||.+|||||++.. ..|+.+.|+|||||+||+|+.|+.||........ ............
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~n--------e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~e 408 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQN--------EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEE 408 (591)
T ss_pred cCCCCccccccCcccccCHHHHcC--------CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhh
Confidence 888888888899999999999965 6699999999999999999999999975443222 233344556677
Q ss_pred CCCCChHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 319 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~ 319 (378)
+++.+|++++++.+.+|++||.+|. .+.++-+
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 8899999999999999999999995 4667766
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=302.65 Aligned_cols=246 Identities=29% Similarity=0.490 Sum_probs=203.3
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
..|...+.||.|+||.||+|.+ .+..||+|++........ ...+.+|+.+++.++||||+++++.+.++ ..++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE----IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3577788999999999999986 468999999875443222 24688999999999999999999998654 7899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 80 IMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCc
Confidence 9999999999998864 4689999999999999999999999999999999999999655 59999999986543322
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.......... .......+.++..++
T Consensus 156 ~~~~~~~~~~~y~apE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 226 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQ--------SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-LIPKNNPPTLTGEFS 226 (277)
T ss_pred cccccccCcccccCHhHhcc--------CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-hhhcCCCCCCchhhh
Confidence 1223467888999998854 567889999999999999999999998766543322 233344556666788
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.++.+++.+||..+|.+||++.+++++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 999999999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=310.19 Aligned_cols=242 Identities=25% Similarity=0.379 Sum_probs=183.4
Q ss_pred cceeecccceEEEEEEEC----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---CCeEEE
Q 017046 63 GSKIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIV 135 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~~~lv 135 (378)
+++||+|+||+||+|+.. ++.||+|.+....... .+.+|+.++++++||||+++++.+.+ ...+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISM-------SACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcH-------HHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 468999999999999853 4789999987543322 36689999999999999999998843 357899
Q ss_pred EeccCCCCHHHHHhhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC---CCCceeEeccc
Q 017046 136 TELLPGMSLRKYLVSLR-------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP---DQKSLKLADFG 205 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~---~~~~vkl~Dfg 205 (378)
|||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++. ..+.+||+|||
T Consensus 79 ~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred Eecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 9999 558888875421 235899999999999999999999999999999999999942 33469999999
Q ss_pred cccccccc----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH-------
Q 017046 206 LAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ------- 274 (378)
Q Consensus 206 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------- 274 (378)
++...... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.......
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 230 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 230 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcC-------CCCcCchhhHHHHHHHHHHHHhCCCCccCCccccccccccc
Confidence 99754322 12234578999999998854 2457889999999999999999999996433210
Q ss_pred -HHHHHHHhc-C------------CC------------------------CCCCCChHHHHHHHHHccccCCCCCCCHHH
Q 017046 275 -AAYAAAFKH-A------------RP------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 316 (378)
Q Consensus 275 -~~~~~~~~~-~------------~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 316 (378)
......... . .+ ......+.++.+||.+||+.||.+|||++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e 310 (317)
T cd07868 231 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 310 (317)
T ss_pred HHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHH
Confidence 000000000 0 00 000123456889999999999999999999
Q ss_pred HHH
Q 017046 317 IIR 319 (378)
Q Consensus 317 ll~ 319 (378)
+++
T Consensus 311 ~l~ 313 (317)
T cd07868 311 AMQ 313 (317)
T ss_pred Hhc
Confidence 987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=302.07 Aligned_cols=251 Identities=27% Similarity=0.487 Sum_probs=205.9
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||.|+||.||++... ++.||+|.+....... ....+.+|++++++++||||+++++.+.+ ...+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEA----IQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChH----HHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 4677889999999999999885 6889999987754432 23468899999999999999999998854 578899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
+||+.+++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHHHH
Confidence 99999999999997643 678999999999999999999999 9999999999999999655 59999999986543222
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCCCCCC
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS----NLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~ 290 (378)
. ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.... ..............+.++.
T Consensus 156 ~-~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (265)
T cd06605 156 A-KTFVGTSSYMAPERIQG--------NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS 226 (265)
T ss_pred h-hcccCChhccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh
Confidence 2 12678889999998864 568889999999999999999999997652 2233333344445555555
Q ss_pred C-ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 291 D-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 291 ~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
. ++.++.++|.+||..+|.+|||+.+++. +.++.
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~--~~~~~ 261 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLE--HPFIK 261 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhh--Cchhh
Confidence 5 8899999999999999999999999988 44443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=295.50 Aligned_cols=244 Identities=35% Similarity=0.610 Sum_probs=199.1
Q ss_pred ceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccCC
Q 017046 64 SKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPG 141 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~ 141 (378)
++||.|+||.||++... ++.||+|.+....... ....+.+|+.+++.++||||+++++++.+ ...++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD----LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 36899999999999875 7899999987655542 22468899999999999999999998865 478999999999
Q ss_pred CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccc---cc
Q 017046 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---TA 218 (378)
Q Consensus 142 ~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~ 218 (378)
++|.+++... ...+++..+..++.+++.||.|||++|++||||+|+||+++.++ .++|+|||++......... ..
T Consensus 77 ~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 77 GSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcceecccc
Confidence 9999998753 34688999999999999999999999999999999999999655 5999999998754321111 11
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 297 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 297 (378)
...+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+..... .............+..++.++.
T Consensus 155 ~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 225 (251)
T cd05041 155 KQIPIKWTAPEALNY--------GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-TRERIESGYRMPAPQLCPEEIY 225 (251)
T ss_pred CcceeccCChHhhcc--------CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-HHHHHhcCCCCCCCccCCHHHH
Confidence 233567999998754 567889999999999999999 889998765433 3333333344556678899999
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHH
Q 017046 298 FIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 298 ~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
+++.+||..+|.+|||+.++++.|+
T Consensus 226 ~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 226 RLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHhccChhhCcCHHHHHHHhh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=299.51 Aligned_cols=238 Identities=24% Similarity=0.413 Sum_probs=187.0
Q ss_pred eeecccceEEEEEEEC--------------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-
Q 017046 65 KIGEGAHGKVYEGRYG--------------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 129 (378)
.||+|+||.||+|+.. ...|++|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-----~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRD-----ISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 6899999999999742 235888887653221 22358889999999999999999998864
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC------ceeEec
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK------SLKLAD 203 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~------~vkl~D 203 (378)
...+++|||+++++|..++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. .++++|
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CCCEEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 478899999999999988765 3456899999999999999999999999999999999999975432 289999
Q ss_pred cccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHH-hCCCCCCCCChHHHHHHHHHh
Q 017046 204 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL-TNRLPFEGMSNLQAAYAAAFK 282 (378)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~ 282 (378)
||++...... ....++..|+|||.+.. ...++.++|||||||++|+|+ .|..||......+. . .. .
T Consensus 156 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~-~~-~ 222 (262)
T cd05077 156 PGIPITVLSR---QECVERIPWIAPECVED-------SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-E-RF-Y 222 (262)
T ss_pred CCCCccccCc---ccccccccccChhhhcC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-H-HH-H
Confidence 9998653221 23457888999998752 256788999999999999998 48889876443221 1 11 1
Q ss_pred cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
..........++++.+|+.+||+.||.+||++.++++.+
T Consensus 223 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 122223344678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=303.68 Aligned_cols=262 Identities=23% Similarity=0.401 Sum_probs=207.5
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv 135 (378)
+|.+.+.||+|+||.||++++. +..||+|.+........ ...+.+|+.++++++||||+++++.+. ++..++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK----FNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHH----HHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence 5788899999999999999874 78999998875432221 235889999999999999999999885 4578999
Q ss_pred EeccCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
|||+++++|..++.... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVAS 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccCC
Confidence 99999999999887521 2368999999999999999999997 5999999999999999654 5999999998654322
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCCCCCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ--AAYAAAFKHARPGLPED 291 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 291 (378)
......+++.|+|||.+...... ....++.++|+|||||++|+|++|..||....... ...........+.++..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPN--QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCC--ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 22344688899999988542110 12346889999999999999999999997544322 12222334455667778
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
++.++.+++.+||..+|.+||++.+++. +.++.....
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~--~~~~~~~~~ 270 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLE--HPWLVKYKN 270 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhc--ChhhhhccC
Confidence 9999999999999999999999999998 455554443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=299.54 Aligned_cols=251 Identities=31% Similarity=0.484 Sum_probs=191.4
Q ss_pred ceeecccceEEEEEEEC----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEec
Q 017046 64 SKIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTEL 138 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~ 138 (378)
++||+|+||.||+|... ...+|+|.+........ ...+.+|+.+++.++||||+++++.+.+ ...++||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE----QLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHH----HHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 36899999999999642 35788887765433221 2357899999999999999999998864 478999999
Q ss_pred cCCCCHHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 139 LPGMSLRKYLVSLRP---NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
+++|+|.+++..... ...++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEEEeccccccccccchh
Confidence 999999999976432 2356788899999999999999999999999999999999655 59999999986532221
Q ss_pred --ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhc----CCCC
Q 017046 215 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH----ARPG 287 (378)
Q Consensus 215 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~----~~~~ 287 (378)
......++..|+|||++...... .....++.++|||||||++|+|++ |..||................ ..+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQD-LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred eeccCCCCCcccccCHHHHhhcccc-ccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 11223456789999987531100 012456889999999999999999 889998776544333332221 1233
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
++..++..+.+++..|| .||.+|||+++|++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 44568889999999999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=302.79 Aligned_cols=238 Identities=24% Similarity=0.422 Sum_probs=188.3
Q ss_pred eeecccceEEEEEEEC--------------------------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCC
Q 017046 65 KIGEGAHGKVYEGRYG--------------------------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 118 (378)
.||+|+||.||+|... +..|++|++..... .....+.+|+.+++.++||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----~~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-----DIALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-----HHHHHHHHHHHHHhcCCCC
Confidence 6999999999998631 13588888864322 1234588899999999999
Q ss_pred CeeeEEeeEec-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC-
Q 017046 119 NLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ- 196 (378)
Q Consensus 119 ~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~- 196 (378)
||+++++++.+ ...++||||+++++|..++.. ..+.+++..+..++.|++.||+|||++||+||||||+|||++..+
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 99999999864 478899999999999998865 345789999999999999999999999999999999999997532
Q ss_pred -----CceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHH-hCCCCCCCC
Q 017046 197 -----KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL-TNRLPFEGM 270 (378)
Q Consensus 197 -----~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~ 270 (378)
..++++|||++...... ....++..|+|||.+.. ...++.++||||||+++|+|+ +|..||.+.
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~-------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG-------GNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred ccCccceeeecCCccccccccc---cccccCCcccCchhhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 13899999987543221 22357788999998753 245788999999999999995 699999876
Q ss_pred ChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 271 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
....... . ......++...++++.+++.+||+.+|.+|||+.++++.|
T Consensus 226 ~~~~~~~-~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 226 TPSEKER-F--YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ChHHHHH-H--HHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 5433211 1 1223345556678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=302.49 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=201.1
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEe---
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK--- 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~--- 128 (378)
...++|.+.+.||+|+||.||++.. .++.+|+|++....... ..+.+|+.+++.+ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~------~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID------EEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchH------HHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3557899999999999999999976 46889999876432211 2467899999999 6999999999873
Q ss_pred ---cCCeEEEEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEec
Q 017046 129 ---DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (378)
Q Consensus 129 ---~~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~D 203 (378)
++..++||||++|++|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||+++.++. ++|+|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~-~kl~d 167 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG-VKLVD 167 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC-EEEcc
Confidence 23589999999999999987642 2356889999999999999999999999999999999999996654 99999
Q ss_pred ccccccccccc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 017046 204 FGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (378)
Q Consensus 204 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 282 (378)
||++....... ......|++.|+|||.+.... .....++.++|||||||++|+|++|..||............ ..
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~-~~ 243 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ---QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI-PR 243 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhh---hccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc-cc
Confidence 99987543221 223446889999999875311 01245788999999999999999999999876543333221 11
Q ss_pred cC--CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 283 HA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 283 ~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
.. ....+..++.++.+++.+||+.||++|||+.++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11 1223455788999999999999999999999999854
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=303.73 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=201.3
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
..+|++.+.||+|+||+||++... ++.||+|++....... ....+.+|+++++.++||||+++++.+.+ ...+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSS----VRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcch----HHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 457888999999999999999875 7889999987543322 23468899999999999999999999865 4788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
+||||+++++|.+++.. .+.+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~~ 156 (284)
T cd06620 80 MCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELIN 156 (284)
T ss_pred EEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchhh
Confidence 99999999999998875 3468999999999999999999997 6999999999999999654 599999999864322
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH----------HHHHHHHHh
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL----------QAAYAAAFK 282 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------~~~~~~~~~ 282 (378)
. ......|+..|+|||++.. ..++.++|||||||++|+|++|..||...... .........
T Consensus 157 ~-~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd06620 157 S-IADTFVGTSTYMSPERIQG--------GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ 227 (284)
T ss_pred h-ccCccccCcccCCHHHHcc--------CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh
Confidence 2 1234578999999998754 46788999999999999999999999864431 112222233
Q ss_pred cCCCCCCCC-ChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 283 HARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 283 ~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
...+.++.. ++.++.+|+.+||..||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 333444433 78899999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=300.44 Aligned_cols=251 Identities=28% Similarity=0.474 Sum_probs=196.9
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHH-HhhccCCCeeeEEeeEe-cCCeEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNM-MSRVKHDNLVKFLGACK-DPLMVI 134 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~l~~~~~-~~~~~l 134 (378)
+|.+.+.||+|+||.||++++. ++.||+|.++........ .++..|+.+ ++.++||||+++++++. +...++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ----KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH----HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 5888899999999999999874 789999998765433321 235556665 56668999999999885 457899
Q ss_pred EEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 135 VTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
+|||++ ++|.+++... ....+++..++.++.|++.||.|||++ +++||||||+||+++.++ .+||+|||++....
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~ 155 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLV 155 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecccccccc
Confidence 999995 6888887653 234689999999999999999999998 999999999999999665 59999999987543
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC-C
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-E 290 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~ 290 (378)
.........++..|+|||.+.+.. ....++.++|+|||||++|+|++|..||..................+.++ .
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPEL----NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAE 231 (283)
T ss_pred cccccccccCCccccChhhcCCcc----cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcc
Confidence 333333356888999999885411 12456889999999999999999999997543322333333344444444 3
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+|.++.+++.+||..+|.+||++.++++
T Consensus 232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 57899999999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=299.65 Aligned_cols=252 Identities=29% Similarity=0.484 Sum_probs=201.6
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC---
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP--- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~--- 130 (378)
..+|.+.+.||+|+||.||+|... ++.+++|++...... ...+.+|+.+++++ .||||+++++++.+.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE------EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh------HHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 467999999999999999999874 578999998764432 23588999999999 799999999998543
Q ss_pred ----CeEEEEeccCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecc
Q 017046 131 ----LMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 131 ----~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Df 204 (378)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~ 157 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDF 157 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCC
Confidence 3789999999999999987643 46789999999999999999999999999999999999999665 5999999
Q ss_pred ccccccccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017046 205 GLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 205 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 283 (378)
|++...... .......++..|+|||.+.... .....++.++||||||+++|+|++|..||............ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~ 233 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDE---QPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI-PRN 233 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccc---cccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh-hcc
Confidence 998643221 2223456888999999875421 11345778999999999999999999999866544443332 222
Q ss_pred CCCCC--CCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 284 ARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 284 ~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
..+.+ +..++.++.+++.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 22222 2347789999999999999999999999987
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=301.11 Aligned_cols=248 Identities=29% Similarity=0.411 Sum_probs=197.5
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
.|.+.+.||+|+||.||+|+.. ++.||+|++........ ....+.+|+.+++.++||||+++++.+.++ ..++|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV---IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc---ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 5888899999999999999874 68999999875432221 123477999999999999999999988654 78899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||++++.|..++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEEECccccceecCCCcc
Confidence 999999888877653 35689999999999999999999999999999999999999665 59999999987543332
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC----------
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA---------- 284 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---------- 284 (378)
......++..|+|||.+.+ ...++.++||||||+++|+|++|..||.+....+..........
T Consensus 156 ~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 156 DYTDYVATRWYRAPELLVG-------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred cccCcccccccCCHHHHhC-------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 2233457889999998753 24567899999999999999999999987766444333211000
Q ss_pred ----------CCC---------CCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 285 ----------RPG---------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 285 ----------~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+. ....++..+.+|+.+||..+|.+|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 01246788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=300.74 Aligned_cols=247 Identities=28% Similarity=0.400 Sum_probs=204.9
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
.|.+.+.||.|+||.||+++.. ++.||+|++......... ..+.+.+|++++++++||||+++++.+.++ ..++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKG--SVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchh--HHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 3788899999999999999875 789999999764432211 234688999999999999999999888654 78999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
+||+.|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus 79 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEEeecccccccCCCcc
Confidence 9999999999999763 5789999999999999999999999999999999999999665 599999999876544433
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCCCCCCh
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 293 (378)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||..... ..... .......+..|..++
T Consensus 156 ~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 226 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCR--------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-AKQETADVLYPATWS 226 (258)
T ss_pred ccccCCChhhcCHHHHcc--------cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-HHhccccccCcccCc
Confidence 445678889999998864 4578899999999999999999999987653 22222 222225667778899
Q ss_pred HHHHHHHHHccccCCCCCCCH--HHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPSF--SQIIR 319 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~--~~ll~ 319 (378)
.++.++|.+||..||.+||++ .++++
T Consensus 227 ~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 227 TEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 999999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=297.53 Aligned_cols=246 Identities=28% Similarity=0.465 Sum_probs=197.2
Q ss_pred cceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEecc
Q 017046 63 GSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELL 139 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~ 139 (378)
...||+|+||.||+|++. +..||+|.+....... ...+.+|+.+++.++|+||+++++++.+ +..++++||+
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY-----VQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHH-----HHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 357999999999999864 5789999886543322 2357899999999999999999998865 4788999999
Q ss_pred CCCCHHHHHhhhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-ccc
Q 017046 140 PGMSLRKYLVSLRPNKL--DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMM 216 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l--~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~ 216 (378)
++++|.+++.... ..+ ++..+..++.|++.||+|||+.||+||||||+||+++.+...++|+|||++...... ...
T Consensus 88 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 88 PGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence 9999999997632 334 788899999999999999999999999999999999865567999999998653221 112
Q ss_pred ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCCCCCChHH
Q 017046 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ-AAYAAAFKHARPGLPEDISPD 295 (378)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 295 (378)
....+++.|+|||.+.. ....++.++|+||||+++|+|++|..||....... ...........+.++..++++
T Consensus 167 ~~~~~~~~~~aPE~~~~------~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06624 167 ETFTGTLQYMAPEVIDK------GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240 (268)
T ss_pred ccCCCCccccChhhhcc------ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHH
Confidence 23457889999998753 12347789999999999999999999997644322 222233334456677889999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 017046 296 LAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 296 l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
+.+++.+||..+|.+|||+.+++++
T Consensus 241 ~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 241 AKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHhC
Confidence 9999999999999999999999873
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=296.84 Aligned_cols=241 Identities=27% Similarity=0.419 Sum_probs=199.8
Q ss_pred eecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEEEeccCCC
Q 017046 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGM 142 (378)
Q Consensus 66 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv~e~~~~~ 142 (378)
||.|+||.||+++.. ++.||+|++......... ....+.+|+.+++.++||||+++++.+.++ ..+++|||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG--QQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhh--HHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 699999999999886 789999999765433222 234688999999999999999999988654 788999999999
Q ss_pred CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccccccCcCc
Q 017046 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222 (378)
Q Consensus 143 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt 222 (378)
+|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.............++
T Consensus 79 ~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 79 ELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred cHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCcccccccccCC
Confidence 99999975 34589999999999999999999999999999999999999665 5999999998765444333345788
Q ss_pred cccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh-HHHHHHHHH-hcCCCCCCCCChHHHHHHH
Q 017046 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAF-KHARPGLPEDISPDLAFIV 300 (378)
Q Consensus 223 ~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~li 300 (378)
+.|+|||.+.. ..++.++|+||||+++|+|++|..||..... ......... ......+|...++++.+++
T Consensus 156 ~~~~~PE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 227 (262)
T cd05572 156 PEYVAPEIILN--------KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLI 227 (262)
T ss_pred cCccChhHhcC--------CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHH
Confidence 89999998753 5678899999999999999999999987652 222233222 2456667777899999999
Q ss_pred HHccccCCCCCCC-----HHHHHH
Q 017046 301 QSCWVEDPNLRPS-----FSQIIR 319 (378)
Q Consensus 301 ~~~l~~dp~~Rps-----~~~ll~ 319 (378)
.+||..+|.+||+ +.++++
T Consensus 228 ~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 228 KQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHccCChhhCcCCcccCHHHHhc
Confidence 9999999999999 899888
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=300.17 Aligned_cols=254 Identities=30% Similarity=0.520 Sum_probs=203.3
Q ss_pred CcceeecceeecccceEEEEEEEC------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 129 (378)
.+.|.+.+.||+|+||.||+++.. +..||+|++...... .....|.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 356778899999999999999863 578999999865553 123468899999999999999999998854
Q ss_pred --CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 130 --~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
...+++|||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~ 156 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-LVKISDFGLA 156 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccccc
Confidence 3688999999999999999763 34699999999999999999999999999999999999999665 5999999998
Q ss_pred cccccccc----cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH---------
Q 017046 208 REETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ--------- 274 (378)
Q Consensus 208 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------- 274 (378)
........ .....++..|+|||.+.. ..++.++||||||+++|+|++|..||.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 228 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRT--------SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG 228 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHcc--------CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccc
Confidence 76442211 112244567999998754 467889999999999999999999986533211
Q ss_pred -----HHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 275 -----AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 275 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
..............+..++.++.+++.+||..+|.+|||+.++++.|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 229 QMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11222223333444567789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=301.03 Aligned_cols=238 Identities=27% Similarity=0.475 Sum_probs=190.8
Q ss_pred eeecccceEEEEEEEC---------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 65 KIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
.||+|+||.||+|... ...||+|.+..... ...+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-----NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhH-----HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence 6899999999999763 23488887754321 123457889999999999999999998865 57889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCc-------eeEeccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-------LKLADFGLA 207 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~-------vkl~Dfg~a 207 (378)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.. ++++|||++
T Consensus 77 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 77 VQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred EEecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999999999763 3468999999999999999999999999999999999999866543 799999988
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCC
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR-LPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
...... ....++..|+|||++.. ...++.++||||||+++|+|++|. .||........ .. ......
T Consensus 156 ~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~--~~~~~~ 222 (258)
T cd05078 156 ITVLPK---EILLERIPWVPPECIEN-------PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQ--FYEDRH 222 (258)
T ss_pred cccCCc---hhccccCCccCchhccC-------CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HH--HHHccc
Confidence 654322 23467889999998853 234688999999999999999984 66665443222 11 223455
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
.+|...+.++.+++.+||+.||.+|||+.++++.|
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 223 QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 67777889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=302.98 Aligned_cols=259 Identities=30% Similarity=0.402 Sum_probs=202.5
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|.+.+.||+|+||.||+|.. .++.||+|.+...............+..|+.+++.++|+||+++++++.+ ...++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 67788999999999999986 46899999998765442222233457789999999999999999999865 4788999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-c
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~ 215 (378)
||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 82 e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 82 EFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSPNRK 158 (298)
T ss_pred ccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-CEEEccceeeeeccCCCcc
Confidence 999 899999997632 3699999999999999999999999999999999999999665 59999999987543321 2
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC----------
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR---------- 285 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------- 285 (378)
.....+++.|+|||.+.. ...++.++|||||||++|+|++|.+||.+................
T Consensus 159 ~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 159 MTHQVVTRWYRAPELLFG-------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred ccccccceeeeCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 223356788999998743 245788999999999999999998888776653322221110000
Q ss_pred -----------C-----CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 286 -----------P-----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 286 -----------~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
+ ......+.++.+++.+||..+|.+|||+.++++ +.++.....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~--~~~~~~~~~ 290 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE--HPYFSNDPA 290 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh--CccccCCCC
Confidence 0 011345778999999999999999999999999 666665443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=296.73 Aligned_cols=250 Identities=29% Similarity=0.448 Sum_probs=202.6
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
++|.+.+.||.|+||+||+|.. .+..+|+|++........ ...+.+|+.+++.++|+||+++++.+.+ ...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS----VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchH----HHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 3688899999999999999986 467899999876544332 2358899999999999999999998854 47889
Q ss_pred EEeccCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||++++++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~~ 155 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADG 155 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhccC
Confidence 9999999999999976433 5689999999999999999999999999999999999999655 5999999998654332
Q ss_pred cc-----cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 214 EM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 214 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
.. .....++..|+|||.+.. ...++.++|+||||+++|+|++|..||........... ......+.+
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~ 227 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQ-------VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML-TLQNDPPSL 227 (267)
T ss_pred ccccccccccccCChhhcChHHHcc-------ccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH-HhcCCCCCc
Confidence 21 133468889999998854 13578899999999999999999999987665433322 223333323
Q ss_pred C-----CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 289 P-----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 289 ~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
+ ..+++.+.+++.+||..||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2 2567899999999999999999999999873
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=297.14 Aligned_cols=252 Identities=29% Similarity=0.546 Sum_probs=200.9
Q ss_pred eeecceeecccceEEEEEEE-----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC----
Q 017046 60 LFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 130 (378)
|.+.+.||+|+||.||+|.. .+..||||++......... .+.+.+|+++++.++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD---IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHH---HHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 56678999999999999975 2578999999765433322 24588999999999999999999987432
Q ss_pred ---CeEEEEeccCCCCHHHHHhhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEec
Q 017046 131 ---LMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (378)
Q Consensus 131 ---~~~lv~e~~~~~sL~~~l~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~D 203 (378)
..+++++|+.+++|.+++.... ...++...++.++.|++.||+|||+.||+|+||||+||+++.++ .++|+|
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-~~kl~d 156 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVAD 156 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-CEEECc
Confidence 2468899999999998875422 12478899999999999999999999999999999999998654 599999
Q ss_pred ccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHH
Q 017046 204 FGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (378)
Q Consensus 204 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 279 (378)
||++....... ......+++.|++||.+.. ..++.++|||||||++|+|++ |..||.+... ......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~ 227 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLAD--------NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNY 227 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhc--------CccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHH
Confidence 99987543221 1122345678999998754 567889999999999999999 8999987654 334444
Q ss_pred HHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 280 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 280 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
.........+...+..+.+++.+||..+|.+|||+.++++.|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 228 LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 444445555667889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=315.35 Aligned_cols=253 Identities=28% Similarity=0.423 Sum_probs=215.5
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~ 132 (378)
....|.+.+.||+|.|++|.+|++ ++..||||++.+....... ...+.+|+++|..++|||||+++.+.. ...+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~---~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK---RQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH---HHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 345689999999999999999987 5789999998876554432 234889999999999999999999986 5589
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
|+||||+.+|.+.+++.. .+.+.+..+..++.|+++|++|||+++|+|||||++|||++.+. ++||+|||++.....
T Consensus 131 ylV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-NIKIADFGFSTFFDY 207 (596)
T ss_pred EEEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-ceeeeccccceeecc
Confidence 999999999999999986 45677799999999999999999999999999999999999654 499999999998888
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
.....+.+|++.|.|||++.+. ...++.+|+||+|+++|.|++|..||++.+-...... .......+|..+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~-------~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r--vl~gk~rIp~~m 278 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGK-------KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR--VLRGKYRIPFYM 278 (596)
T ss_pred cccccccCCCCCccChHhhcCc-------ccCCcceehhhhhhhheeeeecccccCCcccccccch--heeeeeccccee
Confidence 8888899999999999999762 3567899999999999999999999997553222112 223344566778
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
+.++.++|+++|.++|.+|++.+++.++-+.
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 9999999999999999999999999885433
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=297.07 Aligned_cols=245 Identities=30% Similarity=0.472 Sum_probs=201.1
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|.+.+.||+|+||.||+++.. ++.|++|.+..... ...+.+|+.+++.++||||+++++.+.+ ...++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 56888999999999999999875 58899999865322 2458899999999999999999998864 47889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
++||+.+++|.+++.. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 76 ~~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 76 VMEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEecCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchhcccCc
Confidence 9999999999999875 345789999999999999999999999999999999999999665 59999999987544332
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh-cCCCCCCCCC
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-HARPGLPEDI 292 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 292 (378)
......++..|+|||.+.+ ..++.++||||||+++|+|++|..||............... ......+..+
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQE--------IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKW 225 (256)
T ss_pred cccccccCCccccCHHHHhc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhc
Confidence 2233457889999998854 56788999999999999999999999876554333222111 1111234467
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+.++.+++.+||+.||.+|||+.++++
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 889999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=297.74 Aligned_cols=253 Identities=26% Similarity=0.506 Sum_probs=201.2
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCch-----HHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSD-----ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 130 (378)
.|.+.+.||.|+||.||+|.. .++.||+|.+....... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999975 46889999886432211 1122234678999999999999999999988654
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~-~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-ICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC-eEEEeeccccccc
Confidence 788999999999999998763 5789999999999999999999999999999999999999554 5999999998753
Q ss_pred ccc---cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 211 TVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 211 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
... .......++..|+|||.+.. ....++.++|+||||+++|+|++|..||..................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHS------YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP 232 (272)
T ss_pred cccccccccccccCCccccCHHHhcc------ccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCc
Confidence 221 11223467889999998754 113478899999999999999999999976655444443332333333
Q ss_pred CCC----CChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 288 LPE----DISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 288 ~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
++. .++.++.+++.+||..+|.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 333 468899999999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=300.28 Aligned_cols=249 Identities=29% Similarity=0.427 Sum_probs=199.3
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
+|.+.+.||.|+||.||+|.+ .++.||+|++......... ...+.+|+.++++++||||+++++++.++ ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~---~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI---PNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchh---hHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence 478889999999999999986 4689999998765543221 24588999999999999999999998654 78899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||+ +++|.+++... ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 78 MEYM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEP 154 (286)
T ss_pred eccc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-cEEEeeeeecccccCCCC
Confidence 9999 99999998753 36799999999999999999999999999999999999999654 59999999987544332
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC-------
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP------- 286 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------- 286 (378)
......++..|+|||.+.. ...++.++||||||+++|+|++|.+||.+..+.............+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYG-------ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred CccccccCcccccCceeeec-------cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 1234568899999998753 2456889999999999999999988887765533322221110000
Q ss_pred ---------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 287 ---------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 287 ---------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
......+.++.+++.+||..+|.+|||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0113457889999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=294.95 Aligned_cols=250 Identities=28% Similarity=0.461 Sum_probs=202.3
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||+|+||.||++.. .++.|++|.++...... .....+.+|+.+++.++|+||+++++.+.+ ...++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDP---KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccch---HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 477889999999999999986 46899999987665431 123468899999999999999999998854 478899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 78 MEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEcccccccccCCCCC
Confidence 999999999999875 34588999999999999999999999999999999999999654 599999999875433221
Q ss_pred -----cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 216 -----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 216 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
.....++..|+|||.+.... ...++.++||||||+++|+|++|..||..................+.+|.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGK-----GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD 229 (264)
T ss_pred cccccccCCcCCcCccChhhccCCC-----CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCc
Confidence 12346788999999986411 13478899999999999999999999976644333333333344555555
Q ss_pred CC--hHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 291 DI--SPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 291 ~~--~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.. ++.+.+++.+||..+|.+|||+.+++.
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 44 899999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=302.37 Aligned_cols=246 Identities=29% Similarity=0.473 Sum_probs=201.6
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|.+.+.||+|+||.||+|.+ .++.||+|.+........ ...+.+|+.+++.++||||+++++.+.+ ...++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE----IEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHH----HHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 3467788999999999999976 467899999875443222 2468899999999999999999998864 47899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 80 IMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEEEccccccccccCcc
Confidence 9999999999998864 5689999999999999999999999999999999999999655 59999999987543322
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||......... ........+.++..++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 226 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQ--------SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-FLIPKNSPPTLEGQYS 226 (277)
T ss_pred hhhhcccCcccccCHHHhCc--------CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-hhhhcCCCCCCCcccC
Confidence 1223467889999999854 56788999999999999999999999765543322 2233344455666788
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.++.+++.+||..+|.+||++.+++++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999999999994
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=308.25 Aligned_cols=247 Identities=28% Similarity=0.377 Sum_probs=195.3
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec----
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---- 129 (378)
-.+.|.+.+.||+|+||.||+++. +++.||+|++......... ..++.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH---AKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhH---HHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 356799999999999999999986 5789999998654332221 2346789999999999999999998743
Q ss_pred ---CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 130 ---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 130 ---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||+
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~ 164 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGL 164 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCcc
Confidence 24689999995 588888764 289999999999999999999999999999999999999665 499999999
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC--
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-- 284 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-- 284 (378)
+.............+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.............
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP 236 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhC--------CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 976544433344568899999998854 5688999999999999999999999986654322111110000
Q ss_pred ------------------CCC--------------C-------CCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 285 ------------------RPG--------------L-------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 285 ------------------~~~--------------~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+. + +...+..+.++|.+||..||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 0 1134667899999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=303.29 Aligned_cols=245 Identities=29% Similarity=0.449 Sum_probs=208.3
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE-ecCCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~~~~~l 134 (378)
+.|.++.+||+|+||.||++.+ .|..+|||.+..+..-+ .+..|+.+|+++..|++|++||.+ ....+++
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQ-------EIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQ-------EIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHH-------HHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 3477889999999999999966 57999999987655433 377999999999999999999966 5668999
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
|||||..|++.+.++. +...+++.++..++...+.||+|||...-+|||||..|||++.+|. .||+|||.|......
T Consensus 106 VMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~-AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI-AKLADFGVAGQLTDTM 183 (502)
T ss_pred ehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch-hhhhhccccchhhhhH
Confidence 9999999999999976 5678999999999999999999999999999999999999997765 999999998754332
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC--CCCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPED 291 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~ 291 (378)
...++..|||-|||||++.. ..|...+||||||++..||..|++||.+......++.+ -...+|. -|+.
T Consensus 184 AKRNTVIGTPFWMAPEVI~E--------IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-PT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEE--------IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-PTKPPPTFKKPEE 254 (502)
T ss_pred HhhCccccCcccccHHHHHH--------hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-cCCCCCCCCChHh
Confidence 23456789999999999954 67889999999999999999999999987765544332 2233333 3567
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
+|.++.++++.||.++|++|.|+.+++++
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 89999999999999999999999999984
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=303.93 Aligned_cols=249 Identities=26% Similarity=0.422 Sum_probs=193.1
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
+|.+.+.||+|+||.||+|++ .++.||+|.+........ ....+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~---~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc---CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence 377889999999999999987 478999999875432221 123467899999999999999999988654 78899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-c
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-~ 214 (378)
+||++ ++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++...... .
T Consensus 78 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 78 FEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVR 154 (284)
T ss_pred EecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEECccchhhccCCCCC
Confidence 99996 5888887653 35699999999999999999999999999999999999999665 5999999998754322 1
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC----------
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA---------- 284 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---------- 284 (378)
......+++.|+|||.+.+ ...++.++|||||||++|+|++|..||.................
T Consensus 155 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred CcCCCccccCCcChHHHhC-------CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHH
Confidence 2233467889999998754 23468899999999999999999888644333222222211100
Q ss_pred ---------CC---------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 285 ---------RP---------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 285 ---------~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.+ .....+++++.+++.+||..||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 0113467899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=299.80 Aligned_cols=243 Identities=23% Similarity=0.385 Sum_probs=196.3
Q ss_pred eecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccCCC
Q 017046 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGM 142 (378)
Q Consensus 66 lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 142 (378)
||+|+||+||++.. .++.||+|++......... ....+..|+.+++.++||||+++++.+.. +..++||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRK--GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhh--hhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 68999999999875 4789999998754322211 22356789999999999999999998864 5789999999999
Q ss_pred CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccccccCcCc
Q 017046 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222 (378)
Q Consensus 143 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt 222 (378)
+|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.............++
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCccccccCC
Confidence 999999775545799999999999999999999999999999999999999665 5999999998754433333445678
Q ss_pred cccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCCCCCChHHHHHHH
Q 017046 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL--QAAYAAAFKHARPGLPEDISPDLAFIV 300 (378)
Q Consensus 223 ~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li 300 (378)
..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ...............+..+++++.++|
T Consensus 158 ~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 229 (277)
T cd05577 158 PGYMAPEVLQG--------EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC 229 (277)
T ss_pred CCcCCHHHhcC--------CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHH
Confidence 89999998854 45788999999999999999999999765431 111112222334456677899999999
Q ss_pred HHccccCCCCCC-----CHHHHHH
Q 017046 301 QSCWVEDPNLRP-----SFSQIIR 319 (378)
Q Consensus 301 ~~~l~~dp~~Rp-----s~~~ll~ 319 (378)
.+||+.+|.+|| ++.++++
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 230 EALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHccCChhHccCCCcccHHHHHh
Confidence 999999999999 7777876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=310.06 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=212.9
Q ss_pred cCCcceeecceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE-ecCCe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLM 132 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~~~~ 132 (378)
...+.+.++++||+|-||.|.+....+ ..||+|+++.+.....+ ..|.+|+++|.+|+||||++++++| .|+.+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r----~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNAR----NDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHH----HHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 455668899999999999999998876 99999999887665543 4699999999999999999999999 57788
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++|+||+++|+|.+++.......+.......|+.||++|++||.+.++|||||.+.|+|++.+. ++||+|||+++....
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-TIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-cEEecCccccccccc
Confidence 9999999999999999886544556667788999999999999999999999999999999554 699999999985333
Q ss_pred ccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh--CCCCCCCCChHHHHHHHHHhc----
Q 017046 213 TEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--NRLPFEGMSNLQAAYAAAFKH---- 283 (378)
Q Consensus 213 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~---- 283 (378)
+.. ....+-..+|||+|.+.. ++++.++|+|+||+++||+++ ...||...++.+.........
T Consensus 690 g~yy~vqgr~vlpiRwmawEsill--------gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG 761 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHh--------ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence 222 123356689999999875 789999999999999999876 789999887755443322111
Q ss_pred --CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 284 --ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 284 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
..+..|.-++..+.+++..||..+-.+|||++++..+|...
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12234667999999999999999999999999998887654
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=296.67 Aligned_cols=254 Identities=28% Similarity=0.475 Sum_probs=200.6
Q ss_pred eeecceeecccceEEEEEEEC---CeeEEEEEeecCCCch-----HHHHHHHHHHHHHHHHhh-ccCCCeeeEEeeEec-
Q 017046 60 LFIGSKIGEGAHGKVYEGRYG---DRIVAIKVLNRGSTSD-----ERALLEGRFIREVNMMSR-VKHDNLVKFLGACKD- 129 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~-----~~~~~~~~~~~E~~~l~~-l~hp~iv~l~~~~~~- 129 (378)
|.+.+.||+|+||.||++... ++.+|+|.+....... .......++..|+.++.+ ++||||+++++.+.+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 677889999999999999874 4789999876432211 111223457788888875 699999999998854
Q ss_pred CCeEEEEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
+..+++|||++|++|.+++... ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~dfg~ 160 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITDFGL 160 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEecccc
Confidence 5789999999999999988542 34568999999999999999999996 7899999999999999665 599999999
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
+.............++..|+|||.+.. ..++.++|+||||+++|+|++|..||..................+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKN--------EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232 (269)
T ss_pred eeecccccccccccCcccCcChhhhcC--------CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc
Confidence 976554433445678899999998854 557889999999999999999999997655433322222222222
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
.....+++++.+++.+||+.||++||++.++..++.
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 222367899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=304.10 Aligned_cols=256 Identities=29% Similarity=0.445 Sum_probs=202.9
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|.....||+|+||.||++.. ++..||||.+...... ..+.+.+|+.+++.++||||+++++.+.+ +..++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ-----RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH-----HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 3455567899999999999976 4689999988653321 12457899999999999999999998754 57899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++.......
T Consensus 97 v~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 97 VMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEccCcchhhccccc
Confidence 9999999999998854 4689999999999999999999999999999999999999665 59999999986432211
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--CCC
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PED 291 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~ 291 (378)
......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+........ .......+.+ ...
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 243 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-RIRDNLPPRVKDSHK 243 (292)
T ss_pred ccCceeecCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcCCCccccccc
Confidence 1223468889999998854 567889999999999999999999998766543322 2222222222 235
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 333 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 333 (378)
.+..+.+++.+||..||.+|||+.++++ +.++....+++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~--~~~~~~~~~~~~ 283 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ--HPFLKLAGPPSC 283 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh--ChhhhccCCccc
Confidence 7889999999999999999999999998 566665555554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=295.99 Aligned_cols=239 Identities=26% Similarity=0.433 Sum_probs=189.8
Q ss_pred ceeecccceEEEEEEECCe------------eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCC
Q 017046 64 SKIGEGAHGKVYEGRYGDR------------IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL 131 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~------------~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 131 (378)
+.||+|+||.||+|...+. .+++|++...... ...+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD------SLAFFETASLMSQLSHKHLVKLYGVCVRDE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh------HHHHHHHHHHHHcCCCcchhheeeEEecCC
Confidence 3689999999999987532 4788876543322 245889999999999999999999886677
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC------ceeEeccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK------SLKLADFG 205 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~------~vkl~Dfg 205 (378)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||++|++|+||||+|||++.++. .++|+|||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 89999999999999999763 337899999999999999999999999999999999999986651 49999999
Q ss_pred cccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
++..... .....++..|+|||.+... ...++.++||||||+++|+|++ |..||....... ...... .
T Consensus 154 ~a~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~~~~~--~ 221 (259)
T cd05037 154 IPITVLS---REERVERIPWIAPECIRNG------QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFYQ--D 221 (259)
T ss_pred ccccccc---ccccccCCCccChhhhcCC------CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-HHHHHh--c
Confidence 9876433 2234567789999998641 1367889999999999999999 688887664322 111111 2
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
....+......+.+++.+||..+|.+|||+.++++.|
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 222 QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 2223333448899999999999999999999999866
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.02 Aligned_cols=246 Identities=29% Similarity=0.475 Sum_probs=207.6
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
.|.+.+.||+|++|.||+++.. ++.|++|++....... ....+.+|+..+..++||||+++++.+.+ ...+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE----FRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchH----HHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 5778899999999999999874 7899999987655431 23468899999999999999999998854 578899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
|||+++++|.+++... ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 78 LEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTL 154 (264)
T ss_pred EEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecccCC
Confidence 9999999999999763 678999999999999999999999 9999999999999999655 59999999987543332
Q ss_pred cc-ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCCCCCC
Q 017046 215 MM-TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS--NLQAAYAAAFKHARPGLPED 291 (378)
Q Consensus 215 ~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~ 291 (378)
.. ....++..|+|||.+.. ..++.++|+||||+++|+|++|..||.... ..............+.++..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQG--------ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE 226 (264)
T ss_pred CcccceeecccccCHhhhCC--------CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcc
Confidence 22 24467889999998754 567889999999999999999999998765 44444555555556666777
Q ss_pred -ChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 292 -ISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 292 -~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
++..+.+++..||..+|.+||++.++++
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 8999999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=295.39 Aligned_cols=250 Identities=28% Similarity=0.443 Sum_probs=204.4
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||+|+||.||++... +..||+|.+......... ...+.+|+.+++.++||||+++++.+.+ ...++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE---KEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchh---hHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence 3778899999999999999874 688999998764322211 2357799999999999999999998865 478899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
+||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++..++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999999765555689999999999999999999999999999999999998776667999999886543222
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
......|++.|+|||.+.. ..++.++|+||||+++|+|++|..||......... ...........+..++.
T Consensus 158 ~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 228 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN--------RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV-LKICQGYFAPISPNFSR 228 (257)
T ss_pred cccccCCCccccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHhcccCCCCCCCCCH
Confidence 1223468889999998754 56788999999999999999999999865543333 33334444455667889
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
++.+++.+||..+|.+|||+.+++++
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 229 DLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhhC
Confidence 99999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=316.99 Aligned_cols=242 Identities=24% Similarity=0.329 Sum_probs=187.8
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 133 (378)
...|.+.+.||+|+||.||++.+. ++.||||.... ..+.+|++++++++||||+++++++. ++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 346999999999999999999874 57899996422 12568999999999999999999875 45788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+|||++ .++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++.....
T Consensus 237 lv~e~~-~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGS 313 (461)
T ss_pred EEEEcc-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCceecccc
Confidence 999999 5689888865 335799999999999999999999999999999999999999665 4999999998753222
Q ss_pred c---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhc
Q 017046 214 E---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-------LQAAYAAAFKH 283 (378)
Q Consensus 214 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~ 283 (378)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|..|+..... .......+...
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~ 385 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAG--------DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA 385 (461)
T ss_pred cccccccccCCCcCCcCHHHHcC--------CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence 1 1223569999999999864 5688999999999999999998765432211 11111111110
Q ss_pred C--CCCCC-------------------------------CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 284 A--RPGLP-------------------------------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 284 ~--~~~~~-------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
. ...++ ..++.++.+||.+||+.||.+|||+.|++++
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 00010 1345688999999999999999999999983
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=293.22 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=189.3
Q ss_pred eeecccceEEEEEEEC-C---eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEEEecc
Q 017046 65 KIGEGAHGKVYEGRYG-D---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELL 139 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv~e~~ 139 (378)
+||+|+||.||++... + ..+++|.+........ ...+.+|+.+++.++||||+++++.+.+. ..++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE----QNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHH----HHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence 5899999999999653 2 3456666654433222 24688999999999999999999998654 679999999
Q ss_pred CCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc---c
Q 017046 140 PGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---E 214 (378)
Q Consensus 140 ~~~sL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~---~ 214 (378)
++++|.+++..... ..+++..+..++.|++.||.|||+.+++|+||||+|||++.++ .++|+|||++...... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEecccccccccCcchhhh
Confidence 99999999976322 3467778889999999999999999999999999999998655 5999999997542211 1
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHh----cCCCCCC
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK----HARPGLP 289 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~----~~~~~~~ 289 (378)
......++..|+|||++..... ......++.++||||||+++|+|++ |..||............... ...+.++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHG-GLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred cccCCcCcccccCchhcccccC-ccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 1234467889999998743110 0012346789999999999999997 67788766553333322211 1234455
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
..+++.+.+++..|| .+|++||++.++++.|.
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 568899999999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=299.81 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=197.0
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
.|.+.+.||+|+||.||++... ++.||+|.+......... ....+.+|+.+++.++||||+++++.+.++ ..++|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRN--QIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHH--HHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 5788899999999999999874 578999988764322111 224678999999999999999999988654 67899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||++|++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-CEEEeeCCCccccCcCcc
Confidence 9999999999999763 4689999999999999999999999999999999999999654 59999999876311100
Q ss_pred ---------------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHH
Q 017046 215 ---------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (378)
Q Consensus 215 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 279 (378)
......++..|+|||.+.. ..++.++|+|||||++|+|++|..||.+....+ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~~~ 227 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQ 227 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence 0112357888999998754 567889999999999999999999998765533 2333
Q ss_pred HHhcC--CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 280 AFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 280 ~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
..... .+..+..++.++.+++.+||..+|.+||+..++++.|..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 22221 222233578999999999999999999985544444444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=299.75 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=197.6
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||.|+||.||+|+. .++.||||.+........ ....+.+|++++++++||||+++++++.+ ...++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc---cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 377889999999999999987 468999998875433221 12357899999999999999999998864 478899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||+. ++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR 155 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCcc
Confidence 99995 6899988765566799999999999999999999999999999999999999665 59999999986543221
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--------
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-------- 286 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------- 286 (378)
......+++.|+|||.+.+ ...++.++||||||+++|+|++|..||.+.+..............+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred ccccccccccccCCeEEec-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 1223356788999998753 2345788999999999999999999998766544333222111100
Q ss_pred -------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 287 -------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 287 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.....+++++.++|.+||..||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0123467889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=295.19 Aligned_cols=245 Identities=30% Similarity=0.485 Sum_probs=201.9
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
.|.+.+.||+|+||.||+|.. .++.||+|+......... ...+.+|+.++..++||||+++++.+.+ ...++|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE----IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHH----HHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 467788999999999999976 468999998865433222 2458899999999999999999998865 478999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||+++++|.+++.. ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-CEEEeecccceecccchh
Confidence 999999999998864 4689999999999999999999999999999999999999655 59999999986543221
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
......++..|+|||.+.. ..++.++|+|||||++|+|++|..||....... ..........+.++..++.
T Consensus 157 ~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIELAKGEPPHSELHPMK-VLFLIPKNNPPTLEGNYSK 227 (277)
T ss_pred hhccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-HHHHHhcCCCCCCCcccCH
Confidence 1223467889999998754 456789999999999999999999998755433 2333334445566778899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
++.+++.+||..+|.+||++.+++++
T Consensus 228 ~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 228 PLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999999999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=297.85 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=200.6
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
++|.+.+.||+|++|.||+|... ++.||+|.+........ ....+.+|+++++.++||||+++++++.+ ...++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG---VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc---chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 46888999999999999999864 68899999865433221 12357789999999999999999999865 47899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
||||++ ++|.+++.......+++..+..++.||+.||+|||++|++|+||+|+||+++.++..+||+|||++......
T Consensus 79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 999995 588888766444457888999999999999999999999999999999999866666999999998653322
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--------
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-------- 285 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------- 285 (378)
.......+++.|+|||.+.+ ...++.++||||||+++|+|++|..||.+................
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLG-------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cccccCceeecccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 11233467889999998753 245788999999999999999999999876654443332211000
Q ss_pred -----------CC--------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 286 -----------PG--------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 286 -----------~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+. ....+++++.+++.+||..+|.+||++.++++ +.++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~--~~~~~~ 289 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE--HEYFKD 289 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc--CchHhH
Confidence 00 12356788999999999999999999999998 445443
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=295.37 Aligned_cols=247 Identities=30% Similarity=0.455 Sum_probs=197.2
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---CCeE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMV 133 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~~~ 133 (378)
.|...+.||.|++|.||++.. .++.||+|.+....... ...++.+|+++++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD----LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchH----HHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 577889999999999999987 46899999987654332 23468899999999999999999998853 2578
Q ss_pred EEEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~ 156 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV 156 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence 999999999999887542 235689999999999999999999999999999999999999665 49999999986543
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCCC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS----NLQAAYAAAFKHARPG 287 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~ 287 (378)
.... ....++..|+|||.+.. ..++.++|||||||++|+|++|..||.... ..............+.
T Consensus 157 ~~~~-~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd06621 157 NSLA-GTFTGTSFYMAPERIQG--------KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227 (287)
T ss_pred cccc-ccccCCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh
Confidence 2221 23457889999998854 567889999999999999999999997652 1122222222222222
Q ss_pred CC------CCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 288 LP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 288 ~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
++ ..+++.+.+++.+||..+|.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 22 235678999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=304.82 Aligned_cols=242 Identities=24% Similarity=0.373 Sum_probs=182.1
Q ss_pred cceeecccceEEEEEEEC----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe---cCCeEEE
Q 017046 63 GSKIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK---DPLMVIV 135 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~---~~~~~lv 135 (378)
+.+||+|+||+||+|+.. +..||+|.+...... ..+.+|+.+++.++||||+++++++. +...++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 368999999999999863 368999988754332 13678999999999999999999874 3467899
Q ss_pred EeccCCCCHHHHHhhh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC---CCCceeEeccc
Q 017046 136 TELLPGMSLRKYLVSL-------RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP---DQKSLKLADFG 205 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~-------~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~---~~~~vkl~Dfg 205 (378)
|||+. ++|.+++... ....+++..+..++.||+.||.|||+.|++||||||+|||+.. ..+.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 99995 5888877532 1235889999999999999999999999999999999999942 33469999999
Q ss_pred ccccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHH------
Q 017046 206 LAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA------ 275 (378)
Q Consensus 206 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------ 275 (378)
++....... ......+|+.|+|||.+.+ ...++.++|||||||++|+|++|.+||........
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~ 230 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFH 230 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcC-------CCccCcHHHHHhHHHHHHHHHhCCCCccccccccccccccc
Confidence 997543221 1234568899999998854 24578899999999999999999999964332100
Q ss_pred --HHHHHHhc-------------CC------------------------CCCCCCChHHHHHHHHHccccCCCCCCCHHH
Q 017046 276 --AYAAAFKH-------------AR------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 316 (378)
Q Consensus 276 --~~~~~~~~-------------~~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 316 (378)
........ .. .......+..+.+|+.+||..||.+|||+.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e 310 (317)
T cd07867 231 HDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ 310 (317)
T ss_pred HHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHH
Confidence 00000000 00 0001123456889999999999999999999
Q ss_pred HHH
Q 017046 317 IIR 319 (378)
Q Consensus 317 ll~ 319 (378)
+++
T Consensus 311 ~l~ 313 (317)
T cd07867 311 ALQ 313 (317)
T ss_pred Hhc
Confidence 987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=298.35 Aligned_cols=249 Identities=30% Similarity=0.441 Sum_probs=199.9
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|.+.+.||+|+||.||+|.. .++.||+|++......... ....+.+|+.+++.++||||+++++++.+ ...++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE--KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHH--HHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 5588889999999999999986 4789999998654332221 12358899999999999999999999865 47889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||+. |+|.+++.. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 93 VMEYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPA- 168 (307)
T ss_pred EHHhhC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-CEEEeecCcceecCCC-
Confidence 999996 578777754 235689999999999999999999999999999999999999665 5999999998654322
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC-CCCCh
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDIS 293 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 293 (378)
....+++.|+|||++... ....++.++||||||+++|+|++|..||.+........... ....+.+ +..++
T Consensus 169 --~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 240 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLSSNDWS 240 (307)
T ss_pred --CCccCCccccCceeeecc-----CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh-cCCCCCCCchhhC
Confidence 234678899999987431 12557889999999999999999999998776554444332 2222333 34578
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
..+.+++.+||..+|.+||++.+++.+
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 899999999999999999999999884
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=295.41 Aligned_cols=251 Identities=29% Similarity=0.501 Sum_probs=201.3
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc---CCCeeeEEeeEec-CCe
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---HDNLVKFLGACKD-PLM 132 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~~-~~~ 132 (378)
.|.+.+.||+|+||.||+|.+ .++.||+|.+......... ..+.+|+.+++.++ |||++++++++.+ ...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~----~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV----SDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhH----HHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 467788999999999999986 4689999998764433322 35778999999986 9999999998864 478
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
+++|||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~ 153 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCC
Confidence 899999999999998864 3789999999999999999999999999999999999999654 599999999875433
Q ss_pred cc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 017046 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291 (378)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (378)
.. ......|+..|+|||.+.. ...++.++|+||||+++|+|++|..||.+........ .......+.++..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 225 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITE-------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-LIPKSKPPRLEDN 225 (277)
T ss_pred CccccccccCCcceeCHHHhcc-------CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-ccccCCCCCCCcc
Confidence 22 2233468889999998753 2456889999999999999999999998765433222 2222233444443
Q ss_pred -ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 292 -ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 292 -~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
++.++.+++.+||..||.+||++.++++ ..++..
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~R~~~~~il~--~~~~~~ 260 (277)
T cd06917 226 GYSKLLREFVAACLDEEPKERLSAEELLK--SKWIKA 260 (277)
T ss_pred cCCHHHHHHHHHHcCCCcccCcCHHHHhh--ChHhhc
Confidence 7889999999999999999999999988 455544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=295.75 Aligned_cols=254 Identities=29% Similarity=0.441 Sum_probs=200.5
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec---
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD--- 129 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~--- 129 (378)
...+|.+...||+|+||.||++.. .++.+|+|++...... ...+.+|+.+++++ +|||++++++++..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV------DEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH------HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 356799999999999999999987 4688999998653221 13467899999998 79999999998853
Q ss_pred ---CCeEEEEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecc
Q 017046 130 ---PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 130 ---~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Df 204 (378)
...++||||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~df 172 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDF 172 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeec
Confidence 2478999999999999988642 235689999999999999999999999999999999999999665 4999999
Q ss_pred cccccccccc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017046 205 GLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 205 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 283 (378)
|++....... ......++..|+|||.+.... .....++.++|||||||++|+|++|+.||............ ...
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~-~~~ 248 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ---QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI-PRN 248 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCC---CcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH-hcC
Confidence 9987543222 123346888999999875411 01134688999999999999999999999876654443332 222
Q ss_pred CCC--CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 284 ARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 284 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
..+ ..+..++.++.+++.+||..+|.+||++.+++++
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 222 2345677889999999999999999999999884
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=300.27 Aligned_cols=251 Identities=27% Similarity=0.457 Sum_probs=194.8
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec-CCeE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~~~ 133 (378)
++|...+.||+|+||.||++.+ .++.||+|.+........ ...+.+|+.++.++. ||||+++++++.+ ...+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE----QKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHH----HHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 4566778999999999999987 468999999875443322 245889999999996 9999999998754 4788
Q ss_pred EEEeccCCCCHHHHHh---hhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 134 IVTELLPGMSLRKYLV---SLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~---~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
++|||+. ++|.++.. ......+++..+..++.|++.||+|||+. |++||||||+||+++.++ .++|+|||++..
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~ 157 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQ 157 (288)
T ss_pred EEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHH
Confidence 9999984 46655432 22345799999999999999999999975 999999999999999655 599999999875
Q ss_pred cccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
...........|+..|+|||.+... ....++.++|||||||++|+|++|..||..................+.++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPS-----ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232 (288)
T ss_pred hccCCccccccCccCccCHHHhccc-----cccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCC
Confidence 4333333444688899999998541 01367889999999999999999999997655322222222222222222
Q ss_pred ----CCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 290 ----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 290 ----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
..++.++.+|+.+||..+|.+|||+.++++
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 347899999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=297.26 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=193.9
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
..+.|.+.+.||+|+||.||+|.. .++.||||.+......... ..+.+|+.+++.++||||+++++++.++ ..
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP----FTAIREASLLKDLKHANIVTLHDIIHTKKTL 78 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCc----hhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence 346789999999999999999986 4689999998764432211 2366899999999999999999998654 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.....
T Consensus 79 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~ 155 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSV 155 (291)
T ss_pred EEEEecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccccCC
Confidence 89999996 4999988763 34789999999999999999999999999999999999999665 599999999865332
Q ss_pred cc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC------
Q 017046 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR------ 285 (378)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------ 285 (378)
.. ......++..|+|||.+.+ ...++.++||||||+++|+|++|..||.+................
T Consensus 156 ~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 156 PSKTYSNEVVTLWYRPPDVLLG-------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228 (291)
T ss_pred CCccccccccccccCCcHHhhc-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence 21 1122356788999998753 245788999999999999999999999765532222211111000
Q ss_pred --------------------C---CCCCCCh--HHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 286 --------------------P---GLPEDIS--PDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 286 --------------------~---~~~~~~~--~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
. .....++ .++.+++.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0001233 78889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=289.66 Aligned_cols=249 Identities=30% Similarity=0.508 Sum_probs=207.9
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||.|+||.||++.+. +..|++|++......... ...+.+|+++++.++|||++++.+.+.+ ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE---REDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHH---HHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence 4778899999999999999885 789999998765443222 2357899999999999999999998854 478899
Q ss_pred EeccCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||+++++|.+++.... ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSST 156 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECCccceeecccC
Confidence 99999999999997643 36799999999999999999999999999999999999999654 5999999998754333
Q ss_pred c-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
. ......+++.|+|||.+.. ..++.++|+||+|+++|+|++|..||..... ............+.++..+
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 227 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQN--------KPYNYKSDIWSLGCVLYELCTLKHPFEGENL-LELALKILKGQYPPIPSQY 227 (258)
T ss_pred cceecceeeeecccChhHhcc--------CCCCccccHHHHHHHHHHHHcCCCCCCCCcH-HHHHHHHhcCCCCCCCCCC
Confidence 2 2334578889999998754 5578899999999999999999999977653 3344444455566777789
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
+.++.+++.+||..+|.+|||+.+++++
T Consensus 228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 228 SSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=289.25 Aligned_cols=248 Identities=30% Similarity=0.517 Sum_probs=206.3
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---CCeE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMV 133 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~~~ 133 (378)
.|.+.+.||+|++|.||+|... ++.|++|++........ ....+.+|+.++++++||||+++++.+.+ ...+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE---ELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 3677889999999999999875 78999999876554321 23468899999999999999999998865 4678
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+++||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 78 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDI 154 (260)
T ss_pred EEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEcccccEEecccc
Confidence 999999999999999863 3799999999999999999999999999999999999999655 5999999998765544
Q ss_pred cc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCCCCCC
Q 017046 214 EM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-YAAAFKHARPGLP 289 (378)
Q Consensus 214 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~ 289 (378)
.. .....++..|+|||.+.. ...+.++||||||+++|+|++|..||......... .........+.++
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRG--------EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP 226 (260)
T ss_pred cccccccCCCCCccccCHhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCC
Confidence 32 344578899999998854 44788999999999999999999999876532222 2222224556677
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
..++..+.+++.+||..+|.+||++.+++++
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 8889999999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=294.53 Aligned_cols=246 Identities=27% Similarity=0.381 Sum_probs=192.9
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec---CCeE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD---PLMV 133 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~---~~~~ 133 (378)
|.+.+.||+|+||.||++.. .++.||+|+++........ ....+|+.++.++. ||||+++++++.+ +..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ----VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh----hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 56788999999999999986 4688999998764332221 12457888999885 9999999998854 4688
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||+. ++|.+.+... ...+++..+..++.|++.||.|||+.|++||||+|+||+++. +.++|+|||++......
T Consensus 77 lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 77 LVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccC
Confidence 9999996 5888887652 356899999999999999999999999999999999999996 56999999999765444
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc----------
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH---------- 283 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---------- 283 (378)
.......++..|+|||.+.. ...++.++|||||||++|+|++|..||.+.+..+.........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLT-------DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CCcCCCCCCcccCChhHhhc-------CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 33344567889999997643 2456789999999999999999999998765433221111000
Q ss_pred ------CCCCC-----------CCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 284 ------ARPGL-----------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 284 ------~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
....+ ...++.++.+++.+||..+|.+|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00011 13467899999999999999999999999873
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=294.96 Aligned_cols=249 Identities=26% Similarity=0.427 Sum_probs=192.6
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
.+.|.+.+.||+|+||.||+|.. .++.||+|++........ ...+.+|+.+++.++|+||+++++++.++ ..+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV----PFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC----cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 46799999999999999999976 478999999875443221 12367899999999999999999998654 688
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||+. ++|.+++.. ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 80 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIP 156 (291)
T ss_pred EEEeccc-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEeccccccccCCC
Confidence 9999995 688777654 235678889999999999999999999999999999999999665 5999999998753222
Q ss_pred c-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC--------
Q 017046 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-------- 284 (378)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-------- 284 (378)
. ......+++.|+|||.+.+ ...++.++||||||+++|+|++|..||.+...............
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLG-------ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred CCCCCCccccccccCCceeec-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhh
Confidence 1 1233457889999998753 13467789999999999999999999987654322222211100
Q ss_pred ---------CCCC-----C---------CCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 285 ---------RPGL-----P---------EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 285 ---------~~~~-----~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+.+ + ...++++.+++.+||..||.+|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 0 013568899999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=310.21 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=223.6
Q ss_pred cCCcceeecceeecccceEEEEEEECCee--EEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-C
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI--VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 131 (378)
+..+++.++..||.|+||.|-+++..++. +|+|++++....+..+ ++.+..|-.+|..++.|.||++|-.|.|. +
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQ--qeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQ--QEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhH--HHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 45567888899999999999999887655 8999999877766554 35688999999999999999999999765 7
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.|++||-|-||.|+..+.. .+.++...+..++..+++|++|||++|||.|||||+|++++.+|. +||.|||+|+...
T Consensus 495 vYmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy-~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY-LKLVDFGFAKKIG 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc-eEEeehhhHHHhc
Confidence 8899999999999999986 568999999999999999999999999999999999999997765 9999999999998
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (378)
.+..+.+.||||.|.|||++.. ...+.++|.||||+++|||++|.+||.+.+.......+...-....+|..
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILn--------KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~ 643 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILN--------KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRR 643 (732)
T ss_pred cCCceeeecCCcccccchhhhc--------cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccc
Confidence 8888999999999999999975 55688999999999999999999999998876555555444556678999
Q ss_pred ChHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPS-----FSQIIRML 321 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~l 321 (378)
++....+||++++..+|.+|.. +.++-+|-
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 9999999999999999999975 77887743
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=297.76 Aligned_cols=255 Identities=28% Similarity=0.376 Sum_probs=199.2
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC---C
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---L 131 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---~ 131 (378)
.+.|.+.+.||.|+||.||+|.. +++.||+|.+......... ...+.+|+.++++++|+||+++++++.+. .
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI---PISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC---cchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 46799999999999999999987 4789999998754432211 11356899999999999999999988543 5
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~~ 159 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYG 159 (309)
T ss_pred EEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccceeeecC
Confidence 789999995 5898888763 35789999999999999999999999999999999999999655 59999999987543
Q ss_pred cc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-----
Q 017046 212 VT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----- 285 (378)
Q Consensus 212 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----- 285 (378)
.. .......+++.|+|||.+.+ ...++.++|||||||++|+|++|..||.+.+..............
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLG-------CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred CccCCCCcccccccccChhhhcC-------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 32 12223345788999998753 245788999999999999999999999877664443322211000
Q ss_pred ------------CCCC-----------CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 286 ------------PGLP-----------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 286 ------------~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
..++ ...++++.++|.+||..||.+|||+.++++ +.++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~--h~~f~ 294 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE--SSYFK 294 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc--Chhhc
Confidence 0000 125788999999999999999999999998 55554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=296.40 Aligned_cols=248 Identities=27% Similarity=0.440 Sum_probs=196.8
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||+|+||.||+|.+. ++.||+|+++....... ....+.+|+++++.++|+||+++++.+.+ +..+++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDED---VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccccc---chhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 5888999999999999999874 67899998875433221 12458899999999999999999999865 468999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||++++.+..+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEEeeecccccCCCcc
Confidence 999988666655543 45689999999999999999999999999999999999999654 59999999987544332
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC---------
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--------- 284 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------- 284 (378)
......++..|+|||++.. ...++.++||||||+++|+|++|..||.+...............
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVG-------DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred ccccCcccccCCcCCchhcC-------CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh
Confidence 2334567889999999864 12678899999999999999999999987655433322211000
Q ss_pred ---------------------CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 285 ---------------------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 285 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
...++..++.++.+|+.+||..+|++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00122335888999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=298.50 Aligned_cols=250 Identities=28% Similarity=0.428 Sum_probs=199.1
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|.....||+|+||.||++.. .++.||+|++....... ...+.+|+.++..++||||+++++.+.. ...+++|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR-----RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch-----HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 44456799999999999976 47899999986543322 2347799999999999999999998854 5789999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-c
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~ 215 (378)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 98 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 98 EFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred ecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhhccccccc
Confidence 99999999997754 4689999999999999999999999999999999999999665 59999999986432221 1
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC--CCCCCCCCh
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--RPGLPEDIS 293 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~ 293 (378)
.....++..|+|||.+.. ..++.++|||||||++|+|++|..||............ .... ....+..++
T Consensus 174 ~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 244 (297)
T cd06659 174 RKSLVGTPYWMAPEVISR--------TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-RDSPPPKLKNAHKIS 244 (297)
T ss_pred ccceecCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hccCCCCccccCCCC
Confidence 234568899999998854 56788999999999999999999999876554433222 1111 112234578
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
.++.+++.+||..+|.+||++.++++ +.++....
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~--~~~~~~~~ 278 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLD--HPFLLQTG 278 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhh--ChhhccCC
Confidence 89999999999999999999999999 44554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=296.98 Aligned_cols=249 Identities=28% Similarity=0.362 Sum_probs=197.0
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-c--CCe
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-D--PLM 132 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~--~~~ 132 (378)
+.|.+.+.||.|+||.||+|.+. ++.+|+|.++....... ....+.+|+.++..++||||+++++++. + ...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc---chhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 46888999999999999999874 67899999875543321 1234678999999999999999999875 3 578
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+. ++|.+++... ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.....
T Consensus 82 ~lv~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~ 158 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGS 158 (293)
T ss_pred EEEehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-cEEEeecCceeeccC
Confidence 99999996 5999988763 34689999999999999999999999999999999999999665 599999999875443
Q ss_pred c-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh---------
Q 017046 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK--------- 282 (378)
Q Consensus 213 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~--------- 282 (378)
. .......+++.|+|||.+.+ ...++.++|+||||+++|+|++|..||...............
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLG-------AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred CccccccccccccccCchhhcC-------CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence 3 22233467889999998753 134678999999999999999999999876553332221100
Q ss_pred --------------------cCCCCCCCC-ChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 283 --------------------HARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 283 --------------------~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.....++.. +++.+.++|.+||+.+|++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 001122333 5888999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=286.91 Aligned_cols=246 Identities=34% Similarity=0.570 Sum_probs=202.7
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||+|++|.||++... ++.+++|++...... ....+.+|+.+++.++||||+++++.+.+ ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE-----KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchh-----HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4677889999999999999875 688999999765541 12358899999999999999999998864 478899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
+||+++++|.+++... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 76 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 76 MEFCSGGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EecCCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-eEEEeecccccccccccc
Confidence 9999999999998763 25789999999999999999999999999999999999999654 599999999876544332
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC--Ch
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED--IS 293 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~ 293 (378)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||...+.......... ...+.++.. ++
T Consensus 154 ~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 224 (253)
T cd05122 154 RNTMVGTPYWMAPEVING--------KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWS 224 (253)
T ss_pred ccceecCCcccCHHHHcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccC
Confidence 344578889999998854 4478899999999999999999999987654443333322 333344433 38
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
..+.+++.+||..||.+|||+.+++++
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 899999999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=297.15 Aligned_cols=253 Identities=32% Similarity=0.473 Sum_probs=202.9
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
..|.+.+.||+|+||.||++.. ++..||+|.+....... ...+.+|+.+++.++||||+++++.+.+ ...++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK-----KELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH-----HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 5788999999999999999975 46789999986433222 2357899999999999999999998864 47899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
|+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEccCcceecccccc
Confidence 9999999999999865 4588999999999999999999999999999999999999655 59999999876433222
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC--CCCC
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPED 291 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~ 291 (378)
......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||...+........ .....+. .+..
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~ 240 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQNPEK 240 (293)
T ss_pred cccccccCChhhcCchhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-hcCCCCCCCCccc
Confidence 2233468889999998854 55788999999999999999999999876543332221 1122222 2345
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
++..+.+++.+||..+|.+||++.+++. +.++....+
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~--h~~~~~~~~ 277 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKIAKP 277 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhcCcc
Confidence 7788999999999999999999999998 556655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=296.27 Aligned_cols=258 Identities=27% Similarity=0.480 Sum_probs=202.0
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEe
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACK 128 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~ 128 (378)
.+.++.+.|.+.+.||+|+||.||+|.+. ++.||||.++........ ..+..|+.++..+. ||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN----KRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHH----HHHHHHHHHHHhccCCCchHhhheeee
Confidence 34456678999999999999999999886 789999999765433221 24667777777664 999999999986
Q ss_pred c-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 129 D-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 129 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
+ ...+++|||+ +++|.+++... ...+++..+..++.|++.||+|||+ .|++||||+|+||+++.++ .++|+|||+
T Consensus 85 ~~~~~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~ 161 (296)
T cd06618 85 TDSDVFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGI 161 (296)
T ss_pred cCCeEEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECcccc
Confidence 5 4789999998 55888877653 3578999999999999999999997 5999999999999998654 599999999
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
+.............++..|+|||.+.... ....++.++||||||+++|+|++|+.||..................+
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (296)
T cd06618 162 SGRLVDSKAKTRSAGCAAYMAPERIDPPD----PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237 (296)
T ss_pred chhccCCCcccCCCCCccccCHhhcCCCC----CccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC
Confidence 87543333333446788999999985411 02457889999999999999999999997644433333333333333
Q ss_pred CCCC--CChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 287 GLPE--DISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 287 ~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.++. .++.++.+|+.+||..||.+||++.+++++
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 3333 478999999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=297.53 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=197.0
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+.+.||+|+||.||++.+. ++.||+|++........ ..+.+.+|+++++.++||||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKM---VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcch---hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 35888999999999999999874 68999999865443321 223578999999999999999999998654 7899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
||||+++++|..+... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 78 VFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPG 154 (286)
T ss_pred EEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-cEEEEeeeeeeeccCCc
Confidence 9999999888887654 34589999999999999999999999999999999999999655 5999999998753322
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc----------
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH---------- 283 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---------- 283 (378)
.......++..|+|||.+.+ ...++.++||||||+++|+|++|..||................
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVG-------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred cccCcccceeeccCcHHhcc-------ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence 22233467889999998753 2346788999999999999999999997655433222211100
Q ss_pred ----------CCCC---------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 284 ----------ARPG---------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 284 ----------~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
..+. ....++..+.+++.+||..+|.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000 123578889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.64 Aligned_cols=251 Identities=25% Similarity=0.464 Sum_probs=206.9
Q ss_pred eecceeecccceEEEEEEECCe--eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC---CeEEE
Q 017046 61 FIGSKIGEGAHGKVYEGRYGDR--IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---LMVIV 135 (378)
Q Consensus 61 ~~~~~lG~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---~~~lv 135 (378)
+...+||+|+|-+||+|-+..+ .||=-.++........ ....+|..|+.+|+.|+||||+++++++.+. ...+|
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~-~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSP-EELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcCh-HHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 4456899999999999987543 3332222111111111 1124799999999999999999999998653 47799
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+|.+..|+|..|+.. .+.++...+..|++||+.||.|||++ .|||||||-+||+|+.+.+.|||+|+|+|+.....
T Consensus 122 TEL~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 122 TELFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eecccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999999987 45689999999999999999999999 49999999999999988888999999999876544
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC-CCCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDI 292 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 292 (378)
.. ...+|||.|||||++- ..|...+||||||+.|+||+|+..||..-.+.-.+|+.+..+..|.- ..--
T Consensus 200 ~a-ksvIGTPEFMAPEmYE---------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 200 HA-KSVIGTPEFMAPEMYE---------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred cc-ceeccCccccChHHHh---------hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence 43 3479999999999984 68999999999999999999999999988888888988887776653 3344
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.+++++||.+||.. ..+|||+.++|+ +.++..
T Consensus 270 dPevr~fIekCl~~-~~~R~sa~eLL~--d~Ff~~ 301 (632)
T KOG0584|consen 270 DPEVREFIEKCLAT-KSERLSAKELLK--DPFFDE 301 (632)
T ss_pred CHHHHHHHHHHhcC-chhccCHHHHhh--Chhhcc
Confidence 68999999999999 999999999998 566554
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=301.90 Aligned_cols=253 Identities=30% Similarity=0.432 Sum_probs=194.3
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-----
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 130 (378)
++|.+.+.||+|+||.||+|++ +++.||+|++....... ...++.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT----FCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccch----hHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 5799999999999999999976 46899999986432221 223577899999999999999999876432
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
..++++||+. ++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~ 155 (336)
T cd07849 81 NDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLARI 155 (336)
T ss_pred ceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEECcccceee
Confidence 4689999995 588877754 5699999999999999999999999999999999999999655 599999999865
Q ss_pred ccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH----
Q 017046 210 ETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF---- 281 (378)
Q Consensus 210 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~---- 281 (378)
..... ......|++.|+|||.+.. ...++.++|||||||++|+|++|+.||.+............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~ 228 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 33221 1123467889999998643 24578899999999999999999999976543221110000
Q ss_pred ------------------hc--CCCC-----CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 282 ------------------KH--ARPG-----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 282 ------------------~~--~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
.. ..+. .....++++.+++.+||+.+|.+|||+.++++ +.++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~--hp~~~~~ 298 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA--HPYLEQY 298 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc--Ccccccc
Confidence 00 0000 11345788999999999999999999999999 4444443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.60 Aligned_cols=253 Identities=29% Similarity=0.418 Sum_probs=202.0
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|...+.||+|+||.||+++. .+..||+|++......... ....+.+|+++++.++|||++++++++.+ ...++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE--KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchH--HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 3477788999999999999986 4689999998754333221 22458899999999999999999998865 46789
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||+. |+|.+++.. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 103 v~e~~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 103 VMEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASIASP-- 177 (317)
T ss_pred EEeCCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecCCCccccCC--
Confidence 999996 588877754 245689999999999999999999999999999999999998665 599999998865332
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
.....+++.|+|||.+... ....++.++|||||||++|+|++|..||.....................+..+++
T Consensus 178 -~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD 251 (317)
T ss_pred -cccccCCccccChhhhhcC-----CCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccH
Confidence 2344688899999987431 1245788999999999999999999999876654444443333333333456888
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
.+.+++.+||..+|.+||++.++++++..
T Consensus 252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 99999999999999999999999986544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=292.97 Aligned_cols=251 Identities=30% Similarity=0.465 Sum_probs=200.4
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|.-.+.||+|++|.||++.. .++.+++|++....... ...+.+|+.+++.++||||+++++++.. ...++++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhH-----HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 44457899999999999976 46889999886433222 2347899999999999999999998854 5789999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-c
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~ 215 (378)
||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++ .++|+|||++....... .
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 96 EFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred eccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcccccchhhccCCcc
Confidence 99999999999875 4689999999999999999999999999999999999999655 59999999876432211 1
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--CCCCh
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDIS 293 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~ 293 (378)
.....|++.|+|||.+.. ..++.++||||||+++|+|++|..||.+........ .......+.. +..++
T Consensus 172 ~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (285)
T cd06648 172 RKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK-RIRDNLPPKLKNLHKVS 242 (285)
T ss_pred cccccCCccccCHHHhcC--------CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH-HHHhcCCCCCcccccCC
Confidence 223468899999998854 567889999999999999999999998765433322 2222222222 23478
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
..+.+++.+||..+|.+|||+.++++ +.++....+
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~~~~ 277 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN--HPFLAKAGP 277 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc--CcccccCCC
Confidence 99999999999999999999999998 566655444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=287.18 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=203.2
Q ss_pred ceeec-ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-----
Q 017046 59 LLFIG-SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD----- 129 (378)
Q Consensus 59 ~~~~~-~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~----- 129 (378)
+|.|- .+||-|-.|.|....+ +++.+|+|++.... +..+|+++--.. .|||||.++++|+.
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----------KARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 44443 5799999999998755 68999999986532 245787765555 59999999999853
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC--CCceeEeccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLA 207 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~--~~~vkl~Dfg~a 207 (378)
..+.+|||.++||.|.+.++......+++.++..|+.||..|+.|||+.+|.||||||+|+|.... +..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 257799999999999999999777889999999999999999999999999999999999999643 346999999999
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCC
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL--QAAYAAAFKHAR 285 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~ 285 (378)
+.........+.+.||.|.|||++.. ..|+...|+||+|++||-|++|.+||...... ..-+...+....
T Consensus 212 K~t~~~~~L~TPc~TPyYvaPevlg~--------eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 212 KETQEPGDLMTPCFTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ 283 (400)
T ss_pred cccCCCccccCCcccccccCHHHhCc--------hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence 98776677778899999999999864 67999999999999999999999999754431 111233333444
Q ss_pred CCCCC----CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 286 PGLPE----DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 286 ~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
..||. .+|.+.+++|+.+|..+|.+|.|+.+++. +.|+.
T Consensus 284 y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~--hpwi~ 326 (400)
T KOG0604|consen 284 YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD--HPWIN 326 (400)
T ss_pred ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc--Cchhc
Confidence 44553 47889999999999999999999999998 44443
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=291.96 Aligned_cols=251 Identities=32% Similarity=0.509 Sum_probs=203.5
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 134 (378)
+.|.+...||+|+||.||++.+. +..|++|++..... ....+.+|+.+++.++|+||+++++.+. +...++
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45777889999999999999885 78999999976444 1235789999999999999999999885 457889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
++||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-CEEECccchhhhhccch
Confidence 999999999999998733 4799999999999999999999999999999999999999655 59999999876433221
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC--CC
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--ED 291 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~ 291 (378)
......++..|+|||.+.. ..++.++|+||||+++|+|++|..||............. ....+..+ ..
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKR--------KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT-TKGIPPLKNPEK 241 (286)
T ss_pred hhhccccCCcccCCHhHhcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCCCCCcchhh
Confidence 1223457889999998754 567889999999999999999999998766544433332 22222222 33
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
++.++.+++.+||+.+|..|||+.++++ +.++..
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~ 275 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQ--HPFLKK 275 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh--ChHhhc
Confidence 7899999999999999999999999988 444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=291.81 Aligned_cols=243 Identities=24% Similarity=0.361 Sum_probs=189.8
Q ss_pred eeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHh---hccCCCeeeEEeeEe-cCCeEEEEec
Q 017046 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS---RVKHDNLVKFLGACK-DPLMVIVTEL 138 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~---~l~hp~iv~l~~~~~-~~~~~lv~e~ 138 (378)
.||+|+||.||++.. +++.||+|.+.......... ...+.+|..+++ ..+||||+.+++.+. ++..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH--HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 389999999999987 46899999987654432211 112334443333 347999999999885 4578899999
Q ss_pred cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccccc
Q 017046 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 218 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~ 218 (378)
+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+|||++.++ .++|+|||++....... ...
T Consensus 79 ~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~~-~~~ 154 (279)
T cd05633 79 MNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKK-PHA 154 (279)
T ss_pred CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEccCCcceeccccC-ccC
Confidence 999999998875 35699999999999999999999999999999999999999655 59999999986543222 233
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCCCCCChHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAAFKHARPGLPEDISPDLA 297 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~ 297 (378)
..|++.|+|||.+.. ...++.++||||+||++|+|++|..||...... ..............++..+++++.
T Consensus 155 ~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (279)
T cd05633 155 SVGTHGYMAPEVLQK-------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELK 227 (279)
T ss_pred cCCCcCccCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHH
Confidence 468999999998742 245788999999999999999999999754321 112222223345567788999999
Q ss_pred HHHHHccccCCCCCC-----CHHHHHHH
Q 017046 298 FIVQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 298 ~li~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
+++.+||..||.+|| |+.+++++
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 228 SLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 999999999999999 69999884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=295.19 Aligned_cols=250 Identities=28% Similarity=0.396 Sum_probs=194.7
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-C---
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-L--- 131 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~--- 131 (378)
.|.+.+.||+|+||.||+|.+ +++.||||++........ ....+.+|+.+++.+ +||||+++++.+... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG---IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC---CchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 588889999999999999987 468999998765433221 113477899999999 469999999988543 2
Q ss_pred --eEEEEeccCCCCHHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 132 --MVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 132 --~~lv~e~~~~~sL~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
.+++|||+++ +|.+++.... ...+++..++.++.||+.||.|||++|++||||+|+||+++.++..++|+|||+
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 6899999975 8988886533 235899999999999999999999999999999999999997456799999999
Q ss_pred ccccccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017046 207 AREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 207 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
+...... .......+++.|+|||.+.. ...++.++||||||+++|+|++|..||.+.+..............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLG-------STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhC-------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence 8753222 11223356788999998753 245688999999999999999999999877655443332211000
Q ss_pred ------------------CC--------CCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 286 ------------------PG--------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 286 ------------------~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+. ..+.++.++.++|.+||..||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 11347888999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=302.06 Aligned_cols=254 Identities=23% Similarity=0.367 Sum_probs=198.4
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-----
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 130 (378)
.+|.+.+.||.|+||.||+|.. +++.||+|++....... .+.+.+|+.+++.++||||+++++.+.+.
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~-----~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS-----VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCch-----HHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 5789999999999999999987 46899999987654422 13477899999999999999998765432
Q ss_pred ----------CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCcee
Q 017046 131 ----------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200 (378)
Q Consensus 131 ----------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vk 200 (378)
..++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.|++||||||+||+++.++..++
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEE
Confidence 4689999996 589888754 46899999999999999999999999999999999999986666689
Q ss_pred Eecccccccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHH
Q 017046 201 LADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (378)
Q Consensus 201 l~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 276 (378)
|+|||++....... ......++..|+|||.+.. ...++.++|||||||++|+|++|..||.+.......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhC-------ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999986532211 1123357889999997643 245788999999999999999999999876653332
Q ss_pred HHHHHh-----------------------cCCC-----CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 277 YAAAFK-----------------------HARP-----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 277 ~~~~~~-----------------------~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
...... ...+ .+...++.++.+|+.+||..||.+|||+.+++. +.++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--h~~~~~~ 306 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM--HPYMSCY 306 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC--CCccccc
Confidence 221110 0000 012357788999999999999999999999998 5666544
Q ss_pred C
Q 017046 329 R 329 (378)
Q Consensus 329 ~ 329 (378)
.
T Consensus 307 ~ 307 (342)
T cd07854 307 S 307 (342)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=295.21 Aligned_cols=254 Identities=17% Similarity=0.250 Sum_probs=185.9
Q ss_pred cCCcceeecceeecccceEEEEEEECC-----eeEEEEEeecCCCchHHHHH------HHHHHHHHHHHhhccCCCeeeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALL------EGRFIREVNMMSRVKHDNLVKF 123 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~------~~~~~~E~~~l~~l~hp~iv~l 123 (378)
+..+.|.+.+.||+|+||.||+|.+.+ ..+|+|+..........+.. ......++..+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345689999999999999999998743 46777765433322111100 1112334455566789999999
Q ss_pred EeeEecC-----CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCc
Q 017046 124 LGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (378)
Q Consensus 124 ~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~ 198 (378)
++.+... ..+++++++ ..++.+.+... ...++..+..++.|++.||.|||+.|++||||||+|||++.++ .
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~-~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN-R 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-c
Confidence 9876432 346788887 45777776542 3467888999999999999999999999999999999998655 5
Q ss_pred eeEeccccccccccc--------cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCC
Q 017046 199 LKLADFGLAREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (378)
Q Consensus 199 vkl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 270 (378)
++|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--------~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--------ACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999998753211 11223469999999998864 66899999999999999999999999876
Q ss_pred ChHHHHHHH-------HHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 271 SNLQAAYAA-------AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 271 ~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
......... ...... .....++.++.+++..||..+|.+||++.++++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 237 GHNGNLIHAAKCDFIKRLHEGK-IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccchHHHHHhHHHHHHHhhhhh-hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 432221111 111111 12345789999999999999999999999998865
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=290.42 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=190.5
Q ss_pred eeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHH---HHHhhccCCCeeeEEeeEec-CCeEEEEec
Q 017046 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREV---NMMSRVKHDNLVKFLGACKD-PLMVIVTEL 138 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~ 138 (378)
.||+|+||.||+++. .++.||+|++.......... ...+..|. ..++...||+|+.+++.+.+ +..++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh--HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 379999999999876 46899999987654322111 11233343 34445679999999998865 478899999
Q ss_pred cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccccc
Q 017046 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 218 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~ 218 (378)
+.|++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++ .++|+|||++....... ...
T Consensus 79 ~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~~-~~~ 154 (278)
T cd05606 79 MNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKK-PHA 154 (278)
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCccC-CcC
Confidence 999999998865 35699999999999999999999999999999999999999655 59999999986543222 234
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCCCCCChHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAAFKHARPGLPEDISPDLA 297 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~ 297 (378)
..|+..|+|||.+.. ...++.++||||+|+++|+|++|..||.+.... ............+.++..++.++.
T Consensus 155 ~~~~~~y~aPE~~~~-------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 227 (278)
T cd05606 155 SVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 227 (278)
T ss_pred cCCCcCCcCcHHhcC-------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHH
Confidence 578999999999853 235788999999999999999999999765321 111222233445667778899999
Q ss_pred HHHHHccccCCCCCC-----CHHHHHH
Q 017046 298 FIVQSCWVEDPNLRP-----SFSQIIR 319 (378)
Q Consensus 298 ~li~~~l~~dp~~Rp-----s~~~ll~ 319 (378)
+++.+||..+|.+|| ++.++++
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 228 SLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 999999999999999 9999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=299.10 Aligned_cols=246 Identities=24% Similarity=0.388 Sum_probs=190.4
Q ss_pred ceeecc--cceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEEEec
Q 017046 64 SKIGEG--AHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTEL 138 (378)
Q Consensus 64 ~~lG~G--~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv~e~ 138 (378)
..||+| +||+||++++ .++.||+|++......... .+.+.+|+.+++.++||||+++++++.++ ..++||||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEH---LKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHH---HHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 356666 9999999987 5799999998765443322 24688999999999999999999999654 78899999
Q ss_pred cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc---
Q 017046 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--- 215 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--- 215 (378)
+.+++|.+++.......+++..+..++.|++.||+|||+.|++||||||+|||++.++ .++++||+.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhccCcccc
Confidence 9999999999875556799999999999999999999999999999999999999665 599999986432111100
Q ss_pred -----cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC------
Q 017046 216 -----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA------ 284 (378)
Q Consensus 216 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------ 284 (378)
.....++..|+|||++.. ....++.++|||||||++|+|++|..||.+...............
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQ------DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI 233 (328)
T ss_pred ccccccccccCccCccChhhhcC------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence 011234567999999854 123478899999999999999999999987654333222211000
Q ss_pred ---------------------------------------CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 285 ---------------------------------------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 285 ---------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
....+..+++.+.+|+.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00112236678999999999999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=288.36 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=205.3
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||.|+||.||++.. .++.+|+|.+......... ...+.+|+.+++.++||||+++++.+.+ ...++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE---REDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHH---HHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 377889999999999999976 4678999998764433221 2357789999999999999999988754 578899
Q ss_pred EeccCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
|||+++++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKN 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEEeeccchhhhccC
Confidence 99999999999986522 35689999999999999999999999999999999999999654 5999999998765443
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
......+++.|+|||.+.. ..++.++|+||||+++|+|++|+.||...+.. ...........+..+..++
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG--------RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-DLRYKVQRGKYPPIPPIYS 226 (256)
T ss_pred -CcccccCCccccCHHHHCC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCCCCCchhhC
Confidence 3334568889999998854 56788999999999999999999999876543 3334444555566677889
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.++.+++.+||..+|.+|||+.+++++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 227 QDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=298.22 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=198.9
Q ss_pred eeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEec
Q 017046 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTEL 138 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~ 138 (378)
+.+++.+|.|+++.||++..+++.||||++......... ...+.+|+.+++.++||||+++++++.+ ...+++|||
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKED---LKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhH---HHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 445667777788888888888999999999865332221 2468899999999999999999998864 478899999
Q ss_pred cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-----
Q 017046 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----- 213 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~----- 213 (378)
+++++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||.+......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-ceEEecCccceeecccccccc
Confidence 9999999999875556799999999999999999999999999999999999999655 5999999987643211
Q ss_pred ---cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC------
Q 017046 214 ---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA------ 284 (378)
Q Consensus 214 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------ 284 (378)
.......++..|+|||.+.. ....++.++|+|||||++|+|++|..||.................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQ------NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK 233 (314)
T ss_pred ccccccccccccccccCHHHhcC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence 11223457778999998853 123578899999999999999999999987654433322211100
Q ss_pred --------------------------CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 285 --------------------------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 285 --------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
....+..++.++.+++..||..||.+|||+.++++ +.++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~p~~~~~ 301 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN--HSFFKQC 301 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc--CchHhhh
Confidence 00111234567889999999999999999999999 5555443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=292.82 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=196.5
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|.+.+.||.|++|.||+|.+ .+..||+|++........ ....+.+|+.+++.++|||++++++++.+ ...+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG---VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc---chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence 56678999999999999976 478999999876543221 12347789999999999999999998865 4788999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-c
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~ 215 (378)
||+ +++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 78 EFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRT 155 (283)
T ss_pred ecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCCCccc
Confidence 999 46999998764445789999999999999999999999999999999999999654 59999999986543221 1
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-----------
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA----------- 284 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----------- 284 (378)
.....++..|+|||++.. ...++.++|+||||+++|+|++|..||.+.+.............
T Consensus 156 ~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 156 YTHEVVTLWYRAPEILLG-------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred cCccccccCCCCCceeec-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence 123356889999998753 23567899999999999999999999987665443332211100
Q ss_pred ----------------CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 285 ----------------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 285 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.......++.++.+++.+||+.+|.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 001124577899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=300.27 Aligned_cols=254 Identities=27% Similarity=0.407 Sum_probs=197.4
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-----
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 130 (378)
..|.+.+.||+|+||+||+++. +++.||||.+......... ..++.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID---AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch---hHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 4688999999999999999986 4689999998754322211 23467899999999999999999877432
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
..+++|||+ +++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus 82 ~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELM-DTDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCC-CCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCccccc
Confidence 478999999 4689988875 35799999999999999999999999999999999999999665 599999999875
Q ss_pred cccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH-------
Q 017046 210 ETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF------- 281 (378)
Q Consensus 210 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~------- 281 (378)
.... .......++..|+|||.+.. ...++.++|||||||++|+|++|..||.+.+..........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLN-------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred cCCCcccccccccccCccChHHHhc-------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 4333 22334467889999998753 13478899999999999999999999976543221111000
Q ss_pred ---------------h--c--CC---CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 282 ---------------K--H--AR---PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 282 ---------------~--~--~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
. . .. ......+++++.+++.+||+.+|.+|||+.+++++ .++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h--~~~~~ 296 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH--PYLAS 296 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC--cchhh
Confidence 0 0 00 01124578899999999999999999999999994 44443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=283.55 Aligned_cols=246 Identities=31% Similarity=0.560 Sum_probs=205.5
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||+|++|.||++.. .++.|++|.+........ ....+.+|++++++++|||++++++++.+ ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE---ALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHH---HHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 377889999999999999976 467899999987654322 22468899999999999999999998864 478899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 78 LEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSK 154 (254)
T ss_pred EecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEeccccceecCCCcc
Confidence 9999999999998763 5799999999999999999999999999999999999999654 599999999875443322
Q ss_pred -cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 216 -MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 216 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
.....++..|+|||.+.. ..++.++|||+||+++|+|++|..||............ .....+.++..++.
T Consensus 155 ~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 225 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEM--------SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI-VQDDHPPLPEGISP 225 (254)
T ss_pred cccccccchhhcCHhhhcC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-hccCCCCCCCCCCH
Confidence 233467889999998754 34788999999999999999999999876654443333 34556667788999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+.+++.+||..+|++|||+.+++.
T Consensus 226 ~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 226 ELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHHHHhCChhhCcCHHHHhc
Confidence 9999999999999999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=291.88 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=198.5
Q ss_pred ceeecceeecccceEEEEEEE-----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-C
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-L 131 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~ 131 (378)
.|++.+.||.|+||.||.++. .++.||+|++....... .....+++.+|+.++..+ +|+||+++++.+..+ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh-cchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 377889999999999999875 56889999987543221 112234578899999999 699999999988654 6
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+|||++.++ .++|+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEEeeCccceecc
Confidence 7899999999999999876 35688999999999999999999999999999999999999665 59999999987543
Q ss_pred ccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCC
Q 017046 212 VTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFKHARPG 287 (378)
Q Consensus 212 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~ 287 (378)
... ......|+..|+|||.+.. ....++.++||||||+++|+|++|..||..... .............+.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRG------GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 230 (290)
T ss_pred cccccccccccCCcccCChhhccC------CCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC
Confidence 322 1223468899999998753 123467889999999999999999999964322 111122222334456
Q ss_pred CCCCChHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 319 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~ 319 (378)
++..+++.+.+++.+||..||.+|| ++.+++.
T Consensus 231 ~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 6778999999999999999999997 7788877
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=292.09 Aligned_cols=247 Identities=27% Similarity=0.421 Sum_probs=197.9
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv~ 136 (378)
|....+||+|+||+||+|+. .++.|++|++.......... ...+.+|+.+++.++|||++++++++.+. ..++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEK--WQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHH--HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 55567899999999999986 57899999987654432221 23578899999999999999999998654 678999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccc
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~ 216 (378)
||+. ++|.+++.. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..... .
T Consensus 101 e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~~---~ 174 (313)
T cd06633 101 EYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSSP---A 174 (313)
T ss_pred ecCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCcccCC---C
Confidence 9995 588887765 345689999999999999999999999999999999999999665 499999999864322 2
Q ss_pred ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHH
Q 017046 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDL 296 (378)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 296 (378)
....|+..|+|||.+... ....++.++||||||+++|+|++|..||........................++..+
T Consensus 175 ~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (313)
T cd06633 175 NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249 (313)
T ss_pred CCccccccccChhhcccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHH
Confidence 345788899999987421 124578899999999999999999999987765554444433332223334577889
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 017046 297 AFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 297 ~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+++.+||+.+|.+||++.+++.
T Consensus 250 ~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 250 RGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=289.72 Aligned_cols=248 Identities=28% Similarity=0.451 Sum_probs=194.5
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||.|++|.||+|+. +++.||||++......... ..+.+|+.+++.++||||+++++.+.+ +..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP----STAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccch----HHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 477889999999999999987 4789999998765433221 246789999999999999999999865 478999
Q ss_pred EeccCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
|||+++ +|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPV 154 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcCCc
Confidence 999975 8888886533 24589999999999999999999999999999999999999655 59999999986533221
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC---------
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--------- 284 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------- 284 (378)
......+++.|++||.+.. ...++.++||||||+++|+|++|..||.+.+..+..........
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLG-------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPG 227 (284)
T ss_pred cccccccccccccChHHhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHH
Confidence 1233457889999998753 23467899999999999999999999987654332222111000
Q ss_pred -------CCC-----------CCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 285 -------RPG-----------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 285 -------~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
... +.+.++.++.+++.+||+.||.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 11245778999999999999999999999987
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=290.94 Aligned_cols=253 Identities=30% Similarity=0.472 Sum_probs=201.1
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|....+||+|+||.||++.. .++.||||.+...... ....+.+|+.+++.++||||+++++.+.+ +..+++|
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ-----RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchh-----HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 33446799999999999977 4689999987543321 23458899999999999999999998864 5789999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-c
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~ 215 (378)
||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 97 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 97 EFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceeccccccc
Confidence 99999999998754 4689999999999999999999999999999999999999665 59999999876433221 1
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC--CCCCCh
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDIS 293 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~ 293 (378)
.....+++.|+|||.+.. ..++.++|+||+|+++|+|++|..||.+....... .......... ....++
T Consensus 173 ~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06657 173 RKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPKLKNLHKVS 243 (292)
T ss_pred ccccccCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhhCCcccCCcccCC
Confidence 233467889999998753 55788999999999999999999999876543322 2222222222 234578
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
+.+.+++.+||..+|.+||++.++++ +.++....+++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~--~~~~~~~~~~~ 280 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPPS 280 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc--ChHHhccCCCc
Confidence 99999999999999999999999999 67776665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=289.60 Aligned_cols=248 Identities=29% Similarity=0.437 Sum_probs=196.3
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec-CCeEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~~~lv 135 (378)
|.+.+.||.|+||+||+|+. .++.|+||.+......... ....+|+..+.+++ ||||+++++.+.+ ...++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE----CMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhH----HHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 56788999999999999987 4678999998765433221 23557999999998 9999999998854 478999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
|||+ +++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPP 154 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-CEEEeecccceeccCCCC
Confidence 9999 88999988775445789999999999999999999999999999999999999655 599999999876544433
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC---------
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--------- 286 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------- 286 (378)
.....++..|+|||.+.. ...++.++|+||||+++|+|++|..||..................+
T Consensus 155 ~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07830 155 YTDYVSTRWYRAPEILLR-------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227 (283)
T ss_pred cCCCCCcccccCceeeec-------CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh
Confidence 345568889999998753 2457889999999999999999999998765533332221100000
Q ss_pred -------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 287 -------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 287 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
......+.++.+++.+||..+|.+|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0111236789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=289.10 Aligned_cols=251 Identities=29% Similarity=0.446 Sum_probs=199.0
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
+|.+.+.||+|+||.||+++.. +..+++|+++..............+..|+.+++.++||||+++++.+.+ ...++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999774 3456666665433221111112246689999999999999999998854 478899
Q ss_pred EeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 136 TELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
|||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++ ++ .++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-~~-~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NN-LLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-cC-CEeecccCceeecCCC
Confidence 9999999999988642 235689999999999999999999999999999999999998 44 4999999998654222
Q ss_pred -cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 214 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
.......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||...... ...........+.++..+
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 229 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKH--------QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-SVVLRIVEGPTPSLPETY 229 (260)
T ss_pred cccccCCCCCcCccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHcCCCCCCcchh
Confidence 22234467889999998753 45678899999999999999999999765543 333344455566677788
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
+.++.+++.+||..+|.+||++.+++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 230 SRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 9999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=301.16 Aligned_cols=246 Identities=25% Similarity=0.412 Sum_probs=208.2
Q ss_pred cceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEEEecc
Q 017046 63 GSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELL 139 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv~e~~ 139 (378)
.+.||+|.||+||-|++ +|+.||||++.+...+...+ ..+.+|+.||+.++||.||.+-..|+.. ..++|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe---sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE---SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH---HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 46899999999998865 68999999998877665543 4588999999999999999999999765 678999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC--CceeEeccccccccccccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREETVTEMMT 217 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~--~~vkl~Dfg~a~~~~~~~~~~ 217 (378)
.|+..++|-+...+.+++.....++.||+.||.|||.++|+|.||||+|||+.+.. -.+||||||+|+.........
T Consensus 646 -~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 646 -HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred -cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 66777777666778899999999999999999999999999999999999997432 259999999999988888888
Q ss_pred cCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHH
Q 017046 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 297 (378)
Q Consensus 218 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 297 (378)
..+|||.|.|||++.. ..|...-|+||.|+|+|--++|..||....+..+..+...--.++.--..+++++.
T Consensus 725 sVVGTPAYLaPEVLrn--------kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRN--------KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAI 796 (888)
T ss_pred hhcCCccccCHHHHhh--------ccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHH
Confidence 9999999999999975 77889999999999999999999999876654443333322222222245889999
Q ss_pred HHHHHccccCCCCCCCHHHHHHH
Q 017046 298 FIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 298 ~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
+||..+|+..-.+|.|.+..+.+
T Consensus 797 dlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhccc
Confidence 99999999999999998887773
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=291.60 Aligned_cols=250 Identities=28% Similarity=0.395 Sum_probs=197.7
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
..|...+.||+|+||.||+|+. .++.+|+|.+......... ...++.+|+++++.++|+|++++++++.+ ...++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE--KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChH--HHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3466778999999999999987 4678999998753322221 12357889999999999999999998864 46789
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||+. ++|.+++.. ....+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++......
T Consensus 93 v~e~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 93 VMEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEEccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccceeecCc-
Confidence 999995 588887754 235689999999999999999999999999999999999999655 5999999998654322
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
....+++.|+|||.+... ....++.++|||||||++|+|++|..||.....................+..++.
T Consensus 169 --~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241 (308)
T ss_pred --ccccCCccccCHHHHhhc-----ccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccH
Confidence 334678899999987431 1245678999999999999999999999876554443333322222223446888
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.+.++|.+||..+|.+||++.+++++
T Consensus 242 ~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 242 YFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 99999999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=284.62 Aligned_cols=239 Identities=25% Similarity=0.345 Sum_probs=186.1
Q ss_pred ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHH-hhccCCCeeeEEeeEec-CCeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM-SRVKHDNLVKFLGACKD-PLMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~l~~~~~~-~~~~lv~e~~ 139 (378)
+.||.|+||.||+|.. .++.||+|++.......... ...+..|..++ ...+|||++++++.+.+ ...++||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ--VTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHH--HHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 5689999999999987 46899999986543222111 12344554444 44589999999999865 4789999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccccccC
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 219 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 219 (378)
++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..... ....
T Consensus 80 ~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~---~~~~ 153 (260)
T cd05611 80 NGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE---NKKF 153 (260)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEeecccceeccc---cccC
Confidence 99999999875 34689999999999999999999999999999999999999655 599999999875332 2334
Q ss_pred cCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc---CCCCCCCCChHHH
Q 017046 220 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH---ARPGLPEDISPDL 296 (378)
Q Consensus 220 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 296 (378)
.++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ....... ........+++++
T Consensus 154 ~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05611 154 VGTPDYLAPETILG--------VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDNILSRRINWPEEVKEFCSPEA 224 (260)
T ss_pred CCCcCccChhhhcC--------CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcccCCCCcccccCCHHH
Confidence 67889999998854 4478899999999999999999999987655332 2222211 1223344688999
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 017046 297 AFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 297 ~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+++.+||+.+|++||++.++.+
T Consensus 225 ~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 225 VDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred HHHHHHHccCCHHHccCCCcHHH
Confidence 99999999999999996654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=295.61 Aligned_cols=255 Identities=28% Similarity=0.411 Sum_probs=199.8
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 130 (378)
...|.+.+.||+|+||.||++.. .+..||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE---LFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch---HHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 45699999999999999999976 46899999986543222 1234578999999999999999999988532
Q ss_pred ---CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 131 ---~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
..++||||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~ 165 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLA 165 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccc
Confidence 358999999 7899988764 4689999999999999999999999999999999999999655 5999999998
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC---
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--- 284 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--- 284 (378)
...... .....+++.|+|||.+.. ...++.++|+||||+++|+|++|..||.+...............
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 166 RQTDSE--MTGYVVTRWYRAPEVILN-------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred cccccC--ccccccCCcccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 754322 233467889999998753 13477899999999999999999999987654322221111000
Q ss_pred ------------------C--------CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 285 ------------------R--------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 285 ------------------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
. ..+...+++++.+++.+||..||.+|||+.+++. +.++.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~--~~~~~~~~~ 306 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA--HPYFEEFHD 306 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc--CccHhhhcC
Confidence 0 0112457788999999999999999999999997 566655443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=291.60 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=192.4
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC---
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 130 (378)
..+.|.+.++||+|+||.||+++. +++.||||.+......... ...+.+|+.++++++||||+++++++.+.
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF---PITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCc---hhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 446799999999999999999987 4689999998754432221 12356899999999999999999987532
Q ss_pred ------CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecc
Q 017046 131 ------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 131 ------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Df 204 (378)
..++||||+. ++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~df 163 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADF 163 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcC
Confidence 3589999995 588888765 334689999999999999999999999999999999999999655 5999999
Q ss_pred cccccccccc-----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHH
Q 017046 205 GLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (378)
Q Consensus 205 g~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 279 (378)
|++....... ......++..|+|||.+.+ ...++.++||||||+++|+|++|..||.+..........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~ 236 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcC-------CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9986543221 1123457788999998753 234678999999999999999999999876543222111
Q ss_pred HHh--cCCC---------------CCC-------------CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 280 AFK--HARP---------------GLP-------------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 280 ~~~--~~~~---------------~~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
... ...+ .++ ...+..+.++|.+||..||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 110 0000 001 1134677899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=294.15 Aligned_cols=244 Identities=26% Similarity=0.425 Sum_probs=204.8
Q ss_pred ccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD- 129 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~- 129 (378)
.+...+|..+..||+|+||+|.+|... ++.||||+++++...++... +.-+.|-++|... +-|.++++..+|+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDv--ectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDV--ECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcc--cceehhhhheecCCCCchHHHHHHHhhhh
Confidence 456677888999999999999999764 58899999998776554332 1234566777666 56788888888865
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+.+|+||||+.||+|--.++. -+.+.+..+..++.+|+.||-+||++||+.||||.+|||++.+|+ +||+|||+++.
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH-iKi~DFGmcKE 499 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKE 499 (683)
T ss_pred hheeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc-eEeeecccccc
Confidence 589999999999999888876 467999999999999999999999999999999999999998775 99999999986
Q ss_pred cccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 210 ETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 210 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
.-.. ..+.+.+|||.|+|||++.. .+|+.++|+||+|++||||+.|++||++.+. +++++. +....-.+
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~Y--------qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-~elF~a-I~ehnvsy 569 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQA-IMEHNVSY 569 (683)
T ss_pred cccCCcceeeecCCCcccccceEEe--------cccccchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHH-HHHccCcC
Confidence 4433 34567899999999999976 8899999999999999999999999998765 333443 34456678
Q ss_pred CCCChHHHHHHHHHccccCCCCCC
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRP 312 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rp 312 (378)
|..+|.++.++++..|.+.|.+|.
T Consensus 570 PKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 570 PKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cccccHHHHHHHHHHhhcCCcccc
Confidence 899999999999999999999994
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=296.91 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=199.1
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-----C
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-----P 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~ 130 (378)
..|.+.+.||.|+||.||++.. +++.||+|++........ ....+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT---LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc---chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 5788899999999999999976 478999999876433221 12357789999999999999999887742 3
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence 5789999994 689988865 34599999999999999999999999999999999999999665 5999999998654
Q ss_pred cccc-----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH----
Q 017046 211 TVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF---- 281 (378)
Q Consensus 211 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~---- 281 (378)
.... ......++..|+|||.+.. ...++.++|||||||++|+|++|+.||.+............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~ 230 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLS-------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcC-------CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence 3221 1123468889999998753 24578899999999999999999999977554222111100
Q ss_pred ------------------h--cCCCCC-----CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 282 ------------------K--HARPGL-----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 282 ------------------~--~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
. ...... ....+.++.++|.+||+.+|.+|||+.+++. +.++.....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~--~~~~~~~~~ 302 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ--HPFLAQYHD 302 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh--ChhhhhccC
Confidence 0 001111 1346889999999999999999999999998 555554433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=313.48 Aligned_cols=252 Identities=18% Similarity=0.272 Sum_probs=179.5
Q ss_pred cceeecceeecccceEEEEEEECC---eeEEEEEeecCC------------CchHHHHHHHHHHHHHHHHhhccCCCeee
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYGD---RIVAIKVLNRGS------------TSDERALLEGRFIREVNMMSRVKHDNLVK 122 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~~---~~vavK~~~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 122 (378)
..|.++++||+|+||+||++.... ..+++|.+.... ...........+.+|+.+++.++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 579999999999999999986531 222222111000 00001112345789999999999999999
Q ss_pred EEeeEec-CCeEEEEeccCCCCHHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCc
Q 017046 123 FLGACKD-PLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (378)
Q Consensus 123 l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~ 198 (378)
+++++.+ +..+++++++ +++|.+++.... ........+..++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~-~ 305 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG-K 305 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-C
Confidence 9999965 4678999999 567777765421 12244667889999999999999999999999999999999665 5
Q ss_pred eeEecccccccccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCC-CCCCCC--hH
Q 017046 199 LKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMS--NL 273 (378)
Q Consensus 199 vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~-pf~~~~--~~ 273 (378)
+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.. ||.+.. ..
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG--------DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 9999999997543322 2234579999999999864 568899999999999999999875 443322 11
Q ss_pred HHHHHHHHhc--CCCCC----------------------------CCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 274 QAAYAAAFKH--ARPGL----------------------------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 274 ~~~~~~~~~~--~~~~~----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.......... ....+ ...++.++.+++.+||..||.+|||+.|++.
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111111000 00000 0135567888899999999999999999998
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=294.67 Aligned_cols=259 Identities=29% Similarity=0.380 Sum_probs=200.1
Q ss_pred cccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 129 (378)
+....++|.+.+.||+|+||.||++.. +++.||+|++........ ....+.+|+.++++++||||+++++++..
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH---HHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 334567899999999999999999975 478999999876432221 12457789999999999999999998743
Q ss_pred ------CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEec
Q 017046 130 ------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (378)
Q Consensus 130 ------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~D 203 (378)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~d 163 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILD 163 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEec
Confidence 2367888877 8899988764 4689999999999999999999999999999999999999665 599999
Q ss_pred cccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017046 204 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 283 (378)
||++..... ......++..|+|||.+.+ ...++.++|||||||++|+|++|..||.+..............
T Consensus 164 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 164 FGLARHTDD--EMTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred ccccccccc--cccccccCCCccCHHHHhC-------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999875432 2234467889999998743 2457889999999999999999999997655433221111000
Q ss_pred ------------------------CCC-----CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 284 ------------------------ARP-----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 284 ------------------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
..+ ......++++.++|.+||..||.+||++.++++ +.++.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~f~~~~~ 308 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYHD 308 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc--ChhhhhcCC
Confidence 000 011235788999999999999999999999998 556655444
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=291.11 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=194.5
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 130 (378)
...|.+.+.||+|+||.||+|.. .++.||+|+++........ ...+.+|+++++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~---~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGF---PITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCc---hHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45688899999999999999987 4688999998764332211 12467899999999999999999987532
Q ss_pred -------CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEec
Q 017046 131 -------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (378)
Q Consensus 131 -------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~D 203 (378)
..++|+||+++ +|.+.+... ...+++..+..++.|++.||+|||+.||+|+||||+||+++.++ .+||+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~d 159 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLAD 159 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCc
Confidence 57899999965 777777652 45789999999999999999999999999999999999999654 599999
Q ss_pred ccccccccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017046 204 FGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 204 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 281 (378)
||++....... ......++..|+|||.+.. ...++.++|||||||++|+|++|+.||...+..........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLG-------EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99987543222 1122345778999998753 23467899999999999999999999986654333222111
Q ss_pred h--cCCC--------------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 282 K--HARP--------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 282 ~--~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
. ...+ .....++..+.+++..||..||.+|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 0000 0112468899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=286.55 Aligned_cols=247 Identities=28% Similarity=0.412 Sum_probs=193.5
Q ss_pred eeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc---cCCCeeeEEeeEecC-C--
Q 017046 60 LFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACKDP-L-- 131 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~~-~-- 131 (378)
|.+.+.||+|+||.||+|++. ++.||+|++......... ...+.+|+.+++++ +||||+++++.+.+. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI---PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchh---hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 567889999999999999874 689999999754432211 12456777777666 599999999998643 3
Q ss_pred ---eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 132 ---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 132 ---~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
.+++|||+. ++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.
T Consensus 78 ~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~ 155 (287)
T cd07838 78 ELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLAR 155 (287)
T ss_pred CceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcce
Confidence 789999996 589998876544569999999999999999999999999999999999999966 459999999987
Q ss_pred ccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC---
Q 017046 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--- 285 (378)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--- 285 (378)
............++..|+|||.+.. ..++.++|+|||||++|+|++|.+||.+....+...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQ--------SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227 (287)
T ss_pred eccCCcccccccccccccChHHhcc--------CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence 6544433344467889999999854 56788999999999999999999999876654332222111000
Q ss_pred ----------------------CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 286 ----------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 286 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
......+++.+.+++.+||..||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0001234677889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=307.63 Aligned_cols=256 Identities=34% Similarity=0.544 Sum_probs=200.1
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC------
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP------ 130 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------ 130 (378)
.|...+.||+|+||.||+|++ +|+.||||.++........ ++..+|+++|++++|||||+++++-++.
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~----e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPR----ERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchH----HHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 355668899999999999985 5899999999886644433 3578999999999999999999876433
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC---CCceeEeccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD---QKSLKLADFG 205 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~---~~~vkl~Dfg 205 (378)
..+++||||.||||...+..... .++++.+.+.+..++..||.|||++||+||||||.||++-.. ....||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 46799999999999999976332 469999999999999999999999999999999999998432 2358999999
Q ss_pred cccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH----HHHHHHHH
Q 017046 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL----QAAYAAAF 281 (378)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~~~~ 281 (378)
.|+..+......+..||..|.+||++-. ...|+...|.|||||++|++.||..||...... +..+....
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~-------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t 242 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYER-------QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT 242 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhh-------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence 9999888888889999999999999842 378899999999999999999999999643322 12222221
Q ss_pred hcC-------------------CCCCCCCChHH----HHHHHHHccccCCCCCC--CHHHHHHHHHhhh
Q 017046 282 KHA-------------------RPGLPEDISPD----LAFIVQSCWVEDPNLRP--SFSQIIRMLNAFL 325 (378)
Q Consensus 282 ~~~-------------------~~~~~~~~~~~----l~~li~~~l~~dp~~Rp--s~~~ll~~l~~~~ 325 (378)
+.. ..++|..+++. +..++..+|..+|.+|. .+.+....+..++
T Consensus 243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 111 11123333333 44577888899999998 6555555554443
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=295.30 Aligned_cols=257 Identities=30% Similarity=0.444 Sum_probs=202.0
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC------
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP------ 130 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------ 130 (378)
+|.+.+.||.|+||.||+++.. ++.||||++........ ....+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI---DAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccch---hhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 4788899999999999999874 68999999876432111 224588999999999999999999988543
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..+++|||+. ++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||||.|||++.+ +.++|+|||++...
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~ 153 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGV 153 (330)
T ss_pred ceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEee
Confidence 5789999996 589888865 3479999999999999999999999999999999999999966 45999999998765
Q ss_pred cccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017046 211 TVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 211 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
.... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||.+................+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLS-------SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cccccccccccccccccCcCCceeeec-------ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 4432 2334567889999999865 1267889999999999999999999998766433222111100000
Q ss_pred -----------------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 287 -----------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 287 -----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
.....++.++.+++.+||+.+|.+|||+.++++ +.++.....+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~~~~~~~~~~ 298 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA--HPYLAQLHDP 298 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh--CccHHhhccc
Confidence 012346788999999999999999999999998 5566555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=289.40 Aligned_cols=247 Identities=27% Similarity=0.447 Sum_probs=202.3
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec-CCeE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~~~ 133 (378)
++|.+.+.||+|+||.||++.. .++.||+|++......... ....+.+|+.++++++ ||||+++++.+.+ ...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK--KVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchH--HHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 3688899999999999999987 5789999998764332222 1245789999999998 9999999998854 4788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~ 155 (280)
T cd05581 79 FVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCccccccCCc
Confidence 99999999999999976 34799999999999999999999999999999999999999665 4999999998643222
Q ss_pred c---------------------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh
Q 017046 214 E---------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (378)
Q Consensus 214 ~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 272 (378)
. ......++..|+|||.+.. ..++.++|+||||+++|++++|..||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--------KPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--------CCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 1 1123357889999998754 4578899999999999999999999987664
Q ss_pred HHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCH----HHHHH
Q 017046 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF----SQIIR 319 (378)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~ll~ 319 (378)
.... ... ......++..+++.+.+++.+||..+|.+|||+ .++++
T Consensus 228 ~~~~-~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 YLTF-QKI-LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHH-HHH-HhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 3322 222 244556777889999999999999999999999 88876
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=294.66 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=190.5
Q ss_pred ceeecceeecccceEEEEEEE----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC---C
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---L 131 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---~ 131 (378)
.|.+.++||+|+||.||+|.. .++.||+|.+........ .....+.+|+.+++.++||||+++++++.+. .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT--GISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccccc--CccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 377889999999999999987 458999999987431111 0113467899999999999999999998643 5
Q ss_pred eEEEEeccCCCCHHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC---CCCceeEeccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRP---NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP---DQKSLKLADFG 205 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~---~~~~vkl~Dfg 205 (378)
.++||||++ ++|.+++..... ..+++..++.++.|++.||.|||+.|++||||||+||+++. ..+.+||+|||
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 789999995 477777654222 36899999999999999999999999999999999999986 13459999999
Q ss_pred ccccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH-------
Q 017046 206 LAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ------- 274 (378)
Q Consensus 206 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------- 274 (378)
++....... ......++..|+|||++.+ ...++.++||||||+++|+|++|..||.+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 987533221 1223467889999998753 2457889999999999999999999997654321
Q ss_pred -HHHHHHH-------------------------hcCCCCCC-----------CCChHHHHHHHHHccccCCCCCCCHHHH
Q 017046 275 -AAYAAAF-------------------------KHARPGLP-----------EDISPDLAFIVQSCWVEDPNLRPSFSQI 317 (378)
Q Consensus 275 -~~~~~~~-------------------------~~~~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~l 317 (378)
....... ......++ ...+.++.+++.+||..||.+|||+.++
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 0000000 00011111 1466789999999999999999999999
Q ss_pred HHH
Q 017046 318 IRM 320 (378)
Q Consensus 318 l~~ 320 (378)
+++
T Consensus 311 l~~ 313 (316)
T cd07842 311 LEH 313 (316)
T ss_pred hcC
Confidence 873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=293.61 Aligned_cols=247 Identities=29% Similarity=0.393 Sum_probs=193.3
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec---CC
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD---PL 131 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~---~~ 131 (378)
.+|.+.+.||+|+||.||+|.+ .++.||+|.+......... ...+.+|+.+++++ +||||+++++++.. ..
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~---~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD---AQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh---hhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 4688889999999999999987 4689999988653322221 13467899999999 99999999998753 25
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~~~ 158 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLS 158 (337)
T ss_pred EEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccchhccc
Confidence 789999996 599988865 3788999999999999999999999999999999999999665 59999999987533
Q ss_pred ccc------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-
Q 017046 212 VTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA- 284 (378)
Q Consensus 212 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~- 284 (378)
... ......|++.|+|||.+.. ...++.++||||||+++|+|++|+.||.+...............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLG-------STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231 (337)
T ss_pred cccccccCcchhcccccccccCceeeec-------cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 221 1223468889999998753 24567899999999999999999999986554332211111000
Q ss_pred ----------------------------CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 285 ----------------------------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 285 ----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.......++.++.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 00111237889999999999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=293.45 Aligned_cols=254 Identities=27% Similarity=0.382 Sum_probs=194.9
Q ss_pred eecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHH---------HHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 61 FIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERAL---------LEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 61 ~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~---------~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
.+.+.||.|+||.||+|.+ .++.||||++........... ....+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 3457799999999999986 468999999876443321100 01246789999999999999999998854
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
...+++|||+. ++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~-~~kl~dfg~~~ 167 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG-ICKIADFGLAR 167 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC-CEEECCcccee
Confidence 57889999996 699998865 35689999999999999999999999999999999999999655 59999999986
Q ss_pred cccc---------------ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH
Q 017046 209 EETV---------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (378)
Q Consensus 209 ~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 273 (378)
.... ........+++.|+|||.+.+ ...++.++|+|||||++|+|++|..||.+....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-------AEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhccc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5431 111123356788999998853 234688999999999999999999999877654
Q ss_pred HHHHHHHHhcCCC--------------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 274 QAAYAAAFKHARP--------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 274 ~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
............+ ......+.++.+++.+||..+|.+|||+.+++. +.++..
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~--~~~~~~ 318 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK--HEYFKS 318 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc--CcccCC
Confidence 4332221110000 011245788999999999999999999999998 555543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=321.20 Aligned_cols=247 Identities=30% Similarity=0.474 Sum_probs=186.3
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEee----------
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA---------- 126 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~---------- 126 (378)
+|+.+..||+||||.||+++. .|+.||||++.... .. ....++.+|+.+|.+|+|||||+++..
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~---~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SD---KLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HH---HHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 467788999999999999976 58999999998765 22 223568999999999999999999710
Q ss_pred ------------------------------------------------E-------------------------------
Q 017046 127 ------------------------------------------------C------------------------------- 127 (378)
Q Consensus 127 ------------------------------------------------~------------------------------- 127 (378)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred -----------------------ec--------CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 017046 128 -----------------------KD--------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176 (378)
Q Consensus 128 -----------------------~~--------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH 176 (378)
.+ -.+||-||||+...|.+++..+.... ....+++++++|++||+|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 00 12578999999888888887632211 47788999999999999999
Q ss_pred hCCCeeecCCCCcEEEcCCCCceeEeccccccccc-------------------cccccccCcCcccccccccccccccc
Q 017046 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-------------------VTEMMTAETGTYRWMAPELYSTVTLR 237 (378)
Q Consensus 177 ~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 237 (378)
++|+|||||||.||+++.++. |||+|||+|+... .....+..+||.-|+|||++.+..
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~-VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~-- 791 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNS-VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS-- 791 (1351)
T ss_pred hCceeeccCCcceeEEcCCCC-eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc--
Confidence 999999999999999996655 9999999997510 111234568999999999997521
Q ss_pred ccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC---CCCChHHHHHHHHHccccCCCCCCCH
Q 017046 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPNLRPSF 314 (378)
Q Consensus 238 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~ 314 (378)
...|+.++|+||||+|++||+. ||...............+..|.. ...--+.-..+|++|++.||.+||||
T Consensus 792 ---~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA 865 (1351)
T KOG1035|consen 792 ---SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA 865 (1351)
T ss_pred ---cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence 1379999999999999999984 57543332222222222222221 11222446689999999999999999
Q ss_pred HHHHH
Q 017046 315 SQIIR 319 (378)
Q Consensus 315 ~~ll~ 319 (378)
.|+|.
T Consensus 866 ~eLL~ 870 (1351)
T KOG1035|consen 866 TELLN 870 (1351)
T ss_pred HHHhh
Confidence 99988
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=284.29 Aligned_cols=238 Identities=21% Similarity=0.313 Sum_probs=186.4
Q ss_pred ceeecce--eecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-CCe
Q 017046 59 LLFIGSK--IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 59 ~~~~~~~--lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~ 132 (378)
.|.+.+. ||+|+||.||+++. .+..+|+|+........ .|+.....+ +||||+++++.+.+ ...
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3445455 49999999999976 46889999987543221 122222222 69999999999854 478
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++..++|+|||++.....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9999999999999999763 37999999999999999999999999999999999999997764699999999875432
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHH--HhcCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA--FKHARPGLPE 290 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~ 290 (378)
. ....++..|+|||++.. ..++.++||||||+++|+|++|..||............. ........+.
T Consensus 163 ~---~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T PHA03390 163 P---SCYDGTLDYFSPEKIKG--------HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIK 231 (267)
T ss_pred C---ccCCCCCcccChhhhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCccc
Confidence 2 23468889999999854 567889999999999999999999998554322111111 1133334556
Q ss_pred CChHHHHHHHHHccccCCCCCCC-HHHHHH
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPS-FSQIIR 319 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps-~~~ll~ 319 (378)
.+++.+.++|.+||+.+|.+||+ ++++++
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 232 NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 79999999999999999999995 699987
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=285.44 Aligned_cols=241 Identities=31% Similarity=0.483 Sum_probs=192.9
Q ss_pred eecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccCCC
Q 017046 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGM 142 (378)
Q Consensus 66 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 142 (378)
||.|+||.||++... ++.|++|++....... ......+.+|+.++++++||||+++++.+.+ ...+++|||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR--KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh--hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 689999999999875 7899999987654322 1223468899999999999999999988864 4688999999999
Q ss_pred CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc--------
Q 017046 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-------- 214 (378)
Q Consensus 143 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-------- 214 (378)
+|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 79 ~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 79 DLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccccccccc
Confidence 999999763 3789999999999999999999999999999999999999665 59999999987543221
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC-
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI- 292 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 292 (378)
......++..|+|||.... ...+.++|+||||+++|+|++|..||........ ...... .....+...
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~ 225 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--------QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-FQNILN-GKIEWPEDVE 225 (265)
T ss_pred ccccCcccCccccCHHHhcC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhc-CCcCCCcccc
Confidence 1233467889999998754 4478899999999999999999999986654332 222222 233444444
Q ss_pred -hHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 293 -SPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 293 -~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
+..+.+++.+||+.+|.+|||+..+.+.|
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 89999999999999999999994444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=286.47 Aligned_cols=247 Identities=28% Similarity=0.398 Sum_probs=193.4
Q ss_pred eeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---CCeEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVI 134 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~~~l 134 (378)
|.+.+.||.|+||.||+|+.. ++.+|+|.+........ ....+.+|+.+++.++|||++++++++.+ +..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEG---FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccccccc---chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 567889999999999999875 58999999987542211 12347789999999999999999998864 47899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||++ ++|.+++... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 78 VFEYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-VLKLADFGLARPYTKRN 154 (287)
T ss_pred Eecccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-CEEEccccceeeccCCC
Confidence 999996 4898888652 35799999999999999999999999999999999999999655 59999999987544332
Q ss_pred --ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC------
Q 017046 215 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP------ 286 (378)
Q Consensus 215 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------ 286 (378)
......++..|+|||.+.+ ...++.++||||||+++|+|++|..||..................+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLG-------ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred cccccccccccccCCceeeEc-------cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 1233456788999997753 2356889999999999999999999998765432222111100000
Q ss_pred -----------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 287 -----------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 287 -----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+...++..+.+++.+||..+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 001113788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=288.13 Aligned_cols=255 Identities=26% Similarity=0.353 Sum_probs=199.6
Q ss_pred eeecceeecccceEEEEEEE-----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-Ce
Q 017046 60 LFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~ 132 (378)
|.+.+.||+|+||.||+++. .++.||||+++...... ......++.+|+.++.++ +||||+++++.+..+ ..
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQ-KAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHh-hhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 67889999999999999874 35789999987543321 222334688999999999 699999999888644 67
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEEECcccccccc
Confidence 899999999999998865 35689999999999999999999999999999999999999665 599999999865332
Q ss_pred ccc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCC
Q 017046 213 TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFKHARPGL 288 (378)
Q Consensus 213 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~ 288 (378)
... .....++..|+|||.+.. .....+.++|+||||+++|+|++|..||..... .............+..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRG------GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF 231 (288)
T ss_pred ccccccccccCCccccCHHHhcC------CCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC
Confidence 221 123468889999998754 112367899999999999999999999964321 1111222223344566
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
+..++.++.+++.+||+.||.+|||+.++.+.|...
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 778899999999999999999999987776655544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=295.49 Aligned_cols=256 Identities=30% Similarity=0.421 Sum_probs=200.3
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 130 (378)
.++|.+.+.||+|+||.||+|+.. ++.||+|++........ ....+.+|+.+++.++||||+++.+++...
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI---HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhh---HHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 557999999999999999999874 68899999865432221 123577899999999999999998876432
Q ss_pred ---CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 131 ---~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
..++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~ 165 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLA 165 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEcccccc
Confidence 378999999 7799998864 4699999999999999999999999999999999999999655 5999999998
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-- 285 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-- 285 (378)
...... .....++..|+|||.+.. ...++.++||||||+++|+|++|+.||.+................
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 236 (343)
T cd07851 166 RHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236 (343)
T ss_pred cccccc--ccCCcccccccCHHHHhC-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Confidence 764332 234467889999998743 135788999999999999999999999876553322211110000
Q ss_pred ------------------------C---CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 286 ------------------------P---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 286 ------------------------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
. ......++++.+++.+||..+|.+|||+.++++ +.++.....+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~--h~~~~~~~~~ 307 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA--HPYLAEYHDP 307 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc--CCCccccCCC
Confidence 0 011246889999999999999999999999988 5666554443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=291.21 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=194.4
Q ss_pred ceeecceeecccceEEEEEEEC----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEe---c-
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK---D- 129 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~---~- 129 (378)
.|.+.+.||+|+||.||+++.. +..||+|.+........ ....+.+|+.+++++ +||||+++++.+. +
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI---LAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccch---hHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 3778899999999999999875 55899999865332221 123577899999999 5999999998642 1
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
...+++++|+ +++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.++ .++|+|||++.
T Consensus 78 ~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~ 153 (332)
T cd07857 78 FNELYLYEELM-EADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLAR 153 (332)
T ss_pred CCcEEEEEecc-cCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence 2467889988 4689998864 45789999999999999999999999999999999999999665 59999999987
Q ss_pred cccccc-----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH--
Q 017046 209 EETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF-- 281 (378)
Q Consensus 209 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-- 281 (378)
...... ......|++.|+|||.+.. ...++.++||||||+++|+|++|..||.+............
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 226 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLS-------FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence 533211 1223468899999998743 24578899999999999999999999976543211111000
Q ss_pred ------------------------hcCCC---CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 282 ------------------------KHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 282 ------------------------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
..... ......+..+.+++.+||+.||.+|||+.+++. +.++.....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~--~~~~~~~~~ 300 (332)
T cd07857 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE--HPYLAIWHD 300 (332)
T ss_pred CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc--ChhhhhhcC
Confidence 00000 111345788999999999999999999999988 566655543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=294.82 Aligned_cols=255 Identities=27% Similarity=0.396 Sum_probs=196.8
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 130 (378)
...|.+.+.||+|+||.||+|+. +++.||+|++........ ....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI---FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccccc---chhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 35788999999999999999986 478999999875432221 123477999999999999999999987532
Q ss_pred ---CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 131 ---~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
..++||||+. .+|..++. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~ 164 (342)
T cd07879 91 EFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLA 164 (342)
T ss_pred CCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCC
Confidence 3589999995 47776542 4689999999999999999999999999999999999999665 5999999998
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc----
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH---- 283 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---- 283 (378)
..... ......+++.|+|||.+.. ...++.++|||||||++|+|++|+.||.+..............
T Consensus 165 ~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 165 RHADA--EMTGYVVTRWYRAPEVILN-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred cCCCC--CCCCceeeecccChhhhcC-------ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 75432 2234467889999998753 2357889999999999999999999998765433222111100
Q ss_pred -----------------CCCCC--------CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 284 -----------------ARPGL--------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 284 -----------------~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
..+.. ....+.++.+|+.+||+.||.+||++.+++. +.++....+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~--h~~f~~~~~~ 306 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE--HPYFDSFRDA 306 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc--Ccchhhcccc
Confidence 00111 1246778999999999999999999999998 5555555443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=286.38 Aligned_cols=247 Identities=31% Similarity=0.447 Sum_probs=195.9
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|.+.+.||.|++|.||++.. .++.+++|.+........ ....+.+|+.+++.++||||+++++.+.+ ...++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG---IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccch---hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence 45678899999999999986 478899999876544321 22457889999999999999999998865 4788999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-c
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~ 215 (378)
||+++ +|.+++.. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+....... .
T Consensus 78 e~~~~-~l~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 78 EFMDT-DLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRP 154 (283)
T ss_pred eccCC-CHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCCCccc
Confidence 99965 88888866 235789999999999999999999999999999999999999655 59999999987544332 2
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC---------
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--------- 286 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------- 286 (378)
.....++..|+|||.+.. ...++.++|+||||+++|+|++|+.||.+.+..............+
T Consensus 155 ~~~~~~~~~~~~PE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 155 YTHYVVTRWYRAPELLLG-------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred ccCccCcccccCcHHHhc-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccch
Confidence 233457888999998754 2367889999999999999999999998766544332221110000
Q ss_pred -------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 287 -------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 287 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.....++.++.++|.+||..||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 011246788999999999999999999999987
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=277.96 Aligned_cols=247 Identities=26% Similarity=0.448 Sum_probs=200.0
Q ss_pred cceeecccceEEEEEE--ECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-CeEEEEec
Q 017046 63 GSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTEL 138 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~~lv~e~ 138 (378)
.+.||+|+|+.|--+. .++..||||++.+.... ...++.+|++++..+ .|+||++++++|+|+ .+|+|||-
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH-----sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH-----SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCch-----HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 3579999999998654 57899999999876332 235789999999999 499999999999865 78999999
Q ss_pred cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC--ceeEeccccccccccc---
Q 017046 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLAREETVT--- 213 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~--~vkl~Dfg~a~~~~~~--- 213 (378)
+.||+|...|.. ...+++.++.++..+|+.||.+||.+||.|||+||+|||....+. .||||||.++......
T Consensus 158 m~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 158 MRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999999999986 357999999999999999999999999999999999999975443 4999999887532111
Q ss_pred -----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh-------------HHH
Q 017046 214 -----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-------------LQA 275 (378)
Q Consensus 214 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------~~~ 275 (378)
....+.+|+..|||||+..-.. ++...|+.+.|.||||+|+|-||+|.+||.+.-. -+.
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv---~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFV---DQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhc---cccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 1223558999999999875432 2346789999999999999999999999976432 122
Q ss_pred HHHHHHhcCCCCCCC----CChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 276 AYAAAFKHARPGLPE----DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 276 ~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.....+.....+||+ .+|.+.++++..+|..|+.+|.++.+++.
T Consensus 313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 222333445556665 58899999999999999999999999988
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=287.68 Aligned_cols=255 Identities=28% Similarity=0.501 Sum_probs=199.3
Q ss_pred cceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc--cCCCeeeEEeeEec--C---
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV--KHDNLVKFLGACKD--P--- 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~l~~~~~~--~--- 130 (378)
+...+.+.||+|.||+||+|++.|+.||||++..... ..+.+|.++++.. +|+||+.|++.-.. +
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE--------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE--------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccch--------hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 4567789999999999999999999999999975432 2377888888875 99999999987532 1
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeeecCCCCcEEEcCCCCceeEe
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLA 202 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--------givH~dikp~Nill~~~~~~vkl~ 202 (378)
+++||++|.+.|||.|+|.. ..++.+..++++..++.||++||.. .|.|||||..||||.+++ ...|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEe
Confidence 58999999999999999986 6899999999999999999999975 499999999999999665 59999
Q ss_pred ccccccccccc-----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhC----------CCCC
Q 017046 203 DFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN----------RLPF 267 (378)
Q Consensus 203 Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g----------~~pf 267 (378)
|+|+|...... -..+..+||.+|||||++..... .+...--..+||||||.++||++.. .+||
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin--~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETIN--MKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcC--hhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 99999643222 23456689999999999975211 1111222368999999999999862 4687
Q ss_pred CCCChHHH---HHHH--HHhcCCCCCCCCCh-----HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 268 EGMSNLQA---AYAA--AFKHARPGLPEDIS-----PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 268 ~~~~~~~~---~~~~--~~~~~~~~~~~~~~-----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.+..+.+. .+.. .....+|.+|..+. ..+..+++.||..||.-|.|+-.+-+.|..+..
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 65433221 1222 23566777776544 246778999999999999999999888877664
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=305.21 Aligned_cols=252 Identities=29% Similarity=0.492 Sum_probs=215.2
Q ss_pred CcceeecceeecccceEEEEEE--ECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEe-----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK----- 128 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~----- 128 (378)
...|.|...||+|.+|.||+++ +.++.+|+|++......++ .+..|..+++.+ .|||++.+++++.
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de------EiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE------EIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH------HHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 4558899999999999999875 4689999999987766554 356788888887 6999999999872
Q ss_pred -cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 129 -DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 129 -~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
++.+|||||||.|||..|+++...+..+.+..+..|++.++.||.+||...++|||||-.|||++.+++ |||+|||.+
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~-VKLvDFGvS 170 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE-VKLVDFGVS 170 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc-EEEeeeeee
Confidence 458999999999999999999988888999999999999999999999999999999999999997766 999999998
Q ss_pred ccccc-ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017046 208 REETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 208 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
...+. .....+.+|||.|||||++.+. +.....|+.++|+||||++..||.-|.+|+.++.....++.+. .+.+|
T Consensus 171 aQldsT~grRnT~iGtP~WMAPEViac~---e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-RNPPP 246 (953)
T KOG0587|consen 171 AQLDSTVGRRNTFIGTPYWMAPEVIACD---ESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPPP 246 (953)
T ss_pred eeeecccccccCcCCCcccccceeeecc---cCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC-CCCCc
Confidence 75443 3445678999999999999763 2334678889999999999999999999999998876665543 33333
Q ss_pred CC--CCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 287 GL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 287 ~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+ |..++.++.++|..||.+|...||+..++++
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 32 5679999999999999999999999999987
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=310.03 Aligned_cols=262 Identities=32% Similarity=0.561 Sum_probs=222.8
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC---------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCee
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLV 121 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv 121 (378)
.+.++.+.+.+.+.||+|.||.|++|... ...||||.++......+. +.+..|+++|+.+ +||||+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~----~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEK----KDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHH----HHHHHHHHHHHHhcCCcchh
Confidence 67777788888889999999999998642 357999999887766443 3588999999999 699999
Q ss_pred eEEeeEec-CCeEEEEeccCCCCHHHHHhhhC------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCC
Q 017046 122 KFLGACKD-PLMVIVTELLPGMSLRKYLVSLR------P--------NKLDLHVALNFALDIARAMDCLHANGIIHRDLK 186 (378)
Q Consensus 122 ~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------~--------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dik 186 (378)
.++|++.+ +..++|+||+..|+|.+++...+ . ..++..+.+.++.||+.|++||++.++|||||.
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLA 445 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLA 445 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhh
Confidence 99999965 57899999999999999998755 0 138889999999999999999999999999999
Q ss_pred CCcEEEcCCCCceeEecccccccccccccc--ccCc--CccccccccccccccccccccccCCCcccchhhhHHHHHHHh
Q 017046 187 PDNLLLTPDQKSLKLADFGLAREETVTEMM--TAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262 (378)
Q Consensus 187 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~ 262 (378)
.+|||+..+ ..+||+|||+++........ .... -...|||||.+.. ..|+.++||||+|++||||++
T Consensus 446 aRNVLi~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--------~~ft~kSDVWSfGI~L~Eifs 516 (609)
T KOG0200|consen 446 ARNVLITKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--------RVFTSKSDVWSFGILLWEIFT 516 (609)
T ss_pred hhhEEecCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--------CcccccchhhHHHHHHHHHhh
Confidence 999999954 56999999999853332222 1122 2346999999964 789999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 263 -NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 263 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
|..||.+.......+.....+.+...|..+++++.++++.||..+|.+||++.++.+.+...+.
T Consensus 517 LG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 517 LGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 9999998765566677788888999999999999999999999999999999999999988654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=288.13 Aligned_cols=250 Identities=27% Similarity=0.380 Sum_probs=191.3
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 129 (378)
..+|.+.+.||.|+||.||+|.+. ++.||+|++......... ...+.+|+++++.++||||+++++.+.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF---PITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc---chhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 467999999999999999999874 688999998754432211 1235689999999999999999887632
Q ss_pred ----CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 130 ----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 130 ----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
...++||||+. ++|...+.. ....+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||
T Consensus 84 ~~~~~~~~lv~~~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg 160 (311)
T cd07866 84 KRKRGSVYMVTPYMD-HDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFG 160 (311)
T ss_pred cccCceEEEEEecCC-cCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcCc
Confidence 24689999995 477777754 235799999999999999999999999999999999999999665 59999999
Q ss_pred cccccccccc------------cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH
Q 017046 206 LAREETVTEM------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (378)
Q Consensus 206 ~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 273 (378)
++........ .....+++.|+|||.+.. ...++.++|||||||++|+|++|.+||.+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-------ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhC-------CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9874322211 122356788999998753 245788999999999999999999999876653
Q ss_pred HHHHHHHHhcCC---------------------CCCC-------CCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 274 QAAYAAAFKHAR---------------------PGLP-------EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 274 ~~~~~~~~~~~~---------------------~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
............ ...+ ..+++++.+++.+||..||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 322221110000 0001 234467889999999999999999999987
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=287.16 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=198.0
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec--CC
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--PL 131 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~ 131 (378)
....|.+.+.||.|+||.||++.. +++.||+|++........ ....+.+|+.+++.++||||+++.+++.. ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV---LAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccc---hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 345699999999999999999976 468899998765332221 12347789999999999999999998854 46
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.+++|||+ +++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-DLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-CEEeCccccccccC
Confidence 88999998 6789888764 4688889999999999999999999999999999999999554 59999999987543
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHH-----------
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA----------- 280 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~----------- 280 (378)
.. .....+++.|+|||.+.. ...++.++||||||+++|+|++|..||.............
T Consensus 160 ~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 160 PQ--MTGYVSTRYYRAPEIMLT-------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred CC--cCCCcccccccCceeeec-------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 22 233467889999998743 2457889999999999999999999997655321111000
Q ss_pred -----------HhcC--CCC-----CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 281 -----------FKHA--RPG-----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 281 -----------~~~~--~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
.... ... ....+++++.++|.+||+.+|.+|||+.+++. +.++.....+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~--~~~~~~~~~~ 297 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA--HPYLAPYHDP 297 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CCccccccCC
Confidence 0000 001 11346789999999999999999999999988 5555444433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=277.00 Aligned_cols=239 Identities=32% Similarity=0.483 Sum_probs=197.0
Q ss_pred eecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccCCC
Q 017046 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGM 142 (378)
Q Consensus 66 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 142 (378)
||.|+||.||++... ++.||+|++......... ....+..|+.+++.++||||+++++.+.+ ...+++|||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRK--EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchH--HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 699999999999874 689999998775443321 23468899999999999999999988865 4789999999999
Q ss_pred CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-cccccCcC
Q 017046 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETG 221 (378)
Q Consensus 143 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~g 221 (378)
+|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...... .......+
T Consensus 79 ~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 79 ELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCcccCCcC
Confidence 999999763 4689999999999999999999999999999999999999655 5999999998754332 22344568
Q ss_pred ccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 017046 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 301 (378)
Q Consensus 222 t~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 301 (378)
+..|+|||.+.. ...+.++|+||||+++|+|++|..||..... ........ .....++...+.++.+++.
T Consensus 156 ~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~l~~~i~ 225 (250)
T cd05123 156 TPEYLAPEVLLG--------KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKIL-KDPLRFPEFLSPEARDLIS 225 (250)
T ss_pred CccccChHHhCC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHh-cCCCCCCCCCCHHHHHHHH
Confidence 889999998854 4567899999999999999999999976654 23333332 2556778888999999999
Q ss_pred HccccCCCCCCCH---HHHHH
Q 017046 302 SCWVEDPNLRPSF---SQIIR 319 (378)
Q Consensus 302 ~~l~~dp~~Rps~---~~ll~ 319 (378)
+||..||.+||++ .++++
T Consensus 226 ~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 226 GLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHhcCCHhhCCCcccHHHHHh
Confidence 9999999999999 66655
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=266.11 Aligned_cols=252 Identities=22% Similarity=0.373 Sum_probs=206.5
Q ss_pred cCCcceeecceeecccceEEEEEE--ECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEecC-
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP- 130 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~- 130 (378)
...++|++.+++|.|.|++||.|+ .++++++||++++... +++.+|+.+|..|. ||||+.+++...|+
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk--------kKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK--------KKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH--------HHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 356789999999999999999997 4678999999976332 45889999999996 99999999999765
Q ss_pred --CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 131 --LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 131 --~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
...+|+||+.+.+...+.. .++...+..++.+++.||.|+|++||+|||+||.|++|+.....++|+|+|+|.
T Consensus 107 SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred ccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 4679999999988877654 578889999999999999999999999999999999999888889999999998
Q ss_pred ccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCC-CCChHHHHHHHHH------
Q 017046 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE-GMSNLQAAYAAAF------ 281 (378)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~~~~------ 281 (378)
....+...+..+.+..|--||++..+ ..|+.+-|+|||||++..|+..+.||. |.++.+.+..+..
T Consensus 182 FYHp~~eYnVRVASRyfKGPELLVdy-------~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 182 FYHPGKEYNVRVASRYFKGPELLVDY-------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred hcCCCceeeeeeehhhcCCchheeec-------hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 87777777777788889999999763 678999999999999999999888874 4444333332210
Q ss_pred -----h----cCCCC--------------------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 282 -----K----HARPG--------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 282 -----~----~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
. ...+. -..-.++++.+|+.++|..|..+|+|+.|.+. ++++...
T Consensus 255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~--HpyF~~~ 328 (338)
T KOG0668|consen 255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA--HPYFAPV 328 (338)
T ss_pred HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc--CchHHHH
Confidence 0 01111 11225689999999999999999999999988 5555443
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=309.20 Aligned_cols=146 Identities=32% Similarity=0.514 Sum_probs=126.5
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|.+.++||+|+||.||+|.+. ++.||||+++........ ....+..|+.++..++||||+++++.+.+ ...++
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~--~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKN--MVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHH--HHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 57899999999999999999886 789999999764433221 22457899999999999999999988864 57899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
||||+.|++|.+++.. .+.+++..++.++.||+.||.|||..||+||||||+|||++.++ .+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence 9999999999999875 34689999999999999999999999999999999999999665 59999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=301.28 Aligned_cols=253 Identities=29% Similarity=0.521 Sum_probs=216.2
Q ss_pred ceeecceeecccceEEEEEEE--C----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCe
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--G----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLM 132 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 132 (378)
..+..++||+|+||+||+|.+ + .-+||||++......... ..+++|+-+|.++.|||++++++++.....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s----~e~LdeAl~masldHpnl~RLLgvc~~s~~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKAS----IELLDEALRMASLDHPNLLRLLGVCMLSTL 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhh----HHHHHHHHHHhcCCCchHHHHhhhcccchH
Confidence 345568999999999999987 2 257999998876655433 358999999999999999999999988888
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
-||++|+++|+|.++++..+ ..+-....+.|+.||+.||.|||++++|||||-.+||||..-+. +||.|||+++....
T Consensus 773 qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h-vkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH-VKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe-EEEEecchhhccCc
Confidence 89999999999999998854 57888999999999999999999999999999999999996654 99999999986543
Q ss_pred ccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 213 TEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 213 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
... .....-.+.|||-|.+.. ..|+.++|||||||++||++| |..|+.+... .++-.....+.+..-
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~--------~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-~eI~dlle~geRLsq 921 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRI--------RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-EEIPDLLEKGERLSQ 921 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhc--------cCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-HHhhHHHhccccCCC
Confidence 332 222334568999998865 789999999999999999999 9999998765 455566667888888
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
|+.++.++..++.+||..|+..||+++++...+.....
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 99999999999999999999999999999998877653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=274.84 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=205.0
Q ss_pred ccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeE-ec
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC-KD 129 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~-~~ 129 (378)
......++-+..||.|+||+|++-.+ .|+..|||.++......+ +.+++.|.....+- +.||||+++|.. .+
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke----q~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE----QKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH----HHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 34455566678999999999998766 478999999987655332 34688888776555 799999999975 67
Q ss_pred CCeEEEEeccCCCCHHHHH---hhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 130 PLMVIVTELLPGMSLRKYL---VSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l---~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
+..|+.||.+ ..||..+. ...+...+++...-.|....+.||.||-+. .||||||||+|||++..|. |||||||
T Consensus 136 GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~-vKLCDFG 213 (361)
T KOG1006|consen 136 GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD-VKLCDFG 213 (361)
T ss_pred CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC-Eeeeccc
Confidence 7899999999 45665443 333456799999999999999999999865 8999999999999997665 9999999
Q ss_pred cccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017046 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
++......-..+...|...|||||.+.+ ....|+-++|+||||++|||+.||+.||.+....-+....+..+..
T Consensus 214 IcGqLv~SiAkT~daGCrpYmAPERi~p------~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdp 287 (361)
T KOG1006|consen 214 ICGQLVDSIAKTVDAGCRPYMAPERIDP------SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDP 287 (361)
T ss_pred chHhHHHHHHhhhccCCccccChhccCC------ccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCC
Confidence 9976544444455578889999999976 2346899999999999999999999999987776666666666666
Q ss_pred CCCCC-----CChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 286 PGLPE-----DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 286 ~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
|.+.. .++..+..+|..||.+|-..||.+.++.+
T Consensus 288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 65432 37889999999999999999999999987
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=294.38 Aligned_cols=245 Identities=23% Similarity=0.384 Sum_probs=197.7
Q ss_pred ccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 130 (378)
.++.+.|..++.||-|+||+|.+++.. ...||+|.+.+......++. .....|-.||..-..+.||+||..|+|+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQv--aHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQV--AHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhh--hhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 356777889999999999999998754 46899999987665554443 3577888999999999999999999875
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
.+|+||+|++||++-.+|-. -+.|.++.+++|++++.+|+++.|..|+|||||||+|||||.+|+ +||+||||++..
T Consensus 703 nLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH-IKLTDFGLCTGf 779 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGF 779 (1034)
T ss_pred ceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc-eeeeeccccccc
Confidence 89999999999999998865 367999999999999999999999999999999999999998876 999999998621
Q ss_pred c---------c----------------------------------ccccccCcCccccccccccccccccccccccCCCc
Q 017046 211 T---------V----------------------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 247 (378)
Q Consensus 211 ~---------~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 247 (378)
- . .......+||+.|+|||++.. ..|+..
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--------~g~~q~ 851 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--------TGYTQL 851 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--------cCcccc
Confidence 0 0 001123469999999999965 668889
Q ss_pred ccchhhhHHHHHHHhCCCCCCCCChHHHHHHHH--HhcCCCCCCCCChHHHHHHHHHccccCCCCCC
Q 017046 248 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA--FKHARPGLPEDISPDLAFIVQSCWVEDPNLRP 312 (378)
Q Consensus 248 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 312 (378)
.|+||.|+|||||+.|++||-..+..+..+..+ ...........++.++.++|.+++. +++.|.
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 999999999999999999998766655443332 2223333446799999999887553 677775
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=293.83 Aligned_cols=242 Identities=27% Similarity=0.377 Sum_probs=198.0
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-Ce
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~ 132 (378)
.+.|.+...+|.|+|+.|-.+.. +++..++|++.+.... -.+|+.++... +||||+++.+.+.++ +.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~---------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD---------NQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc---------cccccchhhhhcCCCcceeecceecCCcee
Confidence 56688888999999999998865 5788999999876322 22566666555 799999999999776 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++|||.+.|+-|.+.+... ......+..|+++|+.|+.|||++|+|||||||+|||++.+.++++|+|||.+.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSK---PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeehhccccHHHHHHHhc---chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999999999888877652 2333788889999999999999999999999999999952344599999999986544
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
. ....+-|..|.|||++.. ..|+.++||||||++||+||+|+.||.......++... -..+.+...+
T Consensus 469 ~--~~tp~~t~~y~APEvl~~--------~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~---i~~~~~s~~v 535 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLAI--------QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR---IQMPKFSECV 535 (612)
T ss_pred h--hcccchhhcccChhhhcc--------CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh---hcCCcccccc
Confidence 4 334467889999999863 78999999999999999999999999876665333332 3444555889
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
|.++++|+.+||+.||.+||++.++.. +.++
T Consensus 536 S~~AKdLl~~LL~~dP~~Rl~~~~i~~--h~w~ 566 (612)
T KOG0603|consen 536 SDEAKDLLQQLLQVDPALRLGADEIGA--HPWF 566 (612)
T ss_pred CHHHHHHHHHhccCChhhCcChhhhcc--Ccch
Confidence 999999999999999999999999998 4555
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=282.21 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=205.3
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchH--HHHHHHHHHHHHHHHhhccCCCeeeEEeeEe--cC
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDE--RALLEGRFIREVNMMSRVKHDNLVKFLGACK--DP 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~ 130 (378)
.++|.++..||+|||+.||+|-+ ..+.||+|+........+ .+...+...+|..|-+.|.||.||++|++|. ..
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 35688899999999999999965 568999999765544433 3344556789999999999999999999994 34
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCeeecCCCCcEEEcCCC--CceeEecccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--GIIHRDLKPDNLLLTPDQ--KSLKLADFGL 206 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--givH~dikp~Nill~~~~--~~vkl~Dfg~ 206 (378)
.+|-|+|||+|.+|.-|+.. ...+++.+++.|+.||+.||.||.+. .|||-||||.|||+.... +.+||+|||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 78899999999999999986 45799999999999999999999987 599999999999996332 3599999999
Q ss_pred cccccccc--------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHH
Q 017046 207 AREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (378)
Q Consensus 207 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 278 (378)
++.+.... .+....||..|++||.+.-.. .....+.++||||+|+|+|.++.|+.||......+.+..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk----ePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK----EPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCC----CCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 98654332 344568999999999886421 235678899999999999999999999976554443332
Q ss_pred H--HHhcCCCCCC--CCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 279 A--AFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 279 ~--~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
. ++.-....|| +.+++++.+||++||+...++|....++..
T Consensus 696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 2 2222233344 458999999999999999999998888866
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=249.69 Aligned_cols=253 Identities=28% Similarity=0.420 Sum_probs=202.5
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv~ 136 (378)
|...++||+|.||+||+|+. +.+.||+|.++.+...+... ...++|+.+++.++|.|||++++... +..+.+|+
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp---ssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc---HHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 45567899999999999976 46899999988765543322 24679999999999999999999874 66888999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-c
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~ 215 (378)
||| .-+|..+..+ -.+.++.+.+..++.|++.||.++|++++.|||+||.|.||+.+|. +||+|||+++..+.+- -
T Consensus 81 e~c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge-lkladfglarafgipvrc 157 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE-LKLADFGLARAFGIPVRC 157 (292)
T ss_pred HHh-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc-EEecccchhhhcCCceEe
Confidence 999 4599999887 4578999999999999999999999999999999999999997665 9999999998655443 3
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC---CCC--
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP---GLP-- 289 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~---~~~-- 289 (378)
.+..+.|..|.+|.++.+ ..-|+.+.|+||.|||+.|+.. |++.|++....+....+...-..+ .+|
T Consensus 158 ysaevvtlwyrppdvlfg-------akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred eeceeeeeeccCcceeee-------eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 456678999999999987 3568999999999999999997 888888877655555443322211 111
Q ss_pred ----------------------CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 290 ----------------------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 290 ----------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+.++..-+++++++|.-+|..|.++++.++ +.++..
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq--hpyf~d 288 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ--HPYFSD 288 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc--Cccccc
Confidence 112234578999999999999999999888 444433
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=273.50 Aligned_cols=261 Identities=25% Similarity=0.320 Sum_probs=197.5
Q ss_pred cCCcceeecceeecccceEEEEEEEC------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
.....|.+...||+|.||.||+|..+ +..+|||.++..+...-.. ....+|+.+++.++|||++.+..++-
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS---~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS---MSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC---HHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 34456889999999999999999542 2379999998764322211 23569999999999999999988773
Q ss_pred --cCCeEEEEeccCCCCHHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC---CCcee
Q 017046 129 --DPLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD---QKSLK 200 (378)
Q Consensus 129 --~~~~~lv~e~~~~~sL~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~---~~~vk 200 (378)
+...++++||++. +|.+.|.-.+ ...++...+..++.||+.|+.|||++=|+||||||.||||..+ .+.||
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 6688999999966 8998886532 3469999999999999999999999999999999999999755 24699
Q ss_pred Eecccccccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH---
Q 017046 201 LADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL--- 273 (378)
Q Consensus 201 l~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--- 273 (378)
|+|||+++.....- .....+.|..|.|||++.+ ...|+.+.|||++|||+.||++-.+.|.+....
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG-------a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~ 249 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG-------ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKT 249 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcc-------cccccchhhhHHHHHHHHHHHccCccccchhhhccc
Confidence 99999998643321 2234578899999999987 478999999999999999999988888653321
Q ss_pred ---------HHHHHHHHhcCCCCCC--------------------------------CCChHHHHHHHHHccccCCCCCC
Q 017046 274 ---------QAAYAAAFKHARPGLP--------------------------------EDISPDLAFIVQSCWVEDPNLRP 312 (378)
Q Consensus 274 ---------~~~~~~~~~~~~~~~~--------------------------------~~~~~~l~~li~~~l~~dp~~Rp 312 (378)
..++...-......+| ..-++...+|+.++|+.||.+|.
T Consensus 250 ~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI 329 (438)
T KOG0666|consen 250 KNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI 329 (438)
T ss_pred CCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc
Confidence 1111110000000010 11234578899999999999999
Q ss_pred CHHHHHHHHHhhhhcc
Q 017046 313 SFSQIIRMLNAFLFTL 328 (378)
Q Consensus 313 s~~~ll~~l~~~~~~~ 328 (378)
|+++.++ +.++..-
T Consensus 330 ta~qAle--h~yF~~d 343 (438)
T KOG0666|consen 330 TAEQALE--HPYFTED 343 (438)
T ss_pred cHHHHhc--ccccccC
Confidence 9999988 4555444
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=278.73 Aligned_cols=247 Identities=30% Similarity=0.455 Sum_probs=193.8
Q ss_pred eeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|.+.+.||+|+||.||+|+.. ++.||+|++........ ....+..|+.+++.++||||+++++++.+ ...++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccccc---ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence 456688999999999999874 68999999886542221 12346789999999999999999998865 4789999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-c
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~ 215 (378)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 78 e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 78 EYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRT 154 (282)
T ss_pred cCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-CEEEecCCcccccCCCccc
Confidence 9996 59999998632 4699999999999999999999999999999999999999654 59999999987543322 2
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc------------
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH------------ 283 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------------ 283 (378)
.....++..|+|||.+.. ...++.++|+||||+++|+|++|..||.+..............
T Consensus 155 ~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 155 YTHEVVTLWYRAPEILLG-------SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred cCccccCcCcCChHHhcC-------CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhc
Confidence 233456778999998754 2367889999999999999999999998765433322211100
Q ss_pred -------CCCC--------CCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 284 -------ARPG--------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 284 -------~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
..+. .....+..+.+++..||..||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000 01234778999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=270.69 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=204.2
Q ss_pred ccccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEe
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK 128 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 128 (378)
++.+.-.+|.+++.||.|+|++|..+++ +++.||+|+++++...++... .-...|-.+...- +||.+|-+..+|+
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedi--dwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDI--DWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccc--hhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 3445667899999999999999999876 578999999988766554322 1234565566555 7999999999996
Q ss_pred c-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 129 D-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 129 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
. ..+++|.||++||+|--.++. ..+++++.++.+..+|..||.|||++||+.||||.+|+|++.+|. +||+|+|++
T Consensus 322 tesrlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh-ikltdygmc 398 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH-IKLTDYGMC 398 (593)
T ss_pred ccceEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc-eeecccchh
Confidence 5 478999999999999766654 568999999999999999999999999999999999999998775 999999999
Q ss_pred ccc-ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCC--C----ChHHHHHHHH
Q 017046 208 REE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG--M----SNLQAAYAAA 280 (378)
Q Consensus 208 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~----~~~~~~~~~~ 280 (378)
+.. ..+..+++.+|||.|+|||++++ ..|+.+.|+|+||++|+||+.|+.||.- + .+.++....+
T Consensus 399 ke~l~~gd~tstfcgtpnyiapeilrg--------eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv 470 (593)
T KOG0695|consen 399 KEGLGPGDTTSTFCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV 470 (593)
T ss_pred hcCCCCCcccccccCCCcccchhhhcc--------cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence 864 34556678899999999999976 7899999999999999999999999952 1 2233334444
Q ss_pred HhcCCCCCCCCChHHHHHHHHHccccCCCCCC
Q 017046 281 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRP 312 (378)
Q Consensus 281 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 312 (378)
+-.....+|..+|-.+..+++..|.+||.+|.
T Consensus 471 ilekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 471 ILEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 44556678888898899999999999999984
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=277.25 Aligned_cols=260 Identities=31% Similarity=0.495 Sum_probs=200.5
Q ss_pred CCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc--cCCCeeeEEeeEec----
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV--KHDNLVKFLGACKD---- 129 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~l~~~~~~---- 129 (378)
+-....+...||+|.||.||+|...++.||||++..... ..|..|-.|.+.. .|+||++|++.-..
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~k--------qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEK--------QSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccCceeEEEecCHHHH--------HHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 344566778999999999999999999999999964322 2477887777754 79999999987532
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCeeecCCCCcEEEcCCCCce
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN---------GIIHRDLKPDNLLLTPDQKSL 199 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---------givH~dikp~Nill~~~~~~v 199 (378)
..++||++|.+.|+|.+||.. +.+++....+++..+++||+|||+. .|+|||||..||||..|. +.
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-Tc 355 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TC 355 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cE
Confidence 268899999999999999986 6799999999999999999999975 599999999999999665 59
Q ss_pred eEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCC-----------
Q 017046 200 KLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL----------- 265 (378)
Q Consensus 200 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~----------- 265 (378)
.|+|||+|.....+. .....+||.+|||||++.+...-+. ...-.+.||||+|.+||||++...
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d--~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD--RDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc--HHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 999999997654332 2234689999999999976332110 222346899999999999998543
Q ss_pred -CCC---CCC-hHHHHH-HHHHhcCCCCCCCCC-----hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 266 -PFE---GMS-NLQAAY-AAAFKHARPGLPEDI-----SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 266 -pf~---~~~-~~~~~~-~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
||+ +.. ..++.. ..+.+..+|.+|..+ ...+.+.+..||..|++.|.|+.-+.+.+..+....+
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 332 111 122222 234566777777643 3458899999999999999999999998877765543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=270.52 Aligned_cols=253 Identities=24% Similarity=0.333 Sum_probs=199.4
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc--CCC----eeeEEeeEe
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--HDN----LVKFLGACK 128 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~----iv~l~~~~~ 128 (378)
..+|.+++.+|+|.||.|-...+ .+..||||+++....- .+.-+-|+++|+++. .|+ ++++.++|.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY------reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY------REAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH------hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 56799999999999999998765 4689999999753332 233567999999994 333 677778885
Q ss_pred -cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC------------
Q 017046 129 -DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD------------ 195 (378)
Q Consensus 129 -~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~------------ 195 (378)
.++.+||+|.+ |-|+.+++..+...+++...++.|++|++.++++||+.+++|-||||+|||+.+.
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 56899999999 7799999998777889999999999999999999999999999999999998421
Q ss_pred -------CCceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCC
Q 017046 196 -------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (378)
Q Consensus 196 -------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 268 (378)
...|+|+|||.|+...... ...+.|..|.|||++.+ -.++...||||+||||+|+.+|...|+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg--------LGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG--------LGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec--------cCcCCccCceeeeeEEEEeeccceecc
Confidence 2249999999998754443 56688999999999987 567889999999999999999999998
Q ss_pred CCChHHHH--HHHHHh-----------------cCCCCCCCC-------------------------ChHHHHHHHHHcc
Q 017046 269 GMSNLQAA--YAAAFK-----------------HARPGLPED-------------------------ISPDLAFIVQSCW 304 (378)
Q Consensus 269 ~~~~~~~~--~~~~~~-----------------~~~~~~~~~-------------------------~~~~l~~li~~~l 304 (378)
+.++.+.+ ++.+.. .....+++. --..+.+|+++||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 87765432 111111 011121211 0124889999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 305 VEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 305 ~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
..||.+|+|+.|++. +.++..+
T Consensus 391 ~fDP~~RiTl~EAL~--HpFF~~~ 412 (415)
T KOG0671|consen 391 EFDPARRITLREALS--HPFFARL 412 (415)
T ss_pred ccCccccccHHHHhc--CHHhhcC
Confidence 999999999999988 6666554
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=267.94 Aligned_cols=222 Identities=23% Similarity=0.265 Sum_probs=176.8
Q ss_pred ccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccCCCCHH
Q 017046 69 GAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLR 145 (378)
Q Consensus 69 G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~ 145 (378)
|.||.||++++ +++.||+|.+..... +.+|...+....||||+++++.+.+ ...+++|||++|++|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 89999999987 568899999875431 2244444555679999999998865 4788999999999999
Q ss_pred HHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccccccCcCcccc
Q 017046 146 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW 225 (378)
Q Consensus 146 ~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y 225 (378)
+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||.+...... .....++..|
T Consensus 74 ~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~l~df~~~~~~~~~--~~~~~~~~~y 148 (237)
T cd05576 74 SHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH-IQLTYFSRWSEVEDS--CDGEAVENMY 148 (237)
T ss_pred HHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC-EEEecccchhccccc--cccCCcCccc
Confidence 998753 45899999999999999999999999999999999999996654 999999987544322 2233567789
Q ss_pred ccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccc
Q 017046 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 305 (378)
Q Consensus 226 ~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 305 (378)
+|||.+.. ..++.++|+||+|+++|+|++|..||...... ........+|..+++.+.+++.+||+
T Consensus 149 ~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~ 214 (237)
T cd05576 149 CAPEVGGI--------SEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQ 214 (237)
T ss_pred cCCcccCC--------CCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHcc
Confidence 99998753 56788999999999999999999887643211 11122334667789999999999999
Q ss_pred cCCCCCCCH-----HHHHH
Q 017046 306 EDPNLRPSF-----SQIIR 319 (378)
Q Consensus 306 ~dp~~Rps~-----~~ll~ 319 (378)
.||.+||++ .++++
T Consensus 215 ~dp~~R~~~~~~~~~~~~~ 233 (237)
T cd05576 215 FNPTERLGAGVAGVEDIKS 233 (237)
T ss_pred CCHHHhcCCCccchHHHHc
Confidence 999999986 55554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=266.21 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=200.0
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--- 129 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--- 129 (378)
.....|....+||+|.||+||+|+. +++.||+|++..+..... .-...++|+.+|..|+|+|++.++..|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG---fpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC---CcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 3455677788999999999999976 467889887543211110 01135699999999999999999887731
Q ss_pred ------CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEec
Q 017046 130 ------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (378)
Q Consensus 130 ------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~D 203 (378)
..+|+||.+|+. +|.-++.. ....++..++..++.++..||.|+|+..|+|||+||+|+||+.++ .+||+|
T Consensus 91 p~~r~r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklAD 167 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLAD 167 (376)
T ss_pred CcccccceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeec
Confidence 148899999965 88888865 446799999999999999999999999999999999999999665 599999
Q ss_pred cccccccccc-----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHH
Q 017046 204 FGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (378)
Q Consensus 204 fg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 278 (378)
||+++..+.. ...+..+.|..|.+||.+.+ ...|+++.|||+.|||+.+|+++.+-+.+.++.+.+..
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG-------~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~ 240 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG-------DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL 240 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhc-------ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence 9999654332 22345567999999999987 47899999999999999999999999998776554432
Q ss_pred HHHh--cCC------------------CCCCC-------------CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 279 AAFK--HAR------------------PGLPE-------------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 279 ~~~~--~~~------------------~~~~~-------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
+..- ... +++|. .-.++..+|+..+|..||.+|+++++++. +.++
T Consensus 241 Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln--h~~F 318 (376)
T KOG0669|consen 241 ISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN--HDFF 318 (376)
T ss_pred HHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc--hhhh
Confidence 2110 000 11111 12347889999999999999999999998 5555
Q ss_pred hccC
Q 017046 326 FTLR 329 (378)
Q Consensus 326 ~~~~ 329 (378)
..-+
T Consensus 319 ~kdp 322 (376)
T KOG0669|consen 319 WKDP 322 (376)
T ss_pred hcCC
Confidence 5533
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.52 Aligned_cols=241 Identities=23% Similarity=0.391 Sum_probs=183.1
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
+.....||+|+||.||+|+. .+..||+|.+...... ...|++++++++||||+++++++.+ ...++||
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 44567899999999999986 5789999988653322 1246788999999999999999965 4688999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH---ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
||+++|+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++. .++. ||.......
T Consensus 763 Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~-~~~~-~~~~~~~~~- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE-PHLR-LSLPGLLCT- 834 (968)
T ss_pred eCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc-eEEE-ecccccccc-
Confidence 99999999999853 789999999999999999999 669999999999999985543 5554 555432211
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh----HHHHHHHHHh------c
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN----LQAAYAAAFK------H 283 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~~~~~------~ 283 (378)
.....+++.|+|||++.. ..++.++|||||||++|||++|+.||..... .......... .
T Consensus 835 --~~~~~~t~~y~aPE~~~~--------~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 904 (968)
T PLN00113 835 --DTKCFISSAYVAPETRET--------KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW 904 (968)
T ss_pred --CCCccccccccCcccccC--------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe
Confidence 123367899999998854 6789999999999999999999999853221 1111111000 0
Q ss_pred CCCCCC------CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 284 ARPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 284 ~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
..+.+. .....++.+++.+||+.||.+|||+.++++.|+.....
T Consensus 905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 111111 11223577899999999999999999999999887553
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=244.29 Aligned_cols=228 Identities=28% Similarity=0.439 Sum_probs=182.9
Q ss_pred cccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeE-e
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC-K 128 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~-~ 128 (378)
..++..++..+..||+|+||.|-+-++ .|...|+|.+......++ +++.++|+.+..+. .+|.+|+|+|.. .
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~----q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE----QKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH----HHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 445666677788999999999876654 689999999877555443 34688999887776 699999999976 5
Q ss_pred cCCeEEEEeccCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 129 DPLMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
+...++.||.+ ..||..+... .+++.+++..+-+|+..++.||.|||++ .++|||+||+|||++.+|. ||+||||
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq-VKiCDFG 194 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ-VKICDFG 194 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc-EEEcccc
Confidence 66899999999 5688776544 2456799999999999999999999987 8999999999999997765 9999999
Q ss_pred cccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017046 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
++......-..+...|...|||||.+.... +...|+-++||||||+++.||.+++.||+.....-.....+.....
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~----n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPEL----NQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCccc----CcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 987544333333356888999999997633 3457999999999999999999999999876665566666666666
Q ss_pred CCCCC
Q 017046 286 PGLPE 290 (378)
Q Consensus 286 ~~~~~ 290 (378)
|.+|.
T Consensus 271 P~Lp~ 275 (282)
T KOG0984|consen 271 PQLPA 275 (282)
T ss_pred CCCcc
Confidence 66664
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=257.30 Aligned_cols=235 Identities=37% Similarity=0.592 Sum_probs=193.6
Q ss_pred cceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccCCCCHHH
Q 017046 70 AHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRK 146 (378)
Q Consensus 70 ~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~ 146 (378)
+||.||++... ++.+|+|++........ ...+.+|++.+++++|+||+++++.+.+ ...++++||+.+++|.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 58999999885 58999999876554332 2468899999999999999999998864 57889999999999999
Q ss_pred HHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccccccCcCccccc
Q 017046 147 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM 226 (378)
Q Consensus 147 ~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~ 226 (378)
++... ..++...++.++.+++.++.+||..|++|+||+|.||+++.++ .++|+|||.+.............++..|+
T Consensus 77 ~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 77 LLKKR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHhc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCCcCCC
Confidence 98763 2389999999999999999999999999999999999999664 59999999998765544445567888999
Q ss_pred cccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC--ChHHHHHHHHHcc
Q 017046 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCW 304 (378)
Q Consensus 227 aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l 304 (378)
+||.+.. ..++.++|||+||+++|+|++|..||.....................+.. ++.++.+++.+||
T Consensus 154 ~pE~~~~--------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 225 (244)
T smart00220 154 APEVLLG--------KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLL 225 (244)
T ss_pred CHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHc
Confidence 9998853 56788999999999999999999999874444444444433333322222 8899999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 017046 305 VEDPNLRPSFSQIIR 319 (378)
Q Consensus 305 ~~dp~~Rps~~~ll~ 319 (378)
..+|.+||++.++++
T Consensus 226 ~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 226 VKDPEKRLTAEEALQ 240 (244)
T ss_pred cCCchhccCHHHHhh
Confidence 999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=288.69 Aligned_cols=263 Identities=20% Similarity=0.244 Sum_probs=172.1
Q ss_pred cCCcceeecceeecccceEEEEEEEC------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEee--
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-- 126 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~-- 126 (378)
...++|.+.+.||+|+||.||+|++. +..||+|.+........ +..+ .+....+.++..++..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~-------~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI-------WMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH-------HHHH--HHHhhchhhHHHHHHhhh
Confidence 35678999999999999999999874 57899998764322111 1111 1111122222222111
Q ss_pred -----EecCCeEEEEeccCCCCHHHHHhhhCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 017046 127 -----CKDPLMVIVTELLPGMSLRKYLVSLRPN------------------KLDLHVALNFALDIARAMDCLHANGIIHR 183 (378)
Q Consensus 127 -----~~~~~~~lv~e~~~~~sL~~~l~~~~~~------------------~l~~~~~~~i~~qi~~~l~~lH~~givH~ 183 (378)
..+...++||||+.+++|.+++...... ......+..++.||+.||.|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 1344789999999999999998652110 11234466899999999999999999999
Q ss_pred cCCCCcEEEcCCCCceeEecccccccccc--ccccccCcCcccccccccccccccccc--------------ccccCCCc
Q 017046 184 DLKPDNLLLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQG--------------EKKHYNNK 247 (378)
Q Consensus 184 dikp~Nill~~~~~~vkl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~--------------~~~~~~~~ 247 (378)
||||+|||++.+...+||+|||++..... ........+++.|+|||.+........ ....++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999986555699999999975322 222345578999999997643110000 01134556
Q ss_pred ccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc----------CCCCCC----------CCChHHHHHHHHHccccC
Q 017046 248 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH----------ARPGLP----------EDISPDLAFIVQSCWVED 307 (378)
Q Consensus 248 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~----------~~~~~~l~~li~~~l~~d 307 (378)
+|||||||++|+|+++..|+.. ............ ..+... ...+....+||.+||..|
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 7999999999999997776543 111111111100 000000 111233558999999999
Q ss_pred CCCCCCHHHHHHHHHhhhhccCC
Q 017046 308 PNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 308 p~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
|.+|||+.++++ +.++.....
T Consensus 438 P~kR~ta~e~L~--Hpff~~~~~ 458 (566)
T PLN03225 438 GRQRISAKAALA--HPYFDREGL 458 (566)
T ss_pred cccCCCHHHHhC--CcCcCCCCc
Confidence 999999999999 566655433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=288.21 Aligned_cols=242 Identities=27% Similarity=0.396 Sum_probs=183.9
Q ss_pred eeecceeecccceE-EEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-CeEEEE
Q 017046 60 LFIGSKIGEGAHGK-VYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~~lv~ 136 (378)
|.-.+.+|.|+.|+ ||+|...++.||||.+-.... ....+|+..|+.- .|||||++++.-.+. +.||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~--------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFF--------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhH--------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 33446789999976 689999999999998754332 2356999999988 699999999987655 788999
Q ss_pred eccCCCCHHHHHhhh-CCC-CCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC---CC-CceeEecccccccc
Q 017046 137 ELLPGMSLRKYLVSL-RPN-KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP---DQ-KSLKLADFGLAREE 210 (378)
Q Consensus 137 e~~~~~sL~~~l~~~-~~~-~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~---~~-~~vkl~Dfg~a~~~ 210 (378)
|.| ..+|.+++... ... .......+.+..|++.||++||+.+||||||||.||||+. ++ .+++|+|||+++..
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 56999999873 111 1111445788999999999999999999999999999985 23 46999999999865
Q ss_pred cccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017046 211 TVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 211 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
..+. ......||-+|+|||.+.. ..-+.++|||||||++|+.++ |..||.+....+... ......
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--------~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI--l~~~~~ 731 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--------DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI--LTGNYT 731 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--------cccCcccchhhcCceEEEEecCCccCCCchHHhhhhh--hcCccc
Confidence 4432 2455689999999999965 444669999999999999999 589997654332211 111111
Q ss_pred C-CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 286 P-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 286 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
. .+...-..++.+||.+|+.++|..||++.+|+.|
T Consensus 732 L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 LVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1 1111111289999999999999999999999983
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=259.69 Aligned_cols=259 Identities=26% Similarity=0.447 Sum_probs=214.3
Q ss_pred cCCcceeecceeecccceEEEEEEECC-------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
+...++++...+-+|.||.||.|.+.+ +.|-+|.++.....-. ...++.|...+..+.|||+..+.+++
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQ----v~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQ----VNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHH----HHHHHHHHHHHhcCcCCCccceeEEE
Confidence 445567788889999999999997642 4567777765444322 24688999999999999999999987
Q ss_pred ec--CCeEEEEeccCCCCHHHHHhhhC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCce
Q 017046 128 KD--PLMVIVTELLPGMSLRKYLVSLR------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199 (378)
Q Consensus 128 ~~--~~~~lv~e~~~~~sL~~~l~~~~------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~v 199 (378)
.+ ...+.++.+..-|+|..++...+ .+.++..+...++.|++.|++|||.+|+||.||..+|++|+ +...|
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId-d~LqV 435 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID-DQLQV 435 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh-hheeE
Confidence 43 36788899998899999998433 23477788899999999999999999999999999999999 66779
Q ss_pred eEeccccccccccc---cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHH
Q 017046 200 KLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275 (378)
Q Consensus 200 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 275 (378)
||+|=.+++..... ...........||+||.+.. ..|+.++|+||||++||||+| |+.||...++ .+
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n--------~~yssasDvWsfGVllWELmtlg~~PyaeIDP-fE 506 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN--------SHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-FE 506 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhh--------hhhcchhhhHHHHHHHHHHHhcCCCCccccCH-HH
Confidence 99999999864332 33334456678999999964 789999999999999999999 9999987766 44
Q ss_pred HHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 276 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.......+.+..-|-++|+++..++.-||+..|++||+++|+...|..+-..
T Consensus 507 m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 507 MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 5666778889999999999999999999999999999999999999877544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=274.95 Aligned_cols=264 Identities=20% Similarity=0.252 Sum_probs=181.5
Q ss_pred CCcceeecceeecccceEEEEEEE------------------CCeeEEEEEeecCCCchHHHH---------HHHHHHHH
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY------------------GDRIVAIKVLNRGSTSDERAL---------LEGRFIRE 108 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~~---------~~~~~~~E 108 (378)
..++|.+.++||+|+||+||+|.. .++.||||.+........... ..+.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999863 235799999875432211110 01223457
Q ss_pred HHHHhhccCCCe-----eeEEeeEe---------cCCeEEEEeccCCCCHHHHHhhhC----------------------
Q 017046 109 VNMMSRVKHDNL-----VKFLGACK---------DPLMVIVTELLPGMSLRKYLVSLR---------------------- 152 (378)
Q Consensus 109 ~~~l~~l~hp~i-----v~l~~~~~---------~~~~~lv~e~~~~~sL~~~l~~~~---------------------- 152 (378)
+.++.+++|.++ ++++++|. ++..++||||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 55666553 346789999999999999886421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccccc--cCcCccccccccc
Q 017046 153 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT--AETGTYRWMAPEL 230 (378)
Q Consensus 153 ~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~ 230 (378)
...+++..++.++.|++.+|.|||+.+|+||||||+|||++.++ .+||+|||++.......... ...+++.|+|||.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 11245678889999999999999999999999999999999665 59999999986543322222 2345789999998
Q ss_pred cccccccccc--------------cccCCCcccchhhhHHHHHHHhCCC-CCCCCChHHHHHHH---------HHhcCCC
Q 017046 231 YSTVTLRQGE--------------KKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAA---------AFKHARP 286 (378)
Q Consensus 231 ~~~~~~~~~~--------------~~~~~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~~~~---------~~~~~~~ 286 (378)
+......... ......+.||||+||++|+|++|.. ||.+.......... .......
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 7531100000 0011234799999999999999875 77543221111110 0111122
Q ss_pred C--CCCCChHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 017046 287 G--LPEDISPDLAFIVQSCWVEDP---NLRPSFSQIIRM 320 (378)
Q Consensus 287 ~--~~~~~~~~l~~li~~~l~~dp---~~Rps~~~ll~~ 320 (378)
. .....++...+|+.+||..+| .+|+|+.|+++|
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 2 234578899999999999876 689999999983
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=253.30 Aligned_cols=247 Identities=30% Similarity=0.436 Sum_probs=194.5
Q ss_pred eecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC------Ce
Q 017046 61 FIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP------LM 132 (378)
Q Consensus 61 ~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~~ 132 (378)
...+-||-|+||.||-+.+ .++.||+|++...... -...+++.+|+++|..++|.|++..++..+.. .+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~---L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN---LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHH---HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3457899999999998876 4789999988754332 23356899999999999999999988876543 35
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
|+++|.+ ..+|...+.+ +..++...+.-+.+||++||.|||+.||.||||||.|.|++++ ..+||||||+++....
T Consensus 133 YV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN-CILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC-ceEEecccccccccch
Confidence 7888888 5689988875 5779999999999999999999999999999999999999954 5699999999987554
Q ss_pred cc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-----
Q 017046 213 TE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----- 285 (378)
Q Consensus 213 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----- 285 (378)
.. .++..+.|..|.|||++.+ ...|+.+.||||.|||+.||+..+..|..-+..+.+..+..--..
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMG-------aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMG-------ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhc-------chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence 43 3445577899999999987 478999999999999999999999999876665443322111111
Q ss_pred -------------------CCC--------CCCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 286 -------------------PGL--------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 286 -------------------~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
|.+ +..-..+...++..++..||++|.+..+.+.++
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111 112234677888999999999999998887744
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=249.70 Aligned_cols=132 Identities=27% Similarity=0.417 Sum_probs=113.6
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-----C---CCeeeEE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-----H---DNLVKFL 124 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---p~iv~l~ 124 (378)
....+|.+.++||-|-|++||++.++ .+.||+|+.+....-. +..+.||++|++++ | .+||+|+
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYt------EaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYT------EAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHH------HHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 34578999999999999999999875 5899999998644332 34568999999883 2 3699999
Q ss_pred eeEec-----CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEc
Q 017046 125 GACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLT 193 (378)
Q Consensus 125 ~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~ 193 (378)
+.|.. .+.++|+|++ |.+|..+|.......++...+..|++||+.||.|||.. ||||-||||+|||+.
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 99852 3789999999 88999999988888999999999999999999999987 999999999999985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=245.32 Aligned_cols=253 Identities=29% Similarity=0.399 Sum_probs=200.3
Q ss_pred ccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec--
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-- 129 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-- 129 (378)
...+.+|.-++.+|.|.- .|..+-+ .++.||+|.+........ ..++..+|..++..++|+||+.++.+|.-
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~---~akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQT---HAKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCc---cchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 344567777888999998 5655543 578999999876643322 23467799999999999999999998842
Q ss_pred -----CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecc
Q 017046 130 -----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 130 -----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Df 204 (378)
...|+|||++ ..+|.+.+. ..++-..+..+++|+++|+.|||+.||+||||||+||++..+ ..+||.||
T Consensus 89 ~l~~~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~df 162 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKILDF 162 (369)
T ss_pred cHHHHHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeeccc
Confidence 2578999999 559998886 357889999999999999999999999999999999999955 46999999
Q ss_pred ccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017046 205 GLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 205 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
|+++.....-..+..+.|..|.|||++.+ ..+...+||||+||++.||++|...|.|....+...+......
T Consensus 163 g~ar~e~~~~~mtpyVvtRyyrapevil~--------~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lg 234 (369)
T KOG0665|consen 163 GLARTEDTDFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLG 234 (369)
T ss_pred hhhcccCcccccCchhheeeccCchheec--------cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhc
Confidence 99998777766778899999999999976 3488999999999999999999999988666444333221111
Q ss_pred CC-----------------------------CCCC-----------CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 285 RP-----------------------------GLPE-----------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 285 ~~-----------------------------~~~~-----------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
.+ .+|+ .-+..+++++.+||..||++|-|++++|+ +.+
T Consensus 235 tpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~--HPY 312 (369)
T KOG0665|consen 235 TPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR--HPY 312 (369)
T ss_pred CCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc--CCe
Confidence 11 0111 12235789999999999999999999999 555
Q ss_pred hh
Q 017046 325 LF 326 (378)
Q Consensus 325 ~~ 326 (378)
+.
T Consensus 313 ~~ 314 (369)
T KOG0665|consen 313 IK 314 (369)
T ss_pred ee
Confidence 53
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=259.15 Aligned_cols=247 Identities=24% Similarity=0.395 Sum_probs=195.8
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc------CCCeeeEEeeEe
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK------HDNLVKFLGACK 128 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~l~~~~~ 128 (378)
...|.+....|+|-|++|..|.+. +..||||++..... +.+.=+.|+++|++|+ .-|+++|+-.|.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~------M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV------MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH------HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 356778888999999999999874 67999999986433 3345679999999995 346888887774
Q ss_pred -cCCeEEEEeccCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 129 -DPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 129 -~~~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
..++|+|+|-+ ..+|.++|..... -++....+..|+.|++.||..|-..||+|.||||+||||+.....+||||||.
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 56899999999 7899999987433 46889999999999999999999999999999999999998777899999999
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHH-HHhcCC
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA-AFKHAR 285 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~ 285 (378)
|...+.... +.+..+.-|.|||++.+ .+|+...|+||+||+||||.||+..|+|.++.+-+... -.++..
T Consensus 584 A~~~~enei-tPYLVSRFYRaPEIiLG--------~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 584 ASFASENEI-TPYLVSRFYRAPEIILG--------LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred ccccccccc-cHHHHHHhccCcceeec--------CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 976554443 34455668999999987 77999999999999999999999999987763322111 001100
Q ss_pred CC------------C---------------------------C-----------CCCh-------HHHHHHHHHccccCC
Q 017046 286 PG------------L---------------------------P-----------EDIS-------PDLAFIVQSCWVEDP 308 (378)
Q Consensus 286 ~~------------~---------------------------~-----------~~~~-------~~l~~li~~~l~~dp 308 (378)
|. | | ..++ ..+.+|+.+||..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 00 0 0 0011 247899999999999
Q ss_pred CCCCCHHHHHH
Q 017046 309 NLRPSFSQIIR 319 (378)
Q Consensus 309 ~~Rps~~~ll~ 319 (378)
.+|.|..+.|.
T Consensus 735 ~KRit~nqAL~ 745 (752)
T KOG0670|consen 735 EKRITVNQALK 745 (752)
T ss_pred hhcCCHHHHhc
Confidence 99999999987
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=268.33 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=209.2
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE-ecCCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~~~~~ 133 (378)
..+|.++..+|+|+||.||++++ +++..|+|+++.....+.. -+..|+-+++.++||||+.+++.+ ....++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~-----~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFS-----GIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcccc-----ccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 45788999999999999999987 5789999999887665533 256899999999999999999988 566899
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+.||||.||+|.+...- .+.+++.++..++++.+.||+|||++|=+|||||-.|||++..+. +|+.|||.+......
T Consensus 89 icMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD-vklaDfgvsaqitat 165 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD-VKLADFGVSAQITAT 165 (829)
T ss_pred EEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc-eeecccCchhhhhhh
Confidence 99999999999997664 578999999999999999999999999999999999999996655 999999998654322
Q ss_pred -cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC---CC
Q 017046 214 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG---LP 289 (378)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---~~ 289 (378)
.....+.||+.|||||+..- +..+.|....|||++|++..|+-.-++|..+....+..+-....+..+. -+
T Consensus 166 i~KrksfiGtpywmapEvaav-----erkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk 240 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAV-----ERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK 240 (829)
T ss_pred hhhhhcccCCccccchhHHHH-----HhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence 23356789999999998643 2356788999999999999999998899877777666655544433333 23
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
..+++.+.+|++.+|.++|.+||+++.++.
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 468999999999999999999999998877
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=233.34 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=190.2
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEee-Ee-cCCe
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGA-CK-DPLM 132 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~-~~-~~~~ 132 (378)
+.|.|.+.||+|.||.+.++++. ++.+++|.+....... +.|.+|...--.| .|.||+.-+++ |+ .+.+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~------~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQ------ADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhH------HHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 45889999999999999999885 4789999988765533 4588888665556 58999987764 44 3467
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEc-CCCCceeEeccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREET 211 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~-~~~~~vkl~Dfg~a~~~~ 211 (378)
+++|||++.|+|.+-+.. .++-+.....++.|+++||.|+|++++||||||.+||||- .+..+|||||||+.+..+
T Consensus 98 vF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 799999999999987754 6788999999999999999999999999999999999984 444579999999987543
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGL 288 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 288 (378)
..-. ....+..|.+||+..... .......+.+|||.||+++|.+++|++||+.... ....+........+..
T Consensus 175 ~tV~--~~~~~~~y~~pe~~~~~~---ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 175 TTVK--YLEYVNNYHAPELCDTVV---NEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred ceeh--hhhhhcccCCcHHHhhcc---ccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 3221 123455799999876532 2234567889999999999999999999985332 2233344444555555
Q ss_pred CC---CChHHHHHHHHHccccCCCCC---CCHHHHHH
Q 017046 289 PE---DISPDLAFIVQSCWVEDPNLR---PSFSQIIR 319 (378)
Q Consensus 289 ~~---~~~~~l~~li~~~l~~dp~~R---ps~~~ll~ 319 (378)
|. .+++.+..+.++-|..+|.+| -+++....
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 54 478889999999999999999 44444433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-33 Score=257.60 Aligned_cols=204 Identities=24% Similarity=0.371 Sum_probs=168.5
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHH---HHHHHHHHHHHhhcc---CCCeeeEEee
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALL---EGRFIREVNMMSRVK---HDNLVKFLGA 126 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~---~~~~~~E~~~l~~l~---hp~iv~l~~~ 126 (378)
.+..+|..++.+|.|+||.|+++.++ ...|+||.+.+...-.+.... ...+-.||+||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34566999999999999999999875 468999998876553322111 113567999999997 9999999999
Q ss_pred EecC-CeEEEEecc-CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecc
Q 017046 127 CKDP-LMVIVTELL-PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 127 ~~~~-~~~lv~e~~-~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Df 204 (378)
|+++ ++|++||-. +|.+|.++|.. ...+++.++..|+.|++.|+++||+.||||||||-+|+.++.+|. +||+||
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~-~klidf 714 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF-VKLIDF 714 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe-EEEeec
Confidence 9865 778999876 34589999975 467999999999999999999999999999999999999997766 999999
Q ss_pred ccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCC
Q 017046 205 GLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (378)
Q Consensus 205 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 269 (378)
|.+... ........+||..|.|||++.+ ....+...|||+||++||.++....||.+
T Consensus 715 gsaa~~-ksgpfd~f~gtv~~aapevl~g-------~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYT-KSGPFDVFVGTVDYAAPEVLGG-------EKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhh-cCCCcceeeeeccccchhhhCC-------CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 998643 3344567799999999999976 23446788999999999999999999853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-31 Score=226.59 Aligned_cols=210 Identities=38% Similarity=0.654 Sum_probs=177.6
Q ss_pred eecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEeccCCC
Q 017046 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGM 142 (378)
Q Consensus 66 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 142 (378)
||+|++|.||++... ++.+++|++....... ....+.+|++.++.+.|++|+++++++.. ...+++|||+.|+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 689999999999987 7899999998765532 12358899999999999999999999865 5788999999989
Q ss_pred CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-ccccCcC
Q 017046 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETG 221 (378)
Q Consensus 143 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~g 221 (378)
+|.+++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++.....++|+|||.+....... ......+
T Consensus 77 ~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 77 SLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 9999987632 4689999999999999999999999999999999999999623459999999987544332 1233467
Q ss_pred ccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 017046 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQ 301 (378)
Q Consensus 222 t~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 301 (378)
...|++||.+.. ...++.+.|+|+||+++++| ..+.+++.
T Consensus 156 ~~~~~~pe~~~~-------~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~ 195 (215)
T cd00180 156 TPAYMAPEVLLG-------KGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIR 195 (215)
T ss_pred CCCccChhHhcc-------cCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHH
Confidence 789999998854 12678899999999999999 66889999
Q ss_pred HccccCCCCCCCHHHHHHH
Q 017046 302 SCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 302 ~~l~~dp~~Rps~~~ll~~ 320 (378)
.|+..+|.+||++.+++++
T Consensus 196 ~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 196 KMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHhhCCcccCcCHHHHhhC
Confidence 9999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=242.31 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=193.6
Q ss_pred cceeecceeecccceEEEEEEE-----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEe-cC
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK-DP 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~-~~ 130 (378)
+.|.++.+||.|.|++||++.+ .++.||+|.+....... ++..|+++|..+ .+.||+++.+++. .+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~-------ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS-------RILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch-------HHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4578889999999999999854 46899999998766554 478999999999 5999999999885 45
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||++.....+++.. ++...+..+++.++.||.++|..|||||||||.|+|.+.....-.|+|||+|...
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 78899999999999998864 7789999999999999999999999999999999999987777899999998610
Q ss_pred c-----------------c--c--------------------------cccccCcCccccccccccccccccccccccCC
Q 017046 211 T-----------------V--T--------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 245 (378)
Q Consensus 211 ~-----------------~--~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 245 (378)
. . + .......||++|.|||++..+ ...+
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-------~~Qt 256 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-------PRQT 256 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-------cCcC
Confidence 0 0 0 000122499999999999874 4567
Q ss_pred CcccchhhhHHHHHHHhCCCCCCCCCh-HHHHHHHH------------H-hcC---------------------------
Q 017046 246 NKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAA------------F-KHA--------------------------- 284 (378)
Q Consensus 246 ~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~------------~-~~~--------------------------- 284 (378)
.++||||.|+|++.++++..||-...+ ...+.... . .+.
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 899999999999999999999854332 11111100 0 000
Q ss_pred ---------CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 285 ---------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 285 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.....+..+..+.+|+.+||+.||.+|.|+++.|+ +.++.
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk--HpFF~ 385 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK--HPFFD 385 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc--CcCCc
Confidence 00011224557899999999999999999999998 45554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=223.87 Aligned_cols=212 Identities=37% Similarity=0.547 Sum_probs=171.3
Q ss_pred eeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|.+.+.||.|++|.||++... ++.+|+|.+...... .....+.+|+..++.++|+|++++++.+.. ...++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 456788999999999999885 589999999865543 112468899999999999999999998864 5788999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc--
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-- 214 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-- 214 (378)
||+++++|.+++..... .+++..+..++.+++.++.+||..|++|+||+|.||+++.+ ..++|+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 77 EYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred eccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccc
Confidence 99999999999976322 28899999999999999999999999999999999999965 459999999987654332
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCC-CChHHHHHHHHHhcC
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHA 284 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~ 284 (378)
......++..|++||.+.. ...++.++|+|+||+++|+|++|+.||.. ........+.+..+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~-------~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLG-------GKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cccceeccCCcCCHhHhcC-------CCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 2234567788999998731 25677799999999999999999999977 444444455444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-28 Score=229.04 Aligned_cols=256 Identities=24% Similarity=0.328 Sum_probs=201.0
Q ss_pred ceeecceeecccceEEEEEEECC---eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc----CCCeeeEEeeEe--c
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYGD---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK----HDNLVKFLGACK--D 129 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----hp~iv~l~~~~~--~ 129 (378)
.|.+.++||+|+||.||.+.... ..+|+|+.......... .+..|+.++..+. .+++..+++... +
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-----~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-----VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-----cchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 79999999999999999998754 47999998775443321 2557888888886 268899998883 4
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC----CceeEeccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ----KSLKLADFG 205 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~----~~vkl~Dfg 205 (378)
.+.++||+.+ |.+|.++......+.++..++..++.|++.+|.+||+.|++||||||.|+++.... ..+.|.|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 4788999999 89999988765567899999999999999999999999999999999999998543 469999999
Q ss_pred ccc--cccccc--------c-cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH
Q 017046 206 LAR--EETVTE--------M-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274 (378)
Q Consensus 206 ~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 274 (378)
+++ ...... . .....||..|+++.+..+ .+.+.+.|+||+++++.+++.|..||.+.....
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--------~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~ 244 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--------IEQGRRDDLESLFYMLLELLKGSLPWEALEMTD 244 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--------CccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence 998 311111 1 123459999999998865 678899999999999999999999998766432
Q ss_pred HHHHHH--HhcCCCC-CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 275 AAYAAA--FKHARPG-LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 275 ~~~~~~--~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
...... ....... +....+.++..+...+-..+...+|....+...+...+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 245 LKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 222211 1111111 33456678888888888899999999999999988887765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=208.76 Aligned_cols=257 Identities=22% Similarity=0.318 Sum_probs=201.9
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec-C
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-P 130 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~ 130 (378)
+-...|.++++||+|+||.+|.|.. .|+.||||+.+...... .+..|..+.+.|+ ...|..+..+..+ .
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-------qL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-------QLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-------chhHHHHHHHHhccCCCCchhhhhccccc
Confidence 4456799999999999999999975 68999999987655443 2568888888886 5677777766654 4
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC--CceeEecccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAR 208 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~--~~vkl~Dfg~a~ 208 (378)
+-++||+.+ |.||.+++.- ....++..+++-++-|++.-++|+|.++++||||||+|+|+.-+. ..+.|+|||+++
T Consensus 85 ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred cceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 778999999 8999998865 457899999999999999999999999999999999999996432 259999999997
Q ss_pred cccccc--------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHH--HHH
Q 017046 209 EETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA--AYA 278 (378)
Q Consensus 209 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~ 278 (378)
..-... ......||.+|.+--...+ ...+.+.|+-|+|.+|.++..|..||++...... .++
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--------~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLG--------IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhh--------hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 532111 1233479999998776654 5678899999999999999999999998664322 222
Q ss_pred HHHh----cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 279 AAFK----HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 279 ~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
.+.. .....+...+|.++...+.-|-.....+-|...-+.+.++.++..+
T Consensus 235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 2222 1222345678999999999999999999999988888777776554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=262.39 Aligned_cols=193 Identities=21% Similarity=0.295 Sum_probs=139.5
Q ss_pred ccC-CCeeeEEeeE--------ecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecC
Q 017046 115 VKH-DNLVKFLGAC--------KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 185 (378)
Q Consensus 115 l~h-p~iv~l~~~~--------~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~di 185 (378)
++| +||+.++++| .+..++++|||+ +++|.+++.. ....+++.+++.++.||+.||.|||++||+||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 344 4677777765 123567888987 6799999975 2456999999999999999999999999999999
Q ss_pred CCCcEEEcCC------------------CCceeEeccccccccccc-----------------cccccCcCccccccccc
Q 017046 186 KPDNLLLTPD------------------QKSLKLADFGLAREETVT-----------------EMMTAETGTYRWMAPEL 230 (378)
Q Consensus 186 kp~Nill~~~------------------~~~vkl~Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~ 230 (378)
||+||||+.. ...+|++|||+++..... .......||+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999532 224677777776532110 00112358889999999
Q ss_pred cccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCC
Q 017046 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 310 (378)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 310 (378)
+.+ ..++.++|||||||+||||++|..|+...... .........+.......+....++.+||..+|.+
T Consensus 187 ~~~--------~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~ 255 (793)
T PLN00181 187 DNG--------SSSNCASDVYRLGVLLFELFCPVSSREEKSRT---MSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSC 255 (793)
T ss_pred hcc--------CCCCchhhhhhHHHHHHHHhhCCCchhhHHHH---HHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhh
Confidence 864 56899999999999999999999887643221 1111111111111122445678999999999999
Q ss_pred CCCHHHHHHH
Q 017046 311 RPSFSQIIRM 320 (378)
Q Consensus 311 Rps~~~ll~~ 320 (378)
||++.+++++
T Consensus 256 Rps~~eil~h 265 (793)
T PLN00181 256 RPSMSELLQS 265 (793)
T ss_pred CcChHHHhhc
Confidence 9999999983
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=208.94 Aligned_cols=163 Identities=28% Similarity=0.354 Sum_probs=128.6
Q ss_pred CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccccccCcC
Q 017046 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 221 (378)
Q Consensus 142 ~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 221 (378)
|+|.+++.. ....+++..++.++.|++.||.|||+++ ||+|||++.++ .+++ ||++...... ...|
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeeccc----cCCC
Confidence 689999976 3456999999999999999999999998 99999998655 4888 9998754332 2368
Q ss_pred ccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC------CCCChH-
Q 017046 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL------PEDISP- 294 (378)
Q Consensus 222 t~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~- 294 (378)
++.|+|||++.+ ..++.++|||||||++|+|++|..||..................... +..++.
T Consensus 67 ~~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 67 DPYFMAPEVIQG--------QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAA 138 (176)
T ss_pred cccccChHHhcC--------CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhh
Confidence 899999999865 66889999999999999999999999765543333333333222221 122333
Q ss_pred -HHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 295 -DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 295 -~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
++.+++.+||..+|.+||++.++++++.....
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 69999999999999999999999998876643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=209.12 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=206.6
Q ss_pred ccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP 130 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 130 (378)
.+-.-.|.++++||+|+||..+.|.. +++.||||......... .+..|.+..+.| ..++|.+.+-+..++
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP-------QLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP-------QLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCCcc-------hHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 34556799999999999999999974 78999999987655544 256788888888 578998888776655
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC----CCceeEeccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD----QKSLKLADFG 205 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~----~~~vkl~Dfg 205 (378)
+-.+|||.+ |-||.|++.- .+..|+..+++.++.|++.-++|+|++.+|.|||||+|+||... ...+.|+|||
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEecc
Confidence 667999999 8999998875 56889999999999999999999999999999999999999643 3359999999
Q ss_pred cccccccccc--------cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH--HH
Q 017046 206 LAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL--QA 275 (378)
Q Consensus 206 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~ 275 (378)
+|+..-.... .....||.+||+--...+ .+.+.+.|+-|||-++.+.|.|..||.+.... ..
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--------rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~ 246 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE 246 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeecccc--------chhhhhhhHHHhhhhhhhhccCCCccccccCcchHH
Confidence 9986433322 234579999999877665 77889999999999999999999999986542 22
Q ss_pred HHHHHHhcCC----CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 276 AYAAAFKHAR----PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 276 ~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
.++.+-...+ ..+..++|.++...+.-.-..+..+-|..+-+...+..++..+
T Consensus 247 kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 247 KYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred HHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 2333322111 1244678999999999888899999999999888888877544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=213.90 Aligned_cols=164 Identities=21% Similarity=0.209 Sum_probs=123.8
Q ss_pred CcceeecceeecccceEEEEEEE---CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeee-EEeeEecCCe
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK-FLGACKDPLM 132 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~-l~~~~~~~~~ 132 (378)
...|.+.+.||+|+||+||+|++ .++.||||++...............|.+|+++|+.++|+|+++ +++. +..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCc
Confidence 45699999999999999999976 4577899987533211001112345889999999999999985 4442 457
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecC-CCCcEEEcCCCCceeEeccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL-KPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~di-kp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
++||||++|++|.. +.. .. ...++.|++.+|.|||++||+|||| ||+|||++.++ .++|+|||+++...
T Consensus 94 ~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikLiDFGlA~~~~ 163 (365)
T PRK09188 94 GLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAVIDFQLASVFR 163 (365)
T ss_pred EEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEEEECccceecc
Confidence 99999999999963 211 11 1467899999999999999999999 99999998554 59999999997432
Q ss_pred ccc---------ccccCcCcccccccccccc
Q 017046 212 VTE---------MMTAETGTYRWMAPELYST 233 (378)
Q Consensus 212 ~~~---------~~~~~~gt~~y~aPE~~~~ 233 (378)
... ......+++.|+|||.+..
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 221 1134467888999999865
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=204.15 Aligned_cols=262 Identities=28% Similarity=0.473 Sum_probs=212.6
Q ss_pred ccccccccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
++.+..-++.+.+.+.-+|.....|+.|+|++.+..++.|++........ +...|..|.-.|+-+.||||+++++.|
T Consensus 180 tlsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~r---isrdfneefp~lrifshpnilpvlgac 256 (448)
T KOG0195|consen 180 TLSRYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTAR---ISRDFNEEFPALRIFSHPNILPVLGAC 256 (448)
T ss_pred ccccccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchh---hcchhhhhCcceeeecCCchhhhhhhc
Confidence 44455556677777888999999999999999999999999876544332 224588899999999999999999999
Q ss_pred ec-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCcEEEcCCCCceeEe--
Q 017046 128 KD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLA-- 202 (378)
Q Consensus 128 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~g--ivH~dikp~Nill~~~~~~vkl~-- 202 (378)
.. +.+.++..|++.|+|+.++.....--++..++.+++.++++|++|||+.. |.---|....++||.+ .+.+|+
T Consensus 257 nsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarisma 335 (448)
T KOG0195|consen 257 NSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMA 335 (448)
T ss_pred cCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheecc
Confidence 75 48899999999999999998755556889999999999999999999984 3444678888999854 334443
Q ss_pred ccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 017046 203 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (378)
Q Consensus 203 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 282 (378)
|--++.. .......|.||+||.+...+ ....-.++|+|||++++|||.|...||.+.++.+--++....
T Consensus 336 d~kfsfq------e~gr~y~pawmspealqrkp-----ed~n~raadmwsfaillwel~trevpfadlspmecgmkiale 404 (448)
T KOG0195|consen 336 DTKFSFQ------EVGRAYSPAWMSPEALQRKP-----EDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE 404 (448)
T ss_pred cceeeee------ccccccCcccCCHHHHhcCc-----hhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc
Confidence 3222211 11234578999999986522 122345789999999999999999999999999999999999
Q ss_pred cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
+.+..+|+.++..+..|+.-|+..||.+||.++.++-.|+..
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 999999999999999999999999999999999998877754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-24 Score=198.40 Aligned_cols=253 Identities=33% Similarity=0.488 Sum_probs=198.3
Q ss_pred eeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCC-CeeeEEeeEecCC-eEEEEe
Q 017046 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDPL-MVIVTE 137 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~l~~~~~~~~-~~lv~e 137 (378)
|.+.+.||.|+||.||.+... ..+++|.+........ .....+.+|+.++..+.|+ +|+++.+.+.... .+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch--hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 667889999999999999887 7889999887665543 1234688999999999888 7999999986554 689999
Q ss_pred ccCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc--
Q 017046 138 LLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-- 214 (378)
Q Consensus 138 ~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-- 214 (378)
++.++++.+++..... ..++......++.|++.++.|+|+.|++|||+||+||+++..+..++++|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977765221 2689999999999999999999999999999999999999665359999999987433322
Q ss_pred -----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCC
Q 017046 215 -----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARP 286 (378)
Q Consensus 215 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~ 286 (378)
......|+..|++||.+.... ...++...|+|++|++++++++|..||..... .............+
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~-----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLS-----LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccCCHHHhcCCC-----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 235668999999999885410 14678899999999999999999999877664 33334433333322
Q ss_pred ----CCCCCC----hHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 287 ----GLPEDI----SPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 287 ----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
...... ...+.+++..++..+|..|.+..+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111122 2578999999999999999998877764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=222.54 Aligned_cols=250 Identities=20% Similarity=0.243 Sum_probs=181.7
Q ss_pred ceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeEEEEe
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTE 137 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv~e 137 (378)
.+...+.||++.|=+|.++++.+..|+||++-+....-...-.. +-+.|++ ...+++||++++.-+-. +...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~-qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFK-QRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHH-HHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 57778899999999999999987789999987765333222111 2234555 55568999999876653 446678888
Q ss_pred ccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc---
Q 017046 138 LLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--- 214 (378)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~--- 214 (378)
|+ .-+|+|.+.. ..-+...+..+|+.||+.||..+|..||+|||||.+||||++-++ +.|+||...+....++
T Consensus 102 yv-khnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW-~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YV-KHNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW-LYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HH-hhhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech-hhhhcccccCCccCCCCCc
Confidence 88 4599998875 345778888999999999999999999999999999999998888 9999998875321111
Q ss_pred -----ccccCcCcccccccccccccc--cccccccc-CCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017046 215 -----MMTAETGTYRWMAPELYSTVT--LRQGEKKH-YNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 215 -----~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~-~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
...+...--+|+|||.+.... ....+... .+++.||||+||++.||++ |++||.- ..+..... ..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~--~~ 251 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRS--GN 251 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhc--cC
Confidence 112223334799999886522 22333344 7889999999999999998 8899852 11111110 00
Q ss_pred CCCC-----CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 286 PGLP-----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 286 ~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
...+ .--+..+++++..|++.||.+|.++++.|+-
T Consensus 252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000 1123468999999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=186.74 Aligned_cols=174 Identities=16% Similarity=0.185 Sum_probs=131.7
Q ss_pred CcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHH----HHHHHHHHHHhhccCCCeeeEEeeEec---
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLE----GRFIREVNMMSRVKHDNLVKFLGACKD--- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~l~~~~~~--- 129 (378)
...|.+.+.||.|+||.||++..++..+|||++............. ..+.+|+..+.++.||+|....+++.+
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 4578999999999999999987777899999998766544332111 115789999999999999998877542
Q ss_pred ------CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEec
Q 017046 130 ------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (378)
Q Consensus 130 ------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~D 203 (378)
...+++|||++|.+|.++.. +++ ....+++.+|..+|..|++|||+||.||++++++ ++|+|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liD 177 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIID 177 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEE
Confidence 24789999999999988732 233 2456999999999999999999999999998654 99999
Q ss_pred cccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHH
Q 017046 204 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 261 (378)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll 261 (378)
||........... +.+.. ...+..++|+|+||+++..+.
T Consensus 178 fg~~~~~~e~~a~------------d~~vl-------er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK------------DRIDL-------ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH------------HHHHH-------HhHhcccccccceeEeehHHH
Confidence 9987543221111 11110 244667899999999987653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-25 Score=219.52 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=183.0
Q ss_pred eecceeecccceEEEEEEEC--CeeEEEEEeecC--CCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEE
Q 017046 61 FIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRG--STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 61 ~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 135 (378)
.....+|.|++|.|+..... ...++.|..... ....+.. ....+..|+.+-..++|||++..+..+.+. ...-.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~-~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERK-YNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHH-HhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 45678999999988876542 233344433211 1111111 222377888888999999998876655432 23334
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc--
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-- 213 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-- 213 (378)
||||++ +|..++.. ...+...++..++.|++.|+.|+|+.||.|||+|++|++++.++ .+||+|||.+.....+
T Consensus 400 mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-ceEEeecCcceeeccCcc
Confidence 999999 99999876 24788999999999999999999999999999999999999665 6999999998643222
Q ss_pred ---cccccCcCccccccccccccccccccccccCC-CcccchhhhHHHHHHHhCCCCCCCCChHHHHH-HHHHhcC----
Q 017046 214 ---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY-AAAFKHA---- 284 (378)
Q Consensus 214 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~~---- 284 (378)
......+|+..|+|||++.+ ..|. ...||||.|++++.|.+|+.||......+..+ .......
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~--------~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTG--------KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF 547 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccc--------cccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence 23345689999999999976 4554 46799999999999999999997655433321 1111111
Q ss_pred --CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 285 --RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 285 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
...+...++...+.+|.+||+.||.+|.|+.+|++ ..|+..
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~--d~W~~~ 590 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN--DEWIRS 590 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh--ChHhhh
Confidence 11122357788999999999999999999999998 555544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=192.91 Aligned_cols=262 Identities=26% Similarity=0.341 Sum_probs=181.6
Q ss_pred CCcceeecceeecccceEEEEEEECC-------------------------------------eeEEEEEeecCCCchHH
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYGD-------------------------------------RIVAIKVLNRGSTSDER 98 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-------------------------------------~~vavK~~~~~~~~~~~ 98 (378)
..++|.|+..||+|....||.++... =+.|||++..-......
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 34679999999999999999774310 04677876554433322
Q ss_pred HHHHHHHHHHH------H--------HHhh--------ccCCCeeeEEeeEec---------------------------
Q 017046 99 ALLEGRFIREV------N--------MMSR--------VKHDNLVKFLGACKD--------------------------- 129 (378)
Q Consensus 99 ~~~~~~~~~E~------~--------~l~~--------l~hp~iv~l~~~~~~--------------------------- 129 (378)
..+.+..-+|. . ..+. -+|||||++.++|.+
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 22222222332 0 0111 259999998765422
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC--CCC-ceeEeccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQK-SLKLADFG 205 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~--~~~-~vkl~Dfg 205 (378)
..+|+||..++ .+|+.++.. +..+.....-++.|+++|+.|||.+||.|||+|.+|||+.- |+. .+.|+|||
T Consensus 315 ~~tlylvMkrY~-~tLr~yl~~---~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG 390 (598)
T KOG4158|consen 315 PKTLYLVMKRYR-QTLREYLWT---RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG 390 (598)
T ss_pred CceEEEehhcch-hhHHHHHhc---CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence 24789999885 499999975 45778888889999999999999999999999999999942 222 48899999
Q ss_pred cccccccc-------cccccCcCccccccccccccccccccccccC-CCcccchhhhHHHHHHHhCCCCCCCCChHHHHH
Q 017046 206 LAREETVT-------EMMTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (378)
Q Consensus 206 ~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 277 (378)
.+-..... ......-|.-..||||+....+ |..... -.++|.|+.|.+.||++....||.+........
T Consensus 391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P---Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~ 467 (598)
T KOG4158|consen 391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP---GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT 467 (598)
T ss_pred eeeeccccccccccccccccCCCcceecchhhhhcCC---CCceeeccchhhhhhhhhhHHHHhccCCcccccchheech
Confidence 87432221 1112335777899999987533 111111 238999999999999999999997632211111
Q ss_pred HHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 278 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
........|.+|+.+++.+++++..+|+.||.+|++..-....|+-.
T Consensus 468 r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~Ls 514 (598)
T KOG4158|consen 468 RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLS 514 (598)
T ss_pred hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHH
Confidence 22334567788999999999999999999999999866555544433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-25 Score=209.27 Aligned_cols=223 Identities=29% Similarity=0.445 Sum_probs=183.1
Q ss_pred eecccceEEEEEE-----ECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEe-cCCeEEEEec
Q 017046 66 IGEGAHGKVYEGR-----YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTEL 138 (378)
Q Consensus 66 lG~G~~g~Vy~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~-~~~~~lv~e~ 138 (378)
+|+|+||.|++++ +.+..+|+|++++......... +...|-.++..++ ||.++.+...++ +...+++++|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~ 78 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF 78 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence 7999999999653 4568899999887655433221 3456777888886 999999988886 5588999999
Q ss_pred cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccccc
Q 017046 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 218 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~ 218 (378)
..||.|...+.. ...+++.....+...++.+++++|..|++|||+|++||+++.+|. +++.|||+++........
T Consensus 79 ~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh-i~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH-IKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc-cccCCchhhhHhHhhhhc--
Confidence 999998877654 456888888999999999999999999999999999999997765 999999999865444332
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHH
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 298 (378)
|||..|||||++++ ...++|+||+|+++++|++|..||.+ +... .+-...+.+|..++..+++
T Consensus 154 -cgt~eymApEI~~g----------h~~a~D~ws~gvl~felltg~~pf~~-----~~~~-~Il~~~~~~p~~l~~~a~~ 216 (612)
T KOG0603|consen 154 -CGTYEYRAPEIING----------HLSAADWWSFGVLAFELLTGTLPFGG-----DTMK-RILKAELEMPRELSAEARS 216 (612)
T ss_pred -ccchhhhhhHhhhc----------cCCcccchhhhhhHHHHhhCCCCCch-----HHHH-HHhhhccCCchhhhHHHHH
Confidence 99999999999853 56799999999999999999999987 2222 2234566788899999999
Q ss_pred HHHHccccCCCCCCC
Q 017046 299 IVQSCWVEDPNLRPS 313 (378)
Q Consensus 299 li~~~l~~dp~~Rps 313 (378)
++..++..+|..|.-
T Consensus 217 ~~~~l~~r~p~nrLg 231 (612)
T KOG0603|consen 217 LFRQLFKRNPENRLG 231 (612)
T ss_pred HHHHHHhhCHHHHhc
Confidence 999999999999964
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=188.67 Aligned_cols=240 Identities=22% Similarity=0.289 Sum_probs=148.9
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccC-----------CCeee---
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH-----------DNLVK--- 122 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-----------p~iv~--- 122 (378)
.+..+..||.|+++.||.+.+. ++.+|+|+........... .+.+.+|......+.+ ..+++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~--~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANE--YEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTH--HHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHH--HHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 4567789999999999999985 5999999987666333222 2346666544444221 11111
Q ss_pred --EEe---eE---ec------CCeEEEEeccCCCCHHHHHhhh---CCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 017046 123 --FLG---AC---KD------PLMVIVTELLPGMSLRKYLVSL---RPN--KLDLHVALNFALDIARAMDCLHANGIIHR 183 (378)
Q Consensus 123 --l~~---~~---~~------~~~~lv~e~~~~~sL~~~l~~~---~~~--~l~~~~~~~i~~qi~~~l~~lH~~givH~ 183 (378)
+-+ ++ .+ ...+++|+-+ .++|.+++... ... .+.....+.+..|++..+++||+.|++|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 110 11 11 1346788888 56888876431 111 12233345666899999999999999999
Q ss_pred cCCCCcEEEcCCCCceeEeccccccccccccccccCcCcccccccccccccc-ccccccccCCCcccchhhhHHHHHHHh
Q 017046 184 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT-LRQGEKKHYNNKVDVYSFGIVLWELLT 262 (378)
Q Consensus 184 dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~~DiwslG~il~~ll~ 262 (378)
||+|+|++++.+|. ++|+||+.....+..... ...+..|.+||...... ..+ ....++.+.|.|+||+++|.|+|
T Consensus 170 di~~~nfll~~~G~-v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~-~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGG-VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQ-NNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS--EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHH-SEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCC-EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCc-ccceeeeccCHHHHHHHHHHHHH
Confidence 99999999997765 999999987654443322 34457899999764411 001 23567889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCC
Q 017046 263 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 311 (378)
Q Consensus 263 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 311 (378)
|..||........... ..... .++|..++.||..+|+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~-----~f~~C-~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-----DFSRC-RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-----GGTTS-S---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-----cchhc-CCcCHHHHHHHHHHccCCcccC
Confidence 9999986543211100 11122 2789999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=179.83 Aligned_cols=142 Identities=19% Similarity=0.178 Sum_probs=107.9
Q ss_pred cceeecccceEEEEEEE-CCeeEEEEEeecCCCchHH---------------------HHHHHHHHHHHHHHhhccCCCe
Q 017046 63 GSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDER---------------------ALLEGRFIREVNMMSRVKHDNL 120 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~hp~i 120 (378)
...||+|+||.||+|.. +|+.||||+++........ .........|++++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999987 5789999999865432111 0112233469999999987776
Q ss_pred eeEEeeEecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeecCCCCcEEEcCCCCce
Q 017046 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSL 199 (378)
Q Consensus 121 v~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~l-H~~givH~dikp~Nill~~~~~~v 199 (378)
....... ....++||||++|+++...... ...++...+..++.|++.+|.++ |+.||+||||||+|||++ ++ .+
T Consensus 82 ~~p~~~~-~~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~-~v 156 (190)
T cd05147 82 PCPEPIL-LKSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG-KL 156 (190)
T ss_pred CCCcEEE-ecCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC-cE
Confidence 3322222 2234899999988777654322 35789999999999999999999 799999999999999998 44 49
Q ss_pred eEeccccccc
Q 017046 200 KLADFGLARE 209 (378)
Q Consensus 200 kl~Dfg~a~~ 209 (378)
+|+|||++..
T Consensus 157 ~LiDFG~a~~ 166 (190)
T cd05147 157 YIIDVSQSVE 166 (190)
T ss_pred EEEEcccccc
Confidence 9999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=175.13 Aligned_cols=187 Identities=17% Similarity=0.138 Sum_probs=138.0
Q ss_pred ecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEecCCeEEEEeccC
Q 017046 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDPLMVIVTELLP 140 (378)
Q Consensus 62 ~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~lv~e~~~ 140 (378)
+...|++|+||+||.+...+.+++.+.+......... .....+.+|+++|++|. |++|++++++ ...+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~-~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRG-VAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhh-HHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeeec
Confidence 3567999999999998888888888877654442221 11225789999999995 5889999886 34689999999
Q ss_pred CCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecC-CCCcEEEcCCCCceeEeccccccccccccc----
Q 017046 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL-KPDNLLLTPDQKSLKLADFGLAREETVTEM---- 215 (378)
Q Consensus 141 ~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~di-kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---- 215 (378)
|.+|.+.+.. ....++.|++.+|.++|++||+|||| ||.|||++.++ .++|+|||++........
T Consensus 82 G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 82 GAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred CccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCceecCCcchHHHH
Confidence 9998754321 11357889999999999999999999 79999998665 499999999974332221
Q ss_pred ----------cccCcCccccccccccccccccccccccCC-CcccchhhhHHHHHHHhCCCCCCC
Q 017046 216 ----------MTAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEG 269 (378)
Q Consensus 216 ----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~ 269 (378)
......++.|++|+..... ...+ .+.++++.|+-+|.++|+..++.+
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l-------~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVL-------KRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhh-------ccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0011356677777754321 1222 467889999999999999887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=173.69 Aligned_cols=142 Identities=22% Similarity=0.209 Sum_probs=109.5
Q ss_pred cceeecccceEEEEEEEC-CeeEEEEEeecCCCch---------------------HHHHHHHHHHHHHHHHhhccCCCe
Q 017046 63 GSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSD---------------------ERALLEGRFIREVNMMSRVKHDNL 120 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~---------------------~~~~~~~~~~~E~~~l~~l~hp~i 120 (378)
.+.||+|+||.||+|... |+.||||+++...... ........+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 568999999999999874 8999999998763211 111112345689999999999987
Q ss_pred eeEEeeEecCCeEEEEeccCCCCHHHH-HhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCc
Q 017046 121 VKFLGACKDPLMVIVTELLPGMSLRKY-LVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKS 198 (378)
Q Consensus 121 v~l~~~~~~~~~~lv~e~~~~~sL~~~-l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~ 198 (378)
.....+... ..++||||++|+++... +. ...++...+..++.|++.+|.++|+ .||+||||||+|||++ ++ .
T Consensus 82 ~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~-~ 155 (190)
T cd05145 82 PVPEPILLK-KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG-K 155 (190)
T ss_pred CCceEEEec-CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC-C
Confidence 443332222 34899999988755433 33 2467888999999999999999999 9999999999999998 54 5
Q ss_pred eeEecccccccc
Q 017046 199 LKLADFGLAREE 210 (378)
Q Consensus 199 vkl~Dfg~a~~~ 210 (378)
++|+|||++...
T Consensus 156 ~~liDFG~a~~~ 167 (190)
T cd05145 156 PYIIDVSQAVEL 167 (190)
T ss_pred EEEEEcccceec
Confidence 999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=202.13 Aligned_cols=254 Identities=23% Similarity=0.306 Sum_probs=184.3
Q ss_pred CCCcccccccccCCcceeecceeecccceEEEEEEE-CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc---CCC
Q 017046 44 APQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---HDN 119 (378)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~ 119 (378)
.+.+.......+..+.|.|.+.||+|+||+||+|.. +++.||||+-+.....+- .--.+++.+|+ -+.
T Consensus 684 ~~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf--------YI~~q~~~RLk~~~~~~ 755 (974)
T KOG1166|consen 684 VPKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF--------YICLQVMERLKPQMLPS 755 (974)
T ss_pred ccccCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee--------eehHHHHHhhchhhhcc
Confidence 344555566677888999999999999999999976 478999999988776542 22234455555 233
Q ss_pred eeeEEeeE-ecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC----
Q 017046 120 LVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP---- 194 (378)
Q Consensus 120 iv~l~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~---- 194 (378)
|.++...+ ..+..++|+||.+.|+|.+++.. ...+++..+..++.|++..+++||..|||||||||+|+||..
T Consensus 756 ~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 756 IMHISSAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred hHHHHHHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCC
Confidence 33333332 23456899999999999999984 567999999999999999999999999999999999999952
Q ss_pred --CCCceeEecccccccccc---ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCC
Q 017046 195 --DQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (378)
Q Consensus 195 --~~~~vkl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 269 (378)
+...++|+|||.+..+.. +......++|-.+-.+|...+ .++++.+|.|.|+.+++.||.|+.-=
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g--------rpWtYq~DyfGlAa~~h~mLFG~y~q-- 903 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG--------RPWTYQIDYFGLAATVHVMLFGKYME-- 903 (974)
T ss_pred CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC--------CCCchhhhhHHHHHHHHHHHHHHHHH--
Confidence 233599999999875432 223455678889999999865 78999999999999999999986420
Q ss_pred CChHHHHHHHHHhcCCCC----CCCCChHH-HHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 270 MSNLQAAYAAAFKHARPG----LPEDISPD-LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~----~~~~~~~~-l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
...+.... ++.-+-.+ ...++..+|..|-..=|...++...++.++..
T Consensus 904 ----------~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 904 ----------VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred ----------hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 11111111 22212222 34566777775544557777777777766644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-21 Score=164.10 Aligned_cols=134 Identities=17% Similarity=0.317 Sum_probs=102.0
Q ss_pred cceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-----cCCCeeeEEeeEecC----CeE
Q 017046 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-----KHDNLVKFLGACKDP----LMV 133 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~l~~~~~~~----~~~ 133 (378)
...||+|+||.||.-. .....+||++....... .+.+.+|+.+++.+ .||||++++++++++ ..+
T Consensus 7 ~~~LG~G~~~~Vy~hp-~~~~k~IKv~~~~~~~~-----~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYAHP-EDAQRCIKIVYHRGDGG-----DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEECC-CCcCeEEEEEeccccch-----HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 3579999999999622 23334789887643322 13588999999999 579999999999765 223
Q ss_pred -EEEec--cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCeeecCCCCcEEEcCC---CCceeEecccc
Q 017046 134 -IVTEL--LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM-DCLHANGIIHRDLKPDNLLLTPD---QKSLKLADFGL 206 (378)
Q Consensus 134 -lv~e~--~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l-~~lH~~givH~dikp~Nill~~~---~~~vkl~Dfg~ 206 (378)
+|||| +.+++|.+++.. ..+++. ..++.|++.++ +|||+++|+||||||+|||++.. +..++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 557999999965 245555 35678888777 99999999999999999999742 23699999544
Q ss_pred c
Q 017046 207 A 207 (378)
Q Consensus 207 a 207 (378)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=193.54 Aligned_cols=203 Identities=28% Similarity=0.458 Sum_probs=145.3
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCeEE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI 134 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~l 134 (378)
..+|..++.|-.|+||.||..+++ .+.+|+|+-+... +++- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----------ilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----------ILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch-----------hhhc--cccccCCccee-------------
Confidence 456888999999999999999876 5789985433211 1111 12222233332
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
|+-...+... +.++... +.+++|||+.||+|||+||+|.+|+.-|. +|++|||+.+.....
T Consensus 136 -------gDc~tllk~~--g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh-iKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 -------GDCATLLKNI--GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH-IKLTDFGLSKKGLMSL 197 (1205)
T ss_pred -------chhhhhcccC--CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc-ccccchhhhhhhhhhc
Confidence 4444444432 3344332 78899999999999999999999996664 999999998632111
Q ss_pred --------------cc-cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHH
Q 017046 214 --------------EM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (378)
Q Consensus 214 --------------~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 278 (378)
+. ....+||+.|+|||++.. ..|+..+|+|++|+|+|+.+-|..||.+.+.. +++.
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--------qgygkpvdwwamGiIlyeFLVgcvpffGdtpe-elfg 268 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFG 268 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhh--------hccCCCccHHHHHHHHHHHheeeeeccCCCHH-HHHh
Confidence 11 123489999999999965 67999999999999999999999999987763 3343
Q ss_pred HHHhc--CCCCCCCCChHHHHHHHHHccccCCCCCC
Q 017046 279 AAFKH--ARPGLPEDISPDLAFIVQSCWVEDPNLRP 312 (378)
Q Consensus 279 ~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 312 (378)
..+.. .-++-.+.+++++++++..+|..+|..|-
T Consensus 269 ~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 269 QVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 33221 11222455889999999999999999995
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=166.52 Aligned_cols=145 Identities=23% Similarity=0.261 Sum_probs=111.1
Q ss_pred cceeecceeecccceEEEEEE---ECCeeEEEEEeecCCCch-------------------HHHHHHHHHHHHHHHHhhc
Q 017046 58 KLLFIGSKIGEGAHGKVYEGR---YGDRIVAIKVLNRGSTSD-------------------ERALLEGRFIREVNMMSRV 115 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~---~~~~~vavK~~~~~~~~~-------------------~~~~~~~~~~~E~~~l~~l 115 (378)
..|.+.+.||+|+||.||+|. .+++.||+|+++...... ........+..|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357888999999999999998 367999999987643211 1111223467899999999
Q ss_pred cCCC--eeeEEeeEecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeecCCCCcEEE
Q 017046 116 KHDN--LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG-IIHRDLKPDNLLL 192 (378)
Q Consensus 116 ~hp~--iv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~g-ivH~dikp~Nill 192 (378)
.+.+ +...++. ...++||||++|.+|...... ...+....+..++.|++.+|.+||..| ++|+||||+||++
T Consensus 108 ~~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 108 YEAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred HhcCCCCCeeeEe---cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 7533 3444443 345899999999888765432 234666677899999999999999999 9999999999999
Q ss_pred cCCCCceeEeccccccc
Q 017046 193 TPDQKSLKLADFGLARE 209 (378)
Q Consensus 193 ~~~~~~vkl~Dfg~a~~ 209 (378)
+ ++ .++|+|||.+..
T Consensus 183 ~-~~-~i~LiDFg~a~~ 197 (237)
T smart00090 183 H-DG-KVVIIDVSQSVE 197 (237)
T ss_pred E-CC-CEEEEEChhhhc
Confidence 8 44 599999998864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=177.08 Aligned_cols=213 Identities=32% Similarity=0.488 Sum_probs=160.0
Q ss_pred HhhccCCCeeeEEeeEecC-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-eeecCCCCc
Q 017046 112 MSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI-IHRDLKPDN 189 (378)
Q Consensus 112 l~~l~hp~iv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~gi-vH~dikp~N 189 (378)
|+.+.|.|+.+|+|.+.++ ..+.|.+||..|+|.|.+.. ....++......++++|+.||.|||...| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 3567899999999998654 78899999999999999976 55678899999999999999999999876 999999999
Q ss_pred EEEcCCCCceeEecccccccccc---ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCC
Q 017046 190 LLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 266 (378)
Q Consensus 190 ill~~~~~~vkl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p 266 (378)
++++ ..+.+||+|||+...... ........-...|.|||++....... .....+.+.||||+|++++|+++..-|
T Consensus 80 Clvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~-~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 80 CLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQS-LESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccc-ccccccccCCeehHHHHHHHHHhccCc
Confidence 9999 667899999999765421 01111122345799999997632111 112357789999999999999999999
Q ss_pred CCCCChH---HHHHHHHHh-cC---CCCCCC--CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 267 FEGMSNL---QAAYAAAFK-HA---RPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 267 f~~~~~~---~~~~~~~~~-~~---~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
|...... .+....+.. .. +|.+.. ..++++..++..||..+|..||+++++-..+......
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9753221 122222222 22 222221 3455789999999999999999999998877665543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.8e-20 Score=159.42 Aligned_cols=138 Identities=28% Similarity=0.374 Sum_probs=111.5
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCCch---HHHHHHHHHHHHHHHHhhccCCCeeeEEeeE-ecCCeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSD---ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~~~~~lv~e~~ 139 (378)
+.||+|++|.||+|.+.+..|++|+........ .......++.+|+.++..+.|++|.....++ .....+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 578999999999999999999999876543321 1222334678999999999999886554444 345778999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+|++|.+++.... . ....++.+++.+|.++|+.|++|+|++|.|||++ ++ .++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence 9999999986521 2 7789999999999999999999999999999998 44 499999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=154.28 Aligned_cols=134 Identities=25% Similarity=0.344 Sum_probs=104.9
Q ss_pred eeecccceEEEEEEECCeeEEEEEeecCCCc---hHHHHHHHHHHHHHHHHhhccCCCeeeEEe-eEecCCeEEEEeccC
Q 017046 65 KIGEGAHGKVYEGRYGDRIVAIKVLNRGSTS---DERALLEGRFIREVNMMSRVKHDNLVKFLG-ACKDPLMVIVTELLP 140 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~-~~~~~~~~lv~e~~~ 140 (378)
.||+|+||.||+|.+.+..|++|+....... .+......++.+|++++..+.|+++..... ...+...+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3799999999999999999999996543321 112223356889999999998876533222 234456789999999
Q ss_pred CCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 141 ~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+++ ++ .++++|||++..
T Consensus 81 g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence 999999875411 1 7899999999999999999999999999998 44 599999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=175.21 Aligned_cols=138 Identities=25% Similarity=0.315 Sum_probs=109.8
Q ss_pred eeecceeecccceEEEEEEECCeeEEEEEeecCCCc-h--HHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTS-D--ERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIV 135 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~-~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv 135 (378)
|...+.||+|+||+||++.+.+..+++|+....... . .......++.+|++++..++|++++....++. ....++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 455789999999999999988777777654332211 1 12223456889999999999999887665553 3467899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
|||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||++ ++ .++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-RLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC-cEEEEeCccccc
Confidence 99999999999875 2467899999999999999999999999999995 44 499999999865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.3e-19 Score=151.72 Aligned_cols=139 Identities=22% Similarity=0.239 Sum_probs=106.0
Q ss_pred ceeecceeecccceEEEEEEE-CCeeEEEEEeecCCCchHH-----------------HHHHHHHHHHHHHHhhccCCC-
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDER-----------------ALLEGRFIREVNMMSRVKHDN- 119 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~-----------------~~~~~~~~~E~~~l~~l~hp~- 119 (378)
.|.+.+.||+|+||.||++.. +++.||||++......... .........|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 367778999999999999987 5789999997754311100 011223668899999998774
Q ss_pred -eeeEEeeEecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCc
Q 017046 120 -LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (378)
Q Consensus 120 -iv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~ 198 (378)
++..++ ....+++|||++|++|.++... .....++.+++.++.++|+.|++||||+|+||+++.++ .
T Consensus 96 ~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-~ 163 (198)
T cd05144 96 PVPKPID---WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-K 163 (198)
T ss_pred CCCceee---cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-c
Confidence 444443 2355899999999998765421 33567889999999999999999999999999998654 5
Q ss_pred eeEeccccccc
Q 017046 199 LKLADFGLARE 209 (378)
Q Consensus 199 vkl~Dfg~a~~ 209 (378)
++|+|||++..
T Consensus 164 ~~liDfg~~~~ 174 (198)
T cd05144 164 IYIIDWPQMVS 174 (198)
T ss_pred EEEEECCcccc
Confidence 99999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-20 Score=171.40 Aligned_cols=169 Identities=31% Similarity=0.496 Sum_probs=129.9
Q ss_pred CeEEEEeccCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+++|.|++|...+|.+|+...+ ....+....+.++.|++.|+.| +|.+|+|+||.||+...+. .+||.|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhhhhheee
Confidence 5889999999999999997433 3457788899999999999999 9999999999999998554 599999999876
Q ss_pred ccccc-------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017046 210 ETVTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 210 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 281 (378)
..... ..+...||+.||+||.+.+ ..|+.++||||||++|+|++. -..+|+. ......+.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--------~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r 473 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG--------QQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIR 473 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh--------hhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhh
Confidence 54444 4456689999999999975 889999999999999999998 3344332 22233332
Q ss_pred hcCCC-CCCCCChHHHHHHHHHccccCCCCCCCHHH
Q 017046 282 KHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 316 (378)
Q Consensus 282 ~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 316 (378)
.+..| .+-.+.+ .-..|+.+++.+.|.+||++.+
T Consensus 474 ~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHH
Confidence 33222 2222333 3457999999999999995443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.7e-18 Score=148.36 Aligned_cols=138 Identities=22% Similarity=0.286 Sum_probs=104.8
Q ss_pred ceee-cccceEEEEEEECCeeEEEEEeecCCCchH--------HHHHHHHHHHHHHHHhhccCCCe--eeEEeeEe--cC
Q 017046 64 SKIG-EGAHGKVYEGRYGDRIVAIKVLNRGSTSDE--------RALLEGRFIREVNMMSRVKHDNL--VKFLGACK--DP 130 (378)
Q Consensus 64 ~~lG-~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~i--v~l~~~~~--~~ 130 (378)
..|| .||.|+||.+...+..++||.+........ ......++.+|+.++..|.|++| +..++... ..
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4687 899999999988899999998864321000 01123467899999999998875 55666542 22
Q ss_pred C---eEEEEeccCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 131 L---MVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 131 ~---~~lv~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
. .++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||+.||+|+||||.|||++.++ .++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEEEEECCC
Confidence 2 3599999997 689988764 345554 357899999999999999999999999998665 599999998
Q ss_pred ccc
Q 017046 207 ARE 209 (378)
Q Consensus 207 a~~ 209 (378)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=139.76 Aligned_cols=138 Identities=25% Similarity=0.297 Sum_probs=97.1
Q ss_pred cceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHH-------------------HHHHHHHHHHHhhccCCC--e
Q 017046 63 GSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALL-------------------EGRFIREVNMMSRVKHDN--L 120 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~-------------------~~~~~~E~~~l~~l~hp~--i 120 (378)
.+.||+|+||.||+|... ++.||||++............ ......|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999876 889999998764432211100 001135666666665433 3
Q ss_pred eeEEeeEecCCeEEEEeccCCCCHHH-HHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCc
Q 017046 121 VKFLGACKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKS 198 (378)
Q Consensus 121 v~l~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~ 198 (378)
.+.++. ...+++|||++|+.+.. .+... ... ..+..++.+++.++.++|. .||+|+||||+||+++ ++ .
T Consensus 82 ~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-~ 152 (187)
T cd05119 82 PKPIDL---NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-K 152 (187)
T ss_pred CceEec---CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-c
Confidence 444433 34689999999854321 12111 011 6678899999999999999 9999999999999999 54 4
Q ss_pred eeEeccccccc
Q 017046 199 LKLADFGLARE 209 (378)
Q Consensus 199 vkl~Dfg~a~~ 209 (378)
++|+|||.+..
T Consensus 153 ~~liDfg~a~~ 163 (187)
T cd05119 153 VYIIDVPQAVE 163 (187)
T ss_pred EEEEECccccc
Confidence 99999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.4e-19 Score=174.63 Aligned_cols=253 Identities=24% Similarity=0.316 Sum_probs=190.9
Q ss_pred CcceeecceeecccceEEEEEEE---CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEecC-C
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-L 131 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~-~ 131 (378)
...|.+.+.||+|+|+.|-.... ....+|+|.+......... ..++..|..+-..+. |+|++++++...+. .
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~---~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~ 95 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDS---SEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS 95 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccch---hhhcCccccccccccccccccccCCccCCCcc
Confidence 34577778899999999987654 3456677766554422221 123556777777776 99999999988665 6
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH-~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
.+++++|..|+++.+-+........+...+..++.|+..++.|+| ..++.|+||||+|.+++..+..+++.|||+|...
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 779999999999988773212226777888999999999999999 9999999999999999966536999999999754
Q ss_pred cc----ccccccCcC-ccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-
Q 017046 211 TV----TEMMTAETG-TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA- 284 (378)
Q Consensus 211 ~~----~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~- 284 (378)
.. .......+| ++.|+|||.... ........|+||.|+++..+++|..||.........+.......
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~-------~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~ 248 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSG-------KAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG 248 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccc-------hhhcCCCcccccccccccccccCCCCccccccccccceeeccccc
Confidence 43 223345578 999999999864 13457789999999999999999999976554433322222221
Q ss_pred --CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 285 --RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 285 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.......++....+++.+++..+|..|.+.+++-.
T Consensus 249 ~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 12334567888999999999999999999988865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.6e-16 Score=128.99 Aligned_cols=131 Identities=21% Similarity=0.220 Sum_probs=107.5
Q ss_pred ecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccC--CCeeeEEeeEec-CCeEEEEec
Q 017046 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--DNLVKFLGACKD-PLMVIVTEL 138 (378)
Q Consensus 62 ~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~~-~~~~lv~e~ 138 (378)
+.+.||.|.++.||++...+..+++|....... ...+.+|+.++..+.| .++++++..... +..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 346799999999999999888999999866543 1247789999999976 588888887753 468999999
Q ss_pred cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN---GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+.|+++..+ +......++.+++.+|+++|.. +++|+|++|.||+++.. ..++++|||.+..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence 988777543 4556677899999999999985 79999999999999964 4599999998854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.1e-14 Score=120.55 Aligned_cols=127 Identities=21% Similarity=0.229 Sum_probs=95.8
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeee-EEeeEecCCeEEEEeccCCC
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK-FLGACKDPLMVIVTELLPGM 142 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~-l~~~~~~~~~~lv~e~~~~~ 142 (378)
+.|+.|.++.||+++..++.|++|+........ ..+..|+.+++.+.+.++++ ++... ....++||||++|.
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~------~~~~~E~~~l~~l~~~~~~P~~~~~~-~~~~~lv~e~i~G~ 76 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTELL------INRENEAENSKLAAEAGIGPKLYYFD-PETGVLITEFIEGS 76 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcccc------cCHHHHHHHHHHHHHhCCCCceEEEe-CCCCeEEEEecCCC
Confidence 568999999999999999999999976543211 12557888888886555544 44443 33468999999998
Q ss_pred CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----eeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI-----IHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 143 sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~gi-----vH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
++.+. . . ....++.+++.+|+.||..++ +|+|++|.||+++ ++ .++++|||.+..
T Consensus 77 ~l~~~--~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTE--D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAGM 136 (170)
T ss_pred ccccc--c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-eEEEEecccccC
Confidence 87643 0 1 113456799999999999985 9999999999998 44 499999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.7e-14 Score=134.40 Aligned_cols=143 Identities=24% Similarity=0.292 Sum_probs=96.8
Q ss_pred ceeecccceEEEEEEE-CCeeEEEEEeecCCCchHHH-----------------------------H------HHHHHHH
Q 017046 64 SKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERA-----------------------------L------LEGRFIR 107 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~-----------------------------~------~~~~~~~ 107 (378)
+.||.|++|.||+|+. +|+.||||+.+......-.. . .+-.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999987 57999999987653221100 0 0112556
Q ss_pred HHHHHhhcc----CCCeeeEEeeEe--cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 017046 108 EVNMMSRVK----HDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR-AMDCLHANGI 180 (378)
Q Consensus 108 E~~~l~~l~----hp~iv~l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~-~l~~lH~~gi 180 (378)
|+..+.++. |.+-+.+-..+. ....++||||++|++|.++..... ...+ ...++..++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 666666652 222233322221 235689999999999988765321 2222 2345555555 4788999999
Q ss_pred eeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 181 vH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
+|+|++|.||+++.++ .++|+|||++...+
T Consensus 279 ~H~D~hPgNilv~~~g-~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDG-KIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence 9999999999998665 59999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.2e-13 Score=110.23 Aligned_cols=147 Identities=23% Similarity=0.298 Sum_probs=110.6
Q ss_pred cceeecccceEEEEEEECCeeEEEEEeecCC---CchHHHHHHHHHHHHHHHHhhccCCCeee-EEeeEecCCeEEEEec
Q 017046 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGS---TSDERALLEGRFIREVNMMSRVKHDNLVK-FLGACKDPLMVIVTEL 138 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~hp~iv~-l~~~~~~~~~~lv~e~ 138 (378)
...|-+|+-+.|+++.+.|+...||.-.... ..-+.+....+.++|+++|.++.--.|.- -+-++......++|||
T Consensus 12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 4578899999999999999998888643322 22344555678889999999986444422 2222223355799999
Q ss_pred cCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCce--eEeccccccc
Q 017046 139 LPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL--KLADFGLARE 209 (378)
Q Consensus 139 ~~~-~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~v--kl~Dfg~a~~ 209 (378)
++| .++.+++...............++..|-+.+.-||..+++|+||..+||++.+++..+ .|+|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 977 4788888775554444445578999999999999999999999999999998776654 8999999854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.7e-15 Score=139.75 Aligned_cols=244 Identities=27% Similarity=0.292 Sum_probs=179.0
Q ss_pred eeecceeec--ccceEEEEEEE----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-CC
Q 017046 60 LFIGSKIGE--GAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PL 131 (378)
Q Consensus 60 ~~~~~~lG~--G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~ 131 (378)
+-+.+.+|. |.+|.||.++. ....+|+|.-+......... .+-.+|+...+.+ .|+|.++.+..+.+ +.
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~---~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS---KRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc---ccccchhhcccccCccccccccCcccccCCc
Confidence 456788999 99999998866 35788988754433322111 1234677666667 49999997777755 46
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR----AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~----~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
.++-+|++ +.+|.++... ....++...++....+... ||.++|+.+++|-|+||.||++..+....+++|||+.
T Consensus 193 lfiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred ceeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 77778888 6788888765 3455888899999999999 9999999999999999999999977456999999998
Q ss_pred cccccccccc------cCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCC-ChHHHHHHHH
Q 017046 208 REETVTEMMT------AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM-SNLQAAYAAA 280 (378)
Q Consensus 208 ~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~~~ 280 (378)
.......... ...|...|++||+.. .-++...|||+||.++.+..++..+.... .... ....
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~---------~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W--~~~r 339 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN---------GLATFASDIFSLGEVILEAILGSHLPSVGKNSSW--SQLR 339 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhc---------cccchHhhhcchhhhhHhhHhhcccccCCCCCCc--cccc
Confidence 7655444221 115777899999986 45788999999999999998876554332 1101 0000
Q ss_pred HhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 281 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 281 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
......++....+.++...+..++..+|..|++...+..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111233344566777888999999999999999888766
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.6e-13 Score=113.59 Aligned_cols=140 Identities=19% Similarity=0.201 Sum_probs=99.7
Q ss_pred cceeecccceEEEEEEEC--------CeeEEEEEeecCCCc---------------------hHHHHHHHHHHHHHHHHh
Q 017046 63 GSKIGEGAHGKVYEGRYG--------DRIVAIKVLNRGSTS---------------------DERALLEGRFIREVNMMS 113 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~---------------------~~~~~~~~~~~~E~~~l~ 113 (378)
...||.|--+.||.|... +..+|||+.+..... ...........+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 356899999999999754 368999987542211 111222222348999999
Q ss_pred hccC--CCeeeEEeeEecCCeEEEEeccCCCCHHH-HHhhhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeecCCCCc
Q 017046 114 RVKH--DNLVKFLGACKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIARAMDCL-HANGIIHRDLKPDN 189 (378)
Q Consensus 114 ~l~h--p~iv~l~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~l~~~~~~~i~~qi~~~l~~l-H~~givH~dikp~N 189 (378)
++.. -++...+++ ...++||||+.+..+.. .+. ...++......+..+++.+|..| |..|++|+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 9853 455666654 35689999996654322 222 22455666778889999999999 89999999999999
Q ss_pred EEEcCCCCceeEecccccccc
Q 017046 190 LLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 190 ill~~~~~~vkl~Dfg~a~~~ 210 (378)
||++ ++ .++|+|||.+...
T Consensus 156 IL~~-~~-~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWH-DG-KVWFIDVSQSVEP 174 (197)
T ss_pred EEEE-CC-cEEEEECCCceeC
Confidence 9997 44 4999999988653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.8e-13 Score=110.34 Aligned_cols=134 Identities=22% Similarity=0.314 Sum_probs=101.1
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCC---chHHHHHHHHHHHHHHHHhhccCCCee--eEEeeEecCCeEEEEec
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGST---SDERALLEGRFIREVNMMSRVKHDNLV--KFLGACKDPLMVIVTEL 138 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~hp~iv--~l~~~~~~~~~~lv~e~ 138 (378)
..+++|+-+.+|.+.+.|..+++|.=.+... .-+......+-.+|+.++..+.--.|. .+++ +......|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d-vD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD-VDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE-EcCCCCEEEEEE
Confidence 3578999999999988887777776333221 223344456778999999998654442 2333 333456799999
Q ss_pred cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++..+ . +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-R-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-c-EEEEECCcccc
Confidence 9999999998763 14577788888899999999999999999999843 3 99999999864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.2e-13 Score=130.51 Aligned_cols=143 Identities=20% Similarity=0.238 Sum_probs=92.1
Q ss_pred eeecceeecccceEEEEEEEC--CeeEEEEEeecCCCch-----------------------------HHHHHH------
Q 017046 60 LFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSD-----------------------------ERALLE------ 102 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~-----------------------------~~~~~~------ 102 (378)
|.. +.||+|++|.||+|+.. |+.||||+.++..... -.....
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 444 68999999999999874 7999999998653211 000111
Q ss_pred HHHHHHHHHHhhcc----CCCeeeEEeeEe--cCCeEEEEeccCCCCHHHHHhhhCCCCCC-----HHHHHHHHHHHHHH
Q 017046 103 GRFIREVNMMSRVK----HDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLD-----LHVALNFALDIARA 171 (378)
Q Consensus 103 ~~~~~E~~~l~~l~----hp~iv~l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~l~-----~~~~~~i~~qi~~~ 171 (378)
-.+.+|+..+.++. +.+.+.+-.++. ....++||||++|+.+.++..- .....+ ...+..++.
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~----- 274 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFT----- 274 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHH-----
Confidence 12455555555552 333344434443 2457899999999999875321 112222 223333333
Q ss_pred HHHHHhCCCeeecCCCCcEEEcCCC---CceeEeccccccccc
Q 017046 172 MDCLHANGIIHRDLKPDNLLLTPDQ---KSLKLADFGLAREET 211 (378)
Q Consensus 172 l~~lH~~givH~dikp~Nill~~~~---~~vkl~Dfg~a~~~~ 211 (378)
.+...|++|+|+||.||+++.++ ..++++|||++...+
T Consensus 275 --Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 --QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred --HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 34569999999999999998665 259999999987543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.4e-12 Score=115.83 Aligned_cols=255 Identities=19% Similarity=0.296 Sum_probs=166.9
Q ss_pred eecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeee--------EEeeEecCC
Q 017046 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVK--------FLGACKDPL 131 (378)
Q Consensus 61 ~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~--------l~~~~~~~~ 131 (378)
..++.||+|+-+.+|-.-.-...|| |+..........+ -+..|... .||-+-. ++|.-....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~aq--------k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQAQ--------KVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchhhchhh-eeecCCCchHHHH--------HHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 3467899999999996533333444 6766554433221 12222332 4554322 122222223
Q ss_pred eEEEEeccCCCC-HHHHHhhh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 132 MVIVTELLPGMS-LRKYLVSL----RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 132 ~~lv~e~~~~~s-L~~~l~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
.-++|..+.|.. +..++... ......+...++.++.++.+.+.||..|.+-+|+.++|+|++.++. |.|+|-..
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~-V~LVdsDs 163 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK-VVLVDSDS 163 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce-EEEEcccc
Confidence 568899887753 33333221 1234788999999999999999999999999999999999996654 89998665
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhC-CCCCCCCCh-------HHHHHH
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSN-------LQAAYA 278 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~-------~~~~~~ 278 (378)
......+......+|...|.+||.-+-..+ .+...+...|.|.||+++++++.| +.||.+... .+....
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf---~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSF---VGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccc---cccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 544455555566789999999997652221 235567789999999999999985 899976331 111110
Q ss_pred -----HHHhcCCC------CCC-CCChHHHHHHHHHccccC--CCCCCCHHHHHHHHHhhhhcc
Q 017046 279 -----AAFKHARP------GLP-EDISPDLAFIVQSCWVED--PNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 279 -----~~~~~~~~------~~~-~~~~~~l~~li~~~l~~d--p~~Rps~~~ll~~l~~~~~~~ 328 (378)
......+. .+| .-+++++..|..+|+... +.-|||++.++..|..+-..+
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 00011111 112 236788999999999754 568999999998887776554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.9e-12 Score=120.73 Aligned_cols=161 Identities=18% Similarity=0.247 Sum_probs=120.9
Q ss_pred CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-cCCeEEEEeccCCCCHHHHHhhhCCCCCCH
Q 017046 80 GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDL 158 (378)
Q Consensus 80 ~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~ 158 (378)
.+.+|.|.+.+.... .. .....+.++.|+.++||||+.+++.++ ++..|+|+|.+ ..|..++.. +..
T Consensus 36 ~~~~vsVF~~~~~~~--~~---~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~ 103 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EV---TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGK 103 (690)
T ss_pred cCCceEEEEEeCCCc--hh---hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHH
Confidence 457788887766554 11 123668889999999999999999885 56899999998 578888876 236
Q ss_pred HHHHHHHHHHHHHHHHHH-hCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc-cccCcCccccccccccccccc
Q 017046 159 HVALNFALDIARAMDCLH-ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTL 236 (378)
Q Consensus 159 ~~~~~i~~qi~~~l~~lH-~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~ 236 (378)
..+..-+.||+.||.||| ..+++|++|..+.|+|+..|. .||++|.++........ ......-..|..|+.+..
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge-WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~--- 179 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE-WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP--- 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc-EEEeeeEEEeccccCCcccccchhhhcccChhhcCc---
Confidence 667778899999999998 568999999999999997665 99999998754332221 111122234677775532
Q ss_pred cccccccCCCcccchhhhHHHHHHHhC
Q 017046 237 RQGEKKHYNNKVDVYSFGIVLWELLTN 263 (378)
Q Consensus 237 ~~~~~~~~~~~~DiwslG~il~~ll~g 263 (378)
-+...|.|.|||++++++.|
T Consensus 180 -------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 -------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -------cccchhhhhHHHHHHHHhCc
Confidence 22467999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.1e-13 Score=128.54 Aligned_cols=248 Identities=22% Similarity=0.200 Sum_probs=174.8
Q ss_pred CcceeecceeecccceEEEEEEE---CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeE-ecCC
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC-KDPL 131 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~-~~~~ 131 (378)
..+|..+..||.|.|+.|+.... ++..|++|.+.+......... .-+.|+.+...+ .|.+++.++..+ +...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di---~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI---FSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh---cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34567788999999999998643 467899998877665443221 234677666666 488888876554 5667
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++-.|||+++++...+.. ...+++...+++..|++.++.++|+..++|+|+||+||++..++...++.|||......
T Consensus 341 ~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 7899999999987765532 34688888999999999999999999999999999999998765568999999886421
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (378)
... ......+..|-..|.+.. ...+..+.|+++||..+.+..+|...-+.... +..+..+..+..+.
T Consensus 419 ~~~-~~~~~~~r~~p~~~~~~e-------~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~~~~~p~~~~- 485 (524)
T KOG0601|consen 419 FSS-GVFHHIDRLYPIAEILLE-------DYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIRSGDTPNLPG- 485 (524)
T ss_pred eec-ccccccccccccchhhcc-------ccccccccccccccccccccccCcccCccccc----ceeeecccccCCCc-
Confidence 111 111122333312444432 35677899999999999999998753222221 11122233333333
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 322 (378)
....+..+.+.+...++..||.+.++..+.+
T Consensus 486 ~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 486 LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 4488888999999999999999888766443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.6e-12 Score=113.53 Aligned_cols=193 Identities=22% Similarity=0.313 Sum_probs=131.1
Q ss_pred HhhccCCCeeeEEeeEecC------CeEEEEeccCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC--CCe
Q 017046 112 MSRVKHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHAN--GII 181 (378)
Q Consensus 112 l~~l~hp~iv~l~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~--giv 181 (378)
+-.+-|.|||+++.++.+. ...+++||++.|+|.++|+..+. ..+......+|+-||+.||.|||+- -|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 3344699999998887542 46799999999999999987543 3477788889999999999999988 499
Q ss_pred eecCCCCcEEEcCCCCceeEeccccccc-----cccccccccCcCccccccccccccccccccccccCCCcccchhhhHH
Q 017046 182 HRDLKPDNLLLTPDQKSLKLADFGLARE-----ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256 (378)
Q Consensus 182 H~dikp~Nill~~~~~~vkl~Dfg~a~~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i 256 (378)
|+++..+.|++..++. +|+.--..... ...........+.++|.+||.=. .-..+.++|||++|+.
T Consensus 201 hgnlTc~tifiq~ngL-Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~--------~tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGL-IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT--------TTNTTGASDIYKFGMC 271 (458)
T ss_pred cCCcchhheeecCCce-EEecccCccccchhhhhhhHhhhhccccCCccccCCcCc--------ccccccchhhhhhhHH
Confidence 9999999999996654 55442111100 00011112235678899999532 2455678999999999
Q ss_pred HHHHHhCCCCC-CCCChH--HHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 257 LWELLTNRLPF-EGMSNL--QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 257 l~~ll~g~~pf-~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.++|..+..-- .+.+.. +....... ..+..+ --+.++.+|++..|..||++.+++.|
T Consensus 272 AlemailEiq~tnseS~~~~ee~ia~~i----~~len~---lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 272 ALEMAILEIQSTNSESKVEVEENIANVI----IGLENG---LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHHHHheeccCCCcceeehhhhhhhhe----eeccCc---cccCcCcccccCCCCCCcchhhhhcC
Confidence 99998876432 221111 11111111 111111 12357889999999999999998874
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.9e-10 Score=101.89 Aligned_cols=139 Identities=19% Similarity=0.124 Sum_probs=96.9
Q ss_pred cceEEEEEEECCeeEEEEEeecCCCchHHHH------HHHHHHHHHHHHhhccCCCe--eeEEeeEe---c---CCeEEE
Q 017046 70 AHGKVYEGRYGDRIVAIKVLNRGSTSDERAL------LEGRFIREVNMMSRVKHDNL--VKFLGACK---D---PLMVIV 135 (378)
Q Consensus 70 ~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~------~~~~~~~E~~~l~~l~hp~i--v~l~~~~~---~---~~~~lv 135 (378)
....|+.....|+.|.||............. -...+.+|...+..|..-+| +..+++.. + ...++|
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 3344667777888999997643321110000 00136788888888853333 33444432 1 247899
Q ss_pred EeccCCC-CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC------CCCceeEecccccc
Q 017046 136 TELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP------DQKSLKLADFGLAR 208 (378)
Q Consensus 136 ~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~------~~~~vkl~Dfg~a~ 208 (378)
||++++. +|.+++........+......++.+++..+..||..||+|+|+++.|||++. +...+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999886 7999886432345667778899999999999999999999999999999974 23469999999774
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.6e-12 Score=128.80 Aligned_cols=247 Identities=22% Similarity=0.281 Sum_probs=171.0
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE-ecCC
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPL 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~~~ 131 (378)
..+..+.+.+-+-+|+++.++.+.-. +...++|+........... ......+-.++-..++|.++...-.+ ....
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~--~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTND--YESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhcccc--ccccCCccCccccCCCCceecccCCCCCCCC
Confidence 45666778889999999999977542 3334444433221111100 01122333333333456666544443 2346
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.+++++|+.+++|...+.. .+..+.+-+..+...+..+++|||...+.|+|++|.|+++..++. .++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh-~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH-RPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhc--CCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC-cccCccccccccc
Confidence 7899999999999998876 345777778888999999999999999999999999999986654 8999998432100
Q ss_pred c--------------------------------ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHH
Q 017046 212 V--------------------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259 (378)
Q Consensus 212 ~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ 259 (378)
. ........+|+.|.+||.+.+ ......+|+|++|+++++
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--------~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--------RRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--------ccCCCcchhhhhhhhhhh
Confidence 0 001223468999999999875 566788999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCC--CCCCCCChHHHHHHHHHccccCCCCCCCHH
Q 017046 260 LLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFS 315 (378)
Q Consensus 260 ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 315 (378)
.++|.+||......+ .++.+..... +..+...++++++++...+..+|.+|-.+.
T Consensus 1028 ~l~g~pp~na~tpq~-~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETPQQ-IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhcCCCCCCCcchhh-hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999999876633 3333322221 223456889999999999999999997655
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.8e-10 Score=105.11 Aligned_cols=218 Identities=17% Similarity=0.207 Sum_probs=152.4
Q ss_pred cceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe-----cCCeEEEEeccCC-
Q 017046 70 AHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-----DPLMVIVTELLPG- 141 (378)
Q Consensus 70 ~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~~~lv~e~~~~- 141 (378)
-..+.|++.. +|..|++|.+......... +...-++.++++.|+|||+|.+++. |..+++|++|+++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-----k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-----KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc-----cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 3456788754 5788999998433322211 1234567899999999999988764 4468899999987
Q ss_pred CCHHHHHhhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 142 MSLRKYLVSLR-------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 142 ~sL~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
++|.++..... +.+.++..+|.++.|++.||.++|+.|+..+-|.|.+||++.+. +++|+..|+..
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~D 441 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMD 441 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEeccccee
Confidence 46877664322 22477899999999999999999999999999999999998543 58888887764
Q ss_pred ccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCC
Q 017046 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~ 287 (378)
...... + |-+ .--.+-|.=.||.+++.|.||..- +........... .
T Consensus 442 vl~~d~------~-------~~l-----------e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~ 489 (655)
T KOG3741|consen 442 VLQEDP------T-------EPL-----------ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------R 489 (655)
T ss_pred eecCCC------C-------cch-----------hHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------H
Confidence 322111 0 111 112467999999999999998543 222221111011 1
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
+-..++.++++++.-+...++++ -++.+++.++-..++
T Consensus 490 I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff 527 (655)
T KOG3741|consen 490 ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFF 527 (655)
T ss_pred hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHH
Confidence 23568899999999999999887 678888876544443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.9e-11 Score=103.52 Aligned_cols=139 Identities=23% Similarity=0.349 Sum_probs=102.5
Q ss_pred ceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccC--CCeeeEEeeEec----CCeEEEE
Q 017046 64 SKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--DNLVKFLGACKD----PLMVIVT 136 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~~----~~~~lv~ 136 (378)
+.||.|.++.||++...+ +.+++|+......... ...+..|+.+++.+.+ .++.+++.+..+ +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~----~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPS----AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcc----cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 468999999999998776 8999999765443111 1246789999999865 345666766644 2568999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA--------------------------------------- 177 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~--------------------------------------- 177 (378)
||++|.++.+.+.. ..+++.....++.+++.+|.+||+
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99999888765431 346777777777888888888774
Q ss_pred -----------------CCCeeecCCCCcEEEcCC-CCceeEeccccccc
Q 017046 178 -----------------NGIIHRDLKPDNLLLTPD-QKSLKLADFGLARE 209 (378)
Q Consensus 178 -----------------~givH~dikp~Nill~~~-~~~vkl~Dfg~a~~ 209 (378)
..++|+|++|.||+++.+ +..+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236999999999999863 34478999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.3e-10 Score=98.39 Aligned_cols=129 Identities=26% Similarity=0.321 Sum_probs=83.2
Q ss_pred EEEEEEE-CCeeEEEEEeecCCCc---------------------hHHHHHHHHHHHHHHHHhhccCC--CeeeEEeeEe
Q 017046 73 KVYEGRY-GDRIVAIKVLNRGSTS---------------------DERALLEGRFIREVNMMSRVKHD--NLVKFLGACK 128 (378)
Q Consensus 73 ~Vy~~~~-~~~~vavK~~~~~~~~---------------------~~~~~~~~~~~~E~~~l~~l~hp--~iv~l~~~~~ 128 (378)
.||.|.. .+..+|||+.+..... ...........+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899986 5789999987553211 12233445678999999999755 455566543
Q ss_pred cCCeEEEEeccC--CCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 129 DPLMVIVTELLP--GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC-LHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 129 ~~~~~lv~e~~~--~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~-lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
..++||||++ |..+..+... .++......++.+++..+.. +|..|++|+|+.+.|||++.+ .+.|+|||
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~ 151 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG 151 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred --CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence 4479999998 6555544332 12234456677888885555 579999999999999999944 49999999
Q ss_pred ccccc
Q 017046 206 LAREE 210 (378)
Q Consensus 206 ~a~~~ 210 (378)
.+...
T Consensus 152 qav~~ 156 (188)
T PF01163_consen 152 QAVDS 156 (188)
T ss_dssp TEEET
T ss_pred cceec
Confidence 88653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.7e-10 Score=96.40 Aligned_cols=140 Identities=26% Similarity=0.298 Sum_probs=102.1
Q ss_pred ceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHH-----------------HHHHHHHHHHHHHHhhccCC--
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDER-----------------ALLEGRFIREVNMMSRVKHD-- 118 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~-----------------~~~~~~~~~E~~~l~~l~hp-- 118 (378)
...++.+||.|.-|.||.|... +.++|||.-+....+... ........+|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3557889999999999999875 899999987654433211 11122346889999988644
Q ss_pred CeeeEEeeEecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCc
Q 017046 119 NLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (378)
Q Consensus 119 ~iv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~ 198 (378)
.+..-+++ +..++||||++|..|...- ++.+..-.++..|++-+..+-..|+||+|+.+-||+++.+|.
T Consensus 172 ~VP~P~~~---nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~- 240 (304)
T COG0478 172 KVPKPIAW---NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD- 240 (304)
T ss_pred CCCCcccc---ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC-
Confidence 44444443 3568999999997776422 234555566777777777777999999999999999997766
Q ss_pred eeEeccccccc
Q 017046 199 LKLADFGLARE 209 (378)
Q Consensus 199 vkl~Dfg~a~~ 209 (378)
+.++||-.+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.9e-09 Score=92.22 Aligned_cols=104 Identities=30% Similarity=0.419 Sum_probs=80.3
Q ss_pred HHHHHHHHHhhccCCCe--eeEEeeEec-----CCeEEEEeccCCC-CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 017046 104 RFIREVNMMSRVKHDNL--VKFLGACKD-----PLMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175 (378)
Q Consensus 104 ~~~~E~~~l~~l~hp~i--v~l~~~~~~-----~~~~lv~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~l 175 (378)
+..+|...+..|..-+| ...+++... ...++|+|++++. +|.+++.... ..+......++.+++..++-|
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHHH
Confidence 57788888888754333 344444432 1357999999884 7999887622 267777889999999999999
Q ss_pred HhCCCeeecCCCCcEEEcCCC--CceeEeccccccc
Q 017046 176 HANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLARE 209 (378)
Q Consensus 176 H~~givH~dikp~Nill~~~~--~~vkl~Dfg~a~~ 209 (378)
|..||+|+|+++.|||++.++ ..+.|+||+-+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999998665 2589999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.1e-09 Score=89.78 Aligned_cols=142 Identities=15% Similarity=0.145 Sum_probs=100.7
Q ss_pred ecccceEEEEEEECCeeEEEEEeecCCCchHH-HHHHHHHHHHHHHHhhccCCC--eeeEEeeE--ecC---CeEEEEec
Q 017046 67 GEGAHGKVYEGRYGDRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDN--LVKFLGAC--KDP---LMVIVTEL 138 (378)
Q Consensus 67 G~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~--iv~l~~~~--~~~---~~~lv~e~ 138 (378)
|.||.+.|+.....|..+-+|.-.......-. ..-...|.+|+..+..|..-+ +.+.+... ..+ ..+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 67999999998888878888875421111000 001134889999999985333 34443221 122 36799998
Q ss_pred cCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC-ceeEecccccc
Q 017046 139 LPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAR 208 (378)
Q Consensus 139 ~~~-~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~-~vkl~Dfg~a~ 208 (378)
+.| -+|.+++....-...+......++.+++..++-||..|+.|+|+.+.||+++.++. .+.++||.-++
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 854 48998886533345677788899999999999999999999999999999984442 39999997654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.6e-08 Score=86.43 Aligned_cols=139 Identities=19% Similarity=0.246 Sum_probs=91.4
Q ss_pred cceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHH----HHHHHHHHHHhhccCCC---eeeEEeeEe--
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLE----GRFIREVNMMSRVKHDN---LVKFLGACK-- 128 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~----~~~~~E~~~l~~l~hp~---iv~l~~~~~-- 128 (378)
..|.+.+.+-......|.+....++.+++|..+......++.... ....+.+..+.++...+ ...++.+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 456667777777777888888889999999987755443322110 01123444444443222 222222221
Q ss_pred ----cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecc
Q 017046 129 ----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 129 ----~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Df 204 (378)
....+++|||++|..|.++.. +++ .+...+.+++..||..|+.|+|.+|.|++++ +++ ++++||
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~-~~~-i~iID~ 178 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS-NNG-IRIIDT 178 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE-CCc-EEEEEC
Confidence 124568999999988876532 222 2456677889999999999999999999999 444 999999
Q ss_pred cccc
Q 017046 205 GLAR 208 (378)
Q Consensus 205 g~a~ 208 (378)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 7654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.7e-10 Score=109.42 Aligned_cols=143 Identities=16% Similarity=0.363 Sum_probs=101.3
Q ss_pred HHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEeccccccccccccc-----c-----ccCcCcccccccccccccc
Q 017046 167 DIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-----M-----TAETGTYRWMAPELYSTVT 235 (378)
Q Consensus 167 qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-----~-----~~~~gt~~y~aPE~~~~~~ 235 (378)
+++.|+.|+|.. ++||++|.|++|.++..+ .+||+.|+++.....+.. . ....-...|.|||.+..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-- 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-- 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--
Confidence 444999999976 899999999999999655 499999998764322110 1 11123457999999875
Q ss_pred ccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHH---hcCCCCCCCCChHHHHHHHHHccccCCCCC
Q 017046 236 LRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF---KHARPGLPEDISPDLAFIVQSCWVEDPNLR 311 (378)
Q Consensus 236 ~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 311 (378)
...+.++|+||||+++|.+.. |+.-+....... .+.... .-........+++++++=+.+++..++..|
T Consensus 184 ------~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~r 256 (700)
T KOG2137|consen 184 ------TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVR 256 (700)
T ss_pred ------ccccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccC
Confidence 456789999999999999995 555554433211 111111 111222346789999999999999999999
Q ss_pred CCHHHHHH
Q 017046 312 PSFSQIIR 319 (378)
Q Consensus 312 ps~~~ll~ 319 (378)
|++..+..
T Consensus 257 p~~~~l~~ 264 (700)
T KOG2137|consen 257 PTLDLLLS 264 (700)
T ss_pred cchhhhhc
Confidence 98777655
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1e-07 Score=92.59 Aligned_cols=142 Identities=20% Similarity=0.267 Sum_probs=93.6
Q ss_pred ceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHH-----------------------------H------HHHHHHH
Q 017046 64 SKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERA-----------------------------L------LEGRFIR 107 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~-----------------------------~------~~~~~~~ 107 (378)
.-|+.++-|.||+|+.. |+.||||+.++.....-.. . .+-.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 45789999999999986 8999999987644322100 0 0112455
Q ss_pred HHHHHhhcc-----CCCeeeEEeeEe--cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 017046 108 EVNMMSRVK-----HDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180 (378)
Q Consensus 108 E~~~l~~l~-----hp~iv~l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~gi 180 (378)
|...+.++. .|+ +.+-.++. ....+++|||++|..+.+...- +..+++...+.....++ -+..+-..|+
T Consensus 211 EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l-~~~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL-KSAGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHH-HhcCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 655555552 233 23323332 3467899999999988887533 23556655444433332 2344556899
Q ss_pred eeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 181 vH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
+|.|.+|.||++..++. +.+.|||+....
T Consensus 287 fHaDpHpGNi~v~~~g~-i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSDGR-IVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecCCc-EEEEcCcceecC
Confidence 99999999999997754 999999998643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.5e-07 Score=81.44 Aligned_cols=141 Identities=23% Similarity=0.255 Sum_probs=94.6
Q ss_pred cceeecccceEEEEEEE-CCeeEEEEEeecCCCchH-------------------HHHHHHHHHHHHHHHhhccCC--Ce
Q 017046 63 GSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDE-------------------RALLEGRFIREVNMMSRVKHD--NL 120 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~-------------------~~~~~~~~~~E~~~l~~l~hp--~i 120 (378)
...|..|.-+.||+|.. .+..+|+|+.+....... +.....-..+|..-|.++... .+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34678888899999876 478999999866443322 222222345677777777433 23
Q ss_pred eeEEeeEecCCeEEEEeccCCCCH-HHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCc
Q 017046 121 VKFLGACKDPLMVIVTELLPGMSL-RKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKS 198 (378)
Q Consensus 121 v~l~~~~~~~~~~lv~e~~~~~sL-~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~ 198 (378)
.+-+++. ..+|||||+....+ .-.| +.-.+...++..+..+++..+.-|-. .|+||+||..=|||+. ++.
T Consensus 133 P~Pi~~~---~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~- 204 (268)
T COG1718 133 PEPIAFR---NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE- 204 (268)
T ss_pred CCceeec---CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe-
Confidence 3333332 45799999944311 1111 12233444678888899999988877 8999999999999999 554
Q ss_pred eeEeccccccccc
Q 017046 199 LKLADFGLAREET 211 (378)
Q Consensus 199 vkl~Dfg~a~~~~ 211 (378)
+.|+|||.+....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999886543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.2e-07 Score=76.18 Aligned_cols=128 Identities=24% Similarity=0.324 Sum_probs=93.1
Q ss_pred eecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeee-EEeeEecCCeEEEEecc
Q 017046 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK-FLGACKDPLMVIVTELL 139 (378)
Q Consensus 61 ~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~-l~~~~~~~~~~lv~e~~ 139 (378)
...+.||+|++|.||++.+.+..+|+|+-+.+..... +..|+++|..+.-.++-+ ++.+..+ ++.|||+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~-------l~kEakiLeil~g~~~~p~vy~yg~~---~i~me~i 94 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRN-------LEKEAKILEILAGEGVTPEVYFYGED---FIRMEYI 94 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCcchhh-------HHHHHHHHHHhhhcCCCceEEEechh---hhhhhhh
Confidence 4567899999999999999999999999887665443 668999999998776644 4544333 3559999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCC-CC-cEEEcCCCCceeEeccccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK-PD-NLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dik-p~-Nill~~~~~~vkl~Dfg~a~~ 209 (378)
.|-+|.++... .+.. -...+++.---|-..||-|+.|. |. ||++. ++ .+.|+||..|+.
T Consensus 95 ~G~~L~~~~~~-----~~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIG-----GDRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DR-DVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhc-----ccHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEec-CC-cEEEEEccchhh
Confidence 99898876542 1222 33445566556677899999886 33 55554 54 499999998864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.6e-06 Score=76.16 Aligned_cols=71 Identities=21% Similarity=0.319 Sum_probs=49.1
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCe--eeEEeeEec-CCeEEEEeccC
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL--VKFLGACKD-PLMVIVTELLP 140 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i--v~l~~~~~~-~~~~lv~e~~~ 140 (378)
..||+|..+.||+. .+..+++|......... ...+|.++++.+..-++ .+.+++..+ +...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~~~-------~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFDKE-------TIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCCHH-------HHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999984 35567889886533221 35689999988864333 455666543 35578999998
Q ss_pred CCC
Q 017046 141 GMS 143 (378)
Q Consensus 141 ~~s 143 (378)
|.+
T Consensus 78 G~~ 80 (226)
T TIGR02172 78 GKR 80 (226)
T ss_pred Ccc
Confidence 863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.6e-06 Score=74.99 Aligned_cols=76 Identities=18% Similarity=0.308 Sum_probs=54.3
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCC--CeeeEEeeEe----cCCeEEEEe
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD--NLVKFLGACK----DPLMVIVTE 137 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--~iv~l~~~~~----~~~~~lv~e 137 (378)
+.|+.|..+.||+....++.+++|..... . ....+.+|..+++.+... .+..++.... ....+++|+
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~---~----~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP---D----AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH---H----HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC---C----CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 57899999999999988889999997553 1 123467888888888533 2455665432 224689999
Q ss_pred ccCCCCHHH
Q 017046 138 LLPGMSLRK 146 (378)
Q Consensus 138 ~~~~~sL~~ 146 (378)
+++|..+..
T Consensus 76 ~i~g~~~~~ 84 (239)
T PF01636_consen 76 YIPGRPLDD 84 (239)
T ss_dssp EESSEEHHH
T ss_pred Eeccccccc
Confidence 999987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.2e-06 Score=86.68 Aligned_cols=77 Identities=18% Similarity=0.279 Sum_probs=54.9
Q ss_pred cceeecccceEEEEEEECC----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCe--eeEEeeEec----CC
Q 017046 63 GSKIGEGAHGKVYEGRYGD----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNL--VKFLGACKD----PL 131 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i--v~l~~~~~~----~~ 131 (378)
+..|+.|.+..+|+....+ ..+++|+.......... ..+.+|+++++.+. |+++ .+++.++.+ +.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~----~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSA----HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccH----HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 4678999999999887654 46788876543322211 23679999999995 6665 677777765 35
Q ss_pred eEEEEeccCCCC
Q 017046 132 MVIVTELLPGMS 143 (378)
Q Consensus 132 ~~lv~e~~~~~s 143 (378)
.++||||++|..
T Consensus 119 ~flVME~v~G~~ 130 (822)
T PLN02876 119 AFYIMEYLEGRI 130 (822)
T ss_pred ceEEEEecCCcc
Confidence 789999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.2e-08 Score=93.40 Aligned_cols=183 Identities=18% Similarity=0.165 Sum_probs=130.5
Q ss_pred eecceeecccceEEEEEEECCe-eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCC-eeeEEeeEe-cCCeEEEEe
Q 017046 61 FIGSKIGEGAHGKVYEGRYGDR-IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN-LVKFLGACK-DPLMVIVTE 137 (378)
Q Consensus 61 ~~~~~lG~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~l~~~~~-~~~~~lv~e 137 (378)
.....+++|+++++|+.+...+ ....+.+... . ...-++++|.+++||| .+..++.++ +.+.++.|+
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l-----~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----L-----SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-----h-----hhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 3445689999999999886542 2334444332 1 2346788999999999 666665554 457889999
Q ss_pred ccCCC-CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccccc
Q 017046 138 LLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (378)
Q Consensus 138 ~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~ 216 (378)
++.++ +-...... ..-.+...+...+.+.-+.+++++|+.--+|+| ||+... +. .+..||+...........
T Consensus 315 i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~-~~~~~~~v~~~L~~~~~~ 387 (829)
T KOG0576|consen 315 ICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EE-VKLLDFAVPPQLTRTMKP 387 (829)
T ss_pred hhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cc-cccccccCCcccCccccc
Confidence 99877 22211111 112234445566777888999999998778998 888873 33 899999998776665556
Q ss_pred ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCC
Q 017046 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (378)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 268 (378)
....+++.++|||+... ..+....|.|++|.-..+|.-|-+|-.
T Consensus 388 ~t~~~~~~~~~pev~~~--------~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQE--------NTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCCCCCCCCCchhhcc--------cccccCCCccCCCcchhhcCCCCCCCC
Confidence 67789999999998754 677889999999987777777776653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.2e-06 Score=82.06 Aligned_cols=144 Identities=22% Similarity=0.257 Sum_probs=93.9
Q ss_pred ceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHH--------------------------H------HHHHHHHHHH
Q 017046 64 SKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERA--------------------------L------LEGRFIREVN 110 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~--------------------------~------~~~~~~~E~~ 110 (378)
..||.-+.|.||+|+.. |+.||||+-++.-...-.. . .+-.|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 56899999999999875 6889999987644322000 0 0113555665
Q ss_pred HHhhc----cCCCe---eeEEeeEe--cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 017046 111 MMSRV----KHDNL---VKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181 (378)
Q Consensus 111 ~l~~l----~hp~i---v~l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~giv 181 (378)
-..++ .|-+. |.+-.++. ....+|+|||++|..+.|.-. ....+++...+...+.+... ..+-..|++
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~-i~~~gi~~~~i~~~l~~~~~--~qIf~~Gff 323 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA-IDKRGISPHDILNKLVEAYL--EQIFKTGFF 323 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH-HHHcCCCHHHHHHHHHHHHH--HHHHhcCCc
Confidence 54444 34441 22223332 236789999999987776532 23466787766555544432 334456899
Q ss_pred eecCCCCcEEEcC---CCCceeEecccccccc
Q 017046 182 HRDLKPDNLLLTP---DQKSLKLADFGLAREE 210 (378)
Q Consensus 182 H~dikp~Nill~~---~~~~vkl~Dfg~a~~~ 210 (378)
|+|=+|.||++++ .+..+.+.|||+....
T Consensus 324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred cCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 9999999999984 3456999999998653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.9e-06 Score=70.70 Aligned_cols=100 Identities=21% Similarity=0.215 Sum_probs=77.2
Q ss_pred HHHHHHHhhccC-CCeeeEEeeEecCCeEEEEeccCCCCHHHHHhh-hCCCCCCHHHHHHHHHHHHHHHHHHHh---CCC
Q 017046 106 IREVNMMSRVKH-DNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHA---NGI 180 (378)
Q Consensus 106 ~~E~~~l~~l~h-p~iv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~l~~~~~~~i~~qi~~~l~~lH~---~gi 180 (378)
..|.-+++.+++ +++++++|+|.+ +++.||+..+++...... ......++..+.+++.+++..+.+++. ..+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~---~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR---FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC---EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 468888888865 699999999844 689999977766421000 011246899999999999999999998 357
Q ss_pred eeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 181 IHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 181 vH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
.-.|++++|+-++.++ .+|++|...+..
T Consensus 84 ~lcDv~~~nfgv~~~~-~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDG-RLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCC-cEEEEechhcch
Confidence 7889999999999554 599999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.1e-05 Score=71.91 Aligned_cols=74 Identities=18% Similarity=0.218 Sum_probs=50.2
Q ss_pred eecccc-eEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec-CCeEEEEeccCCC
Q 017046 66 IGEGAH-GKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-PLMVIVTELLPGM 142 (378)
Q Consensus 66 lG~G~~-g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~~~lv~e~~~~~ 142 (378)
|-.|.+ ..||+....+..+.+|+...... ..+.+|+++++.+. +--+.+++++..+ +..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~~--------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGPT--------YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCcc--------cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 334444 88999877677888998865431 12557888888874 3334566666644 3578999999998
Q ss_pred CHHHH
Q 017046 143 SLRKY 147 (378)
Q Consensus 143 sL~~~ 147 (378)
+|...
T Consensus 78 ~l~~~ 82 (244)
T cd05150 78 PAAAL 82 (244)
T ss_pred cHhHh
Confidence 77643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.6e-05 Score=67.51 Aligned_cols=129 Identities=29% Similarity=0.428 Sum_probs=91.0
Q ss_pred cceeecceeecccc-eEEEEEEECCeeEEEEEeec---CCC-------ch-H-----HHHHHHHHHHHHHHHhhcc---C
Q 017046 58 KLLFIGSKIGEGAH-GKVYEGRYGDRIVAIKVLNR---GST-------SD-E-----RALLEGRFIREVNMMSRVK---H 117 (378)
Q Consensus 58 ~~~~~~~~lG~G~~-g~Vy~~~~~~~~vavK~~~~---~~~-------~~-~-----~~~~~~~~~~E~~~l~~l~---h 117 (378)
..++.++.||.|.- |.||+++..++.||||++.. ... .. + ......-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888899999999 99999999999999999322 111 00 0 0022235788888887774 4
Q ss_pred CCe--eeEEeeEe-c------------------CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 017046 118 DNL--VKFLGACK-D------------------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176 (378)
Q Consensus 118 p~i--v~l~~~~~-~------------------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH 176 (378)
.++ |+.+|+.. + ....||.||++... .+.. .-+.++.+-|..+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHHH
Confidence 455 88888761 1 12357888875533 1222 23556777788999
Q ss_pred hCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 177 ~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
..||+-+|+++.|.. + -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~---G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---G---GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---C---CEEEecccC
Confidence 999999999999986 3 379999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.19 E-value=9.5e-06 Score=83.67 Aligned_cols=195 Identities=17% Similarity=0.177 Sum_probs=134.6
Q ss_pred HHHHHHhhccCCCeeeEEeeEecC-----CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 017046 107 REVNMMSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181 (378)
Q Consensus 107 ~E~~~l~~l~hp~iv~l~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~giv 181 (378)
.|+..+..+.|+|++.++.+.-+. ...+..+++...++...+.. -+.++....+.+..++.+||.|+|+....
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 466677778999999998876432 22356688888899888876 45788999999999999999999999766
Q ss_pred eecCCCC---cEEEcCCCCceeEe--ccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHH
Q 017046 182 HRDLKPD---NLLLTPDQKSLKLA--DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256 (378)
Q Consensus 182 H~dikp~---Nill~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i 256 (378)
|.-+..+ +-.++.++ .+.++ ||+................+..+.++|.... +........|+|.+|..
T Consensus 309 ~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~------~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE------NTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred eeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCcccccccccccc------ccchhhhhhHHHHHHHH
Confidence 6655554 33334333 35555 8887766555444444455566778887643 22444555799999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 257 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 257 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
...+..|..+-....... .-++......+.+++.+|+.-++.+|+++.+++.+.
T Consensus 382 ~~~~~~~~~i~~~~~~~~-----------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAVPV-----------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HhhhhhcCcccccccchh-----------hhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 999988765422111000 011122222678899999999999999999999854
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.16 E-value=4.1e-05 Score=70.15 Aligned_cols=75 Identities=17% Similarity=0.065 Sum_probs=54.4
Q ss_pred cceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccC---CCeeeEEeeEec----CCeEEE
Q 017046 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH---DNLVKFLGACKD----PLMVIV 135 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---p~iv~l~~~~~~----~~~~lv 135 (378)
.+.||.|..+.||.....+..+++|..+..... ..+..|...|+.+.. -.+.+.++.+.+ +..++|
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~-------~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSFSTP-------GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecccccc-------hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 457999999999998876667888885431121 136789999888843 356778877643 457999
Q ss_pred EeccCCCCH
Q 017046 136 TELLPGMSL 144 (378)
Q Consensus 136 ~e~~~~~sL 144 (378)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.10 E-value=2e-05 Score=69.71 Aligned_cols=72 Identities=14% Similarity=0.220 Sum_probs=43.6
Q ss_pred ceeecccce-EEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCC---CeeeEEeeEec----CCeEEE
Q 017046 64 SKIGEGAHG-KVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD---NLVKFLGACKD----PLMVIV 135 (378)
Q Consensus 64 ~~lG~G~~g-~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---~iv~l~~~~~~----~~~~lv 135 (378)
..|+.|+.. .||+. +..+++|....... ...+.+|.+++..+... -+...++.... +..+++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~~-------~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAGY-------AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccch-------HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 456767766 59975 34577787554221 12467899888887521 23344443332 134789
Q ss_pred EeccCCCCHH
Q 017046 136 TELLPGMSLR 145 (378)
Q Consensus 136 ~e~~~~~sL~ 145 (378)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00018 Score=61.48 Aligned_cols=135 Identities=22% Similarity=0.324 Sum_probs=88.4
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCCchHH-----------HHHHHHHHHHHHHHhhcc------CCCeeeEEee
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDER-----------ALLEGRFIREVNMMSRVK------HDNLVKFLGA 126 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~------hp~iv~l~~~ 126 (378)
..||+|+.=.||.--. +....||+.......... ........+|+.....+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 4689999999997432 445688988776600000 001123556666655555 7889999999
Q ss_pred EecC-CeEEEEeccCC------CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC--C
Q 017046 127 CKDP-LMVIVTELLPG------MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--K 197 (378)
Q Consensus 127 ~~~~-~~~lv~e~~~~------~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~--~ 197 (378)
.+.+ ...+|+|.+.. .+|.+++.. +.++. . +...+-+-..||-+.+|+.+|++|.||++.... .
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 8765 56788887643 368888854 44555 3 333444556688899999999999999996432 2
Q ss_pred -ceeEec-ccc
Q 017046 198 -SLKLAD-FGL 206 (378)
Q Consensus 198 -~vkl~D-fg~ 206 (378)
.+.|+| ||.
T Consensus 159 ~~lvlIDG~G~ 169 (199)
T PF10707_consen 159 FRLVLIDGLGE 169 (199)
T ss_pred eEEEEEeCCCC
Confidence 467776 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.3e-06 Score=73.33 Aligned_cols=138 Identities=20% Similarity=0.241 Sum_probs=95.9
Q ss_pred ceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHH-----------------HHHHHHHHHHHhhcc-CCC
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALL-----------------EGRFIREVNMMSRVK-HDN 119 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~-----------------~~~~~~E~~~l~~l~-hp~ 119 (378)
.+.++.+||-|.-+.||.+-+. |++.++|..+....+...... .-...+|...|+.|. |-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4567889999999999998765 889999976554443321111 112356777788774 222
Q ss_pred -eeeEEeeEecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCc
Q 017046 120 -LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (378)
Q Consensus 120 -iv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~ 198 (378)
+..-++ ....++|||++.|..|...-.- ..+..+...+..-+--|..+|+||+|..--||+|+.++ .
T Consensus 173 pVPkpiD---~~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~-~ 240 (465)
T KOG2268|consen 173 PVPKPID---HNRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD-K 240 (465)
T ss_pred CCCCccc---ccceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC-C
Confidence 223333 3356899999999888764321 12234566677777888999999999999999999555 4
Q ss_pred eeEecccccc
Q 017046 199 LKLADFGLAR 208 (378)
Q Consensus 199 vkl~Dfg~a~ 208 (378)
++++||-...
T Consensus 241 i~vIDFPQmv 250 (465)
T KOG2268|consen 241 IVVIDFPQMV 250 (465)
T ss_pred EEEeechHhh
Confidence 9999997654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.5e-05 Score=67.38 Aligned_cols=134 Identities=19% Similarity=0.209 Sum_probs=76.8
Q ss_pred eecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCe-eeEEeeEecCCeEEEEeccCCCCH
Q 017046 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVIVTELLPGMSL 144 (378)
Q Consensus 66 lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~~lv~e~~~~~sL 144 (378)
+..|-...+|+....++.+++|........... ...+|..+++.+...++ .+++.... .++||||++|..+
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~-----~r~~E~~~l~~l~~~g~~P~~i~~~~---~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGV-----DRQREYQILQALSALGLAPKPILVNE---HWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccC-----cHHHHHHHHHHHHhcCCCCceEEEeC---CEEEEEeccCccc
Confidence 456888899998877888999976543222100 13478888888854333 23343332 3689999998665
Q ss_pred HH--------------HHhhhCC-----CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCCeeecCCC
Q 017046 145 RK--------------YLVSLRP-----NKLDLH-VALNFALDI---------ARAMDCLHA--------NGIIHRDLKP 187 (378)
Q Consensus 145 ~~--------------~l~~~~~-----~~l~~~-~~~~i~~qi---------~~~l~~lH~--------~givH~dikp 187 (378)
.. .+..... ..++.. .+..+..++ ...+..+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 32 1111111 112211 112222111 111222211 2489999999
Q ss_pred CcEEEcCCCCceeEeccccccc
Q 017046 188 DNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 188 ~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
.||+++.++ +.|+||..+..
T Consensus 156 ~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 156 YNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred CcEEEeCCC--CEEEeccccCc
Confidence 999998543 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00022 Score=63.00 Aligned_cols=72 Identities=17% Similarity=0.239 Sum_probs=46.6
Q ss_pred ceeecccceEEEEEEEC---CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCe-eeEEeeEecCCeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRYG---DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~~lv~e~~ 139 (378)
+.|..|-...+|+.... ++.|++|+......... ...+|+.+++.+...++ ++++..+. ..++|||+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~------d~~~E~~~~~~l~~~gl~P~v~~~~~---~~~l~e~i 74 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELII------DRERELRIHKLLSKHGLAPKLYATFQ---NGLIYEFI 74 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcccee------cHHHHHHHHHHHHhCCCCCeEEEEeC---CcEEEEee
Confidence 46778888999998765 47899997754322110 12368888888854333 34444332 24799999
Q ss_pred CCCCH
Q 017046 140 PGMSL 144 (378)
Q Consensus 140 ~~~sL 144 (378)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 88765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00019 Score=66.27 Aligned_cols=138 Identities=19% Similarity=0.268 Sum_probs=78.0
Q ss_pred cceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCC--eeeEEeeE-------ecCCeE
Q 017046 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--LVKFLGAC-------KDPLMV 133 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~~-------~~~~~~ 133 (378)
.+.++.|....+|+....+..+++|+........ .+..|++++..|...+ +.+.+... .++..+
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~~-------~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVKAE-------ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCCCHH-------HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 4567788888999987767788899876532222 2345666666663222 33333321 134578
Q ss_pred EEEeccCCCCHH-----------HHHhhhC--CCCC--------CHH---HHH------------HHHHHHHHHHHHHHh
Q 017046 134 IVTELLPGMSLR-----------KYLVSLR--PNKL--------DLH---VAL------------NFALDIARAMDCLHA 177 (378)
Q Consensus 134 lv~e~~~~~sL~-----------~~l~~~~--~~~l--------~~~---~~~------------~i~~qi~~~l~~lH~ 177 (378)
++++|++|..+. ..+.... ...+ ... ... .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885431 1111000 0000 000 000 001122334555532
Q ss_pred -------CCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 178 -------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 178 -------~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
.+++|+|+.+.||+++.++ .+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence 5899999999999998654 36799999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00062 Score=64.54 Aligned_cols=80 Identities=20% Similarity=0.133 Sum_probs=51.2
Q ss_pred cceeecccceEEEEEEECC--eeEEEEEeecCCCc--hHHHHHHHHHHHHHHHHhhcc---CCCeeeEEeeEecCCeEEE
Q 017046 63 GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTS--DERALLEGRFIREVNMMSRVK---HDNLVKFLGACKDPLMVIV 135 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~~~~~~lv 135 (378)
.+.||.|.+..||++...+ +.|+||.-...... ........++..|.+.|..+. ..++++++.+. +...++|
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-~~~~~lV 109 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-EELAVTV 109 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-CCCCEEE
Confidence 3679999999999998865 48999985422110 100112235667888887763 23455566653 3457899
Q ss_pred EeccCCCC
Q 017046 136 TELLPGMS 143 (378)
Q Consensus 136 ~e~~~~~s 143 (378)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=4.9e-06 Score=87.69 Aligned_cols=155 Identities=12% Similarity=0.028 Sum_probs=113.2
Q ss_pred HHHHHHHHhhccCCCeeeEEeeEe---cCCeEEEEeccCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 017046 105 FIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANG 179 (378)
Q Consensus 105 ~~~E~~~l~~l~hp~iv~l~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~g 179 (378)
...|...++...|+++.....-.. +...+..++|+.+|.+.+.+-.... ..++..-+.....+.+....-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 445555566678999887766542 2356889999999999998865322 22344444444444467777767652
Q ss_pred -----CeeecCCCCcEEEcCCCCceeEecccccc-ccccccccccCcCccccccccccccccccccccccCCCcccchhh
Q 017046 180 -----IIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 253 (378)
Q Consensus 180 -----ivH~dikp~Nill~~~~~~vkl~Dfg~a~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 253 (378)
.+|+++|+.|.+|..+. .+++.++|+.+ ............+++.|+.|+..+. -.++.++|+|..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~--------ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE--------IKFTKRSDILRR 1426 (2724)
T ss_pred cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH--------HhhhhHHHHHHH
Confidence 69999999999998555 49999999998 4444444556678888999998754 567878999999
Q ss_pred hHHHHHHHhCCCCCC
Q 017046 254 GIVLWELLTNRLPFE 268 (378)
Q Consensus 254 G~il~~ll~g~~pf~ 268 (378)
|+.+|....|..+|.
T Consensus 1427 s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHhcccHHHH
Confidence 999999998988874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00051 Score=63.16 Aligned_cols=144 Identities=22% Similarity=0.225 Sum_probs=94.3
Q ss_pred ecceeecccceEEEEEEE-CCeeEEEEEeecCCC---------------------chHHHHHHHHHHHHHHHHhhccCCC
Q 017046 62 IGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGST---------------------SDERALLEGRFIREVNMMSRVKHDN 119 (378)
Q Consensus 62 ~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~---------------------~~~~~~~~~~~~~E~~~l~~l~hp~ 119 (378)
|-..|..|--+-||.+.. .|..+|||+.+.... ...+.++..-...|++-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 445677888888999876 467799998754221 1112222223456888888887655
Q ss_pred eeeEEeeEecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeeecCCCCcEEEcCCCCc
Q 017046 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-ANGIIHRDLKPDNLLLTPDQKS 198 (378)
Q Consensus 120 iv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH-~~givH~dikp~Nill~~~~~~ 198 (378)
|.- -.-..-...+|||+|+. .+=+.. ...+...++...+..+-.+++.-+.-|- ..++||.||.--|+|+. +|.
T Consensus 228 IP~-PePIlLk~hVLVM~FlG-rdgw~a-PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~- 302 (520)
T KOG2270|consen 228 IPC-PEPILLKNHVLVMEFLG-RDGWAA-PKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK- 302 (520)
T ss_pred CCC-CCceeeecceEeeeecc-CCCCcC-cccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE-
Confidence 321 11111124579999994 332110 1112345777788888888888887775 45899999999999998 554
Q ss_pred eeEecccccccc
Q 017046 199 LKLADFGLAREE 210 (378)
Q Consensus 199 vkl~Dfg~a~~~ 210 (378)
+.|+|.+.+...
T Consensus 303 lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 303 LYIIDVSQSVEH 314 (520)
T ss_pred EEEEEccccccC
Confidence 999999987643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0013 Score=60.91 Aligned_cols=72 Identities=11% Similarity=0.026 Sum_probs=42.7
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-----CCCeeeEEe---e-EecCCeEE
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-----HDNLVKFLG---A-CKDPLMVI 134 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~l~~---~-~~~~~~~l 134 (378)
+.|+.|....+|.....+..+++|+.. ..... .+..|+.++..|. -|.++.-.+ + ...+..++
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~-~~~~~-------~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~ 99 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFE-RLTAE-------DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA 99 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEec-cCChH-------HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence 457778888999988777789999875 22211 1223455555553 233332110 0 12345789
Q ss_pred EEeccCCCC
Q 017046 135 VTELLPGMS 143 (378)
Q Consensus 135 v~e~~~~~s 143 (378)
+++|++|..
T Consensus 100 l~~~l~G~~ 108 (319)
T PRK05231 100 IVTFLEGKW 108 (319)
T ss_pred EEEecCCCC
Confidence 999998864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00053 Score=62.85 Aligned_cols=136 Identities=18% Similarity=0.177 Sum_probs=79.2
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCC--eeeEEeeE-------ecCCeEE
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--LVKFLGAC-------KDPLMVI 134 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~~-------~~~~~~l 134 (378)
+.|..|....+|+....+..+++|+... . .. ..+..|+.++..+.+.+ +.+.+... .++..++
T Consensus 20 ~~i~~G~~n~~y~v~~~~~~~vLr~~~~-~-~~------~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 20 EGISAGIENTNYFVTTDSGRYVLTLFEK-V-SA------EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred ecccCccccceEEEEeCCCcEEEEEcCC-C-Ch------HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 4677888889999877777899998765 1 11 12556777777774332 34443321 1345689
Q ss_pred EEeccCCCCHHH-----------HHhh---h----CCC-----CCCHHHH----------HHHHHHHHHHHHHHHh----
Q 017046 135 VTELLPGMSLRK-----------YLVS---L----RPN-----KLDLHVA----------LNFALDIARAMDCLHA---- 177 (378)
Q Consensus 135 v~e~~~~~sL~~-----------~l~~---~----~~~-----~l~~~~~----------~~i~~qi~~~l~~lH~---- 177 (378)
|++|++|..+.. .+.. . ... ...+... ......+..++.++..
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999998866421 1100 0 000 0000000 0011122334444443
Q ss_pred ---CCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 178 ---NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 178 ---~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
.+++|+|+.|.||+++.+ ..+.|+||+.+.
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~ 204 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGD-ELSGVIDFYFAC 204 (296)
T ss_pred cCCCcCCccCcCcccEEEeCC-ceEEEeehhhhc
Confidence 379999999999999954 335799998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00066 Score=62.43 Aligned_cols=73 Identities=26% Similarity=0.342 Sum_probs=45.9
Q ss_pred ceeecccceEEEEEEEC--------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCe-eeEEeeEecCCeEE
Q 017046 64 SKIGEGAHGKVYEGRYG--------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVI 134 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~~l 134 (378)
+.|..|-...||+.... ++.+++|+......... ...+|..++..+...++ .++++.+.+ .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~------~r~~E~~~~~~l~~~g~~P~~~~~~~~---~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLI------DRERELVVFARLSERNLGPKLYGIFPN---GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCccee------chHHHHHHHHHHHhCCCCCceEEEeCC---Cc
Confidence 45666777889988754 37899999765432211 23478888887753333 345555433 35
Q ss_pred EEeccCCCCHH
Q 017046 135 VTELLPGMSLR 145 (378)
Q Consensus 135 v~e~~~~~sL~ 145 (378)
|++|++|.++.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 88998887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00059 Score=63.38 Aligned_cols=77 Identities=19% Similarity=0.135 Sum_probs=46.6
Q ss_pred eeecccceEEEEEEECC--eeEEEEEeecCCC--chHHHHHHHHHHHHHHHHhhcc--CCCeeeEEeeEecCCeEEEEec
Q 017046 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGST--SDERALLEGRFIREVNMMSRVK--HDNLVKFLGACKDPLMVIVTEL 138 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~~lv~e~ 138 (378)
.||-|....||++...+ +.|+||.-..... .........|..-|...|+... -|..++-+-.+......+|||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 57999999999998764 5799996432111 0111111234456777776663 4544444444445566799999
Q ss_pred cCC
Q 017046 139 LPG 141 (378)
Q Consensus 139 ~~~ 141 (378)
++.
T Consensus 82 L~~ 84 (370)
T TIGR01767 82 LSH 84 (370)
T ss_pred Ccc
Confidence 854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00077 Score=64.49 Aligned_cols=152 Identities=20% Similarity=0.340 Sum_probs=90.9
Q ss_pred HHHHHHHHhhccCCCeeeEEeeEec--CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 017046 105 FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182 (378)
Q Consensus 105 ~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH 182 (378)
++-..++++.+.|+|...++++... ....+|||++ +.||.+.+.... +-.. ++ + .+|+.|
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~-------s~---~----~~~~~~ 90 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDE-------SL---L----AHGVLH 90 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchh-------hh---c----ccccce
Confidence 5677788999999999999998754 3578999999 789999887521 1111 11 1 223322
Q ss_pred ecCCCCcEEEcCCCCceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh
Q 017046 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262 (378)
Q Consensus 183 ~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~ 262 (378)
- |+ ++.+| -++.. | | .+..+++|||++|.++.++.-
T Consensus 91 ~-----~~--------~~~td-~~~t~---------------~--~-------------~~~~pKsdVwsl~~i~~el~L 126 (725)
T KOG1093|consen 91 L-----NI--------IYITD-HFLTK---------------Y--P-------------SPIGPKSDVWSLGFIILELYL 126 (725)
T ss_pred e-----hh--------hhccc-ccccc---------------C--C-------------CCCCcchhhhhHHHHHHHHHH
Confidence 2 11 33344 01000 0 1 112259999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCC-----------CCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 263 NRLPFEGMSNLQAAYAAAFKHARPG-----------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 263 g~~pf~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
|...|......+..... .+..... +...++.....+...|+-..|..||...++.+
T Consensus 127 ~~~l~~~~~~s~~l~~i-~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 127 GISLEAELTESEYLEIL-LKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred hhHHHHHHHHHHHHHHH-HHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 98877654443222211 1111110 11124455667888999999988886544433
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0013 Score=59.56 Aligned_cols=31 Identities=29% Similarity=0.533 Sum_probs=24.9
Q ss_pred CCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 179 givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
.++|+|++|.|||++.++...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999985444356999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0017 Score=60.51 Aligned_cols=137 Identities=16% Similarity=0.215 Sum_probs=76.9
Q ss_pred ceeecccceEEEEEEECC-----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCe-eeEEeeEecCCeEEEEe
Q 017046 64 SKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVIVTE 137 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~~lv~e 137 (378)
+.|..|-...+|+....+ ..|++|+........- .-.+|..+++.+..-++ .++++++..+ +|.+
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I------dR~~E~~il~~l~~~gl~P~~l~~~~~G---~i~~ 90 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI------DRERELQAIKYLSAAGFGAKLLGVFGNG---MIQS 90 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe------chHHHHHHHHHHHhcCCCCceeEEeCCc---Eeeh
Confidence 345558888899886543 3789998765432111 12378888888865444 3455555332 5889
Q ss_pred ccCCCCHHH--------------HHhhhCCCC------C-CHHHHHHHHHHH----------------------HHHHHH
Q 017046 138 LLPGMSLRK--------------YLVSLRPNK------L-DLHVALNFALDI----------------------ARAMDC 174 (378)
Q Consensus 138 ~~~~~sL~~--------------~l~~~~~~~------l-~~~~~~~i~~qi----------------------~~~l~~ 174 (378)
|++|..|.. .+....... . ....+..+..++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 987765521 111111111 1 122222222221 111111
Q ss_pred ---HH-hCC----CeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 175 ---LH-ANG----IIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 175 ---lH-~~g----ivH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+. ..+ ++|.|+.+.|||++.+++.++++||..|..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 122 799999999999975545699999998753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00092 Score=62.89 Aligned_cols=79 Identities=22% Similarity=0.171 Sum_probs=49.3
Q ss_pred cceeecccceEEEEEEEC--CeeEEEEEeecCCC-chHHHHHHHHHHHHHHHHhhcc--CCCeeeEEeeEecCCeEEEEe
Q 017046 63 GSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGST-SDERALLEGRFIREVNMMSRVK--HDNLVKFLGACKDPLMVIVTE 137 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~~lv~e 137 (378)
.+.||-|.-..||++... ++.|+||.-..... .........|..-|...|+... -|..++=+-++......+|||
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vME 113 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVME 113 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHH
Confidence 467899999999999874 56799986432111 1111122335567777777763 455555444444456678999
Q ss_pred ccCC
Q 017046 138 LLPG 141 (378)
Q Consensus 138 ~~~~ 141 (378)
+++.
T Consensus 114 dL~~ 117 (409)
T PRK12396 114 DLSD 117 (409)
T ss_pred hCcc
Confidence 9854
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0027 Score=59.51 Aligned_cols=137 Identities=18% Similarity=0.278 Sum_probs=77.8
Q ss_pred ceeecccceEEEEEEEC------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCee-eEEeeEecCCeEEEE
Q 017046 64 SKIGEGAHGKVYEGRYG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV-KFLGACKDPLMVIVT 136 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~l~~~~~~~~~~lv~ 136 (378)
..|-.|-.-.+|+.... ++.|++|+........- . -.+|..+++.+..-++- ++++.+..+ .|.
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-----d-R~~E~~~~~~l~~~gl~P~~~~~~~~g---~v~ 112 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-----D-RDDEIRTFECMSRHGQGPRLLGRFPNG---RVE 112 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-----c-hHHHHHHHHHHHHcCCCCceEEEECCc---eEE
Confidence 34555888999998642 26799998765432111 1 24688888888644443 455655443 578
Q ss_pred eccCCCCHHHH--------------Hh---hhC-CC-C-CC-HHHHHHHHHHH-----------------HHHHHHH---
Q 017046 137 ELLPGMSLRKY--------------LV---SLR-PN-K-LD-LHVALNFALDI-----------------ARAMDCL--- 175 (378)
Q Consensus 137 e~~~~~sL~~~--------------l~---~~~-~~-~-l~-~~~~~~i~~qi-----------------~~~l~~l--- 175 (378)
+|++|.+|... +. ... .. . .+ ...+..+..++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987665321 11 000 00 0 11 22222222111 1111111
Q ss_pred -H----hCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 176 -H----ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 176 -H----~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
. ...++|+|+++.|||++.+...+.|+||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 225899999999999985445699999988753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.014 Score=53.54 Aligned_cols=144 Identities=18% Similarity=0.237 Sum_probs=78.1
Q ss_pred cceeecccceEEEEEEECCeeEEEEEeec-CCCchHHHHHHHHHHHHHHHHhhccCC--CeeeEEeeEecC---CeEEEE
Q 017046 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNR-GSTSDERALLEGRFIREVNMMSRVKHD--NLVKFLGACKDP---LMVIVT 136 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~-~~~~~~~~~~~~~~~~E~~~l~~l~hp--~iv~l~~~~~~~---~~~lv~ 136 (378)
++.+-.|..-.+|....+++.+++. ... ...... .....+|..+++.+.-- -+...++.|.++ ..+.||
T Consensus 30 v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~----~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 30 VEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVES----AHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeccCCcccceEEEecCCceEEEe-cCCccccchh----hhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 3444445555667666668888888 332 111111 12355778887776431 223345566443 468999
Q ss_pred eccCCCCHHHHH------------------hhhCC------------CCCCHHHHHHHHH--------------HHHHHH
Q 017046 137 ELLPGMSLRKYL------------------VSLRP------------NKLDLHVALNFAL--------------DIARAM 172 (378)
Q Consensus 137 e~~~~~sL~~~l------------------~~~~~------------~~l~~~~~~~i~~--------------qi~~~l 172 (378)
+|++|..+.+.+ ..... +.....++..+.. .+..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 999884332211 11000 0000011111111 112223
Q ss_pred HHHHhC--------CCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 173 DCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 173 ~~lH~~--------givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
.+|+.+ .++|+|+.+.|++++.++. +=+.||+++...+.
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~-~gVlDwe~~~lGDP 231 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP-TGVLDWELATLGDP 231 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe-eEEEeccccccCCc
Confidence 344433 4899999999999997666 88999999875443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.033 Score=52.87 Aligned_cols=78 Identities=14% Similarity=0.083 Sum_probs=49.9
Q ss_pred cceeecccceEEEEEEECCeeEEEEEeecCCC--chHHHHHHHHHHHHHHHHhhcc---CCCeeeEEeeEecCCeEEEEe
Q 017046 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGST--SDERALLEGRFIREVNMMSRVK---HDNLVKFLGACKDPLMVIVTE 137 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~~~~~~lv~e 137 (378)
.+.||.|....||+....++.|+||.-..... .........+-..|+..|+.+. ..++.+++.++.+ ..+++||
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded-~~vlvME 115 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT-MALIGMR 115 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC-CCEEEEe
Confidence 46789999999999887777899997652211 0000001123345566666553 2467778887764 4678899
Q ss_pred ccCC
Q 017046 138 LLPG 141 (378)
Q Consensus 138 ~~~~ 141 (378)
++++
T Consensus 116 ~L~~ 119 (418)
T PLN02756 116 YLEP 119 (418)
T ss_pred ecCC
Confidence 9976
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.048 Score=50.23 Aligned_cols=29 Identities=28% Similarity=0.502 Sum_probs=24.5
Q ss_pred CCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 178 ~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
.+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence 47899999999999985 4 48899998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.015 Score=50.01 Aligned_cols=115 Identities=12% Similarity=0.122 Sum_probs=67.3
Q ss_pred ccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEEEeccCCCCHHHH
Q 017046 69 GAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKY 147 (378)
Q Consensus 69 G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv~e~~~~~sL~~~ 147 (378)
|+-++.-.++.+=.+..+|++..-...-.. .-|..+..++.+++ .|+++..- +. ..-++.|+|.....
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~~----~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCIND----ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--- 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcccch----hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---
Confidence 334444444333234455555433332111 23667888888875 37777632 22 34588999843211
Q ss_pred HhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 148 LVSLRPNKLDLHVALNFALDIARAMDCLHAN--GIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 148 l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
... -.+.. =+.+|.-.|+. +.+|||..|+||+-|..|. +||.|-+..
T Consensus 142 --------~~~---N~i~a-gi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~-lKlVDP~~L 190 (308)
T PF07387_consen 142 --------NFS---NFITA-GIKDLMDFHSENQHCLHGDCNPDNIMCDKFGY-LKLVDPVCL 190 (308)
T ss_pred --------chh---HHHHH-hHHHHHHhhccCCCeecCCCChhheeecCCCC-EEecChhhh
Confidence 111 11111 14667788843 6999999999999997765 999998754
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.078 Score=50.34 Aligned_cols=73 Identities=21% Similarity=0.249 Sum_probs=43.2
Q ss_pred ceeecccceEEEEEEECC---ee-----EEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCee-eEEeeEecCCeEE
Q 017046 64 SKIGEGAHGKVYEGRYGD---RI-----VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV-KFLGACKDPLMVI 134 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~---~~-----vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~l~~~~~~~~~~l 134 (378)
+.|..|-...+|++...+ .. |.+++........ -.-.+|+++++.+...++- ++++.+.. ++
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~------IdR~~E~~i~~~Ls~~glgP~l~~~f~~---g~ 126 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV------IDNDLQYNIAKLLGDNNFGPKIIGRFGD---FT 126 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE------eccHHHHHHHHHHHhCCCCCeEEEecCC---EE
Confidence 456568899999986532 12 3433321111100 0123788999999765554 45665543 58
Q ss_pred EEeccCCCCHH
Q 017046 135 VTELLPGMSLR 145 (378)
Q Consensus 135 v~e~~~~~sL~ 145 (378)
+.||++|.+|.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 99999887653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.15 Score=47.03 Aligned_cols=30 Identities=17% Similarity=0.189 Sum_probs=25.6
Q ss_pred CCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 179 givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+++|+|+.++|+|++.++. +.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~-~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG-GYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC-EEEEEhhhccc
Confidence 7999999999999986554 88999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.074 Score=49.30 Aligned_cols=136 Identities=25% Similarity=0.357 Sum_probs=79.7
Q ss_pred eeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCC---eee---EEeeE---ecC--CeE
Q 017046 65 KIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN---LVK---FLGAC---KDP--LMV 133 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~---iv~---l~~~~---~~~--~~~ 133 (378)
.|.+ .-..||+....+..+++|+.... .... .+..|+..+..|.-.+ .++ +-|.. ... +.+
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~~------~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRYILKIYRPG-WTRA------EIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred cccc-ccCceEEEEecCCCeEEEEecCC-CCHH------HHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 3444 55678988888777799999876 3222 2557777787773222 122 11111 123 677
Q ss_pred EEEeccCCCCHHH------------HH-------hhh---CCCC---CCHH----HH---------HHHHHHHHHHHHHH
Q 017046 134 IVTELLPGMSLRK------------YL-------VSL---RPNK---LDLH----VA---------LNFALDIARAMDCL 175 (378)
Q Consensus 134 lv~e~~~~~sL~~------------~l-------~~~---~~~~---l~~~----~~---------~~i~~qi~~~l~~l 175 (378)
-+++|++|..+.. ++ ... .+.. ..+. .. .....++...+..+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999999887762 11 000 0000 1111 00 11334455555555
Q ss_pred HhC--------C--CeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 176 HAN--------G--IIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 176 H~~--------g--ivH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
.+. + +||+|+.|.||+++.++..+-++||+-+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 543 3 99999999999999654337799999774
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.05 Score=49.49 Aligned_cols=72 Identities=14% Similarity=0.081 Sum_probs=44.8
Q ss_pred cceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc---CCCeeeEEeeEe-cCCeEEEEec
Q 017046 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---HDNLVKFLGACK-DPLMVIVTEL 138 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~-~~~~~lv~e~ 138 (378)
.+.|+.|....+|+....++.+.||+-...... .|..|..-|+.|. --.+.+.+++.. ++..+|||||
T Consensus 22 ~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~~--------~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDTDGGSYFVKVNSESGRD--------MFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp EEEE--SSSSEEEEEETTS-EEEEEEEEGGGCC--------HHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eEecCCCChhheEEEECCCccEEEEecChhhHH--------HHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 467889999999999988899999998732221 3667887777773 334556777664 3456899999
Q ss_pred cCCC
Q 017046 139 LPGM 142 (378)
Q Consensus 139 ~~~~ 142 (378)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 9766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.21 Score=48.40 Aligned_cols=74 Identities=16% Similarity=0.175 Sum_probs=46.1
Q ss_pred ecceeecccceEEEEEEEC----------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCee-eEEeeEecC
Q 017046 62 IGSKIGEGAHGKVYEGRYG----------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV-KFLGACKDP 130 (378)
Q Consensus 62 ~~~~lG~G~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~l~~~~~~~ 130 (378)
-++.|..|-.-.+|+.... ++.|.+++.......-. .-..|..+++.+..-+|- ++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI------dR~~E~~v~~~ls~~gi~P~l~~~f~-- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY------NPISEFEVYKTMSKYRIAPQLLNTFS-- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee------CHHHHHHHHHHHHHCCCCCceEEEeC--
Confidence 4456777888888988653 35788888765432211 123677777777654443 3555553
Q ss_pred CeEEEEeccCCCCH
Q 017046 131 LMVIVTELLPGMSL 144 (378)
Q Consensus 131 ~~~lv~e~~~~~sL 144 (378)
.+.|.+|++|.+|
T Consensus 181 -gg~I~efi~g~~l 193 (442)
T PTZ00296 181 -GGRIEEWLYGDPL 193 (442)
T ss_pred -CCEEEEeeCCccC
Confidence 2467899987644
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.12 Score=44.78 Aligned_cols=74 Identities=18% Similarity=0.194 Sum_probs=50.3
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc---CCCeeeEEeeEe-cCCeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---HDNLVKFLGACK-DPLMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~-~~~~~lv~e~~ 139 (378)
+.+.-|.--..|...+....+.+|+-.... ...|..|+.-|..|. .-.+.+.+.+.. ..+.|+||||+
T Consensus 22 ~~v~gG~inea~~v~dg~~~~FvK~n~~~~--------~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLRDGTDPFFVKCNQREQ--------LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEeecCCcceEEEecchhh--------HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 345556667778888888899999754322 124778887777764 345666676654 34789999999
Q ss_pred CCCCHH
Q 017046 140 PGMSLR 145 (378)
Q Consensus 140 ~~~sL~ 145 (378)
+-+.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 876553
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.054 Score=50.91 Aligned_cols=61 Identities=20% Similarity=0.280 Sum_probs=41.6
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeecCCCCcEEEcCC
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL-HANGIIHRDLKPDNLLLTPD 195 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~l-H~~givH~dikp~Nill~~~ 195 (378)
.+++=+|..|.++..++.. ...++.....++.--+.|+-.+ --.+++|.|+.|.||++..+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4566678888888888865 3345545555555445554433 34589999999999999643
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.62 Score=43.30 Aligned_cols=28 Identities=32% Similarity=0.395 Sum_probs=23.7
Q ss_pred CCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 178 ~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
.+++|+|+.+.|||++ + + +.|+||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~-~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-G-PHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-C-cEEEeCCCCC
Confidence 3789999999999995 4 3 7899999774
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.26 Score=52.99 Aligned_cols=32 Identities=34% Similarity=0.533 Sum_probs=25.4
Q ss_pred CCCeeecCCCCcEEEcCCCC-cee-Eeccccccc
Q 017046 178 NGIIHRDLKPDNLLLTPDQK-SLK-LADFGLARE 209 (378)
Q Consensus 178 ~givH~dikp~Nill~~~~~-~vk-l~Dfg~a~~ 209 (378)
.++||+|+.+.|||++.++. .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 47999999999999986541 344 999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.15 Score=47.33 Aligned_cols=71 Identities=23% Similarity=0.332 Sum_probs=54.7
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+.|++|++. |++|.- + .....+++..++.+.+..+.-+... .+-|||+.-.||||+ +|. |.|+||-+++.
T Consensus 300 y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn-vtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN-VTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc-eEEEEeeeeec
Confidence 567888886 666642 2 2246778888998888877777655 689999999999999 554 99999999985
Q ss_pred c
Q 017046 210 E 210 (378)
Q Consensus 210 ~ 210 (378)
.
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 3
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 378 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-37 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-37 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-31 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-31 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-31 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-29 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-29 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-29 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-29 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-29 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-29 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-29 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-29 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-29 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-29 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-29 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-29 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-29 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-29 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-28 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-28 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-28 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-28 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-28 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-28 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-28 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-28 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-28 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-28 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-28 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-28 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-28 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-28 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-28 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-28 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-28 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-28 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-28 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-28 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-28 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-27 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-27 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-27 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-27 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-27 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-27 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-27 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-27 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-27 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-27 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-27 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-27 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-27 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-27 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-27 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-27 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-27 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-27 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-27 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-27 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-27 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-27 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-27 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-27 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-27 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-27 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-27 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-27 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-27 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-27 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-27 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-27 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-27 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-27 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-27 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-27 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-26 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-26 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-26 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-26 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-26 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-26 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-26 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-26 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-26 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-26 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-26 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-25 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-25 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-25 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-25 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-25 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-25 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-25 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-25 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-25 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-25 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-25 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-25 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-25 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-25 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-25 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-25 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-24 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-24 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-24 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-24 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-24 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-24 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-24 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-24 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-24 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-24 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-24 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-24 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-24 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-24 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-24 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-24 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-24 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-24 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-24 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-24 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-24 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-24 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-24 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-24 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-24 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-24 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-24 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-24 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-24 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-24 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-24 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-24 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-24 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-24 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-24 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-24 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-24 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-24 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-24 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-24 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-24 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-24 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-24 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-24 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-24 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-24 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-24 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-24 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-24 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-24 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-24 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-24 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-24 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-24 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-24 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-24 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-23 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-23 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-23 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-23 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-23 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-23 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-23 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-23 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-23 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-23 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-23 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-23 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-23 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-23 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-23 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-23 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-23 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-23 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-23 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-23 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-23 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-22 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-22 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-22 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-22 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-22 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-21 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-21 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-21 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-21 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-20 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-20 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-20 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-20 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-20 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-20 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-20 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-20 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-20 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-20 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-20 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-20 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-20 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-20 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-20 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-20 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-20 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-20 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-20 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-20 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-20 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-20 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-20 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-20 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-20 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-20 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-20 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-20 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-20 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-20 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-20 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-20 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-20 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-19 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-19 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-19 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-19 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-19 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-19 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-19 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-19 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-19 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-19 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-18 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-18 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-18 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-18 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-17 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-17 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-16 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-16 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-16 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-16 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-16 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-16 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-16 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-16 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-16 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-16 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-16 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-16 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-16 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-15 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-15 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-14 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-14 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-12 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-09 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-08 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-08 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 367 bits (943), Expect = e-127
Identities = 101/304 (33%), Positives = 156/304 (51%), Gaps = 17/304 (5%)
Query: 33 SRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRG 92
+ ++ + + L I KIG G+ G V+ + VA+K+L
Sbjct: 12 DYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQ 71
Query: 93 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL-VS 150
ER F+REV +M R++H N+V F+GA + P + IVTE L SL + L S
Sbjct: 72 DFHAER---VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS 128
Query: 151 LRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
+LD L+ A D+A+ M+ LH I+HR+LK NLL+ + ++K+ DFGL+R
Sbjct: 129 GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSR 187
Query: 209 EETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
+ T + GT WMAPE+ + N K DVYSFG++LWEL T + P+
Sbjct: 188 LKASTFLSSKSAAGTPEWMAPEVL--------RDEPSNEKSDVYSFGVILWELATLQQPW 239
Query: 268 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327
++ Q A FK R +P +++P +A I++ CW +P RPSF+ I+ +L + +
Sbjct: 240 GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
Query: 328 LRPP 331
PP
Sbjct: 300 AVPP 303
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 365 bits (940), Expect = e-127
Identities = 89/297 (29%), Positives = 145/297 (48%), Gaps = 22/297 (7%)
Query: 40 GSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDR--IVAIKVLNRGSTSDE 97
G++ + R + + +IG+G G V++GR +VAIK L G + E
Sbjct: 1 GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 98 RALLEGR--FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNK 155
++E F REV +MS + H N+VK G +P +V E +P L L+ + +
Sbjct: 61 TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRLLD-KAHP 118
Query: 156 LDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKS----LKLADFGLARE 209
+ V L LDIA ++ + I+HRDL+ N+ L ++ K+ADFGL+++
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
Query: 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
++ G ++WMAPE E++ Y K D YSF ++L+ +LT PF+
Sbjct: 179 SV--HSVSGLLGNFQWMAPETIG------AEEESYTEKADTYSFAMILYTILTGEGPFDE 230
Query: 270 MSNLQAAYAAA--FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
S + + + RP +PED P L +++ CW DP RP FS I++ L+
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 358 bits (922), Expect = e-124
Identities = 94/282 (33%), Positives = 136/282 (48%), Gaps = 24/282 (8%)
Query: 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
L +D L + IG G GKVY + VA+K D +E +E +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIE-NVRQEAKLF 60
Query: 113 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+ +KH N++ G C K+P + +V E G L + L ++ + +N+A+ IAR
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARG 117
Query: 172 MDCLHANG---IIHRDLKPDNLLLT-------PDQKSLKLADFGLAREETVTEMMTAETG 221
M+ LH IIHRDLK N+L+ K LK+ DFGLARE T M+A G
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AG 176
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281
Y WMAPE+ ++ DV+S+G++LWELLT +PF G+ L AY A
Sbjct: 177 AYAWMAPEVI--------RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228
Query: 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
+P A +++ CW DP+ RPSF+ I+ L
Sbjct: 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 358 bits (922), Expect = e-124
Identities = 90/307 (29%), Positives = 148/307 (48%), Gaps = 23/307 (7%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
++D K + + +G GA G V + ++ + VAIK + S FI E+ +S
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKA-------FIVELRQLS 56
Query: 114 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNFALDIARAM 172
RV H N+VK GAC +P+ +V E G SL L P A+++ L ++ +
Sbjct: 57 RVNHPNIVKLYGACLNPVC-LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 173 DCLHA---NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 229
LH+ +IHRDLKP NLLL LK+ DFG A + + MT G+ WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMAPE 173
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAAFKHARPGL 288
++ E +Y+ K DV+S+GI+LWE++T R PF+ + A RP L
Sbjct: 174 VF--------EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225
Query: 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSN 348
+++ + ++ CW +DP+ RPS +I++++ + + + +
Sbjct: 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGED 285
Query: 349 GAMTEFS 355
G + +
Sbjct: 286 GRVEPYV 292
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-123
Identities = 72/281 (25%), Positives = 127/281 (45%), Gaps = 18/281 (6%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIRE 108
+++ +D K L +K+ E G++++GR+ + +KVL S F E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR---KSRDFNEE 57
Query: 109 VNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
+ H N++ LGAC+ P ++T +P SL L +D A+ FA
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 166 LDIARAMDCLHA--NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 223
LD+AR M LH I L ++++ + + +++ +
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQ----SPGRMYAP 172
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283
W+APE L++ + D++SF ++LWEL+T +PF +SN++ A +
Sbjct: 173 AWVAPEA-----LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG 227
Query: 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
RP +P ISP ++ +++ C EDP RP F I+ +L
Sbjct: 228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-121
Identities = 77/288 (26%), Positives = 139/288 (48%), Gaps = 19/288 (6%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + L IG IG+G G+VY GR+ G+ VAI++++ ++++ F REV
Sbjct: 30 IPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQ---LKAFKREVMAYR 84
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+ +H+N+V F+GAC P + I+T L G +L + LD++ A +I + M
Sbjct: 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGM 143
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT------EMMTAETGTYRWM 226
LHA GI+H+DLK N+ D + + DFGL V + + + G +
Sbjct: 144 GYLHAKGILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 227 APELYSTVTL-RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285
APE+ ++ + +K ++ DV++ G + +EL PF+ + +
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG-TGMK 260
Query: 286 PGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332
P L + + +++ I+ CW + RP+F++++ ML R S
Sbjct: 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-118
Identities = 85/279 (30%), Positives = 144/279 (51%), Gaps = 20/279 (7%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + +G +IG G+ G VY+G++ GD VA+K+LN + + + F EV ++
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQ---QLQAFKNEVGVLR 75
Query: 114 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+ +H N++ F+G P + IVT+ G SL +L + K ++ ++ A AR MD
Sbjct: 76 KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMD 134
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPEL 230
LHA IIHRDLK +N+ L + ++K+ DFGLA E++ +G+ WMAPE+
Sbjct: 135 YLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA-AFKHARPGL- 288
+R + Y+ + DVY+FGIVL+EL+T +LP+ ++N P L
Sbjct: 194 -----IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248
Query: 289 --PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+ + ++ C + + RPSF +I+ +
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 5e-99
Identities = 84/309 (27%), Positives = 131/309 (42%), Gaps = 37/309 (11%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
P L G +G+G G+ + + ++ +K L R +R F++EV +M
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT-----FLKEVKVM 61
Query: 113 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
++H N++KF+G KD + +TE + G +LR + S ++ ++FA DIA
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASG 120
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---------------M 216
M LH+ IIHRDL N L+ + K++ +ADFGLAR +
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276
G WMAPE+ + + Y+ KVDV+SFGIVL E++
Sbjct: 180 YTVVGNPYWMAPEM-----ING---RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231
Query: 277 YAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL---RPPS 332
+ + P + P I C DP RPSF ++ L L P
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
Query: 333 PSVPESDTN 341
P + + D
Sbjct: 292 PQLEQLDRG 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 4e-92
Identities = 75/328 (22%), Positives = 132/328 (40%), Gaps = 59/328 (17%)
Query: 39 NGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDER 98
+GS + L + R K + + +IG+G +G+V+ G++ VA+KV T++E
Sbjct: 21 SGSGSGLPLLVQR---TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVF---FTTEEA 74
Query: 99 ALLEGRFIRE--VNMMSRVKHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSL 151
+ + RE + ++H+N++ F+ A + ++T+ SL YL
Sbjct: 75 S-----WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--- 126
Query: 152 RPNKLDLHVALNFALDIARAMDCLHA--------NGIIHRDLKPDNLLLTPDQKSLKLAD 203
+ LD L A + LH I HRDLK N+L+ + + +AD
Sbjct: 127 KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIAD 185
Query: 204 FGLAREE-----TVTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVL 257
GLA + V GT R+M PE L ++ + D+YSFG++L
Sbjct: 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ---SYIMADMYSFGLIL 242
Query: 258 WELLT----------NRLPFEGMSNLQAAY-----AAAFKHARPGLPE-----DISPDLA 297
WE+ +LP+ + +Y K RP P + +
Sbjct: 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG 302
Query: 298 FIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
++ CW +P R + ++ + L
Sbjct: 303 KLMTECWAHNPASRLTALRVKKTLAKMS 330
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 8e-91
Identities = 72/305 (23%), Positives = 129/305 (42%), Gaps = 54/305 (17%)
Query: 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIRE--VNMMSRV 115
+ + + +G+G +G+V+ G + VA+K+ S+ DE++ + RE + +
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIF---SSRDEKS-----WFRETELYNTVML 59
Query: 116 KHDNLVKFLGAC-----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+H+N++ F+ + + ++T SL YL + LD L L IA
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIAS 116
Query: 171 AMDCLHA--------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-----T 217
+ LH I HRDLK N+L+ + +AD GLA + +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----------NRLPF 267
GT R+MAPE+ Q + +VD+++FG+VLWE+ + PF
Sbjct: 176 PRVGTKRYMAPEVLDETI--QVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 268 EGMSNLQAAY-----AAAFKHARPGLPEDISPD-----LAFIVQSCWVEDPNLRPSFSQI 317
+ ++ RP +P D LA +++ CW ++P+ R + +I
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 318 IRMLN 322
+ L
Sbjct: 294 KKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 9e-87
Identities = 67/306 (21%), Positives = 125/306 (40%), Gaps = 52/306 (16%)
Query: 56 DPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV 115
+ + + IG+G G+V+ G++ VA+K+ + S + E E+ +
Sbjct: 40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFRE----AEIYQTVML 93
Query: 116 KHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+H+N++ F+ A + +V++ SL YL + + + AL A
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTAS 150
Query: 171 AMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLADFGLAREE-----TVTEMMT 217
+ LH I HRDLK N+L+ + + +AD GLA T+
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 218 AETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----------NRLP 266
GT R+MAPE L ++ ++ E + D+Y+ G+V WE+ +LP
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFE---SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 267 FEGMSNLQAAY-----AAAFKHARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFSQ 316
+ + + + RP +P + +A I++ CW + R + +
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326
Query: 317 IIRMLN 322
I + L+
Sbjct: 327 IKKTLS 332
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 250 bits (639), Expect = 7e-81
Identities = 83/341 (24%), Positives = 135/341 (39%), Gaps = 65/341 (19%)
Query: 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNM 111
+D L + IG G +G VY+G +R VA+KV S ++ + FI E N+
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVF---SFANRQN-----FINEKNI 58
Query: 112 --MSRVKHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 163
+ ++HDN+ +F+ + ++V E P SL KY L + D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY---LSLHTSDWVSSCR 115
Query: 164 FALDIARAMDCLHA---------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214
A + R + LH I HRDL N+L+ D + ++DFGL+ T
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNR 174
Query: 215 M---------MTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL--- 261
+ +E GT R+MAPE L V LR E +VD+Y+ G++ WE+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE--SALKQVDMYALGLIYWEIFMRC 232
Query: 262 TNRLPFEGMSNLQAAYAA---------------AFKHARPGLPEDISPD------LAFIV 300
T+ P E + Q A+ + + RP PE + L +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 301 QSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTN 341
+ CW +D R + + + P + +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHH 333
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 4e-78
Identities = 73/310 (23%), Positives = 118/310 (38%), Gaps = 52/310 (16%)
Query: 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
L L + G G V++ + + VA+K+ + EV +
Sbjct: 19 LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQ------NEYEVYSL 72
Query: 113 SRVKHDNLVKFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
+KH+N+++F+GA K V ++T SL +L + N + + + A
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAET 129
Query: 168 IARAMDCLHAN----------GIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTE 214
+AR + LH + I HRD+K N+LL + + +ADFGLA
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAG 188
Query: 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-----------N 263
+ GT R+MAPE+ Q + ++D+Y+ G+VLWEL +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRD---AFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 264 RLPFEGM-----SNLQAAYAAAFKHARPGLPEDISPD-----LAFIVQSCWVEDPNLRPS 313
LPFE S K RP L + L ++ CW D R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 314 FSQIIRMLNA 323
+ +
Sbjct: 306 AGCVGERITQ 315
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 4e-70
Identities = 87/288 (30%), Positives = 139/288 (48%), Gaps = 34/288 (11%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
++ + L +G +IG G G+V+ GR + +VA+K D +A +F++E ++
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA----KFLQEARIL 166
Query: 113 SRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+ H N+V+ +G C K P+ IV EL+ G +L + +L + L D A
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAA 224
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT----YRWM 226
M+ L + IHRDL N L+T ++ LK++DFG++REE A G +W
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGV-YAASGGLRQVPVKWT 282
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 285
APE L G Y+++ DV+SFGI+LWE + P+ +SN Q +
Sbjct: 283 APE-----ALNYG---RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----TREFVE 329
Query: 286 PG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329
G PE + +++ CW +P RPSFS I + L + R
Sbjct: 330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-69
Identities = 85/296 (28%), Positives = 139/296 (46%), Gaps = 36/296 (12%)
Query: 40 GSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERA 99
GS+ A ++ K L + IG+G G V G Y VA+K + +T+
Sbjct: 3 GSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-- 60
Query: 100 LLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLD 157
F+ E ++M++++H NLV+ LG + + IVTE + SL YL S + L
Sbjct: 61 -----FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG 115
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 217
L F+LD+ AM+ L N +HRDL N+L++ + K++DFGL +E + +
Sbjct: 116 GDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS-----S 169
Query: 218 AETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNL 273
+ +W APE LR+ ++ K DV+SFGI+LWE+ + R+P+ +
Sbjct: 170 TQDTGKLPVKWTAPE-----ALREK---KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 221
Query: 274 QAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
G P+ P + ++++CW D +RPSF Q+ L
Sbjct: 222 D-----VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-69
Identities = 85/314 (27%), Positives = 142/314 (45%), Gaps = 36/314 (11%)
Query: 22 QHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD 81
G + + V G++ A ++ K L + IG+G G V G Y
Sbjct: 157 TTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRG 216
Query: 82 RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELL 139
VA+K + +T+ F+ E ++M++++H NLV+ LG + + IVTE +
Sbjct: 217 NKVAVKCIKNDATAQA-------FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199
SL YL S + L L F+LD+ AM+ L N +HRDL N+L++ +
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVA 328
Query: 200 KLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256
K++DFGL +E + + + +W APE LR+ ++ K DV+SFGI+
Sbjct: 329 KVSDFGLTKEAS-----STQDTGKLPVKWTAPE-----ALREK---KFSTKSDVWSFGIL 375
Query: 257 LWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLR 311
LWE+ + R+P+ + G P+ P + ++++CW D R
Sbjct: 376 LWEIYSFGRVPYPRIPLKD-----VVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATR 430
Query: 312 PSFSQIIRMLNAFL 325
P+F Q+ L
Sbjct: 431 PTFLQLREQLEHIR 444
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-68
Identities = 90/281 (32%), Positives = 144/281 (51%), Gaps = 32/281 (11%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
V + L + ++G G G+V+ G Y G VA+K L +GS S + F+ E N+M
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA------FLAEANLMK 63
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+++H LV+ ++P+ I+TE + SL +L + KL ++ L+ A IA M
Sbjct: 64 QLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE 229
+ IHRDL+ N+L++ D S K+ADFGLAR E TA G +W APE
Sbjct: 123 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 180
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG- 287
+ G + K DV+SFGI+L E++T+ R+P+ GM+N + ++ G
Sbjct: 181 -----AINYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQNLERGY 227
Query: 288 ---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
P++ +L +++ CW E P RP+F + +L F
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 7e-67
Identities = 83/283 (29%), Positives = 135/283 (47%), Gaps = 34/283 (12%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDR--IVAIKVLNRGSTSDERALLEGRFIREVNMM 112
++ + + K+G G +G+VYEG + VA+K L + E F++E +M
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVM 63
Query: 113 SRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+KH NLV+ LG C + P I+TE + +L YL ++ V L A I+
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMA 227
AM+ L IHRDL N L+ + +K+ADFGL+R T + TA G +W A
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARP 286
PE +L ++ K DV++FG++LWE+ T P+ G+ Q ++
Sbjct: 181 PE-----SLAYN---KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEK 227
Query: 287 GL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
PE + ++++CW +P+ RPSF++I +
Sbjct: 228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 8e-66
Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 42/311 (13%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
V K + + +G GA G+VYEG+ VA+K L + + F+
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLM 82
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-----KLDLHV 160
E ++S+ H N+V+ +G P I+ EL+ G L+ +L RP L +
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL--KLADFGLAREETVTEMMTA 218
L+ A DIA L N IHRD+ N LLT K+ DFG+AR+
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 219 ETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+WM PE +G + +K D +SFG++LWE+ + +P+ SN +
Sbjct: 202 GGCAMLPVKWMPPE-----AFMEG---IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253
Query: 275 AAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330
+ G P++ + I+ CW P RP+F+ I+ +
Sbjct: 254 V-----LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308
Query: 331 PSPSVPESDTN 341
+ ++P
Sbjct: 309 INTALPIEYGP 319
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-65
Identities = 72/285 (25%), Positives = 132/285 (46%), Gaps = 31/285 (10%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRY---GDRI---VAIKVLNRGSTSDERALLEGRFIR 107
++ +G GA G VY+G + G+++ VAIK L ++ +
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK----EILD 66
Query: 108 EVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
E +M+ V + ++ + LG C + ++T+L+P L Y+ + + LN+ +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCV 124
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---Y 223
IA+ M+ L ++HRDL N+L+ + +K+ DFGLA+ E G
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 224 RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280
+WMA E L+ Y ++ DV+S+G+ +WEL+T P++G+ + +
Sbjct: 184 KWMALESILHRI----------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSIL 232
Query: 281 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
K R P + D+ I++ CW+ D + RP F ++I +
Sbjct: 233 EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-65
Identities = 78/284 (27%), Positives = 130/284 (45%), Gaps = 38/284 (13%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + + + ++G G G V G++ + VA+K++ GS S++ F +E M
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE------FFQEAQTMM 58
Query: 114 RVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
++ H LVKF G C + P+ IVTE + L YL S L+ L D+
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIY-IVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEG 116
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAP 228
M L ++ IHRDL N L+ +K++DFG+ R + + GT +W AP
Sbjct: 117 MAFLESHQFIHRDLAARNCLVD-RDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAP 174
Query: 229 E--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 285
E Y Y++K DV++FGI++WE+ + ++P++ +N +
Sbjct: 175 EVFHYFK----------YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-----VLKVS 219
Query: 286 PG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
G P S + I+ SCW E P RP+F Q++ +
Sbjct: 220 QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 8e-65
Identities = 85/315 (26%), Positives = 143/315 (45%), Gaps = 40/315 (12%)
Query: 23 HVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDR 82
L K ++ + S + ++R+ + + K+G G +G+VYEG +
Sbjct: 191 TTLHYPAPKRNKPTIYGVSPNYDKWEMERTDIT------MKHKLGGGQYGEVYEGVWKKY 244
Query: 83 --IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTEL 138
VA+K L + E F++E +M +KH NLV+ LG C + P I+TE
Sbjct: 245 SLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTREPPFY-IITEF 297
Query: 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198
+ +L YL ++ V L A I+ AM+ L IHR+L N L+ +
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG-ENHL 356
Query: 199 LKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 255
+K+ADFGL+R T + TA G +W APE + ++ K DV++FG+
Sbjct: 357 VKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA--------YNKFSIKSDVWAFGV 407
Query: 256 VLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNL 310
+LWE+ T P+ G+ Q ++ PE + ++++CW +P+
Sbjct: 408 LLWEIATYGMSPYPGIDLSQ-----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 462
Query: 311 RPSFSQIIRMLNAFL 325
RPSF++I +
Sbjct: 463 RPSFAEIHQAFETMF 477
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 9e-65
Identities = 84/284 (29%), Positives = 136/284 (47%), Gaps = 38/284 (13%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+DP L +IG G G V+ G + ++ VAIK + G+ S+E FI E +M
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED------FIEEAEVMM 58
Query: 114 RVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
++ H LV+ G C + P+ +VTE + L YL + + L LD+
Sbjct: 59 KLSHPKLVQLYGVCLEQAPIC-LVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEG 116
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAP 228
M L +IHRDL N L+ + + +K++DFG+ R + T+ TGT +W +P
Sbjct: 117 MAYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP 174
Query: 229 E--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 285
E +S Y++K DV+SFG+++WE+ + ++P+E SN + +
Sbjct: 175 EVFSFSR----------YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDIS 219
Query: 286 PGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
G P S + I+ CW E P RP+FS+++R L
Sbjct: 220 TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 9e-65
Identities = 82/294 (27%), Positives = 130/294 (44%), Gaps = 33/294 (11%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + L + K+G+G G+V+ G + G VAIK L G+ S E F++E +M
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA------FLQEAQVMK 234
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+++H+ LV+ ++P+ IVTE + SL +L L L ++ A IA M
Sbjct: 235 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPEL 230
+ +HRDL+ N+L+ + K+ADFGLAR E + +W APE
Sbjct: 294 AYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG-- 287
+ K DV+SFGI+L EL T R+P+ GM N + G
Sbjct: 353 ALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERGYR 399
Query: 288 --LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESD 339
P + L ++ CW ++P RP+F + L + P +
Sbjct: 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY---FTSTEPQYQPGE 450
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 1e-64
Identities = 83/284 (29%), Positives = 140/284 (49%), Gaps = 38/284 (13%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+DPK L ++G G G V G++ + VAIK++ GS S++ FI E +M
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE------FIEEAKVMM 74
Query: 114 RVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+ H+ LV+ G C + P+ I+TE + L YL +R + L D+ A
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIF-IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEA 132
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAP 228
M+ L + +HRDL N L+ DQ +K++DFGL+R E T+ G+ RW P
Sbjct: 133 MEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPP 190
Query: 229 E--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 285
E +YS +++K D+++FG+++WE+ + ++P+E +N + +H
Sbjct: 191 EVLMYSK----------FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----AEHIA 235
Query: 286 PGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
GL P S + I+ SCW E + RP+F ++ + +
Sbjct: 236 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-64
Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 42/311 (13%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
V K + + +G GA G+VYEG+ VA+K L + + F+
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLM 123
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-----KLDLHV 160
E ++S+ H N+V+ +G P I+ EL+ G L+ +L RP L +
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL--KLADFGLAREETVTEMMTA 218
L+ A DIA L N IHRD+ N LLT K+ DFG+AR+
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 219 ETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+WM PE +G + +K D +SFG++LWE+ + +P+ SN +
Sbjct: 243 GGCAMLPVKWMPPE-----AFMEGI---FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294
Query: 275 AAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330
+ G P++ + I+ CW P RP+F+ I+ +
Sbjct: 295 V-----LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349
Query: 331 PSPSVPESDTN 341
+ ++P
Sbjct: 350 INTALPIEYGP 360
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 6e-64
Identities = 77/286 (26%), Positives = 133/286 (46%), Gaps = 37/286 (12%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREV 109
+ + + +G IGEG G V++G Y VAIK ++ R +F++E
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE----KFLQEA 67
Query: 110 NMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
M + H ++VK +G ++P+ I+ EL LR +L + LDL + +A +
Sbjct: 68 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY-SLDLASLILYAYQL 125
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWM 226
+ A+ L + +HRD+ N+L++ +KL DFGL+R + A G +WM
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 227 APE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKH 283
APE + + + + DV+ FG+ +WE+L + PF+G+ N
Sbjct: 185 APESINF----------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGR 229
Query: 284 ARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
G +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 230 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 9e-64
Identities = 91/281 (32%), Positives = 135/281 (48%), Gaps = 32/281 (11%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + L + K+G G G+V+ Y VA+K + GS S E F+ E N+M
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA------FLAEANVMK 238
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++HD LVK K+P+ I+TE + SL +L S +K L ++F+ IA M
Sbjct: 239 TLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE 229
+ IHRDL+ N+L++ K+ADFGLAR E TA G +W APE
Sbjct: 298 AFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 355
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG- 287
+ + K DV+SFGI+L E++T R+P+ GMSN + + G
Sbjct: 356 AIN--------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGY 402
Query: 288 ---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
PE+ +L I+ CW P RP+F I +L+ F
Sbjct: 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-63
Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 36/290 (12%)
Query: 56 DPKLLFIGSKIGEGAHGKVYEGRYGDR-----IVAIKVLNRGSTSDERALLEGRFIREVN 110
++ IG G G VY G D A+K LNR + E + +F+ E
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGI 78
Query: 111 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
+M H N++ LG C + ++V + LR ++ + N + + F L +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 137
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----- 223
A+ M L + +HRDL N +L ++ ++K+ADFGLAR+ E + T
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282
+WMA E +L+ + + K DV+SFG++LWEL+T P+ ++
Sbjct: 197 KWMALE-----SLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TV 243
Query: 283 HARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328
+ G PE L ++ CW +RPSFS+++ ++A T
Sbjct: 244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 1e-63
Identities = 82/294 (27%), Positives = 130/294 (44%), Gaps = 33/294 (11%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + L + K+G+G G+V+ G + G VAIK L G+ S E F++E +M
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA------FLQEAQVMK 317
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+++H+ LV+ ++P+ IVTE + SL +L L L ++ A IA M
Sbjct: 318 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPEL 230
+ +HRDL+ N+L+ + K+ADFGLAR E + +W APE
Sbjct: 377 AYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG-- 287
+ K DV+SFGI+L EL T R+P+ GM N + G
Sbjct: 436 ALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERGYR 482
Query: 288 --LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESD 339
P + L ++ CW ++P RP+F + L + P +
Sbjct: 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY---FTSTEPQYQPGE 533
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-63
Identities = 76/286 (26%), Positives = 127/286 (44%), Gaps = 36/286 (12%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRI-----VAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
IG+G G VY G Y D+ AIK L+R + + F+RE +M
Sbjct: 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE----AFLREGLLMRG 78
Query: 115 VKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+ H N++ +G + L ++ + L +++ S + N + ++F L +AR M
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGM 137
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY-----RWMA 227
+ L +HRDL N +L + ++K+ADFGLAR+ E + + + +W A
Sbjct: 138 EYLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 286
E +L+ + K DV+SFG++LWELLT P+ +
Sbjct: 197 LE-----SLQTYR---FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL-----THFLAQ 243
Query: 287 G----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328
G PE L ++Q CW DP +RP+F ++ + + L
Sbjct: 244 GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-63
Identities = 75/323 (23%), Positives = 136/323 (42%), Gaps = 41/323 (12%)
Query: 36 VVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDR-----IVAIKVLN 90
++ + I+ +L+ + +G +G+G G V E + VA+K+L
Sbjct: 1 MLDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK 60
Query: 91 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-------KDPLMVIVTELLPGMS 143
+ F+RE M H ++ K +G + P+ +++ +
Sbjct: 61 ADIIASSDIE---EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117
Query: 144 LRKYLVSLRP----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199
L +L++ R L L + F +DIA M+ L + IHRDL N +L D ++
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTV 176
Query: 200 KLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256
+ADFGL+R+ + + +W+A E +L Y DV++FG+
Sbjct: 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALE-----SLADNL---YTVHSDVWAFGVT 228
Query: 257 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLR 311
+WE++T + P+ G+ N + + + G P + ++ ++ CW DP R
Sbjct: 229 MWEIMTRGQTPYAGIENAEI-----YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQR 283
Query: 312 PSFSQIIRMLNAFLFTLRPPSPS 334
PSF+ + L L L S S
Sbjct: 284 PSFTCLRMELENILGHLSVLSTS 306
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-63
Identities = 87/296 (29%), Positives = 140/296 (47%), Gaps = 44/296 (14%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
V + + + ++G+G+ G VYEG + VAIK +N ++ ER F+
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI----EFLN 77
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN--------KLD 157
E ++M ++V+ LG P +VI EL+ L+ YL SLRP
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVI-MELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 217
L + A +IA M L+AN +HRDL N ++ D ++K+ DFG+ R+ T+
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYR 195
Query: 218 AETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273
RWM+PE +L+ G + DV+SFG+VLWE+ T P++G+SN
Sbjct: 196 KGGKGLLPVRWMSPE-----SLKDGV---FTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247
Query: 274 QAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
Q + G P++ L +++ CW +P +RPSF +II + +
Sbjct: 248 QV-----LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-63
Identities = 83/281 (29%), Positives = 125/281 (44%), Gaps = 28/281 (9%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRY----GDRI-VAIKVLNRGSTSDERALLEGRFIRE 108
L+ K L + K+G+G+ G V G + G + VA+K L S A+ + FIRE
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD--FIRE 71
Query: 109 VNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
VN M + H NL++ G P+ +VTEL P SL L L +A+
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQ 129
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGT---Y 223
+A M L + IHRDL NLLL + +K+ DFGL R + + +
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 224 RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAA 280
W APE T +++ D + FG+ LWE+ T + P+ G++ Q +
Sbjct: 189 AWCAPESLKTRT----------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
Query: 281 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
+ R PED D+ ++ CW P RP+F + L
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-63
Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 59/315 (18%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDR------IVAIKVLNRGSTSDERALLEGRFIRE 108
+ L +GEG GKV Y +VA+K L + R+ + +E
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS----GWKQE 83
Query: 109 VNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 164
++++ + H++++K+ G C L +V E +P SLR YL + + L L F
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQ-LVMEYVPLGSLRDYL---PRHSIGLAQLLLF 139
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT- 222
A I M LHA IHRDL N+LL + + +K+ DFGLA+ E
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 223 --YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT---------------N 263
W APE + DV+SFG+ L+ELLT
Sbjct: 199 SPVFWYAPECLKEYK----------FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248
Query: 264 RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+ M+ L+ + G P+ ++ ++++CW + + RP+F +I
Sbjct: 249 GIAQGQMTVLRL-----TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
Query: 320 MLNAFLFTLRPPSPS 334
+L + +PS
Sbjct: 304 ILKTVHEKYQGQAPS 318
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 4e-63
Identities = 80/310 (25%), Positives = 137/310 (44%), Gaps = 61/310 (19%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALL 101
I R +V + ++GEGA GKV+ +VA+K L + + +
Sbjct: 12 IKRRDIV------LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-- 63
Query: 102 EGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN----- 154
F RE +++ ++H+++VKF G C DPL+ +V E + L K+L + P+
Sbjct: 64 ---FQREAELLTNLQHEHIVKFYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 155 ---------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205
+L L L+ A IA M L + +HRDL N L+ +K+ DFG
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFG 178
Query: 206 LAREETVTEMMTAETGTY---RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260
++R+ T+ T RWM PE +Y + + DV+SFG++LWE+
Sbjct: 179 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK----------FTTESDVWSFGVILWEI 228
Query: 261 LT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFS 315
T + P+ +SN + + G P ++ ++ CW +P R +
Sbjct: 229 FTYGKQPWFQLSNTEV-----IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIK 283
Query: 316 QIIRMLNAFL 325
+I ++L+A
Sbjct: 284 EIYKILHALG 293
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 6e-63
Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 55/298 (18%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI---------VAIKVLNRGSTSDERALLEGRF 105
+ + L +G+G K+++G + V +KVL++ + + F
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES-----F 59
Query: 106 IREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 163
+MMS++ H +LV G C D + +V E + SL YL + +++ L
Sbjct: 60 FEAASMMSKLSHKHLVLNYGVCVCGDENI-LVQEFVKFGSLDTYLKKNKN-CINILWKLE 117
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL-------KLADFGLAREETVTEMM 216
A +A AM L N +IH ++ N+LL ++ KL+D G++
Sbjct: 118 VAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------- 170
Query: 217 TAETGTY----RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEG 269
W+ PE K+ N D +SFG LWE+ + P
Sbjct: 171 VLPKDILQERIPWVPPECIENP---------KNLNLATDKWSFGTTLWEICSGGDKPLSA 221
Query: 270 MSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+ + + + LP + +LA ++ +C +P+ RPSF IIR LN+
Sbjct: 222 LDSQRK-----LQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-62
Identities = 80/287 (27%), Positives = 123/287 (42%), Gaps = 36/287 (12%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREV 109
++ + I IG G G+V GR D VAIK L G T +R F+ E
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR----DFLSEA 101
Query: 110 NMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
++M + H N+++ G M IVTE + SL +L + + + +
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAM-IVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRG 159
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT---Y 223
+ M L G +HRDL N+L+ K++DFGL+R E + TG
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFK 282
RW APE + +++ DV+SFG+V+WE+L P+ M+N
Sbjct: 219 RWTAPE-----AIAFR---TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----IS 265
Query: 283 HARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
G P L ++ CW +D RP FSQI+ +L+A +
Sbjct: 266 SVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-62
Identities = 75/286 (26%), Positives = 131/286 (45%), Gaps = 37/286 (12%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY----GDRI-VAIKVLNRGSTSDERALLEGRFIREV 109
+ + + + +GEG G+VYEG Y G++I VA+K + T D + +F+ E
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE----KFMSEA 64
Query: 110 NMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
+M + H ++VK +G ++P I+ EL P L YL + L + + ++L I
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQI 122
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWM 226
+AM L + +HRD+ N+L+ + +KL DFGL+R + A +WM
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVA-SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 227 APE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKH 283
+PE + + DV+ F + +WE+L+ + PF + N
Sbjct: 182 SPESINFRR----------FTTASDVWMFAVCMWEILSFGKQPFFWLENKD-----VIGV 226
Query: 284 ARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
G P+ P L ++ CW DP+ RP F++++ L+
Sbjct: 227 LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-62
Identities = 86/305 (28%), Positives = 139/305 (45%), Gaps = 53/305 (17%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI---------VAIKVLNRGSTSDERALLEGRF 105
L +G +GEGA G+V VA+K+L +T + +
Sbjct: 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS----DL 87
Query: 106 IREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP--------- 153
+ E+ MM + KH N++ LGAC PL VI E +LR+YL + RP
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 154 -----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
++ ++ +AR M+ L + IHRDL N+L+T + +K+ADFGLAR
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLAR 205
Query: 209 EETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 264
+ + T +WMAPE L Y ++ DV+SFG+++WE+ T
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPE-----ALFDRV---YTHQSDVWSFGVLMWEIFTLGG 257
Query: 265 LPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320
P+ G+ + FK + G P + + +L +++ CW P+ RP+F Q++
Sbjct: 258 SPYPGIPVEEL-----FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 321 LNAFL 325
L+ L
Sbjct: 313 LDRIL 317
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-62
Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 27/283 (9%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGDR------IVAIKVLNRGSTSDERALLEGRFIR 107
+ L +G G G V++G + V IKV+ S
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ----AVTD 64
Query: 108 EVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
+ + + H ++V+ LG C L +VT+ LP SL ++ R L + LN+ +
Sbjct: 65 HMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGV 122
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---Y 223
IA+ M L +G++HR+L N+LL +++ADFG+A + +
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFK 282
+WMA E Y ++ DV+S+G+ +WEL+T P+ G+ + K
Sbjct: 182 KWMALESIHF--------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLEK 232
Query: 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
R P+ + D+ ++ CW+ D N+RP+F ++
Sbjct: 233 GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-62
Identities = 78/301 (25%), Positives = 130/301 (43%), Gaps = 50/301 (16%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
+ + + + ++GEGA GKV+ +VA+K L S S + F R
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD-----FQR 92
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN----------- 154
E +++ ++H ++V+F G C PL+++ E + L ++L S P+
Sbjct: 93 EAELLTMLQHQHIVRFFGVCTEGRPLLMV-FEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 155 --KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212
L L L A +A M L +HRDL N L+ +K+ DFG++R+
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYS 210
Query: 213 TEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 268
T+ T RWM PE ++ + + + DV+SFG+VLWE+ T + P+
Sbjct: 211 TDYYRVGGRTMLPIRWMPPE-----SILYRK---FTTESDVWSFGVVLWEIFTYGKQPWY 262
Query: 269 GMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
+SN +A G P P++ I++ CW +P R S + L A
Sbjct: 263 QLSNTEA-----IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
Query: 325 L 325
Sbjct: 318 A 318
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-62
Identities = 86/303 (28%), Positives = 136/303 (44%), Gaps = 46/303 (15%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDR-----IVAIKVLNRGSTSDERALLEG 103
IDR+LL+ +G +GEG G V EG VA+K + ++S R + E
Sbjct: 31 IDRNLLI------LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEE- 82
Query: 104 RFIREVNMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRP---- 153
F+ E M H N+++ LG C + P +++ + L YL+ R
Sbjct: 83 -FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141
Query: 154 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213
+ L L F +DIA M+ L +HRDL N +L D ++ +ADFGL+++
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSKKIYSG 200
Query: 214 EMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269
+ +W+A E +L Y +K DV++FG+ +WE+ T P+ G
Sbjct: 201 DYYRQGRIAKMPVKWIAIE-----SLADRV---YTSKSDVWAFGVTMWEIATRGMTPYPG 252
Query: 270 MSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+ N + + + G PED +L I+ SCW DP RP+FS + L L
Sbjct: 253 VQNHEM-----YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307
Query: 326 FTL 328
+L
Sbjct: 308 ESL 310
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-62
Identities = 80/310 (25%), Positives = 138/310 (44%), Gaps = 58/310 (18%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
K L +G +GEG GKV + G VA+K+L ++ E +
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELR----DLLS 75
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP------------ 153
E N++ +V H +++K GAC PL++IV E SLR +L R
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 154 ----------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203
L + ++FA I++ M L ++HRDL N+L+ + +K++D
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEG-RKMKISD 193
Query: 204 FGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260
FGL+R+ + + +WMA E +L Y + DV+SFG++LWE+
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIE-----SLFDHI---YTTQSDVWSFGVLLWEI 245
Query: 261 LT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFS 315
+T P+ G+ + F + G P++ S ++ ++ CW ++P+ RP F+
Sbjct: 246 VTLGGNPYPGIPPERL-----FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300
Query: 316 QIIRMLNAFL 325
I + L +
Sbjct: 301 DISKDLEKMM 310
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 3e-62
Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 56/307 (18%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALL 101
I S + ++GE GKVY+G + VAIK L + R
Sbjct: 6 ISLSAVR------FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE-- 57
Query: 102 EGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN----- 154
F E + +R++H N+V LG PL ++ L ++LV P+
Sbjct: 58 --EFRHEAMLRARLQHPNVVCLLGVVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGS 114
Query: 155 ---------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205
L+ ++ IA M+ L ++ ++H+DL N+L+ D+ ++K++D G
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY-DKLNVKISDLG 173
Query: 206 LAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
L RE + + RWMAPE + G ++ D++S+G+VLWE+ +
Sbjct: 174 LFREVYAADYYKLLGNSLLPIRWMAPE-----AIMYG---KFSIDSDIWSYGVVLWEVFS 225
Query: 263 -NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQI 317
P+ G SN + R P+D + ++ CW E P+ RP F I
Sbjct: 226 YGLQPYCGYSNQDV-----VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 280
Query: 318 IRMLNAF 324
L A+
Sbjct: 281 HSRLRAW 287
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-62
Identities = 83/314 (26%), Positives = 133/314 (42%), Gaps = 56/314 (17%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIRE 108
+ P + IG G G+VY+G + VAIK L G T +R F+ E
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV----DFLGE 96
Query: 109 VNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
+M + H N+++ G P+M I+TE + +L K+L + + + +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPMM-IITEYMENGALDKFLRE-KDGEFSVLQLVGMLR 154
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT--- 222
IA M L +HRDL N+L+ K++DFGL+R E E +G
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 223 YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAA 279
RW APE Y + + + DV+SFGIV+WE++T P+ +SN +
Sbjct: 214 IRWTAPEAISY----------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---- 259
Query: 280 AFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL---------- 325
K G P D + ++ CW ++ RP F+ I+ +L+ +
Sbjct: 260 -MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 318
Query: 326 -----FTLRPPSPS 334
++R PS S
Sbjct: 319 DFDPRVSIRLPSTS 332
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 3e-62
Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 36/290 (12%)
Query: 56 DPKLLFIGSKIGEGAHGKVYEGRYGDR-----IVAIKVLNRGSTSDERALLEGRFIREVN 110
++ IG G G VY G D A+K LNR + E + +F+ E
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGI 142
Query: 111 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
+M H N++ LG C + ++V + LR ++ + N + + F L +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 201
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----- 223
A+ M L + +HRDL N +L ++ ++K+ADFGLAR+ E + T
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282
+WMA E +L+ + + K DV+SFG++LWEL+T P+ ++
Sbjct: 261 KWMALE-----SLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TV 307
Query: 283 HARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328
+ G PE L ++ CW +RPSFS+++ ++A T
Sbjct: 308 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 7e-62
Identities = 85/305 (27%), Positives = 138/305 (45%), Gaps = 53/305 (17%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI---------VAIKVLNRGSTSDERALLEGRF 105
L +G +GEG G+V VA+K+L +T + +
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS----DL 133
Query: 106 IREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-------- 154
+ E+ MM + KH N++ LGAC PL VI E +LR+YL + RP
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 155 ------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
++ ++ +AR M+ L + IHRDL N+L+T + +K+ADFGLAR
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLAR 251
Query: 209 EETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 264
+ + T +WMAPE L Y ++ DV+SFG+++WE+ T
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPE-----ALFDRV---YTHQSDVWSFGVLMWEIFTLGG 303
Query: 265 LPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320
P+ G+ + FK + G P + + +L +++ CW P+ RP+F Q++
Sbjct: 304 SPYPGIPVEEL-----FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358
Query: 321 LNAFL 325
L+ L
Sbjct: 359 LDRIL 363
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 8e-62
Identities = 74/313 (23%), Positives = 132/313 (42%), Gaps = 43/313 (13%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGDRI------VAIKVLNRGSTSDERALLEGRFIR 107
++ +G GA G VY+G + VAIK L ++ +
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK----EILD 66
Query: 108 EVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
E +M+ V + ++ + LG C + ++T+L+P L Y+ + + LN+ +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCV 124
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---Y 223
IA+ M+ L ++HRDL N+L+ + +K+ DFGLA+ E G
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 224 RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280
+WMA E L+ Y ++ DV+S+G+ +WEL+T P++G+ + +
Sbjct: 184 KWMALESILHRI----------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSIL 232
Query: 281 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL------------FTL 328
K R P + D+ I+ CW+ D + RP F ++I + +
Sbjct: 233 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 292
Query: 329 RPPSPSVPESDTN 341
PSP+
Sbjct: 293 HLPSPTDSNFYRA 305
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 8e-62
Identities = 77/284 (27%), Positives = 134/284 (47%), Gaps = 33/284 (11%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY----GDRI-VAIKVLNRGSTSDERALLEGRFIREV 109
+ + + +G IGEG G V++G Y + VAIK ++ R +F++E
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE----KFLQEA 442
Query: 110 NMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
M + H ++VK +G ++P+ I+ EL LR +L + LDL + +A +
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKF-SLDLASLILYAYQL 500
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWM 226
+ A+ L + +HRD+ N+L++ +KL DFGL+R + A G +WM
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 285
APE ++ + + DV+ FG+ +WE+L + PF+G+ N
Sbjct: 560 APE-----SINFR---RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIE 606
Query: 286 PG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
G +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 607 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 8e-62
Identities = 93/338 (27%), Positives = 148/338 (43%), Gaps = 53/338 (15%)
Query: 22 QHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD 81
H + ++ +L D + L +G +GEGA G+V
Sbjct: 33 HHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIG 92
Query: 82 RI---------VAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KD 129
VA+K+L +T + + I E+ MM + KH N++ LGAC
Sbjct: 93 LDKDKPNRVTKVAVKMLKSDATEKDLS----DLISEMEMMKMIGKHKNIINLLGACTQDG 148
Query: 130 PLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCL 175
PL VI E +LR+YL + RP +L ++ A +AR M+ L
Sbjct: 149 PLYVI-VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYS 232
+ IHRDL N+L+T D +K+ADFGLAR+ + T +WMAPE
Sbjct: 208 ASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE--- 263
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG---- 287
L Y ++ DV+SFG++LWE+ T P+ G+ + FK + G
Sbjct: 264 --ALFDRI---YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-----FKLLKEGHRMD 313
Query: 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
P + + +L +++ CW P+ RP+F Q++ L+ +
Sbjct: 314 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-61
Identities = 86/302 (28%), Positives = 136/302 (45%), Gaps = 55/302 (18%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVN 110
+D + IGEG G+V + R AIK + ++ D+ F E+
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR----DFAGELE 77
Query: 111 MMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA------ 161
++ ++ H N++ LGAC + L + E P +L +L R + D A
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 162 --------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213
L+FA D+AR MD L IHRDL N+L+ + K+ADFGL+R +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQ--- 192
Query: 214 EMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 267
E+ +T RWMA E YS Y DV+S+G++LWE+++ P+
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPY 242
Query: 268 EGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
GM+ + ++ G P + ++ +++ CW E P RPSF+QI+ LN
Sbjct: 243 CGMTCAEL-----YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297
Query: 324 FL 325
L
Sbjct: 298 ML 299
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-61
Identities = 89/315 (28%), Positives = 134/315 (42%), Gaps = 44/315 (13%)
Query: 41 SITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGS 93
I QL D L G +G GA GKV E VA+K+L +
Sbjct: 6 YIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65
Query: 94 TSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVS 150
ER + E+ ++S + H N+V LGAC P +VI TE L +L
Sbjct: 66 HLTERE----ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI-TEYCCYGDLLNFLRR 120
Query: 151 LRPNKLDLHVA----------------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194
R + + + L+F+ +A+ M L + IHRDL N+LLT
Sbjct: 121 KRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180
Query: 195 DQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVY 251
+ K+ DFGLAR+ + +WMAPE ++ Y + DV+
Sbjct: 181 G-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE-----SIFNCV---YTFESDVW 231
Query: 252 SFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 310
S+GI LWEL + P+ GM Y + R PE ++ I+++CW DP
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291
Query: 311 RPSFSQIIRMLNAFL 325
RP+F QI++++ +
Sbjct: 292 RPTFKQIVQLIEKQI 306
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-61
Identities = 75/307 (24%), Positives = 122/307 (39%), Gaps = 59/307 (19%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY---GDR---IVAIKVLNRGSTSDERALLEGRFIRE 108
+ + L ++G+G G V RY D +VA+K L + R F RE
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FERE 61
Query: 109 VNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 164
+ ++ ++HDN+VK+ G C + L ++ E LP SLR YL + ++D L +
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKE-RIDHIKLLQY 119
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT- 222
I + M+ L IHRDL N+L+ ++ +K+ DFGL + E +
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 223 --YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT---------------- 262
W APE S ++ DV+SFG+VL+EL T
Sbjct: 179 SPIFWYAPESLTESK----------FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
Query: 263 NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQII 318
M + + P+ ++ I+ CW + N RPSF +
Sbjct: 229 GNDKQGQMIVFH-----LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 283
Query: 319 RMLNAFL 325
++
Sbjct: 284 LRVDQIR 290
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-61
Identities = 74/307 (24%), Positives = 121/307 (39%), Gaps = 59/307 (19%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDR------IVAIKVLNRGSTSDERALLEGRFIRE 108
+ + L ++G+G G V RY +VA+K L + R F RE
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FERE 92
Query: 109 VNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 164
+ ++ ++HDN+VK+ G C + L ++ E LP SLR YL + ++D L +
Sbjct: 93 IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKE-RIDHIKLLQY 150
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT- 222
I + M+ L IHRDL N+L+ ++ +K+ DFGL + E +
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209
Query: 223 --YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT---------------- 262
W APE S ++ DV+SFG+VL+EL T
Sbjct: 210 SPIFWYAPESLTESK----------FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
Query: 263 NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQII 318
M + + P+ ++ I+ CW + N RPSF +
Sbjct: 260 GNDKQGQMIVFH-----LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 314
Query: 319 RMLNAFL 325
++
Sbjct: 315 LRVDQIR 321
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 4e-61
Identities = 73/305 (23%), Positives = 135/305 (44%), Gaps = 35/305 (11%)
Query: 45 PQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERAL 100
+L + R LL ++G G G V +G Y VAIKVL +G+ +
Sbjct: 2 KKLFLKRD-----NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE- 55
Query: 101 LEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH 159
+RE +M ++ + +V+ +G C + LM +V E+ G L K+LV + ++ +
Sbjct: 56 ---EMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVG-KREEIPVS 110
Query: 160 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TA 218
++ M L +HRDL N+LL ++ K++DFGL++ + TA
Sbjct: 111 NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTA 169
Query: 219 ETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSN 272
+ +W APE + ++++ DV+S+G+ +WE L+ + P++ M
Sbjct: 170 RSAGKWPLKWYAPECINFRK----------FSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219
Query: 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332
+ A + R P + P+L ++ CW+ RP F + + + A ++L
Sbjct: 220 PE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278
Query: 333 PSVPE 337
Sbjct: 279 EGHHH 283
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 6e-61
Identities = 88/320 (27%), Positives = 131/320 (40%), Gaps = 49/320 (15%)
Query: 41 SITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGS 93
+ + D + L G +G GA GKV VA+K+L +
Sbjct: 28 YVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA 87
Query: 94 TSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVS 150
S ER + E+ MM+++ H+N+V LGAC P+ +I E L YL S
Sbjct: 88 DSSERE----ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI-FEYCCYGDLLNYLRS 142
Query: 151 LRPNKLDLHVA---------------------LNFALDIARAMDCLHANGIIHRDLKPDN 189
R + + L FA +A+ M+ L +HRDL N
Sbjct: 143 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 202
Query: 190 LLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNN 246
+L+T K +K+ DFGLAR+ +WMAPE +L +G Y
Sbjct: 203 VLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE-----SLFEGI---YTI 253
Query: 247 KVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWV 305
K DV+S+GI+LWE+ + P+ G+ Y + P + ++ I+QSCW
Sbjct: 254 KSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWA 313
Query: 306 EDPNLRPSFSQIIRMLNAFL 325
D RPSF + L L
Sbjct: 314 FDSRKRPSFPNLTSFLGCQL 333
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 8e-61
Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 43/300 (14%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
L +G +G GA G+V E R VA+K+L G+T E +
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR----ALMS 79
Query: 108 EVNMMSRV-KHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRP---------- 153
E+ ++ + H N+V LGAC PLMVI E +L YL S R
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVI-VEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 154 ----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209
+ L L + ++ +A+ M+ L + IHRDL N+LL+ +K+ DFGLAR+
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARD 197
Query: 210 ETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 265
+ +WMAPE T+ Y + DV+SFG++LWE+ +
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPE-----TIFDRV---YTIQSDVWSFGVLLWEIFSLGAS 249
Query: 266 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
P+ G+ + + R P+ +P++ + CW +P+ RP+FS+++ L L
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 8e-61
Identities = 71/274 (25%), Positives = 122/274 (44%), Gaps = 27/274 (9%)
Query: 55 VDPKLLFI--GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVN 110
+ F+ +IG G+ VY+G + VA L + RF E
Sbjct: 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---RQRFKEEAE 77
Query: 111 MMSRVKHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
M+ ++H N+V+F + + + +V+VTEL+ +L+ YL R + + V ++
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWC 135
Query: 166 LDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 223
I + + LH IIHRDLK DN+ +T S+K+ D GLA + + GT
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTP 194
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY-AAAFK 282
+MAPE+Y ++ Y+ VDVY+FG+ + E+ T+ P+ N Y
Sbjct: 195 EFMAPEMY---------EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 245
Query: 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 316
+ P++ I++ C ++ + R S
Sbjct: 246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-60
Identities = 69/296 (23%), Positives = 123/296 (41%), Gaps = 43/296 (14%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGR 104
+DR L ++G G G V +G Y + VA+K+L + +
Sbjct: 13 LDRK-----LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL---KDE 64
Query: 105 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 163
+ E N+M ++ + +V+ +G C + M +V E+ L KYL + + +
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIE 121
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGT 222
++ M L + +HRDL N+LL Q K++DFGL++ E A+T
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHG 180
Query: 223 ---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAA 276
+W APE Y +++K DV+SFG+++WE + + P+ GM +
Sbjct: 181 KWPVKWYAPECINYYK----------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-- 228
Query: 277 YAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328
G P ++ ++ CW D RP F+ + L + + +
Sbjct: 229 ---VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-60
Identities = 96/366 (26%), Positives = 148/366 (40%), Gaps = 53/366 (14%)
Query: 16 GEQEQNQHVLRGSVEKES-RAVVKNGSITAPQLTIDRSLL-VDPKLLFIGSKIGEGAHGK 73
G E+ H G ++ R V + P T+ +D + I +G G G+
Sbjct: 1 GSDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGE 60
Query: 74 VYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC- 127
V GR + VAIK L G T +R F+ E ++M + H N+++ G
Sbjct: 61 VCSGRLKLPSKKEISVAIKTLKVGYTEKQRR----DFLGEASIMGQFDHPNIIRLEGVVT 116
Query: 128 -KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 186
P+M IVTE + SL +L + + + IA M L G +HRDL
Sbjct: 117 KSKPVM-IVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 174
Query: 187 PDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGE 240
N+L+ K++DFGL R E E G RW +PE Y
Sbjct: 175 ARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--------- 224
Query: 241 KKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPG----LPEDISPD 295
+ + + DV+S+GIVLWE+++ P+ MSN K G P D
Sbjct: 225 -RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-----IKAVDEGYRLPPPMDCPAA 278
Query: 296 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFL-----------FTLRPPSPSVPESDTNEAA 344
L ++ CW +D N RP F QI+ +L+ + RP + + +S+ +
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITT 338
Query: 345 ATSNGA 350
+ G
Sbjct: 339 FRTTGD 344
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-60
Identities = 82/316 (25%), Positives = 135/316 (42%), Gaps = 64/316 (20%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALL 101
R+ + IGEGA G+V++ R +VA+K+L +++D +A
Sbjct: 44 YPRNNIE------YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-- 95
Query: 102 EGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP------ 153
F RE +M+ + N+VK LG C P+ ++ E + L ++L S+ P
Sbjct: 96 --DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL-FEYMAYGDLNEFLRSMSPHTVCSL 152
Query: 154 ----------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 197
L L A +A M L +HRDL N L+ +
Sbjct: 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-M 211
Query: 198 SLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 254
+K+ADFGL+R + A+ RWM PE ++ Y + DV+++G
Sbjct: 212 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE-----SIFYNR---YTTESDVWAYG 263
Query: 255 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPN 309
+VLWE+ + P+ GM++ + + R G PE+ +L +++ CW + P
Sbjct: 264 VVLWEIFSYGLQPYYGMAHEEV-----IYYVRDGNILACPENCPLELYNLMRLCWSKLPA 318
Query: 310 LRPSFSQIIRMLNAFL 325
RPSF I R+L
Sbjct: 319 DRPSFCSIHRILQRMC 334
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-60
Identities = 80/312 (25%), Positives = 128/312 (41%), Gaps = 63/312 (20%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLE 102
++ L +GEG GKV RY VA+K L S + A
Sbjct: 18 FEKRFLK------RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--- 68
Query: 103 GRFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDL 158
+E+ ++ + H+N+VK+ G C + + ++ E LP SL++YL NK++L
Sbjct: 69 -DLKKEIEILRNLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSLKEYLPK-NKNKINL 125
Query: 159 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMT 217
L +A+ I + MD L + +HRDL N+L+ + +K+ DFGL + ET E T
Sbjct: 126 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYT 184
Query: 218 AETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT---------- 262
+ W APE + S + DV+SFG+ L ELLT
Sbjct: 185 VKDDRDSPVFWYAPECLMQSK----------FYIASDVWSFGVTLHELLTYCDSDSSPMA 234
Query: 263 -----NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPS 313
M+ + + G P + ++ +++ CW P+ R S
Sbjct: 235 LFLKMIGPTHGQMTVTRL-----VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTS 289
Query: 314 FSQIIRMLNAFL 325
F +I A L
Sbjct: 290 FQNLIEGFEALL 301
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-60
Identities = 88/325 (27%), Positives = 136/325 (41%), Gaps = 50/325 (15%)
Query: 32 ESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIV 84
ES I QL + L G +G GA GKV E V
Sbjct: 20 ESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKV 79
Query: 85 AIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPG 141
A+K+L + +DE+ + E+ +MS + +H+N+V LGAC P++VI TE
Sbjct: 80 AVKMLKSTAHADEKE----ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI-TEYCCY 134
Query: 142 MSLRKYLVSLRP------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189
L +L + L+F+ +A+ M L + IHRD+ N
Sbjct: 135 GDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 194
Query: 190 LLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNN 246
+LLT K+ DFGLAR+ + +WMAPE ++ Y
Sbjct: 195 VLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE-----SIFDCV---YTV 245
Query: 247 KVDVYSFGIVLWELLT-NRLPFEG-MSNLQAAYAAAFKHARPGL----PEDISPDLAFIV 300
+ DV+S+GI+LWE+ + P+ G + N + +K + G P ++ I+
Sbjct: 246 QSDVWSYGILLWEIFSLGLNPYPGILVNSKF-----YKLVKDGYQMAQPAFAPKNIYSIM 300
Query: 301 QSCWVEDPNLRPSFSQIIRMLNAFL 325
Q+CW +P RP+F QI L
Sbjct: 301 QACWALEPTHRPTFQQICSFLQEQA 325
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 7e-60
Identities = 79/325 (24%), Positives = 126/325 (38%), Gaps = 60/325 (18%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY---GDRI---VAIKVLNRGSTSDERALLEGRFIRE 108
+ + L S++G+G G V RY GD VA+K L +R F RE
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-----FQRE 74
Query: 109 VNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 164
+ ++ + D +VK+ G + L +V E LP LR +L R +LD L +
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGCLRDFLQRHRA-RLDASRLLLY 132
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT- 222
+ I + M+ L + +HRDL N+L+ + +K+ADFGLA+ +
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 223 --YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY 277
W APE + ++ + DV+SFG+VL+EL T A +
Sbjct: 192 SPIFWYAPESLSDNI----------FSRQSDVWSFGVVLYELFTYCDKSCSPS----AEF 237
Query: 278 AAAFKHARPGL-----------------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320
R P ++ +++ CW P RPSFS +
Sbjct: 238 LRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297
Query: 321 LNAFLFTLR----PPSPSVPESDTN 341
L+ R + PE +
Sbjct: 298 LDMLWSGSRGCETHAFTAHPEGKHH 322
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-58
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 45/280 (16%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG G G+V++ + + IK + + E+A REV ++++ H N
Sbjct: 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAE------REVKALAKLDHVN 65
Query: 120 LVKFLGA-----------------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 162
+V + G K + I E +L +++ R KLD +AL
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222
I + +D +H+ +I+RDLKP N+ L ++ +K+ DFGL T GT
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ-VKIGDFGLVTSLKNDGKRTRSKGT 184
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
R+M+PE + Y +VD+Y+ G++L ELL S F
Sbjct: 185 LRYMSPEQI--------SSQDYGKEVDLYALGLILAELLHVCDTAFETSKF-------FT 229
Query: 283 HARPG-LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
R G + + ++Q + P RP+ S+I+R L
Sbjct: 230 DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 6e-58
Identities = 74/300 (24%), Positives = 118/300 (39%), Gaps = 47/300 (15%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G G G V+E + D AIK + + R + +REV +++++H
Sbjct: 9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE----KVMREVKALAKLEHPG 64
Query: 120 LVKFLGACKD-------------PLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFA 165
+V++ A + + I +L +L+ ++ + + V L+
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-------------EETV 212
L IA A++ LH+ G++HRDLKP N+ T D +K+ DFGL
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
T + GT +M+PE Y++KVD++S G++L+ELL PF
Sbjct: 184 YARHTGQVGTKLYMSPEQI--------HGNSYSHKVDIFSLGLILFELLY---PFSTQME 232
Query: 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332
P L P +VQ P RP II NA L P
Sbjct: 233 RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--NAVFEDLDFPG 290
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-57
Identities = 65/292 (22%), Positives = 128/292 (43%), Gaps = 21/292 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--D 118
I +IG G KV++ +I AIK +N ++ + E+ +++++ D
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSD 88
Query: 119 NLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+++ + +V E + L +L + +D ++ ++ A+ +H
Sbjct: 89 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ 145
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPEL---Y 231
+GI+H DLKP N L+ LKL DFG+A +T + + ++ GT +M PE
Sbjct: 146 HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPE 290
S+ K + K DV+S G +L+ + + PF+ + N + +A + P+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNE 342
DL +++ C DP R S +++ + ++ P + + T E
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQIQTHPVNQMAKGTTEE 313
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 2e-57
Identities = 73/310 (23%), Positives = 136/310 (43%), Gaps = 31/310 (10%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALL 101
+L + L LL ++G G G V +G Y VAIKVL +G+ +
Sbjct: 324 ELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-- 381
Query: 102 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 161
+RE +M ++ + +V+ +G C+ +++V E+ G L K+LV R ++ +
Sbjct: 382 --EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNV 438
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAET 220
++ M L +HR+L N+LL ++ K++DFGL++ + TA +
Sbjct: 439 AELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARS 497
Query: 221 GT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+W APE + ++++ DV+S+G+ +WE L+ + P++ M +
Sbjct: 498 AGKWPLKWYAPECINFRK----------FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
Query: 275 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS 334
A + R P + P+L ++ CW+ RP F + + + A +
Sbjct: 548 -VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC---YYSLASK 603
Query: 335 VPESDTNEAA 344
V E A
Sbjct: 604 VEGGSALEVA 613
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-57
Identities = 68/346 (19%), Positives = 142/346 (41%), Gaps = 26/346 (7%)
Query: 13 REEGEQEQNQHVLRGSVEKESRAVVKNGSITAP-----QLTIDRSLLVDPKLLFIGSKIG 67
G + + + K R + + + + + + V ++ I +IG
Sbjct: 6 HSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIG 65
Query: 68 EGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--DNLVKFL 124
G KV++ +I AIK +N ++ + E+ +++++ D +++
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 125 GACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
+ +V E + L +L + +D ++ ++ A+ +H +GI+H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHS 179
Query: 184 DLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPEL---YSTVTLR 237
DLKP N L+ LKL DFG+A +T + + ++ G +M PE S+
Sbjct: 180 DLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPEDISPDL 296
K + K DV+S G +L+ + + PF+ + N + +A + P+ DL
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 297
Query: 297 AFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNE 342
+++ C DP R S +++ + ++ P + + T E
Sbjct: 298 QDVLKCCLKRDPKQRISIPELLA--HPYVQIQTHPVNQMAKGTTEE 341
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 7e-57
Identities = 65/292 (22%), Positives = 128/292 (43%), Gaps = 21/292 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--D 118
I +IG G KV++ +I AIK +N ++ + E+ +++++ D
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSD 69
Query: 119 NLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+++ + +V E + L +L + +D ++ ++ A+ +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ 126
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPEL---Y 231
+GI+H DLKP N L+ LKL DFG+A +T + + ++ GT +M PE
Sbjct: 127 HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPE 290
S+ K + K DV+S G +L+ + + PF+ + N + +A + P+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNE 342
DL +++ C DP R S +++ + ++ P + + T E
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQIQTHPVNQMAKGTTEE 294
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 2e-56
Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 40/292 (13%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +G+GA V+ G + + AIKV N S + RE ++ ++ H N
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM----REFEVLKKLNHKN 68
Query: 120 LVKFLGACKDP---LMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFALDIARAMDCL 175
+VK ++ V++ E P SL L L L D+ M+ L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 176 HANGIIHRDLKPDNLLLTP---DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
NGI+HR++KP N++ Q KL DFG ARE E + GT ++ P++Y
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ--------------AAYA 278
LR+ +K Y VD++S G+ + T LPF + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 279 AAFKHARPG-------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQI 317
+ + A G L + L ++ + D F Q
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-56
Identities = 76/264 (28%), Positives = 128/264 (48%), Gaps = 19/264 (7%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHD 118
KIGEG+ GK + R IK +N +S ER REV +++ +KH
Sbjct: 28 RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES----RREVAVLANMKHP 83
Query: 119 NLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N+V++ + ++ + IV + G L K + + + L++ + I A+ +H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTL 236
I+HRD+K N+ LT D +++L DFG+AR + E+ A GT +++PE+
Sbjct: 144 RKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC----- 197
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDL 296
E K YNNK D+++ G VL+EL T + FE +++ + P + S DL
Sbjct: 198 ---ENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPPVSLHYSYDL 253
Query: 297 AFIVQSCWVEDPNLRPSFSQIIRM 320
+V + +P RPS + I+
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSILEK 277
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-56
Identities = 68/264 (25%), Positives = 115/264 (43%), Gaps = 24/264 (9%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNR-GSTSDERALLEGRFIREVNMMSRV-KH 117
S++G G++G+V++ R + R+ A+K +RA R + EV +V +H
Sbjct: 61 RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA----RKLAEVGSHEKVGQH 116
Query: 118 DNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
V+ A ++ ++ + TEL G SL+++ L + D A+ LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
+ G++H D+KP N+ L P + KL DFGL E + G R+MAPEL L
Sbjct: 175 SQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-----L 228
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDL 296
+ Y DV+S G+ + E+ N G Q + P +S +L
Sbjct: 229 QGS----YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ---GYLPPEFTAGLSSEL 281
Query: 297 AFIVQSCWVEDPNLRPSFSQIIRM 320
++ DP LR + ++ +
Sbjct: 282 RSVLVMMLEPDPKLRATAEALLAL 305
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 8e-56
Identities = 69/300 (23%), Positives = 111/300 (37%), Gaps = 40/300 (13%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +G+GA V+ G + + AIKV N S + RE ++ ++ H N
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM----REFEVLKKLNHKN 68
Query: 120 LVKFLGACKDP---LMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFALDIARAMDCL 175
+VK ++ V++ E P SL L L L D+ M+ L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 176 HANGIIHRDLKPDNLLLTPD---QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
NGI+HR++KP N++ Q KL DFG ARE E + GT ++ P++Y
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-----------LQAAYAAAF 281
LR+ +K Y VD++S G+ + T LPF + + A
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 282 KHARPG----------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+ L + L ++ + D F Q + L
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-55
Identities = 81/297 (27%), Positives = 134/297 (45%), Gaps = 32/297 (10%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I K+G G VY + VAIK + E L RF REV+ S++ H N
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLK--RFEREVHNSSQLSHQN 72
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V + ++ +V E + G +L +Y+ S P L + A+NF I + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM 130
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVT 235
I+HRD+KP N+L+ + K+LK+ DFG+A+ E ++T+ GT ++ +PE
Sbjct: 131 RIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHV-LGTVQYFSPE------ 182
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR---PGLP--- 289
Q + + + D+YS GIVL+E+L PF G + + A KH + P +
Sbjct: 183 --QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI----KHIQDSVPNVTTDV 236
Query: 290 -EDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLRPPSPSVPESDTNEAA 344
+DI L+ ++ +D R + ++ L++ L R A
Sbjct: 237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKMKTIA 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 8e-54
Identities = 64/292 (21%), Positives = 109/292 (37%), Gaps = 52/292 (17%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +G+GA G+V + R R AIK + L EV +++ + H
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL------SEVMLLASLNHQY 63
Query: 120 LVKFLGA--------------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
+V++ A K + I E +L + S
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLF 122
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---------------EE 210
I A+ +H+ GIIHRDLKP N+ + + +K+ DFGLA+
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270
++ +T+ GT ++A E+ HYN K+D+YS GI+ +E++ PF
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLD-------GTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231
Query: 271 SNLQAAYAAAFKHAR---PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+ P ++ I++ DPN RP ++
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-54
Identities = 69/267 (25%), Positives = 122/267 (45%), Gaps = 19/267 (7%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I KIG G +VY VA+K + D +A + I+E++++ ++ H N
Sbjct: 36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD--CIKEIDLLKQLNHPN 93
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDIARAMDCLH 176
++K+ + + + IV EL L + + + K + + + + A++ +H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVT 235
+ ++HRD+KP N+ +T +KL D GL R + T + GT +M+PE
Sbjct: 154 SRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI---- 208
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHARPGLPEDI-S 293
+ YN K D++S G +L+E+ + PF G NL + + P LP D S
Sbjct: 209 ----HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIRM 320
+L +V C DP RP + + +
Sbjct: 265 EELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-53
Identities = 72/273 (26%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGS-TSDERALLEGRFIREVNMMSRVKHD 118
+ IG G++G+ + R +I+ K L+ GS T E+ +L + EVN++ +KH
Sbjct: 10 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML----VSEVNLLRELKHP 65
Query: 119 NLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDIARAMD 173
N+V++ D + IV E G L + + L L + A+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 174 CLH-----ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMA 227
H + ++HRDLKP N+ L Q ++KL DFGLAR T GT +M+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287
PE + YN K D++S G +L+EL PF + + +
Sbjct: 185 PEQM--------NRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRR 235
Query: 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320
+P S +L I+ RPS +I+
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-53
Identities = 67/297 (22%), Positives = 113/297 (38%), Gaps = 35/297 (11%)
Query: 62 IGSKIGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
K+GEG V EG + A+K + D RE +M H N
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA-----QREADMHRLFNHPN 87
Query: 120 LVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAM 172
+++ + C ++ +L + L+ L L L I R +
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----------EMMTAETGT 222
+ +HA G HRDLKP N+LL D+ L D G + + + A+ T
Sbjct: 148 EAIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
+ APEL +++ + + DV+S G VL+ ++ P++ + + A A +
Sbjct: 207 ISYRAPEL---FSVQSHCV--IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
Query: 283 -HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPES 338
S L ++ S DP+ RP ++ L A L+PP+P +
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA----LQPPAPGQHTT 314
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 9e-53
Identities = 83/310 (26%), Positives = 139/310 (44%), Gaps = 36/310 (11%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +G G +V+ R R VA+KVL D L RF RE + + H
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYL--RFRREAQNAAALNHPA 73
Query: 120 LVKFL-----GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+V PL IV E + G++LR + + P + A+ D +A++
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNF 131
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET----GTYRWMAPEL 230
H NGIIHRD+KP N++++ +K+ DFG+AR + +T GT ++++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE- 189
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----- 285
Q + + DVYS G VL+E+LT PF G S + AY +H R
Sbjct: 190 -------QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY----QHVREDPIP 238
Query: 286 -PGLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLRPPSPS-VPESDTNE 342
E +S DL +V ++P R + +++ L P +P + +++
Sbjct: 239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTS 298
Query: 343 AAATSNGAMT 352
+++ G ++
Sbjct: 299 LLSSAAGNLS 308
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-52
Identities = 79/285 (27%), Positives = 130/285 (45%), Gaps = 27/285 (9%)
Query: 63 GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
+G+G +G VY GR +AIK + + + L E+ + +KH N+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL-----HEEIALHKHLKHKNI 81
Query: 121 VKFLGACKDPLMV-IVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHAN 178
V++LG+ + + I E +PG SL L S P K + + I + LH N
Sbjct: 82 VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLR 237
I+HRD+K DN+L+ LK++DFG ++ + TGT ++MAPE+
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII------ 195
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK----HARPGLPEDIS 293
+ Y D++S G + E+ T + PF L AA FK P +PE +S
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPF---YELGEPQAAMFKVGMFKVHPEIPESMS 252
Query: 294 PDL-AFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 337
+ AFI++ C+ DP+ R + ++ + FL + P+
Sbjct: 253 AEAKAFILK-CFEPDPDKRACANDLLV--DEFLKVSSKKKKTQPK 294
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 6e-51
Identities = 52/282 (18%), Positives = 100/282 (35%), Gaps = 41/282 (14%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHD 118
KIG G G V++ I AIK + E +REV + + +H
Sbjct: 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD---EQNALREVYAHAVLGQHS 71
Query: 119 NLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCL 175
++V++ A +D M+I E G SL + + + L + R + +
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 176 HANGIIHRDLKPDNLLLTPDQKS------------------LKLADFGLAREETVTEMMT 217
H+ ++H D+KP N+ ++ K+ D G T
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQ 188
Query: 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
E G R++A E+ E + K D+++ + + +
Sbjct: 189 VEEGDSRFLANEVLQ-------ENYTHLPKADIFALALTVVCAAGAEPLPRNGD----QW 237
Query: 278 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+ P +P+ +S + +++ DP RPS +++
Sbjct: 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-50
Identities = 61/261 (23%), Positives = 105/261 (40%), Gaps = 30/261 (11%)
Query: 63 GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
++G G+ G+V+ + A+K + LE + E+ + + +
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----------LEVFRVEELVACAGLSSPRI 112
Query: 121 VKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V GA ++ V I ELL G SL + + + L AL + ++ LH
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRR 170
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFG----LAREETVTEMMTAET--GTYRWMAPELYST 233
I+H D+K DN+LL+ D L DFG L + ++T + GT MAPE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE---- 226
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-AAFKHARPGLPEDI 292
V + + + KVD++S ++ +L P+ A+ +P
Sbjct: 227 VVMGKP----CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC 282
Query: 293 SPDLAFIVQSCWVEDPNLRPS 313
+P A +Q ++P R S
Sbjct: 283 APLTAQAIQEGLRKEPVHRAS 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-50
Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 22/275 (8%)
Query: 52 SLLVDPKLL---FIGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFI 106
+LVDP+ G +G+G K +E D + A K++ + +
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH--QREKMS 63
Query: 107 REVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
E+++ + H ++V F G +D V +V EL SL + + L A +
Sbjct: 64 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYL 121
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYR 224
I LH N +IHRDLK NL L + +K+ DFGLA + E E GT
Sbjct: 122 RQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPN 180
Query: 225 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 284
++APE+ S KK ++ +VDV+S G +++ LL + PFE S L+ Y K
Sbjct: 181 YIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRI-KKN 230
Query: 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+P+ I+P A ++Q DP RP+ ++++
Sbjct: 231 EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-49
Identities = 80/284 (28%), Positives = 128/284 (45%), Gaps = 22/284 (7%)
Query: 43 TAPQLTIDRSLLVDPKLL---FIGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDE 97
AP +LVDP+ G +G+G K +E D + A K++ +
Sbjct: 23 AAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP 82
Query: 98 RALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKL 156
+ E+++ + H ++V F G +D V +V EL SL + + L
Sbjct: 83 H--QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--AL 138
Query: 157 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEM 215
A + I LH N +IHRDLK NL L + +K+ DFGLA + E E
Sbjct: 139 TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGER 197
Query: 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275
GT ++APE+ S KK ++ +VDV+S G +++ LL + PFE S L+
Sbjct: 198 KKVLCGTPNYIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKE 248
Query: 276 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
Y K +P+ I+P A ++Q DP RP+ ++++
Sbjct: 249 TYLRI-KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 174 bits (441), Expect = 7e-49
Identities = 71/271 (26%), Positives = 111/271 (40%), Gaps = 31/271 (11%)
Query: 62 IGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+ ++G G G V + G++ VAIK + + R E+ +M ++ H
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQ-VAIKQCRQELSPKNRERWC----LEIQIMKKLNHP 72
Query: 119 NLVKFL-------GACKDPLMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFALDIAR 170
N+V + L ++ E G LRKYL L DI+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 171 AMDCLHANGIIHRDLKPDNLLL--TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 228
A+ LH N IIHRDLKP+N++L P + K+ D G A+E E+ T GT +++AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFKHARP 286
EL E+K Y VD +SFG + +E +T PF +
Sbjct: 193 ELL--------EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244
Query: 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 317
+ +D++ + F S + PN
Sbjct: 245 VVYDDLTGAVKF---SSVLPTPNHLSGILAG 272
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 7e-49
Identities = 66/266 (24%), Positives = 124/266 (46%), Gaps = 26/266 (9%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G+ +G+G+ VY VAIK++++ + + R EV + ++KH +
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG--MVQRVQNEVKIHCQLKHPS 72
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+++ +D V +V E+ + +YL + R + A +F I M LH++
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH 131
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAPELYSTVTLR 237
GI+HRDL NLLLT ++K+ADFGLA + + E GT +++PE+ +
Sbjct: 132 GILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT----- 185
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY----AAAFKHARPGLPEDIS 293
+ + + DV+S G + + LL R PF+ ++ A ++ +P +S
Sbjct: 186 ---RSAHGLESDVWSLGCMFYTLLIGRPPFDT-DTVKNTLNKVVLADYE-----MPSFLS 236
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIR 319
+ ++ +P R S S ++
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-48
Identities = 68/263 (25%), Positives = 123/263 (46%), Gaps = 23/263 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG +G+G G VY R I+A+KVL + +E + REV + S ++H N
Sbjct: 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPN 70
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+++ G D V ++ E P ++ + L + +K D + ++A A+ H+
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHSK 128
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
+IHRD+KP+NLLL + LK+ADFG + GT ++ PE+
Sbjct: 129 RVIHRDIKPENLLLGSAGE-LKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMI----- 179
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDL 296
E + ++ KVD++S G++ +E L + PFE + Q Y + P+ ++
Sbjct: 180 ---EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISR-VEFTFPDFVTEGA 234
Query: 297 AFIVQSCWVEDPNLRPSFSQIIR 319
++ +P+ RP +++
Sbjct: 235 RDLISRLLKHNPSQRPMLREVLE 257
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-48
Identities = 78/282 (27%), Positives = 119/282 (42%), Gaps = 40/282 (14%)
Query: 64 SKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG G GKVY+G D VA+K S+ E F E+ +S +H +LV
Sbjct: 45 FLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE---E--FETEIETLSFCRHPHLVS 99
Query: 123 FLGACKDPL-MVIVTELLPGMSLRKYL--VSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+G C + M+++ + + +L+++L L + L + AR + LH
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159
Query: 180 IIHRDLKPDNLLLTPDQK-SLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVT 235
IIHRD+K N+LL D+ K+ DFG+++ E T + T GT ++ PE +
Sbjct: 160 IIHRDVKSINILL--DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-- 215
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF-----EGMSNLQAAYAAAFKHAR----- 285
K DVYSFG+VL+E+L R M NL A +A +
Sbjct: 216 ------GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL-AEWAVESHNNGQLEQI 268
Query: 286 --PGLPEDISPDLAF----IVQSCWVEDPNLRPSFSQIIRML 321
P L + I P+ C RPS ++ L
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 6e-48
Identities = 79/288 (27%), Positives = 123/288 (42%), Gaps = 35/288 (12%)
Query: 56 DPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGR--FIREVNMMS 113
+ + G+K+GEG G VY+G + VA+K L E + F +E+ +M+
Sbjct: 29 ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVD---ITTEELKQQFDQEIKVMA 85
Query: 114 RVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARA 171
+ +H+NLV+ LG D + +V +P SL L L L H+ A A
Sbjct: 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANG 145
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAP 228
++ LH N IHRD+K N+LL + K++DFGLAR + T M + GT +MAP
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTA-KISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE---GMSNLQAAYAAAFKHAR 285
E G K D+YSFG+VL E++T + L +
Sbjct: 205 E-ALR-----G---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LDIKEEIEDEE 254
Query: 286 PGLPEDISPDL-----------AFIVQSCWVEDPNLRPSFSQIIRMLN 322
+ + I + + C E N RP ++ ++L
Sbjct: 255 KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 9e-48
Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 19/261 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG +G+G G VY R I+A+KVL + E +E + RE+ + S ++H N
Sbjct: 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG--VEHQLRREIEIQSHLRHPN 75
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+++ D + ++ E P L K L + + D + F ++A A+ H
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQRSATFMEELADALHYCHER 133
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
+IHRD+KP+NLL+ + LK+ADFG + T GT ++ PE+
Sbjct: 134 KVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM-CGTLDYLPPEMI------- 184
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298
E K ++ KVD++ G++ +E L PF+ + + P +S
Sbjct: 185 -EGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVN-VDLKFPPFLSDGSKD 241
Query: 299 IVQSCWVEDPNLRPSFSQIIR 319
++ P R ++
Sbjct: 242 LISKLLRYHPPQRLPLKGVME 262
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-47
Identities = 74/290 (25%), Positives = 120/290 (41%), Gaps = 42/290 (14%)
Query: 62 IGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +G G G VYE +RIVA+K+++ +SD R RE R++ +
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRT--RMQREARTAGRLQEPH 95
Query: 120 LVKF--LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+V G D + + L+ G+ L L P L A+ I A+D HA
Sbjct: 96 VVPIHDFGE-IDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHA 152
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTV 234
G HRD+KP+N+L++ D L DFG+A +E +T++ GT +MAPE
Sbjct: 153 AGATHRDVKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNT-VGTLYYMAPE----- 205
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH----------A 284
+ + H + D+Y+ VL+E LT P++G + H
Sbjct: 206 ---RFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-----LSVMGAHINQAIPRPSTV 257
Query: 285 RPGLPEDISPDLAFIVQSCWVEDPNLR-PSFSQIIRMLNAFLFTLRPPSP 333
RPG+P ++ ++P R + + +A L T
Sbjct: 258 RPGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRA 303
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-47
Identities = 52/296 (17%), Positives = 107/296 (36%), Gaps = 46/296 (15%)
Query: 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERAL------------LEGRFIREV 109
I + +G K+ ++ A+K + +R F E+
Sbjct: 35 IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 110 NMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVS------LRPNKLDLHVAL 162
+++ +K++ + G + V I+ E + S+ K+ + + V
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 163 NFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 221
+ + +H I HRD+KP N+L+ + +KL+DFG + ++ + G
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKKIKGSR-G 212
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY---- 277
TY +M PE +S E + KVD++S GI L+ + N +PF +L +
Sbjct: 213 TYEFMPPEFFS------NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 278 --------------AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+S + ++ ++P R + ++
Sbjct: 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-46
Identities = 46/342 (13%), Positives = 109/342 (31%), Gaps = 49/342 (14%)
Query: 13 REEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHG 72
+ + ++++ + S ++ G ++ L P+ L G+ +G+
Sbjct: 32 PQANVRTTSEYMQSAADSLVSTSLWNTGQ----PFRVESELGERPRTLVRGTVLGQEDPY 87
Query: 73 KVYEGRYGD--RIVAIKVLNRGSTSDER-----------------------ALLEGRFIR 107
E + + V A + RFI
Sbjct: 88 AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147
Query: 108 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGM-----SLRKYLVSL--RPNKLDLHV 160
+++ + +++ +D ++ L P M + + L+S L H
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 220
L L + R + LH G++H L+P +++L + L F + +
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEHLVRDG---ARVVSS 263
Query: 221 GTYRWMAPEL---YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
+ + PEL +T++ + + D ++ G+V++ + LP
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK-DAALGGS 322
Query: 278 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
F+ ++I + +++ R Q +
Sbjct: 323 EWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 63/286 (22%), Positives = 105/286 (36%), Gaps = 42/286 (14%)
Query: 62 IGSKIGEGAHGKVYEG---RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+ I G G +Y R V +K L ++ +A + E ++ V H
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQA----MAMAERQFLAEVVHP 139
Query: 119 NLVK------FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++V+ DP+ IV E + G SL+ + KL + A+ + L+I A+
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK----RSKGQKLPVAEAIAYLLEILPAL 195
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
LH+ G+++ DLKP+N++LT +Q LKL D G + GT + APE+
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEEQ--LKLIDLGAVSRINSFGYL---YGTPGFQAPEIVR 250
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE-D 291
T D+Y+ G L L + G P
Sbjct: 251 T---------GPTVATDIYTVGRTLAALTLDLPTRNG---------RYVDGLPEDDPVLK 292
Query: 292 ISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLRPPSPSVP 336
+++ DP R + ++ L L + VP
Sbjct: 293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-46
Identities = 72/320 (22%), Positives = 122/320 (38%), Gaps = 49/320 (15%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HD 118
+ + EG VYE + R A+K L RA+ I+EV M ++ H
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI-----IQEVCFMKKLSGHP 86
Query: 119 NLVKFLGACKDP---------LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDI 168
N+V+F A +++TEL G L ++L + L L
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 169 ARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT------------- 213
RA+ +H IIHRDLK +NLLL+ +Q ++KL DFG A +
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
E T + PE+ + K D+++ G +L+ L + PFE + L
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYS-----NFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
Query: 274 QAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331
+ + +P ++++ +P R S ++++ L + R
Sbjct: 260 ------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE-IAAARNV 312
Query: 332 SPSVPESDTNEAAATSNGAM 351
+P P ++ E A
Sbjct: 313 NPKSPITELLEQNGGYGSAT 332
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-45
Identities = 84/278 (30%), Positives = 138/278 (49%), Gaps = 26/278 (9%)
Query: 43 TAPQLTIDRSLLVDPKLLF-IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERA 99
L ++L DP+ LF KIG+G+ G+V++G ++VAIK+++ DE
Sbjct: 6 VQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE 65
Query: 100 LLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD- 157
+ +E+ ++S+ + K+ G+ KD + I+ E L G S L P LD
Sbjct: 66 DI----QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDE 118
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 217
+A +I + +D LH+ IHRD+K N+LL+ + +KLADFG+A + T T +
Sbjct: 119 TQIAT-ILREILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDT-QIK 175
Query: 218 AET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275
T GT WMAPE V + Y++K D++S GI EL P + ++
Sbjct: 176 RNTFVGTPFWMAPE----VIKQSA----YDSKADIWSLGITAIELARGEPPHSELHPMKV 227
Query: 276 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 313
+ K+ P L + S L V++C ++P+ RP+
Sbjct: 228 LFLIP-KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 264
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-45
Identities = 62/269 (23%), Positives = 106/269 (39%), Gaps = 28/269 (10%)
Query: 62 IGSKIGEGAHGK-VYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDN 119
+G GA G VY G + +R VA+K + S REV ++ +H N
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--------REVQLLRESDEHPN 79
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++++ KD I EL +L++Y+ + + + LH+
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 179 GIIHRDLKPDNLLLTPDQKS----LKLADFGLAR----EETVTEMMTAETGTYRWMAPEL 230
I+HRDLKP N+L++ ++DFGL + + GT W+APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYA-AAFKHARPGL 288
L + K++ VD++S G V + +++ PF QA A
Sbjct: 198 -----LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252
Query: 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQI 317
+ +++ DP RPS +
Sbjct: 253 EKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-44
Identities = 75/274 (27%), Positives = 134/274 (48%), Gaps = 22/274 (8%)
Query: 55 VDPKLLF-IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNM 111
+DP ++ I ++G+GA GKVY+ + + + A KV+ S + +I E+ +
Sbjct: 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-----YIVEIEI 69
Query: 112 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDIA 169
++ H +VK LGA D + I+ E PG ++ ++ L + + +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQML 127
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMA 227
A++ LH+ IIHRDLK N+L+T + ++LADFG++ + T + ++ GT WMA
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKT-LQKRDSFIGTPYWMA 185
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287
PE+ V + Y+ K D++S GI L E+ P ++ ++ A K P
Sbjct: 186 PEV---VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPPT 241
Query: 288 L--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
L P S + ++ ++P RPS +Q++
Sbjct: 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 47/362 (12%), Positives = 110/362 (30%), Gaps = 49/362 (13%)
Query: 13 REEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHG 72
+ + ++++ + S ++ G ++ L P+ L G+ +G+
Sbjct: 37 PQANVRTTSEYMQSAADSLVSTSLWNTGQ----PFRVESELGERPRTLVRGTVLGQEDPY 92
Query: 73 KVYEGR--YGDRIVAIKVLN-----------------------RGSTSDERALLEGRFIR 107
E + V RG + ++A + RFI
Sbjct: 93 AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152
Query: 108 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLP-----GMSLRKYLVSL--RPNKLDLHV 160
+++ + +++ +D ++ L P + + L+S L H
Sbjct: 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 212
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 220
L L + R + LH G++H L+P +++L + L F + + +
Sbjct: 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGASAVSPIGR 271
Query: 221 --GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
A + Q D ++ G+ ++ + LP
Sbjct: 272 GFAPPETTAERMLPF---GQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSE 327
Query: 279 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPES 338
F+ ++I + +++ R Q + + S ++P
Sbjct: 328 WIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET-PEYEQLRTELSAALPLY 381
Query: 339 DT 340
T
Sbjct: 382 QT 383
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-44
Identities = 55/289 (19%), Positives = 113/289 (39%), Gaps = 39/289 (13%)
Query: 58 KLLFIGSKIGEGAHGKV-YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
L+ +G G+ G V ++G + R VA+K + + E+ +++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD--------IALMEIKLLTESD 66
Query: 117 -HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLV-----SLRPNKLDLHVALNFALDIA 169
H N++++ + + I EL +L+ + + ++ IA
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKS------------LKLADFGLAR-----EETV 212
+ LH+ IIHRDLKP N+L++ + + ++DFGL + + +
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMS 271
+ +GT W APEL Q K+ +D++S G V + +L+ + PF
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQT-KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 272 NLQAAYAAA---FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 317
+ ++ + + + ++ DP RP+ ++
Sbjct: 245 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-44
Identities = 81/287 (28%), Positives = 140/287 (48%), Gaps = 28/287 (9%)
Query: 48 TIDRSLLVDPKLLF-IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGR 104
ID S L DP +F + +G G +G+VY+GR+ ++ AIKV++ T DE +
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEI--- 67
Query: 105 FIREVNMMSRV-KHDNLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNKL 156
+E+NM+ + H N+ + GA D + +V E S+ + + + N L
Sbjct: 68 -KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 157 D-LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215
+A +I R + LH + +IHRD+K N+LLT + +KL DFG++ + T +
Sbjct: 127 KEEWIAY-ICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRT-V 183
Query: 216 MTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
T GT WMAPE+ + + Y+ K D++S GI E+ P M +
Sbjct: 184 GRRNTFIGTPYWMAPEV---IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240
Query: 274 QAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+A + ++ P L + S ++SC V++ + RP+ Q+++
Sbjct: 241 RALFLIP-RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-43
Identities = 81/316 (25%), Positives = 139/316 (43%), Gaps = 26/316 (8%)
Query: 6 SEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLF-IGS 64
S + + + +++ A + GS+ P + + DP+ LF
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVA-ELFFKDDPEKLFSDLR 60
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+IG G+ G VY R +VAIK ++ + I+EV + +++H N ++
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD--IIKEVRFLQKLRHPNTIQ 118
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDIARAMDCLHANGI 180
+ G ++ +V E G + L+ + L + +A + + LH++ +
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAYLHSHNM 175
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQ 238
IHRD+K N+LL+ + +KL DFG A + M A + GT WMAPE+ +
Sbjct: 176 IHRDVKAGNILLS-EPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEV-----ILA 224
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLA 297
++ Y+ KVDV+S GI EL + P M+ + A Y A ++ P L S
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPALQSGHWSEYFR 283
Query: 298 FIVQSCWVEDPNLRPS 313
V SC + P RP+
Sbjct: 284 NFVDSCLQKIPQDRPT 299
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 3e-43
Identities = 47/262 (17%), Positives = 93/262 (35%), Gaps = 37/262 (14%)
Query: 45 PQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDE 97
P + + KL+++ +GEGA +VYE GD + +KV + +
Sbjct: 52 PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF 111
Query: 98 RALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNK- 155
+ + + +KF A V+V EL +L + +
Sbjct: 112 YIGT-----QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166
Query: 156 --LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP----------DQKSLKLAD 203
+ + ++FA+ + ++ +H IIH D+KPDN +L L L D
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226
Query: 204 FGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260
G + + + + TA+ T + E+ K +N ++D + ++ +
Sbjct: 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEML--------SNKPWNYQIDYFGVAATVYCM 278
Query: 261 LTNRLPFEGMSNLQAAYAAAFK 282
L + F+
Sbjct: 279 LFGTYMKVKNEGGECKPEGLFR 300
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-43
Identities = 48/349 (13%), Positives = 93/349 (26%), Gaps = 51/349 (14%)
Query: 11 VGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGA 70
+ REE + AV + T+D L + L + + G
Sbjct: 15 LKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGD 74
Query: 71 HGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--------- 119
V+ R A+KV G+ + L R +R+ ++
Sbjct: 75 RSVVFLVRDVERLEDFALKVFTMGAENSRSEL--ERLHEATFAAARLLGESPEEARDRRR 132
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRK----YLV------------------SLRPNKLD 157
L+ A +L PG L+ +
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 217
+ + R L + G++H PDNL + PD L L D +
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLGDVSALWKV--GTRGP 249
Query: 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
A + + E + + ++ + G+ ++ + LPF ++
Sbjct: 250 ASSVPVTYAPRE------FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
Query: 278 AAAFKHARPGLPE-------DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
PG + + ++ D R + +
Sbjct: 304 WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-43
Identities = 78/319 (24%), Positives = 134/319 (42%), Gaps = 39/319 (12%)
Query: 29 VEKESRAVVKNGSI-----TAPQLTIDRSLLVDPKLLF---------IGSKIGEGAHGKV 74
V K R + N S + ++ + L VD + ++ + +G GA G+V
Sbjct: 92 VGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV 151
Query: 75 YEG--RYGDRIVAIKVLNR---GSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129
R + VAI+++++ S A E+ ++ ++ H ++K
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211
Query: 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189
IV EL+ G L +V +L + + A+ LH NGIIHRDLKP+N
Sbjct: 212 EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 269
Query: 190 LLLTPDQK--SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 247
+LL+ ++ +K+ DFG ++ T +M GT ++APE+ L YN
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV-----LVSVGTAGYNRA 324
Query: 248 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE----DISP---DLAFIV 300
VD +S G++L+ L+ PF Q + + ++S DL V
Sbjct: 325 VDCWSLGVILFICLSGYPPFSE-HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL---V 380
Query: 301 QSCWVEDPNLRPSFSQIIR 319
+ V DP R + + +R
Sbjct: 381 KKLLVVDPKARFTTEEALR 399
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 74/269 (27%), Positives = 118/269 (43%), Gaps = 31/269 (11%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
K+G GA G V+ R IK +N+ + +E E+ ++ + H N
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE----AEIEVLKSLDHPN 81
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDIARAMDCLH 176
++K +D + IV E G L + +VS + L + A+ H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 177 ANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
+ ++H+DLKP+N+L S +K+ DFGLA E T GT +MAPE++
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF--- 198
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPED 291
K+ K D++S G+V++ LLT LPF G S Q A +A
Sbjct: 199 ------KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE--CRP 250
Query: 292 ISP---DLAFIVQSCWVEDPNLRPSFSQI 317
++P DL ++ +DP RPS +Q+
Sbjct: 251 LTPQAVDL---LKQMLTKDPERRPSAAQV 276
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 2e-42
Identities = 69/329 (20%), Positives = 109/329 (33%), Gaps = 82/329 (24%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKV--LNRGSTSDERALLEGR------------- 104
+G G G V+E + D AIK L + E+ + E +
Sbjct: 10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 105 --------------------------------------FIREVNMMSRVKHDNLVKFLGA 126
++ M N V L
Sbjct: 70 FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 127 CKDPLMV-IVTELLPGMSLRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 184
+ + I +L +L+ ++ + V L+ + IA A++ LH+ G++HRD
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRD 189
Query: 185 LKPDNLLLTPDQKSLKLADFGLAR-------------EETVTEMMTAETGTYRWMAPELY 231
LKP N+ T D +K+ DFGL T + GT +M+PE
Sbjct: 190 LKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE-- 246
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291
Q +Y++KVD++S G++L+ELL F P L
Sbjct: 247 ------QIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQ 297
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320
P +VQ P RP + II
Sbjct: 298 KYPQEHMMVQDMLSPSPTERPEATDIIEN 326
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-42
Identities = 82/284 (28%), Positives = 121/284 (42%), Gaps = 41/284 (14%)
Query: 65 KIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTS-DERALLEGRFIREVNMMSRVKHDNLVK 122
+G G GKVY+GR D +VA+K L T E F EV M+S H NL++
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ-----FQTEVEMISMAVHRNLLR 91
Query: 123 FLGACKDPLM-VIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLH--A 177
G C P ++V + S+ L ++ LD AL AR + LH
Sbjct: 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151
Query: 178 N-GIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTV 234
+ IIHRD+K N+LL + ++ + DFGLA+ + T + TA GT +APE ST
Sbjct: 152 DPKIIHRDVKAANILLDEEFEA-VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST- 209
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-----GLP 289
G + K DV+ +G++L EL+T + F+ + L
Sbjct: 210 ----G---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262
Query: 290 EDISPDL------------AFIVQSCWVEDPNLRPSFSQIIRML 321
+ DL + C P RP S+++RML
Sbjct: 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-42
Identities = 69/273 (25%), Positives = 112/273 (41%), Gaps = 37/273 (13%)
Query: 65 KIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG GA V VAIK +N L ++E+ MS+ H N+V
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL----LKEIQAMSQCHHPNIVS 77
Query: 123 FLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN------FALDIARAMDCL 175
+ + + +V +LL G S+ + + L+ ++ ++ L
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFG----LAREETVTEMMTAET--GTYRWMAPE 229
H NG IHRD+K N+LL + S+++ADFG LA +T +T GT WMAPE
Sbjct: 138 HKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289
+ + + Y+ K D++SFGI EL T P+ ++ ++ P L
Sbjct: 197 VME-------QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPPSLE 248
Query: 290 EDI---------SPDLAFIVQSCWVEDPNLRPS 313
+ ++ C +DP RP+
Sbjct: 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-42
Identities = 86/290 (29%), Positives = 134/290 (46%), Gaps = 31/290 (10%)
Query: 56 DPKLLF-IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DPK + KIG+GA G VY + VAI+ +N + + I E+ +M
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-----INEILVM 71
Query: 113 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDIAR 170
K+ N+V +L + + +V E L G SL + +D +A + +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAA-VCRECLQ 127
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAP 228
A++ LH+N +IHRD+K DN+LL S+KL DFG + T T GT WMAP
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAP 185
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288
E+ + +K Y KVD++S GI+ E++ P+ + L+A Y A + P L
Sbjct: 186 EVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPEL 236
Query: 289 --PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 336
PE +S + C D R S ++++ + FL +P S P
Sbjct: 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HQFLKIAKPLSSLTP 284
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-42
Identities = 81/290 (27%), Positives = 133/290 (45%), Gaps = 31/290 (10%)
Query: 56 DPKLLF-IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DP+LL KIGEG+ G V R R VA+K+++ L EV +M
Sbjct: 42 DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL-----FNEVVIM 96
Query: 113 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDIAR 170
+H N+V+ + + ++ E L G +L + +L+ +A + +
Sbjct: 97 RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIAT-VCEAVLQ 152
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAP 228
A+ LHA G+IHRD+K D++LLT +KL+DFG + + + ++ GT WMAP
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKD-VPKRKSLVGTPYWMAP 210
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288
E+ S + Y +VD++S GI++ E++ P+ S +QA P L
Sbjct: 211 EVIS--------RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-DSPPPKL 261
Query: 289 --PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 336
+SP L ++ V DP R + +++ + FL P VP
Sbjct: 262 KNSHKVSPVLRDFLERMLVRDPQERATAQELLD--HPFLLQTGLPECLVP 309
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 63/266 (23%), Positives = 111/266 (41%), Gaps = 27/266 (10%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERAL-LEGRFIREVNMMSRVKHD 118
+G +G G G VY G VAIK + + SD L R EV ++ +V
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 119 --NLVKFLGACKDPLM-VIVTEL-LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+++ L + P V++ E P L ++ L +A +F + A+
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRH 164
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
H G++HRD+K +N+L+ ++ LKL DFG T + GT + PE
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIR-- 221
Query: 235 TLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293
Y+ V+S GI+L++++ +PFE + + + +S
Sbjct: 222 ------YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVS 267
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIR 319
+ +++ C P+ RP+F +I
Sbjct: 268 SECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 25/293 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +GEG++GKV E + A+K+L + E +E+ ++ R++H N
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 120 LVKF---LGACKDPLMVIVTELLPG--MSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+++ L + M +V E + + + + A + + ++
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEY 124
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTYRWMAPELY 231
LH+ GI+H+D+KP NLLLT +LK++ G+A + G+ + PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291
+ G KVD++S G+ L+ + T PFEG N+ + K +P D
Sbjct: 184 N------GLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGK-GSYAIPGD 235
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRM--LNAFLFTLRPPSPSVPESDTNE 342
P L+ +++ +P R S QI + P P P DT +
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKD 288
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNR---GSTSDERALLEGRFIREVNMMSRVK 116
+ +G GA G+V R + VAIK++++ S A E+ ++ ++
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 117 HDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
H ++K IV EL+ G L +V +L + + A+ LH
Sbjct: 74 HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLH 131
Query: 177 ANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
NGIIHRDLKP+N+LL + ++ +K+ DFG ++ T +M GT ++APE+
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV---- 187
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE---- 290
L YN VD +S G++L+ L+ PF Q + +
Sbjct: 188 -LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSLKDQITSGKYNFIPEVWA 245
Query: 291 DISP---DLAFIVQSCWVEDPNLRPSFSQIIR 319
++S DL V+ V DP R + + +R
Sbjct: 246 EVSEKALDL---VKKLLVVDPKARFTTEEALR 274
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-41
Identities = 63/288 (21%), Positives = 124/288 (43%), Gaps = 42/288 (14%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNR---------------------GSTSDER 98
+ +IG+G++G V + A+KVL++ +
Sbjct: 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 99 ALLEGRFIREVNMMSRVKHDNLVKF---LGACKDPLMVIVTELLPGMSLRKYLVSLRPNK 155
+ +E+ ++ ++ H N+VK L + + +V EL+ + +
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKP 133
Query: 156 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215
L A + D+ + ++ LH IIHRD+KP NLL+ + +K+ADFG++ E ++
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDA 192
Query: 216 MTAET-GTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNL 273
+ + T GT +MAPE S +K ++ +DV++ G+ L+ + + PF +
Sbjct: 193 LLSNTVGTPAFMAPESLS------ETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERI 245
Query: 274 QAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
++ K P+ DI+ DL ++ ++P R +I
Sbjct: 246 MCLHSKI-KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-41
Identities = 66/261 (25%), Positives = 119/261 (45%), Gaps = 18/261 (6%)
Query: 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNM-MSRVKHDNL 120
++G GA+G V + R+ +I+A+K + S E+ R + ++++ M V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK----RLLMDLDISMRTVDCPFT 68
Query: 121 VKFLGAC-KDPLMVIVTELLPGMSLRKYL--VSLRPNKLDLHVALNFALDIARAMDCLHA 177
V F GA ++ + I EL+ SL K+ V + + + A+ I +A++ LH+
Sbjct: 69 VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 178 NG-IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
+IHRD+KP N+L+ +K+ DFG++ + G +MAPE
Sbjct: 128 KLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE----RIN 182
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI-SPD 295
+ +K Y+ K D++S GI + EL R P++ + P LP D S +
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAE 242
Query: 296 LAFIVQSCWVEDPNLRPSFSQ 316
C ++ RP++ +
Sbjct: 243 FVDFTSQCLKKNSKERPTYPE 263
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-41
Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 29/267 (10%)
Query: 56 DPKLLF-IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
P+ +F + K+GEG++G VY+ + + +IVAIK + S E I+E+++M
Sbjct: 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-------IIKEISIM 78
Query: 113 SRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDIAR 170
+ ++VK+ G+ K+ + IV E S+ ++ LR L +A +
Sbjct: 79 QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQSTLK 136
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAP 228
++ LH IHRD+K N+LL + KLADFG+A + T T M T GT WMAP
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDT-MAKRNTVIGTPFWMAP 194
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288
E+ + YN D++S GI E+ + P+ + ++A + + P
Sbjct: 195 EVIQ--------EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP-TNPPPTF 245
Query: 289 --PEDISPDLAFIVQSCWVEDPNLRPS 313
PE S + V+ C V+ P R +
Sbjct: 246 RKPELWSDNFTDFVKQCLVKSPEQRAT 272
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-41
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 29/268 (10%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERAL-LEGRFIREVNMMSRV--- 115
+G +G+G G V+ G VAIKV+ R L EV ++ +V
Sbjct: 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 116 -KHDNLVKFLGACKDPLM-VIVTEL-LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
H +++ L + ++V E LP L Y+ L + F + A+
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAI 152
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
H+ G++HRD+K +N+L+ + KL DFG + GT + PE S
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRVYSPPEWIS 211
Query: 233 TVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291
+ Y+ V+S GI+L++++ +PFE + A P
Sbjct: 212 --------RHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--------LEAELHFPAH 255
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+SPD +++ C P+ RPS +I+
Sbjct: 256 VSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 23/264 (8%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
K+G GA+G+V + AIK++ + S S + + EV ++ + H N
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS---NSKLLEEVAVLKLLDHPN 97
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K +D +V E G L ++ K + A + + LH +
Sbjct: 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
I+HRDLKP+NLLL + ++ + +K+ DFGL+ + M GT ++APE+
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL----- 210
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDIS 293
+K Y+ K DV+S G++L+ LL PF G ++ L+ + P ++S
Sbjct: 211 ----RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK-NVS 265
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQI 317
+++ D R S Q
Sbjct: 266 EGAKDLIKQMLQFDSQRRISAQQA 289
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-40
Identities = 62/268 (23%), Positives = 105/268 (39%), Gaps = 33/268 (12%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ + IG G+ G+V + A K + + D +E+ +M + H N
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK-----QEIEIMKSLDHPN 67
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+++ +D + +V EL G L + +V A D+ A+ H
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL 125
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
+ HRDLKP+N L T S LKL DFGLA +MM + GT +++P++
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL----- 180
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----I 292
+ Y + D +S G++++ LL PF + PE +
Sbjct: 181 ----EGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKI-REGTFTFPEKDWLNV 234
Query: 293 SP---DLAFIVQSCWVEDPNLRPSFSQI 317
SP L ++ + P R + Q
Sbjct: 235 SPQAESL---IRRLLTKSPKQRITSLQA 259
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 69/264 (26%), Positives = 123/264 (46%), Gaps = 23/264 (8%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +G+G+ G+V + R + A+KV+N+ S ++ +REV ++ ++ H N
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD---TSTILREVELLKKLDHPN 82
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K +D IV EL G L ++ + H A + + +H +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH 140
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
I+HRDLKP+N+LL + ++ +K+ DFGL+ M GT ++APE+
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL----- 195
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDIS 293
+ Y+ K DV+S G++L+ LL+ PF G + L+ + P IS
Sbjct: 196 ----RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-TIS 250
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQI 317
D +++ P+LR + +Q
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQC 274
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 66/308 (21%), Positives = 113/308 (36%), Gaps = 57/308 (18%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ IG+G++G V I AIK++N+ R EV +M ++ H N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHV------------------ 160
+ + +D + +V EL G L L +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 161 --------------------ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-L 199
N I A+ LH GI HRD+KP+N L + ++ +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209
Query: 200 KLADFGLAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 254
KL DFGL++ MT + GT ++APE+ L + Y K D +S G
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV-----LN-TTNESYGPKCDAWSAG 263
Query: 255 IVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 311
++L LL +PF G+++ + P +SP ++ + + + R
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYN-VLSPLARDLLSNLLNRNVDER 322
Query: 312 PSFSQIIR 319
+ ++
Sbjct: 323 FDAMRALQ 330
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-40
Identities = 59/259 (22%), Positives = 113/259 (43%), Gaps = 17/259 (6%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLV 121
++G G G+V++ R+ ++A+K + R +E R + +++ ++ +V
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK----RILMDLDVVLKSHDCPYIV 87
Query: 122 KFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NG 179
+ G + + I EL+ + + + + + I +A+ L +G
Sbjct: 88 QCFGTFITNTDVFIAMELMGTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
+IHRD+KP N+LL ++ +KL DFG++ + G +MAPE +
Sbjct: 146 VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI--SPDLA 297
Y+ + DV+S GI L EL T + P++ + P LP + S D
Sbjct: 205 ---DYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ 261
Query: 298 FIVQSCWVEDPNLRPSFSQ 316
V+ C +D RP +++
Sbjct: 262 SFVKDCLTKDHRKRPKYNK 280
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-40
Identities = 61/266 (22%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNR---GSTSDERALLEGRFIREVNMMSRVK 116
S +G GA G V+ + + V +K + + G+ E+ ++SRV+
Sbjct: 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 117 HDNLVKFLGACKDPLMV-IVTEL-LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
H N++K L ++ +V E G+ L ++ R +LD +A + A+
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGY 145
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
L IIHRD+K +N+++ + ++KL DFG A ++ GT + APE+
Sbjct: 146 LRLKDIIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM-- 202
Query: 235 TLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293
Y +++++S G+ L+ L+ PF L+ AA P +S
Sbjct: 203 ------GNPYRGPELEMWSLGVTLYTLVFEENPFC---ELEETVEAAIH-----PPYLVS 248
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIR 319
+L +V P R + +++
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-40
Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 22/280 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +G G GKV G + VA+K+LNR + G+ RE+ + +H +
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHPH 72
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K P +V E + G L Y+ +++ A I A+D H +
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH 130
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
++HRDLKP+N+LL + K+ADFGL+ + E + G+ + APE+ S
Sbjct: 131 MVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS------ 183
Query: 239 GEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 297
+ Y +VD++S G++L+ LL LPF+ ++ + +PE ++ +A
Sbjct: 184 --GRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRG-GVFYIPEYLNRSVA 239
Query: 298 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 337
++ DP R + I F PS PE
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHE---WFKQDLPSYLFPE 276
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-40
Identities = 61/264 (23%), Positives = 119/264 (45%), Gaps = 22/264 (8%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G+G+ G+V + + A+KV+++ + + +REV ++ ++ H N
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLDHPN 87
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K +D +V E+ G L ++S + A + + +H N
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN 145
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
I+HRDLKP+NLLL + + + +++ DFGL+ ++ M + GT ++APE+
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL----- 200
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDIS 293
Y+ K DV+S G++L+ LL+ PF G + L+ + P +S
Sbjct: 201 ----HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVS 255
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQI 317
+++ P++R S
Sbjct: 256 ESAKDLIRKMLTYVPSMRISARDA 279
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 69/282 (24%), Positives = 128/282 (45%), Gaps = 20/282 (7%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEG 103
+++ ++ + L +IG GA+G V + + +I+A+K + E+
Sbjct: 10 KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK---- 65
Query: 104 RFIREVN-MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLR--KYLVSLRPNKLDLH 159
+ + +++ +M +V+F GA ++ I EL+ + KY+ S+ + +
Sbjct: 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125
Query: 160 VALNFALDIARAMDCLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 218
+ L +A++ L N IIHRD+KP N+LL ++KL DFG++ + + T
Sbjct: 126 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTR 184
Query: 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
+ G +MAPE ++ Y+ + DV+S GI L+EL T R P+ +++
Sbjct: 185 DAGCRPYMAPE----RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240
Query: 279 AAFKHARPGLPEDI----SPDLAFIVQSCWVEDPNLRPSFSQ 316
K P L SP V C +D + RP + +
Sbjct: 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-40
Identities = 75/262 (28%), Positives = 126/262 (48%), Gaps = 20/262 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ IG+G KV R+ R VAIK++++ + + REV +M + H N
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS---LQKLFREVRIMKILNHPN 75
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+VK + + ++ E G + YLV+ ++ A + I A+ H
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
I+HRDLK +NLLL ++K+ADFG + E TV + A G + APEL+
Sbjct: 134 RIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ------ 186
Query: 239 GEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 297
K Y+ +VDV+S G++L+ L++ LPF+G NL+ + +P +S D
Sbjct: 187 --GKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR-ERVLRGKYRIPFYMSTDCE 242
Query: 298 FIVQSCWVEDPNLRPSFSQIIR 319
+++ V +P R + QI++
Sbjct: 243 NLLKRFLVLNPIKRGTLEQIMK 264
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 67/272 (24%), Positives = 120/272 (44%), Gaps = 28/272 (10%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEG--------RFIREVNM 111
K+G GA+G+V + G AIKV+ + R + E+++
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 112 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+ + H N++K +D +VTE G L + +++ +K D A N I
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILS 157
Query: 171 AMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 228
+ LH + I+HRD+KP+N+LL + +K+ DFGL+ + + GT ++AP
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHAR 285
E+ KK YN K DV+S G++++ LL PF G ++ ++ +
Sbjct: 218 EVL---------KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
Query: 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 317
+IS + +++ D N R + +
Sbjct: 269 NDWK-NISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-39
Identities = 72/349 (20%), Positives = 129/349 (36%), Gaps = 91/349 (26%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
L +G +G GA G+V E R VA+K+L G+T E +
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR----ALMS 74
Query: 108 EVNMMSRV---------------------------KHDNLVKFLGACKDPLMVIVTELLP 140
E+ ++ + K NL +L + ++ + T+
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGAR 134
Query: 141 GMSLRKYLVS----------------------------------------LRPNKLDLHV 160
+ Y+ + L + L L
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 220
+ ++ +A+ M+ L + IHRDL N+LL+ +K+ DFGLAR+ +
Sbjct: 195 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKG 253
Query: 221 GT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAA 276
+WMAPE + Y + DV+SFG++LWE+ + P+ G+ +
Sbjct: 254 DARLPLKWMAPE--------TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
Query: 277 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+ R P+ +P++ + CW +P+ RP+FS+++ L L
Sbjct: 306 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-39
Identities = 68/268 (25%), Positives = 122/268 (45%), Gaps = 31/268 (11%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +G+G+ G+V + R + A+KV+N+ S ++ +REV ++ ++ H N
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD---TSTILREVELLKKLDHPN 82
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K +D IV EL G L ++ + H A + + +H +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH 140
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
I+HRDLKP+N+LL + ++ +K+ DFGL+ M GT ++APE+
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL----- 195
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----I 292
+ Y+ K DV+S G++L+ LL+ PF G + + + + I
Sbjct: 196 ----RGTYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETGKYAFDLPQWRTI 249
Query: 293 SP---DLAFIVQSCWVEDPNLRPSFSQI 317
S DL ++ P+LR + +Q
Sbjct: 250 SDDAKDL---IRKMLTFHPSLRITATQC 274
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-38
Identities = 69/266 (25%), Positives = 120/266 (45%), Gaps = 23/266 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +GEGA+G+V VA+K+++ D +E+ + + H+N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLNHEN 66
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+VKF G ++ + + E G L + + A F + + LH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTYRWMAPELYSTVT 235
GI HRD+KP+NLLL ++ +LK++DFGLA R ++ GT ++APEL
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--- 180
Query: 236 LRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDIS 293
++ ++ VDV+S GIVL +L LP++ S+ Y+ + P + I
Sbjct: 181 -----RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIR 319
++ VE+P+ R + I +
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKK 261
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 77/285 (27%), Positives = 130/285 (45%), Gaps = 23/285 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +GEG+ GKV + + VA+K ++R + R RE++ + ++H +
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSD--MHMRVEREISYLKLLRHPH 70
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K P + +V E G L Y+V + ++ F I A++ H +
Sbjct: 71 IIKLYDVITTPTDIVMVIEYAGG-ELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH 127
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
I+HRDLKP+NLLL D ++K+ADFGL+ T + G+ + APE+ +
Sbjct: 128 KIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN------ 180
Query: 239 GEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 297
K Y +VDV+S GIVL+ +L RLPF+ + + +P+ +SP
Sbjct: 181 --GKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKV-NSCVYVMPDFLSPGAQ 236
Query: 298 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNE 342
+++ V DP R + +I R F + P P +
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDP---WFNVNLPDYLRPMEEVQG 278
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 8e-38
Identities = 65/360 (18%), Positives = 122/360 (33%), Gaps = 79/360 (21%)
Query: 56 DPKLLF-IGSKIGEGAH--GKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVN 110
+ + + IG+G V RY V ++ +N + S+E E++
Sbjct: 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTF---LQGELH 78
Query: 111 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDI 168
+ H N+V + D + +VT + S + + + + ++ L +A +
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-ILQGV 137
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA--------REETVTEMMTAET 220
+A+D +H G +HR +K ++L++ + L+ R+ V +
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA----- 275
W++PE+ L+Q + Y+ K D+YS GI EL +PF+ M Q
Sbjct: 197 KVLPWLSPEV-----LQQ-NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250
Query: 276 ---------------------------------------AYAAAFKHARPGLPEDISPDL 296
+ SP
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310
Query: 297 AFIVQSCWVEDPNLRPS---------FSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATS 347
V+ C +P+ RPS F QI R + L L P + + +++ S
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHS 370
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 70/294 (23%), Positives = 125/294 (42%), Gaps = 26/294 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +GEGA+G+V VA+K+++ D +E+ + + H+N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLNHEN 66
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+VKF G ++ + + E G L + + A F + + LH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTYRWMAPELYSTVT 235
GI HRD+KP+NLLL ++ +LK++DFGLA R ++ GT ++APEL
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--- 180
Query: 236 LRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDIS 293
++ ++ VDV+S GIVL +L LP++ S+ Y+ + P + I
Sbjct: 181 -----RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 294 PDLAFIVQSCWVEDPNLRPSFSQIIR---MLNAFLFTLRPPSPSVPESDTNEAA 344
++ VE+P+ R + I + + P + + +
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSG 289
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-37
Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 30/268 (11%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ ++G+GA V + A K++N S + RE + +++H N
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPN 66
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V+ + ++ +V +L+ G L + +V+ A + I ++ H+N
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN 124
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
GI+HR+LKP+NLLL + + + +KLADFGLA E +E GT +++PE+ L
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-----L 179
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----I 292
+ K Y+ VD+++ G++L+ LL PF Q A K P +
Sbjct: 180 K---KDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDYPSPEWDTV 234
Query: 293 SP---DLAFIVQSCWVEDPNLRPSFSQI 317
+P L + S +P R + Q
Sbjct: 235 TPEAKSL---IDSMLTVNPKKRITADQA 259
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-37
Identities = 80/330 (24%), Positives = 141/330 (42%), Gaps = 41/330 (12%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHD 118
+ ++G+GA V + A K++N + ++ + LE RE + +++H
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE----REARICRKLQHP 88
Query: 119 NLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N+V+ + ++ +V +L+ G L + +V+ A + I ++ H+
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS 146
Query: 178 NGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT 235
NGI+HR+LKP+NLLL + + + +KLADFGLA E +E GT +++PE+
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV----- 201
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED---- 291
L+ K Y+ VD+++ G++L+ LL PF Q A K P
Sbjct: 202 LK---KDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDYPSPEWDT 256
Query: 292 ISP---DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSN 348
++P L + S +P R + Q L R S
Sbjct: 257 VTPEAKSL---IDSMLTVNPKKRITADQA---LKVPWICNRERVASAIHRQDTVD----- 305
Query: 349 GAMTEFSARARGKFAFLRQLFTAKRTKNLQ 378
+ +F+AR + K A L + + NL
Sbjct: 306 -CLKKFNARRKLKGAILTTMIATRNLSNLG 334
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 66/252 (26%), Positives = 115/252 (45%), Gaps = 18/252 (7%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG+G+ GKV + D ++ A+K +N+ + + +E+ +M ++H LV
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV--RNVFKELQIMQGLEHPFLVNL 80
Query: 124 LGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
+ +D M +V +LL G LR +L + F ++ A+D L IIH
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELVMALDYLQNQRIIH 138
Query: 183 RDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
RD+KPDN+LL D+ + + DF +A +T GT +MAPE+ +
Sbjct: 139 RDMKPDNILL--DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEM-----FSSRKG 191
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEGMS--NLQAAYAAAFKHARPGLPEDISPDLAFI 299
Y+ VD +S G+ +ELL R P+ S + + F+ P S ++ +
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV-HTFETTVVTYPSAWSQEMVSL 250
Query: 300 VQSCWVEDPNLR 311
++ +P+ R
Sbjct: 251 LKKLLEPNPDQR 262
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 71/299 (23%), Positives = 116/299 (38%), Gaps = 30/299 (10%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG G G R +VA+K + RG A ++ RE+ ++H N
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERG------AAIDENVQREIINHRSLRHPN 77
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V+F P + I+ E G L + + + + A F + + H+
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM 135
Query: 179 GIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
I HRDLK +N LL LK+ DFG ++ + + GT ++APE+
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL----- 190
Query: 238 QGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG---LPED-- 291
++ Y+ DV+S G+ L+ +L PFE Y + +P+D
Sbjct: 191 ---RQEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPRDYRKTIQRILSVKYSIPDDIR 246
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIR---MLNAFLFTLRPPSPSVPESDTNEAAATS 347
ISP+ ++ +V DP R S +I L L S + + E S
Sbjct: 247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQS 305
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 71/288 (24%), Positives = 127/288 (44%), Gaps = 22/288 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +G G GKV G++ VA+K+LNR + G+ RE+ + +H +
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD--VVGKIRREIQNLKLFRHPH 77
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K P + +V E + G L Y+ +LD + I +D H +
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRH 135
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
++HRDLKP+N+LL + K+ADFGL+ + E + G+ + APE+ S
Sbjct: 136 MVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS------ 188
Query: 239 GEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 297
+ Y +VD++S G++L+ LL LPF+ ++ + P+ ++P +
Sbjct: 189 --GRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKI-CDGIFYTPQYLNPSVI 244
Query: 298 FIVQSCWVEDPNLRPSFSQIIR---MLNAFLFTLRPPSPSVPESDTNE 342
+++ DP R + I L P PS + ++
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDD 292
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 43/293 (14%), Positives = 89/293 (30%), Gaps = 52/293 (17%)
Query: 62 IGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ G + ++ DR VA+ ++ + L + +SR+
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVL--QETLSRTLRLSRIDKPG 92
Query: 120 LVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+ + L ++V E + G SL++ + A+ +A A D H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRA 148
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
G+ P + ++ D + LA + +
Sbjct: 149 GVALSIDHPSRVRVSID-GDVVLAYPATMPDA------NPQD------------------ 183
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE------DI 292
D+ G L+ LL NR P + +++ A A + E DI
Sbjct: 184 ----------DIRGIGASLYALLVNRWPLPE-AGVRSGLAPAERDTAGQPIEPADIDRDI 232
Query: 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAA 345
++ + D +R + S ++ ++ P + +AA
Sbjct: 233 PFQISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRTEVLGPIDEAPVSAA 284
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 85/324 (26%), Positives = 138/324 (42%), Gaps = 34/324 (10%)
Query: 9 NRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLF-IGSKIG 67
+ G +++ S+ + + + P ID S F + S++G
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELG 62
Query: 68 EGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125
GA VY + + A+KVL + T D++ + E+ ++ R+ H N++K
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVR-----TEIGVLLRLSHPNIIKLKE 115
Query: 126 ACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 184
+ P + +V EL+ G L +V A + I A+ LH NGI+HRD
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRD 173
Query: 185 LKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 242
LKP+NLL TP + LK+ADFGL++ +M GT + APE+ LR
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI-----LR---GC 225
Query: 243 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE----DISP---D 295
Y +VD++S GI+ + LL PF Q + + ++S D
Sbjct: 226 AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF-RRILNCEYYFISPWWDEVSLNAKD 284
Query: 296 LAFIVQSCWVEDPNLRPSFSQIIR 319
L V+ V DP R + Q ++
Sbjct: 285 L---VRKLIVLDPKKRLTTFQALQ 305
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 35/224 (15%)
Query: 65 KIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFI-REVNMMSRVKHDNLVK 122
IG G+ G V++ + + VAIK + L + RF RE+ +M VKH N+V
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIK----------KVLQDKRFKNRELQIMRIVKHPNVVD 96
Query: 123 FL------GACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDL---HVALNFALDIARAM 172
G KD + + +V E +P ++ + K + + L + + R++
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKL-YMYQLLRSL 154
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE--TGTYRWMAPEL 230
+H+ GI HRD+KP NLLL P LKL DFG A+ E + + YR APEL
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--APEL 212
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
T +Y +D++S G V+ EL+ + F G S +
Sbjct: 213 IFGAT-------NYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 75/321 (23%), Positives = 130/321 (40%), Gaps = 40/321 (12%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ IG+G V R + A+K+++ + L RE ++ +KH +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDIARAMDCLH 176
+V+ L M+ +V E + G L +V VA ++ I A+ H
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 177 ANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLARE-ETVTEMMTAETGTYRWMAPELYST 233
N IIHRD+KP +LL + + + +KL FG+A + + GT +MAPE+
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV--- 204
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFKHARPGLPED 291
++ ++ Y VDV+ G++L+ LL+ LPF G + +K
Sbjct: 205 --VK---REPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWS-H 258
Query: 292 ISP---DLAFIVQSCWVEDPNLRPSFSQIIR---MLNAFLFTLRPPSPSVPESDTNEAAA 345
IS DL V+ + DP R + + + + + + P E
Sbjct: 259 ISESAKDL---VRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQ------- 308
Query: 346 TSNGAMTEFSARARGKFAFLR 366
+ +F+AR + K A L
Sbjct: 309 -----LRKFNARRKLKGAVLA 324
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 60/271 (22%), Positives = 105/271 (38%), Gaps = 25/271 (9%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNR----GSTSDERALLEGRFIREVNMMSRV 115
+G G V + + A+K+++ +++E L ++EV+++ +V
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 116 K-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
H N+++ + +V +L+ L YL L + +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVIC 138
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
LH I+HRDLKP+N+LL D ++KL DFG + + E + GT ++APE+
Sbjct: 139 ALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 197
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--- 290
Y +VD++S G++++ LL PF Q
Sbjct: 198 SM--NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMIMSGNYQFGSPEW 253
Query: 291 -DISP---DLAFIVQSCWVEDPNLRPSFSQI 317
D S DL V V P R + +
Sbjct: 254 DDYSDTVKDL---VSRFLVVQPQKRYTAEEA 281
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 77/289 (26%), Positives = 123/289 (42%), Gaps = 45/289 (15%)
Query: 1 MSCSNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLL 60
+ S +E + ++ + K + V G + +
Sbjct: 6 RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT------ 59
Query: 61 FIGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFI-REVNMMSRVKH 117
IG G+ G VY+ + D +VAIK + L + RF RE+ +M ++ H
Sbjct: 60 ---KVIGNGSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDH 106
Query: 118 DNLVKFL------GACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDL---HVALNFALD 167
N+V+ G KD + + +V + +P ++ + K L +V L +
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKL-YMYQ 164
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRW 225
+ R++ +H+ GI HRD+KP NLLL PD LKL DFG A++ E + + YR
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR- 223
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
APEL T Y + +DV+S G VL ELL + F G S +
Sbjct: 224 -APELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 4e-35
Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 21/216 (9%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG++G V++ R D +IVAIK S++ +++ +RE+ M+ ++KH NLV
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLE---SEDDPVIKKIALREIRMLKQLKHPNLVN 66
Query: 123 FLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
L + + +V E ++ L + H+ + +A++ H + I
Sbjct: 67 LLEVFRRKRRLHLVFEYCD-HTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTVTLRQ 238
HRD+KP+N+L+T +KL DFG AR T ++ E T YR +PEL +
Sbjct: 125 HRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELL----VGD 177
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
Y VDV++ G V ELL+ + G S++
Sbjct: 178 ---TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-35
Identities = 68/270 (25%), Positives = 118/270 (43%), Gaps = 33/270 (12%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G GA +V+ R ++ A+K + + + +L E+ ++ ++KH+N
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-----NEIAVLKKIKHEN 67
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V + +V +L+ G L ++ A + A+ LH N
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
GI+HRDLKP+NLL TP++ S + + DFGL++ E M TA GT ++APE+
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA-CGTPGYVAPEVL----- 179
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE----DI 292
+K Y+ VD +S G++ + LL PF + ++ K DI
Sbjct: 180 ---AQKPYSKAVDCWSIGVITYILLCGYPPFYEET--ESKLFEKIKEGYYEFESPFWDDI 234
Query: 293 SP---DLAFIVQSCWVEDPNLRPSFSQIIR 319
S D + +DPN R + + +
Sbjct: 235 SESAKDF---ICHLLEKDPNERYTCEKALS 261
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 64/300 (21%)
Query: 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
S++G G G V++ + ++A K+++ R + IRE+ ++ +V
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI----IRELQVLHECNSPYIV 94
Query: 122 KFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG- 179
F GA D + I E + G SL + L + ++ + ++ + + + L
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR-Q 238
I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE R Q
Sbjct: 153 IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-------RLQ 203
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR------------- 285
G HY+ + D++S G+ L E+ R P + +
Sbjct: 204 GT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 286 ----------------------------PGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQ 316
P LP + S + V C +++P R Q
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 68/266 (25%), Positives = 112/266 (42%), Gaps = 30/266 (11%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I ++G GA G V+ R A K + SD+ + +E+ MS ++H
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR-----KEIQTMSVLRHPT 215
Query: 120 LVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
LV A +D MV++ E + G L + + NK+ A+ + + + + +H N
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 179 GIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
+H DLKP+N++ T LKL DFGL + + TGT + APE+
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA------ 328
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----IS 293
E K D++S G++ + LL+ PF G + K + + IS
Sbjct: 329 --EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCDWNMDDSAFSGIS 384
Query: 294 P---DLAFIVQSCWVEDPNLRPSFSQ 316
D ++ + DPN R + Q
Sbjct: 385 EDGKDF---IRKLLLADPNTRMTIHQ 407
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 49/218 (22%), Positives = 99/218 (45%), Gaps = 29/218 (13%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLV 121
K+G G + +V+E + V +K+L + + + RE+ ++ ++ N++
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIKREIKILENLRGGPNII 94
Query: 122 KFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
KDP+ +V E + ++ +L D + + +I +A+D H+
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT----DYDIRF-YMYEILKALDYCHSM 149
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYSTVTLR 237
GI+HRD+KP N+++ + + L+L D+GLA + + R+ PEL
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPELLVDY--- 205
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 274
+ Y+ +D++S G +L ++ + P F G N
Sbjct: 206 ----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 239
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 61/271 (22%), Positives = 108/271 (39%), Gaps = 26/271 (9%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNR---GSTSDERALLEGRFIREVNMMSRVK 116
IG G V R A+K++ + ++ + RE +++ +V
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 117 -HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
H +++ + + + + +V +L+ L YL L + + A+
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSF 215
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE-LYST 233
LHAN I+HRDLKP+N+LL + ++L+DFG + E + GT ++APE L +
Sbjct: 216 LHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 274
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--- 290
+ Y +VD+++ G++L+ LL PF Q +
Sbjct: 275 MDETH---PGYGKEVDLWACGVILFTLLAGSPPFWHRR--QILMLRMIMEGQYQFSSPEW 329
Query: 291 -DISP---DLAFIVQSCWVEDPNLRPSFSQI 317
D S DL + DP R + Q
Sbjct: 330 DDRSSTVKDL---ISRLLQVDPEARLTAEQA 357
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 78/308 (25%), Positives = 126/308 (40%), Gaps = 52/308 (16%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+GEG++G V + R D RIVAIK SD+ +++ +RE+ ++ +++H+NLV
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLE---SDDDKMVKKIAMREIKLLKQLRHENLVN 88
Query: 123 FLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
L CK +V E + ++ L L PN LD V + I + H++ II
Sbjct: 89 LLEVCKKKKRWYLVFEFVD-HTILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNII 146
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTVTLRQ 238
HRD+KP+N+L++ +KL DFG AR E+ E T YR APEL
Sbjct: 147 HRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLV------ 197
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPF------------------------EGMSNLQ 274
G+ Y VDV++ G ++ E+ F E +
Sbjct: 198 GD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 275 AAYAAAFKHARPGLP-----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329
+ P +S + + + C DP+ RP ++++ F
Sbjct: 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH--DFFQMDG 314
Query: 330 PPSPSVPE 337
E
Sbjct: 315 FAERFSQE 322
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 75/328 (22%), Positives = 135/328 (41%), Gaps = 42/328 (12%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHD 118
+ ++G+GA V + A ++N + ++ + LE RE + +KH
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE----REARICRLLKHP 70
Query: 119 NLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N+V+ + + ++ +L+ G L + +V+ A + I A+ H
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQ 128
Query: 178 NGIIHRDLKPDNLLL-TPDQKS-LKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTV 234
G++HR+LKP+NLLL + + + +KLADFGLA E E + GT +++PE+
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV---- 184
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED--- 291
LR K Y VD+++ G++L+ LL PF Q K P
Sbjct: 185 -LR---KDPYGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQIKAGAYDFPSPEWD 238
Query: 292 -ISP---DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATS 347
++P DL + +P+ R + ++ L + R S
Sbjct: 239 TVTPEAKDL---INKMLTINPSKRITAAEA---LKHPWISHRSTVASCMHRQETVD---- 288
Query: 348 NGAMTEFSARARGKFAFLRQLFTAKRTK 375
+ +F+AR + K A L + +
Sbjct: 289 --CLKKFNARRKLKGAILTVMLATRNFS 314
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 70/320 (21%), Positives = 124/320 (38%), Gaps = 40/320 (12%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHD 118
IG ++G G V + + A K + R S + R + REV+++ +V H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 119 NLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ ++ +V++ EL+ G L +L L A +F I ++ LH
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT 133
Query: 178 NGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
I H DLKP+N++L +KL DFGLA E GT ++APE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI---- 189
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPED 291
+ + + D++S G++ + LL+ PF G + L A ++
Sbjct: 190 -VNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS-Q 244
Query: 292 ISP---DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP---SPSVPESDTNEAAA 345
S D ++ V++ R + + LR P ++ +
Sbjct: 245 TSELAKDF---IRKLLVKETRKRLTIQEA----------LRHPWITPVDTQQAMVRRESV 291
Query: 346 TSNGAMTEFSARARGKFAFL 365
+ + R R K +F
Sbjct: 292 VNLENFKKQYVRRRWKLSFS 311
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHD 118
IG ++G G V + + A K + R S + R + REV+++ +V H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 119 NLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ ++ +V++ EL+ G L +L L A +F I ++ LH
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT 133
Query: 178 NGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
I H DLKP+N++L +KL DFGLA E GT ++APE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI---- 189
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ + + D++S G++ + LL+ PF G
Sbjct: 190 -VNY---EPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 59/265 (22%), Positives = 117/265 (44%), Gaps = 28/265 (10%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I ++G GA G V+ + R+ K +N D+ + E+++M+++ H
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK-----NEISIMNQLHHPK 109
Query: 120 LVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
L+ A +D MV++ E L G L + + K+ +N+ + +H +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 179 GIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
I+H D+KP+N++ T S+K+ DFGLA + E++ T T + APE+
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV------ 222
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISP 294
+++ D+++ G++ + LL+ PF G + LQ ++ +SP
Sbjct: 223 --DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS-SVSP 279
Query: 295 ---DLAFIVQSCWVEDPNLRPSFSQ 316
D +++ ++P R +
Sbjct: 280 EAKDF---IKNLLQKEPRKRLTVHD 301
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHD 118
+G ++G G V + + + A K + R +S R + REVN++ ++H
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 119 NLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ ++ +V++ EL+ G L +L L A F I + LH+
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHS 126
Query: 178 NGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
I H DLKP+N++L +KL DFG+A + GT ++APE+
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI---- 182
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ + + D++S G++ + LL+ PF G
Sbjct: 183 -VNY---EPLGLEADMWSIGVITYILLSGASPFLG 213
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 60/268 (22%), Positives = 111/268 (41%), Gaps = 27/268 (10%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHD 118
G ++G G V + + A K + R + S R + REV+++ ++H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 119 NLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ ++ ++++ EL+ G L +L L A F I + LH+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHS 132
Query: 178 NGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
I H DLKP+N++L + +K+ DFGLA + GT ++APE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI---- 188
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPED 291
+ + + D++S G++ + LL+ PF G + L A ++ +
Sbjct: 189 -VNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS-N 243
Query: 292 ISP---DLAFIVQSCWVEDPNLRPSFSQ 316
S D ++ V+DP R +
Sbjct: 244 TSALAKDF---IRRLLVKDPKKRMTIQD 268
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRG-------STSDERALLEGRFIREVNMMSRV 115
KIGEG +G V++ + IVA+K + S++ +RE+ ++ +
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----------LREICLLKEL 58
Query: 116 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
KH N+V+ D + +V E L+KY S LD + +F + + +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGF 116
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELY 231
H+ ++HRDLKP NLL+ LKLA+FGLAR + +AE T YR P++
Sbjct: 117 CHSRNVLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDV- 172
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 274
L K Y+ +D++S G + EL P F G
Sbjct: 173 ----LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-33
Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 65 KIGEGAHGKVYEGRY-GDRIVAIKVLNRG-------STSDERALLEGRFIREVNMMSRVK 116
KIGEG +G VY+ + A+K + ST+ IRE++++ +K
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT----------IREISILKELK 58
Query: 117 HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
H N+VK +V+V E L L+K L L+ A +F L + +
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYC 116
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYS 232
H ++HRDLKP NLL+ + LK+ADFGLAR + T E T YR AP++
Sbjct: 117 HDRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDV-- 171
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
L K Y+ +D++S G + E++ F G+S
Sbjct: 172 ---LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-33
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVN---MMSRVKHDN 119
+IG GA+G VY+ R + VA+K + + L +REV + +H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 120 LVKFL------GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+V+ + ++ + +V E + LR YL P L + R +D
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELY 231
LHAN I+HRDLKP+N+L+T ++KLADFGLAR + +T T YR APE+
Sbjct: 135 FLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYR--APEVL 191
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
L Y VD++S G + E+ + F G S
Sbjct: 192 ----L--QST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 34/222 (15%)
Query: 65 KIGEGAHGKVYEGRY-GDRIVAIKVLNRG-------STSDERALLEGRFIREVNMMSRVK 116
K+GEG +G VY+ + RIVA+K + ST+ IRE++++ +
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA----------IREISLLKELH 77
Query: 117 HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
H N+V + + + +V E + L+K L L + + R +
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYS 232
H + I+HRDLKP NLL+ +LKLADFGLAR + T E T YR AP++
Sbjct: 136 HQHRILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDV-- 190
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
L G K Y+ VD++S G + E++T + F G+++
Sbjct: 191 ---L-MGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 46/266 (17%), Positives = 109/266 (40%), Gaps = 31/266 (11%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +G G G V+ + K + + + +E+++++ +H N
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISILNIARHRN 62
Query: 120 LVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++ + + +V++ E + G+ + + + + +L+ +++ + A+ LH++
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 179 GIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
I H D++P+N++ T ++K+ +FG AR+ + + APE+ +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-----HQ 176
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED----IS 293
+ D++S G +++ LL+ PF + +A E+ IS
Sbjct: 177 H---DVVSTATDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAEYTFDEEAFKEIS 231
Query: 294 P---DLAFIVQSCWVEDPNLRPSFSQ 316
D V V++ R + S+
Sbjct: 232 IEAMDF---VDRLLVKERKSRMTASE 254
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 65/275 (23%), Positives = 112/275 (40%), Gaps = 43/275 (15%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLV 121
+G G +GKV E R + A+K+L + +EV+ + ++V
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSP----------KARQEVDHHWQASGGPHIV 85
Query: 122 KFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
L ++ I+ E + G L + A DI A+ LH
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 177 ANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
++ I HRD+KP+NLL + ++ + LKL DFG A+E T + T T ++APE+
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL--- 201
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE---- 290
+ Y+ D++S G++++ LL PF + QA + R G
Sbjct: 202 -----GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG-QAISPGMKRRIRLGQYGFPNP 255
Query: 291 ---DISP---DLAFIVQSCWVEDPNLRPSFSQIIR 319
++S L ++ DP R + +Q +
Sbjct: 256 EWSEVSEDAKQL---IRLLLKTDPTERLTITQFMN 287
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 70/332 (21%), Positives = 131/332 (39%), Gaps = 35/332 (10%)
Query: 2 SCSNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLF 61
+ + + E E N + K R I AP D ++ +
Sbjct: 26 NSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAV 85
Query: 62 -----IGSK--IGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
+ +G G G+V++ +A K++ D+ + E+++M
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK-----NEISVM 140
Query: 113 SRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+++ H NL++ A + +V+V E + G L ++ L + F I
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQICEG 199
Query: 172 MDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 230
+ +H I+H DLKP+N+L D K +K+ DFGLAR E + GT ++APE+
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPG 287
+ + D++S G++ + LL+ PF G ++ L A +
Sbjct: 260 -----VNY---DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311
Query: 288 LPEDISP---DLAFIVQSCWVEDPNLRPSFSQ 316
DIS + + +++ + R S S+
Sbjct: 312 FQ-DISEEAKEF---ISKLLIKEKSWRISASE 339
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 63/264 (23%), Positives = 106/264 (40%), Gaps = 45/264 (17%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGS---------TSDERALLEGRFIREVNMMSR 114
+GEG+ V R R AIK+L + + ER ++MSR
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRER-----------DVMSR 86
Query: 115 VKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+ H VK +D + L KY+ + D + +I A++
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALE 144
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAET--GTYRWMAPEL 230
LH GIIHRDLKP+N+LL + +++ DFG A+ ++ A + GT ++++PEL
Sbjct: 145 YLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK---HARPG 287
+K D+++ G ++++L+ PF + F+
Sbjct: 204 L--------TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-----IFQKIIKLEYD 250
Query: 288 LPEDISPDLAFIVQSCWVEDPNLR 311
PE P +V+ V D R
Sbjct: 251 FPEKFFPKARDLVEKLLVLDATKR 274
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 55/230 (23%), Positives = 99/230 (43%), Gaps = 42/230 (18%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRF----IREVNMMSRVKHD 118
G+G G V G+ VAIK + + + RF ++ + ++ + H
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIK----------KVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 119 NLVKFL--------GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL---HVALNFALD 167
N+V+ +D + +V E +P +L + + ++ + + F
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKV-FLFQ 137
Query: 168 IARAMDCLHAN--GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--Y 223
+ R++ CLH + HRD+KP N+L+ +LKL DFG A++ + +E A + Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
R APEL HY VD++S G + E++ F G ++
Sbjct: 198 R--APELIFGNQ-------HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 47/233 (20%)
Query: 65 KIGEGAHGKVYEGR---YGDRIVAIKVLNRGSTSDERALLEGRF----IREVN---MMSR 114
+IGEGA+GKV++ R G R VA+K + + EG IREV +
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE------EG-MPLSTIREVAVLRHLET 70
Query: 115 VKHDNLVKFL------GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
+H N+V+ ++ + +V E + L YL + + + +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWM 226
R +D LH++ ++HRDLKP N+L+T +KLADFGLAR + +T+ T YR
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYR-- 186
Query: 227 APEL-----YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
APE+ Y+T VD++S G + E+ + F G S++
Sbjct: 187 APEVLLQSSYAT-------------PVDLWSVGCIFAEMFRRKPLFRGSSDVD 226
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-32
Identities = 61/319 (19%), Positives = 115/319 (36%), Gaps = 41/319 (12%)
Query: 61 FIGSKIGEGAHGKVYEG--RYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKH 117
++G G V + + + A K L R D RA + E+ ++ K
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL----HEIAVLELAKS 87
Query: 118 D-NLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
++ ++ ++++ E G + + + + + I + L
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 176 HANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
H N I+H DLKP N+LL + +K+ DFG++R+ + GT ++APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI--- 204
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPE 290
L D+++ GI+ + LLT+ PF G N ++
Sbjct: 205 --LNY---DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS- 258
Query: 291 DISP---DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP--SPSVPESDTNEAAA 345
+S D +QS V++P RP+ L E+ +
Sbjct: 259 SVSQLATDF---IQSLLVKNPEKRPTAEIC----------LSHSWLQQWDFENLFHPEET 305
Query: 346 TSNGAMTEFSARARGKFAF 364
+S+ + S R+
Sbjct: 306 SSSSQTQDHSVRSSEDKTS 324
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-32
Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 37/226 (16%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRG------STSDERALLEGRFIREVNMMSRVK 116
K+G G + VY+G VA+K + ST+ IRE+++M +K
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA----------IREISLMKELK 61
Query: 117 HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL----VSLRPNKLDLHVALNFALDIARA 171
H+N+V+ + + +V E + L+KY+ V P L+L++ F + +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAP 228
+ H N I+HRDLKP NLL+ + LKL DFGLAR + ++E T YR AP
Sbjct: 121 LAFCHENKILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--AP 177
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
++ + G + Y+ +D++S G +L E++T + F G ++ +
Sbjct: 178 DVL----M--GS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-32
Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 66 IGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVK 122
+GEGAH +V + A+K++ + R REV M+ + + H N+++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-----RVFREVEMLYQCQGHRNVLE 75
Query: 123 FLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ ++ +V E + G S+ ++ R + A D+A A+D LH GI
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIA 133
Query: 182 HRDLKPDNLLL-TPDQKS-LKLADFGLAR--------EETVTEMMTAETGTYRWMAPELY 231
HRDLKP+N+L P+Q S +K+ DF L T + G+ +MAPE+
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV- 192
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLP 289
V E Y+ + D++S G++L+ LL+ PF S+ A + L
Sbjct: 193 --VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 290 EDI--------SPDLAFI-------VQSCWVEDPNLRPSFSQIIR 319
E I D A I + V D R S +Q+++
Sbjct: 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRF----IREVNMMSRVKHD 118
+GEG VY+ R ++IVAIK + G S+ + +G +RE+ ++ + H
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK---DG-INRTALREIKLLQELSHP 72
Query: 119 NLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ L A + +V + + L + L + L + ++ LH
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFME-TDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTV 234
+ I+HRDLKP+NLLL + LKLADFGLA+ T + T YR APEL
Sbjct: 131 HWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYR--APEL---- 183
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
L + Y VD+++ G +L ELL G S+L
Sbjct: 184 -LFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 63/281 (22%), Positives = 115/281 (40%), Gaps = 40/281 (14%)
Query: 58 KLLFIGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV 115
L +GEG+ + + ++ A+K++++ ++ + +E+ +
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--------KEITALKLC 62
Query: 116 K-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+ H N+VK D L +V ELL G L + + + A + A+
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVS 120
Query: 174 CLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLARE-ETVTEMMTAETGTYRWMAPEL 230
+H G++HRDLKP+NLL + +K+ DFG AR + + T + APEL
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA-----AFKHAR 285
L + Y+ D++S G++L+ +L+ ++PF+ +A K
Sbjct: 181 -----LN---QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
Query: 286 PGLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQIIR 319
+ +S DL +Q DPN R S +
Sbjct: 233 FSFEGEAWKNVSQEAKDL---IQGLLTVDPNKRLKMSGLRY 270
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 66/340 (19%), Positives = 119/340 (35%), Gaps = 45/340 (13%)
Query: 4 SNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLF-- 61
SNS+ ++ PQ + L + +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDD 62
Query: 62 ---IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV- 115
+G G +GKV + + A+K+L + REV + R
Sbjct: 63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----------KARREVELHWRAS 112
Query: 116 KHDNLVKFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+ ++V+ + ++ IV E L G L + A I
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 171 AMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 228
A+ LH+ I HRD+KP+NLL + + LKL DFG A+E T +T T ++AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARP 286
E+ + Y+ D++S G++++ LL PF + + +
Sbjct: 233 EVL--------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 287 GLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQIIR 319
P +S L +++ +P R + ++ +
Sbjct: 285 EFPNPEWSEVSEEVKML---IRNLLKTEPTQRMTITEFMN 321
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 34/222 (15%)
Query: 65 KIGEGAHGKVYEGRYG--DRIVAIKVLNRG------STSDERALLEGRFIREVNMMSRVK 116
K+GEG + VY+G+ D +VA+K + T+ IREV+++ +K
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA----------IREVSLLKDLK 58
Query: 117 HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
H N+V + + +V E L L++YL N +++H F + R +
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYC 116
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYS 232
H ++HRDLKP NLL+ ++ LKLADFGLAR +++ T+ E T YR P++
Sbjct: 117 HRQKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPDI-- 171
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
L Y+ ++D++ G + +E+ T R F G + +
Sbjct: 172 ---LLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 68/321 (21%), Positives = 126/321 (39%), Gaps = 41/321 (12%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR-VKHD 118
+ IG G++ + + A+K++++ + + E+ ++ R +H
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-------SKRDPT--EEIEILLRYGQHP 76
Query: 119 NLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ D V +VTEL+ G L ++ + A I + ++ LHA
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHA 134
Query: 178 NGIIHRDLKPDNLLLT---PDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYST 233
G++HRDLKP N+L + +S+++ DFG A++ ++ T ++APE
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE---- 190
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLPED- 291
V RQG Y+ D++S G++L+ +LT PF + A + L
Sbjct: 191 VLERQG----YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY 246
Query: 292 ---ISP---DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAA 345
+S DL V DP+ R + + + L P + +
Sbjct: 247 WNSVSDTAKDL---VSKMLHVDPHQRLTAALV---LRHPWIVHWDQLPQYQLNRQDAPHL 300
Query: 346 TSNGAMTEFSARARGKFAFLR 366
+SA R + L
Sbjct: 301 VKGAMAATYSALNRNQSPVLE 321
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-31
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 41/228 (17%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRG-------STSDERALLEGRFIREVNMMSRV 115
K+GEG +G+VY+ + VAIK + T+ IREV+++ +
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA----------IREVSLLKEL 90
Query: 116 KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+H N+++ L ++ E L+KY+ + + V +F + ++
Sbjct: 91 QHRNIIELKSVIHHNHRLH-LIFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVN 146
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKS----LKLADFGLAREETV-TEMMTAETGT--YRWM 226
H+ +HRDLKP NLLL+ S LK+ DFGLAR + T E T YR
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR-- 204
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
PE+ L G +HY+ VD++S + E+L F G S +
Sbjct: 205 PPEIL----L--GS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID 245
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 7e-31
Identities = 60/242 (24%), Positives = 109/242 (45%), Gaps = 23/242 (9%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGS--TSDERALLEGRFIREVNMMSRVKHDNLV 121
IG GA G+V + + ++ A+K+LN+ E A F E +++ +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA----CFREERDVLVNGDSKWIT 137
Query: 122 KFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
A +D + +V + G L L+S ++L +A + ++ A+D +H
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY 196
Query: 181 IHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLR 237
+HRD+KPDN+L+ D ++LADFG + + + GT +++PE+ +
Sbjct: 197 VHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI---LQAM 251
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH----ARPGLPEDIS 293
+G K Y + D +S G+ ++E+L PF +L Y H P D+S
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVS 310
Query: 294 PD 295
+
Sbjct: 311 EN 312
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 27/226 (11%)
Query: 64 SKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSD------ERALLEGRFIREVNMMSRVK 116
I G++G V G + VAIK + + + L R +RE+ +++
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 117 HDNLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
H N++ +VTEL+ L + + R H+ F I
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY-FMYHILL 145
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAP 228
+ LH G++HRDL P N+LL + + + DF LARE+T T YR AP
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNND-ITICDFNLAREDTADANKTHYVTHRWYR--AP 202
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
EL + K + VD++S G V+ E+ + F G +
Sbjct: 203 ELV-------MQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 60/257 (23%), Positives = 104/257 (40%), Gaps = 68/257 (26%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFI-REVNMMSRVKHDNLV 121
+G G+ G V E + + A+K + L + R+ RE+++M + H N++
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALK----------KVLQDPRYKNRELDIMKVLDHVNII 63
Query: 122 K---FLGACKDPLMV------------------------------------IVTELLPGM 142
K + D ++ E +P
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-D 122
Query: 143 SLRKYLVSLRPNKLDL---HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199
+L K L S + + +++ + + RA+ +H+ GI HRD+KP NLL+ +L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 200 KLADFGLAREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 257
KL DFG A++ +E A + YR APEL T Y +D++S G V
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGAT-------EYTPSIDLWSIGCVF 232
Query: 258 WELLTNRLPFEGMSNLQ 274
EL+ + F G +++
Sbjct: 233 GELILGKPLFSGETSID 249
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 54/241 (22%), Positives = 104/241 (43%), Gaps = 19/241 (7%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGS--TSDERALLEGRFIREVNMMSRVKHDNLV 121
IG GA +V + + ++ A+K++N+ E + F E +++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVS----CFREERDVLVNGDRRWIT 124
Query: 122 KFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ A +D + +V E G L L+S ++ +A + +I A+D +H G
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLL-TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY 183
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQ 238
+HRD+KPDN+LL ++LADFG + + + GT +++PE+ V
Sbjct: 184 VHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----PGLPEDISP 294
G Y + D ++ G+ +E+ + PF + Y + P + E +
Sbjct: 243 GTGS-YGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGVPE 300
Query: 295 D 295
+
Sbjct: 301 E 301
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 24/221 (10%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG GA G+V + ++ A+K+L++ +R+ F E ++M+ +V+
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSK-FEMIKRSDSA-FFWEERDIMAFANSPWVVQL 134
Query: 124 LGACKDPLMV-IVTELLPG---MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
A +D + +V E +PG ++L + + A + ++ A+D +H+ G
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNL------MSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 180 IIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
IHRD+KPDN+LL D+ LKLADFG + M+ +T GT +++PE V
Sbjct: 189 FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE----VLK 242
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
QG +Y + D +S G+ L+E+L PF +L Y
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTY 282
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 70/260 (26%), Positives = 118/260 (45%), Gaps = 42/260 (16%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGS---------TSDERALLEGRFIREVNMMSR 114
+G G+ G+V+ R+ R A+KVL + T+DER M+S
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER-----------LMLSI 62
Query: 115 VKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
V H +++ G +D + ++ + + G L L + + VA +A ++ A++
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLALE 120
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELY 231
LH+ II+RDLKP+N+LL + +K+ DFG A+ T GT ++APE
Sbjct: 121 YLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD----VTYTLCGTPDYIAPE-- 173
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291
V + YN +D +SFGI+++E+L PF SN Y +A P
Sbjct: 174 --VVSTKP----YNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTY-EKILNAELRFPPF 225
Query: 292 ISPDLAFIVQSCWVEDPNLR 311
+ D+ ++ D + R
Sbjct: 226 FNEDVKDLLSRLITRDLSQR 245
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-29
Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 40/259 (15%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGS---------TSDERALLEGRFIREVNMMSR 114
+G G+ G+V ++ + A+K+L++ T +E+ ++
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-----------RILQA 97
Query: 115 VKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
V LVK + KD + +V E + G + +L R + A +A I +
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFE 155
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
LH+ +I+RDLKP+NLL+ DQ+ +++ DFG A+ V GT +APE
Sbjct: 156 YLHSLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPE--- 208
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292
+ L +G YN VD ++ G++++E+ PF Y + P
Sbjct: 209 -IILSKG----YNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIY-EKIVSGKVRFPSHF 261
Query: 293 SPDLAFIVQSCWVEDPNLR 311
S DL ++++ D R
Sbjct: 262 SSDLKDLLRNLLQVDLTKR 280
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 42/235 (17%)
Query: 61 FIGSKIGEGAHGKVYEGRYGD----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
+ G K+G G +G VY+ + D + A+K + S RE+ ++ +K
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-------CREIALLRELK 76
Query: 117 HDNLVK----FLGACKDPLMVIVTELLPGMSLRKYLVSLR-------PNKLDLHVALNFA 165
H N++ FL + ++ + L + R P +L + +
Sbjct: 77 HPNVISLQKVFLSHADRKVW-LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS---LKLADFGLAREETV-TEMMTAETG 221
I + LHAN ++HRDLKP N+L+ + +K+AD G AR + +
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 222 T-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
YR APEL L G +HY +D+++ G + ELLT+ F
Sbjct: 195 VVVTFWYR--APELL----L--GA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 73/320 (22%), Positives = 138/320 (43%), Gaps = 31/320 (9%)
Query: 4 SNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIG 63
E G G + + N + A ++ I+ + +LL +
Sbjct: 8 HEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE-----NFELLKV- 61
Query: 64 SKIGEGAHGKVY-----EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+G GA+GKV+ G ++ A+KVL + + + E E ++ ++
Sbjct: 62 --LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE-HTRTERQVLEHIRQS 118
Query: 119 N-LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
LV A + + ++ + + G L +L + + H + +I A++ LH
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLH 176
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTV 234
GII+RD+K +N+LL + + L DFGL++E E A GT +MAP++
Sbjct: 177 KLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV--- 232
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK---HARPGLPED 291
+G ++ VD +S G++++ELLT PF + + A + + P P++
Sbjct: 233 ---RGGDSGHDKAVDWWSLGVLMYELLTGASPFTV-DGEKNSQAEISRRILKSEPPYPQE 288
Query: 292 ISPDLAFIVQSCWVEDPNLR 311
+S ++Q ++DP R
Sbjct: 289 MSALAKDLIQRLLMKDPKKR 308
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 71/262 (27%), Positives = 121/262 (46%), Gaps = 42/262 (16%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
+G+G+ GKV+ E + ++ AIK L + T E+ +L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS----------LA 74
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+H L + K+ L V E L G L ++ +K DL A +A +I
Sbjct: 75 WEHPFLTH-MFCTFQTKENLF-FVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILG 130
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
+ LH+ GI++RDLK DN+LL D +K+ADFG+ +E + T GT ++APE
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKEN-MLGDAKTNTFCGTPDYIAPE 188
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289
+ + YN+ VD +SFG++L+E+L + PF G + + + + + P P
Sbjct: 189 IL--------LGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELF-HSIRMDNPFYP 238
Query: 290 EDISPDLAFIVQSCWVEDPNLR 311
+ + ++ +V +P R
Sbjct: 239 RWLEKEAKDLLVKLFVREPEKR 260
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-28
Identities = 69/269 (25%), Positives = 118/269 (43%), Gaps = 47/269 (17%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
IG G++ KV + DRI A+KV+ + E+ + E
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE----------QA 66
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
H LV L +C + L V E + G L ++ R KL A ++ +I+ A
Sbjct: 67 SNHPFLVG-LHSCFQTESRLF-FVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLA 122
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
++ LH GII+RDLK DN+LL + +KL D+G+ +E + T T GT ++APE
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPE 180
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-------AAFK 282
+ + Y VD ++ G++++E++ R PF+ + +
Sbjct: 181 ----ILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232
Query: 283 HARPGLPEDISPDLAFIVQSCWVEDPNLR 311
+ +P +S A +++S +DP R
Sbjct: 233 EKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 64 SKIGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVKHDN 119
+G G +G V + R VAIK + + AL RE+ ++ R+ HDN
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKR-VAIKKIVLTDPQSVKHAL------REIKIIRRLDHDN 69
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRK-YLVS----------LRPNKL-DLHVALNFALD 167
+VK + ++ L Y+V L L + H L F
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQ 128
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGT- 222
+ R + +H+ ++HRDLKP NL + + LK+ DFGLAR + ++ T
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 223 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
YR +P L +Y +D+++ G + E+LT + F G L+
Sbjct: 189 WYR--SPRLL-------LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 66/262 (25%), Positives = 109/262 (41%), Gaps = 43/262 (16%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
+G+G GKV R R A+K+L + T E +L+
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-----------N 61
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+H L L D L V E G L +L R A + +I A
Sbjct: 62 TRHPFLTA-LKYAFQTHDRLC-FVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSA 117
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
++ LH+ +++RD+K +NL+L D +K+ DFGL +E +++ T +T GT ++APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPE 175
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289
V Y VD + G+V++E++ RLPF + + + P
Sbjct: 176 ----VLEDND----YGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLF-ELILMEEIRFP 225
Query: 290 EDISPDLAFIVQSCWVEDPNLR 311
+SP+ ++ +DP R
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQR 247
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 68/269 (25%), Positives = 118/269 (43%), Gaps = 47/269 (17%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
IG G++ KV + DRI A++V+ + E+ + E
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE----------QA 109
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
H LV L +C + L V E + G L ++ R KL A ++ +I+ A
Sbjct: 110 SNHPFLVG-LHSCFQTESRLF-FVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLA 165
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
++ LH GII+RDLK DN+LL + +KL D+G+ +E + T T GT ++APE
Sbjct: 166 LNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPE 223
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-------AAFK 282
+ + Y VD ++ G++++E++ R PF+ + +
Sbjct: 224 ----ILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275
Query: 283 HARPGLPEDISPDLAFIVQSCWVEDPNLR 311
+ +P +S A +++S +DP R
Sbjct: 276 EKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 51/237 (21%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRF----IREVNMMSRVKHD 118
KIG+G G+V++ R + VA+K + + E+ EG F +RE+ ++ +KH+
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EK---EG-FPITALREIKILQLLKHE 76
Query: 119 NLVKFLGACKDPLMVIVTELLPGMSLRK--YLV------------SLRPNKLDLHVALNF 164
N+V + + T+ P + YLV S K L
Sbjct: 77 NVVNLIE-------ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 129
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-----ETVTEMMTAE 219
+ + +H N I+HRD+K N+L+T LKLADFGLAR + T
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 220 TGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
T YR PEL L GE + Y +D++ G ++ E+ T +G +
Sbjct: 189 VVTLWYR--PPELL----L--GE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 236
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 72/262 (27%), Positives = 114/262 (43%), Gaps = 42/262 (16%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
+G+G+ GKV + + A+KVL + T E+ +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS----------LA 80
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
H L + L C D L V E + G L ++ + + D A +A +I A
Sbjct: 81 RNHPFLTQ-LFCCFQTPDRLF-FVMEFVNGGDLMFHIQ--KSRRFDEARARFYAAEIISA 136
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
+ LH GII+RDLK DN+LL + KLADFG+ +E + +T T GT ++APE
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEG-ICNGVTTATFCGTPDYIAPE 194
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289
+ Y VD ++ G++L+E+L PFE N + A + P
Sbjct: 195 ----ILQEML----YGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLF-EAILNDEVVYP 244
Query: 290 EDISPDLAFIVQSCWVEDPNLR 311
+ D I++S ++P +R
Sbjct: 245 TWLHEDATGILKSFMTKNPTMR 266
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 55/277 (19%), Positives = 96/277 (34%), Gaps = 61/277 (22%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHD 118
+G G +GKV + + A+K+L R REV + R +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKAR--------REVELHWRASQCP 71
Query: 119 NLVKFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
++V+ + ++ IV E L G L + A I A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 174 CLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
LH+ I HRD+KP+NLL + + LKL DFG A E
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------KET- 170
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLP 289
+ Y+ D++S G++++ LL PF + + + P
Sbjct: 171 --------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222
Query: 290 ED----ISP---DLAFIVQSCWVEDPNLRPSFSQIIR 319
+S L +++ +P R + ++ +
Sbjct: 223 NPEWSEVSEEVKML---IRNLLKTEPTQRMTITEFMN 256
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 73/266 (27%), Positives = 116/266 (43%), Gaps = 47/266 (17%)
Query: 66 IGEGAHGKVYEGRYG-----DRIVAIKVLNRG----------STSDERALLEGRFIREVN 110
+G+G +GKV++ R +I A+KVL + T ER +LE
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE-------- 76
Query: 111 MMSRVKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
VKH +V L L ++ E L G L L R A + +
Sbjct: 77 ---EVKHPFIVD-LIYAFQTGGKL-YLILEYLSGGELFMQLE--REGIFMEDTACFYLAE 129
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 225
I+ A+ LH GII+RDLKP+N++L +KL DFGL +E + + T GT +
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKES-IHDGTVTHTFCGTIEY 187
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285
MAPE + +R G +N VD +S G +++++LT PF G N + +
Sbjct: 188 MAPE----ILMRSG----HNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTI-DKILKCK 237
Query: 286 PGLPEDISPDLAFIVQSCWVEDPNLR 311
LP ++ + +++ + R
Sbjct: 238 LNLPPYLTQEARDLLKKLLKRNAASR 263
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 68/262 (25%), Positives = 119/262 (45%), Gaps = 42/262 (16%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
+G+G+ GKV D + A+K+L + T E+ +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA----------LP 398
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
K L + L +C D L V E + G L ++ + + A+ +A +IA
Sbjct: 399 GKPPFLTQ-LHSCFQTMDRLY-FVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIG 454
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
+ L + GII+RDLK DN++L + +K+ADFG+ +E + + +T +T GT ++APE
Sbjct: 455 LFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEN-IWDGVTTKTFCGTPDYIAPE 512
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289
+ Q Y VD ++FG++L+E+L + PFEG + + + P
Sbjct: 513 ----IIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELF-QSIMEHNVAYP 562
Query: 290 EDISPDLAFIVQSCWVEDPNLR 311
+ +S + I + + P R
Sbjct: 563 KSMSKEAVAICKGLMTKHPGKR 584
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 75/264 (28%), Positives = 127/264 (48%), Gaps = 45/264 (17%)
Query: 66 IGEGAHGKVY-----EGRYGDRIVAIKVLNRGS--------TSDERALLEGRFIREVNMM 112
+G+G+ GKV+ G ++ A+KVL + + T ER +L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV---------- 81
Query: 113 SRVKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
V H +VK L + L ++ + L G L L + + ++A
Sbjct: 82 -EVNHPFIVK-LHYAFQTEGKL-YLILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELA 136
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMA 227
A+D LH+ GII+RDLKP+N+LL + +KL DFGL++E + A + GT +MA
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKES-IDHEKKAYSFCGTVEYMA 194
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287
PE V R+G + D +SFG++++E+LT LPF+G + + A+ G
Sbjct: 195 PE----VVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETM-TMILKAKLG 244
Query: 288 LPEDISPDLAFIVQSCWVEDPNLR 311
+P+ +SP+ +++ + +P R
Sbjct: 245 MPQFLSPEAQSLLRMLFKRNPANR 268
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 58/256 (22%), Positives = 106/256 (41%), Gaps = 26/256 (10%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGS--TSDERALLEGRFIREVNMMSRVKHDNLV 121
+G+G G+V + ++ A K L + A+ + E ++ +V +V
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA----LNEKQILEKVNSRFVV 247
Query: 122 KFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
L KD L +V L+ G L+ ++ + A+ +A +I ++ LH
Sbjct: 248 S-LAYAYETKDAL-CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
I++RDLKP+N+LL D ++++D GLA + + GT +MAPE V +
Sbjct: 306 RIVYRDLKPENILL-DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE----VVKNE 360
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK---HARPGLPEDISPD 295
Y D ++ G +L+E++ + PF+ + + E SP
Sbjct: 361 R----YTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSERFSPQ 415
Query: 296 LAFIVQSCWVEDPNLR 311
+ +DP R
Sbjct: 416 ARSLCSQLLCKDPAER 431
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 64 SKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
+ +G GA+G V VAIK L+R S+ A R RE+ ++ ++H+N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK---RAYRELLLLKHMQHENVI 86
Query: 122 KFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
L + +V + L+K + + + + + +
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM---GLKFSEEKIQY-LVYQMLKGLKY 141
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-MAPELYST 233
+H+ G++HRDLKP NL + D + LK+ DFGLAR MT T RW APE+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLAR--HADAEMTGYVVT-RWYRAPEVI-- 195
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
HYN VD++S G ++ E+LT + F+G L
Sbjct: 196 -----LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 69/262 (26%), Positives = 121/262 (46%), Gaps = 42/262 (16%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
+G+G+ GKV E + D + A+K+L + T E+ +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA----------LP 77
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
K L + L +C D L V E + G L ++ + + A+ +A +IA
Sbjct: 78 GKPPFLTQ-LHSCFQTMDRLY-FVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIG 133
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
+ L + GII+RDLK DN++L + +K+ADFG+ +E + + +T +T GT ++APE
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEN-IWDGVTTKTFCGTPDYIAPE 191
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289
+ Q Y VD ++FG++L+E+L + PFEG + + + P
Sbjct: 192 ----IIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELF-QSIMEHNVAYP 241
Query: 290 EDISPDLAFIVQSCWVEDPNLR 311
+ +S + I + + P R
Sbjct: 242 KSMSKEAVAICKGLMTKHPGKR 263
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 73/220 (33%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G GA+G V VA+K L+R S A R RE+ ++ +KH+N++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVIGL 93
Query: 124 LGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDCL 175
L + +VT L+ G L + KL D HV I R + +
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQF-LIYQILRGLKYI 148
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-MAPELYSTV 234
H+ IIHRDLKP NL + D + LK+ DFGLAR + MT T RW APE+
Sbjct: 149 HSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR--HTADEMTGYVAT-RWYRAPEIMLNW 204
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
HYN VD++S G ++ ELLT R F G ++
Sbjct: 205 -------MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 74/262 (28%), Positives = 107/262 (40%), Gaps = 42/262 (16%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLN---------RGSTSDERALLEGRFIREVNMMSR 114
IG+G+ GKV R+ A+KVL ER +L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL----------KN 95
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
VKH LV L D L V + + G L +L R A +A +IA A
Sbjct: 96 VKHPFLVG-LHFSFQTADKL-YFVLDYINGGELFYHLQ--RERCFLEPRARFYAAEIASA 151
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
+ LH+ I++RDLKP+N+LL + L DFGL +E + T T GT ++APE
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKEN-IEHNSTTSTFCGTPEYLAPE 209
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289
V +Q Y+ VD + G VL+E+L PF N Y + L
Sbjct: 210 ----VLHKQP----YDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMY-DNILNKPLQLK 259
Query: 290 EDISPDLAFIVQSCWVEDPNLR 311
+I+ +++ +D R
Sbjct: 260 PNITNSARHLLEGLLQKDRTKR 281
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 67/233 (28%), Positives = 94/233 (40%), Gaps = 47/233 (20%)
Query: 64 SKIGEGAHGKV---YEGRYGDRIVAIKVLN--RGSTSDERALLEGRFIREVNMMSRVKHD 118
S +GEGA+G V G+ VAIK + R L RE+ ++ KH+
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEI-VAIKKIEPFDKPLFALRTL------REIKILKHFKHE 69
Query: 119 NLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARA 171
N++ + I+ EL+ L + + L D H+ F RA
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---STQMLSDDHIQY-FIYQTLRA 124
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----------EETVTEMMTAET 220
+ LH + +IHRDLKP NLL+ + LK+ DFGLAR M
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 221 GT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
T YR APE+ Y+ +DV+S G +L EL R F G
Sbjct: 184 ATRWYR--APEVM-------LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 59/260 (22%), Positives = 108/260 (41%), Gaps = 31/260 (11%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGS--TSDERALLEGRFIREVNMMSRVKHDNLV 121
+G G G+V+ + ++ A K LN+ + E ++++V +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA----MVEKKILAKVHSRFIV 248
Query: 122 KFLGAC---KDPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLH 176
L K L +V ++ G +R ++ ++ A+ + I ++ LH
Sbjct: 249 S-LAYAFETKTDL-CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTV 234
II+RDLKP+N+LL D +++++D GLA E + GT +MAPEL
Sbjct: 307 QRNIIYRDLKPENVLLD-DDGNVRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPELL--- 361
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK---HARPGLPED 291
+ Y+ VD ++ G+ L+E++ R PF + + P+
Sbjct: 362 -----LGEEYDFSVDYFALGVTLYEMIAARGPFRA-RGEKVENKELKQRVLEQAVTYPDK 415
Query: 292 ISPDLAFIVQSCWVEDPNLR 311
SP ++ +DP R
Sbjct: 416 FSPASKDFCEALLQKDPEKR 435
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 31/227 (13%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD- 118
+ K+G G V+ + + VA+K++ E A E + ++ VN K D
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 119 ----NLVKFL------GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
+++K L G + V+V E+L G +L + + L + +
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHV-VMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 169 ARAMDCLHAN-GIIHRDLKPDNLLLTPDQKS-----LKLADFGLAREETVTEMMTAETGT 222
+D +H GIIH D+KP+N+L+ +K+AD G A + +T
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 200
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
YR +PE V L + D++S +++EL+T FE
Sbjct: 201 YR--SPE----VLLGAP----WGCGADIWSTACLIFELITGDFLFEP 237
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 66/229 (28%), Positives = 94/229 (41%), Gaps = 50/229 (21%)
Query: 64 SKIGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
IG GA G V Y+ VAIK L+R + A R RE+ +M V H N+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAK---RAYRELVLMKCVNHKNI 86
Query: 121 VKFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD------ 167
+ L + IV EL+ +L + LD
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMDA---------------NLCQVIQMELDHERMSY 131
Query: 168 ----IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 223
+ + LH+ GIIHRDLKP N+++ D LK+ DFGLAR + MMT T
Sbjct: 132 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVT- 189
Query: 224 RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
R+ APE+ Y VD++S G ++ E++ + F G
Sbjct: 190 RYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G GA+G V G VAIK L R S+ A R RE+ ++ ++H+N++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMRHENVIGL 89
Query: 124 LGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDCL 175
L + +V + G L K + + KL + + + + + +
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQF-LVYQMLKGLRYI 144
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYSTV 234
HA GIIHRDLKP NL + D + LK+ DFGLAR MT T RW APE+
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR--QADSEMTGYVVT-RWYRAPEVI--- 197
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
Y VD++S G ++ E++T + F+G +L
Sbjct: 198 ----LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 66 IGEGAHG---KVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG GA G Y+ VAIK L+R + A R RE+ +M V H N++
Sbjct: 70 IGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAK---RAYRELVLMKCVNHKNIIS 125
Query: 123 FLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
L + +V EL+ +L + + + ++ + + L
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI---QMELDHERMSY-LLYQMLCGIKHL 180
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELYST 233
H+ GIIHRDLKP N+++ D LK+ DFGLAR + MMT T YR APE+
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYYR--APEVILG 237
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
Y VD++S G ++ E++ +++ F G
Sbjct: 238 --------MGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 71/226 (31%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLN--RGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
IGEGA+G V VAIK ++ T +R L RE+ ++ R +H+N++
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL------REIKILLRFRHENII 88
Query: 122 KFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDC 174
+ P + IV +L+ L K L + L + H+ F I R +
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT---QHLSNDHICY-FLYQILRGLKY 143
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGT--YRWMAP 228
+H+ ++HRDLKP NLLL LK+ DFGLAR + T +T T YR AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYR--AP 200
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
E+ K Y +D++S G +L E+L+NR F G L
Sbjct: 201 EIM-------LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 66/263 (25%), Positives = 107/263 (40%), Gaps = 44/263 (16%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
+G+G GKV + R A+K+L + T E +L+
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-----------N 204
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+H L L D L V E G L +L R A + +I A
Sbjct: 205 SRHPFLTA-LKYSFQTHDRLC-FVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSA 260
Query: 172 MDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAP 228
+D LH+ +++RDLK +NL+L D +K+ DFGL +E + + T +T GT ++AP
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAP 318
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288
E V Y VD + G+V++E++ RLPF + + +
Sbjct: 319 E----VLEDND----YGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLF-ELILMEEIRF 368
Query: 289 PEDISPDLAFIVQSCWVEDPNLR 311
P + P+ ++ +DP R
Sbjct: 369 PRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 62/260 (23%), Positives = 113/260 (43%), Gaps = 34/260 (13%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
IG G G+VY R D ++ A+K L++ +ER +L ++S
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS--------LVST 248
Query: 115 VKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+V A P + + +L+ G L +L +A +I ++
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLE 306
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
+H +++RDLKP N+LL + ++++D GLA + + + + GT+ +MAPE+
Sbjct: 307 HMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEV--- 361
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPED 291
L++G Y++ D +S G +L++LL PF + LP+
Sbjct: 362 --LQKGVA--YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDS 416
Query: 292 ISPDLAFIVQSCWVEDPNLR 311
SP+L +++ D N R
Sbjct: 417 FSPELRSLLEGLLQRDVNRR 436
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 79/319 (24%), Positives = 124/319 (38%), Gaps = 70/319 (21%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG G++G V E + R+VAIK + R R +RE+ +++R+ HD++VK
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK---RILREIAILNRLNHDHVVK 116
Query: 123 FLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDCL 175
L + +V E+ +K + P L +LH+ ++ + +
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKT-LLYNLLVGVKYV 172
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--------------------------- 208
H+ GI+HRDLKP N L+ D S+K+ DFGLAR
Sbjct: 173 HSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 209 -EETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 265
+ + +T T YR APEL L Q ++Y +DV+S G + ELL
Sbjct: 232 HTKNLKRQLTGHVVTRWYR--APEL----ILLQ---ENYTEAIDVWSIGCIFAELLNM-- 280
Query: 266 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
A P P L+ ++ + R + Q+ + N
Sbjct: 281 --------IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN--- 329
Query: 326 FTLRPPSPSVPESDTNEAA 344
L PS E+ E A
Sbjct: 330 -ILGTPSEEDIEALEKEDA 347
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 27/223 (12%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ IG+G+ G+V + + VA+K++ +A E R + + + N
Sbjct: 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 120 LVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ L C + ELL M+L + + + L + FA I + +
Sbjct: 161 VIHMLENFTFRNHIC------MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 173 DCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
D LH N IIH DLKP+N+LL + +K+ DFG + E ++ YR APE
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APE-- 269
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
V L Y +D++S G +L ELLT G
Sbjct: 270 --VILGAR----YGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 51/236 (21%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG G++G VY + ++ VAIK +NR R +RE+ +++R+K D +++
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---RILREITILNRLKSDYIIR 89
Query: 123 FLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDCL 175
++ IV E+ L+K + P L + H+ ++ + +
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKT--PIFLTEEHIKT-ILYNLLLGENFI 145
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----------------------EETV 212
H +GIIHRDLKP N LL D +K+ DFGLAR + +
Sbjct: 146 HESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 213 TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 266
+ +T+ T YR APEL +++Y +D++S G + ELL
Sbjct: 205 KKQLTSHVVTRWYR--APELILL-------QENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 57/239 (23%), Positives = 102/239 (42%), Gaps = 49/239 (20%)
Query: 64 SKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNL 120
K+G+GA+G V++ +VA+K + + A R RE+ +++ + H+N+
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFREIMILTELSGHENI 71
Query: 121 VKFLGACKDPLMV---IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDCLH 176
V L + +V + + L + + N L +H + + + LH
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA---NILEPVHKQY-VVYQLIKVIKYLH 126
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----------------------EETVTE 214
+ G++HRD+KP N+LL + +K+ADFGL+R +
Sbjct: 127 SGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 215 MMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
++T T YR APE+ Y +D++S G +L E+L + F G S
Sbjct: 186 ILTDYVATRWYR--APEILLGS-------TKYTKGIDMWSLGCILGEILCGKPIFPGSS 235
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 5e-21
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 29/225 (12%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I S IG+G+ G+V + VAIK++ +A +E R + +N
Sbjct: 58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYY 117
Query: 120 LVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+V C +V E+L +L L + + L++ FA + A+
Sbjct: 118 IVHLKRHFMFRNHLC------LVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 173 DCLHAN--GIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 229
L IIH DLKP+N+LL P + ++K+ DFG + + ++ YR +PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPE 228
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
V L Y+ +D++S G +L E+ T F G + +
Sbjct: 229 ----VLLGMP----YDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 61/279 (21%), Positives = 98/279 (35%), Gaps = 85/279 (30%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR--VKH 117
+ K+G G V+ G + VA+KV+ E AL E R ++ V
Sbjct: 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 118 DNLVKFLGA-----------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
+ +V+ L C +V E+L G L K+++ L L
Sbjct: 101 EMVVQLLDDFKISGVNGTHIC------MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 167 DIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSL-------------------------- 199
+ + +D LH IIH D+KP+N+LL+ +++ +
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 200 ----------------------KLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTVT 235
K+AD G A + TE + T YR + E V
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ--TRQYR--SLE----VL 265
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
+ G YN D++S + +EL T FE S +
Sbjct: 266 IGSG----YNTPADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-20
Identities = 64/244 (26%), Positives = 94/244 (38%), Gaps = 51/244 (20%)
Query: 62 IGSKIGEGAHGKVYEG---RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
I +GEGA GKV E + G R VA+K++ E A E + + +N
Sbjct: 18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTF 77
Query: 119 NLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNK---LDLHVALNFALDI 168
V+ L C IV ELL G+S ++ + N L A I
Sbjct: 78 RCVQMLEWFEHHGHIC------IVFELL-GLSTYDFI---KENGFLPFRLDHIRKMAYQI 127
Query: 169 ARAMDCLHANGIIHRDLKPDNLLL------------------TPDQKSLKLADFGLAREE 210
++++ LH+N + H DLKP+N+L T +K+ DFG A +
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270
T YR APE V L G ++ DV+S G +L E F
Sbjct: 188 DEHHSTLVSTRHYR--APE----VILALG----WSQPCDVWSIGCILIEYYLGFTVFPTH 237
Query: 271 SNLQ 274
+ +
Sbjct: 238 DSKE 241
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 60/243 (24%), Positives = 90/243 (37%), Gaps = 49/243 (20%)
Query: 62 IGSKIGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
I +GEG GKV + G VA+K++ E A LE ++++ +
Sbjct: 23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKF 82
Query: 119 NLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
V C I ELL G + ++L L + A + A
Sbjct: 83 LCVLMSDWFNFHGHMC------IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 172 MDCLHANGIIHRDLKPDNLLLT------------------PDQKSLKLADFGLA--REET 211
+ LH N + H DLKP+N+L S+++ADFG A E
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195
Query: 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
T ++ T YR PE V L G + DV+S G +L+E F+
Sbjct: 196 HTTIV--ATRHYR--PPE----VILELG----WAQPCDVWSIGCILFEYYRGFTLFQTHE 243
Query: 272 NLQ 274
N +
Sbjct: 244 NRE 246
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 59/255 (23%), Positives = 99/255 (38%), Gaps = 69/255 (27%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD- 118
+ K+G+G G+V + A+KV+ A +E ++++ D
Sbjct: 39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQ-----NDDI 93
Query: 119 ---NLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNK---LDLHVALNFA 165
N+VK+ G C ++ E L G SL + + N + +
Sbjct: 94 NNNNIVKYHGKFMYYDHMC------LIFEPL-GPSLYEII---TRNNYNGFHIEDIKLYC 143
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLL------------------------TPDQKSLKL 201
++I +A++ L + H DLKP+N+LL +KL
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 202 ADFGLA--REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259
DFG A + + ++ T YR APE V L G ++ D++SFG VL E
Sbjct: 204 IDFGCATFKSDYHGSII--NTRQYR--APE----VILNLG----WDVSSDMWSFGCVLAE 251
Query: 260 LLTNRLPFEGMSNLQ 274
L T L F +++
Sbjct: 252 LYTGSLLFRTHEHME 266
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 37/227 (16%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G KIG G G++ G+ Y + VAIK+ + + LE RF +++ +
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM-KSRAPQLHLEYRFYKQLGSGDGIPQ-- 69
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V + G C +V ELL G SL + L L L L A+ + M+ +H+
Sbjct: 70 -VYYFGPCGK-YNAMVLELL-GPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 180 IIHRDLKPDNLLL----TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMA 227
+I+RD+KP+N L+ Q+ + + DF LA+E ET + E TGT R+M
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM- 184
Query: 228 PELYSTVTLRQGEKKHYNN----KVDVYSFGIVLWELLTNRLPFEGM 270
S T H + D+ + G + L LP++G+
Sbjct: 185 ----SINT-------HLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 35/165 (21%), Positives = 60/165 (36%), Gaps = 20/165 (12%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVN---MMSRVK 116
+G KIG G G +Y + A V+ + E +F + V + +
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 117 HDNLVKFLG-----------ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
+ +LG +V E L G+ L+K L
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLG 157
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARE 209
+ + ++ +H N +H D+K NLLL + + LAD+GL+
Sbjct: 158 IRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 37/227 (16%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +IGEG+ G ++EG ++ VAIK + + E R + + + + +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPN-- 70
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V + G V+V +LL G SL + L+ L K + A + + +H
Sbjct: 71 -VYYFGQEGL-HNVLVIDLL-GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 180 IIHRDLKPDNLLL----TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMA 227
+++RD+KPDN L+ + + + + DFG+ + T + E +GT R+M
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM- 185
Query: 228 PELYSTVTLRQGEKKHYNN----KVDVYSFGIVLWELLTNRLPFEGM 270
S T H + D+ + G V L LP++G+
Sbjct: 186 ----SINT-------HLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 32/166 (19%), Positives = 58/166 (34%), Gaps = 19/166 (11%)
Query: 62 IGSKIGEGAHGKVYEGR----------YGDRIVAIKVLNRGSTSDERALLEGRFIR--EV 109
+ S G +YE + ++K+ + R + +V
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 110 NMMSRVKHDNL-----VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 164
N ++ L G +D +V L G SL+ L + L L
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQV 164
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARE 209
A + A++ LH N +H ++ +N+ + DQ + LA +G A
Sbjct: 165 ACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 34/195 (17%), Positives = 62/195 (31%), Gaps = 35/195 (17%)
Query: 62 IGSKIGEGAHGKVYEGR-------YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
+G IG+G G +Y D +KV + + E +F + +
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV---EPSDNGPLFTELKFYQRAAKPEQ 95
Query: 115 VKHDNLVKFLGACKDPLM--------------VIVTELLPGMSLRKYLVSLRPNKLDLHV 160
++ + L P ++ + G L+K +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY-EANAKRFSRKT 153
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARE----ETVTEM 215
L +L I ++ +H + +H D+K NLLL + + L D+GLA
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213
Query: 216 MTAE----TGTYRWM 226
GT +
Sbjct: 214 AADPKRCHDGTIEFT 228
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 41/230 (17%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G KIG G+ G +Y G VAIK + L E + ++
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIK---LECVKTKHPQLH----IESKIYKMMQGGV 65
Query: 120 ---LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+++ GA D V+V ELL G SL + L + K L L A + ++ +H
Sbjct: 66 GIPTIRWCGAEGD-YNVMVMELL-GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 177 ANGIIHRDLKPDNLLL--TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWM 226
+ IHRD+KPDN L+ + + DFGLA++ T + E TGT R+
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 227 APELYSTVTLRQGEKKHYNN----KVDVYSFGIVLWELLTNRLPFEGMSN 272
S T H + D+ S G VL LP++G+
Sbjct: 183 -----SINT-------HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALL-EGRFIREVNMMSRVKHD 118
+G KIG G+ G++Y G + VAIK+ N + LL E + R + + + +
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTGIPN- 67
Query: 119 NLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
V++ G D V+V +LL G SL + L + KL L L A + ++ +H+
Sbjct: 68 --VRWFGVEGD-YNVLVMDLL-GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 179 GIIHRDLKPDNLLL--TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMAP 228
+HRD+KPDN L+ + + DFGLA++ T + E TGT R+
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA-- 180
Query: 229 ELYSTVTLRQGEKKHYNN----KVDVYSFGIVLWELLTNRLPFEGM 270
S T H + D+ S G VL L LP++G+
Sbjct: 181 ---SVNT-------HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.1 bits (160), Expect = 3e-12
Identities = 37/193 (19%), Positives = 61/193 (31%), Gaps = 48/193 (24%)
Query: 65 KIGEGAHGKVYEGRYGDRIVAIKVLNRGS---------TSDERALLEGRFIREVNMMS-- 113
KIGEG G+V++ VAIK++ + E L E +E++++S
Sbjct: 27 KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 114 -RVKHDNLVKFLGAC-------------------------------KDPLMVIVTELLPG 141
+ + + KD + IV E G
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLK 200
L +R L A + + ++ A+ HRDL N+LL K
Sbjct: 147 GID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK-TSLKK 202
Query: 201 LADFGLAREETVT 213
L + T+
Sbjct: 203 LHYTLNGKSSTIP 215
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 27/168 (16%), Positives = 56/168 (33%), Gaps = 22/168 (13%)
Query: 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTS------DERALLEGR 104
L+ K+ IG +GEG V+ + ++ + ++R +
Sbjct: 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLH 142
Query: 105 FIREVNMMSRVKHDNLVKFLGA-CKDPLM----VIVTELLPGMSLRKYLVSLRPNKLDLH 159
F +R + L K G ++ EL+ L ++ +
Sbjct: 143 FSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELY---------RVRVE 193
Query: 160 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207
I + + GI+H DL N+L++ + + + DF +
Sbjct: 194 NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG--IWIIDFPQS 239
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 2e-06
Identities = 53/423 (12%), Positives = 116/423 (27%), Gaps = 109/423 (25%)
Query: 3 CSNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLV-----DP 57
+ N R + + S++ E R ++K+ LLV +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRI--HSIQAELRRLLKS-----KPYE--NCLLVLLNVQNA 256
Query: 58 KLL--F-IGSKI-----GEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREV 109
K F + KI + + +++ + T DE ++ ++ +
Sbjct: 257 KAWNAFNLSCKILLTTRFKQVTDFLSAATTTH--ISLDHHSMTLTPDE---VKSLLLKYL 311
Query: 110 NMMSRVKHDNLVKFLGACK-DPLMV-IVTELLPGMSLR-KYLVSLRPNKLD--LHVALNF 164
+ + +L + +P + I+ E + + +KL + +LN
Sbjct: 312 DC----RPQDLPR--EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN- 364
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY- 223
L+ A + P + + L L ++ ++ + Y
Sbjct: 365 VLEPAEYRKMFDRLSVF-----PPSAHIPT--ILLSL--IWFDVIKSDVMVVVNKLHKYS 415
Query: 224 ---RWMAPELYS--------TVTLRQGEKKH------YN------------NKVDVYSFG 254
+ S V L H YN +D Y +
Sbjct: 416 LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFY- 474
Query: 255 IVLWEL---LTNRLPFEGMSNLQAAY------AAAFKHARPGL--PEDISPDLA------ 297
+ L N E M+ + + +H I L
Sbjct: 475 ---SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYK 531
Query: 298 -FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAA-ATSNGAMTEFS 355
+I + P + +++ + FL + +D A + A+ E +
Sbjct: 532 PYICDND--------PKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEA 583
Query: 356 ARA 358
+
Sbjct: 584 HKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 4e-06
Identities = 62/371 (16%), Positives = 113/371 (30%), Gaps = 107/371 (28%)
Query: 29 VEKESRAVVKNGS----ITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIV 84
V+ ++++ I + + +L + LL ++ + +V Y +
Sbjct: 38 VQDMPKSILSKEEIDHIIMSKD-AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS 96
Query: 85 AIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSL 144
IK R + +++ +I + + R+ +DN F K V+ L P + L
Sbjct: 97 PIKTEQR-----QPSMMTRMYIEQRD---RLYNDN-QVFA---KYN----VSRLQPYLKL 140
Query: 145 RKYLVSLRPNK-LDLHVALNF-----ALDIARAMD--CLHANGI----IHRDLKPD---- 188
R+ L+ LRP K + + L ALD+ + C I + P+
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 189 ---NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY--STVTLRQGEKKH 243
LL D +D + + + R + + Y + L
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHS---IQAELRRLLKSKPYENCLLVLL------ 251
Query: 244 YNNKVDVYSFGIVLWE--------LLTNR-------------------------LPFEGM 270
+V + W LLT R P E
Sbjct: 252 -----NVQNAKA--WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK 304
Query: 271 SNLQAAYAAAFKHARPGLPE---DISP-DLAFIVQSC------WVEDPNLRPSFSQIIRM 320
S L Y LP +P L+ I +S W D + ++ +
Sbjct: 305 S-LLLKYL---DCRPQDLPREVLTTNPRRLSIIAESIRDGLATW--DNWKHVNCDKLTTI 358
Query: 321 LNAFLFTLRPP 331
+ + L L P
Sbjct: 359 IESSLNVLEPA 369
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 36/148 (24%), Positives = 53/148 (35%), Gaps = 19/148 (12%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLN----RGSTSDERALLEGRFIREVNMMSRVKHDNL- 120
IG+GA + Y D V IK R DE R RE ++ VK +
Sbjct: 344 IGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKS-RTAREARYLALVKDFGIP 402
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
++ I+ + G + + L+ A I + LH N +
Sbjct: 403 APYIFDVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDV 452
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAR 208
IH DL N + D L + DFGL +
Sbjct: 453 IHNDLTTSNFIFDKD---LYIIDFGLGK 477
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 28/201 (13%), Positives = 58/201 (28%), Gaps = 27/201 (13%)
Query: 30 EKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGR----YGDRIVA 85
+ E R + + L L + +G I G V+ +A
Sbjct: 20 DGEERKIYAE-VLDGRTLKTLYKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMA 78
Query: 86 IKV--LNRGSTSDERALLEGRFIREVNMMSRVKHDNL-----VKFLGACKDP-------- 130
+K+ + L G ++ +S + + + L K+
Sbjct: 79 VKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPY 138
Query: 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLK 186
V++ E + L + +L D+ + L+ ++H DL
Sbjct: 139 TYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLS 198
Query: 187 PDNLLLTPDQKSLKLADFGLA 207
N++ + D G A
Sbjct: 199 EYNIMYIDK---VYFIDMGQA 216
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 378 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.21 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.73 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.57 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.44 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.42 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.4 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.96 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.89 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.84 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.59 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.51 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.35 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.28 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.16 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.14 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.99 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.68 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.72 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.51 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.0 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-61 Score=436.64 Aligned_cols=266 Identities=30% Similarity=0.517 Sum_probs=221.4
Q ss_pred ccccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCC
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL 131 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 131 (378)
.|.++.+++.+.++||+|+||+||+|++.+ .||||+++........ .+.|.+|+.+|++++|||||++++++.++.
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 105 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQ---FQAFRNEVAVLRKTRHVNILLFMGYMTKDN 105 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHH---HHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEECCe
Confidence 467888899999999999999999999876 5999999765444332 346999999999999999999999998888
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
+++|||||+||+|.+++.. ....+++..+..|+.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+...
T Consensus 106 ~~iVmEy~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKS 183 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-EEEECCCSSCBC--
T ss_pred EEEEEEcCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-cEEEeeccCceecc
Confidence 9999999999999999976 345799999999999999999999999999999999999999554 69999999997543
Q ss_pred c---ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC---
Q 017046 212 V---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--- 285 (378)
Q Consensus 212 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--- 285 (378)
. .......+||+.|||||++... ....|+.++|||||||+||||+||+.||.+.+..............
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~-----~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~ 258 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQ-----DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD 258 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC
T ss_pred cCCcceeecccccCCCccCHHHhhcc-----CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC
Confidence 2 2233456899999999998541 1246899999999999999999999999987776655555544332
Q ss_pred -CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 286 -PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 286 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
+..+..+|+++.+|+.+||+.||.+|||+.+++++|+.+-..+
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 2356679999999999999999999999999999988765443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-61 Score=445.48 Aligned_cols=251 Identities=30% Similarity=0.425 Sum_probs=213.0
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
-++|+++++||+|+||+||+|++. ++.||||++......... .+++.+|+.+|+.|+|||||++++++.++ .+|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE---REESRREVAVLANMKHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHH---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHH---HHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 367999999999999999999874 789999999876654432 34689999999999999999999999754 789
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
||||||+||+|.+++...+...+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+|+.....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEESCCCHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccceeecCC
Confidence 999999999999999876666789999999999999999999999999999999999999665 5999999999865443
Q ss_pred -cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 214 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
......+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+ ....+.....+.++..+
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~--------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~~~~~~~ 249 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICEN--------KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFPPVSLHY 249 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCCCCTTS
T ss_pred cccccccCCCccccCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCCCCCccC
Confidence 23345689999999999865 678999999999999999999999999876644 44455556667778889
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
|+++.+||.+||+.||.+|||+.|++++
T Consensus 250 s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 250 SYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999999983
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-60 Score=432.14 Aligned_cols=258 Identities=27% Similarity=0.508 Sum_probs=219.4
Q ss_pred cCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
++.++|.+.++||+|+||+||+|++. +..||||+++..... ..+.|.+|+++|++++|||||++++++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-----~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN-----ARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChH-----HHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 45678999999999999999999863 578999999754321 134699999999999999999999999
Q ss_pred ec-CCeEEEEeccCCCCHHHHHhhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC
Q 017046 128 KD-PLMVIVTELLPGMSLRKYLVSLR-----------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 195 (378)
Q Consensus 128 ~~-~~~~lv~e~~~~~sL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~ 195 (378)
.+ +..++|||||++|+|.+++.... ...+++.+++.++.||+.||.|||+++|+||||||+|||++.+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 75 47899999999999999997632 3469999999999999999999999999999999999999965
Q ss_pred CCceeEeccccccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCC
Q 017046 196 QKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 271 (378)
Q Consensus 196 ~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 271 (378)
+ .+||+|||+++....... .....||+.|||||++.. ..|+.++|||||||++|||+| |+.||.+.+
T Consensus 165 ~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 165 L-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp G-CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred C-cEEECCcccceecCCCCceeecCceecChhhcCHHHHcC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 4 599999999975433322 223468999999999965 679999999999999999998 999999877
Q ss_pred hHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 272 NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.. .....+..+..+..|..+|+++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 236 ~~-~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 236 NN-EVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HH-HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH-HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 64 44555666777888999999999999999999999999999999999887654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-60 Score=438.11 Aligned_cols=253 Identities=29% Similarity=0.470 Sum_probs=215.4
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|.++++||+|+||+||+|++. ++.||||++........ +.+.+|+.+|+.++|||||++++++.+ +.+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~-----~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR-----ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSG-----GGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHH-----HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46999999999999999999884 78999999976443332 247899999999999999999999965 47899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|+.....
T Consensus 149 vmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSS
T ss_pred EEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCC
Confidence 9999999999999975 4699999999999999999999999999999999999999665 5999999999865433
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--CCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PED 291 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~ 291 (378)
......+||+.|||||++.. ..|+.++|||||||++|+|++|..||.+.+.... +..+.....+.+ +..
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-~~~i~~~~~~~~~~~~~ 295 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNLPPRLKNLHK 295 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSSCCCCSCGGG
T ss_pred CcccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHcCCCCCCCcccc
Confidence 34556799999999999864 6789999999999999999999999998766443 344444443333 356
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
+|+++.+||.+||..||.+|||+.|+++ +.++....+
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~--Hp~~~~~~~ 332 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGP 332 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhcCCCC
Confidence 8999999999999999999999999999 677766544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=433.07 Aligned_cols=259 Identities=29% Similarity=0.526 Sum_probs=215.8
Q ss_pred ccCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEee
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 126 (378)
.++.++|.+.++||+|+||+||+|++. ++.||||+++..... ..+.|.+|+++|++++|||||+++++
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-----~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES-----ARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHH-----HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHH-----HHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 356678999999999999999999863 578999999754321 23469999999999999999999999
Q ss_pred Eec-CCeEEEEeccCCCCHHHHHhhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEE
Q 017046 127 CKD-PLMVIVTELLPGMSLRKYLVSLR-------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 192 (378)
Q Consensus 127 ~~~-~~~~lv~e~~~~~sL~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill 192 (378)
|.+ +..++|||||++|+|.+++.... ...+++.+++.++.||+.||+|||+++||||||||+||||
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 975 47899999999999999997532 2458999999999999999999999999999999999999
Q ss_pred cCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCC
Q 017046 193 TPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 268 (378)
Q Consensus 193 ~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 268 (378)
+.+ ..+||+|||+++...... ......||+.|||||++.. ..++.++|||||||+||||+| |+.||.
T Consensus 192 ~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~ 262 (329)
T 4aoj_A 192 GQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDVWSFGVVLWEIFTYGKQPWY 262 (329)
T ss_dssp ETT-TEEEECCCC----------------CCCCGGGCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCC-CcEEEcccccceeccCCCcceecCcccccccccChhhhcC--------CCCCccccccchHHHHHHHHcCCCCCCC
Confidence 955 469999999998543322 2334579999999999865 679999999999999999999 999999
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 269 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+.+..+ ....+..+.++..|..+++++.+|+.+||+.||.+|||+.+|+++|+.+...
T Consensus 263 ~~~~~~-~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 263 QLSNTE-AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp SSCHHH-HHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCHHH-HHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 877644 4455566778889999999999999999999999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=430.53 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=218.3
Q ss_pred cCCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
+....+++.++||+|+||+||+|++ .++.||||+++....... .+.|.+|+.++++++|||||+++|++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~----~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL----REEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-C----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHH----HHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 4556788899999999999999986 347899999976544332 23689999999999999999999999
Q ss_pred ec-CCeEEEEeccCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEE
Q 017046 128 KD-PLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 192 (378)
Q Consensus 128 ~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill 192 (378)
.+ +..++|||||++|+|.++|.... ...+++..++.++.||+.||+|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 65 47899999999999999996532 1358999999999999999999999999999999999999
Q ss_pred cCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCC
Q 017046 193 TPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 268 (378)
Q Consensus 193 ~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 268 (378)
+.++ .+||+|||+++...... .....+||+.|||||++.. ..|+.++|||||||+||||+| |..||.
T Consensus 179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~~s~ksDVwSfGvvl~El~t~g~~Pf~ 249 (308)
T 4gt4_A 179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--------GKFSIDSDIWSYGVVLWEVFSYGLQPYC 249 (308)
T ss_dssp CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--------CCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence 9554 59999999998643322 2345689999999999865 679999999999999999998 899999
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 269 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
+.+.. .....+..+..++.|..+|+++.+|+.+||+.||.+|||+.+|+++|+++
T Consensus 250 ~~~~~-~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 250 GYSNQ-DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCHH-HHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 88764 44555666777888999999999999999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-60 Score=434.51 Aligned_cols=255 Identities=23% Similarity=0.278 Sum_probs=214.4
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
....|.+.++||+|+||+||+|++. ++.||||+++.... +.+|+.+++.++|||||++++++.++ .+
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4467899999999999999999874 78999999986433 24799999999999999999999754 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++..+||+|||+|+....
T Consensus 126 ~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999999999863 57999999999999999999999999999999999999997765699999999986433
Q ss_pred cc------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-
Q 017046 213 TE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR- 285 (378)
Q Consensus 213 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~- 285 (378)
.. .....+||+.|||||++.+ ..|+.++|||||||++|+|++|..||.+.+..............
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~ 275 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMG--------KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI 275 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG
T ss_pred CCcccceecCCccccCccccCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc
Confidence 22 1234579999999999965 67899999999999999999999999876654333333222211
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
..++..+++++.+||.+||+.||.+|||+.|++++|...+.....
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 246788999999999999999999999999999999988876543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-60 Score=432.81 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=211.8
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
.+++|.+++.||+|+||+||+|++ +++.||||++.+....... ....+.+|+++|+.++|||||+++++++++ .+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 346799999999999999999987 4789999999754322111 124688999999999999999999999765 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 108 yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSP 184 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCT
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCC
Confidence 9999999999999999863 5799999999999999999999999999999999999999665 599999999986432
Q ss_pred ---ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 213 ---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 213 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
.......+||+.|||||++.+ ..|+.++|||||||++|+|++|..||.+.+..+ .+..+. .....+|
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~-~~~~~~p 254 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKII-KLEYDFP 254 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHH--------SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-HTCCCCC
T ss_pred CCCcccccCcccCcccCCHHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-cCCCCCC
Confidence 223456799999999999965 678999999999999999999999998866543 333333 3456788
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
..+|+++.+||.+||..||.+|||+.|++.
T Consensus 255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 255 EKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred cccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 999999999999999999999999988643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-59 Score=423.42 Aligned_cols=252 Identities=29% Similarity=0.528 Sum_probs=212.6
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-----C
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-----P 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~ 130 (378)
+.|++.++||+|+||+||+|.+. +..||+|++......... ..+|.+|+.+|+.++|||||++++++.+ .
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH---HHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH---HHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 34567788999999999999874 689999999865544332 3468999999999999999999999853 3
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~g--ivH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
.+++|||||+||+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+||||+...+.+||+|||+|+
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 578999999999999999863 57999999999999999999999999 99999999999998544569999999997
Q ss_pred ccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC-C
Q 017046 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-G 287 (378)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~ 287 (378)
.... ......+||+.|||||++. ..|+.++|||||||++|+|++|+.||.+..........+.....+ .
T Consensus 181 ~~~~-~~~~~~~GTp~YmAPE~~~---------~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~ 250 (290)
T 3fpq_A 181 LKRA-SFAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 250 (290)
T ss_dssp GCCT-TSBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred eCCC-CccCCcccCccccCHHHcC---------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCC
Confidence 5433 3345678999999999874 358999999999999999999999998877766666665554433 4
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
++..+++++.+||.+||+.||.+|||+.++++ ++++.
T Consensus 251 ~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~--Hp~~~ 287 (290)
T 3fpq_A 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFFQ 287 (290)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGC
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc--Ccccc
Confidence 56678899999999999999999999999998 45543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-59 Score=418.88 Aligned_cols=251 Identities=30% Similarity=0.488 Sum_probs=198.3
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
.+|++++.||+|+||+||+|++ +++.||||++.+....... ...++.+|+.+++.++|||||++++++.++ ..|+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD--MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHH--HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4699999999999999999987 4789999999875543322 234688999999999999999999999765 7899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||+ +|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 91 vmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CEEECCSSCC-------
T ss_pred EEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-CEEEeecCCCeecCCCC
Confidence 99999 7899999976 35799999999999999999999999999999999999999665 59999999998766666
Q ss_pred ccccCcCcccccccccccccccccccccc-CCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKH-YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
.....+||+.|||||++.+ .. ++.++|||||||++|+|++|+.||.+.+. ......+ ....+.+|..+|
T Consensus 167 ~~~~~~GT~~Y~APE~~~~--------~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-~~~~~~i-~~~~~~~p~~~s 236 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISG--------KLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-PVLFKNI-SNGVYTLPKFLS 236 (275)
T ss_dssp --------CTTSCHHHHSS--------SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH-HHTCCCCCTTSC
T ss_pred ccCCeeECcccCChhhhcC--------CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHH-HcCCCCCCCCCC
Confidence 6667899999999999864 34 46799999999999999999999987654 3333333 345567888999
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
+++.+||.+||+.||.+|||+.|+++ +.++.
T Consensus 237 ~~~~~li~~~L~~dP~~R~s~~eil~--hpw~k 267 (275)
T 3hyh_A 237 PGAAGLIKRMLIVNPLNRISIHEIMQ--DDWFK 267 (275)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHH--CHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHc--Ccccc
Confidence 99999999999999999999999999 45553
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-59 Score=440.07 Aligned_cols=253 Identities=29% Similarity=0.460 Sum_probs=215.9
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|.++++||+|+||+||+|++. ++.||||++........ +.+.+|+.+|+.++|||||++++++.+ +.+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~-----~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR-----ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSG-----GGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHH-----HHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence 46999999999999999999874 78999999986554332 247899999999999999999999965 47899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
|||||+||+|.+++.. ..+++..+..++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.....
T Consensus 226 VmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSC
T ss_pred EEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCC
Confidence 9999999999999975 4699999999999999999999999999999999999999766 4999999999865433
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--CCCCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPED 291 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~ 291 (378)
......+||+.|||||++.. ..|+.++|||||||++|+|++|..||.+.+..... ..+.....+ ..+..
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-~~i~~~~~~~~~~~~~ 372 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPRLKNLHK 372 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSCCCCCSCTTS
T ss_pred ccccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-HHHHcCCCCCCccccc
Confidence 34456799999999999864 67899999999999999999999999987765443 334444333 33457
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
+|+++.+||.+||..||.+|||+.|+++ +.++....+
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~--Hp~~~~~~~ 409 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGP 409 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc--CHHhcCCCC
Confidence 9999999999999999999999999999 677766443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=427.65 Aligned_cols=254 Identities=28% Similarity=0.466 Sum_probs=207.7
Q ss_pred cCCcceeecceeecccceEEEEEEE-----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
+++++|++++.||+|+||+||+|+. +++.||||++++........ .++.+|+.+|++++|||||++++++.+
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~---~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR---VRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEEC---C------CCCCCCCCTTEECEEEEEEE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHH---HHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 4567899999999999999999976 35789999997644322111 247789999999999999999999975
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
+..|+|||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~ 174 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSK 174 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-CEEEESSEEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-CEEecccccce
Confidence 4789999999999999999863 5799999999999999999999999999999999999999665 49999999998
Q ss_pred cccc-ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 209 EETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 209 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
.... .......+||+.|||||++.+ ..|+.++|||||||++|+|++|..||.+.+..+.. ..+. ...+.
T Consensus 175 ~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-~~i~-~~~~~ 244 (304)
T 3ubd_A 175 ESIDHEKKAYSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM-TMIL-KAKLG 244 (304)
T ss_dssp C-----CCCCSCCCCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHH-HCCCC
T ss_pred eccCCCccccccccCcccCCHHHhcc--------CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH-HHHH-cCCCC
Confidence 5432 334456789999999999865 67899999999999999999999999987664433 3332 34567
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCC-----HHHHHHHHHhhhh
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 326 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~l~~~~~ 326 (378)
+|..+|+++.+||.+||+.||.+||| ++|+++ +.++.
T Consensus 245 ~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~--Hp~f~ 286 (304)
T 3ubd_A 245 MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR--HSFFS 286 (304)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT--SGGGT
T ss_pred CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc--Ccccc
Confidence 88899999999999999999999998 578887 44543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=430.65 Aligned_cols=263 Identities=30% Similarity=0.540 Sum_probs=226.6
Q ss_pred ccccCCcceeecceeecccceEEEEEEECC-------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeE
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKF 123 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l 123 (378)
.|.++.++|++++.||+|+||+||+|++.+ +.||||++......... +.|.+|+.+|.+++ |||||++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~----~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHH----HHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHH----HHHHHHHHHHHHcCCCCcEEEE
Confidence 466788899999999999999999998642 57999999876554432 45899999999996 5999999
Q ss_pred EeeEec--CCeEEEEeccCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCC
Q 017046 124 LGACKD--PLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 187 (378)
Q Consensus 124 ~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp 187 (378)
+++|.+ ..+++|||||++|+|.++|.... ...+++..+..++.||+.||+|||+++||||||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~ 213 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 213 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCc
Confidence 999854 36899999999999999997532 23589999999999999999999999999999999
Q ss_pred CcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-C
Q 017046 188 DNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 263 (378)
Q Consensus 188 ~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g 263 (378)
+|||++.++ .+||+|||+|+...... .....+||+.|||||++.. ..|+.++|||||||+||||+| |
T Consensus 214 ~NILl~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 214 RNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp GGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTS
T ss_pred cceeeCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhc--------CCCCCcccEeehHHHHHHHHhCC
Confidence 999999655 59999999998543222 2334578999999999965 679999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 264 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 264 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
..||.+..........+..+.++..|..+++++.+++.+||+.||.+|||+.+++++|..++..
T Consensus 285 ~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 285 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 9999987766667777777888899999999999999999999999999999999999988754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=409.86 Aligned_cols=253 Identities=29% Similarity=0.442 Sum_probs=194.1
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-----
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 130 (378)
++|.+++.||+|+||+||+|++. ++.||||+++....... .+++.+|+.+|+.++|||||++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA----REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 35899999999999999999874 78999999986554322 34688999999999999999999988532
Q ss_pred --------CeEEEEeccCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeE
Q 017046 131 --------LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 201 (378)
Q Consensus 131 --------~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl 201 (378)
++|+|||||+||+|.+++..... ...++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl 159 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKV 159 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEE
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEE
Confidence 36899999999999999976322 2356677899999999999999999999999999999999665 5999
Q ss_pred ecccccccccccc-------------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCC
Q 017046 202 ADFGLAREETVTE-------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (378)
Q Consensus 202 ~Dfg~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 268 (378)
+|||+|+...... .....+||+.|||||++.+ ..|+.++|||||||++|||++ ||.
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--------NSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC--------CCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 9999997543321 1234579999999999864 679999999999999999996 886
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 269 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
+................+..+...++.+.+||.+||+.||.+|||+.++++ +.++..+
T Consensus 229 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~--h~~~~~~ 286 (299)
T 4g31_A 229 TQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--NAVFEDL 286 (299)
T ss_dssp SHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGCCC
T ss_pred CccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhCCC
Confidence 543322223333333333333345567889999999999999999999998 5666554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=410.71 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=211.4
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec------
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------ 129 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 129 (378)
++|.+++.||+|+||+||+|++ +++.||||+++........ ..++.+|+++|+.++|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN---AKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHH---HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHH---HHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 5799999999999999999987 4799999999765544332 2468899999999999999999998742
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
...|+|||||+ |+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCB
T ss_pred CCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEeecceee
Confidence 36799999995 689999875 46799999999999999999999999999999999999999665 59999999997
Q ss_pred cccc-----ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017046 209 EETV-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 209 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 283 (378)
.... .......+||+.|+|||++.+ ...++.++||||+||++|+|++|++||.+.+.......+....
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~-------~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLS-------LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred ecccCccccccccccceeChHhcCHHHhcC-------CCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 5432 223456799999999999864 2457899999999999999999999999887655544433222
Q ss_pred CCCC-----------------------------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 284 ARPG-----------------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 284 ~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
..+. +...+++++.+||.+||..||.+|||+.|+++ +.++.....
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~~ 353 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR--HPFLAKYHD 353 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGGTTTCC
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc--CHhhCcCCC
Confidence 1111 01347889999999999999999999999999 677776543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=401.95 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=198.8
Q ss_pred cceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-----Ce
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-----LM 132 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~ 132 (378)
++|.+.++||+|+||+||+|+++++.||||++..... .. ..+..|+..+..++|||||++++++.++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~---~~---~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---RS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH---HH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch---hh---HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4688899999999999999999999999999965321 11 1234567777889999999999998643 46
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeeecCCCCcEEEcCCCCceeEecc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--------givH~dikp~Nill~~~~~~vkl~Df 204 (378)
+|||||+++|+|.+++.. ..+++..+..++.|++.||+|||++ ||+||||||+||||+.++ .+||+||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DF 152 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred EEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeC
Confidence 899999999999999976 4699999999999999999999987 999999999999999665 5999999
Q ss_pred cccccccccc-----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCC----------
Q 017046 205 GLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG---------- 269 (378)
Q Consensus 205 g~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~---------- 269 (378)
|+++...... .....+||+.|||||++.+... .....++.++|||||||++|||+||..||..
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~--~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSC--TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhccccc--ccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 9997543322 1224579999999999864110 0123567899999999999999999776532
Q ss_pred CC----hHHHHHHHH-HhcCCCCCCCC-----ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 270 MS----NLQAAYAAA-FKHARPGLPED-----ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 270 ~~----~~~~~~~~~-~~~~~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.. ......... ....+|.+|.. .+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11 112222222 23445555543 335788999999999999999999999999887543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=398.42 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=199.5
Q ss_pred cceeecceeecccceEEEEEEE-----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-C
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-P 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~ 130 (378)
+.|.+.++||+|+||+||+|++ +++.||||++...... .++.+|+++|+.+ +||||+++++++.+ +
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP-------IRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH-------HHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH-------HHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 4699999999999999999975 3578999998764432 2477999999998 69999999999965 4
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
+.++||||++||+|.+++. .+++.++..++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+..
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 7899999999999999884 48999999999999999999999999999999999999876567999999999643
Q ss_pred ccc-----------------------------cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHH
Q 017046 211 TVT-----------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 261 (378)
Q Consensus 211 ~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll 261 (378)
... ......+||+.|+|||++.+ ...|+.++||||+||++|+|+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-------CPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHH
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC-------CCCCCCccchhhhHHHHHHHH
Confidence 211 11234579999999999864 245889999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHh-------------------------------------cC----------------CCCC
Q 017046 262 TNRLPFEGMSNLQAAYAAAFK-------------------------------------HA----------------RPGL 288 (378)
Q Consensus 262 ~g~~pf~~~~~~~~~~~~~~~-------------------------------------~~----------------~~~~ 288 (378)
+|+.||...++.......+.. .. ....
T Consensus 242 ~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 321 (361)
T 4f9c_A 242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG 321 (361)
T ss_dssp HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred HCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence 999999655443222211110 00 0011
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
...+|+++.+||.+||..||.+|||++|+++ ++++..+
T Consensus 322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~--Hp~f~~i 359 (361)
T 4f9c_A 322 WNEVPDEAYDLLDKLLDLNPASRITAEEALL--HPFFKDM 359 (361)
T ss_dssp CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT--SGGGTTC
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhc--CcccCCC
Confidence 2357899999999999999999999999998 6666553
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=417.08 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=209.6
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHH-HHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 130 (378)
+.-++|.+++.||+|+||+||+|++ +++.||||++.+....... .........++.+++.++|||||+++++|+++
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3456899999999999999999987 4789999999753321111 11111233456777788999999999999765
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
.+|+|||||+||+|.+++... +.+++..+..|+.||+.||.|||++|||||||||+||||+.++ .+||+|||+|+..
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-CEEecccceeeec
Confidence 789999999999999999863 5799999999999999999999999999999999999999766 4999999999865
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCC
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFKHARPGL 288 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~ 288 (378)
.... ..+.+||+.|||||++.. +..|+.++|||||||++|+|++|.+||.+.+. ...... ......+.+
T Consensus 343 ~~~~-~~t~~GTp~YmAPEvl~~-------~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~-~i~~~~~~~ 413 (689)
T 3v5w_A 343 SKKK-PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTMAVEL 413 (689)
T ss_dssp SSCC-CCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH-HHHHCCCCC
T ss_pred CCCC-CCCccCCcCccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-hhcCCCCCC
Confidence 4433 356799999999999853 24689999999999999999999999976432 222222 334556778
Q ss_pred CCCChHHHHHHHHHccccCCCCCCC-----HHHHHHHHHhhh
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFL 325 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~l~~~~ 325 (378)
|..+|+++.+||.+||..||.+|++ +.++++ +.++
T Consensus 414 p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~--HpfF 453 (689)
T 3v5w_A 414 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFF 453 (689)
T ss_dssp CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT--SGGG
T ss_pred CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc--Cccc
Confidence 8999999999999999999999997 799988 4454
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=416.22 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=215.5
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
++|.+++.||+|+||+||+|++ +++.||||++....... ...+.+|+.+|+.++|||||++++++.++ .+++
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~-----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-----KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH-----HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh-----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4799999999999999999987 47899999997654322 23578999999999999999999999765 7899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC-CCceeEeccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD-QKSLKLADFGLAREETVT 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~-~~~vkl~Dfg~a~~~~~~ 213 (378)
|||||+||+|.+++.. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.+ .+.+||+|||+++.....
T Consensus 232 v~E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 232 IYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EEECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EEeecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999999865 34579999999999999999999999999999999999999854 346999999999877666
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--CCCCCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPED 291 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~ 291 (378)
......+||+.|||||++.+ ..|+.++|||||||++|+|++|..||.+.+..+........... ...+..
T Consensus 311 ~~~~~~~GT~~y~APEv~~~--------~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 382 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTT
T ss_pred CceeeeEECccccCHHHhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccC
Confidence 66667799999999999865 67899999999999999999999999987765544433322222 223357
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+|+++.+||.+||..||.+|||+.|+++ +.++..
T Consensus 383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~--Hpw~~~ 416 (573)
T 3uto_A 383 ISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTP 416 (573)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTSC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc--CcCcCC
Confidence 8999999999999999999999999998 556544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=371.94 Aligned_cols=269 Identities=37% Similarity=0.632 Sum_probs=218.0
Q ss_pred ccccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 130 (378)
.+.+...+|.+.+.||+|+||+||+|++.++.||||++......... ...+.+|+.++++++||||+++++++.+.
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER---VNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHH---HHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 44466788999999999999999999999999999999876544332 24688999999999999999999999654
Q ss_pred CeEEEEeccCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~g--ivH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++| |+||||||+|||++.++ .+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a 186 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGLS 186 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-CEEECCCC--
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-cEEECCCCCC
Confidence 78999999999999999975221 13899999999999999999999999 99999999999999665 5999999999
Q ss_pred ccccccc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017046 208 REETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 208 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.................
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRD--------EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258 (309)
T ss_dssp ---------------CCTTSCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC
T ss_pred ccccccccccccCCCCccccChhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 7543322 2344579999999999864 567899999999999999999999999887766655555567777
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
.++..+++++.+||.+||..||.+|||+.++++.|+.++....+++
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 8889999999999999999999999999999999999988765443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=368.19 Aligned_cols=264 Identities=29% Similarity=0.501 Sum_probs=219.2
Q ss_pred ccCCcceeecceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
.+....|.+.+.||+|+||.||+|++. +..||||+++....... ...+.+|+.+++.++||||+++++++.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ----RRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHH----HHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 356678999999999999999999873 35699999986544332 246889999999999999999999996
Q ss_pred cC-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 129 DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 129 ~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
++ ..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a 198 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLS 198 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCSSC
T ss_pred eCCccEEEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEEECCCCcc
Confidence 54 78999999999999999975 345799999999999999999999999999999999999999655 5999999999
Q ss_pred ccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 017046 208 REETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (378)
Q Consensus 208 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 282 (378)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.... ........
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~ 269 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAF--------RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-DVISSVEE 269 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHHHHHHT
T ss_pred cccccCccceeeccCCCCcccccCHhHhcC--------CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHHc
Confidence 7543221 1223356778999999864 568889999999999999999 99999887664 34455556
Q ss_pred cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
......+..+++++.+|+..||..||.+|||+.++++.|+.++.......
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~ 319 (325)
T 3kul_A 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLR 319 (325)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC---
T ss_pred CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccc
Confidence 66777788899999999999999999999999999999999987755433
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=367.30 Aligned_cols=253 Identities=29% Similarity=0.463 Sum_probs=215.3
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
...|.+.+.||+|+||.||+|++ +++.||||++......... ..++.+|+.+++.++||||+++++++.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS---LQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH---HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 35699999999999999999987 5789999999875543322 24688999999999999999999999654 788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||++|++|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCCC
Confidence 999999999999999763 5699999999999999999999999999999999999999665 5999999999876655
Q ss_pred cccccCcCccccccccccccccccccccccC-CCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+.... ... .......+|..+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~-i~~~~~~~p~~~ 237 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQG--------KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL-RER-VLRGKYRIPFYM 237 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHT--------CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH-HHHCCCCCCTTS
T ss_pred CccccccCCcceeCcccccC--------CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH-HHH-HHhCCCCCCCCC
Confidence 56667789999999999865 333 5789999999999999999999988765333 222 234455677889
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
++++.+|+.+||..||.+|||+.++++ +.++..
T Consensus 238 s~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~~ 270 (328)
T 3fe3_A 238 STDCENLLKRFLVLNPIKRGTLEQIMK--DRWINA 270 (328)
T ss_dssp CHHHHHHHHHHCCSSTTTSCCHHHHTT--CTTTTT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc--CHhhcC
Confidence 999999999999999999999999999 555544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=368.74 Aligned_cols=262 Identities=30% Similarity=0.573 Sum_probs=220.5
Q ss_pred cccCCcceeecceeecccceEEEEEEEC---------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeee
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVK 122 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~ 122 (378)
+.+..+.|.+++.||+|+||.||+|++. +..||||+++....... ...+.+|+.+++.+ +||||++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~hpnIv~ 151 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD----LSDLVSEMEMMKMIGKHKNIIN 151 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHH----HHHHHHHHHHHHHSCCCTTBCC
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHH----HHHHHHHHHHHHHhcCCCCEee
Confidence 3456678999999999999999999752 35799999986644322 24688999999999 8999999
Q ss_pred EEeeEec-CCeEEEEeccCCCCHHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCC
Q 017046 123 FLGACKD-PLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 187 (378)
Q Consensus 123 l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp 187 (378)
+++++.+ +..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 152 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 231 (370)
T 2psq_A 152 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 231 (370)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred EEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence 9999865 478999999999999999986432 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-C
Q 017046 188 DNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 263 (378)
Q Consensus 188 ~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g 263 (378)
+|||++.++ .+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |
T Consensus 232 ~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il~ellt~g 302 (370)
T 2psq_A 232 RNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEIFTLG 302 (370)
T ss_dssp GGEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred hhEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcC--------CCCCcHHHHHHHHHHHHHHHcCC
Confidence 999999665 59999999997543221 2234467889999999864 678999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 264 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 264 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
..||.+... ............+..+..+++++.+++.+||..||.+|||+.++++.|+.++...
T Consensus 303 ~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 303 GSPYPGIPV-EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp CCSSTTCCG-GGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 999987654 3445555666677888899999999999999999999999999999999987643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=360.54 Aligned_cols=254 Identities=31% Similarity=0.443 Sum_probs=213.0
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
.+.|.+.+.||+|+||+||+|++ +++.||||++........ ..+.+|+.+++.++||||+++++++.+ +..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-----ELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCH-----HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHH-----HHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence 35689999999999999999976 578999999876544332 247899999999999999999999864 4788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCST
T ss_pred EEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCc
Confidence 99999999999999976 3699999999999999999999999999999999999999665 5999999998754332
Q ss_pred c-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCCCCC
Q 017046 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLPED 291 (378)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~ 291 (378)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+............... ....+..
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHC--------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGG
T ss_pred ccccCCccCCcCccChhhhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence 2 2345689999999999864 6789999999999999999999999988776555444433322 3345667
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
+++.+.+|+.+||+.||.+|||+.++++ +.++....
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~~~~ 277 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQ--HQFLKIAK 277 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCC
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh--ChhhcccC
Confidence 9999999999999999999999999998 56665543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=350.97 Aligned_cols=258 Identities=31% Similarity=0.553 Sum_probs=220.5
Q ss_pred ccccCCcceeecceeecccceEEEEEEE-CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 129 (378)
.+.++.+.|.+.+.||+|+||.||++++ .++.||+|++....... +.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH------HHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH------HHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4567788999999999999999999988 56889999998765443 247899999999999999999999965
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
...++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++..
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRF 155 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECCTTGGGG
T ss_pred CceEEEEEeCCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-CEEecccccccc
Confidence 478999999999999999976 345699999999999999999999999999999999999998655 599999999975
Q ss_pred ccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017046 210 ETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 210 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
..... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.... ...........+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-~~~~~~~~~~~~ 226 (269)
T 4hcu_A 156 VLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRL 226 (269)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCCC
T ss_pred ccccccccccCcccccccCCHHHhcC--------CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHHhcCccC
Confidence 43322 2234457788999999864 568899999999999999999 99999876653 445555566677
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
..+..+++++.+++.+||..||.+|||+.+++++|..+..
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 7788899999999999999999999999999999988764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=350.56 Aligned_cols=260 Identities=28% Similarity=0.470 Sum_probs=222.2
Q ss_pred cccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--- 129 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--- 129 (378)
..++.+.|.+.+.||+|+||.||+|++.++.||+|++......... ...+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRK---SRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHH---HHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHH---HHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 3456778999999999999999999999999999999876544432 2468899999999999999999999865
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~g--ivH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
...++||||+++++|.+++.......+++..++.++.|++.||.|||++| ++||||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~~ 160 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADVK 160 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-CEEEEGGGSC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-ceeEEeccce
Confidence 46799999999999999998754446999999999999999999999999 99999999999999655 4899988876
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
.... .....||+.|+|||++.+.. ...++.++||||||+++|+|++|..||.+................+.
T Consensus 161 ~~~~----~~~~~~t~~y~aPE~~~~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (271)
T 3kmu_A 161 FSFQ----SPGRMYAPAWVAPEALQKKP-----EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT 231 (271)
T ss_dssp CTTS----CTTCBSCGGGSCHHHHHSCG-----GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred eeec----ccCccCCccccChhhhccCC-----CCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC
Confidence 5422 23457899999999986411 12334479999999999999999999998887776666667777888
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
++..+++++.+++.+||+.||.+|||+.++++.|..+.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 89999999999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=377.68 Aligned_cols=263 Identities=33% Similarity=0.523 Sum_probs=225.3
Q ss_pred cccccCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
..+.+..+.|.+.+.||+|+||+||+|.+. +..||||+++...... +.|.+|+.+|+.++||||+++++++.+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV------EAFLAEANVMKTLQHDKLVKLHAVVTK 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCH------HHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccH------HHHHHHHHHHhhCCCCCEeeEEEEEeC
Confidence 456677889999999999999999999985 6889999998654332 358899999999999999999999988
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+..++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~ 333 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARV 333 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTGGGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCCceE
Confidence 8899999999999999999764444689999999999999999999999999999999999999655 599999999976
Q ss_pred ccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017046 210 ETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 210 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
..... ......+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+....+ ...........
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-~~~~i~~~~~~ 404 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERGYRM 404 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHHTCCC
T ss_pred cCCCceeccCCCcccccccCHHHhcc--------CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCC
Confidence 43322 1233456788999999864 568999999999999999999 999999877644 34445566677
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
..|..+++++.+||.+||..||.+|||+.++++.|+.++....
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 7788999999999999999999999999999999999876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=352.55 Aligned_cols=268 Identities=26% Similarity=0.533 Sum_probs=226.1
Q ss_pred ccccCCcceeecc-eeecccceEEEEEEE----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEee
Q 017046 52 SLLVDPKLLFIGS-KIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (378)
Q Consensus 52 ~~~~~~~~~~~~~-~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 126 (378)
.+.+..+.|.+.+ .||+|+||.||+|.+ .+..||||++........ ...+.+|+.+++.++||||++++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~ 78 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD----TEEMMREAQIMHQLDNPYIVRLIGV 78 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhH----HHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4556677888877 999999999999975 467899999987543322 2468899999999999999999999
Q ss_pred EecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 127 CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 127 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
+.++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.|++||||||+||+++.++ .+||+|||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~ 156 (287)
T 1u59_A 79 CQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGL 156 (287)
T ss_dssp EESSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred ecCCCcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccc
Confidence 988889999999999999999975 345699999999999999999999999999999999999999554 599999999
Q ss_pred cccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017046 207 AREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 207 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 281 (378)
+....... ......+|+.|+|||++.. ..++.++||||||+++|+|++ |..||.+.... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~i~ 227 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIE 227 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHHH
T ss_pred eeeeccCcceeeccccccccccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHh
Confidence 97543222 1233456889999999854 567889999999999999998 99999887653 3445555
Q ss_pred hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCCCC
Q 017046 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS 334 (378)
Q Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~ 334 (378)
....+.++..+++++.+++..||..||.+|||+.+++++|+.++.+...+...
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 228 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred cCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 66677888899999999999999999999999999999999999887655443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=362.79 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=210.1
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
..++|.+++.||+|+||+||+++.. ++.||||++++....... ....+.+|+.+++.++||||+++++++.+. ..
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhh--HHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence 3468999999999999999999874 789999999753211111 123578999999999999999999999754 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc-c
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE-T 211 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~-~ 211 (378)
++||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.. .
T Consensus 81 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccchhhccc
Confidence 9999999999999999763 5699999999999999999999999999999999999999665 5999999999753 2
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (378)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+... ....+ ......+|..
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i-~~~~~~~p~~ 227 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELI-LMEEIRFPRT 227 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH-HHCCCCCCTT
T ss_pred CCCcccccccChhhCChhhhcC--------CCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-HHHHH-HcCCCCCCCC
Confidence 2334456689999999999864 578999999999999999999999998766533 33333 2345667888
Q ss_pred ChHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 017046 292 ISPDLAFIVQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
+++++.+||.+||..||.+|| ++.+++++
T Consensus 228 ~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 999999999999999999999 89999983
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=355.61 Aligned_cols=262 Identities=33% Similarity=0.612 Sum_probs=214.6
Q ss_pred cCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCeEE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI 134 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~l 134 (378)
++.+.|.+.+.||+|+||+||++++.++.||||++..... ...+.+|+.++++++||||+++++++.+ ..++
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~l 76 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE-------RKAFIVELRQLSRVNHPNIVKLYGACLN-PVCL 76 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTH-------HHHHHHHHHHHHHCCCTTBCCEEEBCTT-TTEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhH-------HHHHHHHHHHHhcCCCCCcCeEEEEEcC-CcEE
Confidence 4667899999999999999999999999999999864321 2358899999999999999999998875 4789
Q ss_pred EEeccCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHA---NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~---~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
||||+++++|.+++..... ..++...++.++.|++.||.|||+ +||+||||||+|||++.++..+||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999999999999976332 247899999999999999999999 899999999999999866655899999998754
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCCC
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGLP 289 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~ 289 (378)
... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... .............+..+
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (307)
T 2eva_A 157 QTH--MTNNKGSAAWMAPEVFEG--------SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 226 (307)
T ss_dssp ----------CCTTSSCHHHHTC--------CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCB
T ss_pred ccc--cccCCCCCceEChhhhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcc
Confidence 322 234468999999999864 5788999999999999999999999986433 22333344556667777
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCCCC
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS 334 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~ 334 (378)
..+++.+.+++.+||..||.+|||+.++++.|..+....+....+
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 889999999999999999999999999999999988776554443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=363.98 Aligned_cols=269 Identities=31% Similarity=0.554 Sum_probs=226.9
Q ss_pred cccccCCcceeecceeecccceEEEEEEEC---------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCe
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNL 120 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i 120 (378)
..+.+..+.|.+++.||+|+||.||+|++. +..||||++........ ..++.+|+++++.+ +||||
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~hpnI 137 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD----LSDLISEMEMMKMIGKHKNI 137 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHH----HHHHHHHHHHHHHHCCCTTB
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHH----HHHHHHHHHHHHHhcCCchh
Confidence 345667789999999999999999999852 25799999987644332 24688999999999 89999
Q ss_pred eeEEeeEec-CCeEEEEeccCCCCHHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecC
Q 017046 121 VKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDL 185 (378)
Q Consensus 121 v~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~lH~~givH~di 185 (378)
+++++++.+ +..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.||+||||
T Consensus 138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 217 (382)
T 3tt0_A 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 217 (382)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred hhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 999999965 478999999999999999987442 35999999999999999999999999999999
Q ss_pred CCCcEEEcCCCCceeEeccccccccccc---cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh
Q 017046 186 KPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262 (378)
Q Consensus 186 kp~Nill~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~ 262 (378)
||+|||++.++ .+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 218 kp~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~ellt 288 (382)
T 3tt0_A 218 AARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEIFT 288 (382)
T ss_dssp CGGGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHT
T ss_pred CcceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--------CCCCchhHHHHHHHHHHHHHh
Confidence 99999999665 5999999999754332 22334567889999999864 678899999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 017046 263 -NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 333 (378)
Q Consensus 263 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 333 (378)
|..||.+... ............+..+..+++++.+|+.+||+.||.+|||+.+++++|+.++........
T Consensus 289 ~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 289 LGGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp TSCCSSTTCCH-HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred CCCCCCCCCCH-HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 9999987664 445566666777788889999999999999999999999999999999999877654443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=374.74 Aligned_cols=257 Identities=32% Similarity=0.556 Sum_probs=220.3
Q ss_pred ccccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 130 (378)
.+.++.+.|.+.+.||+|+||.||+|.+.++.||||+++..... ..|.+|+.+|+.++||||+++++++.+.
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA-------QAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTS-------HHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHH-------HHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 45677889999999999999999999999999999999865422 2588999999999999999999987543
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
..++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~ 338 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKE 338 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCCCccc
Confidence 689999999999999999876555589999999999999999999999999999999999999665 599999999975
Q ss_pred cccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
..... ....+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+....+ .......+.++..
T Consensus 339 ~~~~~--~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~~~i~~~~~~~~ 407 (450)
T 1k9a_A 339 ASSTQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVEKGYKMDA 407 (450)
T ss_dssp CC--------CCCTTTSCHHHHHS--------SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-HHHHHHTTCCCCC
T ss_pred ccccc--cCCCCCcceeCHHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCC
Confidence 43322 23467889999999864 678999999999999999998 999998766533 3444556667788
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
|..+++++.+||.+||..||.+|||+.++++.|+.+...
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 899999999999999999999999999999999887643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=353.10 Aligned_cols=260 Identities=28% Similarity=0.533 Sum_probs=210.0
Q ss_pred cccCCcceeecceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
..+..+.|.+.+.||+|+||.||+|++. +..||+|++....... ..+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS----VREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHH----HHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 4456778999999999999999999873 3569999987654332 234688999999999999999999999
Q ss_pred ecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
.++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++||||||+|||++.++ .+||+|||++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~ 163 (281)
T 1mp8_A 86 TENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLS 163 (281)
T ss_dssp CSSSCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC----
T ss_pred ccCccEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECccccc
Confidence 88889999999999999999976 345799999999999999999999999999999999999999554 5999999999
Q ss_pred cccccccc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 208 REETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 208 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
........ .....+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+..... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-~~~~i~~~~ 234 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENGE 234 (281)
T ss_dssp ---------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHHTTC
T ss_pred cccCcccccccccCCCcccccChhhccc--------CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-HHHHHHcCC
Confidence 76433221 233456789999999864 568889999999999999997 999998766543 334444556
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
...++..+++++.+++.+||..||.+|||+.++++.|..++..
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 6678889999999999999999999999999999999987653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=350.31 Aligned_cols=256 Identities=34% Similarity=0.627 Sum_probs=208.9
Q ss_pred cCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
++...|.+.+.||+|+||.||+|.+.++.||||++......... .....+.+|+.+++.++||||+++++++.++ ..+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHH-HHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 45678999999999999999999999999999998765433221 1224688999999999999999999999654 789
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CeeecCCCCcEEEcCC-------CCceeEec
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG---IIHRDLKPDNLLLTPD-------QKSLKLAD 203 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~g---ivH~dikp~Nill~~~-------~~~vkl~D 203 (378)
+||||+++++|.+++.. ..+++..++.++.|++.||.|||++| ++||||||+|||++.+ .+.+||+|
T Consensus 83 lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999998853 57999999999999999999999999 8999999999999852 44599999
Q ss_pred cccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017046 204 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 283 (378)
||++........ ....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+..............
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 160 FGLAREWHRTTK-MSAAGAYAWMAPEVIRA--------SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp CCC--------------CCGGGSCHHHHHH--------CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred CCcccccccccc-cCCCCccceeCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 999975443322 34578999999999864 568899999999999999999999999888776666666666
Q ss_pred CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
.....+..+++++.+++.+||..||.+|||+.+++++|..
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 6777888999999999999999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=366.29 Aligned_cols=263 Identities=30% Similarity=0.552 Sum_probs=222.4
Q ss_pred ccccCCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeE
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKF 123 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l 123 (378)
.+.+..++|.+++.||+|+||.||+|++ .++.||||+++....... ...+.+|+.++.++ +||||+++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE----HRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH----HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHH----HHHHHHHHHHHHhhcCCcceeee
Confidence 4456678899999999999999999974 237899999986544333 24588999999999 79999999
Q ss_pred EeeEecC--CeEEEEeccCCCCHHHHHhhhCC------------------------------------------------
Q 017046 124 LGACKDP--LMVIVTELLPGMSLRKYLVSLRP------------------------------------------------ 153 (378)
Q Consensus 124 ~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~------------------------------------------------ 153 (378)
++++.+. ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 9998653 48899999999999999976432
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc---c
Q 017046 154 ----------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---E 214 (378)
Q Consensus 154 ----------------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~---~ 214 (378)
..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCE
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccch
Confidence 1289999999999999999999999999999999999998655 5999999999754222 1
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
......||+.|+|||++.. ..++.++|||||||++|+|++ |..||.+...................+..++
T Consensus 251 ~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 322 (359)
T ss_dssp EC--CEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCC
T ss_pred hccccCCCceeEChhhhcC--------CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCC
Confidence 2334568889999999864 678899999999999999998 9999998776666666677777788888999
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+++.+++.+||+.||.+|||+.+++++|..++..
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999988754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=366.69 Aligned_cols=263 Identities=29% Similarity=0.493 Sum_probs=220.1
Q ss_pred cccCCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEe
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 125 (378)
..+..+.|.+++.||+|+||+||+|++ .++.||||++......... ..+.+|+.+++.++||||+++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~hpnIv~~~~ 141 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----LDFLMEALIISKFNHQNIVRCIG 141 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHH----HHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhH----HHHHHHHHHHHhCCCCCCCeEEE
Confidence 345567899999999999999999984 3468999999765443332 35889999999999999999999
Q ss_pred eEecC-CeEEEEeccCCCCHHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC--C
Q 017046 126 ACKDP-LMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--K 197 (378)
Q Consensus 126 ~~~~~-~~~lv~e~~~~~sL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~--~ 197 (378)
++.+. ..++||||++||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCc
Confidence 99654 78999999999999999987542 3589999999999999999999999999999999999998433 2
Q ss_pred ceeEeccccccccccc---cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChH
Q 017046 198 SLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273 (378)
Q Consensus 198 ~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 273 (378)
.+||+|||+++..... .......+|+.|+|||++.. ..++.++|||||||++|+|++ |..||.+...
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il~ellt~g~~pf~~~~~- 292 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 292 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred eEEECCCccccccccccccccCCCcCCcccEECHHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 5999999999743222 12234467899999999864 678999999999999999998 9999988665
Q ss_pred HHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 274 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
............+..+..+++.+.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus 293 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 293 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 4445555666677778889999999999999999999999999999998887654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=351.52 Aligned_cols=266 Identities=31% Similarity=0.512 Sum_probs=223.3
Q ss_pred cccccCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
+.+.+..+.|.+.+.||+|+||.||+|... +..||+|++....... ..+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP------DAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccH------HHHHHHHHHHHhCCCcCcceEEEEEcC
Confidence 456677889999999999999999999876 4689999997654432 247899999999999999999999988
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+..++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++..
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARL 158 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCccccc
Confidence 8899999999999999999754334699999999999999999999999999999999999999654 599999999975
Q ss_pred ccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017046 210 ETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 210 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
..... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~ 229 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGYRM 229 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCCC
T ss_pred ccCcccccccCCCCccCccChhhhcc--------CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-HHHHHHhcccCC
Confidence 43322 1223456788999999864 567889999999999999999 99999886653 344445555666
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
..+..+++++.+++.+||..||.+|||+.++++.|+.++.......
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 7778899999999999999999999999999999999987765433
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=355.18 Aligned_cols=269 Identities=32% Similarity=0.504 Sum_probs=226.1
Q ss_pred cccccccccCCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCC
Q 017046 47 LTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHD 118 (378)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp 118 (378)
......+.+....|.+.+.||+|+||.||+|.+ .++.||||++........ ...+.+|+.+++.+ +||
T Consensus 12 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~h~ 87 (313)
T 1t46_A 12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE----REALMSELKVLSYLGNHM 87 (313)
T ss_dssp SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH----HHHHHHHHHHHHHHCCCT
T ss_pred CCCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHH----HHHHHHHHHHHhhcccCC
Confidence 334455667778999999999999999999985 347899999986554332 24688999999999 999
Q ss_pred CeeeEEeeEec-CCeEEEEeccCCCCHHHHHhhhCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 017046 119 NLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPN----------------KLDLHVALNFALDIARAMDCLHANGII 181 (378)
Q Consensus 119 ~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~----------------~l~~~~~~~i~~qi~~~l~~lH~~giv 181 (378)
||+++++++.+ +..++||||+++++|.+++...... .+++..++.++.|++.||.|||++|++
T Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 167 (313)
T 1t46_A 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167 (313)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 99999999965 4789999999999999999874322 489999999999999999999999999
Q ss_pred eecCCCCcEEEcCCCCceeEeccccccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHH
Q 017046 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 258 (378)
Q Consensus 182 H~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 258 (378)
||||||+|||++.++ .+||+|||++........ .....+++.|+|||.+.. ..++.++||||||+++|
T Consensus 168 H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 238 (313)
T 1t46_A 168 HRDLAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGIFLW 238 (313)
T ss_dssp CSCCSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred cCCCccceEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcC--------CCCChHHHHHHHHHHHH
Confidence 999999999999554 599999999975433321 233456788999998864 56889999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 259 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 259 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
+|++ |..||.+...................+..+++++.+++.+||..||.+|||+.+++++|+..+...
T Consensus 239 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 9999 999998877656666666666666777889999999999999999999999999999999988764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=365.53 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=209.2
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP- 130 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~- 130 (378)
+..++|.+++.||+|+||+||+++.. ++.||||++++........ ...+.+|..++..+ +||||+++++++.+.
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~--~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED--IDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHH--HHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 45578999999999999999999874 6899999998754433221 13477899999887 899999999999765
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc-
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE- 209 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~- 209 (378)
..++||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla~~~ 203 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCC
T ss_pred EEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeecceeeec
Confidence 689999999999999999763 5699999999999999999999999999999999999999665 599999999975
Q ss_pred cccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh-------HHHHHHHHHh
Q 017046 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-------LQAAYAAAFK 282 (378)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~ 282 (378)
..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ..........
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~--------~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~ 275 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred ccCCCccccccCCcccCCchhhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence 233344566789999999999865 6789999999999999999999999964321 1122233344
Q ss_pred cCCCCCCCCChHHHHHHHHHccccCCCCCCCH------HHHHH
Q 017046 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIR 319 (378)
Q Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~ 319 (378)
.....+|..+++++.+||.+||..||.+||++ .++++
T Consensus 276 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 276 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 56677888999999999999999999999985 67777
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=369.47 Aligned_cols=263 Identities=30% Similarity=0.550 Sum_probs=221.0
Q ss_pred ccccccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
...+.++.+.|.+.+.||+|+||.||+|++. ++.||||+++....... ...|.+|+.+++.++||||+++++++
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~ 181 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL----KAKFLQEARILKQYSHPNIVRLIGVC 181 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHH----HTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHH----HHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456778889999999999999999999984 78999999976543222 23588999999999999999999999
Q ss_pred ec-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 128 KD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 128 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
.+ +..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 182 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~ 259 (377)
T 3cbl_A 182 TQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGM 259 (377)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGG
T ss_pred ecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEEECcCCC
Confidence 65 4789999999999999999763 34689999999999999999999999999999999999999665 599999999
Q ss_pred cccccccccc---ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 017046 207 AREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (378)
Q Consensus 207 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 282 (378)
+......... ....+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+....+ .......
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-~~~~~~~ 330 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNY--------GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-TREFVEK 330 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-HHHHHHT
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc
Confidence 9754322211 12235678999999864 567889999999999999998 999999876643 3445556
Q ss_pred cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
......|..+++++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 331 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 331 GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 667778888999999999999999999999999999999887543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=350.70 Aligned_cols=260 Identities=33% Similarity=0.597 Sum_probs=215.9
Q ss_pred ccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHH--HHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALL--EGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
.+..+.|.+.+.||+|+||+||+|++ +++.||+|++............ ...+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 45678899999999999999999988 4789999998765543322211 1468899999999999999999999876
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCcEEEcCCCC----ceeEec
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQK----SLKLAD 203 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~g--ivH~dikp~Nill~~~~~----~vkl~D 203 (378)
.. ++||||+++++|.+++.. ....+++..++.++.|++.||.|||++| ++||||||+|||++.++. .+||+|
T Consensus 95 ~~-~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP-RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT-EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC-eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 55 799999999999998865 3457999999999999999999999999 999999999999985442 399999
Q ss_pred cccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHH--HHHHHH
Q 017046 204 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA--AYAAAF 281 (378)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~ 281 (378)
||++..... ......||+.|+|||++.. ....++.++|||||||++|+|++|..||........ ......
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGA------EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSC------SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred CCccccccc--cccccCCCccccCchhhcc------CCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 999975433 2345679999999999843 235678899999999999999999999987554333 233344
Q ss_pred hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
....+.++..+++++.+++.+||+.||.+|||+.++++.|+.
T Consensus 245 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 566677888999999999999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=365.18 Aligned_cols=254 Identities=27% Similarity=0.397 Sum_probs=206.2
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP- 130 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~- 130 (378)
+..++|.+++.||+|+||+||++++. ++.||||+++........ ....+.+|..++..+ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~--~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD--DVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHT--THHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchh--HHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 45578999999999999999999874 689999999764322111 123577899999988 799999999999765
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a~~~ 174 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEccccceeec
Confidence 788999999999999999763 5699999999999999999999999999999999999999665 5999999999753
Q ss_pred c-cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 211 T-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 211 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
. ........+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+.... ...+ ......+|
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-~~~i-~~~~~~~p 244 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQE--------MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL-FEAI-LNDEVVYP 244 (353)
T ss_dssp CC---------CCGGGCCHHHHHH--------HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH-HHCCCCCC
T ss_pred ccCCccccccCCCcCeEChhhcCC--------CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH-HHHH-HcCCCCCC
Confidence 2 2333456689999999999864 5689999999999999999999999988765433 3333 34456678
Q ss_pred CCChHHHHHHHHHccccCCCCCCCH------HHHHHHHHhhh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSF------SQIIRMLNAFL 325 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~l~~~~ 325 (378)
..+++++.+||.+||..||.+||++ .++++ +.++
T Consensus 245 ~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~--hp~f 284 (353)
T 3txo_A 245 TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR--HPFF 284 (353)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT--SGGG
T ss_pred CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh--CCcc
Confidence 8899999999999999999999998 88888 4444
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=363.17 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=209.3
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHH-HHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
+.|.+++.||+|+||.||++++. ++.||+|++......... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 46999999999999999999874 789999999876543210 00113578999999999999999999999765 688
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC---ceeEecccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREE 210 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~---~vkl~Dfg~a~~~ 210 (378)
+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. .+||+|||++...
T Consensus 92 lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 99999999999999975 457999999999999999999999999999999999999986653 5999999999876
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-- 288 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 288 (378)
.........+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..... ..+.. ....+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~-~~i~~-~~~~~~~ 239 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANITA-VSYDFDE 239 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHHT-TCCCCCH
T ss_pred CCCCccccCCCCccEECchHHcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHh-cCCCCCc
Confidence 55555566789999999999864 57899999999999999999999999887654433 33222 22222
Q ss_pred --CCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 289 --PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 289 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+..+++++.+||.+||..||.+|||+.++++
T Consensus 240 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 240 EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2568999999999999999999999999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=360.18 Aligned_cols=263 Identities=30% Similarity=0.501 Sum_probs=219.1
Q ss_pred cccCCcceeecceeecccceEEEEEEECC-------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEe
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 125 (378)
+.+..+.|.+.+.||+|+||.||+|++.+ +.||||+++....... ...+.+|+.+++.++||||+++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM----QADFQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHH----HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHH----HHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34566789999999999999999998753 7899999986554332 346889999999999999999999
Q ss_pred eEec-CCeEEEEeccCCCCHHHHHhhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 017046 126 ACKD-PLMVIVTELLPGMSLRKYLVSLRP----------------------NKLDLHVALNFALDIARAMDCLHANGIIH 182 (378)
Q Consensus 126 ~~~~-~~~~lv~e~~~~~sL~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~~l~~lH~~givH 182 (378)
++.+ ...++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 9865 478999999999999999976431 56899999999999999999999999999
Q ss_pred ecCCCCcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHH
Q 017046 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259 (378)
Q Consensus 183 ~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ 259 (378)
|||||+|||++.++ .+||+|||++....... ......+|+.|+|||++.. ..++.++||||||+++|+
T Consensus 198 ~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~e 268 (343)
T 1luf_A 198 RDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWE 268 (343)
T ss_dssp SCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHH
T ss_pred CCCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhcc--------CCcCcccccHHHHHHHHH
Confidence 99999999999655 59999999987543221 2234567899999998864 568899999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 260 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 260 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
|++ |..||.+.... ...........+..+..+++++.+++.+||..||.+|||+.+++++|+.+.....
T Consensus 269 l~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 269 IFSYGLQPYYGMAHE-EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HHTTTCCTTTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred HHhcCCCcCCCCChH-HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 999 99999887653 3444455566667888999999999999999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=373.95 Aligned_cols=265 Identities=30% Similarity=0.498 Sum_probs=222.3
Q ss_pred cccccCCcceeecceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
..+.+..+.|.+.+.||+|+||.||+|.+.+ ..||||+++...... +.|.+|+.+|+.++||||+++++++.+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCH------HHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 4566778889999999999999999999865 679999998655432 258899999999999999999999988
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+..++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~ 329 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARL 329 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC-
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCcccee
Confidence 8899999999999999999764445699999999999999999999999999999999999998554 599999999975
Q ss_pred ccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017046 210 ETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 210 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
..... ......+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+....+ .........+.
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~~~i~~~~~~ 400 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRM 400 (452)
T ss_dssp -------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCCC
T ss_pred cCCCceecccCCcccccccCHhHHhc--------CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCC
Confidence 43222 1223356789999999864 578999999999999999999 999999877644 44445566677
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
..|..+++.+.++|.+||..||.+|||+.++++.|+.++....+.
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 788899999999999999999999999999999999988775543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=350.54 Aligned_cols=260 Identities=28% Similarity=0.436 Sum_probs=212.0
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
.++|.+.+.||+|+||.||++++. ++.||+|++......... ...++.+|+.+++.++||||+++++++.++ ..+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEE--TLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHH--HHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHH--HHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 457999999999999999999874 689999998765544332 235689999999999999999999999754 688
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||++|++|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 88 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC---
T ss_pred EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCCCccccccc
Confidence 999999999999999863 4699999999999999999999999999999999999999665 5999999999764433
Q ss_pred c--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC----
Q 017046 214 E--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG---- 287 (378)
Q Consensus 214 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---- 287 (378)
. ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+............ ...+.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 235 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKG--------EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ-DSVPNVTTD 235 (294)
T ss_dssp ----------CCSSCCHHHHHT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS-SCCCCHHHH
T ss_pred cccccCccccCccccCHhHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh-ccCCCcchh
Confidence 2 2234579999999999864 5678899999999999999999999998776554444332 22222
Q ss_pred CCCCChHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhhhccCC
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~~~~~~~~ 330 (378)
.+..+++.+.+++.+||+.||.+|| ++.++.+.|..++.....
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 3567899999999999999999999 899999999887765443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=361.11 Aligned_cols=267 Identities=31% Similarity=0.495 Sum_probs=219.7
Q ss_pred ccccccCCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCee
Q 017046 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLV 121 (378)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv 121 (378)
+..+.+..+.|.+.+.||+|+||.||+|++ .+..||||++........ ...+.+|+.++..+ +||||+
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~hp~iv 112 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE----REALMSELKMMTQLGSHENIV 112 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHH----HHHHHHHHHHHHhhcCCCCee
Confidence 345667788999999999999999999986 346899999975433222 24688999999999 899999
Q ss_pred eEEeeEec-CCeEEEEeccCCCCHHHHHhhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 017046 122 KFLGACKD-PLMVIVTELLPGMSLRKYLVSLRP---------------------NKLDLHVALNFALDIARAMDCLHANG 179 (378)
Q Consensus 122 ~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~l~~lH~~g 179 (378)
++++++.+ +..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++|
T Consensus 113 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 192 (344)
T 1rjb_A 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192 (344)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999865 478999999999999999976432 23799999999999999999999999
Q ss_pred CeeecCCCCcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHH
Q 017046 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256 (378)
Q Consensus 180 ivH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i 256 (378)
|+||||||+|||++.++ .+||+|||++....... ......+|+.|+|||++.. ..++.++||||||++
T Consensus 193 ivH~Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~i 263 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWSYGIL 263 (344)
T ss_dssp EEETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHH
T ss_pred cccCCCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--------CCCChhHhHHHHHHH
Confidence 99999999999999655 59999999997543322 1233457788999998864 568899999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 257 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 257 l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
+|+|++ |..||.+................+..+..+++++.+|+.+||..||.+|||+.+++++|+.++...+
T Consensus 264 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 264 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp HHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 999998 9999988776566666666666777888899999999999999999999999999999999876643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=361.00 Aligned_cols=262 Identities=29% Similarity=0.457 Sum_probs=211.5
Q ss_pred ccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-C
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-P 130 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 130 (378)
.+..++|.+++.||+|+||+||++.+. ++.||+|++...... ....+.+|+.+++.++||||+++++++.+ .
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 80 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE-----TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHH-----HHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence 356788999999999999999999874 789999988543221 22468899999999999999999999865 4
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARLM 158 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred eeEEEEEecCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence 78899999999999999986 346799999999999999999999999999999999999999655 5999999999754
Q ss_pred cccccc---------------ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHH
Q 017046 211 TVTEMM---------------TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (378)
Q Consensus 211 ~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 275 (378)
...... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~ 230 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--------RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcC--------CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH
Confidence 322211 14579999999999864 6788999999999999999999999875322110
Q ss_pred HH-HHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 276 AY-AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 276 ~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
.. ...........+..+++++.+++.+||+.||.+|||+.++++.|+.+...+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 231 DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp TSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00 00000111234567889999999999999999999999999999988776544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=362.39 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=213.3
Q ss_pred cccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 130 (378)
..+..+.|.+++.||+|+||.||+++.. ++.||+|++......... ....+.+|+.+++.++||||+++++++.+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~--~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN--EVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3456678999999999999999999874 688999998753321111 123578999999999999999999999764
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
..++||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~ 164 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAM 164 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccceeee
Confidence 78899999999999999975 45799999999999999999999999999999999999999665 599999999987
Q ss_pred cccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCC
Q 017046 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFKHARPG 287 (378)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~ 287 (378)
..........+||+.|+|||++... ....++.++|||||||++|+|++|..||..... .... ..........
T Consensus 165 ~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~-~~~~~~~~~~ 238 (384)
T 4fr4_A 165 LPRETQITTMAGTKPYMAPEMFSSR-----KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI-VHTFETTVVT 238 (384)
T ss_dssp CCTTCCBCCCCSCGGGCCGGGTCCC-----SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH-HHHHHHCCCC
T ss_pred ccCCCceeccCCCccccCCeeeccC-----CCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH-HHHHhhcccC
Confidence 6655556677899999999998531 124588999999999999999999999975332 2222 2233455677
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCC-HHHHHH
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPS-FSQIIR 319 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~ 319 (378)
+|..+++++.+||.+||..||.+||+ +.++++
T Consensus 239 ~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 239 YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 88899999999999999999999998 888876
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=361.56 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=208.9
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+.+.||+|+||.||++.+. ++.||+|++......... ...+.+|+.+++.++||||+++++++.+. ..++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHH---HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHH---HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 46999999999999999999874 789999999876554322 24588999999999999999999999765 6789
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC--CceeEecccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREETV 212 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~--~~vkl~Dfg~a~~~~~ 212 (378)
||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ ..+||+|||++.....
T Consensus 106 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999999999999875 35699999999999999999999999999999999999998543 3599999999987655
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC--C
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--E 290 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~ 290 (378)
........||+.|+|||++.. ..++.++|||||||++|+|++|..||.+...................+ .
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 255 (362)
T 2bdw_A 184 SEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 255 (362)
T ss_dssp CCSCCCSCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGG
T ss_pred CcccccCCCCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence 555556789999999999854 578999999999999999999999998876543333222222211111 3
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.+++++.+||.+||..||.+|||+.+++++
T Consensus 256 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 256 TVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 578999999999999999999999999984
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=354.54 Aligned_cols=264 Identities=28% Similarity=0.538 Sum_probs=221.3
Q ss_pred ccccccCCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeee
Q 017046 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122 (378)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 122 (378)
+..+.+..+.|.+.+.||+|+||.||+|.+ .++.||||++........ ...+.+|+.+++.++||||++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~ 90 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE----LRDLLSEFNVLKQVNHPHVIK 90 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHH----HHHHHHHHHHHTTCCCTTBCC
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHH----HHHHHHHHHHHhhCCCCceee
Confidence 345566778999999999999999999976 237899999986544332 245889999999999999999
Q ss_pred EEeeEec-CCeEEEEeccCCCCHHHHHhhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 017046 123 FLGACKD-PLMVIVTELLPGMSLRKYLVSLRP----------------------NKLDLHVALNFALDIARAMDCLHANG 179 (378)
Q Consensus 123 l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~~l~~lH~~g 179 (378)
+++++.+ ...++||||+++++|.+++..... ..+++..++.++.||+.||.|||++|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 170 (314)
T 2ivs_A 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK 170 (314)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999865 478999999999999999987432 23899999999999999999999999
Q ss_pred CeeecCCCCcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHH
Q 017046 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256 (378)
Q Consensus 180 ivH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i 256 (378)
|+||||||+|||++.++ .+||+|||++....... ......+++.|+|||.+.+ ..++.++|||||||+
T Consensus 171 ivH~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 241 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--------HIYTTQSDVWSFGVL 241 (314)
T ss_dssp EECCCCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--------CEECHHHHHHHHHHH
T ss_pred CcccccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcC--------CCcCchhhHHHHHHH
Confidence 99999999999999554 59999999987543222 2234467889999999864 568899999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 257 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 257 l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+|+|++ |..||.+.... ...........+..+..+++++.+++.+||+.||.+|||+.+++++|+.++..
T Consensus 242 l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 242 LWEIVTLGGNPYPGIPPE-RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHTTSCCSSTTCCGG-GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHhCCCCCCCCCCHH-HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 999999 99999876653 34455555666778888999999999999999999999999999999988764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=350.48 Aligned_cols=262 Identities=31% Similarity=0.570 Sum_probs=208.5
Q ss_pred ccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCeE
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV 133 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 133 (378)
.+....|.+.+.||+|+||+||+|++.+ .||+|+++........ ...+.+|+.+++.++||||+++++++.+...+
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 95 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ---LQAFKNEVGVLRKTRHVNILLFMGYSTAPQLA 95 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHH---HHHHHHHHHHHTTCCCTTBCCEEEEECSSSCE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHH---HHHHHHHHHHHHhCCCCcEEEEEeeccCCccE
Confidence 4567789999999999999999998766 5999999766544332 24688999999999999999999988888899
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV- 212 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~- 212 (378)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC--------
T ss_pred EEEEecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceeccccccc
Confidence 99999999999999965 346799999999999999999999999999999999999999665 599999999875432
Q ss_pred --ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC----
Q 017046 213 --TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP---- 286 (378)
Q Consensus 213 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---- 286 (378)
........||+.|+|||++... ....++.++||||||+++|+|++|..||.+.................
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQ-----DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248 (289)
T ss_dssp ----------CCCTTCCHHHHC---------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT
T ss_pred cccccccccCCCccccCchhhccc-----CCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh
Confidence 2223345789999999988521 13567889999999999999999999998877666555554443322
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.++..+++++.+|+.+||..||.+|||+.++++.|+.+..
T Consensus 249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 2345788999999999999999999999999999988753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=344.91 Aligned_cols=256 Identities=29% Similarity=0.522 Sum_probs=216.7
Q ss_pred ccCCcceeecceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-C
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 131 (378)
.+..+.|.+.+.||+|+||.||+++..+ ..||+|++....... ..+.+|+.++..++||||+++++++.+. .
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE------DEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH------HHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH------HHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 3566789999999999999999998864 689999998765443 2478999999999999999999999654 7
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVL 155 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCEEECC
T ss_pred eEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccceecc
Confidence 89999999999999999763 34699999999999999999999999999999999999999665 59999999987543
Q ss_pred ccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 212 VTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 212 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
... ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||....... .............
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~ 226 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHY--------FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-VVLKVSQGHRLYR 226 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHH--------SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTCCCCC
T ss_pred hhhhhcccCCCcCcccCCHHHHhc--------cCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-HHHHHHcCCCCCC
Confidence 332 2233456778999999864 567889999999999999999 999998776644 3444455566667
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
+..+++++.+++..||+.||.+|||+.+++++|+.+..
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 77889999999999999999999999999999988754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=347.54 Aligned_cols=260 Identities=28% Similarity=0.526 Sum_probs=217.9
Q ss_pred cccccCCcceeecceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
..+.+..++|.+.+.||+|+||.||++.+.+ ..||+|++....... ..+.+|+.++..++||||+++++++.+
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE------DEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH------HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH------HHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 3456778899999999999999999998864 689999998765443 247899999999999999999999965
Q ss_pred C-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 ~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
. ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~ 168 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSR 168 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEEECSTTGGG
T ss_pred CCCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-CEEEccccccc
Confidence 4 789999999999999999763 35699999999999999999999999999999999999999655 59999999997
Q ss_pred cccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017046 209 EETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 209 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
...... ......+|+.|+|||++.. ..++.++||||||+++|+|++ |..||...... ...........
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~~~~~~ 239 (283)
T 3gen_A 169 YVLDDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIAQGLR 239 (283)
T ss_dssp GBCCHHHHSTTSTTSCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHTTCC
T ss_pred cccccccccccCCccCcccCCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCccccChh-HHHHHHhcccC
Confidence 543322 2233456788999999864 568899999999999999998 99999887654 34444555666
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
...+..+++.+.+++.+||+.||.+|||+.+++++|..++..
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 777788999999999999999999999999999999988754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=357.23 Aligned_cols=250 Identities=18% Similarity=0.326 Sum_probs=208.8
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|.+.+.||+|+||.||++.+. ++.||+|++..... . ...+.+|+.+++.++||||+++++++.+ ...++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--D----QVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--H----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc--c----HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 57999999999999999999874 68999999875422 1 2347899999999999999999999965 47889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC-CCceeEeccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD-QKSLKLADFGLAREETVT 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~-~~~vkl~Dfg~a~~~~~~ 213 (378)
||||++|++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.+ ...+||+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 79 IFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999999975 33569999999999999999999999999999999999999852 456999999999876555
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC----
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP---- 289 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 289 (378)
.......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+........... .. ...++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-~~-~~~~~~~~~ 227 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM-NA-EYTFDEEAF 227 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-HT-CCCCCHHHH
T ss_pred CccccccCChhhcCcHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH-cC-CCCCChhhh
Confidence 44556679999999999864 557889999999999999999999998876644333322 22 22222
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
..+++++.+|+.+||..||.+|||+.++++ +.++.
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~~~ 262 (321)
T 1tki_A 228 KEISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLK 262 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc--Chhhc
Confidence 468999999999999999999999999999 44544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=367.11 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=208.1
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+.+.||+|+||.||++.+ +++.||+|++......... ...+.+|+.+++.++||||+++++++.++ ..++
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD---HQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHH---HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHH---HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 5699999999999999999987 5789999999876654332 24688999999999999999999999755 7889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC--CCCceeEecccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAREETV 212 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~--~~~~vkl~Dfg~a~~~~~ 212 (378)
||||+.||+|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++. ++..+||+|||++.....
T Consensus 88 v~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 9999999999999986 356999999999999999999999999999999999999984 234699999999976443
Q ss_pred cc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--C
Q 017046 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--P 289 (378)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~ 289 (378)
.. ......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+................... .
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 237 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRK--------DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred CCceeecccCCcccCCHHHhcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc
Confidence 32 2345689999999999854 57899999999999999999999999887654433333222222221 2
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
..+++++.+||.+||..||.+|||+.++++ +.++
T Consensus 238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~--hp~~ 271 (444)
T 3soa_A 238 DTVTPEAKDLINKMLTINPSKRITAAEALK--HPWI 271 (444)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SCTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHhc--Cccc
Confidence 468999999999999999999999999999 4444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=351.61 Aligned_cols=259 Identities=27% Similarity=0.479 Sum_probs=211.1
Q ss_pred cCCcceeecceeecccceEEEEEEE------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+..+.|++++.||+|+||+||++++ .++.||||++....... ...+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-----LRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHH-----HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4567899999999999999999984 46899999987543221 235889999999999999999999884
Q ss_pred c---CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 129 D---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 129 ~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
+ ...++||||+++++|.+++... ...+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+||+|||
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg 159 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFG 159 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccCc
Confidence 3 4689999999999999999763 34699999999999999999999999999999999999999654 59999999
Q ss_pred ccccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH--------
Q 017046 206 LAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-------- 273 (378)
Q Consensus 206 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------- 273 (378)
++....... ......++..|+|||.+.. ..++.++||||||+++|+|++|..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 231 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTT
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcC--------CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCc
Confidence 997543322 2233457788999999864 56889999999999999999999998643211
Q ss_pred -------HHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 274 -------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 274 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
...............+..+++++.+++.+||..||.+|||+.++++.|+.+...+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 232 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1222334445566778889999999999999999999999999999999887654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=358.85 Aligned_cols=258 Identities=27% Similarity=0.500 Sum_probs=211.7
Q ss_pred cCCcceeecceeecccceEEEEEEEC--Ce----eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DR----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+...+|.+.+.||+|+||+||+|++. ++ +||+|.+........ ..++.+|+.+++.++||||+++++++.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------C----HHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHH----HHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 45678999999999999999999873 33 468888764332222 246889999999999999999999999
Q ss_pred cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
++..++|+||+.+|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~ 165 (327)
T 3poz_A 88 TSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAK 165 (327)
T ss_dssp SSSEEEEEECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTHHH
T ss_pred cCCeEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccCccee
Confidence 8889999999999999999976 346799999999999999999999999999999999999999655 59999999997
Q ss_pred cccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 209 EETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 209 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
...... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.... ..........
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~ 236 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGE 236 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTC
T ss_pred EccCCcccccccCCCccccccChHHhcc--------CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-HHHHHHHcCC
Confidence 543222 1223456889999999865 678999999999999999999 99999876653 3344455566
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
....+..++.++.+++.+||+.||.+|||+.+++++|..+...
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 6677888999999999999999999999999999999887643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=356.92 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=210.7
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-C
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-L 131 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~ 131 (378)
..++|.+++.||+|+||.||++++. ++.||||++.......... ...+.+|..++..+ +||||+++++++.+. .
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED--IDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHH--HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHH--HHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 4567999999999999999999874 7899999998765433322 24578999999988 899999999999754 7
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEecccccccc
Confidence 89999999999999999763 4699999999999999999999999999999999999999665 59999999997532
Q ss_pred -cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC--------hHHHHHHHHHh
Q 017046 212 -VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS--------NLQAAYAAAFK 282 (378)
Q Consensus 212 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~ 282 (378)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ....... ...
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~i~ 232 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-VIL 232 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH-HHH
T ss_pred CCCCcccccCCCccccCccccCC--------CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH-HHH
Confidence 2334456689999999999864 568999999999999999999999997521 1122222 333
Q ss_pred cCCCCCCCCChHHHHHHHHHccccCCCCCCCH------HHHHHHHHhhh
Q 017046 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIRMLNAFL 325 (378)
Q Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~l~~~~ 325 (378)
.....+|..+++++.+||.+||..||.+||++ .++++ +.++
T Consensus 233 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~--hp~f 279 (345)
T 3a8x_A 233 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG--HPFF 279 (345)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT--SGGG
T ss_pred cCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc--CCcc
Confidence 45667888999999999999999999999985 77777 4444
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=348.18 Aligned_cols=261 Identities=28% Similarity=0.504 Sum_probs=216.9
Q ss_pred ccccCCcceeecceeecccceEEEEEEECC-----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEee
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 126 (378)
.+.+..++|.+.+.||+|+||.||+|++.+ ..||+|++........ ..++.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN----KEKFMSEAVIMKNLDHPHIVKLIGI 81 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHH----HHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchH----HHHHHHHHHHHHhCCCCCcceEEEE
Confidence 344567889999999999999999998532 4699999987644332 2468899999999999999999999
Q ss_pred EecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 127 CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 127 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
+.++..++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+
T Consensus 82 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~ 159 (281)
T 3cc6_A 82 IEEEPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGL 159 (281)
T ss_dssp ECSSSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCG
T ss_pred EcCCCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCC
Confidence 9888889999999999999999763 35699999999999999999999999999999999999999655 599999999
Q ss_pred cccccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 017046 207 AREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 207 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 283 (378)
+....... ......+++.|+|||++.. ..++.++||||||+++|+|++ |..||....... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-~~~~~~~~ 230 (281)
T 3cc6_A 160 SRYIEDEDYYKASVTRLPIKWMSPESINF--------RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEKG 230 (281)
T ss_dssp GGCC---------CCCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-HHHHHHHT
T ss_pred CcccccccccccccCCCCcceeCchhhcc--------CCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-HHHHHhcC
Confidence 87543322 1233467889999999854 568899999999999999998 999998665533 33444455
Q ss_pred CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.....+..+++.+.+++.+||..||.+|||+.+++++|..++..
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 231 DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 56677788999999999999999999999999999999887643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=354.63 Aligned_cols=269 Identities=28% Similarity=0.477 Sum_probs=217.6
Q ss_pred cccccccCCcceeecceeecccceEEEEEEE------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeee
Q 017046 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122 (378)
Q Consensus 49 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 122 (378)
+.+...+..+.|.+++.||+|+||+||++.+ +++.||||++........ ...+.+|+.+++.++||||++
T Consensus 22 pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~ 97 (318)
T 3lxp_A 22 PGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH----RSGWKQEIDILRTLYHEHIIK 97 (318)
T ss_dssp --CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHH----HHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHH----HHHHHHHHHHHHhCCCcchhh
Confidence 3334445566679999999999999998865 568999999987644332 245889999999999999999
Q ss_pred EEeeEec---CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCce
Q 017046 123 FLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199 (378)
Q Consensus 123 l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~v 199 (378)
+++++.+ ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+
T Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~ 173 (318)
T 3lxp_A 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LV 173 (318)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CE
T ss_pred EEEEEecCCCceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-CE
Confidence 9999965 357899999999999999975 3599999999999999999999999999999999999999665 59
Q ss_pred eEecccccccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH--
Q 017046 200 KLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-- 273 (378)
Q Consensus 200 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-- 273 (378)
||+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus 174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~ 245 (318)
T 3lxp_A 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE--------YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL 245 (318)
T ss_dssp EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH
T ss_pred EECCccccccccccccccccccCCCCCceeeChHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh
Confidence 999999997644322 2234468888999999864 56778999999999999999999999753221
Q ss_pred ------------HHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 017046 274 ------------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 333 (378)
Q Consensus 274 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 333 (378)
...............+..+++++.+|+.+||..||.+|||+.++++.|..+...+....|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 246 ELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp HHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred hhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 112233344556677888999999999999999999999999999999999887765544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=350.66 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=204.9
Q ss_pred CcceeecceeecccceEEEEEEE-CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
.++|.+++.||+|+||+||+|++ .++.||+|++........ ....+.+|+.+++.++||||+++++++.++ ..++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG---IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------C---HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccch---hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 46799999999999999999988 468999999976543221 224578999999999999999999999654 7899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
||||+++ +|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 97 v~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEETTSCC
T ss_pred EEcCCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEEEccCcCceecCCCc
Confidence 9999964 88888876 345699999999999999999999999999999999999999665 5999999999764322
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC------
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG------ 287 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------ 287 (378)
.......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+................+.
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMG-------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp C---CCCCCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred ccccCCcccCCcCCHHHhcC-------CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 23345578999999998854 24678999999999999999999999987665444333222111110
Q ss_pred ----------------------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 288 ----------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 288 ----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
....+++++.+||.+||..||.+|||+.++++ +.++..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~ 308 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN--HPYFKDLD 308 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTTSC
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc--CcccccCC
Confidence 12346789999999999999999999999999 66766543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=362.62 Aligned_cols=260 Identities=30% Similarity=0.507 Sum_probs=207.2
Q ss_pred ccCCcceeecceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
.++...|.+.+.||+|+||.||+|+.. +..||||+++....... ...|.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 356678999999999999999999763 56799999976543322 246899999999999999999999996
Q ss_pred cC-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 129 DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 129 ~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
+. ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a 194 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLG 194 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred eCCceEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEEECcCccc
Confidence 54 78999999999999999976 345799999999999999999999999999999999999999665 5999999999
Q ss_pred ccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 017046 208 REETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (378)
Q Consensus 208 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 282 (378)
....... ......+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+.... ........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-~~~~~i~~ 265 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-DVIKAVDE 265 (373)
T ss_dssp -------------------CTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-HHHHHHHT
T ss_pred cccccCCccceeccCCCcCCCccChhhhcc--------CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc
Confidence 7543321 1122345678999999864 678899999999999999998 99999887653 34444455
Q ss_pred cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
......+..++.++.+++.+||+.||.+||++.++++.|+.++...
T Consensus 266 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 5556667789999999999999999999999999999999987553
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=360.34 Aligned_cols=258 Identities=26% Similarity=0.460 Sum_probs=213.0
Q ss_pred cCCcceeecceeecccceEEEEEEEC--Ce----eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DR----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+..+.|.+.+.||+|+||+||+|++. ++ +||+|.+......... ..+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF----QAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCB----CSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHH----HHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 45678999999999999999999874 33 3888887554322211 23678999999999999999999998
Q ss_pred cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
+...++||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~ 163 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVAD 163 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCccc
Confidence 88899999999999999999752 35789999999999999999999999999999999999998665 59999999997
Q ss_pred cccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 209 EETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 209 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
...... ......+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+.... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~ 234 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHF--------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EVPDLLEKGE 234 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-HHHHHHHTTC
T ss_pred ccCcccccccccCCCCcccccChHHhcc--------CCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-HHHHHHHcCC
Confidence 643322 2234567889999999864 568999999999999999999 99999876653 3344445556
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
....+..++.++.+++.+||..||.+|||+.+++++|..+...
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 235 RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 6777788999999999999999999999999999999888644
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=354.43 Aligned_cols=268 Identities=27% Similarity=0.493 Sum_probs=206.1
Q ss_pred ccccCCcceeecceeecccceEEEEEEECC--e---eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEee
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGD--R---IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~---~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 126 (378)
...+..+.|.+.+.||+|+||.||+|++.. + .||||++......... ...+.+|+.+++.++||||++++++
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD---IEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHH---HHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHH---HHHHHHHHHHHHHCCCCceehhhce
Confidence 345667789999999999999999998643 2 7999999765433322 2468899999999999999999999
Q ss_pred EecC-C------eEEEEeccCCCCHHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC
Q 017046 127 CKDP-L------MVIVTELLPGMSLRKYLVSLRP----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 195 (378)
Q Consensus 127 ~~~~-~------~~lv~e~~~~~sL~~~l~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~ 195 (378)
+.+. . .++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 8654 2 3899999999999999865322 258999999999999999999999999999999999999966
Q ss_pred CCceeEeccccccccccccc---cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCC
Q 017046 196 QKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 271 (378)
Q Consensus 196 ~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 271 (378)
+ .+||+|||++........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 174 ~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 174 M-TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD--------NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp S-CEEECCCCC-----------------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred C-CEEEeeccccccccccccccccccccCcccccCchhhcC--------CCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 5 599999999975433222 223456788999999864 568899999999999999999 999998876
Q ss_pred hHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 272 NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
... .............+..+++++.+|+.+||..||.+|||+.++++.|+.++.......
T Consensus 245 ~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 245 NAE-IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp GGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred hHH-HHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 643 344455566677788899999999999999999999999999999999987765433
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=349.28 Aligned_cols=258 Identities=32% Similarity=0.556 Sum_probs=212.0
Q ss_pred cccccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 129 (378)
..+.+..+.|.+.+.||+|+||.||++.+.++.||||++..... ...+.+|+.+++.++||||+++++++.+
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-------AQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhH-------HHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34556778999999999999999999999999999999976442 1358899999999999999999998743
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
+..++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~ 165 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTK 165 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC--
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeeccccc
Confidence 3689999999999999999764333489999999999999999999999999999999999999665 59999999987
Q ss_pred ccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
...... ....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||...... ...........+.
T Consensus 166 ~~~~~~--~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~~~~~~ 234 (278)
T 1byg_A 166 EASSTQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYKMD 234 (278)
T ss_dssp ------------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-GHHHHHTTTCCCC
T ss_pred cccccc--cCCCccccccCHHHhCC--------CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhcCCCCC
Confidence 543322 23467889999999854 568899999999999999998 99999876543 3344444556677
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.+..+++.+.+++.+||..||.+|||+.++++.|+.+...
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 7888999999999999999999999999999999887543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=350.74 Aligned_cols=267 Identities=29% Similarity=0.512 Sum_probs=221.8
Q ss_pred CcccccccccCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCC
Q 017046 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118 (378)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 118 (378)
+....+.+.+..+.|.+.+.||+|+||.||+|++. ++.||||++........ ...+.+|+.+++.++||
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~ 88 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE----RIEFLNEASVMKEFNCH 88 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHH----HHHHHHHHHHGGGCCCT
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHH----HHHHHHHHHHHHhcCCC
Confidence 33445566777889999999999999999999754 57899999986544332 23588999999999999
Q ss_pred CeeeEEeeEec-CCeEEEEeccCCCCHHHHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCc
Q 017046 119 NLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR--------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189 (378)
Q Consensus 119 ~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~N 189 (378)
||+++++++.+ ...++||||+++++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 89 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 168 (322)
T 1p4o_A 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 168 (322)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred CEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccce
Confidence 99999999965 47899999999999999987532 1457999999999999999999999999999999999
Q ss_pred EEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCC
Q 017046 190 LLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 265 (378)
Q Consensus 190 ill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 265 (378)
||++.++ .+||+|||++....... ......+|+.|+|||++.+ ..++.++||||||+++|+|++ |..
T Consensus 169 Ili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~ 239 (322)
T 1p4o_A 169 CMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQ 239 (322)
T ss_dssp EEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred EEEcCCC-eEEECcCccccccccccccccccCCCCCCCccChhhhcc--------CCCCchhhHHHHHHHHHHHHhcCCC
Confidence 9999665 59999999997543322 2233456889999999864 568899999999999999999 899
Q ss_pred CCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 266 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 266 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
||.+.... ...........+..+..+++++.+++.+||..||.+|||+.+++++|+..+.
T Consensus 240 p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 240 PYQGLSNE-QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TTTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ccccCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 99876653 3444455556667788899999999999999999999999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=355.87 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=205.4
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
.++|.+++.||+|+||+||+|++. ++.||||++........ .+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC----PENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccch----HHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 357999999999999999999874 78999999976544322 23578999999999999999999999765 678
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV- 212 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~- 212 (378)
+||||++|++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEET
T ss_pred EEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeeccceeccC
Confidence 99999999999998865 35699999999999999999999999999999999999999665 599999999975322
Q ss_pred --ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCCC
Q 017046 213 --TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLP 289 (378)
Q Consensus 213 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~ 289 (378)
........||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.......+....... .....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHC-------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTG
T ss_pred CcccccCCCccCcCccCcHHhcc-------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCcc
Confidence 222345689999999999864 12346789999999999999999999987665433333332222 22223
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
..+++++.+|+.+||..||.+|||+.++++ +.++..
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~~ 267 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKK--DRWYNK 267 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTTC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhh--Chhhcc
Confidence 568999999999999999999999999998 455543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=355.40 Aligned_cols=256 Identities=22% Similarity=0.351 Sum_probs=210.1
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHH-HHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
+.|.+.+.||+|+||.||++++. ++.||+|++......... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46999999999999999999874 789999999875543210 00123578999999999999999999999764 688
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC---ceeEecccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREE 210 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~---~vkl~Dfg~a~~~ 210 (378)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 99999999999999975 457999999999999999999999999999999999999986552 5999999999876
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--CC
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GL 288 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~ 288 (378)
..........||+.|+|||++.. ..++.++|||||||++|+|++|..||.+................. ..
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CCCCccccccCCcCcCCceeecC--------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc
Confidence 54444556689999999999854 568899999999999999999999998876544333322221111 12
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
+..+++.+.+||.+||..||.+|||+.++++ +.++
T Consensus 241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~ 275 (326)
T 2y0a_A 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWI 275 (326)
T ss_dssp HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhc--CCCc
Confidence 2568899999999999999999999999998 4444
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=340.69 Aligned_cols=257 Identities=31% Similarity=0.562 Sum_probs=219.0
Q ss_pred cccCCcceeecceeecccceEEEEEEE-CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-C
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-P 130 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 130 (378)
+.++.+.|.+.+.||+|+||.||++.+ .++.||+|++....... +.+.+|+.+++.++||||+++++++.+ .
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 76 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLVQLYGVCLEQA 76 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH------HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH------HHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 457788999999999999999999988 46789999998765443 247899999999999999999999965 4
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++...
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV 154 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred CeEEEEeCCCCCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-CEEEccccccccc
Confidence 78999999999999999976 345789999999999999999999999999999999999998655 5999999998754
Q ss_pred cccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 211 TVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 211 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
.... ......+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+.... .............
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~i~~~~~~~ 225 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRLY 225 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTCCCC
T ss_pred ccccccccccccccccccChhhhcC--------CCccchhchhhhHHHHHHHhccCCCCCCCCCHH-HHHHHHhcCCcCC
Confidence 3322 2234467789999999864 567889999999999999999 89999876653 3444455556666
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.+..+++++.+++.+||..||.+|||+.+++++|..+..
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 778899999999999999999999999999999988764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=353.86 Aligned_cols=250 Identities=30% Similarity=0.451 Sum_probs=199.8
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 130 (378)
.+.|.+.+.||+|+||.||++++ .++.||||++......... ...++.+|+.+++.++||||+++++++.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPS--FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHH--HHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHH--HHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 46799999999999999999986 5789999999876544322 234688999999999999999999988542
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
..++||||++|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~ 165 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC--
T ss_pred cccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCccc
Confidence 248999999999999999763 4699999999999999999999999999999999999999665 599999999975
Q ss_pred ccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017046 210 ETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 210 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+................
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237 (311)
T ss_dssp ----------------CCTTCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred ccccccccccccccCcCcccCCHHHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Confidence 43221 2233468999999999864 56889999999999999999999999987765554444433222
Q ss_pred CC--CCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 286 PG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 286 ~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+. .+..+++++.+++.+||+.||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 238 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 21 23568999999999999999999997666665
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=354.26 Aligned_cols=269 Identities=30% Similarity=0.480 Sum_probs=224.0
Q ss_pred CcccccccccCCcceeecceeecccceEEEEEEECC-------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cC
Q 017046 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KH 117 (378)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 117 (378)
.+...+.+.+..+.|.+.+.||+|+||.||+|.+.+ ..||+|++........ ...+.+|+.+++.+ +|
T Consensus 34 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~h 109 (333)
T 2i1m_A 34 QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE----KEALMSELKIMSHLGQH 109 (333)
T ss_dssp SSCCCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHH----HHHHHHHHHHHHHHCCC
T ss_pred cccccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHH----HHHHHHHHHHHHhhcCC
Confidence 334445667788999999999999999999998742 4799999987554332 24588999999999 89
Q ss_pred CCeeeEEeeEec-CCeEEEEeccCCCCHHHHHhhhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 017046 118 DNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR------------PNKLDLHVALNFALDIARAMDCLHANGIIHRD 184 (378)
Q Consensus 118 p~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~d 184 (378)
|||+++++++.+ +..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++||+|||
T Consensus 110 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 189 (333)
T 2i1m_A 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189 (333)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred CCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCC
Confidence 999999999965 47899999999999999997532 34689999999999999999999999999999
Q ss_pred CCCCcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHH
Q 017046 185 LKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 261 (378)
Q Consensus 185 ikp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll 261 (378)
|||+|||++.++ .+||+|||++....... ......+|+.|+|||++.. ..++.++|||||||++|+|+
T Consensus 190 lkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~ 260 (333)
T 2i1m_A 190 VAARNVLLTNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYGILLWEIF 260 (333)
T ss_dssp CSGGGCEEEGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHT
T ss_pred cccceEEECCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhcc--------CCCChHHHHHHHHHHHHHHH
Confidence 999999999554 59999999997543222 1233456788999998864 56889999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 262 T-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 262 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+ |..||.+...................+..+++++.+++.+||+.||.+|||+.+++++|+.....
T Consensus 261 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 261 SLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp TTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 8 99999887665555555556666777788999999999999999999999999999999887654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=346.77 Aligned_cols=262 Identities=27% Similarity=0.526 Sum_probs=217.3
Q ss_pred ccccCCcceeecc-eeecccceEEEEEEE----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEee
Q 017046 52 SLLVDPKLLFIGS-KIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (378)
Q Consensus 52 ~~~~~~~~~~~~~-~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 126 (378)
...++.+.|.+.+ .||+|+||.||+|.+ .++.||||++........ ....+.+|+.+++.++||||++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA---LKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH---HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHH---HHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3455677899988 999999999999954 257899999976543322 23468899999999999999999999
Q ss_pred EecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 127 CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 127 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
+.++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||+
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~ 163 (291)
T 1xbb_A 87 CEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGL 163 (291)
T ss_dssp EESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred ECCCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCc
Confidence 988889999999999999999986 35699999999999999999999999999999999999999655 599999999
Q ss_pred cccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017046 207 AREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 207 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 281 (378)
+....... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+... ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~ 234 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTAMLE 234 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHH
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhcc--------CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHH
Confidence 87543222 1223356789999999854 567889999999999999999 9999988765 34445555
Q ss_pred hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
....+..+..+++++.+++.+||..||.+|||+.++++.|+.++...
T Consensus 235 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 235 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 66677788899999999999999999999999999999999998664
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=352.34 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=210.5
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
..++|.+.+.||+|+||+||+++. +++.||+|++........ .....+.+|+.+++.++||||+++++++.+. ..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL--KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT--TCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh--hHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 346799999999999999999987 478999999975322111 1123577899999999999999999999765 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS
T ss_pred EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcceecCC
Confidence 899999999999999986 35699999999999999999999999999999999999999665 599999999976432
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
.....+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+.... +..+. .....+|..+
T Consensus 159 --~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~-~~~~~~p~~~ 226 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKIL-NAELRFPPFF 226 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHH-HCCCCCCTTS
T ss_pred --ccccccCCccccCHhHhcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHH-hCCCCCCCCC
Confidence 2345689999999999864 5688999999999999999999999987665443 33333 3456678889
Q ss_pred hHHHHHHHHHccccCCCCCC-----CHHHHHHHHHhhh
Q 017046 293 SPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFL 325 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~l~~~~ 325 (378)
++++.++|.+||..||.+|| ++.++++ +.++
T Consensus 227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~--hp~f 262 (318)
T 1fot_A 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--HPWF 262 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--SGGG
T ss_pred CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc--Cccc
Confidence 99999999999999999999 8999988 4444
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=352.10 Aligned_cols=267 Identities=30% Similarity=0.568 Sum_probs=222.4
Q ss_pred ccccccCCcceeecceeecccceEEEEEEEC---------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCC
Q 017046 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDN 119 (378)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~ 119 (378)
...+.+..+.|.+.+.||+|+||.||+|++. +..||||++........ ...+.+|+.+++.+ +|||
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~hp~ 102 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD----LSDLVSEMEMMKMIGKHKN 102 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHH----HHHHHHHHHHHHHHCCCTT
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHH----HHHHHHHHHHHHHhhcCCC
Confidence 3455667789999999999999999999863 46799999986554332 24588999999999 8999
Q ss_pred eeeEEeeEec-CCeEEEEeccCCCCHHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 017046 120 LVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRD 184 (378)
Q Consensus 120 iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~lH~~givH~d 184 (378)
|+++++++.+ +..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.||+|||
T Consensus 103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 182 (334)
T 2pvf_A 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 182 (334)
T ss_dssp BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 9999999965 478999999999999999986432 2489999999999999999999999999999
Q ss_pred CCCCcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHH
Q 017046 185 LKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 261 (378)
Q Consensus 185 ikp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll 261 (378)
|||+|||++.++ .+||+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 183 lkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell 253 (334)
T 2pvf_A 183 LAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEIF 253 (334)
T ss_dssp CSGGGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHH
T ss_pred CccceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcC--------CCcChHHHHHHHHHHHHHHH
Confidence 999999999665 59999999997543322 2234467889999998864 56789999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 262 T-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 262 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
+ |..||.+... ............+..+..++.++.+++.+||..||.+|||+.++++.|..++.....
T Consensus 254 t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 254 TLGGSPYPGIPV-EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp TTSCCSSTTCCH-HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred hCCCCCcCcCCH-HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 9 9999987654 444555556666778888999999999999999999999999999999999876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=359.00 Aligned_cols=250 Identities=27% Similarity=0.455 Sum_probs=208.1
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP- 130 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~- 130 (378)
+..++|.+.+.||+|+||.||+|++. ++.||||+++........ ....+..|..++..+ +||||+++++++.+.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD--DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhh--hHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 45678999999999999999999874 789999999764221110 123467889999877 899999999999764
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhhhhc
Confidence 788999999999999999763 4699999999999999999999999999999999999999665 5999999999753
Q ss_pred cc-ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 211 TV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 211 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+... .+..+ ....+.+|
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i-~~~~~~~p 238 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-LFHSI-RMDNPFYP 238 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH-HHCCCCCC
T ss_pred ccCCCcccCCCCCcccCChhhhcC--------CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH-HhCCCCCC
Confidence 32 233456689999999999864 568999999999999999999999998766533 33333 33456778
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHH-HHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFS-QIIR 319 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~ 319 (378)
..+++++.+||.+||..||.+||++. ++++
T Consensus 239 ~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 239 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 88999999999999999999999997 7776
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=377.61 Aligned_cols=265 Identities=26% Similarity=0.537 Sum_probs=219.8
Q ss_pred cccCCcceeecc-eeecccceEEEEEEE----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 53 LLVDPKLLFIGS-KIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 53 ~~~~~~~~~~~~-~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
+.+....+.+.+ .||+|+||.||+|.+ .+..||||+++........ +.|.+|+.+|+.++||||+++++++
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~ 405 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT----EEMMREAQIMHQLDNPYIVRLIGVC 405 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTH----HHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHH----HHHHHHHHHHHhCCCCCEeeEEEEe
Confidence 345556666666 899999999999976 3467999999875433322 3588999999999999999999999
Q ss_pred ecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
.++..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 406 ~~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla 483 (613)
T 2ozo_A 406 QAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLS 483 (613)
T ss_dssp ESSSEEEEEECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTT
T ss_pred ccCCeEEEEEeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCc
Confidence 88889999999999999999975 345799999999999999999999999999999999999999554 6999999999
Q ss_pred cccccccc----cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 017046 208 REETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (378)
Q Consensus 208 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 282 (378)
+....... .....+++.|+|||++.. ..++.++|||||||++|||++ |..||.+....+ ....+..
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~--------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~~~i~~ 554 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQ 554 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-HHHHHHT
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHc
Confidence 76432221 122345688999999864 678999999999999999998 999999877644 4555566
Q ss_pred cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
+.+...|..+++++.+||..||..||.+|||+.++++.|..++.......
T Consensus 555 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 555 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 77788889999999999999999999999999999999999988765533
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=376.77 Aligned_cols=264 Identities=30% Similarity=0.500 Sum_probs=226.0
Q ss_pred cccccCCcceeecceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
..+.+..+.|.+.++||+|+||.||+|.+.+ ..||||+++...... +.|.+|+.+|+.++||||+++++++.+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~hpniv~~~~~~~~ 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSE 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCH------HHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 4566778889999999999999999999865 689999998755432 258899999999999999999999988
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+..++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~ 412 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARL 412 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTSTTT
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEccccccee
Confidence 8899999999999999999764445699999999999999999999999999999999999998554 599999999976
Q ss_pred ccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 017046 210 ETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 210 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
..... ......++..|+|||++.. ..++.++|||||||+||+|++ |..||.+....+ ....+....+.
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-~~~~i~~~~~~ 483 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRM 483 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-HHHHHHTTCCC
T ss_pred cCCCceecccCCcCcccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCC
Confidence 43322 1223456789999998864 568999999999999999999 999999877643 44455566677
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
..+..++.++.+||.+||..||.+|||+.+|++.|+.++....+
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 77889999999999999999999999999999999998876544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=359.41 Aligned_cols=254 Identities=22% Similarity=0.370 Sum_probs=211.2
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+.+.||+|+||.||+|... ++.||+|++....... ...+.+|+.+++.++||||+++++++.+. ..++
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-----KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH-----HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh-----HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 56999999999999999999874 6899999997654322 23578999999999999999999999754 7889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC-CCceeEeccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD-QKSLKLADFGLAREETVT 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~-~~~vkl~Dfg~a~~~~~~ 213 (378)
||||++|++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ ...+||+|||++......
T Consensus 126 v~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999999875 33579999999999999999999999999999999999999743 346999999999876554
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC--CCCCCCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--RPGLPED 291 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~ 291 (378)
.......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+............... .......
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 276 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred cceeeeccCCCccCchhccC--------CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccc
Confidence 44455689999999999864 5688999999999999999999999998766444333322221 2223356
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+++++.+||.+||..||.+|||+.++++ +.++..
T Consensus 277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~ 310 (387)
T 1kob_A 277 VSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLKG 310 (387)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTSS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhh--CccccC
Confidence 8999999999999999999999999998 455543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=373.37 Aligned_cols=260 Identities=30% Similarity=0.534 Sum_probs=222.2
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
.+.+....|.+.+.||+|+||.||+|++. +..||||+++...... ..|.+|+.+|+.++||||+++++++.+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV------EEFLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccch------HHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 45667788999999999999999999885 6899999998654432 358899999999999999999999965
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
...++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~ 366 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSR 366 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEE
T ss_pred CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEEEeecccce
Confidence 4789999999999999999875556799999999999999999999999999999999999998554 59999999997
Q ss_pred cccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017046 209 EETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 209 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
...... ......+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+.... ..........+
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~ 437 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYR 437 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCC
T ss_pred eccCCceeecCCCcCCcceeCHhHHhc--------CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCC
Confidence 643222 1223356788999999864 568899999999999999999 99999887653 34445556667
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
...|..+++++.+||.+||+.||.+|||+.++++.|+.++..
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 778889999999999999999999999999999999887643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=360.03 Aligned_cols=265 Identities=21% Similarity=0.347 Sum_probs=211.1
Q ss_pred ccccCCcceeecceeecc--cceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 52 SLLVDPKLLFIGSKIGEG--AHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G--~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
....+..+|.+++.||+| +||+||++++. ++.||||++........ ....+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE---MVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHH---HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChH---HHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 344567889999999999 99999999985 78999999987654433 234688999999999999999999998
Q ss_pred ec-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 128 KD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 128 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
.+ +..++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||.
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg~ 174 (389)
T 3gni_B 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRS 174 (389)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGGG
T ss_pred EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEccccc
Confidence 65 4789999999999999999876557799999999999999999999999999999999999999665 599999998
Q ss_pred ccccccc--------cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHH
Q 017046 207 AREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (378)
Q Consensus 207 a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 278 (378)
+...... .......||+.|+|||++.. ....++.++|||||||++|+|++|..||.+.........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 248 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHST------TSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred ceeeccccccccccccccccccccccccCHHHHhc------cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 7543211 11223478999999999864 124688999999999999999999999987654333322
Q ss_pred HHHhc--------------------------------------------CCCCCCCCChHHHHHHHHHccccCCCCCCCH
Q 017046 279 AAFKH--------------------------------------------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 314 (378)
Q Consensus 279 ~~~~~--------------------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 314 (378)
..... ....++..+++++.+||.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 328 (389)
T 3gni_B 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328 (389)
T ss_dssp C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence 11100 0112345688999999999999999999999
Q ss_pred HHHHHHHHhhhhcc
Q 017046 315 SQIIRMLNAFLFTL 328 (378)
Q Consensus 315 ~~ll~~l~~~~~~~ 328 (378)
.++++ +.++...
T Consensus 329 ~ell~--hp~f~~~ 340 (389)
T 3gni_B 329 STLLN--HSFFKQI 340 (389)
T ss_dssp HHHTT--SGGGGGC
T ss_pred HHHhc--CHHHHHH
Confidence 99998 5555544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=350.98 Aligned_cols=261 Identities=28% Similarity=0.498 Sum_probs=213.4
Q ss_pred ccCCcceeecceeecccceEEEEEEECC------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
.+..+.|.+.+.||+|+||.||+|.... ..||||++........ ...+.+|+.+++.++||||+++++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ----RVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHH----HHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4567889999999999999999997632 3599999986543322 23588999999999999999999999
Q ss_pred ec-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 128 KD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 128 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
.+ ...++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~ 193 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGL 193 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-cEEECCCCc
Confidence 65 478999999999999999976 346799999999999999999999999999999999999999655 599999999
Q ss_pred cccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017046 207 AREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 207 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 281 (378)
+....... ......+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+.... .......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~~~~~ 264 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAIN 264 (333)
T ss_dssp -----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHH
T ss_pred chhhccccccccccCCCCccccccCchhccc--------CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHH
Confidence 97543221 1123356788999999854 568889999999999999999 99999876653 3444555
Q ss_pred hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
.......+..+++++.+++.+||+.||.+||++.++++.|+.++....
T Consensus 265 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 555667778899999999999999999999999999999998876543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=356.69 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=196.8
Q ss_pred ccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 130 (378)
.....+|.+.+.||+|+||+||+++. +++.||||++........ .+.+|+.+++.++||||+++++++.++
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE------NVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCH------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccH------HHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 34667899999999999999999988 478999999986554332 367999999999999999999999654
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC-ceeEeccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARE 209 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~-~vkl~Dfg~a~~ 209 (378)
..++||||++||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++. .+||+|||+++.
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 788999999999999999763 46999999999999999999999999999999999999985432 499999999975
Q ss_pred cccccccccCcCccccccccccccccccccccccCC-CcccchhhhHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCC
Q 017046 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNL---QAAYAAAFKHAR 285 (378)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~~~ 285 (378)
...........||+.|+|||++.+ ..++ .++|||||||++|+|++|..||.+.... ........ ...
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~-~~~ 238 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLR--------QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL-SVK 238 (361)
T ss_dssp -------------CTTSCHHHHHC--------SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH-TTC
T ss_pred ccccCCCCCCcCCCCcCChhhhcC--------CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh-cCC
Confidence 544444556689999999999864 3444 4489999999999999999999865432 22222222 222
Q ss_pred CCCC--CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 286 PGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 286 ~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
..+| ..+++++.+||.+||..||.+|||+.++++ +.++..
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~--hp~f~~ 280 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKT--HSWFLK 280 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SHHHHT
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh--Ccchhc
Confidence 2333 368999999999999999999999999999 455533
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=344.83 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=204.7
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
++|.+.+.||+|+||+||+|++ +++.||||++......... ...+.+|+.+++.++||||+++++++.+ ...++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV---PSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCc---chHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence 4699999999999999999988 4689999999866544332 2357899999999999999999999965 47889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
||||+++ +|.+.+.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 79 v~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 79 VFEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCC
T ss_pred EEecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCcc
Confidence 9999965 66666654 346799999999999999999999999999999999999999665 5999999999754322
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-C-------
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-R------- 285 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~------- 285 (378)
.......||+.|+|||++.+ ...++.++|||||||++|+|++|..||................. .
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred ccccCCccccCCcChHHHcC-------CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 23345578999999999854 23478999999999999999998877544444333333332211 0
Q ss_pred --------------------CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 286 --------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 286 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
......+++++.+|+.+||+.||.+|||+.++++ +.++....+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~p 291 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFCP 291 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTC--
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc--CcccccCCC
Confidence 1122357899999999999999999999999999 677766544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=351.50 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=203.0
Q ss_pred cCCcceeecceeecccceEEEEEEE-----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
+..+.|.+.+.||+|+||.||+++. .++.||+|+++........ .....+.+|+.+++.++||||+++++++.+
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA-KDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhh-hHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 4567899999999999999999986 5689999999865432211 112357799999999999999999999965
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
+..++||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEEeCCccc
Confidence 4789999999999999999763 4689999999999999999999999999999999999999665 59999999987
Q ss_pred cccc-ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 209 EETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 209 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
.... .......+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+......... + ......
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-i-~~~~~~ 239 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMR--------SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK-I-LKCKLN 239 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTT--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-H-HHTCCC
T ss_pred ccccCCccccccCCCcCccCHhhCcC--------CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH-H-HhCCCC
Confidence 5332 223345689999999999864 5678999999999999999999999988765443322 2 234566
Q ss_pred CCCCChHHHHHHHHHccccCCCCCC-----CHHHHHHHHHhhh
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFL 325 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~l~~~~ 325 (378)
+|..+++++.+||.+||..||.+|| ++.++++ +.++
T Consensus 240 ~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~--hp~f 280 (327)
T 3a62_A 240 LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA--HPFF 280 (327)
T ss_dssp CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH--SGGG
T ss_pred CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc--CCcc
Confidence 7888999999999999999999999 7889988 4454
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=351.41 Aligned_cols=259 Identities=28% Similarity=0.399 Sum_probs=204.6
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc---cCCCeeeEEeeEecC-
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACKDP- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~~- 130 (378)
..+|.+.+.||+|+||+||+|++ +++.||||++...............+.+|+.+++.+ +||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 56799999999999999999985 578999999875432111000011355677777666 499999999998643
Q ss_pred -----CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 131 -----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 131 -----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
..++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg 165 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFG 165 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEECSCS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEeeCc
Confidence 3689999995 6999999876555699999999999999999999999999999999999998665 59999999
Q ss_pred cccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017046 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
++.............||+.|+|||++.. ..++.++|||||||++|+|++|..||.+................
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHT--------SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccCCCcccCCccccccccCchHHcC--------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9987655555566789999999999864 56899999999999999999999999987765544443322111
Q ss_pred CC-------------------------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 286 PG-------------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 286 ~~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+. ....+++++.+||.+||+.||.+|||+.++++ +.++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--h~~~~~ 302 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ--HSYLHK 302 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--STTC--
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc--CccccC
Confidence 10 11357889999999999999999999999998 555543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=346.33 Aligned_cols=260 Identities=30% Similarity=0.527 Sum_probs=221.7
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
.+.+....|.+.+.||+|+||.||+|.+. +..||+|++....... ..+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV------EEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHH------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 45567788999999999999999999885 7899999997644322 358899999999999999999999965
Q ss_pred C-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 ~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
+ ..++||||++|++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~ 159 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSR 159 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGGG
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCccce
Confidence 4 789999999999999999876666799999999999999999999999999999999999998655 59999999997
Q ss_pred cccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017046 209 EETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 209 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
...... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~~~~~~~~~~ 230 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDYR 230 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCC
T ss_pred eccCCccccccCCccccCcCChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhccCC
Confidence 544322 2233356788999999864 568899999999999999999 99999876543 34445555667
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
...+..+++++.+|+.+||..||.+|||+.++++.|..++..
T Consensus 231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 777888999999999999999999999999999999988765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=353.36 Aligned_cols=258 Identities=27% Similarity=0.499 Sum_probs=211.7
Q ss_pred cCCcceeecceeecccceEEEEEEEC--Ce----eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DR----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+...+|.+.+.||+|+||+||+|++. ++ +||+|.+......... ..+.+|+.+++.++||||+++++++.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~ 87 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN----KEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCH----HHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHH----HHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence 45678999999999999999999873 33 4577777654433322 35889999999999999999999998
Q ss_pred cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
++..++|++|+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a~ 165 (327)
T 3lzb_A 88 TSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAK 165 (327)
T ss_dssp SSSEEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTC--
T ss_pred cCCceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccCccee
Confidence 88899999999999999999763 45799999999999999999999999999999999999998655 59999999997
Q ss_pred cccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 209 EETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 209 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
...... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.... ..........
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~~~ 236 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGE 236 (327)
T ss_dssp --------------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTC
T ss_pred EccCccccccccCCCccccccCHHHHcC--------CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCC
Confidence 543322 2223456788999999864 678899999999999999999 99999876653 3344555566
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
....+..++.++.+++.+||..||.+|||+.++++.|..+...
T Consensus 237 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 6777888999999999999999999999999999999988744
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=351.25 Aligned_cols=264 Identities=26% Similarity=0.407 Sum_probs=210.2
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC---
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 130 (378)
....|.+.+.||+|+||+||+|++. ++.||||++......... ..+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV----DVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCH----HHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchH----HHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 4567999999999999999999885 789999999764433222 3477999999999999999999988643
Q ss_pred CeEEEEeccCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEE----cCCCCceeEeccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL----TPDQKSLKLADFG 205 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill----~~~~~~vkl~Dfg 205 (378)
..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ + ....+||+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg 161 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED-GQSVYKLTDFG 161 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTT-SCEEEEECCCT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCC-CCceEEEccCC
Confidence 67899999999999999976432 239999999999999999999999999999999999998 5 33459999999
Q ss_pred cccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh---HHHHHHHHHh
Q 017046 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFK 282 (378)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~ 282 (378)
++.............||+.|+|||++............++.++|||||||++|+|++|..||..... ..........
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 9987655555556789999999998864322222246789999999999999999999999964332 2222333332
Q ss_pred cCCC------------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 283 HARP------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 283 ~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
...+ .++..++..+.+++.+||+.||.+|||+.|++++...-
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 2221 12233567889999999999999999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=374.89 Aligned_cols=258 Identities=22% Similarity=0.353 Sum_probs=216.2
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-C
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 131 (378)
+..+.|.+.+.||+|+||.||+++. +++.||||++......... ....+.+|+.+++.++||||+++++++.+. .
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~--~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhH--HHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 5667899999999999999999987 4789999999753221111 123578999999999999999999999754 7
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~~ 337 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccceecc
Confidence 89999999999999999875555699999999999999999999999999999999999999665 59999999998765
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGL 288 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 288 (378)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ..... .........+
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~--------~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~-~~i~~~~~~~ 408 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE-RLVKEVPEEY 408 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTT--------CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH-HHHHHCCCCC
T ss_pred cCccccccCCCccccCHHHHcC--------CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH-HHhhcccccC
Confidence 5555556789999999999864 5688999999999999999999999987542 22222 3334556678
Q ss_pred CCCChHHHHHHHHHccccCCCCCC-----CHHHHHHHHHhhhh
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 326 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~l~~~~~ 326 (378)
+..+++++.+||.+||..||.+|| ++.++++ +.++.
T Consensus 409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~--HpfF~ 449 (576)
T 2acx_A 409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE--HPLFK 449 (576)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT--SGGGT
T ss_pred CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh--Chhhc
Confidence 888999999999999999999999 7899988 44543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=360.08 Aligned_cols=268 Identities=18% Similarity=0.249 Sum_probs=208.9
Q ss_pred cCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHH------HHHHHHHHHHHHhhccCCCee
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERAL------LEGRFIREVNMMSRVKHDNLV 121 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv 121 (378)
+....|.+++.||+|+||.||+|.+. ++.||||++.........+. ....+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 34668999999999999999999873 37899999987553221111 011245566778888999999
Q ss_pred eEEeeEec-----CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEc--C
Q 017046 122 KFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--P 194 (378)
Q Consensus 122 ~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~--~ 194 (378)
++++++.+ ...++||||+ |++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 99998854 3478999999 9999999976 346799999999999999999999999999999999999998 4
Q ss_pred CCCceeEeccccccccccccc--------cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCC
Q 017046 195 DQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 266 (378)
Q Consensus 195 ~~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p 266 (378)
++ .+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 190 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~P 260 (364)
T 3op5_A 190 PD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--------VAPSRRGDLEILGYCMIQWLTGHLP 260 (364)
T ss_dssp TT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred CC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--------CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 44 599999999975433221 123459999999999864 5689999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhcCCCC---------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 017046 267 FEGMSNLQAAYAAAFKHARPG---------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 333 (378)
Q Consensus 267 f~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 333 (378)
|.+.................. .+..+++++.+++..||..||.+||++.++++.|..++........
T Consensus 261 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 261 WEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp TGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred ccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 986433222221111111001 1256889999999999999999999999999999999987665543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=348.41 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=200.5
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHH---------------------HHHHHHHHHHHHHH
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER---------------------ALLEGRFIREVNMM 112 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~---------------------~~~~~~~~~E~~~l 112 (378)
....|.+.+.||+|+||.||+|++ +++.||||++......... ....+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 346799999999999999999987 4789999999765432210 01124588999999
Q ss_pred hhccCCCeeeEEeeEec---CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCc
Q 017046 113 SRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189 (378)
Q Consensus 113 ~~l~hp~iv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~N 189 (378)
+.++||||+++++++.+ ...++||||+++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999999864 46899999999999987653 3579999999999999999999999999999999999
Q ss_pred EEEcCCCCceeEeccccccccccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCC
Q 017046 190 LLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (378)
Q Consensus 190 ill~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 268 (378)
||++.++ .+||+|||++...... .......||+.|+|||++.... ...++.++|||||||++|+|++|..||.
T Consensus 168 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 168 LLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR-----KIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp EEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC-----CCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCC-----CCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 9999665 5999999999754332 2234568999999999986411 1124678999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 269 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
+......................+++++.+||.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 242 DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 7665433222222222223345789999999999999999999999999883
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=356.04 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=208.0
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP- 130 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~- 130 (378)
+...+|.+++.||+|+||+||+++.. ++.||||+++........ ....+..|..++..+ +||||+++++++.+.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~--~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTT--CHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcch--HHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 34578999999999999999999985 578999999764221111 123577899999988 799999999999764
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCccccc
Confidence 789999999999999999763 4699999999999999999999999999999999999999665 5999999999753
Q ss_pred c-cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 211 T-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 211 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
. ........+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+... .+..+. .....+|
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~-~~~~~~p 241 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIM-EHNVAYP 241 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTT--------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-HCCCCCC
T ss_pred ccCCcccccccCCccccChhhhcC--------CCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-HHHHHH-hCCCCCC
Confidence 2 2333456689999999999864 568999999999999999999999998766533 333333 3456788
Q ss_pred CCChHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 319 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~ 319 (378)
..+++++.+||.+||..||.+||+ +.++++
T Consensus 242 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 899999999999999999999994 688887
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=356.28 Aligned_cols=264 Identities=26% Similarity=0.380 Sum_probs=208.3
Q ss_pred ccccccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
...+.+....|.+.+.||+|+||+||+|++.++.||||++...... ...+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ------SWQNEYEVYSLPGMKHENILQFIGAEKR 89 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHH------HHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred ccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchH------HHHHHHHHHHHhcCCCCCchhhcceecc
Confidence 3456678899999999999999999999999999999999653211 1235579999999999999999999864
Q ss_pred C-----CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCeeecCCCCcEEEcC
Q 017046 130 P-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN----------GIIHRDLKPDNLLLTP 194 (378)
Q Consensus 130 ~-----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~----------givH~dikp~Nill~~ 194 (378)
. ..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~ 166 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence 3 36899999999999999976 4599999999999999999999999 9999999999999996
Q ss_pred CCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 017046 195 DQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (378)
Q Consensus 195 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 271 (378)
++ .+||+|||++....... ......||+.|+|||++.+... ....++.++|||||||++|+|++|..||.+..
T Consensus 167 ~~-~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 167 NL-TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN---FQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp TC-CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCC---CCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred CC-eEEEccCCcccccccccCccccccCccCccccCHhhcccccc---cCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 55 59999999997543222 2234579999999999864110 01345678899999999999999999997532
Q ss_pred h---------------HHHHHHHHH-hcCCCCCCC-----CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 272 N---------------LQAAYAAAF-KHARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 272 ~---------------~~~~~~~~~-~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
. ......... ....+.++. ..++++.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2 111222221 222222222 234569999999999999999999999999988654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=345.43 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=202.4
Q ss_pred cceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
++|.+++.||+|+||+||+|+.. ++.||+|++......... ...+.+|+.+++.++||||+++++++.+ +..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI---PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC---CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccccc---chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 46999999999999999999875 789999998765433211 1347799999999999999999999965 478999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-c
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-~ 214 (378)
|||+++ +|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...... .
T Consensus 79 ~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EECCSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC---
T ss_pred EEecCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccccCcccc
Confidence 999965 99998876 346799999999999999999999999999999999999999665 5999999998754322 2
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--------
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-------- 286 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------- 286 (378)
......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+................+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp ------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccccccccccccCchheeC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhh
Confidence 2334578999999999853 2457899999999999999999999999877655444332211100
Q ss_pred -------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 287 -------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 287 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.+...+++++.+|+.+||..||.+|||+.++++ +.++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~ 285 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE--HAYFK 285 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGG
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc--Ccchh
Confidence 112457899999999999999999999999998 44443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=354.23 Aligned_cols=264 Identities=27% Similarity=0.372 Sum_probs=204.2
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
.+.|.+.+.||+|+||.||+|++. ++.||||++...............+.+|+.+++.++||||+++++++.+ ...+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 467999999999999999999874 7899999997654433222223457899999999999999999999965 4789
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||+++ +|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 89 lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSC
T ss_pred EEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEEEecccceeccCC
Confidence 99999975 89888875 345689999999999999999999999999999999999999665 5999999999764322
Q ss_pred -cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC---CC-
Q 017046 214 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP---GL- 288 (378)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~~- 288 (378)
.......||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+................+ .+
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred cccCCcccccccccCchHhhC-------CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 23345678999999998853 2457889999999999999999999999877655544433221111 00
Q ss_pred ----------------------CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 289 ----------------------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 289 ----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
...+++++.+||.+||..||.+|||+.++++ +.++...+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--h~~f~~~~~~~ 302 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFSNRPGPT 302 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTSSSCCC
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc--ChhhhcCCCCC
Confidence 1456789999999999999999999999999 66766554433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=356.35 Aligned_cols=247 Identities=24% Similarity=0.335 Sum_probs=209.2
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
..++|.+++.||+|+||.||++++. ++.||||++........ .....+.+|+.+++.++||||+++++++.+. ..
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL--KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT--TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 3468999999999999999999874 78999999975322111 1123578999999999999999999999754 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSS
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccceeccC
Confidence 9999999999999999863 4699999999999999999999999999999999999999665 599999999976433
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+... .+..+. .....+|..+
T Consensus 194 ~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~-~~~~~~p~~~ 261 (350)
T 1rdq_E 194 R--TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIV-SGKVRFPSHF 261 (350)
T ss_dssp C--BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-HCCCCCCTTC
T ss_pred C--cccccCCccccCHHHhcC--------CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-HHHHHH-cCCCCCCCCC
Confidence 2 345689999999999864 568899999999999999999999998766543 333333 3456778889
Q ss_pred hHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPS-----FSQIIR 319 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps-----~~~ll~ 319 (378)
++++.++|.+||..||.+||+ +.++++
T Consensus 262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 999999999999999999998 899988
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=366.84 Aligned_cols=262 Identities=26% Similarity=0.377 Sum_probs=210.1
Q ss_pred cccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 130 (378)
..+..++|.+++.||+|+||+||++++. ++.||+|++.+....... ....+.+|+.++..++||||+++++++.++
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~--~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS--DSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTC--CCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhH--HHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3356678999999999999999999884 689999998752211100 012377899999999999999999999765
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
..++||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~ 217 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMK 217 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEeccceeEe
Confidence 68899999999999999875 4699999999999999999999999999999999999999665 599999999976
Q ss_pred ccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 210 ETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 210 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
..... .....+||+.|+|||++... +....++.++|||||||++|+|++|..||.+.+................
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 293 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTT----TTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eccCCcccccCCcCCccccCHHHhhcc----CCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc
Confidence 44332 23466899999999998641 1112378899999999999999999999998765444333332222233
Q ss_pred CC--CCChHHHHHHHHHccccCCCC--CCCHHHHHHHHHhhhh
Q 017046 288 LP--EDISPDLAFIVQSCWVEDPNL--RPSFSQIIRMLNAFLF 326 (378)
Q Consensus 288 ~~--~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~l~~~~~ 326 (378)
+| ..+++++.+||.+||..+|.+ ||++.++++ +.++.
T Consensus 294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~--Hp~f~ 334 (410)
T 3v8s_A 294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR--HLFFK 334 (410)
T ss_dssp CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT--SGGGC
T ss_pred CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc--Ccccc
Confidence 33 469999999999999988888 999999999 45553
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=350.51 Aligned_cols=262 Identities=30% Similarity=0.556 Sum_probs=220.4
Q ss_pred cccCCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEE
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFL 124 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~ 124 (378)
+.+..+.|.+.+.||+|+||.||+|++ .++.||||++........ ...+.+|+.++..+ +||||++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE----HRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH----HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHH----HHHHHHHHHHHHhcccCCCeeeEE
Confidence 345667899999999999999999974 347899999987654332 23588999999999 799999999
Q ss_pred eeEecC--CeEEEEeccCCCCHHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCC
Q 017046 125 GACKDP--LMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 188 (378)
Q Consensus 125 ~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~ 188 (378)
+++.+. ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 998643 58999999999999999986432 12889999999999999999999999999999999
Q ss_pred cEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CC
Q 017046 189 NLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 264 (378)
Q Consensus 189 Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~ 264 (378)
||+++.++ .+||+|||++....... ......+|+.|+|||++.. ..++.++||||||+++|+|++ |.
T Consensus 178 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 178 NILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp GEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred eEEECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcc--------ccccchhHHHHHHHHHHHHHhCCC
Confidence 99998555 59999999997543221 1233467889999999864 668899999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 265 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 265 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.||.+...................+..+++++.+++.+||..||.+|||+.+++++|..++..
T Consensus 249 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 249 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 999887765666666666667778888999999999999999999999999999999998765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=353.38 Aligned_cols=263 Identities=29% Similarity=0.459 Sum_probs=214.2
Q ss_pred ccCCcceeecceeecccceEEEEEEE------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
+++.+.|.+.+.||+|+||.||++++ .++.||||++....... ...+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-----QRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHH-----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHH-----HHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 35678899999999999999999984 46899999997653222 24588999999999999999999987
Q ss_pred e---cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecc
Q 017046 128 K---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 128 ~---~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Df 204 (378)
. ....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+||+||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~Df 171 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADF 171 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEccc
Confidence 4 235789999999999999997632 4699999999999999999999999999999999999998655 5999999
Q ss_pred cccccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh--------
Q 017046 205 GLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-------- 272 (378)
Q Consensus 205 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------- 272 (378)
|++....... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~ 243 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--------NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC 243 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-
T ss_pred ccceecccCCccceeeccCCccccccCHHHhcc--------CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc
Confidence 9997543222 2234468888999999864 5678899999999999999999999864332
Q ss_pred ------HHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 273 ------LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 273 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
................+..+++++.+|+.+||..||.+|||+.+++++|+.+.......
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 244 ERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp ---CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred ccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 12333444556667778889999999999999999999999999999999987765443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=359.09 Aligned_cols=252 Identities=29% Similarity=0.458 Sum_probs=207.1
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
..|.+.+.||+|+||.||+|++ +++.||||++........ ....++.+|+.+++.++||||+++++++.++ ..++
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKS--DMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT--TCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccch--hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 5699999999999999999997 578999999875321111 1123578999999999999999999999754 6889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||+ +|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEEEEEeccceeccCCc
Confidence 99999 78999988763 5699999999999999999999999999999999999999655 59999999998766666
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
.....+||+.|+|||++.+ ....+.++|||||||++|+|++|..||.+...... . .........+|..+++
T Consensus 163 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~-~~i~~~~~~~p~~~s~ 233 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVING-------KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-F-KKVNSCVYVMPDFLSP 233 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCC-------SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-B-CCCCSSCCCCCTTSCH
T ss_pred ccccccCCcCcCCHHHHcC-------CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-H-HHHHcCCCCCcccCCH
Confidence 5667789999999999864 12237899999999999999999999976442111 0 1112234456778999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
++.+||.+||..||.+|||+.++++ +.++.
T Consensus 234 ~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~ 263 (336)
T 3h4j_B 234 GAQSLIRRMIVADPMQRITIQEIRR--DPWFN 263 (336)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHTT--CHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHh--Chhhc
Confidence 9999999999999999999999999 44443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=356.81 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=203.1
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
.+.|.+.+.||+|+||+||++.+ +++.||||++...............+.+|+.+++.++||||+++++++.+ +..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35799999999999999999987 47899999986422110000012358899999999999999999999865 4789
Q ss_pred EEEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC--CceeEeccccccc
Q 017046 134 IVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLARE 209 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~--~~vkl~Dfg~a~~ 209 (378)
+||||++|++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999887653 234589999999999999999999999999999999999997543 2499999999976
Q ss_pred ccccc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 210 ETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 210 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
..... .....+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.. ...............
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~i~~~~~~~~ 252 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKR--------EPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMN 252 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHHHHHTCCCCC
T ss_pred ecCCCeeecCCcCCcCccCHHHHcC--------CCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHHHHcCCCCCC
Confidence 54332 2345689999999999864 568899999999999999999999998743 233333333222111
Q ss_pred ---CCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 289 ---PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 289 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
...+++++.+||.+||..||.+|||+.++++
T Consensus 253 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1468999999999999999999999999998
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=356.71 Aligned_cols=244 Identities=24% Similarity=0.364 Sum_probs=199.2
Q ss_pred ecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEEEEec
Q 017046 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTEL 138 (378)
Q Consensus 62 ~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv~e~ 138 (378)
..+.||+|+||.||+|+. +++.||+|++....... ...+.+|+.+++.++||||+++++++.+. ..++||||
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD-----KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHH-----HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccccc-----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 367899999999999987 47899999998654322 23588999999999999999999999754 68899999
Q ss_pred cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC-CCCceeEeccccccccccccccc
Q 017046 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP-DQKSLKLADFGLAREETVTEMMT 217 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~-~~~~vkl~Dfg~a~~~~~~~~~~ 217 (378)
+++++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+|||++. +...+||+|||++..........
T Consensus 168 ~~~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 168 VDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp CTTCEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred CCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 999999998875 3356999999999999999999999999999999999999942 34569999999998765555555
Q ss_pred cCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--CCCCCChHH
Q 017046 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPD 295 (378)
Q Consensus 218 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 295 (378)
...||+.|+|||++.. ..++.++|||||||++|+|++|..||.+................. .....++++
T Consensus 247 ~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 318 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNY--------DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318 (373)
T ss_dssp CCCSSCTTCCHHHHTT--------CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred cccCCCcEeChhhccC--------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence 6689999999998854 568889999999999999999999999877655444433322221 122468999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 017046 296 LAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 296 l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+.+||.+||..||.+|||+.++++
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999999999999999999
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=339.12 Aligned_cols=257 Identities=24% Similarity=0.351 Sum_probs=213.5
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
.+.|.+.+.||+|+||.||+|.+. ++.||+|++......... ...+.+|+.+++.++||||+++++++.++ ..+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHH---HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHH---HHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 467999999999999999999874 689999999875544322 24588999999999999999999999755 678
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC--CceeEeccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREET 211 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~--~~vkl~Dfg~a~~~~ 211 (378)
+||||+++++|.+.+... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ ..+||+|||++....
T Consensus 82 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999999988763 5699999999999999999999999999999999999997543 249999999997766
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC--CC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG--LP 289 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~ 289 (378)
.........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.................. ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 231 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred cCccccCCCCCcCCcCchhhcC--------CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhh
Confidence 5555556789999999999864 5688999999999999999999999988766444333332222222 22
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
..+++++.+|+.+||+.||.+|||+.++++ +.++...
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~~ 268 (284)
T 3kk8_A 232 DTVTPEAKSLIDSMLTVNPKKRITADQALK--VPWICNR 268 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SHHHHSC
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhc--CccccCC
Confidence 468999999999999999999999999999 5565553
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=353.63 Aligned_cols=252 Identities=28% Similarity=0.403 Sum_probs=195.5
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
.+.|.+.+.||+|+||.||+|++. ++.||||++..... .+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-------HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 356999999999999999999985 57899999986432 13477999999999999999999999764 688
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC--CCCceeEeccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAREET 211 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~--~~~~vkl~Dfg~a~~~~ 211 (378)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+|||++. ++..+||+|||++....
T Consensus 125 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999999875 356999999999999999999999999999999999999974 24469999999998655
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC---CC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP---GL 288 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~~ 288 (378)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+................. ..
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 274 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRG--------CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274 (349)
T ss_dssp ----------CGGGSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTT
T ss_pred cccccccccCCCCccCHHHhcC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCch
Confidence 5444456689999999999864 568899999999999999999999998776655455444433222 23
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
...++.++.+||.+||..||.+|||+.++++ +.++..
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~ 311 (349)
T 2w4o_A 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ--HPWVTG 311 (349)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTTS
T ss_pred hhhCCHHHHHHHHHHccCChhhCcCHHHHhc--CcccCC
Confidence 3568999999999999999999999999998 555543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=348.59 Aligned_cols=261 Identities=26% Similarity=0.432 Sum_probs=195.5
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
.+.|.+++.||+|+||.||+|... ++.||+|++......... ..+.+|+.+++.++||||+++++++.++ ..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP----STAIREISLMKELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSC----HHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccH----HHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence 457899999999999999999864 789999999765433221 2477999999999999999999999654 788
Q ss_pred EEEeccCCCCHHHHHhhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLR----PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+||||++ ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARA 157 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence 9999997 59999986532 24589999999999999999999999999999999999999665 599999999976
Q ss_pred cccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC---
Q 017046 210 ETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--- 285 (378)
Q Consensus 210 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--- 285 (378)
.... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+................
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 230 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMG-------SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCT
T ss_pred cCCCcccCCCCcccccccCchHhhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 4322 22345578999999999854 245789999999999999999999999987764443332211110
Q ss_pred -----------------------------CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 286 -----------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 286 -----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
+..+..++.++.+||.+||..||.+|||+.++++ +.++.......
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~~~~~~ 304 (317)
T 2pmi_A 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH--HPWFAEYYHHA 304 (317)
T ss_dssp TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGGGGCC--
T ss_pred hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC--Chhhhcccchh
Confidence 0112357889999999999999999999999998 67776655443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=346.13 Aligned_cols=265 Identities=31% Similarity=0.554 Sum_probs=211.7
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEee
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 126 (378)
...++.+.|.+.+.||+|+||.||+|... +..||+|++......... ...+.+|+.+++.++||||++++++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE---IEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHH---HHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhH---HHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 34466788999999999999999999763 358999999865544332 2468899999999999999999998
Q ss_pred EecC------CeEEEEeccCCCCHHHHHhhh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC
Q 017046 127 CKDP------LMVIVTELLPGMSLRKYLVSL----RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ 196 (378)
Q Consensus 127 ~~~~------~~~lv~e~~~~~sL~~~l~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~ 196 (378)
+.+. ..++||||+++++|.+++... ....+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 8643 358999999999999998542 235699999999999999999999999999999999999999665
Q ss_pred CceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCCh
Q 017046 197 KSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272 (378)
Q Consensus 197 ~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 272 (378)
.+||+|||++....... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+...
T Consensus 185 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 185 -TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp -CEEECSCSCC----------------CCGGGSCHHHHHS--------SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred -cEEEeecCcceecccccccCcccccCCCccccCchhhcC--------CCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 59999999987543322 1233457889999999854 668899999999999999999 8999987665
Q ss_pred HHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
.. ..........+..+..+++++.+++.+||..||.+|||+.+++++|..++..++
T Consensus 256 ~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 256 HE-MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp GG-HHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HH-HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 33 344455666777888999999999999999999999999999999999987764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=366.66 Aligned_cols=263 Identities=22% Similarity=0.332 Sum_probs=210.5
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-C
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 131 (378)
+..++|.+++.||+|+||+||+|++. ++.||||++.+....... ....+.+|+.++..++||||+++++++.++ .
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~--~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA--ETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTT--TTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHH--HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 45678999999999999999999875 689999999752211110 112377899999999999999999999765 7
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||++||+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLM 226 (437)
T ss_dssp EEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhhhhcc
Confidence 8999999999999999976 346799999999999999999999999999999999999999665 59999999997543
Q ss_pred ccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc---CCC
Q 017046 212 VTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH---ARP 286 (378)
Q Consensus 212 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---~~~ 286 (378)
... .....+||+.|+|||++.... .....++.++|||||||++|+|++|..||.+.+..+......... ..+
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAME---GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHH---TSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred cCCCcccccccCCcCeeChHHHhhcc---cCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence 322 223468999999999986210 012568899999999999999999999999877654443333222 223
Q ss_pred CCCCCChHHHHHHHHHccccCCCC--CCCHHHHHHHHHhhhh
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNL--RPSFSQIIRMLNAFLF 326 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~l~~~~~ 326 (378)
.....+++++.+||.+||..+|.+ ||++.++++ +.++.
T Consensus 304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~--Hpff~ 343 (437)
T 4aw2_A 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK--HPFFS 343 (437)
T ss_dssp SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT--SGGGT
T ss_pred cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC--CCccC
Confidence 333458999999999999888887 999999999 55553
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=343.50 Aligned_cols=257 Identities=28% Similarity=0.496 Sum_probs=211.4
Q ss_pred cCCcceeecceeecccceEEEEEEE------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+....|.+.+.||+|+||.||++++ .++.||+|++........ ...+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CC----HHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchh----HHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 4456799999999999999999984 578999999976543222 235889999999999999999999986
Q ss_pred c---CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 129 D---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 129 ~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
+ ...++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg 171 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFG 171 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECccc
Confidence 4 4578999999999999999663 35699999999999999999999999999999999999998655 59999999
Q ss_pred ccccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCC------------
Q 017046 206 LAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG------------ 269 (378)
Q Consensus 206 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~------------ 269 (378)
++....... ......+|..|+|||++.+ ..++.++||||||+++|+|++|..|+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 243 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ--------SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecC--------CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCc
Confidence 997543322 2334568888999999865 5677899999999999999999987642
Q ss_pred --CChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 270 --MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 270 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
...................+..+++++.+|+.+||..||.+|||+.++++.|+.++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 244 HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 22233334445556667778899999999999999999999999999999998875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=349.67 Aligned_cols=264 Identities=30% Similarity=0.493 Sum_probs=215.8
Q ss_pred ccccCCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEE
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFL 124 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 124 (378)
...+..+.|.+.+.||+|+||.||+|++ .++.||||++........ ..++.+|+.+++.++||||++++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD----ELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHH----HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhh----HHHHHHHHHHHhhCCCCCCCeEE
Confidence 3345678899999999999999999984 346899999975443332 23588999999999999999999
Q ss_pred eeEecC-CeEEEEeccCCCCHHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC--C
Q 017046 125 GACKDP-LMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--Q 196 (378)
Q Consensus 125 ~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~--~ 196 (378)
+++.+. ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence 999654 78999999999999999987432 348999999999999999999999999999999999999843 2
Q ss_pred CceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCCh
Q 017046 197 KSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272 (378)
Q Consensus 197 ~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 272 (378)
..+||+|||++....... ......+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+...
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHhcC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 359999999986432221 2233467889999999864 568899999999999999998 9999987655
Q ss_pred HHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
............+..+..+++.+.+++.+||..||.+|||+.+++++|+.+....
T Consensus 252 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 252 -QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp -HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 3444555556667778889999999999999999999999999999998887543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=356.31 Aligned_cols=246 Identities=27% Similarity=0.390 Sum_probs=198.7
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHH-HhhccCCCeeeEEeeEecC-
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNM-MSRVKHDNLVKFLGACKDP- 130 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~l~~~~~~~- 130 (378)
...++|.+++.||+|+||+||++++. ++.||||++.+........ ...+.+|..+ ++.++||||+++++++.+.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~--~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE--EKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHH--HHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 45678999999999999999999874 6789999998755433221 2346677776 5678999999999999754
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGG
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCcccccc
Confidence 789999999999999999763 5689999999999999999999999999999999999999665 5999999999753
Q ss_pred c-cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 211 T-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 211 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
. ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+... .+..+. .....++
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~-~~~~~~~ 259 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNIL-NKPLQLK 259 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHH-HSCCCCC
T ss_pred ccCCCccccccCCccccCHHHhCC--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH-hcccCCC
Confidence 2 2334456689999999999864 668999999999999999999999998766543 333333 3455677
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFS 315 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~ 315 (378)
..++.++.+||.+||..||.+||++.
T Consensus 260 ~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 260 PNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp SSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 88999999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=349.44 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=210.9
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|.+.+.||+|+||+||+|+. +++.||||++......... ....+.+|+.+++.++||||+++++++.+ ...++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE--KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHH--HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 4589999999999999999986 5789999999865543322 23468899999999999999999999865 47889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||+. |+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 132 v~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSSB-
T ss_pred EEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCCC-
Confidence 999996 6888888653 35799999999999999999999999999999999999999655 5999999999764432
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
....||+.|+|||++... ....++.++|||||||++|+|++|..||.+...................+..+++
T Consensus 208 --~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 280 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTT-----SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred --CcccCCcceeCHhhhccc-----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Confidence 345799999999988531 1356889999999999999999999999887766655554444444444567899
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.+.+||.+||+.||.+|||+.+++++ .++..
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h--~~~~~ 311 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKH--RFVLR 311 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTC--HHHHS
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhC--hhhhc
Confidence 99999999999999999999999984 44433
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=376.45 Aligned_cols=261 Identities=27% Similarity=0.524 Sum_probs=215.9
Q ss_pred cccCCcceeec-ceeecccceEEEEEEE----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 53 LLVDPKLLFIG-SKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 53 ~~~~~~~~~~~-~~lG~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
+.++.+.+.+. ++||+|+||+||+|.+ .++.||||+++....... ....+.+|+.+++.++||||+++++++
T Consensus 363 ~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~ 439 (635)
T 4fl3_A 363 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA---LKDELLAEANVMQQLDNPYIVRMIGIC 439 (635)
T ss_dssp SBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG---GHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 33444555554 4899999999999965 347899999976543322 124588999999999999999999999
Q ss_pred ecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
.++..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 440 ~~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla 516 (635)
T 4fl3_A 440 EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLS 516 (635)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHH
T ss_pred ecCCEEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCc
Confidence 88889999999999999999975 45799999999999999999999999999999999999999655 5999999999
Q ss_pred ccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 017046 208 REETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (378)
Q Consensus 208 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 282 (378)
+...... ......+|+.|+|||++.. ..++.++|||||||++|+|++ |..||.+.... .....+..
T Consensus 517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~~~~i~~ 587 (635)
T 4fl3_A 517 KALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEK 587 (635)
T ss_dssp HHTTC-------------CGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHT
T ss_pred cccccCccccccccCCCCceeeeChhhhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc
Confidence 7543222 2233456788999999864 678999999999999999998 99999987764 44555666
Q ss_pred cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
...+..|..+++++.+||..||..||.+|||+.++++.|+.++..+
T Consensus 588 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 588 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 7778888999999999999999999999999999999999988654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=348.42 Aligned_cols=262 Identities=32% Similarity=0.537 Sum_probs=215.3
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCee--EEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRI--VAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD 129 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~--vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 129 (378)
++.++|.+.+.||+|+||.||+|++ ++.. ||+|.+........ ...+.+|+.+++.+ +||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD----HRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHH----HHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 5567899999999999999999976 4554 49999875433222 23588999999999 89999999999865
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~ 194 (378)
+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 47889999999999999997632 246999999999999999999999999999999999999986
Q ss_pred CCCceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChH
Q 017046 195 DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273 (378)
Q Consensus 195 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 273 (378)
++ .+||+|||++.............+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+....
T Consensus 178 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 178 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp GG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CC-eEEEcccCcCccccccccccCCCCCccccChhhhcc--------ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 55 599999999975544444445567889999999854 567889999999999999998 99999886653
Q ss_pred HHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 274 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
..............+..+++++.+|+.+||..||.+|||+.+++++|..++.....
T Consensus 249 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 249 -ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp -HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred -HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 34444455556677788999999999999999999999999999999999876543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=342.44 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=211.7
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-C
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-L 131 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~ 131 (378)
-.+.|.+.+.||+|+||.||+|++ +++.||||++....... .+.+|+.+++.+ +|+|++++++++.+. .
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC-------CHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccH-------HHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 456799999999999999999985 57999999987654432 367899999999 799999999998654 7
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC----ceeEeccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK----SLKLADFGLA 207 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~----~vkl~Dfg~a 207 (378)
.++||||+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++. .+||+|||++
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 78999999 99999999863 456999999999999999999999999999999999999975432 3999999999
Q ss_pred ccccccc--------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh--HHHHH
Q 017046 208 REETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAY 277 (378)
Q Consensus 208 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~ 277 (378)
....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 230 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcC--------CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence 7543321 1244579999999999864 5688999999999999999999999987432 12222
Q ss_pred HHH----HhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 278 AAA----FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 278 ~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
... .....+.+...+++++.+++.+||+.||.+|||+.++++.|..++..+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 231 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 111 112222234578999999999999999999999999999999998876543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=364.17 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=203.3
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CC
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PL 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 131 (378)
+....|.+.+.||+|+||.||+++. +++.||||++......... ....+.+|+.+++.++||||+++++++.+ +.
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD--EVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC---------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhH--HHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 3456799999999999999999987 4689999999753211111 12357789999999999999999999965 47
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
.++||||++|++|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++...
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEG 299 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCTT
T ss_pred EEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCceec
Confidence 88999999999999999763 579999999999999999999998 9999999999999999665 5999999999753
Q ss_pred c-cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 211 T-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 211 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
. ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....... .. .......+|
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~-i~~~~~~~p 369 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-EL-ILMEEIRFP 369 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH-HHHCCCCCC
T ss_pred cCCCcccccccCCccccCHhhcCC--------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-HH-HHhCCCCCC
Confidence 2 2333456789999999999864 67899999999999999999999999876654332 22 233456678
Q ss_pred CCChHHHHHHHHHccccCCCCCC-----CHHHHHHHHHhhhh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 326 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~l~~~~~ 326 (378)
..+++++.+||.+||..||.+|| ++.++++ +.++.
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~--hp~f~ 409 (446)
T 4ejn_A 370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ--HRFFA 409 (446)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGGT
T ss_pred ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh--Ccccc
Confidence 88999999999999999999999 9999998 44443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=362.06 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=208.8
Q ss_pred ccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 130 (378)
.+..++|.+.+.||+|+||+||+++. +++.||||++.+...... .....+.+|..++..++||||+++++++.+.
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~--~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR--GEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH--GGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhH--HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 35567899999999999999999987 478999999975321111 1112477899999999999999999999765
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla~~~ 212 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKL 212 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhheec
Confidence 688999999999999999763 34799999999999999999999999999999999999999665 5999999999764
Q ss_pred ccccc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh---cCC
Q 017046 211 TVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK---HAR 285 (378)
Q Consensus 211 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---~~~ 285 (378)
..... ....+||+.|+|||++...... .....++.++|||||||++|+|++|..||.+.+........... ...
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~-~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGG-PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTC-TTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred cCCCccccceeccccCcCCHHHHhhcccC-cCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence 43322 2345899999999998631000 00246889999999999999999999999887664433333221 222
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCC---CCHHHHHHHHHhhhh
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLR---PSFSQIIRMLNAFLF 326 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~l~~~~~ 326 (378)
+..+..+++++.+||.+||. +|.+| |++.++++ +.++.
T Consensus 292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~--Hpff~ 332 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT--HPFFF 332 (412)
T ss_dssp C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT--SGGGT
T ss_pred CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc--CCCcC
Confidence 33446799999999999999 99998 59999988 55553
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=348.43 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=208.2
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-C
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-L 131 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~ 131 (378)
-.+.|.+.+.||+|+||+||+|+. +++.||||++....... .+.+|+.+++.+ +||||+++++++.++ .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-------QLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSC-------CHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchH-------HHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 356799999999999999999985 57999999997654432 377999999999 999999999998654 6
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC----ceeEeccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK----SLKLADFGLA 207 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~----~vkl~Dfg~a 207 (378)
.++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.||+||||||+|||++.++. .+||+|||++
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred cEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 78999999 99999999863 467999999999999999999999999999999999999985542 2999999999
Q ss_pred cccccccc--------cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh--HHHHH
Q 017046 208 REETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAY 277 (378)
Q Consensus 208 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~ 277 (378)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~ 229 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--------KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY 229 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcC--------CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH
Confidence 75433221 245689999999999864 6688999999999999999999999987432 22222
Q ss_pred HHHHhcC----CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 278 AAAFKHA----RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 278 ~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
....... ...+...++ ++.+++..||..||.+||++.++++.|..++.....
T Consensus 230 ~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 230 QKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 2221111 111223456 999999999999999999999999999988866543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=341.08 Aligned_cols=258 Identities=29% Similarity=0.508 Sum_probs=211.7
Q ss_pred cceeecceeecccceEEEEEEECC-----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe--cC
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK--DP 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~ 130 (378)
..|.+.+.||+|+||.||+|...+ ..||+|.+........ ...+.+|+.++++++||||+++++++. ++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHH----HHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHH----HHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 458899999999999999998632 3589999876544332 235889999999999999999999863 34
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++||||||+|||++.++ .+||+|||++...
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDM 178 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSCGGGCCC
T ss_pred ceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECcccccccc
Confidence 78899999999999999975 346789999999999999999999999999999999999999655 5999999999754
Q ss_pred cccc-----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 211 TVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 211 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
.... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++ |.+||.+.... ..........
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-~~~~~~~~~~ 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGR 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-THHHHHHTTC
T ss_pred cccchhccccccCCCCCccccChHHhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-HHHHHHhcCC
Confidence 3322 1233467789999999864 568899999999999999999 66777665543 3344445566
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
....+..+++++.+++.+||..||.+|||+.++++.|..++..+..
T Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 6667788999999999999999999999999999999998876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=354.33 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=196.7
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEecC---C
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP---L 131 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~---~ 131 (378)
++|.+++.||+|+||.||+|.+ +++.||||++......... ..++.+|+.++..+. ||||+++++++... .
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD---AQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHH---HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHH---HHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 5799999999999999999987 4789999998765433322 245789999999997 99999999998632 5
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+++...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEESS
T ss_pred EEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCccccccc
Confidence 899999996 599999876 4799999999999999999999999999999999999999665 59999999997432
Q ss_pred c----------------------ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCC
Q 017046 212 V----------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (378)
Q Consensus 212 ~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 269 (378)
. .......+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-------STKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcC-------CCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 1 112344589999999999854 25689999999999999999999999998
Q ss_pred CChHHHHHHHHHhcCCCC---------------------------------------------CCCCChHHHHHHHHHcc
Q 017046 270 MSNLQAAYAAAFKHARPG---------------------------------------------LPEDISPDLAFIVQSCW 304 (378)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~l~~li~~~l 304 (378)
.+..............+. .+..+++++.+||.+||
T Consensus 234 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 776554433321111110 11267889999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 305 VEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 305 ~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
..||.+|||+.++++ +.++....
T Consensus 314 ~~dP~~R~t~~e~l~--Hp~~~~~~ 336 (388)
T 3oz6_A 314 QFNPNKRISANDALK--HPFVSIFH 336 (388)
T ss_dssp CSSGGGSCCHHHHTT--STTTTTTC
T ss_pred ccCcccCCCHHHHhC--CHHHHHhc
Confidence 999999999999999 56655443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=357.53 Aligned_cols=253 Identities=26% Similarity=0.341 Sum_probs=205.1
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec------
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------ 129 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 129 (378)
..|.+.+.||+|+||.||+|++ +++.||||++...... +.+|+++++.++||||+++++++..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh---------HHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 4699999999999999999998 4789999998764322 3479999999999999999998732
Q ss_pred -CCeEEEEeccCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
.++++||||+++ +|.+.+.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++..+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 136799999965 67666543 23467999999999999999999999999999999999999997766789999999
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR- 285 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~- 285 (378)
++............||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+....+...........
T Consensus 204 a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 204 AKQLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276 (420)
T ss_dssp CEECCTTCCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred hhhcccCCCceeeeeCCCcCCHHHHcC-------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 986555544556789999999999854 246889999999999999999999999987765544443321110
Q ss_pred --------------CC------------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 286 --------------PG------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 286 --------------~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
.. ++..+++++.+||.+||..||.+|||+.++++ +.++..+.
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~--hp~f~~~~ 344 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA--HSFFDELR 344 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGGGG
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC--CHhhcccc
Confidence 01 23457899999999999999999999999998 56665543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=344.13 Aligned_cols=249 Identities=30% Similarity=0.457 Sum_probs=206.9
Q ss_pred ceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
.|...+.||+|+||.||+|+.. ++.||||++........ +.+.+|+.+++.++||||+++++++.+ ...++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR-----ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSH-----HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHH-----HHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 3677789999999999999874 78999999986554332 247899999999999999999999864 578999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-c
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-~ 214 (378)
|||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++...... .
T Consensus 121 ~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp ECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSC
T ss_pred EecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCcc
Confidence 999999999998864 4699999999999999999999999999999999999999665 5999999998754332 2
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--CCCC
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDI 292 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~ 292 (378)
......||+.|+|||++.. ..++.++||||||+++|+|++|..||.+....... ........+.+ +..+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~ 267 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISR--------SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-KRLRDSPPPKLKNSHKV 267 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSSCCCCTTGGGS
T ss_pred ccccccCCccccCHhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhcCCCCCcCccccC
Confidence 2345689999999999854 56889999999999999999999999877654433 33333333332 3458
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
++++.+++.+||..||.+|||+.++++ +.++..
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~--hp~~~~ 300 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLD--HPFLLQ 300 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGGG
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc--Chhhcc
Confidence 899999999999999999999999998 455544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=364.53 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=210.3
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
....|.+++.||+|+||.||+|++. ++.||||++........ .....+.+|+.+++.++||||+++++++.+. ..
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSL--DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHT--TTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3457999999999999999999874 78999999975322110 1124688999999999999999999999754 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccchhhccc
Confidence 899999999999999975 45799999999999999999999999999999999999999665 599999999987655
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
.......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||.+..... ....+. ......|..+
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~-~~~~~~p~~~ 239 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKIC-DGIFYTPQYL 239 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTT-------CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-HHHHHH-TTCCCCCTTC
T ss_pred cccccccCCCcCeEChhhccC-------CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-HHHHHh-cCCcCCCccC
Confidence 555566789999999999864 1234679999999999999999999998766533 333332 3345667789
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
++++.+||.+||..||.+|||+.++++
T Consensus 240 s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 240 NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 999999999999999999999999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=343.57 Aligned_cols=255 Identities=28% Similarity=0.469 Sum_probs=206.6
Q ss_pred cCCcceeecceeecccceEEEEEEECC---------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD---------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 125 (378)
+..++|.+.+.||+|+||+||+|++.. ..||+|++....... ...+.+|+.+++.++||||+++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~ 79 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY-----SESFFEAASMMSKLSHKHLVLNYG 79 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGG-----HHHHHHHHHHHHTSCCTTBCCEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHH-----HHHHHHHHHHHHhCCCCCEeEEEE
Confidence 456789999999999999999997642 569999986543322 235889999999999999999999
Q ss_pred eEec-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCc------
Q 017046 126 ACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS------ 198 (378)
Q Consensus 126 ~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~------ 198 (378)
++.+ +..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++..
T Consensus 80 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 80 VCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp EECCTTCCEEEEECCTTCBHHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred EEEeCCCCEEEEECCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 9965 478899999999999999986 33459999999999999999999999999999999999999865432
Q ss_pred -eeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhC-CCCCCCCChHHHH
Q 017046 199 -LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAA 276 (378)
Q Consensus 199 -vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~ 276 (378)
+||+|||++....... ...+++.|+|||++.. ...++.++||||||+++|+|++| .+||..... ...
T Consensus 159 ~~kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~ 227 (289)
T 4fvq_A 159 FIKLSDPGISITVLPKD---ILQERIPWVPPECIEN-------PKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRK 227 (289)
T ss_dssp EEEECCCCSCTTTSCHH---HHHHTTTTSCHHHHHC-------GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHH
T ss_pred eeeeccCcccccccCcc---ccCCcCcccCHHHhCC-------CCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHH
Confidence 9999999986543322 2357889999998853 24688999999999999999995 555555443 222
Q ss_pred HHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 277 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
... ......++...++++.+++.+||+.||.+|||+.+++++|..++...
T Consensus 228 ~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 228 LQF--YEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HHH--HHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred HHH--hhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 222 23455667778899999999999999999999999999999887653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=339.28 Aligned_cols=253 Identities=28% Similarity=0.443 Sum_probs=201.9
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+.+.||+|+||.||+++.. +..||+|++......... ..+.+|+++++.++||||+++++++.+. ..++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM----EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCH----HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhH----HHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 56999999999999999999874 689999998765433222 3578999999999999999999999754 6889
Q ss_pred EEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC--CCceeEecccccccc
Q 017046 135 VTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREE 210 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~--~~~vkl~Dfg~a~~~ 210 (378)
||||+++++|.+++... ....+++..++.++.|++.||.|||+.||+||||||+|||++.+ ...+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999999988653 23679999999999999999999999999999999999999532 345999999999865
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC-CC
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG-LP 289 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~ 289 (378)
..........||+.|+|||++. ..++.++||||||+++|+|++|..||.+.................. ..
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVFK---------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC 248 (285)
T ss_dssp ---------CTTGGGCCHHHHT---------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--
T ss_pred CCcccCcCcccccCcCChHHhc---------cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc
Confidence 5555555668999999999874 4578899999999999999999999998765443333332222221 22
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
..+++++.+|+.+||+.||.+|||+.++++ +.++
T Consensus 249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~f 282 (285)
T 3is5_A 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLH--HEWF 282 (285)
T ss_dssp CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT--SGGG
T ss_pred CcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHh
Confidence 347899999999999999999999999998 4444
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=339.15 Aligned_cols=256 Identities=26% Similarity=0.468 Sum_probs=209.6
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
..++|.+.+.||+|+||.||+|.+. ++.||+|++....... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK--AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--HTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch--hhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 4467999999999999999999875 5689999986533211 11234588999999999999999999999765 68
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++ .++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccccccCCc
Confidence 8999999999999999764 4699999999999999999999999999999999999998665 599999999865433
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
.. .....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+....... . ........+|..+
T Consensus 162 ~~-~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~-~~~~~~~~~~~~~ 230 (279)
T 3fdn_A 162 SR-RTDLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-K-RISRVEFTFPDFV 230 (279)
T ss_dssp -------CCCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-H-HHHHTCCCCCTTS
T ss_pred cc-ccccCCCCCccCHhHhcc--------CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH-H-HHHhCCCCCCCcC
Confidence 22 244578999999999864 56788999999999999999999999876653332 2 2334556677889
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
++++.+|+.+||..||.+|||+.++++ +.++....
T Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~e~l~--h~~~~~~~ 265 (279)
T 3fdn_A 231 TEGARDLISRLLKHNPSQRPMLREVLE--HPWITANS 265 (279)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHH--CHHHHHHC
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhh--CccccCCc
Confidence 999999999999999999999999999 55665543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=351.29 Aligned_cols=245 Identities=23% Similarity=0.390 Sum_probs=201.3
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-Ce
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~ 132 (378)
.+.|.+.+.||+|+||.||++.+. ++.||||++...... ..+|++++.++ +||||+++++++.++ ..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 356999999999999999999874 789999999875432 34678888888 799999999999765 67
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC---ceeEeccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLARE 209 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~---~vkl~Dfg~a~~ 209 (378)
++||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+..+++ .+||+|||++..
T Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 899999999999999875 457999999999999999999999999999999999999854432 499999999975
Q ss_pred cccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCC
Q 017046 210 ETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS--NLQAAYAAAFKHARP 286 (378)
Q Consensus 210 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~ 286 (378)
.... ......+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.. ........+......
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 241 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLER--------QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHH--------HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred CcCCCCceeccCCCccccCHHHhcC--------CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence 4332 23445689999999999864 457889999999999999999999998632 233333333322211
Q ss_pred ---CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 287 ---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 287 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
..+..+++++.+||.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2235689999999999999999999999999993
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=355.92 Aligned_cols=244 Identities=25% Similarity=0.399 Sum_probs=190.0
Q ss_pred cceeec-ceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhh-ccCCCeeeEEeeEec----
Q 017046 58 KLLFIG-SKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR-VKHDNLVKFLGACKD---- 129 (378)
Q Consensus 58 ~~~~~~-~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~l~~~~~~---- 129 (378)
..|.+. +.||+|+||+||++.+. ++.||||++... ..+.+|+.++.+ .+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 456665 78999999999999874 689999999642 135678888754 489999999998753
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC--CCceeEecccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGL 206 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~--~~~vkl~Dfg~ 206 (378)
...++||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+ ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 368899999999999999987444569999999999999999999999999999999999999862 34699999999
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH---HHHHHHHhc
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ---AAYAAAFKH 283 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~~~ 283 (378)
+............+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+..... .....+. .
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~-~ 281 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-M 281 (400)
T ss_dssp CEECC-----------CTTCCGGGSCC--------CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH-H
T ss_pred ccccCCCCccccCCCCCCccCHhhcCC--------CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH-c
Confidence 986655555566789999999999854 678999999999999999999999997654321 0111111 1
Q ss_pred CCCCCC----CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 284 ARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 284 ~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
....++ ..+++++.+||.+||..||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 122222 4689999999999999999999999999994
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=365.37 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=209.2
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+.+.||+|+||+||++++. ++.||||++......... ...+.+|+.+++.++||||+++++++.+. ..++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD---TSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchH---HHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 56999999999999999999874 789999998653221111 13578999999999999999999999765 6889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC--CCceeEecccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETV 212 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~--~~~vkl~Dfg~a~~~~~ 212 (378)
||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.. ...+||+|||++.....
T Consensus 99 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999988763 569999999999999999999999999999999999999632 33599999999986655
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC--C
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--E 290 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~ 290 (378)
.......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+...................+ .
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLR---------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247 (486)
T ss_dssp C----CCTTGGGGCCGGGGG---------SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGG
T ss_pred CCccCCCcCCCCCCCHHHhC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccC
Confidence 55556678999999999985 358899999999999999999999999877654444333332222222 4
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
.+++++.+||.+||..||.+|||+.++++ +.++....
T Consensus 248 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~--hp~~~~~~ 284 (486)
T 3mwu_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQKYS 284 (486)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHHH--CHHHHHTC
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhc--CHhhccCc
Confidence 58899999999999999999999999999 55665543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=338.32 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=208.1
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+.+.||+|+||.||+|.+. +..||+|++........ ..+.+|+.+++.++||||+++++++.+. ..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-----DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCH-----HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchH-----HHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 46999999999999999999885 46899999876544332 3588999999999999999999999765 6889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEE---cCCCCceeEeccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREET 211 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill---~~~~~~vkl~Dfg~a~~~~ 211 (378)
||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||++ +.+ ..++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 84 VMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFK 160 (277)
T ss_dssp EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT-CCEEECCCTTCEECC
T ss_pred EEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCC-CcEEEEecccceecc
Confidence 99999999999998763 469999999999999999999999999999999999999 533 459999999998765
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC-
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE- 290 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 290 (378)
.........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+............ ....++.
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~---------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~ 229 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEG---------LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE--GTFTFPEK 229 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTT---------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCHH
T ss_pred CccchhccCCCCCccChHHhcc---------cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--CCCCCCch
Confidence 5555566789999999998753 478999999999999999999999998776444333322 2233332
Q ss_pred ---CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 291 ---DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 291 ---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.+++++.+++.+||+.||.+|||+.++++ +.++..
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~--h~~~~~ 267 (277)
T 3f3z_A 230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALE--HEWFEK 267 (277)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHHH
T ss_pred hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhc
Confidence 68999999999999999999999999998 444433
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=338.53 Aligned_cols=259 Identities=29% Similarity=0.449 Sum_probs=213.0
Q ss_pred ceeecceeecccceEEEEEEEC--C---eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC--C
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYG--D---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--L 131 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~ 131 (378)
.|.+.+.||+|+||+||+|++. + ..||+|++........ .+.+.+|+.+++.++||||+++++++.+. .
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ----VEAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHH----HHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHH----HHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence 4667899999999999999862 2 3799999876444332 24688999999999999999999998543 4
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||+.+++|.+++.. ....+++..++.++.|++.||.|||++|++||||||+|||++.++ .+||+|||++....
T Consensus 98 ~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDIL 175 (298)
T ss_dssp CEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCTTSSCTTT
T ss_pred cEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcCCCccccc
Confidence 4899999999999999976 346789999999999999999999999999999999999999655 59999999997533
Q ss_pred ccc-----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017046 212 VTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 212 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...................
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--------YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC
T ss_pred CCcccccccCcCCCCCccccChhhhcc--------CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC
Confidence 221 2234467889999999864 568899999999999999999555543333434455555566667
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
..+..+++++.+++.+||..||.+|||+.++++.|..++..+...
T Consensus 248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 778889999999999999999999999999999999998876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=351.99 Aligned_cols=264 Identities=26% Similarity=0.380 Sum_probs=206.1
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
.+.|.+.+.||+|+||.||+|++. ++.||+|++...............+.+|+.+++.++||||+++++++.+. ..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 467999999999999999999874 67899999875422111111234688999999999999999999999755 688
Q ss_pred EEEeccCCCCHHHHHhhhC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 017046 134 IVTELLPGMSLRKYLVSLR--------------------------------------PNKLDLHVALNFALDIARAMDCL 175 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qi~~~l~~l 175 (378)
+||||++||+|.+++.... ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999985210 11246778899999999999999
Q ss_pred HhCCCeeecCCCCcEEEcCCCC-ceeEecccccccccccc-----ccccCcCccccccccccccccccccccccCCCccc
Q 017046 176 HANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 249 (378)
Q Consensus 176 H~~givH~dikp~Nill~~~~~-~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D 249 (378)
|++||+||||||+|||++.++. .+||+|||++....... ......||+.|+|||++.. ....++.++|
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~D 258 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT------TNESYGPKCD 258 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC------SSSCCCTHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc------CCCCCCcHHH
Confidence 9999999999999999985542 59999999997532211 2345579999999999853 2356889999
Q ss_pred chhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC--CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 250 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 250 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
||||||++|+|++|..||.+...................+ ..+++++.+||.+||+.||.+|||+.++++ +.++..
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~--hp~~~~ 336 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ--HPWISQ 336 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH--SHHHHT
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc--Chhhcc
Confidence 9999999999999999999887765554444333332222 247899999999999999999999999999 455544
Q ss_pred c
Q 017046 328 L 328 (378)
Q Consensus 328 ~ 328 (378)
.
T Consensus 337 ~ 337 (345)
T 3hko_A 337 F 337 (345)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=347.28 Aligned_cols=261 Identities=23% Similarity=0.414 Sum_probs=206.3
Q ss_pred cccCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccC--CCeeeEEeeEec
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--DNLVKFLGACKD 129 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~~ 129 (378)
+.+....|.+.+.||+|+||.||++... ++.||||++......... ...+.+|+.++..++| |||+++++++.+
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHH---HHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHH---HHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 4466788999999999999999999874 678999999876544322 2468899999999976 999999999865
Q ss_pred C-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 ~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
+ ..++|||+ .+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++ .+||+|||++.
T Consensus 81 ~~~~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~-~~kl~DFG~a~ 155 (343)
T 3dbq_A 81 DQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIAN 155 (343)
T ss_dssp SSEEEEEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSC
T ss_pred CCEEEEEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC-cEEEeeccccc
Confidence 4 78899995 58899999986 35799999999999999999999999999999999999998 44 59999999997
Q ss_pred cccccc---ccccCcCcccccccccccccccccc---ccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHH-HHH
Q 017046 209 EETVTE---MMTAETGTYRWMAPELYSTVTLRQG---EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-AAF 281 (378)
Q Consensus 209 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~ 281 (378)
...... ......||+.|+|||++........ ....++.++|||||||++|+|++|..||.+......... ...
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 643322 2235579999999999854211100 125678899999999999999999999987655433333 333
Q ss_pred hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
......++...+.++.+|+.+||..||.+|||+.+++++.
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 3455567788889999999999999999999999999943
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=366.57 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=209.8
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-C
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 131 (378)
+..+.|.+.+.||+|+||.||+++. +++.||||++......... ....+.+|+.+++.++||||+++++++.+. .
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~--~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK--GYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhH--HHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 4567899999999999999999987 4789999999753321111 123578999999999999999999998754 7
Q ss_pred eEEEEeccCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
.++||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~~ 338 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVE 338 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeecceeee
Confidence 899999999999999987643 34699999999999999999999999999999999999999665 599999999976
Q ss_pred cccccc-cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCC
Q 017046 210 ETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHAR 285 (378)
Q Consensus 210 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~ 285 (378)
...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .......+ ....
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i-~~~~ 409 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLG--------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQA 409 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH-HHCC
T ss_pred ccCCCcccccccCCccccChhhhcC--------CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH-hhcc
Confidence 543332 334589999999999864 5789999999999999999999999987532 23333333 3455
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 319 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~ 319 (378)
..+|..+++++.+||.+||..||.+||+ +.++++
T Consensus 410 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 6778899999999999999999999996 477877
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=341.03 Aligned_cols=258 Identities=27% Similarity=0.389 Sum_probs=204.3
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
++|.+++.||+|+||+||+|++. ++.||||++........ ....+.+|+.+++.++||||+++++++.+. ..++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV---IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HH---HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchH---HHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 56999999999999999999884 78999999876554332 234688999999999999999999999654 7889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-c
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-T 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~-~ 213 (378)
||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++..... .
T Consensus 80 v~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC---
T ss_pred EEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhccCcc
Confidence 9999999999988765 45699999999999999999999999999999999999999665 599999999976442 2
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC---------
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--------- 284 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------- 284 (378)
.......||+.|+|||++.+ ...++.++||||||+++|+|++|..||.+...............
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVG-------DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp ---------GGGCCHHHHHT-------CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cccCCCcCCccccChHHHhc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 23345578999999998853 25678999999999999999999999998776544433221100
Q ss_pred ----------CCCC----------CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 285 ----------RPGL----------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 285 ----------~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
.... ...+++++.+|+.+||..||.+|||+.++++ +.++..+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~~ 293 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH--HPYFENIRE 293 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT--SGGGTTCC-
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc--ChHHHhccC
Confidence 0000 1357889999999999999999999999999 677766544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=343.24 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=210.2
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHH-HHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
+.|.+.+.||+|+||.||++++. ++.||+|++......... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 46999999999999999999874 789999999875543210 00123588999999999999999999999754 688
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC---ceeEecccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREE 210 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~---~vkl~Dfg~a~~~ 210 (378)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++. .+||+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999999999999975 457899999999999999999999999999999999999986653 5999999999865
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-- 288 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 288 (378)
..........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+......... ... ....+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-i~~-~~~~~~~ 239 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-ITS-VSYDFDE 239 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-HHT-TCCCCCH
T ss_pred CccccccccCCCCCccCcccccC--------CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHh-cccccCh
Confidence 55444456679999999999854 5688999999999999999999999988765443332 222 22222
Q ss_pred --CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 289 --PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 289 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
+..+++.+.+||.+||..||.+|||+.++++ +.++.
T Consensus 240 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~--hp~~~ 277 (321)
T 2a2a_A 240 EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR--HPWIT 277 (321)
T ss_dssp HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH--STTTS
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc--Ccccc
Confidence 2568899999999999999999999999998 44443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=342.39 Aligned_cols=261 Identities=32% Similarity=0.516 Sum_probs=206.6
Q ss_pred ccCCcceeecceeecccceEEEEEEEC---C--eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG---D--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
.+..+.|.+.+.||+|+||.||+|++. + ..||||+++........ ....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE--AMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CH--HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHH--HHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 456678999999999999999999852 2 36999998765432221 2346889999999999999999999998
Q ss_pred cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
++..++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus 92 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~ 169 (291)
T 1u46_A 92 TPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMR 169 (291)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCE
T ss_pred cCCceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEccccccc
Confidence 88899999999999999999763 35699999999999999999999999999999999999998555 59999999987
Q ss_pred cccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 017046 209 EETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 209 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 283 (378)
...... ......+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+..............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 241 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred cccccccchhhhccCCCCceeeCchhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence 543222 1233467888999999864 567889999999999999999 999999877655444444444
Q ss_pred CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.....+..++.++.+++.+||..||.+|||+.+++++|.....
T Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 5566677899999999999999999999999999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=350.27 Aligned_cols=263 Identities=20% Similarity=0.272 Sum_probs=201.9
Q ss_pred cCCcceeecceeecccceEEEEEEE-----CCeeEEEEEeecCCCchHHHH------HHHHHHHHHHHHhhccCCCeeeE
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERAL------LEGRFIREVNMMSRVKHDNLVKF 123 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~l 123 (378)
+...+|.+.+.||+|+||.||+|.+ .+..||||++.........+. ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 3457899999999999999999988 457899999987654322111 11236788899999999999999
Q ss_pred EeeEec-----CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC-C
Q 017046 124 LGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ-K 197 (378)
Q Consensus 124 ~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~-~ 197 (378)
++++.+ ...++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 998854 3688999999 99999999763 3799999999999999999999999999999999999998654 2
Q ss_pred ceeEecccccccccccc--------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCC
Q 017046 198 SLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (378)
Q Consensus 198 ~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 269 (378)
.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--------VALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 59999999997543221 1244579999999999864 5689999999999999999999999965
Q ss_pred CChHHHHHHHHHhcCCCCCC---------CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 270 MSNLQAAYAAAFKHARPGLP---------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
..................++ ..+++++.+++..||..||.+|||+.++++.|+......
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 263 NLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp GTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred cccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 32222222211111112222 278899999999999999999999999999998865543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=348.25 Aligned_cols=246 Identities=27% Similarity=0.427 Sum_probs=195.4
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-----
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 130 (378)
++|.+.+.||+|+||.||+|++ +++.||||++........ .+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA----REKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTH----HHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhH----HHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 4689999999999999999988 478999999986554332 23588999999999999999999987432
Q ss_pred -----------------------------------------------------CeEEEEeccCCCCHHHHHhhhCC-CCC
Q 017046 131 -----------------------------------------------------LMVIVTELLPGMSLRKYLVSLRP-NKL 156 (378)
Q Consensus 131 -----------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~-~~l 156 (378)
..++||||+++++|.+++..... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 27899999999999999976332 235
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-------------ccccCcCcc
Q 017046 157 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-------------MMTAETGTY 223 (378)
Q Consensus 157 ~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~gt~ 223 (378)
++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... ......||+
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 6677899999999999999999999999999999999665 59999999997644321 223457999
Q ss_pred ccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHc
Q 017046 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSC 303 (378)
Q Consensus 224 ~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 303 (378)
.|+|||++.+ ..++.++|||||||++|+|++|..|+.. .............+..+...++++.+|+.+|
T Consensus 241 ~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 241 LYMSPEQIHG--------NNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp GGSCHHHHHC--------CCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHH
T ss_pred CccChHHhcC--------CCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcccccCChhHHHHHHHH
Confidence 9999999864 5789999999999999999998777532 1222222222222222334667889999999
Q ss_pred cccCCCCCCCHHHHHH
Q 017046 304 WVEDPNLRPSFSQIIR 319 (378)
Q Consensus 304 l~~dp~~Rps~~~ll~ 319 (378)
|+.||.+|||+.++++
T Consensus 310 l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 310 LSPSPTERPEATDIIE 325 (332)
T ss_dssp HCSSGGGSCCHHHHHH
T ss_pred ccCCCCcCCCHHHHhh
Confidence 9999999999999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=348.46 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=203.8
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 130 (378)
.+.|.+.+.||+|+||.||+|.+ +++.||||++........ ...++.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL---FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH---HHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHH---HHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 46799999999999999999987 478999999976544332 234688999999999999999999998643
Q ss_pred ---CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 131 ---~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a 175 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLA 175 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred cCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeecc
Confidence 359999999 8899999876 4699999999999999999999999999999999999999665 5999999999
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC-
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP- 286 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~- 286 (378)
+.... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..............+
T Consensus 176 ~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 176 RQADS--EMTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246 (367)
T ss_dssp EECCS--SCCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccc--ccCcCcCCCCcCCHHHHhC-------CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 76433 2345688999999998854 2468899999999999999999999999877654433322111110
Q ss_pred ----------------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 287 ----------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 287 ----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
.+....++++.+|+.+||..||.+|||+.++++ +.++.....+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~--hp~f~~~~~~ 317 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA--HPYFESLHDT 317 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTTC--
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc--ChHHHhhcCC
Confidence 123467899999999999999999999999999 6777665443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=361.68 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=200.2
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCch---HHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCe
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSD---ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLM 132 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 132 (378)
+.|.+.+.||+|+||+||+|.+. ++.||||++....... ........+.+|+.+++.++||||+++++++.++..
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 214 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 214 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSEE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCce
Confidence 56999999999999999999874 6899999987643211 111112247899999999999999999999988888
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC--CceeEecccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREE 210 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~--~~vkl~Dfg~a~~~ 210 (378)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++ ..+||+|||++...
T Consensus 215 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred EEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 999999999999998864 45799999999999999999999999999999999999997433 35999999999876
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-- 288 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 288 (378)
.........+||+.|+|||++... ....++.++|||||||++|+|++|..||.+...................
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp C-----------CTTCCTTTTC---------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred CCCccccccCCCCCccCceeeecC-----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence 655555667899999999998531 1256788999999999999999999999875543333333333222222
Q ss_pred -CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 289 -PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 289 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
...+++.+.+|+.+||+.||.+|||+.++++ +.++
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~ 403 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALR--HPWL 403 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGG
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhC--Cccc
Confidence 2468899999999999999999999999998 4444
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=352.00 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=207.1
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec----
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---- 129 (378)
....|.+++.||+|+||+||+|++ +++.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 456899999999999999999987 5789999998765432 2379999999999999999998732
Q ss_pred -----------------------------------CCeEEEEeccCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHH
Q 017046 130 -----------------------------------PLMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAM 172 (378)
Q Consensus 130 -----------------------------------~~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l 172 (378)
...++||||++ ++|.+.+.. .....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 13789999997 588877754 2356799999999999999999
Q ss_pred HHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchh
Q 017046 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 252 (378)
Q Consensus 173 ~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diws 252 (378)
.|||++||+||||||+|||++.+++.+||+|||++.............+|+.|+|||++.+ ...++.++||||
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Diws 227 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG-------ATEYTPSIDLWS 227 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT-------CSSCCTHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC-------CCCCCcchhhhh
Confidence 9999999999999999999985555799999999987655555566788999999998864 245899999999
Q ss_pred hhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC---------------------------CCCCCChHHHHHHHHHccc
Q 017046 253 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP---------------------------GLPEDISPDLAFIVQSCWV 305 (378)
Q Consensus 253 lG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~ 305 (378)
|||++|+|++|..||.+....+...........+ .++..+++++.+||.+||.
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 9999999999999999877765554443221111 1355688999999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhhhcc
Q 017046 306 EDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 306 ~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
.||.+|||+.++++ +.++..+
T Consensus 308 ~dP~~R~t~~e~l~--hp~f~~~ 328 (383)
T 3eb0_A 308 YEPDLRINPYEAMA--HPFFDHL 328 (383)
T ss_dssp SSGGGSCCHHHHHT--SGGGHHH
T ss_pred CChhhCCCHHHHhc--CHHHHHH
Confidence 99999999999998 5555443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=346.74 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=202.0
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+++.||+|+||+||+|+.. ++.||||++........ ...+.+|+.+++.++||||+++++++.++ ..++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc----chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence 46999999999999999999874 78999999875443221 11355799999999999999999999654 7899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
||||++ ++|.+++.. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++......
T Consensus 78 v~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPT 154 (324)
T ss_dssp EEECCS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEECC----
T ss_pred Eecccc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCc
Confidence 999996 599998876 345799999999999999999999999999999999999999665 5999999998754422
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC---C---
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP---G--- 287 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~--- 287 (378)
.......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+................+ .
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp --------CGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccCcccccChhhhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence 22344578999999998854 2467899999999999999999999999877654433332211111 0
Q ss_pred ----------------------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 017046 288 ----------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 333 (378)
Q Consensus 288 ----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 333 (378)
....+++++.+||.+||+.||.+|||+.++++ +.++........
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~~~~~ 293 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK--HPFFLSLGERIH 293 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGGGGCSTTS
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc--Chhhhhcccccc
Confidence 11346889999999999999999999999999 677776654443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=353.98 Aligned_cols=258 Identities=29% Similarity=0.509 Sum_probs=205.5
Q ss_pred cceeecceeecccceEEEEEEEC--C---eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe--cC
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--D---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK--DP 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~ 130 (378)
..|.+.+.||+|+||+||+|.+. + ..||+|.+........ ..++.+|+.+++.++||||+++++++. ++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHH----HHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHH----HHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence 34788899999999999999762 2 4689999876444332 246889999999999999999999864 34
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDM 242 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC------
T ss_pred CeEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEeeccccccc
Confidence 78899999999999999975 345689999999999999999999999999999999999999655 5999999999754
Q ss_pred cccc-----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 211 TVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 211 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
.... ......+++.|+|||++.. ..++.++|||||||++|+|++ |.+||.+....+ .........
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-~~~~~~~~~ 313 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR 313 (373)
T ss_dssp ---------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-HHHHHHTTC
T ss_pred cccccccccccCCCCCcccccChHHhcC--------CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-HHHHHHcCC
Confidence 3221 1223457789999999864 678899999999999999999 788887765433 233444556
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
....|..+++.+.+++.+||..||.+|||+.++++.|..++..+..
T Consensus 314 ~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 314 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 6667788999999999999999999999999999999999877653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=336.89 Aligned_cols=253 Identities=29% Similarity=0.525 Sum_probs=210.4
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec----
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---- 129 (378)
+...|.+.+.||+|+||.||+|.+. +..||+|++......... ...+.+|+.+++.++||||+++++++.+
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH---HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHH---HHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 4556889999999999999999874 578999999865544332 3468899999999999999999998753
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCcEEEcCCCCceeEecccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~g--ivH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
...++||||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++||||||+|||++.+.+.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred CceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 3578999999999999999763 56899999999999999999999999 999999999999984445699999999
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR- 285 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~- 285 (378)
+...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+................
T Consensus 179 ~~~~~~~-~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (290)
T 1t4h_A 179 ATLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 248 (290)
T ss_dssp GGGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred ccccccc-ccccccCCcCcCCHHHHh---------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc
Confidence 9654332 234457999999999874 35889999999999999999999999987766666555544333
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
..++...++++.+++.+||..||.+|||+.++++ +.++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~f 286 (290)
T 1t4h_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFF 286 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGG
T ss_pred cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh--Cccc
Confidence 2345667899999999999999999999999998 4444
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=348.25 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=207.5
Q ss_pred cCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
.....|.+.+.||+|+||.||+|++. ++.||||++........ ..+.+|+.+++.++||||+++++++.+ +..
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI-----EEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHH-----HHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHH-----HHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34567999999999999999999875 68999999876544322 358899999999999999999999864 478
Q ss_pred EEEEeccCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+|||++.++ .+||+|||++...
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFGISKKG 189 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence 999999999999999865332 3589999999999999999999999999999999999999655 5999999998753
Q ss_pred ccc---cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH-----HHHHHHHh
Q 017046 211 TVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ-----AAYAAAFK 282 (378)
Q Consensus 211 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~ 282 (378)
... .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+..... ........
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIK--------GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHH--------CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ccccccccccccCCCccccCHHHhcC--------CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 221 12234468999999999864 568899999999999999999999997543211 10000110
Q ss_pred cC------CC----CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 283 HA------RP----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 283 ~~------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
.. .+ .++...+..+.+++.+||+.||.+|||+.+++++|+.++...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 00 11 122335677999999999999999999999999999887653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=343.27 Aligned_cols=254 Identities=27% Similarity=0.490 Sum_probs=198.3
Q ss_pred CcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhh--ccCCCeeeEEeeEec-----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR--VKHDNLVKFLGACKD----- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~l~~~~~~----- 129 (378)
.++|.+.+.||+|+||+||+|+++++.||||++.... . ..+.+|.+++.. ++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~-----~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---E-----KSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG---H-----HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc---c-----hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 4679999999999999999999999999999986531 1 235567777766 799999999998642
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeeecCCCCcEEEcCCCCceeE
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH--------ANGIIHRDLKPDNLLLTPDQKSLKL 201 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH--------~~givH~dikp~Nill~~~~~~vkl 201 (378)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.||+||||||+|||++.++ .+||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl 154 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCI 154 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEE
T ss_pred ceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEE
Confidence 257899999999999999954 57999999999999999999999 99999999999999999665 5999
Q ss_pred eccccccccccccc-----cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhC----------CCC
Q 017046 202 ADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN----------RLP 266 (378)
Q Consensus 202 ~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g----------~~p 266 (378)
+|||++........ .....||+.|+|||++.+... .....++.++|||||||++|+|++| ..|
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQ--VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCC--TTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCC--CCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 99999865332221 233479999999999865110 0001455789999999999999999 888
Q ss_pred CCCCCh----HHHHHHHH-HhcCCCCCCC-----CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 267 FEGMSN----LQAAYAAA-FKHARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 267 f~~~~~----~~~~~~~~-~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
|..... ........ .....+.++. .+++++.+|+.+||+.||.+|||+.++++.|..+
T Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 865322 12222211 1223333332 2567899999999999999999999999998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=361.33 Aligned_cols=252 Identities=29% Similarity=0.398 Sum_probs=198.0
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC---
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 130 (378)
..++|.+++.||+|+||+||+|++ +++.||||++........ ...++.+|+.+++.++||||+++++++.+.
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT---HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHH---HHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChH---HHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 356799999999999999999987 478999999986533222 234688999999999999999999998543
Q ss_pred ----CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 131 ----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 131 ----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEEe
Confidence 36899999965 5766664 2489999999999999999999999999999999999999665 599999999
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
++...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..............+
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred eeecCCCcccCCCcccccccCHHHHcC--------CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 987665555566789999999999865 578999999999999999999999999877654443332211111
Q ss_pred --------------------CC---------CCC-----------ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 287 --------------------GL---------PED-----------ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 287 --------------------~~---------~~~-----------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.. +.. .++++.+||.+||..||.+|||+.|+++ +.++.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~~~ 360 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ--HPYIN 360 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTG
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc--Chhhh
Confidence 00 000 1577999999999999999999999999 44543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=364.23 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=203.3
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+++.||+|+||+||+|++. +..||+|++......... ...+.+|+.+++.++||||+++++++.+. ..++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS---NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT---THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH---HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 36999999999999999999884 689999999865432211 23578999999999999999999999765 6889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC--CCceeEecccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETV 212 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~--~~~vkl~Dfg~a~~~~~ 212 (378)
||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.. ...+||+|||++.....
T Consensus 114 v~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999999999988763 569999999999999999999999999999999999999753 23599999999987665
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--CC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PE 290 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~ 290 (378)
.......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+................... ..
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLR---------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK 262 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT
T ss_pred CccccccCCCcCeeCHHHHc---------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc
Confidence 55556678999999999874 45889999999999999999999999987764443333322222222 24
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.+++++.+||.+||..||.+|||+.+++++
T Consensus 263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 689999999999999999999999999983
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=337.31 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=197.8
Q ss_pred ccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 130 (378)
.+..++|.+.+.||+|+||+||++++ +++.||+|++......... ...+.++...++.++||||+++++++.++
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~ 79 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ---KRLLMDLDISMRTVDCPFTVTFYGALFREG 79 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHH---HHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHH---HHHHHHHHHHHHhCCCCeEEEEeeeeeccC
Confidence 35567899999999999999999998 6799999999765443332 22344555667888999999999998654
Q ss_pred CeEEEEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
..++||||++ ++|.+++... ....+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++
T Consensus 80 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~ 157 (290)
T 3fme_A 80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGIS 157 (290)
T ss_dssp SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC---
T ss_pred CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCc
Confidence 7899999996 5888877542 346799999999999999999999998 999999999999999655 5999999999
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
.............||+.|+|||++... .....++.++||||||+++|+|++|..||..................+.
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPE----LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 233 (290)
T ss_dssp ------------CCCCCCSCHHHHSCC----TTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC
T ss_pred ccccccccccccCCCccccChhhcChh----hcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC
Confidence 765555444556799999999997321 0135688899999999999999999999987554444444444444444
Q ss_pred CC-CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 288 LP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 288 ~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.+ ..+++++.+++.+||+.||.+|||+.++++ +.++.
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~--hp~f~ 271 (290)
T 3fme_A 234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ--HPFFT 271 (290)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--SHHHH
T ss_pred cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh--Ccccc
Confidence 43 568999999999999999999999999999 44443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=364.65 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=208.6
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchH--------HHHHHHHHHHHHHHHhhccCCCeeeEEee
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDE--------RALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 126 (378)
.+.|.++++||+|+||+||+|+.. ++.||||++........ .......+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 356999999999999999999874 68999999986543221 01123468899999999999999999999
Q ss_pred EecC-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC--ceeEec
Q 017046 127 CKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLAD 203 (378)
Q Consensus 127 ~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~--~vkl~D 203 (378)
+.++ ..++||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 9765 688999999999999998763 56999999999999999999999999999999999999986553 599999
Q ss_pred cccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017046 204 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 283 (378)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+........... .
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-~- 261 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK---------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE-K- 261 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-H-
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhc---------cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-c-
Confidence 99998766555556678999999999874 358899999999999999999999999876644333332 2
Q ss_pred CCCCCC----CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 284 ARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 284 ~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
....++ ..+++++.+||.+||..||.+|||+.++++ +.++...
T Consensus 262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~ 308 (504)
T 3q5i_A 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN--SRWIKKY 308 (504)
T ss_dssp CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHHT
T ss_pred CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc--CHhhhhc
Confidence 222222 568999999999999999999999999999 4555543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=349.83 Aligned_cols=261 Identities=23% Similarity=0.424 Sum_probs=206.2
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc--CCCeeeEEeeEe
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--HDNLVKFLGACK 128 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~ 128 (378)
...+....|.+++.||+|+||.||++... ++.||||++......... ...+.+|+.+++.++ ||||+++++++.
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHH---HHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHH---HHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 34456678999999999999999999875 688999999876543322 246889999999996 599999999886
Q ss_pred c-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 129 D-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 129 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
+ ...++||| +.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++ .+||+|||++
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~-~~kl~DFG~a 201 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIA 201 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS-CEEECCCSSS
T ss_pred cCCEEEEEEe-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC-eEEEEecCcc
Confidence 5 46889999 458899999986 34789999999999999999999999999999999999996 44 5999999999
Q ss_pred ccccccc---ccccCcCccccccccccccccccc---cccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017046 208 REETVTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 208 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 281 (378)
....... .....+||+.|+|||++....... .....++.++|||||||++|+|++|..||.+............
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~ 281 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281 (390)
T ss_dssp CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence 7643322 234567999999999986421100 0123688899999999999999999999987654433333332
Q ss_pred -hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 282 -KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 282 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
......++...+.++.+||.+||..||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 344456677788999999999999999999999999984
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=340.75 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=206.8
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec--
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-- 129 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-- 129 (378)
.....|.+.+.||+|+||.||+|++ .++.||||++....... ..+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE------EEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT------HHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH------HHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 4567899999999999999999998 57899999997654332 2477999999999 79999999999853
Q ss_pred -----CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecc
Q 017046 130 -----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 130 -----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Df 204 (378)
...++||||+++++|.+++.......+++..++.++.||+.||.|||+.|++|+||||+|||++.++ .+||+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Df 173 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDF 173 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeC
Confidence 4688999999999999999875556799999999999999999999999999999999999999655 5999999
Q ss_pred ccccccccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017046 205 GLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 205 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 283 (378)
|++...... .......|++.|+|||++.... .....++.++|||||||++|+|++|..||.+..............
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp TTTC-------------CCGGGCCHHHHC-----------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred cCceecCcCccccccccCCccccChhhhcccc---ccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 998754322 2233457899999999985311 113568899999999999999999999998877655544443333
Q ss_pred CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.....+..+++.+.+||.+||..||.+|||+.++++ +.++..
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--hp~~~~ 292 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK--HPFIRD 292 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT--SHHHHC
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh--ChHHhh
Confidence 333345678999999999999999999999999998 445543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=357.46 Aligned_cols=257 Identities=28% Similarity=0.398 Sum_probs=190.0
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 129 (378)
.++|.+++.||+|+||+||+|++ +++.||||++......... ..++.+|+.+|+.++||||+++++++..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID---CKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHH---HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHH---HHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 46899999999999999999976 4689999999765443322 3468899999999999999999999832
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
...|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+++
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCB
T ss_pred CceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-CEeecccccch
Confidence 3589999998 6799999875 45799999999999999999999999999999999999999665 59999999997
Q ss_pred ccccc----------------------------cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHH
Q 017046 209 EETVT----------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260 (378)
Q Consensus 209 ~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~l 260 (378)
..... ......+||+.|+|||++.. ...++.++|||||||++|||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-------QENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHH
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC-------CCCCCcHhHHHHHHHHHHHH
Confidence 54321 12344578999999998643 25689999999999999999
Q ss_pred Hh-----------CCCCCCCCChH--------------------HHHHHHHH----------------------hcCC--
Q 017046 261 LT-----------NRLPFEGMSNL--------------------QAAYAAAF----------------------KHAR-- 285 (378)
Q Consensus 261 l~-----------g~~pf~~~~~~--------------------~~~~~~~~----------------------~~~~-- 285 (378)
++ |.++|.+.... ........ ....
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 98 67777664310 00000000 0000
Q ss_pred -----CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 286 -----PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 286 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
......+++++.+||.+||..||.+|||+.++++ +.++....
T Consensus 358 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~--Hp~f~~~~ 404 (458)
T 3rp9_A 358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA--HPFFKEVR 404 (458)
T ss_dssp CCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTTC
T ss_pred CCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc--CHhhhhcC
Confidence 0012346899999999999999999999999999 77776654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=345.47 Aligned_cols=258 Identities=19% Similarity=0.328 Sum_probs=206.3
Q ss_pred cceeec-ceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-Ce
Q 017046 58 KLLFIG-SKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 58 ~~~~~~-~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~ 132 (378)
..|.+. +.||+|+||.||+++.. ++.||+|++......... ...+.+|+.++..+ +||||+++++++.+. ..
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC---RAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH---HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 346666 89999999999999875 789999998764433321 13578999999999 579999999999754 68
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC--CCCceeEecccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAREE 210 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~--~~~~vkl~Dfg~a~~~ 210 (378)
++||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++. +.+.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 89999999999999986655567999999999999999999999999999999999999985 1345999999999876
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc--CCCCC
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH--ARPGL 288 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~ 288 (378)
..........||+.|+|||++.. ..++.++||||||+++|+|++|..||.+.............. .....
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 256 (327)
T 3lm5_A 185 GHACELREIMGTPEYLAPEILNY--------DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256 (327)
T ss_dssp ---------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred CCccccccccCCcCccCCeeecC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh
Confidence 55555556689999999999864 678899999999999999999999998877655444333222 22233
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
...+++.+.+||.+||..||.+|||+.++++ +.++...
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~--h~~~~~~ 294 (327)
T 3lm5_A 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLS--HSWLQQW 294 (327)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--CGGGCCC
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhC--CHhhccc
Confidence 4568999999999999999999999999998 5555443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=337.09 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=208.1
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE-e-cCCe
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-K-DPLM 132 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~-~~~~ 132 (378)
.+.|.+.+.||+|+||.||+|++ +++.||||++....... .+.+|+.+++.++|++++..+..+ . +...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC-------HHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh-------HHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 46799999999999999999985 57999999987655433 377999999999988877766655 3 4467
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEc--CCCCceeEecccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLAREE 210 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~--~~~~~vkl~Dfg~a~~~ 210 (378)
++||||+ +++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++ .+++.+||+|||++...
T Consensus 81 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEec-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 8999999 9999999975 345799999999999999999999999999999999999994 23446999999999754
Q ss_pred ccccc--------cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh------HHHH
Q 017046 211 TVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN------LQAA 276 (378)
Q Consensus 211 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~ 276 (378)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred cccccccccccccccccccccccCChhhhcC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence 33221 245579999999999864 5688999999999999999999999986432 1111
Q ss_pred HHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 277 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
.........+.++..+++++.+++.+||+.||.+|||+.++++.|+.++.....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 122222222223467899999999999999999999999999999999877654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=343.06 Aligned_cols=248 Identities=27% Similarity=0.371 Sum_probs=197.6
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-CCeE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~ 133 (378)
+.|.+.++||+|+||+||+|++. ++.||||++.......... .++..|+..+..+ +||||+++++++.+ +..+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR---ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH---HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 57999999999999999999884 7899999987654443322 2455666666655 89999999999965 4788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||+ +++|.+++... ...+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++......
T Consensus 134 lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-CEEECCCTTCEECC--
T ss_pred EEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEccceeeeecccC
Confidence 999999 77999988764 45799999999999999999999999999999999999998665 5999999999876555
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCCh
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (378)
.......||+.|+|||++. ..++.++|||||||++|+|++|..|+.+..... ........+.++..++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 278 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQ---------GSYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAGLS 278 (311)
T ss_dssp ----CCCCCGGGCCGGGGG---------TCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTTCCCHHHHTTSC
T ss_pred CCCcccCCCccccCHhHhc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhccCCCcccccCCC
Confidence 5555667999999999874 357889999999999999999977665432211 1111122233456789
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
+++.+++.+||+.||.+|||+.++++ +.++
T Consensus 279 ~~l~~li~~~L~~dP~~Rpt~~ell~--hp~~ 308 (311)
T 3p1a_A 279 SELRSVLVMMLEPDPKLRATAEALLA--LPVL 308 (311)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHT--SGGG
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh--Cccc
Confidence 99999999999999999999999998 4444
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=337.22 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=207.8
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec------
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------ 129 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 129 (378)
..|.+.+.||+|+||.||+|++. ++.||+|++..... .+.+|+.+++.++||||+++++++.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---------KAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG---------GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH---------HHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 46899999999999999999985 78999999976432 35689999999999999999998743
Q ss_pred -----------CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCc
Q 017046 130 -----------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (378)
Q Consensus 130 -----------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~ 198 (378)
...++||||+++++|.+++.......+++..++.++.|++.||.|||++||+|+||||+|||++.++ .
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~ 160 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-Q 160 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-E
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-C
Confidence 2478999999999999999875556799999999999999999999999999999999999999554 5
Q ss_pred eeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHH
Q 017046 199 LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (378)
Q Consensus 199 vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 278 (378)
+||+|||++.............|++.|+|||++.. ..++.++||||||+++|+|++|..||... .....
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS--------QDYGKEVDLYALGLILAELLHVCDTAFET---SKFFT 229 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC--------SCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHH
T ss_pred EEECcchhheeccccccccccCCcccccChhhhcc--------CCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHH
Confidence 99999999876555444456679999999999864 56889999999999999999999887532 11222
Q ss_pred HHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 279 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
.. ....++..++.++.+++.+||..||.+|||+.+++++|+.+....+
T Consensus 230 ~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 230 DL---RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HH---HTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred Hh---hcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 22 2234567789999999999999999999999999999988766543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=349.82 Aligned_cols=258 Identities=25% Similarity=0.332 Sum_probs=205.5
Q ss_pred CcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 130 (378)
...|.+.+.||+|+||+||+|++. +..||+|++...... ..+|+.+++.++||||+++++++...
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 356999999999999999999884 566999988754432 23799999999999999999988421
Q ss_pred --CeEEEEeccCCCCHHHHHhh-hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 131 --LMVIVTELLPGMSLRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 131 --~~~lv~e~~~~~sL~~~l~~-~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
..++||||++++.+...... .....+++..++.++.||+.||.|||++||+||||||+|||++...+.+||+|||++
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 27799999976443333221 234679999999999999999999999999999999999999854556999999999
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC-
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP- 286 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~- 286 (378)
+............||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..............+
T Consensus 190 ~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 190 KILIAGEPNVSYICSRYYRAPELIFG-------ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp EECCTTCCCCSSCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccCCCCCcccccCcCccCHHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 87655555566789999999998854 2458999999999999999999999999887655544433211110
Q ss_pred --------------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 287 --------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 287 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
.++..+++++.+||.+||..||.+|||+.++++ +.++..+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~~~~ 332 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC--HPFFDELRTGE 332 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT--SGGGSTTTSSC
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc--Chhhhhhcccc
Confidence 123458899999999999999999999999998 67776665443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=344.04 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=199.7
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
....|.+.+.||+|+||+||+|++ +++.||||++........ ....+.+|+.+++.++||||+++++++.++ ..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG---VPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccc---cchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 345799999999999999999976 478999999976544332 224577999999999999999999999654 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC----CCCceeEecccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP----DQKSLKLADFGLAR 208 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~----~~~~vkl~Dfg~a~ 208 (378)
++||||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +...+||+|||++.
T Consensus 109 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 89999996 599999976 346999999999999999999999999999999999999953 23359999999997
Q ss_pred ccccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 209 EETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 209 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
..... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+................+.
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLG-------SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258 (329)
T ss_dssp HHC-----------CCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccCCcccccCCCcCCccccCHHHhcC-------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence 54322 22344578999999999864 24578999999999999999999999998777655544433221111
Q ss_pred C----------------------------CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 288 L----------------------------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 288 ~----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
. +..+++++.+||.+||..||.+|||+.++++ +.++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~ 324 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE--HPYFSH 324 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGSS
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC--CcccCC
Confidence 0 0116789999999999999999999999998 555544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=342.88 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=212.3
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
....|.+.+.||+|+||.||++++. ++.||+|++......... ....+.+|+.+++.++||||+++++++.+. ..
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH--QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHH--HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 3467999999999999999999875 678999998765433222 234688999999999999999999999765 68
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEY 193 (335)
T ss_dssp EEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-CEEEeeccCceeccc
Confidence 8999999999999998763 5699999999999999999999999999999999999999665 599999999975432
Q ss_pred -ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 017046 213 -TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291 (378)
Q Consensus 213 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (378)
........|++.|+|||++.. ..++.++||||||+++|+|++|..||........... .......++..
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~ 263 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR--IKKNEYSIPKH 263 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHT--------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--HHHTCCCCCTT
T ss_pred CcccccccCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH--HhcCCCCCCcc
Confidence 222345579999999999864 5678899999999999999999999987665433322 23345567788
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+++++.+||.+||..||.+|||+.++++ +.++..
T Consensus 264 ~~~~~~~li~~~l~~dp~~Rps~~ell~--~~~~~~ 297 (335)
T 2owb_A 264 INPVAASLIQKMLQTDPTARPTINELLN--DEFFTS 297 (335)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc--CccccC
Confidence 9999999999999999999999999998 444443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=364.69 Aligned_cols=257 Identities=24% Similarity=0.418 Sum_probs=212.0
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
.+.|.+.+.||+|+||.||+++. +++.||||++.......... ...+.+|+.+++.++||||+++++++.+. ..+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC--HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH--HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35799999999999999999987 47899999997654322111 13588999999999999999999999764 788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC--CCCceeEeccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAREET 211 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~--~~~~vkl~Dfg~a~~~~ 211 (378)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ....+||+|||++....
T Consensus 103 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 99999999999999875 457999999999999999999999999999999999999952 33469999999997655
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC--
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP-- 289 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 289 (378)
........+||+.|+|||++. ..++.++|||||||++|+|++|..||.+...................+
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 251 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLH---------GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHH---------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG
T ss_pred cccccccCCCCccccCceeec---------CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 555555668999999999884 358899999999999999999999999877655444333332222222
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
..+++++.+||.+||..||.+|||+.++++ +.++...
T Consensus 252 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--h~~~~~~ 288 (484)
T 3nyv_A 252 KKVSESAKDLIRKMLTYVPSMRISARDALD--HEWIQTY 288 (484)
T ss_dssp GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SHHHHHH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhh--Chhhccc
Confidence 468999999999999999999999999999 4555443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=345.50 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=209.4
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCc---hHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-C
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTS---DERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-P 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~ 130 (378)
..|.+.+.||+|+||.||+|++. ++.||||++...... .........+.+|+.+++.+ +||||+++++++.. .
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 46899999999999999999874 789999999765422 22233345688999999999 79999999999865 4
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||++|++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++ .++|+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEEecCccccc
Confidence 788999999999999999763 4699999999999999999999999999999999999999665 5999999999866
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-- 288 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 288 (378)
..........||+.|+|||++.+... .....++.++|||||||++|+|++|..||.+...................
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMD--ETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTC--TTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CCCcccccCCCCCCccChhhcccccc--ccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 55555566789999999998854210 01235788999999999999999999999876654433322222222111
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
...+++++.++|.+||..||.+|||+.++++
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1467889999999999999999999999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=335.16 Aligned_cols=254 Identities=25% Similarity=0.409 Sum_probs=210.8
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
..+.|.+.+.||+|+||.||+|+.. ++.||+|++........ .....+.+|+.+++.++||||+++++++.+. ..
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE--GVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHT--TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchH--HHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 4467999999999999999999874 68899999875322111 1124588999999999999999999999754 68
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTTCEECSS
T ss_pred EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccccccCcc
Confidence 8999999999999999763 4699999999999999999999999999999999999999665 599999999865433
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
. ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||........... .......+|..+
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~ 235 (284)
T 2vgo_A 167 L-RRRTMCGTLDYLPPEMIEG--------KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR--IVNVDLKFPPFL 235 (284)
T ss_dssp S-CBCCCCSCGGGCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--HHTTCCCCCTTS
T ss_pred c-ccccccCCCCcCCHHHhcc--------CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH--HhccccCCCCcC
Confidence 2 2245579999999999864 5678899999999999999999999987665443222 234456677889
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+.++.+++.+||..||.+|||+.++++ +.++..
T Consensus 236 ~~~~~~li~~~l~~~p~~Rps~~~ll~--h~~~~~ 268 (284)
T 2vgo_A 236 SDGSKDLISKLLRYHPPQRLPLKGVME--HPWVKA 268 (284)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT--CHHHHH
T ss_pred CHHHHHHHHHHhhcCHhhCCCHHHHhh--CHHHHh
Confidence 999999999999999999999999998 344443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=335.91 Aligned_cols=266 Identities=24% Similarity=0.393 Sum_probs=203.0
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
....|.+.+.||+|+||.||+|.. +++.||||++......... ....+.+|+.+++.++||||+++++++.+ +..
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK--ARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 446799999999999999999986 4789999999764433222 23468899999999999999999999864 578
Q ss_pred EEEEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
++||||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++...
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEeccceeee
Confidence 8999999999999998652 345699999999999999999999999999999999999999665 5999999998754
Q ss_pred cccc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCC
Q 017046 211 TVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPGL 288 (378)
Q Consensus 211 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~ 288 (378)
.... ......|++.|+|||++.. ..++.++||||||+++|+|++|..||.+... .............+..
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 258 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 258 (310)
T ss_dssp ------------CCSSCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC
T ss_pred cCCCccccccCCCeeEeChHHhCC--------CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC
Confidence 3322 2234578999999998864 5688899999999999999999999976432 2223333333333333
Q ss_pred -CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 289 -PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 289 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
+..+++++.+++.+||..||.+|||+.++++.|+.+.....++.
T Consensus 259 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 259 PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 35689999999999999999999999999999999987766544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=334.68 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=212.5
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
....|.+.+.||+|+||.||++++. ++.||+|++......... ....+.+|+.+++.++||||+++++++.+. ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH--QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHH--HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHH--HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 3467999999999999999999885 688999998765433222 234688999999999999999999999755 67
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-CEEEEeccCceeccc
Confidence 8999999999999998763 4699999999999999999999999999999999999999665 599999999875432
Q ss_pred -ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCC
Q 017046 213 -TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291 (378)
Q Consensus 213 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (378)
........|++.|+|||.+.. ..++.++||||||+++|+|++|..||.+......... .......++..
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~ 237 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR--IKKNEYSIPKH 237 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTT--------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--HHTTCCCCCTT
T ss_pred CccccccccCCCCcCCcchhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HhhccCCCccc
Confidence 222344578999999999854 5678899999999999999999999987665443222 23445567788
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+++.+.+++.+||..||.+|||+.++++ +.++..
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rps~~~ll~--~~~~~~ 271 (294)
T 2rku_A 238 INPVAASLIQKMLQTDPTARPTINELLN--DEFFTS 271 (294)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHT
T ss_pred cCHHHHHHHHHHcccChhhCcCHHHHhh--Chheec
Confidence 9999999999999999999999999999 445544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=338.75 Aligned_cols=260 Identities=26% Similarity=0.379 Sum_probs=202.7
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
...|.+.+.||+|+||.||++++ .++.||+|++........ .....+.+|+.+++.++||||+++++++.+ +..+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDP--VFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCH--HHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 46799999999999999999987 478999999976543322 223468899999999999999999999864 5788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccCcccccc
Confidence 999999999999999863 4699999999999999999999999999999999999999665 5999999998754332
Q ss_pred c--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--CCCC
Q 017046 214 E--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--PGLP 289 (378)
Q Consensus 214 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~ 289 (378)
. ......|++.|+|||++.. ..++.++||||||+++|+|++|..||.+.... ........... ...+
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 258 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSE--------SHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVR 258 (309)
T ss_dssp ---------CCGGGCCGGGTCC------------CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTS
T ss_pred ccccccccCCCcCccCHHHHcC--------CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccC
Confidence 2 2234578999999999864 56788999999999999999999999876543 22222222111 1345
Q ss_pred CCChHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhhhccCC
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~~~~~~~~ 330 (378)
..+++++.+++.+||..||.+|| ++.++++.|+.++.....
T Consensus 259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 67899999999999999999999 999999999988766543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=345.34 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=203.3
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCch---HHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCCe
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSD---ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLM 132 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 132 (378)
+.|.+.+.||+|+||.||+|++. ++.||||++....... ........+.+|+.+++.++||||+++++++.++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 89 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence 46999999999999999999874 6899999987643211 111112347899999999999999999999988889
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC--ceeEecccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLAREE 210 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~--~vkl~Dfg~a~~~ 210 (378)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||++...
T Consensus 90 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 999999999999998875 457999999999999999999999999999999999999985432 4999999999865
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC---C
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP---G 287 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~ 287 (378)
..........||+.|+|||++... ....++.++|||||||++|+|++|..||................... .
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHT-----TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred ccccccccccCCcCccCchhhccC-----CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 544444455789999999987421 12567889999999999999999999997654432222222222222 1
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+..++.++.+|+.+||..||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 23568899999999999999999999999997
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=350.64 Aligned_cols=247 Identities=23% Similarity=0.384 Sum_probs=204.9
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHH---HHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-C
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER---ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 131 (378)
+.|.+.+.||+|+||.||+|++ +++.||||++......... ......+.+|+.+++.++||||+++++++.+. .
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 5699999999999999999976 5789999999876532210 00012366899999999999999999999755 6
Q ss_pred eEEEEeccCCC-CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 132 MVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 132 ~~lv~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
.++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-cEEEeecccceEC
Confidence 78999999766 99999875 45699999999999999999999999999999999999999665 5999999999876
Q ss_pred ccccccccCcCccccccccccccccccccccccC-CCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
..........||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||...... .......+
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~ 244 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMG--------NPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEAAIHPP 244 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTT--------CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------TTTCCCCS
T ss_pred CCCCceeccCCCccccChhhhcC--------CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------HhhccCCC
Confidence 55555556689999999999864 333 78899999999999999999999764321 22334456
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
..+++++.+||.+||..||.+|||+.++++ +.++
T Consensus 245 ~~~~~~l~~li~~~L~~dP~~Rps~~ell~--hp~~ 278 (335)
T 3dls_A 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVT--DPWV 278 (335)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHH--CTTT
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc--Cccc
Confidence 678999999999999999999999999999 4444
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=335.73 Aligned_cols=248 Identities=29% Similarity=0.477 Sum_probs=211.0
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
.+.|.+.+.||+|+||.||+|+. .++.||||++......... ..+.+|+.+++.++||||+++++++.+ ...+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI----EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTH----HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHH----HHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 35699999999999999999987 4789999999876544322 358899999999999999999999864 4788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||+++++|.+++.. +.+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++......
T Consensus 97 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTT
T ss_pred EEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccceecCcc
Confidence 99999999999999864 5799999999999999999999999999999999999999665 5999999999754332
Q ss_pred c-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
. ......|++.|+|||++.. ..++.++||||||+++|+|++|..||........ .........+.++..+
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 243 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIELARGEPPHSELHPMKV-LFLIPKNNPPTLEGNY 243 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCCCCSSC
T ss_pred ccccCccCCCcCccCHHHHhc--------CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH-HHHhhcCCCCCCcccc
Confidence 2 2345578999999999864 5678899999999999999999999987665443 3344455666778889
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
+..+.+|+.+||..||.+|||+.+++++.
T Consensus 244 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 244 SKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 99999999999999999999999999843
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=339.64 Aligned_cols=251 Identities=20% Similarity=0.328 Sum_probs=205.0
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec--
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-- 129 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-- 129 (378)
...+.|.+++.||+|+||+||+|++ +++.||||++..... ..+.+|+.+++.++ ||||+++++++.+
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--------KKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH--------HHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch--------HHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 3457899999999999999999976 578999999874331 24789999999997 9999999999975
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
...++||||+.+++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++..+||+|||++.
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 367899999999999998853 89999999999999999999999999999999999999777679999999998
Q ss_pred ccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH-------
Q 017046 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF------- 281 (378)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~------- 281 (378)
............|++.|+|||++.. ...++.++|||||||++|+|++|..||..............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~ 252 (330)
T 3nsz_A 180 FYHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252 (330)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred EcCCCCccccccccccccChhhhcC-------CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCch
Confidence 6655555566789999999999853 25688999999999999999999999954433222111110
Q ss_pred -----hcCC------------------------CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 282 -----KHAR------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 282 -----~~~~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.... ...+..+++++.+||.+||..||.+|||+.++++ +.++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~--hp~f~~ 325 (330)
T 3nsz_A 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME--HPYFYT 325 (330)
T ss_dssp HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT--SGGGTT
T ss_pred hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc--CccHhh
Confidence 0111 1112237899999999999999999999999999 566554
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=335.49 Aligned_cols=260 Identities=24% Similarity=0.407 Sum_probs=208.7
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe---cCCe
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK---DPLM 132 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~---~~~~ 132 (378)
..|.+++.||+|+||.||++.+ +++.||+|++........ ......+.+|+.+++.++||||+++++++. ....
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI-PNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc-chhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 5689999999999999999987 468999999875322110 011246889999999999999999999883 2378
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||++++ |.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeeccccccccCc
Confidence 9999999775 88888776667899999999999999999999999999999999999999665 599999999875432
Q ss_pred ---ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 213 ---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 213 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
........|++.|+|||++.+. ...++.++||||||+++|+|++|..||.+..... .... .......++
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~-i~~~~~~~~ 233 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGL------DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-LFEN-IGKGSYAIP 233 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCC------SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH-HHHCCCCCC
T ss_pred cccccccccCCCCCCCcChhhccCc------ccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHH-HhcCCCCCC
Confidence 2223355799999999988541 1334779999999999999999999998765433 2332 233455677
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
..+++++.+++.+||..||.+|||+.++++ +.++....+
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~~~~ 272 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ--HSWFRKKHP 272 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH--SHHHHSCCC
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhc--CcccccCCC
Confidence 889999999999999999999999999998 455554433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=354.41 Aligned_cols=267 Identities=27% Similarity=0.415 Sum_probs=211.1
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC---
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 130 (378)
....|.+.+.||+|+||+||+|++. ++.||||++......... ..+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV----DVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCH----HHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchH----HHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 4567999999999999999999885 789999999764433222 3477999999999999999999998643
Q ss_pred CeEEEEeccCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEE----cCCCCceeEeccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL----TPDQKSLKLADFG 205 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill----~~~~~~vkl~Dfg 205 (378)
..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||+ + +...+||+|||
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG 161 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED-GQSVYKLTDFG 161 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTT-SCEEEEECCGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCC-CceeEEEecCC
Confidence 57899999999999999976332 239999999999999999999999999999999999998 4 33459999999
Q ss_pred cccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC---hHHHHHHHHHh
Q 017046 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS---NLQAAYAAAFK 282 (378)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~ 282 (378)
++.............||+.|+|||++............++.++|||||||++|+|++|..||.... ...........
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 998766555556678999999999886422211112467789999999999999999999996432 12233333333
Q ss_pred cCCCC------------------------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 283 HARPG------------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 283 ~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
..++. ++..++..+.+++.+||..||.+|||+.++++.+..++..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 32211 1123556789999999999999999999999999888743
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=342.61 Aligned_cols=265 Identities=23% Similarity=0.318 Sum_probs=207.4
Q ss_pred cccccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+.+.++.+.|.+.+.||+|+||.||+++. .++.||||++...... ....+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ-----DREEAQREADMHRLFNHPNILRLVAYCL 96 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHH-----HHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHH-----HHHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence 34557788999999999999999999986 5789999998764322 1245889999999999999999999885
Q ss_pred c-----CCeEEEEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeE
Q 017046 129 D-----PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 201 (378)
Q Consensus 129 ~-----~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl 201 (378)
+ ...++||||+++++|.+++... ....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||
T Consensus 97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~kl 175 (317)
T 2buj_A 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVL 175 (317)
T ss_dssp EEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEE
T ss_pred eccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEEE
Confidence 2 2678999999999999998763 345699999999999999999999999999999999999998665 5999
Q ss_pred ecccccccccccc----------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 017046 202 ADFGLAREETVTE----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (378)
Q Consensus 202 ~Dfg~a~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 271 (378)
+|||++....... ......||+.|+|||++... ....++.++||||||+++|+|++|..||....
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 250 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ-----SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC-----SEEEECTHHHHHHHHHHHHHHHHSSCTTHHHH
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccC-----CCcCCCchhhHHHHHHHHHHHHhCCCChhhhh
Confidence 9999886532211 11233579999999998541 11346889999999999999999999995311
Q ss_pred hH-HHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 272 NL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 272 ~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.. ...............+..+++++.+++.+||..||.+|||+.+++++|..+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 251 QKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred cccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 10 01111222233334456789999999999999999999999999999987643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=334.58 Aligned_cols=245 Identities=20% Similarity=0.309 Sum_probs=204.9
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-CCeE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~ 133 (378)
..|.+.+.||+|+||.||+|++. ++.||||++......... ...+.+|+..+..+ +||||+++++++.+ +..+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD---EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH---HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH---HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 56899999999999999999884 789999999876544332 23578999999999 89999999999864 5788
Q ss_pred EEEeccCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC---------------
Q 017046 134 IVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--------------- 196 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~--------------- 196 (378)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999999997632 25689999999999999999999999999999999999998432
Q ss_pred ---CceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH
Q 017046 197 ---KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (378)
Q Consensus 197 ---~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 273 (378)
..+||+|||++...... ....||+.|+|||++.. ...++.++|||||||++|+|++|.+|+.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~- 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQE-------NYTHLPKADIFALALTVVCAAGAEPLPRNGDQ- 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTT-------CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred CCceEEEEcccccccccCCc---cccCCCccccChhHhcC-------CCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence 35999999998765433 23468999999999864 23566799999999999999999987765432
Q ss_pred HHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 274 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.........+.++..+++++.+++.+||..||.+|||+.++++
T Consensus 237 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 3344556667788899999999999999999999999999998
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=336.01 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=209.5
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe---cCC
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK---DPL 131 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~---~~~ 131 (378)
.++|.+.+.||+|+||.||+++. +++.||+|++......... ...+.+|+.+++.++||||+++++++. +..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE---KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHH---HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHH---HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 46799999999999999999987 4789999999876544332 346889999999999999999999874 346
Q ss_pred eEEEEeccCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CeeecCCCCcEEEcCCCCceeEecc
Q 017046 132 MVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANG-----IIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~g-----ivH~dikp~Nill~~~~~~vkl~Df 204 (378)
.++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.| ++||||||+||+++.++ .+||+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~df 160 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF 160 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CEEEecC
Confidence 899999999999999997632 345999999999999999999999999 99999999999999655 5999999
Q ss_pred cccccccccc-ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017046 205 GLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 205 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 283 (378)
|++....... ......|++.|+|||++.. ..++.++||||||+++|+|++|..||..... ..........
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~i~~~ 231 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIREG 231 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHC--------C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHT
T ss_pred chheeeccccccccccCCCccccChHHhcc--------CCCCchhhHHHHHHHHHHHHHCCCCCcccCH-HHHHHHHhhc
Confidence 9987543221 1233468999999999864 5678999999999999999999999988765 3344445556
Q ss_pred CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 017046 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321 (378)
Q Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 321 (378)
..+.++..+++++.+++.+||..||.+|||+.++++++
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 66678888999999999999999999999999999844
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=343.62 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=199.8
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-----CCCeeeEEeeEec
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-----HDNLVKFLGACKD 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~l~~~~~~ 129 (378)
...|.+.++||+|+||+||+|++ +++.||||++..... ....+..|+.+++.+. ||||+++++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK------YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH------HHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh------hhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 46799999999999999999998 578999999974221 1234678999999986 9999999999864
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC--------------
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP-------------- 194 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~-------------- 194 (378)
...++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 5788999999 999999998866567999999999999999999999999999999999999974
Q ss_pred ----------CCCceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCC
Q 017046 195 ----------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 264 (378)
Q Consensus 195 ----------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~ 264 (378)
....+||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN--------LGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC--------CCCCCccchHHHHHHHHHHHHCC
Confidence 244699999999975433 2345679999999999865 56899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCC------------------------CCC--------------------CCChHHHHHHH
Q 017046 265 LPFEGMSNLQAAYAAAFKHARP------------------------GLP--------------------EDISPDLAFIV 300 (378)
Q Consensus 265 ~pf~~~~~~~~~~~~~~~~~~~------------------------~~~--------------------~~~~~~l~~li 300 (378)
.||.+................. .+| ...++.+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 9998866544332221111000 011 11236788999
Q ss_pred HHccccCCCCCCCHHHHHH
Q 017046 301 QSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 301 ~~~l~~dp~~Rps~~~ll~ 319 (378)
.+||+.||.+|||+.++++
T Consensus 337 ~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCChhhCCCHHHHhc
Confidence 9999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=351.43 Aligned_cols=259 Identities=29% Similarity=0.380 Sum_probs=200.5
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 129 (378)
.++|.+.+.||+|+||.||+|++. ++.||||++......... ..++.+|+.+++.++||||+++++++..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID---CKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHH---HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHH---HHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 567999999999999999999874 689999999765443322 3468899999999999999999999854
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
...++||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~~kL~DFGla~ 177 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLAR 177 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred CCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-CEEEccCCCcc
Confidence 35899999995 699999975 45699999999999999999999999999999999999999665 59999999997
Q ss_pred cccccc-----------------------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhC--
Q 017046 209 EETVTE-----------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-- 263 (378)
Q Consensus 209 ~~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g-- 263 (378)
...... .....+||+.|+|||++.. ...++.++|||||||++|+|++|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-------QENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc-------CCCCCcccccchHHHHHHHHHhccc
Confidence 543321 2356689999999998643 25689999999999999999984
Q ss_pred ---------CCCCCCCCh-----------------HHHHHHH----------------------HHhcCCCCC-------
Q 017046 264 ---------RLPFEGMSN-----------------LQAAYAA----------------------AFKHARPGL------- 288 (378)
Q Consensus 264 ---------~~pf~~~~~-----------------~~~~~~~----------------------~~~~~~~~~------- 288 (378)
.++|.+... ....... .........
T Consensus 251 p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (432)
T 3n9x_A 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK 330 (432)
T ss_dssp TTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred ccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH
Confidence 444444321 0110000 001111111
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
...+++++.+||.+||..||.+|||+.++++ +.++.....+
T Consensus 331 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~~~ 371 (432)
T 3n9x_A 331 YPSISDDGINLLESMLKFNPNKRITIDQALD--HPYLKDVRKK 371 (432)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--CGGGTTTCCT
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc--ChhhhhccCc
Confidence 1458899999999999999999999999999 6777665443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=342.87 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=194.5
Q ss_pred cccccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeE
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGAC 127 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~ 127 (378)
+.+.+....|.+.+.||+|+||.||++++ +++.||||++....... ...+.+|+.++..+. ||||+++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK-----NRAIIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHH-----HHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHH-----HHHHHHHHHHHHHhccCCChhhccccc
Confidence 44556677899999999999999999998 57899999986543222 235889999999995 99999999988
Q ss_pred e--------c-CCeEEEEeccCCCCHHHHHhhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCcEEEcCC
Q 017046 128 K--------D-PLMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPD 195 (378)
Q Consensus 128 ~--------~-~~~~lv~e~~~~~sL~~~l~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~g--ivH~dikp~Nill~~~ 195 (378)
. + ...+++|||+. |+|.+++... ....+++..++.++.||+.||.|||+.| |+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT
T ss_pred cccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC
Confidence 3 1 13789999995 7999988652 3456999999999999999999999999 9999999999999966
Q ss_pred CCceeEeccccccccccccc-------------cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh
Q 017046 196 QKSLKLADFGLAREETVTEM-------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262 (378)
Q Consensus 196 ~~~vkl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~ 262 (378)
+ .+||+|||++........ .....||+.|+|||++... ....++.++|||||||++|+|++
T Consensus 175 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~~Dv~slG~il~el~~ 248 (337)
T 3ll6_A 175 G-TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-----SNFPIGEKQDIWALGCILYLLCF 248 (337)
T ss_dssp S-CEEBCCCTTCBCCSSCC-------------------------------CC-----TTSCSSHHHHHHHHHHHHHHHHH
T ss_pred C-CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-----ccCCCChHHhHHHHHHHHHHHHh
Confidence 5 599999999975433211 1144689999999988321 13567889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 263 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 263 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
|..||.+..... ..........+...+..+.+|+.+||+.||.+|||+.+++++|+.+......
T Consensus 249 g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 249 RQHPFEDGAKLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp SSCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCCcchhHHH----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 999997644322 1222233344566778899999999999999999999999999998876543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=332.41 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=213.6
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCC----chHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGST----SDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~ 129 (378)
.+.|.+.+.||+|+||.||++++ +++.||||++..... ..........+.+|+.+++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46799999999999999999988 468999999976542 1222334457889999999995 9999999999975
Q ss_pred C-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 ~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
. ..++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEEEecccchh
Confidence 4 688999999999999999863 5699999999999999999999999999999999999999665 59999999998
Q ss_pred ccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC
Q 017046 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288 (378)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 288 (378)
............|++.|+|||++..... .....++.++||||||+++|+|++|..||.+...................
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMN--DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHC--TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hcCCCcccccccCCccccCHHHhccccc--cccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 6655555556689999999998853211 01246788999999999999999999999877654433332222222222
Q ss_pred C--CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 289 P--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 289 ~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+ ..++.++.+++.+||..||.+|||+.++++ +.++..
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~ 289 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--HPFFQQ 289 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGGCT
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHh--ChHhhh
Confidence 2 358899999999999999999999999998 555543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=334.77 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=202.9
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHH-HHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
+.|.+.+.||+|+||.||+++.. ++.||+|++......... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46899999999999999999885 789999998875433210 00123588999999999999999999999754 688
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC---ceeEecccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREE 210 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~---~vkl~Dfg~a~~~ 210 (378)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++. .+||+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999763 46999999999999999999999999999999999999986542 5999999999865
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCC--
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-- 288 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 288 (378)
..........|++.|+|||++.. ..++.++||||||+++|+|++|..||.+........... .....+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~ 232 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS--AVNYDFDE 232 (283)
T ss_dssp C--------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCH
T ss_pred cCCCcccccCCCcCccCcceecC--------CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH--hcccCCcc
Confidence 55444455679999999998854 568899999999999999999999998876544332222 122222
Q ss_pred --CCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 289 --PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 289 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+..+++.+.+++.+||..||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 233 EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 2568899999999999999999999999998
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.73 Aligned_cols=244 Identities=25% Similarity=0.418 Sum_probs=181.9
Q ss_pred ceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEecC-CeEEEEecc
Q 017046 64 SKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-LMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~-~~~lv~e~~ 139 (378)
+.||+|+||.||++++. ++.||||++.... ...+.+|+.+++.+. ||||+++++++.++ ..++||||+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG--------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhh--------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 78999999999999874 6899999997531 124678999999996 99999999999765 688999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC--ceeEeccccccccccc-ccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLAREETVT-EMM 216 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~--~vkl~Dfg~a~~~~~~-~~~ 216 (378)
+|++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++. .+||+|||++...... ...
T Consensus 89 ~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 89 NGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp CSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 99999999986 357999999999999999999999999999999999999985442 5999999999754332 233
Q ss_pred ccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh------HHHHHHHHHhcCCCCCC-
Q 017046 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN------LQAAYAAAFKHARPGLP- 289 (378)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~~~- 289 (378)
...+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+... ......... .....++
T Consensus 167 ~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~-~~~~~~~~ 237 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQ--------NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK-KGDFSFEG 237 (325)
T ss_dssp -------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT-TTCCCCCS
T ss_pred cccCCCcCccCHHHhcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH-cCCCCCCc
Confidence 45578999999999854 6688999999999999999999999986432 122222222 2222232
Q ss_pred ---CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 290 ---EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 290 ---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
..+++++.+||.+||..||.+|||+.++++ +.++...
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--h~w~~~~ 277 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY--NEWLQDG 277 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT--CGGGCTT
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc--ChhhccC
Confidence 258899999999999999999999999988 5666543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=346.59 Aligned_cols=251 Identities=29% Similarity=0.392 Sum_probs=193.0
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 130 (378)
.+.|.+++.||+|+||.||+|.+ .++.||||++......... ...+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH---AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHH---HHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHH---HHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 46799999999999999999987 4789999999865443322 24688999999999999999999998543
Q ss_pred ---CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 131 ---~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
..++||||++ ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 101 ~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a 174 (371)
T 2xrw_A 101 EFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA 174 (371)
T ss_dssp TCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC-
T ss_pred cccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEeecc
Confidence 4689999996 47888875 3589999999999999999999999999999999999999665 5999999999
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC---
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--- 284 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--- 284 (378)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.............
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 246 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246 (371)
T ss_dssp ---------------CTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCC
T ss_pred cccccccccCCceecCCccCHHHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 86655444456689999999999864 5688999999999999999999999998766443332221100
Q ss_pred -----------------CCCC--------------CC------CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 285 -----------------RPGL--------------PE------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 285 -----------------~~~~--------------~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.+.+ |. ..++++.+||.+||..||.+|||+.++++ +.++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~ 323 (371)
T 2xrw_A 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ--HPYIN 323 (371)
T ss_dssp HHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHH
T ss_pred HHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC--Ccchh
Confidence 1111 10 12678999999999999999999999999 44443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=332.85 Aligned_cols=255 Identities=26% Similarity=0.434 Sum_probs=201.4
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
....|.+.+.||+|+||.||+|++. ++.||||++....... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRS--LDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccc--hhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 4467999999999999999999874 7899999987532111 11124588999999999999999999998654 68
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeecccccccCC
Confidence 8999999999999999763 4689999999999999999999999999999999999999665 599999999987655
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
........+++.|+|||.+.+ ....+.++||||||+++|+|++|..||.+..... .... .......+|..+
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~-~~~~~~~~~~~~ 234 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-LFKK-IRGGVFYIPEYL 234 (276)
T ss_dssp -------------CCTGGGTT-------SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH-HHHCCCCCCTTS
T ss_pred CcceecccCCccccCHHHHcC-------CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHH-hhcCcccCchhc
Confidence 544455678999999999864 1223678999999999999999999998765433 2332 234455677889
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
+.++.+++.+||..||.+|||+.++++ +.++.
T Consensus 235 ~~~l~~li~~~l~~~p~~Rps~~~~l~--h~~~~ 266 (276)
T 2h6d_A 235 NRSVATLLMHMLQVDPLKRATIKDIRE--HEWFK 266 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHh--Chhhc
Confidence 999999999999999999999999999 44444
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=345.36 Aligned_cols=256 Identities=20% Similarity=0.266 Sum_probs=207.6
Q ss_pred CcceeecceeecccceEEEEEEEC----------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeee----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG----------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK---- 122 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~---- 122 (378)
.+.|.+.+.||+|+||.||+|++. ++.||||++.... .+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~----------~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG----------RLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS----------THHHHHHHHHHHCCHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc----------hHHHHHHHHHHhcccchhhhhhh
Confidence 578999999999999999999874 5789999997641 3679999999999999887
Q ss_pred -----------EEeeEe--cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCc
Q 017046 123 -----------FLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189 (378)
Q Consensus 123 -----------l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~N 189 (378)
+++++. +...++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 455554 45789999999 9999999987544679999999999999999999999999999999999
Q ss_pred EEEcCCC-CceeEecccccccccccc--------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHH
Q 017046 190 LLLTPDQ-KSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260 (378)
Q Consensus 190 ill~~~~-~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~l 260 (378)
||++.++ ..+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 261 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--------CGPSRRSDLQSLGYCMLKW 261 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHH
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--------CCCCchhhHHHHHHHHHHH
Confidence 9999654 169999999997543322 1233479999999999864 5688999999999999999
Q ss_pred HhCCCCCCCCC-hHHHHHHHH--HhcCCCCCCC------CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 261 LTNRLPFEGMS-NLQAAYAAA--FKHARPGLPE------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 261 l~g~~pf~~~~-~~~~~~~~~--~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
++|..||.+.. ......... .......++. .+++++.+|+.+||..||.+|||+.++++.|..++......
T Consensus 262 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 262 LYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp HHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 99999998754 222222221 1222232222 46899999999999999999999999999999998876543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=335.29 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=203.5
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE-e-cCCe
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-K-DPLM 132 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~-~~~~ 132 (378)
.+.|.+.+.||+|+||+||+|++ .++.||||++....... .+.+|+.+++.++|++++..+..+ . +...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC-------CHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch-------HHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 35799999999999999999985 57899999876544332 367899999999988877766655 3 4467
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEE---cCCCCceeEeccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQKSLKLADFGLARE 209 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill---~~~~~~vkl~Dfg~a~~ 209 (378)
++||||+ +++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||+ +.+ +.+||+|||++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEECC-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGT-TCEEECCCTTCEE
T ss_pred EEEEEcc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCC-CeEEEecCcccee
Confidence 8999999 9999999975 34579999999999999999999999999999999999999 534 4599999999975
Q ss_pred ccccc--------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH------HH
Q 017046 210 ETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL------QA 275 (378)
Q Consensus 210 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~ 275 (378)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 229 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 229 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcC--------CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhh
Confidence 43322 1234579999999999864 56889999999999999999999999764321 11
Q ss_pred HHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 276 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
............+...+++++.+++..||+.||.+|||+.++++.|+.++.....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 230 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 1122222222223367899999999999999999999999999999999877654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=337.23 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=200.1
Q ss_pred cceeec-ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec-CCe
Q 017046 58 KLLFIG-SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 58 ~~~~~~-~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~ 132 (378)
+.|.+. +.||+|+||.||++++ +++.||||++........ .++.+|+.++.++ +||||+++++++.+ +..
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR-----SRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCH-----HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhH-----HHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 457774 7899999999999986 478999999976543322 3578999999985 79999999999965 478
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC--ceeEecccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLAREE 210 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~--~vkl~Dfg~a~~~ 210 (378)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999999999763 46999999999999999999999999999999999999986543 3999999998653
Q ss_pred ccc--------cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH---------
Q 017046 211 TVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL--------- 273 (378)
Q Consensus 211 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------- 273 (378)
... ......+||+.|+|||++..... ....++.++|||||||++|+|++|..||.+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE---EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSH---HHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccc---cccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 221 11223469999999999853110 1145788999999999999999999999865421
Q ss_pred -----HHHHHHHHhcCCCCCC----CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 274 -----QAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 274 -----~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
...... .......++ ..+++++.+|+.+||..||.+|||+.++++ +.++...
T Consensus 242 ~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~~~~ 302 (316)
T 2ac3_A 242 CPACQNMLFES-IQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ--HPWVQGC 302 (316)
T ss_dssp CHHHHHHHHHH-HHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--STTCC--
T ss_pred chhHHHHHHHH-HhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc--ChhhcCC
Confidence 112222 223333444 358899999999999999999999999999 5666543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=344.87 Aligned_cols=250 Identities=23% Similarity=0.396 Sum_probs=204.5
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CC
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PL 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 131 (378)
+..+.|.+.+.||+|+||.||++++. ++.||+|++........ ...+.+|+.+++.++||||+++++++.+ +.
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI----RNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHH----HHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHH----HHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 44567999999999999999999985 78999999987644332 3468899999999999999999999865 47
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
.++||||++|++|.+++... ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++ .+||+|||++...
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL 182 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHH
T ss_pred EEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCccc
Confidence 88999999999999999763 4699999999999999999999996 999999999999999665 5999999998654
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHH--------------
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-------------- 276 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------------- 276 (378)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 183 ~~~-~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3eqc_A 183 IDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253 (360)
T ss_dssp HHH-C----CCCCTTCCHHHHTT--------CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred ccc-cccCCCCCCCeECHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence 322 2345589999999999864 56889999999999999999999999865542211
Q ss_pred ---------------------------HHHHHhcCCCCCC-CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 277 ---------------------------YAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 277 ---------------------------~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.........+..+ ..++.++.+||.+||..||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1112222233333 3478999999999999999999999999993
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=337.47 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=208.5
Q ss_pred CcceeecceeecccceEEEEEEE---CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc---cCCCeeeEEeeEe--
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACK-- 128 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~-- 128 (378)
.+.|.+.+.||+|+||.||+|++ .++.||+|++.......... ..+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC---chhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 46799999999999999999987 36889999987543221100 1255677777666 8999999999885
Q ss_pred ----cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecc
Q 017046 129 ----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 129 ----~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Df 204 (378)
....++||||+. ++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Df 164 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADF 164 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecC
Confidence 236789999996 6999999876556799999999999999999999999999999999999999665 5999999
Q ss_pred ccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017046 205 GLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 205 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
|++.............|++.|+|||++.. ..++.++||||||+++|+|++|..||.+...............
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccccccCCCCccccccccceeCHHHHhc--------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 99987655555556789999999999864 5688999999999999999999999998776544433322111
Q ss_pred C-------------------------CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 285 R-------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 285 ~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
. ..+...++..+.+|+.+||..||.+|||+.++++ +.++.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~~~~ 305 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--HPYFQDLER 305 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGTTCCC
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc--Cccccccch
Confidence 0 1133568899999999999999999999999998 666655543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=334.82 Aligned_cols=250 Identities=24% Similarity=0.414 Sum_probs=204.6
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+.+.||+|+||.||+++.. ++.||+|++........ ..+.+|+.+++.++||||+++++++.+. ..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD-----SSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccch-----HHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 56899999999999999999874 78999999986543221 3478999999999999999999998754 6789
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEE---cCCCCceeEeccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREET 211 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill---~~~~~~vkl~Dfg~a~~~~ 211 (378)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++ + ++..++|+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~-~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 84 VMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE-ENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSS-TTCCEEBCSCSTTCCCC
T ss_pred EEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCC-CCCCEEEccCCcceecC
Confidence 99999999999998763 468999999999999999999999999999999999999 4 34469999999987543
Q ss_pred cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC---CCCC
Q 017046 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA---RPGL 288 (378)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---~~~~ 288 (378)
.. ......|++.|+|||++.. ..++.++||||||+++|+|++|..||.+...... ........ ....
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~ 230 (304)
T 2jam_A 161 NG-IMSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-FEKIKEGYYEFESPF 230 (304)
T ss_dssp CB-TTHHHHSCCCBCCTTTBSS--------CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHCCCCCCTTT
T ss_pred CC-ccccccCCCCccChHHhcc--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcCCCCCCccc
Confidence 32 2234468999999999864 5688999999999999999999999987665433 33322222 2234
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+..+++++.+++.+||..||.+|||+.++++ +.++..
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~ 267 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALS--HPWIDG 267 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHHHHS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CccccC
Confidence 4678999999999999999999999999998 445544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=367.36 Aligned_cols=261 Identities=28% Similarity=0.530 Sum_probs=218.0
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEee
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 126 (378)
...+..+.|.+.+.||+|+||.||+|.+. +..||||++....... ..+.+.+|+.+++.++||||++++++
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS----VREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHH----HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHH----HHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34456678999999999999999999873 3579999987644332 23468899999999999999999999
Q ss_pred EecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 127 CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 127 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
+.++..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 460 ~~~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG~ 537 (656)
T 2j0j_A 460 ITENPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGL 537 (656)
T ss_dssp ECSSSCEEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCC
T ss_pred EecCceEEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecCC
Confidence 988889999999999999999976 345699999999999999999999999999999999999999655 599999999
Q ss_pred ccccccccc--cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 017046 207 AREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 207 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 283 (378)
+........ .....+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+....+ ........
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~~~i~~~ 608 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENG 608 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHHT
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcC--------CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHcC
Confidence 976433221 223456789999999864 578899999999999999997 999999876643 44445556
Q ss_pred CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
..+..+..+++++.+++.+||..||.+|||+.++++.|..++..
T Consensus 609 ~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 609 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 67778889999999999999999999999999999999987643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=336.16 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=188.1
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
.+.|.+.+.||+|+||.||+|+. .++.||||++........ ....++.+|+.+++.++||||+++++++.+. ..+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKA--GMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT--TCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhh--hHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 45799999999999999999986 578999999865321111 1124588999999999999999999999765 678
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTCEECC--
T ss_pred EEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecceeeccCC
Confidence 99999999999999976 345799999999999999999999999999999999999999665 5999999998754322
Q ss_pred -cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 214 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
.......||+.|+|||.+.. ..++.++||||||+++|+|++|..||........... ........|..+
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATR--------SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK--VVLADYEMPSFL 235 (278)
T ss_dssp ----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------CCSSCCCCCTTS
T ss_pred CCcceeccCCCCcCCcchhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH--HhhcccCCcccc
Confidence 22234578999999998864 5678899999999999999999999987554322211 122334567778
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
+.++.+++.+||..||.+|||+.++++ +.++.
T Consensus 236 ~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~ 267 (278)
T 3cok_A 236 SIEAKDLIHQLLRRNPADRLSLSSVLD--HPFMS 267 (278)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTT--STTTC
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhc--Ccccc
Confidence 999999999999999999999999988 44443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=342.42 Aligned_cols=254 Identities=28% Similarity=0.383 Sum_probs=205.9
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 130 (378)
...|.+++.||+|+||.||+|++ +++.||||++........ ..++.+|+.++..++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY----CQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHH----HHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHH----HHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 46799999999999999999987 478999999975443322 24688999999999999999999988532
Q ss_pred --CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 131 --LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 131 --~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
..++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~ 176 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLAR 176 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred cceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcceE
Confidence 5789999996 599999875 4699999999999999999999999999999999999999665 49999999997
Q ss_pred ccccccc----cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017046 209 EETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 209 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
....... .....||+.|+|||++.. ...++.++|||||||++|+|++|..||.+...............
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 249 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHT-------BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcC-------CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence 5443322 234589999999998753 24578999999999999999999999988765443333221111
Q ss_pred CC-----------------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 285 RP-----------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 285 ~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
.+ .+...+++++.+||.+||..||.+|||+.++++ +.++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~~~~~ 320 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA--HPYLEQY 320 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGTTT
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--Ccchhhc
Confidence 10 012457899999999999999999999999999 6666554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=331.69 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=205.3
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+.+.||+|+||.||+|+.. ++.||+|++........ ...+.+|+.+++.++||||+++++++.++ ..++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC----PENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTH----HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhh----hHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 46899999999999999999874 78999999976543332 23578999999999999999999998654 6789
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 83 FLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETT
T ss_pred EEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCc
Confidence 9999999999998864 35699999999999999999999999999999999999999655 5999999998754322
Q ss_pred --cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCCCC
Q 017046 214 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLPE 290 (378)
Q Consensus 214 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 290 (378)
.......|++.|+|||.+.. ...++.++||||||+++|+|++|..||................. ......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTC-------SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGG
T ss_pred chhcccCCccccCccChHHHhc-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchh
Confidence 22345679999999999854 12246789999999999999999999987655333333322221 122234
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.+++++.+++.+||..||.+|||+.++++ +.++..
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~ 267 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIKK--DRWYNK 267 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTTC
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHhc--CccccC
Confidence 68899999999999999999999999988 444443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=338.81 Aligned_cols=258 Identities=28% Similarity=0.386 Sum_probs=206.2
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 129 (378)
.+.|.+.+.||+|+||.||+|++. ++.||||++........ ..++.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF----ALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchH----HHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 467999999999999999999875 78999999975433222 2357899999999999999999998753
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
...++||||+. ++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~ 160 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLAR 160 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred cceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEEeccccc
Confidence 46799999996 699999876 4699999999999999999999999999999999999999665 59999999987
Q ss_pred cccccc-----------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHH
Q 017046 209 EETVTE-----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (378)
Q Consensus 209 ~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 277 (378)
...... ......||+.|+|||++.. ...++.++|||||||++|+|++|..||.+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 233 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHS-------CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeecc-------CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 543211 1223478999999998743 2568889999999999999999999998876544332
Q ss_pred HHHHhcCCC----------------------C--------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 278 AAAFKHARP----------------------G--------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 278 ~~~~~~~~~----------------------~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
........+ . ....+++++.+||.+||..||.+|||+.++++ +.++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~ 311 (353)
T 2b9h_A 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE--HPYLQT 311 (353)
T ss_dssp HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTT
T ss_pred HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc--Cccccc
Confidence 221111110 0 12468899999999999999999999999999 677766
Q ss_pred cCCCC
Q 017046 328 LRPPS 332 (378)
Q Consensus 328 ~~~~~ 332 (378)
...+.
T Consensus 312 ~~~~~ 316 (353)
T 2b9h_A 312 YHDPN 316 (353)
T ss_dssp TCCTT
T ss_pred cCCcc
Confidence 55443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=372.04 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=208.9
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP- 130 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~- 130 (378)
+...+|.+++.||+|+||+||+|++. ++.||||+++........ ....+..|..++..+ +||+|+.+++++.+.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~--~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTT--TTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHH--HHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 45678999999999999999999874 578999999753221111 123477899999987 799999999999764
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
.+++||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++..
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~~ 492 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTCEEC
T ss_pred EEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeecceeecc
Confidence 788999999999999999863 5699999999999999999999999999999999999999665 5999999999753
Q ss_pred c-cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 211 T-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 211 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
. ........+||+.|+|||++.. ..++.++|||||||++|||++|..||.+.+..+ .+..+ ......+|
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-~~~~i-~~~~~~~p 562 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSI-MEHNVAYP 562 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTC--------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH-HSSCCCCC
T ss_pred ccCCcccccccCCCcccCHhhhcC--------CCCCccceEechHHHHHHHHcCCCCCCCCCHHH-HHHHH-HhCCCCCC
Confidence 2 2334456789999999999864 678999999999999999999999999866533 33333 34566788
Q ss_pred CCChHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSF-----SQIIR 319 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~ 319 (378)
..+++++.+||.+||..||.+||++ .++++
T Consensus 563 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 563 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 8999999999999999999999987 78877
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=338.90 Aligned_cols=258 Identities=27% Similarity=0.476 Sum_probs=211.3
Q ss_pred cCCcceeecceeecccceEEEEEEE------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+....|.+++.||+|+||.||++++ .++.||||++....... ...+.+|+.+++.++||||+++++++.
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-----LRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHH-----HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHH-----HHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 4567799999999999999999984 47899999997643322 235889999999999999999999885
Q ss_pred c---CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 129 D---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 129 ~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
+ ...++||||+++++|.+++... ...+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+||+|||
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Dfg 190 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFG 190 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecCc
Confidence 3 2678999999999999999863 35699999999999999999999999999999999999999654 59999999
Q ss_pred ccccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH--------
Q 017046 206 LAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-------- 273 (378)
Q Consensus 206 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------- 273 (378)
++....... ......++..|+|||.+.. ..++.++||||||+++|+|++|..||......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~ 262 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTT
T ss_pred chhhccccccccccccCCCCceeEECchhhcC--------CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccc
Confidence 997543322 1233457788999999864 55788999999999999999999998642110
Q ss_pred -------HHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 274 -------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 274 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
............+..+..+++++.+++.+||..||.+|||+.++++.|+.+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 263 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 011223334445667788999999999999999999999999999999887654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=349.59 Aligned_cols=255 Identities=25% Similarity=0.342 Sum_probs=203.0
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc------cCCCeeeEEeeEe
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV------KHDNLVKFLGACK 128 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~l~~~~~ 128 (378)
..+|.+++.||+|+||+||+|.+. ++.||||++..... ....+.+|+.+++.+ +|+||+++++.+.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR------FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH------HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc------hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 346999999999999999999874 68999999975321 123466788887777 5779999999986
Q ss_pred c-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC-ceeEecccc
Q 017046 129 D-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGL 206 (378)
Q Consensus 129 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~-~vkl~Dfg~ 206 (378)
. ...++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 4 57889999995 69999998866667999999999999999999999999999999999999996553 399999999
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
+..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+...........+
T Consensus 249 a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 249 SCYEHQ--RVYTYIQSRFYRAPEVILG--------ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp CEETTC--CCCSSCSCGGGCCHHHHHT--------BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ceecCC--cccccCCCCCccChHHHhC--------CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 965432 2345689999999999865 568999999999999999999999999877654433322111000
Q ss_pred ---------------------------------------------------------CCCCCChHHHHHHHHHccccCCC
Q 017046 287 ---------------------------------------------------------GLPEDISPDLAFIVQSCWVEDPN 309 (378)
Q Consensus 287 ---------------------------------------------------------~~~~~~~~~l~~li~~~l~~dp~ 309 (378)
.++...++++.+||.+||..||.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~ 398 (429)
T 3kvw_A 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398 (429)
T ss_dssp CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence 01123478899999999999999
Q ss_pred CCCCHHHHHHHHHhhhhccCC
Q 017046 310 LRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 310 ~Rps~~~ll~~l~~~~~~~~~ 330 (378)
+|||+.|+++ +.++....+
T Consensus 399 ~Rpta~e~L~--Hpw~~~~~~ 417 (429)
T 3kvw_A 399 VRMTPGQALR--HPWLRRRLP 417 (429)
T ss_dssp TSCCHHHHHT--STTTC----
T ss_pred hCCCHHHHhC--ChhhccCCC
Confidence 9999999999 667765443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=337.77 Aligned_cols=256 Identities=30% Similarity=0.442 Sum_probs=203.7
Q ss_pred ceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEe
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTE 137 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e 137 (378)
.|..++.||+|+||.||+|...++.||+|++......... .....+.+|+.+++.++||||+++++++.+ ...++|||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE-ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTT-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchH-HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 3455689999999999999999999999998764322111 123468899999999999999999999965 47899999
Q ss_pred ccCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc---
Q 017046 138 LLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT--- 213 (378)
Q Consensus 138 ~~~~~sL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~--- 213 (378)
|+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQT 189 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSCSSC
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEEeeccccccccccccc
Confidence 999999999997532 34699999999999999999999999999999999999999655 5999999998754322
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH---HHHHHHH---------
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ---AAYAAAF--------- 281 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~--------- 281 (378)
.......||+.|+|||.+. ..++.++||||||+++|+|++|..||.+..... .......
T Consensus 190 ~~~~~~~g~~~y~aPE~~~---------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALR---------GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY 260 (307)
T ss_dssp EECSSCCSCGGGCCHHHHT---------TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred ccccccCCCcCcCChHHhc---------CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence 1223457899999999874 347889999999999999999999998654321 1111111
Q ss_pred -hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 282 -KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 282 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
.......+...+..+.+++.+||..||.+|||+.+++++|+.+.
T Consensus 261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11112233345678999999999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=349.00 Aligned_cols=260 Identities=30% Similarity=0.434 Sum_probs=203.2
Q ss_pred ccccCCcceeecceeecccceEEEEEEE-CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 129 (378)
...+..+.|.+.+.||+|+||.||+|+. +++.||||++......... ..+.+|+.+++.++||||+++++++.+
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE----LQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CC----CHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHH----HHHHHHHHHHHhccCCCccceEEEEecC
Confidence 3445677899999999999999999986 4789999998765433221 247899999999999999999999865
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCeeecCCCCcEEEcCCCCceeEecc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHAN---GIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---givH~dikp~Nill~~~~~~vkl~Df 204 (378)
...++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Df 178 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDF 178 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCC
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccC
Confidence 478899999999999999976432 3499999999999999999999999 999999999999999655 5999999
Q ss_pred ccccccccc--cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC-------hHHH
Q 017046 205 GLAREETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS-------NLQA 275 (378)
Q Consensus 205 g~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~ 275 (378)
|++...... .......||+.|+|||++.. ..++.++|||||||++|+|++|..||.... ....
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHH--------SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred ccccccCcccccccccccCCcCccCHHHhcc--------CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 999754322 22344569999999999864 567899999999999999999999995210 0000
Q ss_pred HHHHHHhc----------CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 276 AYAAAFKH----------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 276 ~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
........ ....++...+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 00000000 01112223457799999999999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=340.59 Aligned_cols=259 Identities=24% Similarity=0.341 Sum_probs=205.4
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 129 (378)
...|.+++.||+|+||+||+|++ +++.||||++......... ...+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF---PITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS---CHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc---hHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 46799999999999999999987 4789999998665443321 1247799999999999999999998854
Q ss_pred ----CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 130 ----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 130 ----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
+..++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg 169 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFG 169 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred ccCCceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccch
Confidence 247899999965 88877765 335699999999999999999999999999999999999999665 59999999
Q ss_pred ccccccc-----ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017046 206 LAREETV-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (378)
Q Consensus 206 ~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 280 (378)
++..... ........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+...........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcC-------CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9875431 222345578999999998854 2457899999999999999999999999877644433332
Q ss_pred Hh--cCCCCCCCC----------------------------ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 281 FK--HARPGLPED----------------------------ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 281 ~~--~~~~~~~~~----------------------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
.. ...+..... .++++.+||.+||..||.+|||+.++++ +.++.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~~ 320 (351)
T 3mi9_A 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFWSDPM 320 (351)
T ss_dssp HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGSSSC
T ss_pred HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC--CCCcCCCCC
Confidence 21 111111111 2677999999999999999999999999 677765433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=342.40 Aligned_cols=265 Identities=26% Similarity=0.446 Sum_probs=199.7
Q ss_pred cCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHH--HHHHHHhhccCCCeeeEEeeEec---
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFI--REVNMMSRVKHDNLVKFLGACKD--- 129 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~--~E~~~l~~l~hp~iv~l~~~~~~--- 129 (378)
++.+.|.+.+.||+|+||.||+|+..++.||||++...... .+. .|+..+..++||||+++++.+..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~--------~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ--------NFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHH--------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred cChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchh--------hHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 46678999999999999999999999999999999753211 233 34444556899999999975531
Q ss_pred ---CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCeeecCCCCcEEEcCCCC
Q 017046 130 ---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN---------GIIHRDLKPDNLLLTPDQK 197 (378)
Q Consensus 130 ---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---------givH~dikp~Nill~~~~~ 197 (378)
...++||||+++|+|.+++.. ...++..++.++.||+.||.|||+. ||+||||||+|||++.++
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~- 157 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG- 157 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-
T ss_pred CCCceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-
Confidence 246899999999999999976 3468999999999999999999999 999999999999999665
Q ss_pred ceeEeccccccccccc---------cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCC
Q 017046 198 SLKLADFGLAREETVT---------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (378)
Q Consensus 198 ~vkl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 268 (378)
.+||+|||++...... .......||+.|+|||++.+... ......++.++|||||||++|+|++|..||.
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN-LRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCC-GGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcc-cccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 5999999999754321 12234579999999999864210 0011356678999999999999999976653
Q ss_pred CCCh-----------------HHHHHH-HHHhcCCCCCCCC------ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 269 GMSN-----------------LQAAYA-AAFKHARPGLPED------ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 269 ~~~~-----------------~~~~~~-~~~~~~~~~~~~~------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
.... ...... .......+.++.. +++++.+||.+||..||.+|||+.++++.|..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 2111 111111 1122334444443 445899999999999999999999999999999
Q ss_pred hhccCCCC
Q 017046 325 LFTLRPPS 332 (378)
Q Consensus 325 ~~~~~~~~ 332 (378)
+.....-.
T Consensus 317 l~~~~~~~ 324 (336)
T 3g2f_A 317 MMIWERNK 324 (336)
T ss_dssp HHCCCC--
T ss_pred HHHHHhcc
Confidence 87765433
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=341.69 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=203.3
Q ss_pred ccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 130 (378)
....+.|.+.+.||+|+||.||++++. ++.||||++......... ...+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 97 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV---KKIAMREIKLLKQLRHENLVNLLEVCKKKK 97 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHH---HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHH---HHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence 345678999999999999999999885 789999998766544332 34578999999999999999999999654
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++...
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTL 174 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC---
T ss_pred EEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCceee
Confidence 68899999999889887654 45799999999999999999999999999999999999999665 5999999999754
Q ss_pred cc-ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC----
Q 017046 211 TV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR---- 285 (378)
Q Consensus 211 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---- 285 (378)
.. ........|++.|+|||++.+ ...++.++|||||||++|+|++|..||.+................
T Consensus 175 ~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (331)
T 4aaa_A 175 AAPGEVYDDEVATRWYRAPELLVG-------DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247 (331)
T ss_dssp ---------CCCCCTTCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cCCccccCCCcCCccccCcccccC-------CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 33 223345578999999999854 236789999999999999999999999987765544433221110
Q ss_pred ----------------CC---------CCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 286 ----------------PG---------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 286 ----------------~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+. ....+++++.+|+.+||..||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 01357899999999999999999999999998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=348.41 Aligned_cols=257 Identities=26% Similarity=0.371 Sum_probs=205.5
Q ss_pred cCCcceeecceeecccceEEEEEEE-----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 128 (378)
+....|.+.+.||+|+||.||+++. .++.||||+++......... ....+.+|+.+++.+ +||||+++++++.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK-TTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES-SGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhh-HHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 4457899999999999999999987 57899999986533211000 012366899999999 6999999999986
Q ss_pred c-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 129 D-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 129 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
+ ...++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a 206 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLS 206 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEE
T ss_pred eCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEeeCCCC
Confidence 5 4788999999999999999763 4699999999999999999999999999999999999999665 5999999999
Q ss_pred cccccc--cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh--HHHHHHHHHhc
Q 017046 208 REETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFKH 283 (378)
Q Consensus 208 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~ 283 (378)
...... ......+||+.|+|||++.+ ....++.++|||||||++|+|++|..||..... ...........
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 280 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred eecccCCCCcccCcccCcCccChhhhcC------CCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc
Confidence 754322 22334579999999999864 124578899999999999999999999975322 12222223334
Q ss_pred CCCCCCCCChHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 017046 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRML 321 (378)
Q Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~l 321 (378)
..+.++..++..+.+||.+||..||.+|| |+.+++++.
T Consensus 281 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 281 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 56677888999999999999999999999 999999843
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=345.00 Aligned_cols=257 Identities=30% Similarity=0.387 Sum_probs=191.4
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec----
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---- 129 (378)
-.+.|.+++.||+|+||.||+|.+ +++.||||++........ ...++.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHH---HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHH---HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence 347899999999999999999986 478999999976544332 23468899999999999999999998853
Q ss_pred ---CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 130 ---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 130 ---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
...++|||++ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 104 ~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG~ 178 (367)
T 2fst_X 104 EEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGL 178 (367)
T ss_dssp GGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC---
T ss_pred ccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeeccc
Confidence 3578999999 7899998864 5799999999999999999999999999999999999999665 599999999
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR- 285 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~- 285 (378)
++..... .....||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..............
T Consensus 179 a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 179 ARHTADE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249 (367)
T ss_dssp --------------CCCTTCCHHHHTT-------CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred ccccccc--CCCcCcCcCccChHHHcC-------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9764322 345689999999998854 246889999999999999999999999987764443332211110
Q ss_pred --------------------CC--------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 286 --------------------PG--------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 286 --------------------~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
+. .....++++.+||.+||..||.+|||+.++++ +.++.....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~--hp~~~~~~~~ 321 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYHDP 321 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTTCCG
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc--ChhhhhccCC
Confidence 11 11346789999999999999999999999999 6677665443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=338.72 Aligned_cols=251 Identities=27% Similarity=0.506 Sum_probs=197.8
Q ss_pred cceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc--cCCCeeeEEeeEec-----C
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV--KHDNLVKFLGACKD-----P 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~l~~~~~~-----~ 130 (378)
+.|.+.+.||+|+||.||+|++.++.||||++..... ..+.+|.+++..+ +||||+++++++.+ .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE--------ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGH--------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEecccc--------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 5799999999999999999999999999999864321 1244555555544 89999999998854 3
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeeecCCCCcEEEcCCCCceeEe
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLA 202 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--------givH~dikp~Nill~~~~~~vkl~ 202 (378)
..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++ .+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEEC
T ss_pred ceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEE
Confidence 67899999999999999976 4699999999999999999999999 999999999999999665 59999
Q ss_pred ccccccccccccc-----cccCcCccccccccccccccccccccccCCC------cccchhhhHHHHHHHhC--------
Q 017046 203 DFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNN------KVDVYSFGIVLWELLTN-------- 263 (378)
Q Consensus 203 Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------~~DiwslG~il~~ll~g-------- 263 (378)
|||++........ .....||+.|+|||++.. ...+. ++|||||||++|+|++|
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--------SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTT--------CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhccc--------ccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 9999965432221 124579999999999865 22333 48999999999999999
Q ss_pred --CCCCCCCCh----HHHHHHH-HHhcCCCCCCC-----CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 264 --RLPFEGMSN----LQAAYAA-AFKHARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 264 --~~pf~~~~~----~~~~~~~-~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
..||..... ....... ......+.++. .+++++.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 777765322 1111111 12233444443 46678999999999999999999999999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=330.60 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=206.1
Q ss_pred eeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 136 (378)
|.....||+|+||.||+|.+ +++.||||++....... ...+.+|+.+++.++||||+++++++.+ +..++||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY-----SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC--------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHH-----HHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 33445899999999999987 46899999997654322 2358899999999999999999999965 4788999
Q ss_pred eccCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-c
Q 017046 137 ELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-~ 214 (378)
||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||+++..++.+||+|||++...... .
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999999986422 356789999999999999999999999999999999999864556999999998754332 2
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCCCh
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA-AYAAAFKHARPGLPEDIS 293 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 293 (378)
......|++.|+|||++... ...++.++||||||+++|+|++|..||........ ..........+.++..++
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKG------PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 252 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHG------GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSC
T ss_pred cccccCCCccccChhhhcCC------CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCC
Confidence 23455789999999998541 13478899999999999999999999976544332 233334456677888999
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 294 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 294 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
+++.+++.+||..||.+|||+.++++ +.++...
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~--~~~~~~~ 285 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLV--DEFLKVS 285 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHT--SGGGCC-
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc--Chhhhhc
Confidence 99999999999999999999999998 5665543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=354.32 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=202.9
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCC-CeeeEEeeEe-cCCe
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD-NLVKFLGACK-DPLM 132 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~l~~~~~-~~~~ 132 (378)
.+.|.++++||+|+||.||+|++. ++.||||++....... .+.+|+.+++.++|+ +|..+..++. ....
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-------CHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-------HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 367999999999999999999864 7899999987655433 367899999999764 4445544444 4467
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEc--CCCCceeEecccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLAREE 210 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~--~~~~~vkl~Dfg~a~~~ 210 (378)
++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||||+ .+.+.+||+|||+++..
T Consensus 79 ~lvme~~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEECC-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 8999999 9999999975 346799999999999999999999999999999999999993 23446999999999754
Q ss_pred ccccc--------cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh--HHHHHHH-
Q 017046 211 TVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAA- 279 (378)
Q Consensus 211 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~- 279 (378)
..... .....||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+... ....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred cCCccccccccccccccCCCccccCHHHhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence 33221 225579999999999865 5688999999999999999999999987543 1111211
Q ss_pred ---HHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 280 ---AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 280 ---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
........++..++.++.+|+..||..+|.+||++.+|++.|+.++..
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 229 SEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 111222233467899999999999999999999999999999888643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=331.43 Aligned_cols=248 Identities=27% Similarity=0.459 Sum_probs=204.7
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+.+.||+|+||.||+++. .++.||||++......... ...+.+|+.+++.++||||+++++++.+. ..++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD---TSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH---HHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 5799999999999999999988 4789999998764432211 13588999999999999999999998754 6789
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC--CceeEecccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREETV 212 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~--~~vkl~Dfg~a~~~~~ 212 (378)
||||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ ..+||+|||++.....
T Consensus 99 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999999999988763 4699999999999999999999999999999999999997543 2599999999876544
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC--C
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--E 290 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~ 290 (378)
........+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+...................+ .
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~---------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRG---------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTT---------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGT
T ss_pred CCccccccCcccccChHHhcC---------CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhh
Confidence 444444568999999998753 47889999999999999999999998876544333322222222222 4
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.+++++.+++.+||..||.+|||+.++++
T Consensus 248 ~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 68999999999999999999999999998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=339.07 Aligned_cols=264 Identities=21% Similarity=0.299 Sum_probs=200.1
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-C--
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-P-- 130 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~-- 130 (378)
..+.|.+.+.||+|+||.||+|++. ++.||||++........ ++.++++.+..++||||+++++++.+ .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN------RELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCC------HHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccH------HHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 4467999999999999999999874 78999999876544332 35578888899999999999998842 1
Q ss_pred -----CeEEEEeccCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCeeecCCCCcEEEcCCCCceeE
Q 017046 131 -----LMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCLH--ANGIIHRDLKPDNLLLTPDQKSLKL 201 (378)
Q Consensus 131 -----~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~lH--~~givH~dikp~Nill~~~~~~vkl 201 (378)
..++||||+++ +|...+.. .....+++..+..++.|++.||.||| +.||+||||||+|||++..++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 27899999976 55554432 23457899999999999999999999 9999999999999999964557999
Q ss_pred eccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017046 202 ADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 202 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 281 (378)
+|||++.............||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+............
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFG-------NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 99999987665555556689999999998854 24578999999999999999999999998776544433322
Q ss_pred hcC------------------------------CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 282 KHA------------------------------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 282 ~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
... .+..+...++++.+||.+||+.||.+|||+.++++ +.++.....+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~~~~~ 324 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC--HPYFDELHDP 324 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT--SGGGGGGGCT
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc--CccccccCCc
Confidence 111 11223346789999999999999999999999999 7788776655
Q ss_pred CCCC
Q 017046 332 SPSV 335 (378)
Q Consensus 332 ~~~~ 335 (378)
....
T Consensus 325 ~~~~ 328 (360)
T 3e3p_A 325 ATKL 328 (360)
T ss_dssp TCCC
T ss_pred cccC
Confidence 5443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=342.29 Aligned_cols=273 Identities=27% Similarity=0.496 Sum_probs=211.6
Q ss_pred ccccccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
.+.+.+..+.|.+.+.||+|+||.||+|++.+ .||+|++......... ...+.+|+.+++.++||||+++++++.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ---LKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC---CCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH---HHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 34566788899999999999999999999876 5999998764332211 1236789999999999999999999865
Q ss_pred C-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 ~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
. ..++||||++|++|.+++.. ....+++..++.++.|++.||.|||++|++||||||+|||++ ++ .+||+|||++.
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~ 177 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVVITDFGLFS 177 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC
T ss_pred CCceEEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEEEeecCCcc
Confidence 4 78999999999999999976 335699999999999999999999999999999999999998 44 59999999976
Q ss_pred cccc------ccccccCcCccccccccccccccccc-cccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017046 209 EETV------TEMMTAETGTYRWMAPELYSTVTLRQ-GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 209 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 281 (378)
.... ........|++.|+|||++....... .....++.++||||||+++|+|++|..||.+........ ...
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~ 256 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-QMG 256 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH-HHH
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-Hhc
Confidence 4321 11223446899999999986421100 012457889999999999999999999998876544333 333
Q ss_pred hcCCCCC-CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 282 KHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 282 ~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
....+.. +..++.++.+++.+||..||.+|||+.++++.|+.+......
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 3333333 346889999999999999999999999999999988766543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=332.38 Aligned_cols=252 Identities=28% Similarity=0.436 Sum_probs=203.8
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
..+.|.+.+.||+|+||.||+|.+. ++.||||++...... ..+.+|+.+++.++||||+++++++.+ ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-------QEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC-------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH-------HHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 3467999999999999999999885 789999999875432 247799999999999999999998864 578
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++.....
T Consensus 100 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBT
T ss_pred EEEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhh
Confidence 999999999999999874 246799999999999999999999999999999999999999665 599999999875433
Q ss_pred c-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--CCC
Q 017046 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLP 289 (378)
Q Consensus 213 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~ 289 (378)
. .......|++.|+|||.+.. ..++.++||||||+++|+|++|..||.+.......... .....+ ..+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 248 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQE--------IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI-PTNPPPTFRKP 248 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSS--------SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSCCCCCSSG
T ss_pred hccccCccCCCCCccChhhcCC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hcCCCcccCCc
Confidence 2 22344578999999999864 56889999999999999999999999887665443332 222222 234
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
..++.++.+++.+||..||.+|||+.++++ +.++..
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~--~~~~~~ 284 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ--HPFVRS 284 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHhc
Confidence 568899999999999999999999999998 445543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=333.18 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=198.9
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe------
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK------ 128 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~------ 128 (378)
...|.+.+.||+|+||.||+|.+. ++.||+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ-----SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHH-----HHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChH-----HHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 467999999999999999999885 789999998754321 1245889999999999999999998863
Q ss_pred ---------cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCce
Q 017046 129 ---------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199 (378)
Q Consensus 129 ---------~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~v 199 (378)
....++||||++ ++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++..+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 235789999996 699998864 5799999999999999999999999999999999999998666679
Q ss_pred eEeccccccccccc----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHH
Q 017046 200 KLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (378)
Q Consensus 200 kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 275 (378)
||+|||++...... .......+++.|+|||.+.. ...++.++|||||||++|+|++|..||.+......
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 233 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC-------TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcC-------cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999754321 12234467899999998753 25678899999999999999999999998776443
Q ss_pred HHHHHHhcC-----------------------CC-----CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 276 AYAAAFKHA-----------------------RP-----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 276 ~~~~~~~~~-----------------------~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
......... .+ .++..++.++.+|+.+||+.||.+|||+.++++ +.++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~ 311 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS--HPYMSI 311 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT--SHHHHT
T ss_pred HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC--Cccccc
Confidence 332221110 00 122468999999999999999999999999999 556655
Q ss_pred cC
Q 017046 328 LR 329 (378)
Q Consensus 328 ~~ 329 (378)
..
T Consensus 312 ~~ 313 (320)
T 2i6l_A 312 YS 313 (320)
T ss_dssp TC
T ss_pred cc
Confidence 43
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=340.34 Aligned_cols=257 Identities=20% Similarity=0.248 Sum_probs=205.7
Q ss_pred ccccccccCCcceeecceeecccceEEEEEE-------ECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc---C
Q 017046 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGR-------YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---H 117 (378)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h 117 (378)
.......+..+.|.+.+.||+|+||+||+|. ..++.||||++..... ..+..|++++..++ |
T Consensus 55 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~e~~~~~~l~~~~~ 126 (365)
T 3e7e_A 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP--------WEFYIGTQLMERLKPSMQ 126 (365)
T ss_dssp CSSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH--------HHHHHHHHHHHHSCGGGG
T ss_pred ccceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh--------hHHHHHHHHHHHhhhhhh
Confidence 3444566778899999999999999999993 2578999999976432 13667777777775 9
Q ss_pred CCeeeEEeeEec-CCeEEEEeccCCCCHHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEc
Q 017046 118 DNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSL---RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 193 (378)
Q Consensus 118 p~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~ 193 (378)
+||+.+++++.+ +..++||||++||+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 127 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206 (365)
T ss_dssp GGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred hhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec
Confidence 999999999864 5789999999999999999753 245699999999999999999999999999999999999998
Q ss_pred CC----------CCceeEeccccccccc---cccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHH
Q 017046 194 PD----------QKSLKLADFGLAREET---VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260 (378)
Q Consensus 194 ~~----------~~~vkl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~l 260 (378)
.+ ...+||+|||++.... ........+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 278 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--------KPWNYQIDYFGVAATVYCM 278 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--------CCBSTHHHHHHHHHHHHHH
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC--------CCCCccccHHHHHHHHHHH
Confidence 51 3459999999996432 2334456689999999999865 5689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCCC-CCCChHHHHHHHHHccccCCCCC-CCHHHHHHHHHhhhhc
Q 017046 261 LTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLR-PSFSQIIRMLNAFLFT 327 (378)
Q Consensus 261 l~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~R-ps~~~ll~~l~~~~~~ 327 (378)
++|+.||....... ......+ ....++.+.+++..||..+|.+| |++.++.+.|+.++..
T Consensus 279 ltg~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 279 LFGTYMKVKNEGGE-------CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp HHSSCCCEEEETTE-------EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HhCCCccccCCCCc-------eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 99999996433210 0001111 11357789999999999999999 5788888889888866
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=331.30 Aligned_cols=259 Identities=28% Similarity=0.469 Sum_probs=204.4
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
..+.|.+.+.||+|+||.||+|++. ++.||+|++....... ...+.+|+.+++.++||||+++++++.+ +..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH-----HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 3467999999999999999999985 6899999987644332 2358899999999999999999999865 478
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++.....
T Consensus 92 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLK 169 (302)
T ss_dssp EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCCccccc
Confidence 9999999999999998763 35699999999999999999999999999999999999999665 599999998754221
Q ss_pred c-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--CCC
Q 017046 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLP 289 (378)
Q Consensus 213 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~ 289 (378)
. .......|++.|+|||++..... ....++.++||||||+++|+|++|..||............. ....+ ..+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 245 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETM---KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPPTLLTP 245 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHT---TSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCSSG
T ss_pred cccccccccCChhhcCCeeeccccC---CCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHh-ccCCcccCCc
Confidence 1 22234578999999998842110 12567889999999999999999999998876654433332 23322 234
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
..++.++.+++.+||..||.+|||+.++++ +.++..
T Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~ 281 (302)
T 2j7t_A 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLE--HPFVSS 281 (302)
T ss_dssp GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT--STTTTT
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhc--ChHHhh
Confidence 568899999999999999999999999988 444443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=338.86 Aligned_cols=257 Identities=25% Similarity=0.476 Sum_probs=204.6
Q ss_pred CcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhh--ccCCCeeeEEeeEecC----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR--VKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~l~~~~~~~---- 130 (378)
.+.|.+.+.||+|+||.||+|+++++.||||++.... ...+.+|++++.. ++||||+++++++.+.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE--------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG--------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh--------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 3579999999999999999999999999999986431 1246788888887 6899999999998654
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeeecCCCCcEEEcCCCCceeE
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH--------ANGIIHRDLKPDNLLLTPDQKSLKL 201 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH--------~~givH~dikp~Nill~~~~~~vkl 201 (378)
..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.||+||||||+|||++.++ .+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL 188 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCI 188 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEE
T ss_pred ceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEE
Confidence 68899999999999999976 46999999999999999999999 89999999999999999665 5999
Q ss_pred ecccccccccccc-----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhC----------CCC
Q 017046 202 ADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN----------RLP 266 (378)
Q Consensus 202 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g----------~~p 266 (378)
+|||++....... ......||+.|+|||++...... ....++.++|||||||++|+|++| ..|
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM--KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT--TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccc--cccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 9999997543322 22445799999999998642100 001334689999999999999999 789
Q ss_pred CCCCCh----HHHHHHHH-HhcCCCCCCC-----CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 267 FEGMSN----LQAAYAAA-FKHARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 267 f~~~~~----~~~~~~~~-~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
|..... ........ .....+.++. .++..+.+|+.+||..||.+|||+.+++++|+.+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 876432 22222222 2233444443 3446899999999999999999999999999988765
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=337.32 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=203.2
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-C--
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L-- 131 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~-- 131 (378)
.+.|.+.+.||+|+||.||+|.+. ++.||||++........ ...++.+|+.+++.++||||+++++++.+. .
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI---FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHH---HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchh---HHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 467999999999999999999874 78999999987554432 234688999999999999999999998643 2
Q ss_pred ----eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 132 ----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 132 ----~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
.++||||+. ++|.+++. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a 191 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLA 191 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC
T ss_pred cceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCcc
Confidence 389999996 68888764 3599999999999999999999999999999999999999665 5999999999
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC-
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP- 286 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~- 286 (378)
...... .....||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+....+...........+
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 192 RHADAE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 262 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccC--cCCcccCccccCHHHhcC-------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 754332 345678999999998854 2568899999999999999999999999877654443332211111
Q ss_pred ----------------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 287 ----------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 287 ----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
..+..+++++.+||.+||+.||.+|||+.++++ +.++.....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~~ 332 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT--HPFFEPFRD 332 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTTTCC
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc--CcccccCCC
Confidence 012457899999999999999999999999999 667665443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=334.81 Aligned_cols=260 Identities=26% Similarity=0.436 Sum_probs=191.2
Q ss_pred cccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 129 (378)
+.+..+.|.+.+.||+|+||.||+|.+ +++.||||++........ ...+.+|+.+++.++||||+++++++.+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESS
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchh----HHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 345678899999999999999999976 578999999865433221 2357899999999999999999999865
Q ss_pred CCeEEEEeccCCCCHHHHHhhh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEec
Q 017046 130 PLMVIVTELLPGMSLRKYLVSL------RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~------~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~D 203 (378)
+..++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~d 164 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIAD 164 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEEe
Confidence 4789999999999999998742 235699999999999999999999999999999999999999665 599999
Q ss_pred cccccccccc------cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHH
Q 017046 204 FGLAREETVT------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (378)
Q Consensus 204 fg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 277 (378)
||++...... .......||+.|+|||++.. ...++.++||||||+++|+|++|..||.+........
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 237 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ-------VRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 237 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHH-------HHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhcc-------ccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH
Confidence 9998643322 11234578999999998853 1357889999999999999999999998766544433
Q ss_pred HHHHhcCCC---------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 278 AAAFKHARP---------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 278 ~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
... ....+ .....++.++.+++.+||..||.+|||+.++++ +.++..
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~~~~ 293 (303)
T 2vwi_A 238 LTL-QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR--HKFFQK 293 (303)
T ss_dssp HHH-TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT--STTC--
T ss_pred HHh-ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh--Chhhhc
Confidence 322 22222 223567899999999999999999999999998 455544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=339.71 Aligned_cols=263 Identities=24% Similarity=0.329 Sum_probs=200.6
Q ss_pred CCcceeecceeecccceEEEEEEE-CCeeEEEEEeecCCCch------HHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSD------ERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
-.+.|.+.+.||+|+||.||+|.. .++.||||++....... .......++.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 356799999999999999999976 46899999986543321 11222356899999999999999999999873
Q ss_pred c------CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEe
Q 017046 129 D------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (378)
Q Consensus 129 ~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~ 202 (378)
. ...++||||+. ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~ 176 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITIC 176 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEEC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CEEEE
Confidence 2 14789999996 688888875 345799999999999999999999999999999999999999665 59999
Q ss_pred ccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 017046 203 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (378)
Q Consensus 203 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 282 (378)
|||++.............||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.............
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 249 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQ-------FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ecCcccccccccccceecccceecCcHHhcC-------CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999986555555556689999999998853 246789999999999999999999999987654443332221
Q ss_pred cCCC----------------------C--------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 283 HARP----------------------G--------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 283 ~~~~----------------------~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
...+ . .+..+++.+.+||.+||..||.+|||+.++++ +.++.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~~ 325 (362)
T 3pg1_A 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR--HPYFESLFD 325 (362)
T ss_dssp HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGTTTCC
T ss_pred cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc--CchhhhccC
Confidence 1111 1 12356888999999999999999999999999 677766543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=351.34 Aligned_cols=252 Identities=17% Similarity=0.228 Sum_probs=190.3
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHH---HHHhhccCCCeeeEE-----
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREV---NMMSRVKHDNLVKFL----- 124 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hp~iv~l~----- 124 (378)
...+.|.+.+.||+|+||+||+|++ +++.||||++.......... .+.+.+|+ ++++.++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA--IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTH--HHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHH--HHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 3457899999999999999999985 47899999998643322211 24588999 455556899999987
Q ss_pred --eeEecC------------------CeEEEEeccCCCCHHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 017046 125 --GACKDP------------------LMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVALNFALDIARAMDCLHANG 179 (378)
Q Consensus 125 --~~~~~~------------------~~~lv~e~~~~~sL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~g 179 (378)
+++.++ ..++||||+ +|+|.+++..... ..+++..++.++.||+.||+|||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 555433 378999999 6799999976321 11334788889999999999999999
Q ss_pred CeeecCCCCcEEEcCCCCceeEeccccccccccccccccCcCcccccccccccccc---ccccccccCCCcccchhhhHH
Q 017046 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT---LRQGEKKHYNNKVDVYSFGIV 256 (378)
Q Consensus 180 ivH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~~~~DiwslG~i 256 (378)
|+||||||+|||++.++ .+||+|||++..... ......| +.|+|||++.+.. ........++.++|||||||+
T Consensus 227 ivHrDikp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp EECSCCCGGGEEECTTC-CEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCC-CEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 99999999999999665 599999999986433 3345577 9999999986510 000001268999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 257 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 257 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
+|+|++|..||.+....... ......+..+++++.+||.+||..||.+|||+.++++
T Consensus 303 l~elltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCS------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccch------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999764432110 1111223678999999999999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=335.31 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=184.8
Q ss_pred ccccccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHH-HHhhccCCCeeeEEee
Q 017046 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLVKFLGA 126 (378)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~ 126 (378)
...+.+..+.|.+.+.||+|+||.||+|... ++.||||++......... ..+..|+. +++.++||||++++++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~e~~~~~~~~~h~niv~~~~~ 89 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ----KQLLMDLDVVMRSSDCPYIVQFYGA 89 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHH----HHHHHHHHHHHSSCCCTTBCCEEEE
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHH----HHHHHHHHHHHHcCCCCcEeeeeeE
Confidence 3455567789999999999999999999885 799999999876543322 23555655 6777899999999999
Q ss_pred EecC-CeEEEEeccCCCCHHHHHhh---hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeE
Q 017046 127 CKDP-LMVIVTELLPGMSLRKYLVS---LRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKL 201 (378)
Q Consensus 127 ~~~~-~~~lv~e~~~~~sL~~~l~~---~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl 201 (378)
+.++ ..++||||+++ +|.+++.. .....+++..+..++.|++.||.|||+. |++||||||+|||++.++ .+||
T Consensus 90 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl 167 (327)
T 3aln_A 90 LFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKL 167 (327)
T ss_dssp EECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEE
T ss_pred EEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEE
Confidence 8654 78899999975 88877753 2346799999999999999999999999 999999999999999655 5999
Q ss_pred eccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 017046 202 ADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 202 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 281 (378)
+|||++.............||+.|+|||++.... ....++.++|||||||++|+|++|..||.+............
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (327)
T 3aln_A 168 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA----SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243 (327)
T ss_dssp CCCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC
T ss_pred ccCCCceecccccccccCCCCccccCceeecccc----CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh
Confidence 9999997655444444557999999999984210 125688999999999999999999999987544322222222
Q ss_pred hcCCCCCC----CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 282 KHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 282 ~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
....+.++ ..+++++.+|+.+||..||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 22233332 3588999999999999999999999999883
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=340.31 Aligned_cols=259 Identities=21% Similarity=0.343 Sum_probs=209.5
Q ss_pred CcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHH------------HHHHHHHHHHHHHhhccCCCeeeEE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERA------------LLEGRFIREVNMMSRVKHDNLVKFL 124 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~------------~~~~~~~~E~~~l~~l~hp~iv~l~ 124 (378)
..+|.+.+.||+|+||.||+|+++++.||||++.......... .....+.+|+.+++.++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4679999999999999999999999999999987532211000 0013588999999999999999999
Q ss_pred eeEecC-CeEEEEeccCCCCHHHH------HhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCC
Q 017046 125 GACKDP-LMVIVTELLPGMSLRKY------LVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQ 196 (378)
Q Consensus 125 ~~~~~~-~~~lv~e~~~~~sL~~~------l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~ 196 (378)
+++.+. ..++||||+++++|.++ +.......+++..++.++.|++.||.|||+ .|++||||||+||+++.++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~ 189 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG 189 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTS
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCC
Confidence 998654 78899999999999998 654335679999999999999999999999 9999999999999999665
Q ss_pred CceeEeccccccccccccccccCcCccccccccccccccccccccccCCC-cccchhhhHHHHHHHhCCCCCCCCChHHH
Q 017046 197 KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNN-KVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (378)
Q Consensus 197 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~ 275 (378)
.+||+|||++...... ......|++.|+|||++.+ ...++. ++||||||+++|+|++|..||........
T Consensus 190 -~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 190 -RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSN-------ESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp -CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSS-------CCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred -cEEEeccccccccccc-cccCCCCCcCccCchhhcC-------CCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 5999999999764333 3345689999999999864 124445 89999999999999999999987766344
Q ss_pred HHHHHHhcCCCCCC-------------------CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 276 AYAAAFKHARPGLP-------------------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 276 ~~~~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
...... .....++ ..+++++.+|+.+||..||.+|||+.++++ +.++..
T Consensus 261 ~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~--hp~f~~ 328 (348)
T 2pml_X 261 LFNNIR-TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK--HEWLAD 328 (348)
T ss_dssp HHHHHT-SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT--SGGGTT
T ss_pred HHHHHh-ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc--CccccC
Confidence 444333 3333444 568999999999999999999999999998 455543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=344.82 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=184.9
Q ss_pred ceee-cceeecccceEEEEEEEC----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe---cC
Q 017046 59 LLFI-GSKIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK---DP 130 (378)
Q Consensus 59 ~~~~-~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~---~~ 130 (378)
.|.+ +++||+|+||+||+|++. ++.||||++....... .+.+|+.+|+.++||||+++++++. +.
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM-------SACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH-------HHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH-------HHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3555 568999999999999864 5789999997654432 3679999999999999999999984 34
Q ss_pred CeEEEEeccCCCCHHHHHhhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEc---CCCCcee
Q 017046 131 LMVIVTELLPGMSLRKYLVSLR-------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLK 200 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~---~~~~~vk 200 (378)
..++||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+. .+.+.+|
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 6889999995 58888875321 22499999999999999999999999999999999999993 1334699
Q ss_pred Eeccccccccccc----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH---
Q 017046 201 LADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL--- 273 (378)
Q Consensus 201 l~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--- 273 (378)
|+|||++...... ......+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+....
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 245 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTT-------CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcC-------CCcccchhhhHHHHHHHHHHHhCCCCCCCccccccc
Confidence 9999999754322 22345678999999999864 245889999999999999999999999765431
Q ss_pred ------HHHHHHHHhcCCCC------------------------------------CCCCChHHHHHHHHHccccCCCCC
Q 017046 274 ------QAAYAAAFKHARPG------------------------------------LPEDISPDLAFIVQSCWVEDPNLR 311 (378)
Q Consensus 274 ------~~~~~~~~~~~~~~------------------------------------~~~~~~~~l~~li~~~l~~dp~~R 311 (378)
............+. .....++++.+||.+||..||.+|
T Consensus 246 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R 325 (405)
T 3rgf_A 246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR 325 (405)
T ss_dssp -CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence 11111111111110 011226788999999999999999
Q ss_pred CCHHHHHHHHHhhhhccCC
Q 017046 312 PSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 312 ps~~~ll~~l~~~~~~~~~ 330 (378)
||+.++++ +.++...+.
T Consensus 326 ~ta~e~L~--hp~f~~~~~ 342 (405)
T 3rgf_A 326 ITSEQAMQ--DPYFLEDPL 342 (405)
T ss_dssp CCHHHHHT--SGGGTSSSC
T ss_pred CCHHHHhc--ChhhccCCC
Confidence 99999999 677765443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=338.94 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=196.1
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc--------CCCeeeEEee
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--------HDNLVKFLGA 126 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hp~iv~l~~~ 126 (378)
..+|.+.+.||+|+||+||+|++ +++.||||++.... .....+.+|+.+++.++ ||||++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE------HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH------HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC------cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 46799999999999999999987 47899999997431 12245789999999985 7889999998
Q ss_pred Ee----c-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCC----
Q 017046 127 CK----D-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQ---- 196 (378)
Q Consensus 127 ~~----~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~---- 196 (378)
+. + ...++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence 85 2 3688999999 66777777665556799999999999999999999999 999999999999998654
Q ss_pred --------------------------------------------CceeEeccccccccccccccccCcCccccccccccc
Q 017046 197 --------------------------------------------KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232 (378)
Q Consensus 197 --------------------------------------------~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 232 (378)
..+||+|||++...... .....||+.|+|||++.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhc
Confidence 25999999999764432 34557999999999986
Q ss_pred cccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCCh------HHHHHHHHH-hcC---------------------
Q 017046 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN------LQAAYAAAF-KHA--------------------- 284 (378)
Q Consensus 233 ~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~-~~~--------------------- 284 (378)
+ ..++.++|||||||++|+|++|..||.+... ......... .+.
T Consensus 267 ~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 267 G--------SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp T--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred C--------CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 5 5688999999999999999999999976442 111111110 000
Q ss_pred ------------------CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 285 ------------------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 285 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
...++...++++.+||.+||..||.+|||+.++++
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01122334577899999999999999999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=333.24 Aligned_cols=254 Identities=28% Similarity=0.406 Sum_probs=202.3
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 130 (378)
.+.|.+.+.||+|+||.||+|++ +++.||||++........ ...++.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI---FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHH---HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchH---HHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 35799999999999999999987 478999999976544332 234688999999999999999999998653
Q ss_pred ---CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 131 ---~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
..++||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~ 173 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLA 173 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCT
T ss_pred cceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccc
Confidence 2489999996 58887664 3599999999999999999999999999999999999999665 5999999999
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc----
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH---- 283 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---- 283 (378)
...... .....+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+..............
T Consensus 174 ~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 174 RHADAE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244 (353)
T ss_dssp TC----------CCSBCCSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred cCCCCC--ccccccCcCcCCHHHHhC-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 764332 334578999999998853 2467889999999999999999999998876544333221110
Q ss_pred -------------------------CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 284 -------------------------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 284 -------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
........+++++.+||.+||..||.+|||+.++++ +.++.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~f~~~~~ 314 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT--HPFFEPFRD 314 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTTTCC
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc--CcchhhccC
Confidence 011233467899999999999999999999999998 666655443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=331.44 Aligned_cols=253 Identities=24% Similarity=0.306 Sum_probs=202.1
Q ss_pred CcceeecceeecccceEEEEEEE---CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCC------eeeEEeeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN------LVKFLGAC 127 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~------iv~l~~~~ 127 (378)
.++|.+.+.||+|+||.||++.+ .++.||||++.... . ....+.+|+.+++.++|++ |+++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--R----YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--H----HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--c----hhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 46799999999999999999986 46899999996432 1 1245778999999887654 99999998
Q ss_pred ec-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC-----------
Q 017046 128 KD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD----------- 195 (378)
Q Consensus 128 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~----------- 195 (378)
.+ +..++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 64 5789999999 8899999987555579999999999999999999999999999999999999853
Q ss_pred -------CCceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCC
Q 017046 196 -------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (378)
Q Consensus 196 -------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 268 (378)
...+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA--------LGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT--------SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC--------CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 335999999999754322 345579999999999864 568999999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCC------------------------------------------CCCCCCChHHHHHHHHHcccc
Q 017046 269 GMSNLQAAYAAAFKHAR------------------------------------------PGLPEDISPDLAFIVQSCWVE 306 (378)
Q Consensus 269 ~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~l~~li~~~l~~ 306 (378)
+................ ...+...++++.+||.+||..
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 76654332221111000 001123467899999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhhcc
Q 017046 307 DPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 307 dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
||.+|||+.++++ +.++..+
T Consensus 316 dP~~Rpt~~ell~--hp~f~~~ 335 (339)
T 1z57_A 316 DPAKRITLREALK--HPFFDLL 335 (339)
T ss_dssp STTTSCCHHHHTT--SGGGGGG
T ss_pred CcccccCHHHHhc--CHHHHHH
Confidence 9999999999998 5565543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=326.14 Aligned_cols=267 Identities=24% Similarity=0.422 Sum_probs=207.3
Q ss_pred cccccCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc--CCCeeeEEeeE
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--HDNLVKFLGAC 127 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~ 127 (378)
+...+..+.|.+.+.||+|+||.||++... ++.||||++......... ...+.+|+.++..++ ||||+++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHH---HHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccc---hHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 345567788999999999999999999874 678999999865544322 246889999999996 59999999998
Q ss_pred ecC-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 128 KDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 128 ~~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
.++ ..++||| +.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++ + +.+||+|||+
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~-~~~kL~Dfg~ 172 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGI 172 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-T-TEEEECCCSS
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-C-CeEEEeeccc
Confidence 654 6789999 458899999986 35789999999999999999999999999999999999997 4 4599999999
Q ss_pred cccccccc---ccccCcCccccccccccccccccc---cccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHH-
Q 017046 207 AREETVTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA- 279 (378)
Q Consensus 207 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~- 279 (378)
+....... ......|++.|+|||++....... .....++.++||||||+++|+|++|..||............
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 97543322 123457899999999986421100 01246788999999999999999999999876543333333
Q ss_pred HHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 280 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 280 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
........++...+.++.+++.+||..||.+|||+.++++ +.++..
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~~~~ 298 (313)
T 3cek_A 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQI 298 (313)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHC
T ss_pred HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc--CccccC
Confidence 3334445677778999999999999999999999999998 444443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=343.72 Aligned_cols=251 Identities=14% Similarity=0.172 Sum_probs=183.5
Q ss_pred CCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc--cCCCeeeEE-------
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV--KHDNLVKFL------- 124 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~l~------- 124 (378)
....|.+.+.||+|+||.||+|++ +++.||||++.......... ...+.+|+.+++.+ +||||++++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE--LERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHH--HHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccH--HHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 445699999999999999999986 47899999999866533222 34577886555555 599988855
Q ss_pred eeEec------------------CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHH------HHHHHHHHHHHHHHHhCCC
Q 017046 125 GACKD------------------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA------LNFALDIARAMDCLHANGI 180 (378)
Q Consensus 125 ~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~------~~i~~qi~~~l~~lH~~gi 180 (378)
+++.. ...++||||++ ++|.+++.... ..++...+ ..++.||+.||+|||++||
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i 215 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGL 215 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence 33321 22799999997 89999998632 23455555 6777999999999999999
Q ss_pred eeecCCCCcEEEcCCCCceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHH
Q 017046 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260 (378)
Q Consensus 181 vH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~l 260 (378)
+||||||+|||++.++ .+||+|||++....... ....+|+.|+|||++.. ....++.++|||||||++|+|
T Consensus 216 vHrDikp~NIll~~~~-~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~------~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDG-RLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNA------STATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp EETTCSGGGEEECTTS-CEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTC------SEEECCHHHHHHHHHHHHHHH
T ss_pred ccCcCCHHHEEECCCC-CEEEEecceeeecCCCc--cCccCCcCCcChhhccC------CCCCcCccccHHHHHHHHHHH
Confidence 9999999999999665 59999999998654332 24467799999999853 125689999999999999999
Q ss_pred HhCCCCCCCCChHHHH-HH----HHHhcCCC--CCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 261 LTNRLPFEGMSNLQAA-YA----AAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 261 l~g~~pf~~~~~~~~~-~~----~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
++|..||.+....... +. ........ ..+..+++++.+||.+||..||.+|||+.++++
T Consensus 287 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999999875321100 00 00001111 222478999999999999999999999999988
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.64 Aligned_cols=260 Identities=24% Similarity=0.412 Sum_probs=192.7
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
......++|.+.+.||+|+||.||+|++. ++.||||++......... ...+.++..+++.++||||+++++++.+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN---KRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHH---HHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHH---HHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 34456678999999999999999999884 789999999876544332 2234455567888899999999999865
Q ss_pred C-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 130 ~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
+ ..++||||+ ++.+..+... ....+++..++.++.|++.||.|||++ |++|+||||+||+++.++ .+||+|||++
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~ 172 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGIS 172 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred CCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCc
Confidence 4 788999999 6566665544 346799999999999999999999995 999999999999999665 5999999999
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
.............|++.|+|||++.... .....++.++||||||+++|+|++|..||..................+.
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 173 GRLVDDKAKDRSAGCAAYMAPERIDPPD---PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL 249 (318)
T ss_dssp --------------CCTTCCHHHHC-----------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC
T ss_pred hhccCCccccccCCCccccChhhccccc---ccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC
Confidence 7655444445567999999999985311 0125678899999999999999999999987655555555555555555
Q ss_pred CC--CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 288 LP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 288 ~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
++ ..+++++.+++.+||..||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 54 3589999999999999999999999999983
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=336.09 Aligned_cols=256 Identities=20% Similarity=0.295 Sum_probs=201.5
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-----------CCCee
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-----------HDNLV 121 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~iv 121 (378)
+....|.+.+.||+|+||+||+|++ .++.||||++..... ....+.+|+.+++.++ ||||+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV------YTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH------HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc------chhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 3567899999999999999999986 578999999974321 1235778999988886 89999
Q ss_pred eEEeeEecC-----CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCC
Q 017046 122 KFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPD 195 (378)
Q Consensus 122 ~l~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~ 195 (378)
++++++.+. ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence 999988532 578999999 89999999876666799999999999999999999998 99999999999999532
Q ss_pred -----CCceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCC
Q 017046 196 -----QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (378)
Q Consensus 196 -----~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 270 (378)
...+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG--------APWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 225999999999764432 345579999999999864 56899999999999999999999999864
Q ss_pred Ch------HHHHHHHHH----------------------------------------hcCCCCCCCCChHHHHHHHHHcc
Q 017046 271 SN------LQAAYAAAF----------------------------------------KHARPGLPEDISPDLAFIVQSCW 304 (378)
Q Consensus 271 ~~------~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~l~~li~~~l 304 (378)
.. ......... ......++..++.++.+||.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 42 111111110 00112234456788999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 305 VEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 305 ~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
..||.+|||+.++++ +.++....
T Consensus 319 ~~dP~~Rpt~~ell~--hp~f~~~~ 341 (373)
T 1q8y_A 319 QLDPRKRADAGGLVN--HPWLKDTL 341 (373)
T ss_dssp CSSTTTCBCHHHHHT--CGGGTTCT
T ss_pred ccCccccCCHHHHhh--Chhhhccc
Confidence 999999999999999 66665543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=324.75 Aligned_cols=244 Identities=26% Similarity=0.413 Sum_probs=191.8
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec------
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------ 129 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 129 (378)
+.|.+.+.||+|+||.||+|+. +++.||||++.... . ....+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---E---KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---H---HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---H---HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 4689999999999999999987 47899999996421 1 12468899999999999999999998743
Q ss_pred --------CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeE
Q 017046 130 --------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 201 (378)
Q Consensus 130 --------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl 201 (378)
...++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++||||||+|||++.++ .+||
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl 157 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKI 157 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEE
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEE
Confidence 357899999999999999986 345688999999999999999999999999999999999999665 5999
Q ss_pred eccccccccccc---------------cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCC
Q 017046 202 ADFGLAREETVT---------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 266 (378)
Q Consensus 202 ~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p 266 (378)
+|||++...... .......|++.|+|||++.+ ...++.++|||||||++|+|++ |
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-------TGHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTS-------CSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC-------CCCCcchhhHHHHHHHHHHHHh---c
Confidence 999998754321 12234578999999999853 2468899999999999999998 6
Q ss_pred CCCCChHHHHHHHHHh---cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 267 FEGMSNLQAAYAAAFK---HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 267 f~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
|............... ...+.++...++.+.+++.+||..||.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 228 FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp CSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 6543332222322221 1233455567788999999999999999999999998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.05 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=175.7
Q ss_pred Ccceeecc-eeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHH-HHHhhccCCCeeeEEeeEec---
Q 017046 57 PKLLFIGS-KIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREV-NMMSRVKHDNLVKFLGACKD--- 129 (378)
Q Consensus 57 ~~~~~~~~-~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~l~~~~~~--- 129 (378)
..+|.+.+ .||+|+||+||+|++. ++.||||++.... . ..+|+ ..++.+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~--------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--K--------ARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--H--------HHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--H--------HHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 45688855 6999999999999885 7899999996521 1 12233 33566789999999998853
Q ss_pred --CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC--CCceeEeccc
Q 017046 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFG 205 (378)
Q Consensus 130 --~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~--~~~vkl~Dfg 205 (378)
...++||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+ ...+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 247899999999999999987555679999999999999999999999999999999999999753 2359999999
Q ss_pred cccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHH--HHHHh-
Q 017046 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY--AAAFK- 282 (378)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~~~~~- 282 (378)
++...... ......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+........ .....
T Consensus 177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (336)
T 3fhr_A 177 FAKETTQN-ALQTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247 (336)
T ss_dssp TCEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred cceecccc-ccccCCCCcCccChhhhCC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence 99754432 2345578999999999854 567889999999999999999999997654322111 11111
Q ss_pred ---cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 283 ---HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 283 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.........+++++.+|+.+||..||.+|||+.++++ +.++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~ 293 (336)
T 3fhr_A 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN--HPWINQ 293 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHHT
T ss_pred cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Cccccc
Confidence 1111222568999999999999999999999999999 444443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=329.14 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=199.5
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHH-HHHHHHHHHHHHHhhc----cCCCeeeEEeeEec
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERA-LLEGRFIREVNMMSRV----KHDNLVKFLGACKD 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~-~~~~~~~~E~~~l~~l----~hp~iv~l~~~~~~ 129 (378)
.+.|.+.+.||+|+||.||+|++ +++.||||++.......... .....+.+|+.++.++ +||||+++++++.+
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 46799999999999999999987 46899999997654432111 1112356799999998 89999999999864
Q ss_pred -CCeEEEEec-cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 130 -PLMVIVTEL-LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 130 -~~~~lv~e~-~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
+..++|||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+++.+||+|||++
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 478899999 7899999999863 469999999999999999999999999999999999999844456999999998
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
...... ......|++.|+|||++.. ....+.++||||||+++|+|++|..||..... .......
T Consensus 188 ~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~ 251 (312)
T 2iwi_A 188 ALLHDE-PYTDFDGTRVYSPPEWISR-------HQYHALPATVWSLGILLYDMVCGDIPFERDQE--------ILEAELH 251 (312)
T ss_dssp EECCSS-CBCCCCSCTTTSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHHTCCC
T ss_pred hhcccC-cccccCCcccccCceeeec-------CCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------HhhhccC
Confidence 765433 2345578999999998854 12234589999999999999999999975321 1224456
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
++..++.++.++|.+||..||.+|||+.++++ +.++....
T Consensus 252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--~~~~~~~~ 291 (312)
T 2iwi_A 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL--DPWMQTPA 291 (312)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH--STTTCC--
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHhc--ChhhcCch
Confidence 77889999999999999999999999999998 55555443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=326.53 Aligned_cols=254 Identities=24% Similarity=0.297 Sum_probs=200.2
Q ss_pred CcceeecceeecccceEEEEEEEC--C-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCC------eeeEEeeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--D-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN------LVKFLGAC 127 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~------iv~l~~~~ 127 (378)
.+.|.+.+.||+|+||+||++... + +.||+|+++... . ....+.+|+.+++.++|++ ++.+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--K----YREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--H----HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--c----chhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 467999999999999999999873 3 789999997432 1 1235778999999987665 88898888
Q ss_pred e-cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC------------
Q 017046 128 K-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP------------ 194 (378)
Q Consensus 128 ~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~------------ 194 (378)
. .+..++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 6 45789999999 678888887655567999999999999999999999999999999999999932
Q ss_pred ------CCCceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCC
Q 017046 195 ------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (378)
Q Consensus 195 ------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 268 (378)
....+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE--------LGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeec--------CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 2346999999999754322 345689999999999864 568899999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCC-C-----------------------------------------CCCCCChHHHHHHHHHcccc
Q 017046 269 GMSNLQAAYAAAFKHAR-P-----------------------------------------GLPEDISPDLAFIVQSCWVE 306 (378)
Q Consensus 269 ~~~~~~~~~~~~~~~~~-~-----------------------------------------~~~~~~~~~l~~li~~~l~~ 306 (378)
+................ + ......+.++.+||.+||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 87654433222111100 0 00112356789999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhhccC
Q 017046 307 DPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 307 dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
||.+|||+.++++ +.++....
T Consensus 321 dP~~Rpt~~e~l~--hp~f~~~~ 341 (355)
T 2eu9_A 321 DPAQRITLAEALL--HPFFAGLT 341 (355)
T ss_dssp STTTSCCHHHHTT--SGGGGGCC
T ss_pred ChhhCcCHHHHhc--ChhhcCCC
Confidence 9999999999998 66666543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=329.80 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=198.7
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CC-----CeeeEEeeEe
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HD-----NLVKFLGACK 128 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----~iv~l~~~~~ 128 (378)
..+|.+.+.||+|+||+||+|++. ++.||||+++.... ....+..|+.+++.++ |+ +|+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA------FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH------HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH------HHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 467999999999999999999874 68999999974321 1234667888888874 55 4999999886
Q ss_pred c-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCeeecCCCCcEEEcC-CCCceeEecc
Q 017046 129 D-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH--ANGIIHRDLKPDNLLLTP-DQKSLKLADF 204 (378)
Q Consensus 129 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH--~~givH~dikp~Nill~~-~~~~vkl~Df 204 (378)
+ ...++||||+. ++|.+++.......+++..+..++.|++.||.||| ..||+||||||+|||++. +...+||+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 4 57899999995 59999998765567999999999999999999999 579999999999999963 3446999999
Q ss_pred ccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017046 205 GLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 205 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
|++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...............
T Consensus 206 G~a~~~~~--~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 206 GSSCQLGQ--RIYQYIQSRFYRSPEVLLG--------MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp TTCEETTC--CCCSSCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cCceeccc--ccccccCCccccChHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99976532 2345689999999999865 5689999999999999999999999998776554433322111
Q ss_pred CCC----------------CCC------------------C----------------------------ChHHHHHHHHH
Q 017046 285 RPG----------------LPE------------------D----------------------------ISPDLAFIVQS 302 (378)
Q Consensus 285 ~~~----------------~~~------------------~----------------------------~~~~l~~li~~ 302 (378)
.+. ++. . .++++.+||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 100 000 0 01478999999
Q ss_pred ccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 303 CWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 303 ~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
||..||.+|||+.++++ +.++..
T Consensus 356 mL~~dP~~Rpta~e~L~--hp~f~~ 378 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQ--HSFFKK 378 (382)
T ss_dssp HTCSCTTTSCCHHHHTT--SGGGCC
T ss_pred hcCCChhhCCCHHHHhc--Cccccc
Confidence 99999999999999998 555543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=324.38 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=204.3
Q ss_pred cccCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHH-HHHHHHHHHHHHHhhcc--CCCeeeEEeeE
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERA-LLEGRFIREVNMMSRVK--HDNLVKFLGAC 127 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~--hp~iv~l~~~~ 127 (378)
...-.+.|.+.+.||+|+||.||+|++ +++.||||++.......... ....++.+|+.+++.++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 334467799999999999999999987 57899999997654321000 00123668999999996 59999999999
Q ss_pred ecC-CeEEEEeccCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 128 KDP-LMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 128 ~~~-~~~lv~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
.++ ..++|||++.+ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+.+.+||+|||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 754 67899999976 8999999763 5699999999999999999999999999999999999998555569999999
Q ss_pred cccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017046 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
++...... ......||+.|+|||++.. ...++.++||||||+++|+|++|..||..... .....
T Consensus 196 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~~~ 259 (320)
T 3a99_A 196 SGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIRGQ 259 (320)
T ss_dssp TCEECCSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHHCC
T ss_pred cccccccc-cccCCCCCccCCChHHhcc-------CCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------hhccc
Confidence 98765432 2344579999999998854 12346789999999999999999999975321 11234
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
..++..+++++.+||.+||..||.+|||+.++++ +.++..
T Consensus 260 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--hp~~~~ 299 (320)
T 3a99_A 260 VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQD 299 (320)
T ss_dssp CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGSS
T ss_pred ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc--CHhhcC
Confidence 4567789999999999999999999999999998 445443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=337.19 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=190.0
Q ss_pred cccCCcceeecceeecccceEE-EEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKV-YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP 130 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V-y~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 130 (378)
..+....|.+.+.||+|+||+| |.+..+++.||||++....... +.+|+.+++.+ +||||+++++++.+.
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~--------~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSF--------ADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEE--------CHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHH--------HHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 3455567999999999999985 5667788999999997644332 45899999999 799999999998755
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC----CceeEeccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ----KSLKLADFG 205 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~----~~vkl~Dfg 205 (378)
..++||||+. |+|.+++... ...+.+..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred CEEEEEEECCC-CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 6789999995 6999999763 33455566789999999999999999999999999999995322 247899999
Q ss_pred cccccccc----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 017046 206 LAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (378)
Q Consensus 206 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~ 280 (378)
++...... .......||+.|+|||++... ....++.++|||||||++|+|++ |..||........ ...
T Consensus 169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--~~~ 241 (432)
T 3p23_A 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED-----CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NIL 241 (432)
T ss_dssp EEECC------------CCSCTTSCCGGGTSCC--------CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--HHH
T ss_pred ceeeccCCCcceeeccccCCCcCccChhhhhcc-----cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--HHH
Confidence 99764432 223456799999999998631 12456789999999999999999 9999976543322 122
Q ss_pred HhcCCCC-C--CCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 281 FKHARPG-L--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 281 ~~~~~~~-~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
....... . +...+..+.+||.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 2111111 1 1234567899999999999999999999997
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=314.73 Aligned_cols=231 Identities=17% Similarity=0.160 Sum_probs=184.7
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 133 (378)
...|.+.+.||+|+||.||+|++. ++.||||++......... ....+.+|+.++..++||||+++++++.+ +..+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDD--VLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHH--HHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 357999999999999999999985 799999999876554322 23468899999999999999999999965 4789
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~ 213 (378)
+||||++|++|.+++.. .....++..++.|++.||.|||++||+||||||+|||++.++ .+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-~~kl~~~~-------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPA-------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-CEEECSCC--------
T ss_pred EEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-CEEEEecc--------
Confidence 99999999999999853 246667899999999999999999999999999999999665 48888543
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHH--HHHhcCCC---CC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAFKHARP---GL 288 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--~~~~~~~~---~~ 288 (378)
|++ .++.++|||||||++|+|++|+.||.+.+....... .......+ .+
T Consensus 175 -----------~~~---------------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T 3uqc_A 175 -----------TMP---------------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADI 228 (286)
T ss_dssp -----------CCT---------------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHH
T ss_pred -----------ccC---------------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhc
Confidence 222 256799999999999999999999987554211000 00000001 12
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
+..+++++.+++.+||+.||.+| |+.++++.|........
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 35689999999999999999999 99999999999876544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=329.08 Aligned_cols=250 Identities=22% Similarity=0.387 Sum_probs=184.1
Q ss_pred cceeecceeecccceEEEE-EEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYE-GRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+.+.||+|+||+||. +...++.||||++..... ..+.+|+.+++.+ +||||+++++++.++ ..++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--------DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGH--------HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 4566778999999999975 456789999999875321 2367899999887 899999999998754 6789
Q ss_pred EEeccCCCCHHHHHhhhCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC------------CC
Q 017046 135 VTELLPGMSLRKYLVSLRPNK-----LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD------------QK 197 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~-----l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~------------~~ 197 (378)
||||+. |+|.+++....... .++..++.++.||+.||.|||++||+||||||+|||++.+ ..
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999995 69999997632211 1233457899999999999999999999999999999743 23
Q ss_pred ceeEecccccccccccc-----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCC
Q 017046 198 SLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 271 (378)
Q Consensus 198 ~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 271 (378)
.+||+|||++....... ......||+.|+|||++.+.... .....++.++|||||||++|+|++ |..||.+..
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL-QTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTT-SCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccc-ccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 69999999997644322 12345799999999998642100 012568899999999999999999 999997654
Q ss_pred hHHHHHHHHHhcCC-CCC----CCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 272 NLQAAYAAAFKHAR-PGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 272 ~~~~~~~~~~~~~~-~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
..... ....... +.. +..+++++.+||.+||..||.+|||+.++++
T Consensus 245 ~~~~~--i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SRESN--IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp THHHH--HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhHHH--HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 43321 1111111 111 1235688999999999999999999999998
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=327.20 Aligned_cols=252 Identities=15% Similarity=0.172 Sum_probs=184.6
Q ss_pred cCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccC-CCe-----------
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH-DNL----------- 120 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i----------- 120 (378)
.....|.+.+.||+|+||+||+|++. ++.||||++......... ..+.+.+|+.+++.++| +|.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~--~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN--AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHH--HHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 44566889999999999999999975 799999998854443321 12458899999999976 221
Q ss_pred ----------eeEEeeEe------cCCeEEEEeccCCCCHHHHHhhh-----CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 017046 121 ----------VKFLGACK------DPLMVIVTELLPGMSLRKYLVSL-----RPNKLDLHVALNFALDIARAMDCLHANG 179 (378)
Q Consensus 121 ----------v~l~~~~~------~~~~~lv~e~~~~~sL~~~l~~~-----~~~~l~~~~~~~i~~qi~~~l~~lH~~g 179 (378)
..+...+. ....+++|+++ +++|.+++... ....+++..++.++.||+.||.|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 11111111 12356777776 78999998521 2345788899999999999999999999
Q ss_pred CeeecCCCCcEEEcCCCCceeEeccccccccccccccccCcCcccccccccccccccccc--ccccCCCcccchhhhHHH
Q 017046 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG--EKKHYNNKVDVYSFGIVL 257 (378)
Q Consensus 180 ivH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~~~~~~~~DiwslG~il 257 (378)
|+||||||+|||++.++. +||+|||+++..... ....+| +.|+|||++.......+ ....++.++|||||||++
T Consensus 232 iiHrDiKp~NILl~~~~~-~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGG-VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp EECSCCCGGGEEECTTCC-EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCe-EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999997665 999999998764433 345577 99999999843110000 235678899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 258 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 258 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
|+|++|+.||.+...... ... .......+|+++.+||.+||..||.+|||+.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~-~~~-----~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG-SEW-----IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC-SGG-----GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhh-HHH-----HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999987543221 111 11122468899999999999999999999777755
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=342.34 Aligned_cols=249 Identities=28% Similarity=0.343 Sum_probs=195.7
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec------
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------ 129 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 129 (378)
..|.+.+.||+|+||.||+|.+ +++.||||++........ ...+.+|+.+++.++||||+++++++.+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~----~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN----RERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHH----HHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHH----HHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 5799999999999999999986 478999999876544332 2468899999999999999999998643
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC--ceeEeccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFG 205 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~--~vkl~Dfg 205 (378)
...++||||++|++|.+++..... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. .+||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 467899999999999999976332 35899999999999999999999999999999999999986543 38999999
Q ss_pred cccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHH-------
Q 017046 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA------- 278 (378)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~------- 278 (378)
++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQ--------KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCC--------SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred cccccccccccccccCCcccCChHHhcc--------CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 9987665555566789999999999864 6789999999999999999999999976432211100
Q ss_pred -HHHh--------------cCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHH
Q 017046 279 -AAFK--------------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 318 (378)
Q Consensus 279 -~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 318 (378)
.... .....++..+++.+.+++.+||..||.+|||+.+++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0000 000112234678999999999999999999998743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=307.40 Aligned_cols=229 Identities=24% Similarity=0.418 Sum_probs=179.9
Q ss_pred cceeec-ceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHH-hhccCCCeeeEEeeEec----
Q 017046 58 KLLFIG-SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM-SRVKHDNLVKFLGACKD---- 129 (378)
Q Consensus 58 ~~~~~~-~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~l~~~~~~---- 129 (378)
..|.+. +.||+|+||.||++.+ +++.||+|++... ..+.+|+.++ +.++||||+++++++.+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 346666 7899999999999987 4789999999642 1356888888 55589999999998853
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC--CCceeEecccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGL 206 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~--~~~vkl~Dfg~ 206 (378)
...++||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.+ ...+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 467899999999999999987555679999999999999999999999999999999999999863 34699999998
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHH--HHhcC
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA--AFKHA 284 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~--~~~~~ 284 (378)
+.... ...++.++|||||||++|+|++|..||.+.......... .....
T Consensus 167 a~~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 217 (299)
T 3m2w_A 167 AKETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217 (299)
T ss_dssp CEECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTT
T ss_pred ccccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhc
Confidence 85321 134677999999999999999999999765432211000 00111
Q ss_pred CCCCC----CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 285 RPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 285 ~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
...++ ..+++++.+|+.+||..||.+|||+.++++ +.++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~--hp~~~~ 262 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQ 262 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHT
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc--Chhhcc
Confidence 11222 468899999999999999999999999999 445443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=340.87 Aligned_cols=234 Identities=26% Similarity=0.344 Sum_probs=189.9
Q ss_pred CcceeecceeecccceEEEEEEE---CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-C-
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L- 131 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~- 131 (378)
...|.+.+.||+|+||.||++.+ +++.||||++........ ...+.+|+.++..++||||+++++++.+. .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEA----QAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHH----HHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHH----HHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 46899999999999999999987 468999999876443322 24588999999999999999999998643 2
Q ss_pred ----eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 132 ----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 132 ----~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
.++||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a 228 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAV 228 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccc
Confidence 6999999999999987653 69999999999999999999999999999999999999854 5999999999
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
...... ....||+.|+|||++.. .++.++|||||||++|+|++|..||.+... ..
T Consensus 229 ~~~~~~---~~~~gt~~y~aPE~~~~---------~~~~~sDi~slG~~l~~l~~g~~~~~~~~~-------------~~ 283 (681)
T 2pzi_A 229 SRINSF---GYLYGTPGFQAPEIVRT---------GPTVATDIYTVGRTLAALTLDLPTRNGRYV-------------DG 283 (681)
T ss_dssp EETTCC---SCCCCCTTTSCTTHHHH---------CSCHHHHHHHHHHHHHHHHSCCCEETTEEC-------------SS
T ss_pred hhcccC---CccCCCccccCHHHHcC---------CCCCceehhhhHHHHHHHHhCCCCCccccc-------------cc
Confidence 764432 45579999999998853 347899999999999999999999875221 01
Q ss_pred CCC-----CChHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhh
Q 017046 288 LPE-----DISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFL 325 (378)
Q Consensus 288 ~~~-----~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~~~ 325 (378)
++. ..++.+.++|.+||..||.+|| +++++...|...+
T Consensus 284 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 111 1357899999999999999999 4666666665554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=309.81 Aligned_cols=244 Identities=16% Similarity=0.156 Sum_probs=184.6
Q ss_pred cCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCch---HHHHHHHHHHHHHHHHhhcc---------CCCeee
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSD---ERALLEGRFIREVNMMSRVK---------HDNLVK 122 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~---------hp~iv~ 122 (378)
+..++|.+.+.||+|+||+||+|+++++.||||++....... ........+.+|+.+++.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 345679999999999999999999999999999998764320 00000124678888888775 888888
Q ss_pred EEeeEe-------------------------------cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHH
Q 017046 123 FLGACK-------------------------------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171 (378)
Q Consensus 123 l~~~~~-------------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~ 171 (378)
+.+.+. +...++||||+++|++.+.+.. ..+++..++.++.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 777542 4678999999999976666533 568999999999999999
Q ss_pred HHHHH-hCCCeeecCCCCcEEEcCCC-------------------CceeEeccccccccccccccccCcCcccccccccc
Q 017046 172 MDCLH-ANGIIHRDLKPDNLLLTPDQ-------------------KSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231 (378)
Q Consensus 172 l~~lH-~~givH~dikp~Nill~~~~-------------------~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 231 (378)
|.||| ++||+||||||+|||++.++ ..+||+|||+++..... ..+||+.|+|||++
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence 99999 99999999999999998654 16999999999865432 34799999999998
Q ss_pred ccccccccccccCCCcccchhhhHH-HHHHHhCCCCCCCCChHHHHHHHHHhcC-CC-C----CCCCChHHHHHHHHHcc
Q 017046 232 STVTLRQGEKKHYNNKVDVYSFGIV-LWELLTNRLPFEGMSNLQAAYAAAFKHA-RP-G----LPEDISPDLAFIVQSCW 304 (378)
Q Consensus 232 ~~~~~~~~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~-~----~~~~~~~~l~~li~~~l 304 (378)
.+ . .+.++|||||+++ .+++++|..||.+............... .. . .+..+++++.+||.+||
T Consensus 250 ~g--------~-~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 250 TG--------D-GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp CC--------C-SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred cC--------C-CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHh
Confidence 64 2 2789999998777 7778889999854221111222222111 11 1 12247889999999999
Q ss_pred ccCCCCCCCHHHHH-H
Q 017046 305 VEDPNLRPSFSQII-R 319 (378)
Q Consensus 305 ~~dp~~Rps~~~ll-~ 319 (378)
+.| |+.+++ +
T Consensus 321 ~~d-----sa~e~l~~ 331 (336)
T 2vuw_A 321 NFS-----SATDLLCQ 331 (336)
T ss_dssp GSS-----SHHHHHHH
T ss_pred ccC-----CHHHHHhc
Confidence 976 999998 6
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=282.31 Aligned_cols=186 Identities=17% Similarity=0.167 Sum_probs=128.9
Q ss_pred eeecccceEEEEEE--ECCeeEEEEEeecCCC-----chHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEecC-CeEEE
Q 017046 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGST-----SDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIV 135 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~--~~~~~vavK~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~~lv 135 (378)
.++.|++|.+..++ +.++.||+|++..... ....+...+.|.+|+++|+++ .|+||++++++++++ ..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45677777776554 3688999999986542 223334446799999999999 799999999999765 78999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-c
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-~ 214 (378)
|||++|++|.++|.. .+.+++. .|+.||+.||+|+|++|||||||||+|||++.++ .+||+|||+|+..... .
T Consensus 321 MEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEeecccCeeCCCCCc
Confidence 999999999999986 4567664 5889999999999999999999999999999665 5999999999764332 2
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCC
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 265 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~ 265 (378)
.....+||+.|+|||++.+ .+..++|+|++|+++++|.++..
T Consensus 395 ~~~t~vGTp~YmAPE~l~g---------~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE---------NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CSHHHHHHHHHHHHHHC--------------------------CCCCTTHH
T ss_pred cccCceechhhccHHHhCC---------CCCCcccccccccchhhhccccc
Confidence 3345689999999999853 45678999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=251.73 Aligned_cols=188 Identities=22% Similarity=0.284 Sum_probs=145.1
Q ss_pred eecceeecccceEEEEEEECCeeEEEEEeecCCCch---HHHHHHHHHHHHHHHHhhccCCCee--eEEeeEecCCeEEE
Q 017046 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSD---ERALLEGRFIREVNMMSRVKHDNLV--KFLGACKDPLMVIV 135 (378)
Q Consensus 61 ~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv--~l~~~~~~~~~~lv 135 (378)
...+.||+|+||+||++...++.+++|+........ ......+++.+|++++++++||||+ .+++. .+...++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-DLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-ETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-eCCccEEE
Confidence 345689999999999998889999999876544322 2222345689999999999999999 55555 34567999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
|||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCccc
Confidence 999999999999864 5689999999999999999999999999999995 599999999986544322
Q ss_pred --------cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCC
Q 017046 216 --------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (378)
Q Consensus 216 --------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 268 (378)
.....||+.|+|||++... ...|+...|+|+..+-.++.+.++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~------~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERF------LEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHH------HHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHH------HHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2356899999999998642 1457778899999988888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=203.43 Aligned_cols=149 Identities=19% Similarity=0.177 Sum_probs=114.6
Q ss_pred cceeecceeecccceEEEEEEE-CCeeEEEEEeecCCCchH-----H--------HHHHHHHHHHHHHHhhccCCCeeeE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDE-----R--------ALLEGRFIREVNMMSRVKHDNLVKF 123 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~-----~--------~~~~~~~~~E~~~l~~l~hp~iv~l 123 (378)
..|.+++.||+|+||.||+|.+ +++.||||+++....... . ......+.+|+.+++.++| +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 3455669999999999999998 478999999975432111 0 0123468899999999984 555
Q ss_pred EeeEecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEec
Q 017046 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (378)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~D 203 (378)
.+++..+..++||||++|++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ ++ .+||+|
T Consensus 167 ~~~~~~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~-~vkl~D 235 (282)
T 1zar_A 167 PKVYAWEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE-GIWIID 235 (282)
T ss_dssp CCEEEEETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT-EEEECC
T ss_pred CeEEeccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC-cEEEEE
Confidence 55555567799999999999987 421 23457999999999999999999999999999999 54 599999
Q ss_pred cccccccccccccccCcCccccccccccc
Q 017046 204 FGLAREETVTEMMTAETGTYRWMAPELYS 232 (378)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 232 (378)
||++.. +..++|||.+.
T Consensus 236 FG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE------------TTSTTHHHHHH
T ss_pred CCCCeE------------CCCCCHHHHHH
Confidence 999853 34578888774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=181.48 Aligned_cols=141 Identities=16% Similarity=0.165 Sum_probs=108.2
Q ss_pred cceeecceeecccceEEEEEEE--CCee--EEEEEeecCCCchH-------------------HHHHHHHHHHHHHHHhh
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRI--VAIKVLNRGSTSDE-------------------RALLEGRFIREVNMMSR 114 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~--vavK~~~~~~~~~~-------------------~~~~~~~~~~E~~~l~~ 114 (378)
..|.+.+.||+|+||.||+|.+ .++. ||||+++....... .......+.+|+.++..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3477889999999999999987 7888 99999765422110 11223467899999999
Q ss_pred ccCCCe--eeEEeeEecCCeEEEEeccCC-C----CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeeecCC
Q 017046 115 VKHDNL--VKFLGACKDPLMVIVTELLPG-M----SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-ANGIIHRDLK 186 (378)
Q Consensus 115 l~hp~i--v~l~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH-~~givH~dik 186 (378)
+.|+++ +..++. ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +.||+|||||
T Consensus 127 l~~~~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHHTTCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HHhCCCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 988764 334432 356899999942 3 77776543 234567889999999999999 9999999999
Q ss_pred CCcEEEcCCCCceeEeccccccc
Q 017046 187 PDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 187 p~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
|.|||++. .++|+|||++..
T Consensus 199 p~NILl~~---~~~liDFG~a~~ 218 (258)
T 1zth_A 199 EYNIMYID---KVYFIDMGQAVT 218 (258)
T ss_dssp TTSEEESS---SEEECCCTTCEE
T ss_pred HHHEEEcC---cEEEEECccccc
Confidence 99999985 599999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.8e-19 Score=166.38 Aligned_cols=143 Identities=17% Similarity=0.232 Sum_probs=102.3
Q ss_pred CCcceeecceeecccceEEEEEEE-CCeeEEEEEeecCCCc---------------h--HHHHHHHHHHHHHHHHhhccC
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTS---------------D--ERALLEGRFIREVNMMSRVKH 117 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~---------------~--~~~~~~~~~~~E~~~l~~l~h 117 (378)
....|.++..||+|+||.||+|.. .|+.||||+++..... . ..........+|...|.++.+
T Consensus 93 rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 93 RKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 344589999999999999999986 4789999997642111 0 011111123467778888865
Q ss_pred CCee--eEEeeEecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC
Q 017046 118 DNLV--KFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 195 (378)
Q Consensus 118 p~iv--~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~ 195 (378)
.++. ..++. ...++||||++|++|..+.. ......++.|++.+|.+||..|||||||||.|||++.+
T Consensus 173 ~gv~vp~p~~~---~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 173 EGFPVPEPIAQ---SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp TTCSCCCEEEE---ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred cCCCCCeeeec---cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 5542 22322 23479999999988865432 12346788999999999999999999999999999855
Q ss_pred CC---------ceeEeccccccc
Q 017046 196 QK---------SLKLADFGLARE 209 (378)
Q Consensus 196 ~~---------~vkl~Dfg~a~~ 209 (378)
+. .+.|+||+.+..
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcccccccccceEEEEeCCccc
Confidence 42 278999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=5.8e-13 Score=118.66 Aligned_cols=137 Identities=15% Similarity=0.067 Sum_probs=105.3
Q ss_pred ceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec-CCeEEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-PLMVIVT 136 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~~~lv~ 136 (378)
.|.+...+|.|+.+.||++...++.+++|+......... ..+.+|+.+++.+. +..+.++++++.+ +..++||
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~-----~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT-----YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTST-----TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCH-----HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 466777888899999999988889999999875321111 13678999999884 6677788887754 4788999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA--------------------------------------- 177 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~--------------------------------------- 177 (378)
||++|.+|.+.+.. ......++.+++.+|..||+
T Consensus 90 e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 90 SEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp ECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999999875321 12234788899999999998
Q ss_pred --------------------CCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 178 --------------------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 178 --------------------~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
..++|+|++|.|||++. +..+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcc
Confidence 44899999999999984 4445699998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.30 E-value=8.5e-12 Score=116.39 Aligned_cols=139 Identities=16% Similarity=0.262 Sum_probs=104.9
Q ss_pred cceeecccceEEEEEEECCeeEEEEEee--cCCCchHHHHHHHHHHHHHHHHhhcc--CCCeeeEEeeEecC----CeEE
Q 017046 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLN--RGSTSDERALLEGRFIREVNMMSRVK--HDNLVKFLGACKDP----LMVI 134 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~----~~~l 134 (378)
.+.|+.|.++.||+....+..+++|+.. ....... ...+.+|+.+++.+. +..+++++..+.+. ..++
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~----~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPS----AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCc----HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 4678999999999998888889999876 3321111 124678999999996 45577888887653 4789
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA------------------------------------- 177 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~------------------------------------- 177 (378)
||||++|..+.+. ....++......++.+++..|+.||.
T Consensus 119 vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999999877541 12347888889999999999999997
Q ss_pred ---------------------CCCeeecCCCCcEEEcCCCC-ceeEeccccccc
Q 017046 178 ---------------------NGIIHRDLKPDNLLLTPDQK-SLKLADFGLARE 209 (378)
Q Consensus 178 ---------------------~givH~dikp~Nill~~~~~-~vkl~Dfg~a~~ 209 (378)
.+++|+|++|.|||++.++. .+.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999986553 358999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.24 E-value=6.7e-11 Score=104.80 Aligned_cols=130 Identities=15% Similarity=0.110 Sum_probs=92.0
Q ss_pred eeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCC--eeeEEeeEec-CCeEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--LVKFLGACKD-PLMVIV 135 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~~~~-~~~~lv 135 (378)
+.+....+.|..+.||++... ++.+++|+...... ..+.+|+.+++.+.+.+ +.+++++..+ +..++|
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~--------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCcccc--------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 333333346667999998764 46799999765421 13668999999886445 4557777654 467999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG------------------------------------ 179 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~g------------------------------------ 179 (378)
|||++|.+|. .. ..+. ..++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~-----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 94 LGEVPGQDLL--SS-----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EECCSSEETT--TS-----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEecCCcccC--cC-----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 9999998884 21 1122 356777888888888753
Q ss_pred ----------------------CeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 180 ----------------------IIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 180 ----------------------ivH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
++|+|++|.|||++. +..+.|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhcc
Confidence 999999999999984 4435699999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.21 E-value=3e-11 Score=110.02 Aligned_cols=191 Identities=19% Similarity=0.229 Sum_probs=120.7
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCC--eeeEEeeEecC----CeEEEE
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDN--LVKFLGACKDP----LMVIVT 136 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~--iv~l~~~~~~~----~~~lv~ 136 (378)
+.++.|.+..||+.. ..+++|+.... . ....+.+|..+++.+ .+.. +...+....+. ..|+||
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~---~----~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS---R----GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH---H----HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc---c----hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 468999999999873 67899986432 1 123578999999888 3333 33444443322 347899
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA--------------------------------------- 177 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~--------------------------------------- 177 (378)
++++|.+|.+... ..++..+...++.+++..|..||+
T Consensus 96 ~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999988875433 247788888889999999999886
Q ss_pred -------------------CCCeeecCCCCcEEEcCC-CCceeEeccccccccccccccccCcCcccccccccccc----
Q 017046 178 -------------------NGIIHRDLKPDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST---- 233 (378)
Q Consensus 178 -------------------~givH~dikp~Nill~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---- 233 (378)
..++|+|++|.||+++.+ +..+.|+||+.+.................-..|+....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 136999999999999964 44578999998864322211110000000012221110
Q ss_pred ccccc--cccccCCCcccchhhhHHHHHHHhCCCCCC
Q 017046 234 VTLRQ--GEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (378)
Q Consensus 234 ~~~~~--~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 268 (378)
+.... ..........+.|+++.++|.+.+|..+|.
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00000 000011123588999999999999988763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=8.1e-08 Score=87.30 Aligned_cols=132 Identities=20% Similarity=0.205 Sum_probs=92.0
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCC---CeeeEEeeEe--cCCeEEEEec
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD---NLVKFLGACK--DPLMVIVTEL 138 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---~iv~l~~~~~--~~~~~lv~e~ 138 (378)
..++.|....||+. ++.+++|+... .. ....+.+|..+|+.+.+. .+.+.+.+.. ++..++||||
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~---~~----~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS---QQ----GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS---HH----HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC---ch----HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 45788999999988 67889998522 11 123578999999999642 2445555553 3467899999
Q ss_pred cCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 017046 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN---------------------------------------- 178 (378)
Q Consensus 139 ~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---------------------------------------- 178 (378)
++|.+|.+... ..++......++.++...|..||+.
T Consensus 95 i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 95 VQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred cCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 99988876322 1345555556666666666666643
Q ss_pred --------------------CCeeecCCCCcEEEcC---CCCceeEeccccccc
Q 017046 179 --------------------GIIHRDLKPDNLLLTP---DQKSLKLADFGLARE 209 (378)
Q Consensus 179 --------------------givH~dikp~Nill~~---~~~~vkl~Dfg~a~~ 209 (378)
.++|+|++|.||+++. ++..+.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999986 244357999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.2e-06 Score=77.78 Aligned_cols=128 Identities=17% Similarity=0.144 Sum_probs=86.6
Q ss_pred eecccce-EEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec-CCeEEEEeccC
Q 017046 66 IGEGAHG-KVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-PLMVIVTELLP 140 (378)
Q Consensus 66 lG~G~~g-~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~~~lv~e~~~ 140 (378)
+..|..+ .||+... .+..+++|+-.... ...+.+|..+|+.+. +--+.++++++.+ +..++|||+++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~--------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV--------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHH--------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCC--------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 4455555 6887654 35679999875421 124678999988884 3235667777754 46789999999
Q ss_pred CCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 017046 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN------------------------------------------ 178 (378)
Q Consensus 141 ~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~------------------------------------------ 178 (378)
|.++.+..... ......++.++...|..||..
T Consensus 104 G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 104 GKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp SEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred CccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 98887765431 122234556666666666641
Q ss_pred ----------------CCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 179 ----------------GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 179 ----------------givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
.++|+|+.+.|||++. ++.+-|+||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~-~~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDE-GKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEEC-CeEEEEEECcccc
Confidence 1799999999999984 4445699999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=7.2e-07 Score=82.67 Aligned_cols=78 Identities=8% Similarity=0.003 Sum_probs=52.7
Q ss_pred ccee-ecccceEEEEEEEC--------CeeEEEEEeecCC---CchHHHHHHHHHHHHHHHHhhcc-C--CCeeeEEeeE
Q 017046 63 GSKI-GEGAHGKVYEGRYG--------DRIVAIKVLNRGS---TSDERALLEGRFIREVNMMSRVK-H--DNLVKFLGAC 127 (378)
Q Consensus 63 ~~~l-G~G~~g~Vy~~~~~--------~~~vavK~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~-h--p~iv~l~~~~ 127 (378)
.+.| +.|....+|+.... ++.+++|+..... .... ..+.+|+.+++.+. + -.+.+++.++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~-----~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT-----YRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC-----CCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch-----hHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 4567 88989999988764 6789999865432 1000 12557888888774 3 3466677776
Q ss_pred ecC----CeEEEEeccCCCCHH
Q 017046 128 KDP----LMVIVTELLPGMSLR 145 (378)
Q Consensus 128 ~~~----~~~lv~e~~~~~sL~ 145 (378)
.+. ..++||||++|.++.
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCCC
T ss_pred cCCCccCCceEEEEecCCCChh
Confidence 543 468999999886653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=4.8e-07 Score=85.22 Aligned_cols=79 Identities=23% Similarity=0.198 Sum_probs=48.2
Q ss_pred cceeecccceEEEEEEE--CCeeEEEEEeecCCC-chHH-HHHHHHHHHHHHHHhhccC--CCe-eeEEeeEecCCeEEE
Q 017046 63 GSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGST-SDER-ALLEGRFIREVNMMSRVKH--DNL-VKFLGACKDPLMVIV 135 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~-~~~~~~~~~E~~~l~~l~h--p~i-v~l~~~~~~~~~~lv 135 (378)
.+.||.|.++.||++.. .++.++||....... .... .....++..|.++++.+.. |.. ..++.+ ..+..++|
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~~~~~lv 113 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV 113 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cCCccEEE
Confidence 45789999999999954 457899998653221 0000 0011245678888887742 333 345543 34466899
Q ss_pred EeccCCC
Q 017046 136 TELLPGM 142 (378)
Q Consensus 136 ~e~~~~~ 142 (378)
||+++|.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=2.5e-05 Score=71.50 Aligned_cols=72 Identities=11% Similarity=0.182 Sum_probs=41.2
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-----CCCeeeEE-e--e-EecCCeEE
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-----HDNLVKFL-G--A-CKDPLMVI 134 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~l~-~--~-~~~~~~~l 134 (378)
..|+.|..+.||+....+..+++|+.... .. .+..|+.+++.|. .|.++... + + ..++..++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~~------~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---EK------KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC---HH------HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC---HH------HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 35666788999999887778999998752 11 1234445554442 34444311 1 1 12456789
Q ss_pred EEeccCCCCH
Q 017046 135 VTELLPGMSL 144 (378)
Q Consensus 135 v~e~~~~~sL 144 (378)
+|+|++|.++
T Consensus 109 l~~~i~G~~~ 118 (346)
T 2q83_A 109 VYDWIEGRPF 118 (346)
T ss_dssp EEECCCCBCC
T ss_pred EEEeecCccC
Confidence 9999998643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.96 E-value=8e-05 Score=62.82 Aligned_cols=143 Identities=16% Similarity=0.168 Sum_probs=93.5
Q ss_pred CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCCceeEeccccccccccccccccCc
Q 017046 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 220 (378)
Q Consensus 142 ~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 220 (378)
.+|.++|.. .+.+++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|. |-+.+ +.+. .
T Consensus 33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~-V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA-VTLAP-AADD-----------A 98 (229)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC-EEECC-C---------------
T ss_pred ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc-eeccc-cccc-----------c
Confidence 379999987 46799999999999999999887622 11123334568888887765 55442 1110 1
Q ss_pred CccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 017046 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 300 (378)
Q Consensus 221 gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 300 (378)
....+.|||... ...+.+.=|||||++||.-+--..| +.-+..+|+.+..||
T Consensus 99 ~~~~~~~pe~~~---------~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL 150 (229)
T 2yle_A 99 GEPPPVAGKLGY---------SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLI 150 (229)
T ss_dssp --------CCSS---------SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHH
T ss_pred cccCCCChhhcc---------ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHH
Confidence 233577888752 2346788999999999998863332 122356899999999
Q ss_pred HHcccc-------------------------CCCCCCCHHHHHHHHHhhhh
Q 017046 301 QSCWVE-------------------------DPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 301 ~~~l~~-------------------------dp~~Rps~~~ll~~l~~~~~ 326 (378)
..|... .+..|+++++|++.-..-+.
T Consensus 151 ~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~ 201 (229)
T 2yle_A 151 DHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLP 201 (229)
T ss_dssp HHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSS
T ss_pred HHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhcc
Confidence 999765 24678899999886665444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.89 E-value=9.4e-05 Score=70.02 Aligned_cols=34 Identities=24% Similarity=0.371 Sum_probs=28.0
Q ss_pred HhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 176 H~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
+...++|+|++|.|||++.+ + +.|+||+.+....
T Consensus 230 ~~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFYGP 263 (420)
T ss_dssp BCCEEECSCCSGGGEEECSS-C-EEECCCTTCEEEC
T ss_pred CCCeEEecCCCCCcEEEeCC-C-CEEEeCcccccCc
Confidence 45679999999999999854 3 8999999886543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.89 E-value=5.9e-05 Score=68.35 Aligned_cols=74 Identities=15% Similarity=0.124 Sum_probs=56.2
Q ss_pred cceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc---CCCeeeEEeeEec-CCeEEEEec
Q 017046 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---HDNLVKFLGACKD-PLMVIVTEL 138 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~~-~~~~lv~e~ 138 (378)
...|+.|.+..+|+....++.+++|+..... ...+..|...|+.|. ...+++.+.+..+ +..++||||
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~--------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSY--------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGG--------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCccc--------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 3578999999999998878899999876431 124778988888884 2456777777653 468899999
Q ss_pred cCCCCH
Q 017046 139 LPGMSL 144 (378)
Q Consensus 139 ~~~~sL 144 (378)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.84 E-value=5.6e-05 Score=68.13 Aligned_cols=71 Identities=11% Similarity=0.107 Sum_probs=44.1
Q ss_pred cceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCe-eeEEeeEecCCeEEEEecc-C
Q 017046 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVIVTELL-P 140 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~~lv~e~~-~ 140 (378)
.+.|+.|....+|+. +.+++|+......... ...+|+.+++.+...++ .++++.. ....++++||+ +
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~------~r~~E~~~l~~l~~~g~~P~~~~~~-~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEYI------NRANEAVAAREAAKAGVSPEVLHVD-PATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----CC------CHHHHHHHHHHHHHTTSSCCEEEEC-TTTCCEEEECCTT
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcccee------CHHHHHHHHHHHHHcCCCCceEEEE-CCCCEEEEeecCC
Confidence 467899999999998 6788998765321110 12357777776643233 3455543 33457899999 6
Q ss_pred CCCH
Q 017046 141 GMSL 144 (378)
Q Consensus 141 ~~sL 144 (378)
|.+|
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00011 Score=65.71 Aligned_cols=76 Identities=12% Similarity=0.091 Sum_probs=52.1
Q ss_pred eeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccC--C-CeeeEEeeEecCCeEEE
Q 017046 60 LFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--D-NLVKFLGACKDPLMVIV 135 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p-~iv~l~~~~~~~~~~lv 135 (378)
+.-+..+|.|..+.||+.... |+.|++|+......... ..|.+|...|+.|.. + -+.+.++.. ..++|
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~-----~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---~~~lv 88 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALD-----GLFRAEALGLDWLGRSFGSPVPQVAGWD---DRTLA 88 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCT-----THHHHHHHHHHHHTCSTTCCSCCEEEEE---TTEEE
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchh-----hHHHHHHHHHHHHHhhCCCCcceEEecc---CceEE
Confidence 344578999999999999875 58899998765433221 136689988888842 1 234445432 34789
Q ss_pred EeccCCCC
Q 017046 136 TELLPGMS 143 (378)
Q Consensus 136 ~e~~~~~s 143 (378)
|||++++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00016 Score=66.06 Aligned_cols=137 Identities=12% Similarity=0.123 Sum_probs=70.4
Q ss_pred ceeecccceE-EEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccC--CCeeeEEeeEecCCeEEEEecc
Q 017046 64 SKIGEGAHGK-VYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--DNLVKFLGACKDPLMVIVTELL 139 (378)
Q Consensus 64 ~~lG~G~~g~-Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~~~~~~lv~e~~ 139 (378)
..|+.|+... +|+.... ++.+++|........ .+..|+.+++.+.. -.+.+++.+..+. .+++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~--------~~~~e~~~l~~L~~~g~~vP~v~~~d~~~-g~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGG--------DTQPFVDLAQYLRNLDISAPEIYAEEHAR-GLLLIEDL 94 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTTC--------CSHHHHHHHHHHHHTTCBCCCEEEEETTT-TEEEECCC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCc--------cccHHHHHHHHHHhCCCCCCceeeecCCC-CEEEEeeC
Confidence 3465665554 6677664 667778765543211 13356666666632 2244566554333 37899999
Q ss_pred CCCCHHHHHhhhC---------------------C---CCCCHHHHH-------H-HH------------HHHHHHHHHH
Q 017046 140 PGMSLRKYLVSLR---------------------P---NKLDLHVAL-------N-FA------------LDIARAMDCL 175 (378)
Q Consensus 140 ~~~sL~~~l~~~~---------------------~---~~l~~~~~~-------~-i~------------~qi~~~l~~l 175 (378)
.+..+.+++.... . ..++..... . +. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 7767765443210 0 012221110 0 00 0111122222
Q ss_pred ------HhCCCeeecCCCCcEEEcCC---CCceeEeccccccc
Q 017046 176 ------HANGIIHRDLKPDNLLLTPD---QKSLKLADFGLARE 209 (378)
Q Consensus 176 ------H~~givH~dikp~Nill~~~---~~~vkl~Dfg~a~~ 209 (378)
+...++|||+.+.|||++.+ ...+.|+||+.+..
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 23469999999999999853 13589999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.0002 Score=64.98 Aligned_cols=139 Identities=22% Similarity=0.220 Sum_probs=75.7
Q ss_pred cceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCC--eeeEEee-------EecCCeE
Q 017046 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--LVKFLGA-------CKDPLMV 133 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~-------~~~~~~~ 133 (378)
.+.|+.|....+|+....+..+++|+........ .+..|+.+++.+...+ +.+++.. ..++..+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~-------~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKN-------DLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC---CC-------HHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eeccCCCcccceEEEEeCCccEEEEEeCCCCCHH-------HHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 4567888889999998777789999987632111 2446777777664222 2223221 1234568
Q ss_pred EEEeccCCCCHH-----------HH---Hhhh-CC--CC----CC---HHHHHH------------HHHHHHHHHHHHHh
Q 017046 134 IVTELLPGMSLR-----------KY---LVSL-RP--NK----LD---LHVALN------------FALDIARAMDCLHA 177 (378)
Q Consensus 134 lv~e~~~~~sL~-----------~~---l~~~-~~--~~----l~---~~~~~~------------i~~qi~~~l~~lH~ 177 (378)
++|+|++|..+. .. +... .. .. .. +..... +...+...+..++.
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 999999886431 01 1110 00 00 11 111000 00113344555542
Q ss_pred -------CCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 178 -------NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 178 -------~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
.+++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence 369999999999999844 3347999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00021 Score=67.80 Aligned_cols=71 Identities=18% Similarity=0.275 Sum_probs=48.0
Q ss_pred cceeecccceEEEEEEEC---------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCe-eeEEeeEecCCe
Q 017046 63 GSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLM 132 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~ 132 (378)
.+.|+.|....||+.... ++.+++|+...... . ..+.+|..+++.+...++ .++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-~------~~li~E~~~l~~L~~~g~~P~l~~~~~~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-E------SHLVAESVIFTLLSERHLGPKLYGIFSG--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-H------HHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-H------HHHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence 457888999999998764 46899998844211 0 124478888888853344 556666543
Q ss_pred EEEEeccCCCC
Q 017046 133 VIVTELLPGMS 143 (378)
Q Consensus 133 ~lv~e~~~~~s 143 (378)
.+|+||++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38999998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00045 Score=64.22 Aligned_cols=137 Identities=15% Similarity=0.246 Sum_probs=77.7
Q ss_pred ceeecccceEEEEEEEC---------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCC-eeeEEeeEecCCeE
Q 017046 64 SKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN-LVKFLGACKDPLMV 133 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~l~~~~~~~~~~ 133 (378)
+.|..|-...+|+.... ++.+++|+........ ..+.+|..+++.+..-+ ..++++.+.+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~------~~~~rE~~vl~~L~~~gv~P~ll~~~~~---g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGV------DSLVLESVMFAILAERSLGPQLYGVFPE---G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCH------HHHHHHHHHHHHHHHTTSSCCEEEEETT---E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchH------HHHHHHHHHHHHHHhcCCCCeEEEEcCC---c
Confidence 46777888899998763 3689999864321111 12458999888884322 3556766654 2
Q ss_pred EEEeccCCCCHH--------------HHHhhhC------CCCCC--HHHHHHHHHHHHH-------------------HH
Q 017046 134 IVTELLPGMSLR--------------KYLVSLR------PNKLD--LHVALNFALDIAR-------------------AM 172 (378)
Q Consensus 134 lv~e~~~~~sL~--------------~~l~~~~------~~~l~--~~~~~~i~~qi~~-------------------~l 172 (378)
+||||++|.+|. +.+.... ..... +.++.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 899999886542 1111100 11111 3445555544322 12
Q ss_pred HHH----HhC----CCeeecCCCCcEEEcCC---CCceeEeccccccc
Q 017046 173 DCL----HAN----GIIHRDLKPDNLLLTPD---QKSLKLADFGLARE 209 (378)
Q Consensus 173 ~~l----H~~----givH~dikp~Nill~~~---~~~vkl~Dfg~a~~ 209 (378)
..| ... .++|+|+.+.|||++.+ .+.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 222 58999999999999865 24589999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00042 Score=64.28 Aligned_cols=71 Identities=14% Similarity=0.159 Sum_probs=42.5
Q ss_pred ceeecccceEEEEEEECC----------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCC-eeeEEeeEecCCe
Q 017046 64 SKIGEGAHGKVYEGRYGD----------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN-LVKFLGACKDPLM 132 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~l~~~~~~~~~ 132 (378)
..|+.|....+|+....+ +.+++|+......... ....|..+++.+...+ +.++++.. + .
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~------~~~~E~~~l~~L~~~g~~P~~~~~~-~--~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELY------NTISEFEVYKTMSKYKIAPQLLNTF-N--G 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTS------CHHHHHHHHHHHHHTTSSCCEEEEE-T--T
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcccee------cHHHHHHHHHHHHhcCCCCceEEec-C--C
Confidence 567888889999987654 6889998754321110 1246777777774333 33566544 2 3
Q ss_pred EEEEeccCCCC
Q 017046 133 VIVTELLPGMS 143 (378)
Q Consensus 133 ~lv~e~~~~~s 143 (378)
++||+|++|.+
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0029 Score=60.39 Aligned_cols=73 Identities=14% Similarity=0.079 Sum_probs=47.5
Q ss_pred cceeecccceEEEEEEECC--eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCe-eeEEeeEecCCeEEEEecc
Q 017046 63 GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVIVTELL 139 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~~lv~e~~ 139 (378)
++.|+.|-...+|+....+ ..+++|+......... ...+|..++..|...++ .++++.+.+ .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i------dR~~E~~vl~~L~~~gl~P~ll~~~~~---G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII------NREREKKISCILYNKNIAKKIYVFFTN---GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS------CHHHHHHHHHHHTTSSSBCCEEEEETT---EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc------CHHHHHHHHHHHHhcCCCCCEEEEeCC---eEEEEee
Confidence 3568889999999998876 8899998754321110 01378888888865444 457776632 3599999
Q ss_pred CCCCH
Q 017046 140 PGMSL 144 (378)
Q Consensus 140 ~~~sL 144 (378)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0034 Score=56.88 Aligned_cols=72 Identities=11% Similarity=0.146 Sum_probs=44.2
Q ss_pred eeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCC--eeeEEee-----E-ecCCeEEE
Q 017046 65 KIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--LVKFLGA-----C-KDPLMVIV 135 (378)
Q Consensus 65 ~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~-----~-~~~~~~lv 135 (378)
.|+ |....||+.... ++.+++|+........ ..+..|..+++.+...+ +++++.. . .++..+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~------~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH------HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 466 888899988764 4579999987443222 13556777777764222 3333332 0 13455789
Q ss_pred EeccCCCC
Q 017046 136 TELLPGMS 143 (378)
Q Consensus 136 ~e~~~~~s 143 (378)
|+|++|..
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0039 Score=57.00 Aligned_cols=31 Identities=19% Similarity=0.339 Sum_probs=25.6
Q ss_pred CCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 178 ~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
..++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence 3699999999999998544 489999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0095 Score=56.12 Aligned_cols=73 Identities=10% Similarity=0.099 Sum_probs=47.0
Q ss_pred cceeecccceEEEEEEEC---------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCe-eeEEeeEecCCe
Q 017046 63 GSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLM 132 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~ 132 (378)
++.|..|-...+|+.... ++.+++++......... ...+|..+++.+..-++ .++++.+. .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i------dR~~E~~~l~~L~~~gi~P~l~~~~~---~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY------DSKVELDVFRYLSNINIAPNIIADFP---E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC------CHHHHHHHHHHHHHTTSSCCEEEEET---T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc------CHHHHHHHHHHHHhcCCCCCEEEEcC---C
Confidence 356777889999998875 57899998754321110 12367788877743233 44555432 3
Q ss_pred EEEEeccCCCCH
Q 017046 133 VIVTELLPGMSL 144 (378)
Q Consensus 133 ~lv~e~~~~~sL 144 (378)
++||+|++|.+|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 789999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.72 E-value=0.12 Score=48.29 Aligned_cols=30 Identities=30% Similarity=0.490 Sum_probs=24.5
Q ss_pred CeeecCCCCcEEEcC-----CCCceeEeccccccc
Q 017046 180 IIHRDLKPDNLLLTP-----DQKSLKLADFGLARE 209 (378)
Q Consensus 180 ivH~dikp~Nill~~-----~~~~vkl~Dfg~a~~ 209 (378)
++|+|+.+.|||+.. +...+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 689999999999942 344699999998864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.51 E-value=0.053 Score=51.70 Aligned_cols=61 Identities=11% Similarity=0.035 Sum_probs=16.8
Q ss_pred eecceeecccceEEEEEEECC--eeEEE------EEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 61 FIGSKIGEGAHGKVYEGRYGD--RIVAI------KVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 61 ~~~~~lG~G~~g~Vy~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
.+.+.|| ||.||+|.+.+ .+||+ |..+......+. ...+.+|..+++.++|||+++.+++.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~---~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKR---LTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC--------------------------------------CBCCCEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccc---cccccccccccccccccccCCCcceE
Confidence 3456777 99999998764 47888 665543322221 13477899999999999999876643
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.00 E-value=2.6 Score=35.39 Aligned_cols=113 Identities=10% Similarity=0.124 Sum_probs=71.8
Q ss_pred cCCCeeeEEeeEecCCeEEEEeccCCC-CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCeeecCCCCcEEEc
Q 017046 116 KHDNLVKFLGACKDPLMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMD-CLHANGIIHRDLKPDNLLLT 193 (378)
Q Consensus 116 ~hp~iv~l~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~-~lH~~givH~dikp~Nill~ 193 (378)
.||++ +.--...++.+.+.++.-+++ ++.. +. .++....++++.+|+.... +++ .-+|--+.|+|++++
T Consensus 48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~~-i~-----~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFAA-IR-----KTTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS-EEEEEECSSEEEEEEECCTTCEEHHH-HH-----TSCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGEEEC
T ss_pred cCCCC-CeEEEEeCCEEEEEEEcCcccCcHHH-HH-----hcCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceEEEe
Confidence 68888 432223344555555554333 3443 32 4788999999999887665 443 458889999999999
Q ss_pred CCCCceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccch-hhhHHHHHHHhCCCCCC
Q 017046 194 PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY-SFGIVLWELLTNRLPFE 268 (378)
Q Consensus 194 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diw-slG~il~~ll~g~~pf~ 268 (378)
.++ .++|.-.|+-. -++|.-+ + ..|.| .+=|++..++.++..|.
T Consensus 119 ~~~-~p~i~hRGi~~----------------~lpP~e~-------------~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 119 RAL-EPFFLHVGVKE----------------SLPPDEW-------------D-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp TTC-CEEESCCEETT----------------TBSSCSC-------------C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred CCC-cEEEEEcCCcc----------------cCCCCCC-------------C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 554 59998877642 2233321 1 22333 47788888988887763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 378 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-82 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-75 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-74 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-73 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-72 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-71 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-71 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-70 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-70 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-70 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-70 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-68 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-68 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-68 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-67 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-67 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-67 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-66 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-65 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-65 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-63 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-62 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-62 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-61 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-60 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-59 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-58 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-58 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-57 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-57 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-56 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-54 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-53 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-52 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-51 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-51 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-50 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-50 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-50 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-49 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-49 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-48 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-45 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-45 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-42 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-39 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-38 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-26 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (639), Expect = 4e-82
Identities = 82/281 (29%), Positives = 144/281 (51%), Gaps = 18/281 (6%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
+ + +G +IG G+ G VY+G++ VA+K+LN + + ++ F EV ++ +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQ---LQAFKNEVGVLRK 60
Query: 115 VKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+H N++ F+G P + IVT+ G SL +L + K ++ ++ A A+ MD
Sbjct: 61 TRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDY 119
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELY 231
LHA IIHRDLK +N+ L D ++K+ DFGLA + + +G+ WMAPE+
Sbjct: 120 LHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV- 177
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----PG 287
+R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N +
Sbjct: 178 ----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328
+ + + ++ C + + RP F QI+ + +L
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 1e-75
Identities = 80/274 (29%), Positives = 127/274 (46%), Gaps = 18/274 (6%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
V + L + ++G G G+V+ G Y G VA+K L +GS S + F+ E N+M
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA------FLAEANLMK 63
Query: 114 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+++H LV+ + I+TE + SL +L + KL ++ L+ A IA M
Sbjct: 64 QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELY 231
+ IHRDL+ N+L+ D S K+ADFGLAR E+ +W APE
Sbjct: 124 FIEERNYIHRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291
+ + K DV+SFGI+L E++T+ + R P++
Sbjct: 183 NY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+L +++ CW E P RP+F + +L F
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 2e-74
Identities = 81/269 (30%), Positives = 129/269 (47%), Gaps = 20/269 (7%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
++ K L + IG+G G V G Y VA+K + +T+ F+ E ++M++
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ-------AFLAEASVMTQ 56
Query: 115 VKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++H NLV+ LG + + IVTE + SL YL S + L L F+LD+ AM
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
+ L N +HRDL N+L++ D K++DFGL +E + +W APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALR 173
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292
K ++ K DV+SFGI+LWE+ + L+ K + P+
Sbjct: 174 E--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 225
Query: 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
P + ++++CW D +RPSF Q+ L
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 2e-73
Identities = 70/292 (23%), Positives = 135/292 (46%), Gaps = 29/292 (9%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALL 101
+L + R LL ++G G G V +G Y VAIKVL +G+ +
Sbjct: 2 KLFLKRD-----NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-- 54
Query: 102 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 161
+RE +M ++ + +V+ +G C+ +++V E+ G L K+LV + ++ +
Sbjct: 55 --EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNV 111
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMT 217
++ M L +HRDL N+LL K++DFGL++ +++ +
Sbjct: 112 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARS 170
Query: 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAA 276
A +W APE + + ++++ DV+S+G+ +WE L+ + P++ M +
Sbjct: 171 AGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-V 221
Query: 277 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328
A + R P + P+L ++ CW+ RP F + + + A ++L
Sbjct: 222 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 9e-72
Identities = 74/274 (27%), Positives = 125/274 (45%), Gaps = 25/274 (9%)
Query: 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
D + L +IG G+ VY+G VA L + RF E M+
Sbjct: 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---RQRFKEEAEMLK 63
Query: 114 RVKHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
++H N+V+F + + + +V+VTEL+ +L+ YL R + + V ++ I
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQI 121
Query: 169 ARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM 226
+ + LH IIHRDLK DN+ +T S+K+ D GLA + A GT +M
Sbjct: 122 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFM 180
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286
APE+Y ++ Y+ VDVY+FG+ + E+ T+ P+ N Y +P
Sbjct: 181 APEMY---------EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 231
Query: 287 G-LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+ P++ I++ C ++ + R S ++
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 1e-71
Identities = 72/284 (25%), Positives = 128/284 (45%), Gaps = 25/284 (8%)
Query: 53 LLVDPKLLFIGSK-IGEGAHGKVYEGRYGD----RIVAIKVLNRGSTSDERALLEGRFIR 107
+ +D KLL + K +G G G V +G Y + VA+K+L + L+ +
Sbjct: 1 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA---LKDELLA 57
Query: 108 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
E N+M ++ + +V+ +G C+ ++V E+ L KYL R + +
Sbjct: 58 EANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQ 115
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTY 223
++ M L + +HRDL N+LL K++DFGL++ +E + T
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFK 282
+W APE + +++K DV+SFG+++WE + + P+ GM + A K
Sbjct: 175 KWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEK 225
Query: 283 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326
R G P ++ ++ CW D RP F+ + L + +
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 1e-71
Identities = 65/261 (24%), Positives = 121/261 (46%), Gaps = 19/261 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG +G+G G VY R I+A+KVL + +E + REV + S ++H N
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPN 67
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+++ G D + ++ E P ++ + L + +K D + ++A A+ H+
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHSK 125
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
+IHRD+KP+NLLL LK+ADFG + + T GT ++ PE+
Sbjct: 126 RVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEG----- 178
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298
+ ++ KVD++S G++ +E L + PFE + + P+ ++
Sbjct: 179 ---RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARD 233
Query: 299 IVQSCWVEDPNLRPSFSQIIR 319
++ +P+ RP +++
Sbjct: 234 LISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 1e-70
Identities = 73/271 (26%), Positives = 130/271 (47%), Gaps = 16/271 (5%)
Query: 55 VDPKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNM 111
++P+ + I ++G+GA GKVY+ + + A KV++ S + ++ E+++
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-----DYMVEIDI 62
Query: 112 MSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
++ H N+VK L A + I+ E G ++ ++ L L
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLD 121
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPE 229
A++ LH N IIHRDLK N+L T D +KLADFG++ + T T + + GT WMAPE
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-AAFKHARPGL 288
+ T + + Y+ K DV+S GI L E+ P ++ ++ A +
Sbjct: 181 VVMCETSKD---RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
P S + ++ C ++ + R + SQ+++
Sbjct: 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 1e-70
Identities = 76/280 (27%), Positives = 122/280 (43%), Gaps = 18/280 (6%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + L + K+G+G G+V+ G + G VAIK L G+ S E F++E +M
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA------FLQEAQVMK 67
Query: 114 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+++H+ LV+ + + IVTE + SL +L L L ++ A IA M
Sbjct: 68 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELY 231
+ +HRDL+ N+L+ + K+ADFGLAR E+ +W APE
Sbjct: 128 YVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291
+ K DV+SFGI+L EL T + + R P +
Sbjct: 187 LY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331
L ++ CW ++P RP+F + L + + P
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 221 bits (563), Expect = 2e-70
Identities = 76/285 (26%), Positives = 121/285 (42%), Gaps = 19/285 (6%)
Query: 56 DPKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DP+ LF +IG G+ G VY R +VAIK ++ I+EV +
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW--QDIIKEVRFL 69
Query: 113 SRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+++H N +++ G +V E G + V +P L +
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQG 127
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
+ LH++ +IHRD+K N+LL+ +KL DFG A GT WMAPE+
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSFV---GTPYWMAPEV- 182
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 291
+ ++ Y+ KVDV+S GI EL + P M+ + A Y A +
Sbjct: 183 ----ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 336
S V SC + P RP+ +++ + F+ RPP+ +
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRERPPTVIMD 281
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 3e-70
Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 22/272 (8%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+DPK L ++G G G V G++ G VAIK++ GS S++ FI E +M
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE------FIEEAKVMM 54
Query: 114 RVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+ H+ LV+ G C + I+TE + L YL ++ L D+ AM
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAM 113
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAPEL 230
+ L + +HRDL N L+ +K++DFGL+R + RW PE+
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLP 289
+++K D+++FG+++WE+ + ++P+E +N + A A + R P
Sbjct: 173 LMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRP 223
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
S + I+ SCW E + RP+F ++ +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 4e-70
Identities = 84/280 (30%), Positives = 123/280 (43%), Gaps = 22/280 (7%)
Query: 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFI 106
+ L+ K L + K+G+G+ G V G + VA+K L S A+ FI
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM--DDFI 59
Query: 107 REVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
REVN M + H NL++ G P M +VTEL P SL L L +A+
Sbjct: 60 REVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAV 118
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGT 222
+A M L + IHRDL NLLL +K+ DFGL R + M
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAF 281
+ W APE T + +++ D + FG+ LWE+ T + P+ G++ Q +
Sbjct: 178 FAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
Query: 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
+ R PED D+ ++ CW P RP+F + L
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-68
Identities = 75/272 (27%), Positives = 123/272 (45%), Gaps = 20/272 (7%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
++DP L +IG G G V+ G + + VAIK + G+ S+E FI E +M
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED------FIEEAEVM 54
Query: 113 SRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
++ H LV+ G C + + +V E + L YL + + L LD+
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEG 113
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPE 229
M L +IHRDL N L+ + + +K++DFG+ R + T +W +PE
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289
++S Y++K DV+SFG+++WE+ + + R P
Sbjct: 173 VFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 224
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
S + I+ CW E P RP+FS+++R L
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (547), Expect = 3e-68
Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 20/276 (7%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
++ + + K+G G +G+VYEG + VA+K L + E F++E +M
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVM 67
Query: 113 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+KH NLV+ LG C ++P I+TE + +L YL ++ V L A I+ A
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPE 229
M+ L IHRDL N L+ + +K+ADFGL+R +W APE
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289
+ ++ K DV++FG++LWE+ T + +L Y K R P
Sbjct: 187 SLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 238
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
E + ++++CW +P+ RPSF++I +
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-68
Identities = 72/271 (26%), Positives = 115/271 (42%), Gaps = 26/271 (9%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ IG G++G+ + R +I+ K L+ GS ++ + + EVN++ +KH N
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE---KQMLVSEVNLLRELKHPN 64
Query: 120 LVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDC 174
+V++ D + IV E G L + + LD L + A+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 175 LH-----ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAP 228
H + ++HRDLKP N+ L Q ++KL DFGLAR T A GT +M+P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 288
E + YN K D++S G +L+EL PF S + + +
Sbjct: 184 EQMNR--------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-LAGKIREGKFRRI 234
Query: 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
P S +L I+ RPS +I+
Sbjct: 235 PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 2e-67
Identities = 72/271 (26%), Positives = 124/271 (45%), Gaps = 21/271 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
+G IGEG G V++G Y VAIK ++ R +F++E M +
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE----KFLQEALTMRQFD 66
Query: 117 HDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
H ++VK +G + + I+ EL LR +L R LDL + +A ++ A+ L
Sbjct: 67 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLE 125
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTV 234
+ +HRD+ N+L++ +KL DFGL+R E++ + +WMAPE +
Sbjct: 126 SKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF- 183
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294
+ + + DV+ FG+ +WE+L + + R +P + P
Sbjct: 184 -------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236
Query: 295 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
L ++ CW DP+ RP F+++ L+ L
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 5e-67
Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 25/287 (8%)
Query: 56 DPKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DPK + KIG+GA G VY + VAI+ +N + I E+ +M
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-----LIINEILVM 71
Query: 113 SRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
K+ N+V +L + + +V E L G SL + +D + +A
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQA 128
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPEL 230
++ LH+N +IHRD+K DN+LL D S+KL DFG + T + + GT WMAPE+
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLP 289
+ K Y KVD++S GI+ E++ P+ + L+A Y A P
Sbjct: 188 VTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 336
E +S + C D R S ++++ + FL +P S P
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIAKPLSSLTP 284
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 7e-67
Identities = 78/289 (26%), Positives = 124/289 (42%), Gaps = 28/289 (9%)
Query: 51 RSLLVDPKLLFI--GSKIGEGAHGKVYEGRYGDR-----IVAIKVLNRGSTSDERALLEG 103
+ +++ P L + IG G G VY G D A+K LNR + E +
Sbjct: 18 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS---- 73
Query: 104 RFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 161
+F+ E +M H N++ LG C + ++V + LR ++ + + +
Sbjct: 74 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDL 132
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMM 216
+ F L +A+ M L + +HRDL N +L +K+ADFGLAR E
Sbjct: 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNK 191
Query: 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276
T +WMA E T + + K DV+SFG++LWEL+T P N
Sbjct: 192 TGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243
Query: 277 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+ R PE L ++ CW +RPSFS+++ ++A
Sbjct: 244 TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-66
Identities = 86/314 (27%), Positives = 127/314 (40%), Gaps = 47/314 (14%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGR-------YGDRIVAIKVLNRGSTSDER 98
+ D + L G +G GA GKV VA+K+L + S ER
Sbjct: 25 EYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 84
Query: 99 ALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRP--- 153
+ E+ MM+++ H+N+V LGAC + ++ E L YL S R
Sbjct: 85 E----ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140
Query: 154 ------------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 195
N L L FA +A+ M+ L +HRDL N+L+T
Sbjct: 141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG 200
Query: 196 QKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 252
K +K+ DFGLAR ++ + +WMAPE Y K DV+S
Sbjct: 201 -KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWS 251
Query: 253 FGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 311
+GI+LWE+ + P+ G+ Y + P + ++ I+QSCW D R
Sbjct: 252 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311
Query: 312 PSFSQIIRMLNAFL 325
PSF + L L
Sbjct: 312 PSFPNLTSFLGCQL 325
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-65
Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 21/265 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +GEGA+G+V + VA+K+++ D +E+ + + H+N
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE----NIKKEICINKMLNHEN 64
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+VKF G ++ + + E G L + + A F + + LH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVT 235
GI HRD+KP+NLLL +LK++DFGLA ++ GT ++APEL
Sbjct: 123 GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-- 179
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA-FKHARPGLPEDISP 294
++ + VDV+S GIVL +L LP++ S+ Y+ K + I
Sbjct: 180 -----REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 295 DLAFIVQSCWVEDPNLRPSFSQIIR 319
++ VE+P+ R + I +
Sbjct: 235 APLALLHKILVENPSARITIPDIKK 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 208 bits (531), Expect = 4e-65
Identities = 65/264 (24%), Positives = 113/264 (42%), Gaps = 20/264 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I ++G GA G V+ A K + SD+ +E+ MS ++H
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-----TVRKEIQTMSVLRHPT 84
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
LV A +D MV++ E + G L + + NK+ A+ + + + + +H N
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 179 GIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
+H DLKP+N++ T + + LKL DFGL + + TGT + APE+
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG---- 199
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAFKHARPGLPEDISPD 295
K D++S G++ + LL+ PF G ++ + + + IS D
Sbjct: 200 ----KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255
Query: 296 LAFIVQSCWVEDPNLRPSFSQIIR 319
++ + DPN R + Q +
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 207 bits (527), Expect = 2e-64
Identities = 56/264 (21%), Positives = 114/264 (43%), Gaps = 20/264 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I ++G GA G V+ R+ K +N D+ E+++M+++ H
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-----TVKNEISIMNQLHHPK 87
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
L+ A +D MV++ E L G L + + K+ +N+ + +H +
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 179 GIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
I+H D+KP+N++ + S+K+ DFGLA + E++ T T + APE+
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV------ 200
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPD 295
+++ D+++ G++ + LL+ PF G +L+ +SP+
Sbjct: 201 --DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258
Query: 296 LAFIVQSCWVEDPNLRPSFSQIIR 319
+++ ++P R + +
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (520), Expect = 5e-64
Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 28/293 (9%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERAL 100
+ + + +D + I IG G G+V G + VAIK L G T +R
Sbjct: 14 EAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR- 72
Query: 101 LEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLH 159
F+ E ++M + H N++ G ++I+TE + SL +L + +
Sbjct: 73 ---DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVI 128
Query: 160 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR------EETVT 213
+ IA M L +HRDL N+L+ + K++DFGL+R +
Sbjct: 129 QLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTY 187
Query: 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
RW APE + + + DV+S+GIV+WE+++ P+ M+N
Sbjct: 188 TSALGGKIPIRWTAPEAIQY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
Q A + R P D L ++ CW +D N RP F QI+ L+ +
Sbjct: 240 -QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-63
Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 25/282 (8%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIRE 108
+ P + IG G G+VY+G VAIK L G T +R F+ E
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV----DFLGE 59
Query: 109 VNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
+M + H N+++ G M+I+TE + +L K+L + + + +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRG 118
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTY 223
IA M L +HRDL N+L+ + K++DFGL+R + T +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283
RW APE S + + + DV+SFGIV+WE++T + A
Sbjct: 178 RWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229
Query: 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
R P D + ++ CW ++ RP F+ I+ +L+ +
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 201 bits (512), Expect = 4e-63
Identities = 60/268 (22%), Positives = 110/268 (41%), Gaps = 15/268 (5%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGS----TSDERALLEGRFIREVNMMSRV 115
+G G V + + A+K+++ +++E L ++EV+++ +V
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 116 K-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
H N+++ + +V +L+ L YL L + +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVIC 124
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
LH I+HRDLKP+N+LL D +KL DFG + + E + GT ++APE+
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE- 182
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--D 291
Y +VD++S G++++ LL PF + + + G PE D
Sbjct: 183 -CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
S + +V V P R + + +
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-62
Identities = 65/262 (24%), Positives = 107/262 (40%), Gaps = 21/262 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
G +GEG+ V R R AIK+L + E + RE ++MSR+ H
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP--YVTRERDVMSRLDHPF 69
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
VK +D + L KY+ + D + +I A++ LH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVT 235
GIIHRDLKP+N+LL D +++ DFG A+ E+ + GT ++++PEL +
Sbjct: 128 GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-- 184
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295
K D+++ G ++++L+ PF + PE P
Sbjct: 185 ------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFFPK 236
Query: 296 LAFIVQSCWVEDPNLRPSFSQI 317
+V+ V D R ++
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEM 258
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-62
Identities = 81/285 (28%), Positives = 127/285 (44%), Gaps = 35/285 (12%)
Query: 62 IGSKIGEGAHGKVYEGRYGD----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-K 116
IGEG G+V + R AIK + ++ D+ F E+ ++ ++
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR----DFAGELEVLCKLGH 69
Query: 117 HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYL--------------VSLRPNKLDLHVA 161
H N++ LGAC+ + + E P +L +L + + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 221
L+FA D+AR MD L IHRDL N+L+ + K+ADFGL+R + V T
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGLSRGQEVYVKKTMGRL 188
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAA 280
RWMA E + Y DV+S+G++LWE+++ P+ GM Y
Sbjct: 189 PVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKL 239
Query: 281 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+ R P + ++ +++ CW E P RPSF+QI+ LN L
Sbjct: 240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (508), Expect = 3e-62
Identities = 82/310 (26%), Positives = 133/310 (42%), Gaps = 57/310 (18%)
Query: 55 VDPKL---------LFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDER 98
++PKL + IGEGA G+V++ R +VA+K+L +++D +
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 99 ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN--- 154
A F RE +M+ + N+VK LG C M ++ E + L ++L S+ P+
Sbjct: 61 A----DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 155 -------------------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 195
L L A +A M L +HRDL N L+ +
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN 176
Query: 196 QKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 252
+K+ADFGL+R + + RWM PE Y + DV++
Sbjct: 177 -MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWA 227
Query: 253 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 311
+G+VLWE+ + P+ GM++ + Y PE+ +L +++ CW + P R
Sbjct: 228 YGVVLWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADR 286
Query: 312 PSFSQIIRML 321
PSF I R+L
Sbjct: 287 PSFCSIHRIL 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 4e-62
Identities = 59/304 (19%), Positives = 113/304 (37%), Gaps = 62/304 (20%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
S++G G G V++ + ++A K+++ R + IRE+ ++
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN----QIIRELQVLHECNSPY 65
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-A 177
+V F GA + I E + G SL + L + ++ + ++ + + + L
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
+ I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE
Sbjct: 124 HKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQG---- 177
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN------------------------- 272
HY+ + D++S G+ L E+ R P
Sbjct: 178 ----THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 273 ----------------LQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFS 315
+ P LP S + V C +++P R
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 316 QIIR 319
Q++
Sbjct: 294 QLMV 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 6e-62
Identities = 87/305 (28%), Positives = 131/305 (42%), Gaps = 42/305 (13%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDER 98
QL D L G +G GA GKV E VA+K+L + ER
Sbjct: 11 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 70
Query: 99 ALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-- 154
+ E+ ++S + H N+V LGAC +++TE L +L R +
Sbjct: 71 E----ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 155 --------------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
LDL L+F+ +A+ M L + IHRDL N+LLT + + K
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-K 185
Query: 201 LADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 257
+ DFGLAR ++ + +WMAPE Y + DV+S+GI L
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGIFL 237
Query: 258 WELLTNRLP-FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 316
WEL + + GM Y + R PE ++ I+++CW DP RP+F Q
Sbjct: 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297
Query: 317 IIRML 321
I++++
Sbjct: 298 IVQLI 302
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 7e-62
Identities = 46/264 (17%), Positives = 111/264 (42%), Gaps = 21/264 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +G G G V+ + K + T +E+++++ +H N
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL------VKKEISILNIARHRN 62
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++ + + +V++ E + G+ + + + + +L+ +++ + A+ LH++
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 179 GIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
I H D++P+N++ + S +K+ +FG AR+ + + APE++
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH------ 175
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPD 295
+ + D++S G +++ LL+ PF +N Q ++IS +
Sbjct: 176 --QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 296 LAFIVQSCWVEDPNLRPSFSQIIR 319
V V++ R + S+ ++
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-61
Identities = 81/287 (28%), Positives = 132/287 (45%), Gaps = 34/287 (11%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
V + + + ++G+G+ G VYEG + VAIK +N ++ ER F+
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI----EFLN 72
Query: 108 EVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP--------NKLDL 158
E ++M ++V+ LG + +++ EL+ L+ YL SLRP L
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 159 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEM 215
+ A +IA M L+AN +HRDL N ++ D ++K+ DFG+ R E
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRK 191
Query: 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
RWM+PE + DV+SFG+VLWE+ T P++G+SN Q
Sbjct: 192 GGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
Query: 275 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 321
+ P++ L +++ CW +P +RPSF +II +
Sbjct: 244 V-LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 3e-61
Identities = 73/298 (24%), Positives = 127/298 (42%), Gaps = 26/298 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV 115
+G GA G VY+G + VAIK L ++ + E +M+ V
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK----EILDEAYVMASV 68
Query: 116 KHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
+ ++ + LG C + ++T+L+P L Y+ + + LN+ + IA+ M+ L
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYS 232
++HRDL N+L+ + +K+ DFGLA+ E +WMA E
Sbjct: 128 EDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPED 291
+ Y ++ DV+S+G+ +WEL+T P++G+ + K R P
Sbjct: 187 H--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERLPQPPI 237
Query: 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL-RPPSPSVPESDTNEAAATSN 348
+ D+ I+ CW+ D + RP F ++I + R E + SN
Sbjct: 238 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSN 295
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 1e-60
Identities = 60/265 (22%), Positives = 113/265 (42%), Gaps = 21/265 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G GA +V ++VAIK + + + + E+ ++ ++KH N
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG----SMENEIAVLHKIKHPN 68
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V + + ++ +L+ G L +V A + A+ LH
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 179 GIIHRDLKPDNLLLTPDQKS--LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
GI+HRDLKP+NLL + + ++DFGL++ E +++ GT ++APE+ +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ--- 183
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISP 294
K Y+ VD +S G++ + LL PF ++ + P +DIS
Sbjct: 184 -----KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 295 DLAFIVQSCWVEDPNLRPSFSQIIR 319
++ +DP R + Q ++
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 9e-60
Identities = 63/299 (21%), Positives = 115/299 (38%), Gaps = 50/299 (16%)
Query: 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
+ IG+G G+V+ G++ VA+K+ + E+ ++H+N++
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSW------FREAEIYQTVMLRHENIL 60
Query: 122 KFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
F+ A + +V++ SL Y L + + + AL A + LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDY---LNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 177 A--------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTY 223
I HRDLK N+L+ + + +AD GLA +T+ GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY------ 277
R+MAPE+ + + + D+Y+ G+V WE+ + Q Y
Sbjct: 177 RYMAPEVLDDSINMKHFE--SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 278 ---------AAAFKHARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 322
+ RP +P + +A I++ CW + R + +I + L+
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-59
Identities = 62/264 (23%), Positives = 114/264 (43%), Gaps = 23/264 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEG-RFIREVNMMSRVK-- 116
+G +G G G VY G + VAIK + + SD L G R EV ++ +V
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 117 HDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
+++ L + P V++ E + ++ L +A +F + A+
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHC 126
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT 235
H G++HRD+K +N+L+ ++ LKL DFG T + T GT + PE
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-- 183
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295
+++ V+S GI+L++++ +PFE + + + +S +
Sbjct: 184 -----HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSE 230
Query: 296 LAFIVQSCWVEDPNLRPSFSQIIR 319
+++ C P+ RP+F +I
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-58
Identities = 68/263 (25%), Positives = 119/263 (45%), Gaps = 20/263 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHD 118
+ +G+G+ GKV+ + ++ AIK L + + + + E ++S +H
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHP 63
Query: 119 NLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
L + + V E L G L ++ +K DL A +A +I + LH+
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTL 236
GI++RDLK DN+LL D K+ADFG+ +E GT ++APE+
Sbjct: 122 KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--- 177
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDL 296
+ YN+ VD +SFG++L+E+L + PF G + + + + P P + +
Sbjct: 178 -----QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH--SIRMDNPFYPRWLEKEA 230
Query: 297 AFIVQSCWVEDPNLRPSFSQIIR 319
++ +V +P R IR
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDIR 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 188 bits (477), Expect = 5e-58
Identities = 72/270 (26%), Positives = 112/270 (41%), Gaps = 24/270 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +G G +V+ R R VA+KVL D L RF RE + + H
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYL--RFRREAQNAAALNHPA 68
Query: 120 LVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+V + PL IV E + G++LR + + A+ D +A++
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNF 126
Query: 175 LHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
H NGIIHRD+KP N++++ +A A GT ++++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLP 289
+ + DVYS G VL+E+LT PF G S + AY + P
Sbjct: 187 RG--------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238
Query: 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
E +S DL +V ++P R + +R
Sbjct: 239 EGLSADLDAVVLKALAKNPENRYQTAAEMR 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 5e-58
Identities = 83/308 (26%), Positives = 137/308 (44%), Gaps = 41/308 (13%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY---------GDRIVAIKVLNRGSTSD 96
+L D + L +G +GEGA G+V VA+K+L +T
Sbjct: 1 ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 60
Query: 97 ERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRP- 153
+ + I E+ MM + KH N++ LGAC + ++ E +LR+YL + RP
Sbjct: 61 DLS----DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 116
Query: 154 -------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
+L ++ A +AR M+ L + IHRDL N+L+T D K
Sbjct: 117 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-K 175
Query: 201 LADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 257
+ADFGLAR + T +WMAPE + Y ++ DV+SFG++L
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLL 227
Query: 258 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 317
WE+ T ++ + + R P + + +L +++ CW P+ RP+F Q+
Sbjct: 228 WEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287
Query: 318 IRMLNAFL 325
+ L+ +
Sbjct: 288 VEDLDRIV 295
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-57
Identities = 59/267 (22%), Positives = 109/267 (40%), Gaps = 19/267 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGST-SDERALLEGRFIREVNMMSRVKHD 118
G ++G G V + R A K + + T S R + REV+++ ++H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 119 NLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ ++ ++++ EL+ G L +L L A F I + LH+
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHS 131
Query: 178 NGIIHRDLKPDNLLLTPD---QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
I H DLKP+N++L + +K+ DFGLA + GT ++APE+
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV--- 188
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAFKHARPGLPEDI 292
+ + D++S G++ + LL+ PF G + + A +
Sbjct: 189 -----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 293 SPDLAFIVQSCWVEDPNLRPSFSQIIR 319
S ++ V+DP R + ++
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-57
Identities = 61/275 (22%), Positives = 111/275 (40%), Gaps = 34/275 (12%)
Query: 61 FIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KH 117
+G G +GKV + A+K+L + REV + R +
Sbjct: 15 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----------KARREVELHWRASQC 64
Query: 118 DNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++V+ + ++ ++IV E L G L + A I A+
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 173 DCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 230
LH+ I HRD+KP+NLL T LKL DFG A+E T +T T ++APE+
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAFKHARPGL 288
+ Y+ D++S G++++ LL PF L + + +
Sbjct: 185 LG--------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236
Query: 289 PE----DISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
P ++S ++ ++++ +P R + ++ +
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 185 bits (471), Expect = 1e-56
Identities = 68/258 (26%), Positives = 122/258 (47%), Gaps = 20/258 (7%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +G G+ G+V+ R + R A+KVL + + + E M+S V H
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV--EHTNDERLMLSIVTHPF 65
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+++ G +D + ++ + + G L L + + VA +A ++ A++ LH+
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
II+RDLKP+N+LL + +K+ DFG A+ V ++ GT ++APE+ ST
Sbjct: 124 DIIYRDLKPENILLDKN-GHIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVST----- 175
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298
K YN +D +SFGI+++E+L PF + ++ +A P + D+
Sbjct: 176 ---KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE--KILNAELRFPPFFNEDVKD 230
Query: 299 IVQSCWVEDPNLRPSFSQ 316
++ D + R Q
Sbjct: 231 LLSRLITRDLSQRLGNLQ 248
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-56
Identities = 78/292 (26%), Positives = 132/292 (45%), Gaps = 41/292 (14%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
+G +G GA G+V E R VA+K+L G+T E + E+ ++
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR----ALMSELKILIH 72
Query: 115 VKHD-NLVKFLGACKDP--LMVIVTELLPGMSLRKYLVS--------------LRPNKLD 157
+ H N+V LGAC P ++++ E +L YL S L + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTE 214
L + ++ +A+ M+ L + IHRDL N+LL+ +K+ DFGLAR ++
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYV 191
Query: 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273
+WMAPE + Y + DV+SFG++LWE+ + P+ G+
Sbjct: 192 RKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 274 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325
+ + R P+ +P++ + CW +P+ RP+FS+++ L L
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 180 bits (457), Expect = 5e-54
Identities = 70/301 (23%), Positives = 122/301 (40%), Gaps = 31/301 (10%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--- 116
+ IG G G+VY R D ++ A+K L++ ++ E + E M+S V
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGD 65
Query: 117 HDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
+V A P + + +L+ G L +L +A +I ++ +
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD--MRFYAAEIILGLEHM 123
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT 235
H +++RDLKP N+LL + ++++D GLA + + A GT+ +MAPE+
Sbjct: 124 HNRFVVYRDLKPANILLD-EHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQK-- 179
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAAFKHARPGLPEDISP 294
Y++ D +S G +L++LL PF + LP+ SP
Sbjct: 180 -----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 295 DLAFIVQSCWVEDPNLRPSFSQI----------IRMLN-AFLFTLRPPSPSVPESDTNEA 343
+L +++ D N R R L+ +F + P P +P A
Sbjct: 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNA 294
Query: 344 A 344
A
Sbjct: 295 A 295
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (444), Expect = 7e-53
Identities = 56/287 (19%), Positives = 100/287 (34%), Gaps = 37/287 (12%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G KIG G+ G +Y G VAIK+ + + E + ++
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGV 63
Query: 120 LVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+ + C + V+V ELL + K L L A + ++ +H+
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKL--ADFGLAR--------EETVTEMMTAETGTYRWMA 227
IHRD+KPDN L+ +K + DFGLA+ + TGT R+ +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-- 285
+ + + D+ S G VL LP++G+ +
Sbjct: 182 INTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233
Query: 286 ----PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328
L + + A + C + +P +S + ++
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-52
Identities = 60/256 (23%), Positives = 105/256 (41%), Gaps = 19/256 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G+G GKV R R A+K+L + + + + E ++ +H
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA--HTVTESRVLQNTRHPF 66
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
L A + + V E G L +L R A + +I A++ LH+
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR 124
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLR 237
+++RD+K +NL+L D +K+ DFGL +E + M GT ++APE+
Sbjct: 125 DVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED---- 179
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLA 297
Y VD + G+V++E++ RLPF + + P +SP+
Sbjct: 180 ----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAK 233
Query: 298 FIVQSCWVEDPNLRPS 313
++ +DP R
Sbjct: 234 SLLAGLLKKDPKQRLG 249
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-51
Identities = 71/300 (23%), Positives = 121/300 (40%), Gaps = 42/300 (14%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+GEG VY+ R ++IVAIK + G S+ + + +RE+ ++ + H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 123 FLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
L A + +V + + ++ L + L + ++ LH + I+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP+NLLL + LKLADFGLA+ T + T + APEL
Sbjct: 123 HRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG------- 174
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE---------- 290
+ Y VD+++ G +L ELL G S+L P +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 291 ----------------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS 334
DL ++Q ++ +P R + +Q ++M + P+P
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRPGPTPG 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-51
Identities = 68/292 (23%), Positives = 114/292 (39%), Gaps = 44/292 (15%)
Query: 62 IGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
++IGEGA+GKV++ R G R VA+K + + + L R + + + +H
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 119 NLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
N+V+ C + +V E + YL + + + + R +
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
D LH++ ++HRDLKP N+L+T +KLADFGLAR + +T+ T + APE+
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 188
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG----- 287
Y VD++S G + E+ + F G S++ PG
Sbjct: 189 Q--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 288 --------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
DI ++ C +P R S +
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 5e-50
Identities = 72/304 (23%), Positives = 128/304 (42%), Gaps = 43/304 (14%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
KIGEG +G VY+ R +VA+K + + ++ + IRE++++ + H N
Sbjct: 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELNHPN 62
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+VK L + + L+K++ + + L + ++ + + + H++
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQ 238
++HRDLKP NLL+ + ++KLADFGLAR V T E T + APE+
Sbjct: 123 VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL------ 175
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA----------------AAFK 282
K+Y+ VD++S G + E++T R F G S + + +
Sbjct: 176 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 283 HARPGLPE-----------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331
+P P+ + D ++ DPN R S + F + P
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQDVTKP 292
Query: 332 SPSV 335
P +
Sbjct: 293 VPHL 296
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 8e-50
Identities = 71/312 (22%), Positives = 116/312 (37%), Gaps = 55/312 (17%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG G+ G VY+ + D +VAIK + + RE+ +M ++ H N
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCN 74
Query: 120 LVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARA 171
+V+ + +V + +P R R + L + + + R+
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
+ +H+ GI HRD+KP NLLL PD LKL DFG A++ E + + + APEL
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA------------- 278
Y + +DV+S G VL ELL + F G S +
Sbjct: 195 F-------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 279 --AAFKHARPGLPE------------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
+ P+ P+ + P R + + ++F
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA--HSF 305
Query: 325 LFTLRPPSPSVP 336
LR P+ +P
Sbjct: 306 FDELRDPNVKLP 317
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 167 bits (423), Expect = 9e-50
Identities = 49/289 (16%), Positives = 98/289 (33%), Gaps = 37/289 (12%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH-D 118
+G +IGEG+ G ++EG ++ VAIK R S + + E +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-------LRDEYRTYKLLAGCT 61
Query: 119 NLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+ ++ L ++ L G SL L K + A + + +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 179 GIIHRDLKPDNLLLT----PDQKSLKLADFGLAR--------EETVTEMMTAETGTYRWM 226
+++RD+KPDN L+ + + + DFG+ + + +GT R+M
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA------AA 280
+ + + + + D+ + G V L LP++G+
Sbjct: 181 SINTH--------LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232
Query: 281 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329
L + + + P + + + + L L
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-49
Identities = 72/298 (24%), Positives = 109/298 (36%), Gaps = 55/298 (18%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
S IGEGA+G V VAIK ++ R +RE+ ++ R +H+N
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ----RTLREIKILLRFRHEN 67
Query: 120 LVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
++ + P + V + L G L K L + L F I R +
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLKY 124
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWMAPEL 230
+H+ ++HRDLKP NLLL LK+ DFGLAR + T +T T + APE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG--- 287
K Y +D++S G +L E+L+NR F G L P
Sbjct: 184 MLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 288 --------------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
L + ++ +P+ R Q +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 9e-49
Identities = 67/266 (25%), Positives = 122/266 (45%), Gaps = 21/266 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
+ +G GA+GKV+ R ++ A+KVL + + + E E ++ ++
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE-HTRTERQVLEHIR 86
Query: 117 H-DNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
LV A + + ++ + + G L +L + + H + +I A++
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEH 144
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAPELYS 232
LH GII+RD+K +N+LL + + L DFGL++E TE GT +MAP++
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV- 202
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS--NLQAAYAAAFKHARPGLPE 290
+G ++ VD +S G++++ELLT PF N QA + + P P+
Sbjct: 203 -----RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 291 DISPDLAFIVQSCWVEDPNLRPSFSQ 316
++S ++Q ++DP R
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRLGCGP 283
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (414), Expect = 8e-48
Identities = 60/266 (22%), Positives = 109/266 (40%), Gaps = 25/266 (9%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G G+ G+V ++ A+K+L++ + + + E ++ V
Sbjct: 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE--HTLNEKRILQAVNFPF 102
Query: 120 LVKFLGACKDPLMVI-VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
LVK + KD + V E + G + +L R + A +A I + LH+
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
+I+RDLKP+NLL+ +++ DFG A+ GT +APE+ +
Sbjct: 161 DLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILS----- 212
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAF 298
K YN VD ++ G++++E+ PF +Q + P S DL
Sbjct: 213 ---KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE--KIVSGKVRFPSHFSSDLKD 267
Query: 299 IVQSCWVEDP-----NLRPSFSQIIR 319
++++ D NL+ + I
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 161 bits (408), Expect = 9e-48
Identities = 66/288 (22%), Positives = 108/288 (37%), Gaps = 43/288 (14%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
KIGEG +G VY+ + A+K + + + IRE++++ +KH N+
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG---IPSTTIREISILKELKHSNI 62
Query: 121 VKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
VK +V+V E L + V L+ A +F L + + H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-MAPELYSTVTLRQ 238
++HRDLKP NLL+ + LK+ADFGLAR + W AP++
Sbjct: 121 VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM------ 173
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ-----------------------A 275
K Y+ +D++S G + E++ F G+S
Sbjct: 174 -GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 276 AYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
Y F P + + ++ DPN R + Q +
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 156 bits (396), Expect = 2e-45
Identities = 50/300 (16%), Positives = 105/300 (35%), Gaps = 62/300 (20%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HD 118
+ K+G G + +V+E + V +K+L + RE+ ++ ++
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--------KIKREIKILENLRGGP 90
Query: 119 NLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
N++ KDP +V E + ++ L + + +I +A+D
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYC 145
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT 235
H+ GI+HRD+KP N+++ + + L+L D+GLA + + + PEL
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV--- 202
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK------------- 282
+ + Y+ +D++S G +L ++ + PF + K
Sbjct: 203 ----DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 283 -----------------------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+SP+ + D R + + +
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-45
Identities = 57/302 (18%), Positives = 116/302 (38%), Gaps = 47/302 (15%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
KIGEG +G V++ + IVA+K + + + +RE+ ++ +KH N
Sbjct: 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKN 62
Query: 120 LVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V+ + +V E + + + + +F + + + H+
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE--IVKSFLFQLLKGLGFCHSR 120
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLR 237
++HRDLKP NLL+ + + KLA+FGLAR + +AE T + P++
Sbjct: 121 NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG---- 175
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK--------------- 282
K Y+ +D++S G + EL P +++ F+
Sbjct: 176 ---AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 283 -------------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329
+ + ++ ++Q+ +P R S + ++ + +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFC 290
Query: 330 PP 331
PP
Sbjct: 291 PP 292
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-45
Identities = 63/318 (19%), Positives = 116/318 (36%), Gaps = 61/318 (19%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+KIG+G G+V++ R+ + VA+K + +E+ +RE+ ++ +KH+N
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKHEN 70
Query: 120 LVKFLGACKDP---------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+V + C+ + +V + L K L +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLN 128
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRW 225
+ +H N I+HRD+K N+L+T D LKLADFGLAR + + T T +
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA---------- 275
PEL ++ Y +D++ G ++ E+ T +G +
Sbjct: 188 RPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 276 ---------------AYAAAFKHARPGLPEDI-----SPDLAFIVQSCWVEDPNLRPSFS 315
K + + + + P ++ V DP R
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 316 QIIRMLNAFLFTLRPPSP 333
+ + F ++ PS
Sbjct: 301 DALN--HDFFWSDPMPSD 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-42
Identities = 73/320 (22%), Positives = 121/320 (37%), Gaps = 59/320 (18%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G GA+G V G VAIK L R S+ R RE+ ++ ++H+N
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL---FAKRAYRELRLLKHMRHEN 78
Query: 120 LVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ L +V + + ++ KL + + +
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL----MKHEKLGEDRIQFLVYQMLKGL 134
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
+HA GIIHRDLKP NL + D + K+ DFGLAR+ MT T + APE+
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY--------------- 277
Y VD++S G ++ E++T + F+G +L
Sbjct: 192 -------NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 278 ---AAAFKHARPGLPE-----------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323
+ K+ GLPE + SP +++ V D R + + +
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH--P 302
Query: 324 FLFTLRPPS--PSVPESDTN 341
+ +L P V + D +
Sbjct: 303 YFESLHDTEDEPQVQKYDDS 322
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-39
Identities = 76/309 (24%), Positives = 118/309 (38%), Gaps = 55/309 (17%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
S +G GA+G V VA+K L+R S A R RE+ ++ +KH+N
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHEN 78
Query: 120 LVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
++ L V + L G L + + KL I R +
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLK 135
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
+H+ IIHRDLKP NL + LK+ DFGLAR + MT T + APE+
Sbjct: 136 YIHSADIIHRDLKPSNLA-VNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML- 191
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY---------------- 277
HYN VD++S G ++ ELLT R F G ++
Sbjct: 192 ------NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 278 -----AAAFKHARPGLPE--------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324
A + + +P+ +P +++ V D + R + +Q + +A+
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAY 303
Query: 325 LFTLRPPSP 333
P
Sbjct: 304 FAQYHDPDD 312
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 9e-38
Identities = 66/267 (24%), Positives = 104/267 (38%), Gaps = 27/267 (10%)
Query: 62 IGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG GA G V DR VAIK L+R + A R RE+ +M V H N
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVNHKN 77
Query: 120 LVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ L + +V EL+ + +LD + +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSYLLYQMLCGI 132
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
LH+ GIIHRDLKP N+++ D K+ DFGLAR + MMT T + APE+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292
Y VD++S G ++ E++ +++ F G + + + PE +
Sbjct: 192 --------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFM 242
Query: 293 SPDLAFIVQSCWVEDPNLRPSFSQIIR 319
+ +F ++
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFP 269
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (292), Expect = 3e-30
Identities = 50/319 (15%), Positives = 103/319 (32%), Gaps = 69/319 (21%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--- 116
+ K+G G V+ + + VA+K++ E A E + ++ VN K
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 117 --HDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
++++K L + + V++ + G +L + + L + +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 171 AMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWM 226
+D +H GIIH D+KP+N+L+ L +A E T T +
Sbjct: 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG----------------- 269
+PE+ + D++S +++EL+T FE
Sbjct: 197 SPEVLLG--------APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 270 -----------------------------MSNLQAAYAAAFKHARPGLPEDISPDLAFIV 300
+S L+ + +D + +++ +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 301 QSCWVEDPNLRPSFSQIIR 319
DP R ++
Sbjct: 309 SPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (253), Expect = 3e-26
Identities = 33/199 (16%), Positives = 62/199 (31%), Gaps = 26/199 (13%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDE-----RALLEGRFIREVNMMSRV 115
IG +GEG V+ +K G TS + R + F +R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 116 KHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
+ L K G + V L + + + ++ + I +
Sbjct: 64 EFRALQKLQGLA----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY--ST 233
+ GI+H DL N+L++ + + + DF + E E+
Sbjct: 120 YHRGIVHGDLSQYNVLVSEEG--IWIIDFPQSVE------------VGEEGWREILERDV 165
Query: 234 VTLRQGEKKHYNNKVDVYS 252
+ + Y + D+ S
Sbjct: 166 RNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 378 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.5 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.94 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.89 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.19 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.11 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.5 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-59 Score=420.73 Aligned_cols=266 Identities=30% Similarity=0.531 Sum_probs=221.2
Q ss_pred ccccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecCC
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL 131 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 131 (378)
.|.++.++|.+++.||+|+||+||+|++.+ .||||+++........ .+.|.+|+.+|++++|||||++++++.++.
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 77 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ---LQAFKNEVGVLRKTRHVNILLFMGYSTAPQ 77 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTH---HHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHH---HHHHHHHHHHHHhCCCCCEeeeeEEEeccE
Confidence 356778899999999999999999998766 5999999765443332 246899999999999999999999998888
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~ 211 (378)
.++||||++||+|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKS 155 (276)
T ss_dssp CEEEEECCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCCSCC--
T ss_pred EEEEEecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEccccceeecc
Confidence 9999999999999999976 345799999999999999999999999999999999999999665 59999999997643
Q ss_pred cc---cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--
Q 017046 212 VT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-- 286 (378)
Q Consensus 212 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-- 286 (378)
.. .......||+.|+|||++... ....++.++|||||||++|||++|+.||.+.+...............
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQ-----DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC
T ss_pred ccCCcccccccccCcccCCHHHHhcc-----cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc
Confidence 32 223456899999999998641 12468899999999999999999999999887766655555444332
Q ss_pred --CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 287 --GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 287 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
..+..+|+++.+|+.+||..||.+|||+.+++++|+.+..++
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 356679999999999999999999999999999998877654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-58 Score=415.07 Aligned_cols=264 Identities=29% Similarity=0.450 Sum_probs=226.7
Q ss_pred cccccccCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 49 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
.++.+.++.+.|.+++.||+|+||+||+|++. ++.||||+++...... +.|.+|+.++++++|||||++++++
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~------~~~~~E~~~l~~l~HpnIv~~~g~~ 77 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP------DAFLAEANLMKQLQHQRLVRLYAVV 77 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH------HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH------HHHHHHHHHHHhCCCCCEeEEEeee
Confidence 34567788899999999999999999999986 5789999997655433 2588999999999999999999999
Q ss_pred ecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
.++..++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++
T Consensus 78 ~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla 156 (272)
T d1qpca_ 78 TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLA 156 (272)
T ss_dssp CSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred ccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-ceeeccccce
Confidence 888889999999999999988664445699999999999999999999999999999999999999655 5999999999
Q ss_pred cccccc--cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 017046 208 REETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 208 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
+..... .......||+.|+|||++.. ..++.++|||||||++|||+||..|+............+....+
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~ 228 (272)
T d1qpca_ 157 RLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228 (272)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred EEccCCccccccccCCcccccChHHHhC--------CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Confidence 865332 23345578999999999864 67899999999999999999965554444444556666777788
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+..|..+++++.+|+.+||+.||.+|||+.++++.|+.++.+
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 888999999999999999999999999999999999988754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-58 Score=415.74 Aligned_cols=251 Identities=31% Similarity=0.444 Sum_probs=214.0
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
++|.+.++||+|+||+||+|++ +++.||||++........ +.+.+|+.+++.++|||||++++++.+ +..++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-----ELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCH-----HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHH-----HHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence 4699999999999999999986 478999999876544332 358899999999999999999999965 47899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 95 vmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTT
T ss_pred EEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-cEeeccchhheeecccc
Confidence 9999999999998865 4699999999999999999999999999999999999999665 5999999999865332
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCCCCCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLPEDI 292 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 292 (378)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+............. ....+..+
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSS--------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGS
T ss_pred ccccccccCCCccChhhhcC--------CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccC
Confidence 33456689999999999864 6789999999999999999999999998776655554443322 33456779
Q ss_pred hHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
++++.+||.+||..||.+|||+.|+++ +.++..
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~--Hp~~~~ 275 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKI 275 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT--CGGGGG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc--CHhhCC
Confidence 999999999999999999999999998 566654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=411.55 Aligned_cols=262 Identities=26% Similarity=0.547 Sum_probs=224.2
Q ss_pred ccccCCcceeecc-eeecccceEEEEEEEC----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEee
Q 017046 52 SLLVDPKLLFIGS-KIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (378)
Q Consensus 52 ~~~~~~~~~~~~~-~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 126 (378)
.+.++.+.|.+.+ +||+|+||+||+|.+. +..||||+++....... .++|.+|+++|++++|||||+++++
T Consensus 2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~----~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD----TEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHH----HHHHHHHHHHHHhCCCCCEeeEeee
Confidence 3456677888888 4999999999999763 35799999986554332 2468999999999999999999999
Q ss_pred EecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccc
Q 017046 127 CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (378)
Q Consensus 127 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~ 206 (378)
+.++..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 78 ~~~~~~~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGl 155 (285)
T d1u59a_ 78 CQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGL 155 (285)
T ss_dssp EESSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred eccCeEEEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchh
Confidence 988889999999999999998865 345799999999999999999999999999999999999999655 599999999
Q ss_pred cccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017046 207 AREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 207 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 281 (378)
++...... ......||+.|+|||++.. ..++.++|||||||++|||+| |..||.+.+.. .....+.
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~~~i~ 226 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIE 226 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHHH
T ss_pred hhcccccccccccccccccCccccChHHHhC--------CCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHH
Confidence 97543322 2234578999999999864 678999999999999999998 99999987764 4455666
Q ss_pred hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
.+.++..|..+|+++.+||.+||+.||.+|||+.++++.|+..+..+
T Consensus 227 ~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 227 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 77788899999999999999999999999999999999998887654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-57 Score=412.97 Aligned_cols=261 Identities=30% Similarity=0.510 Sum_probs=225.8
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
.|.++.++|.+.++||+|+||+||+|++. ++.||||+++...... ++|.+|+.+|++++|||||++++++.+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV------EEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchH------HHHHHHHHHHHhCCCCCEecCCccEee
Confidence 46788899999999999999999999874 7899999997655432 358899999999999999999999965
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
+..++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~ 163 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSR 163 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCCTT
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-cEEEcccccee
Confidence 4789999999999999999876667899999999999999999999999999999999999999665 59999999998
Q ss_pred cccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017046 209 EETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 209 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
...... ......|++.|+|||++.. ..++.++|||||||++|||++|..||..................+
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~ 235 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 235 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred ecCCCCceeeccccccccccChHHHcC--------CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC
Confidence 643322 2233457899999999865 678999999999999999999777665555556667777777888
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
..|..+|+++.+|+.+||+.||.+|||+.++++.|+.++..
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 89999999999999999999999999999999999877543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-58 Score=408.80 Aligned_cols=246 Identities=27% Similarity=0.498 Sum_probs=210.5
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
++|.+++.||+|+||+||+|++. ++.||+|++.+...... .....+.+|+.+++.++||||+++++++.++ ..++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA--GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT--TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccCh--HHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999874 68999999875322111 1234588999999999999999999999765 7889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 84 vmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCSCSCCCCCC
T ss_pred EEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-CEeecccceeeecCCCc
Confidence 99999999999999763 5699999999999999999999999999999999999999665 59999999997654332
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+ .... .....+.+|..+|+
T Consensus 161 -~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~-i~~~~~~~p~~~s~ 229 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKR-ISRVEFTFPDFVTE 229 (263)
T ss_dssp -CEETTEEGGGCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHH-HHTTCCCCCTTSCH
T ss_pred -ccccCCCCcccCHHHHcC--------CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHH-HHcCCCCCCccCCH
Confidence 345689999999999865 678999999999999999999999998866543 3333 33455678889999
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
++.+||.+||+.||.+|||+.|+++
T Consensus 230 ~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 230 GARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHc
Confidence 9999999999999999999999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=405.69 Aligned_cols=255 Identities=31% Similarity=0.547 Sum_probs=210.6
Q ss_pred cCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
+++++|.++++||+|+||+||+|++. ++.||||+++...... +.|.+|++++++++||||+++++++.+ +..
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~------~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH------HHHHHHHHHHHhcCCCCcccccceeccCCce
Confidence 57889999999999999999999985 5789999998655443 258899999999999999999999864 578
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++....
T Consensus 76 ~lv~E~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD 153 (263)
T ss_dssp EEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-CEEECSCC-------
T ss_pred EEEEEecCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-CeEecccchheeccC
Confidence 999999999999999876 346789999999999999999999999999999999999999665 599999999976433
Q ss_pred cc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 213 TE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 213 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
.. ......||+.|+|||++.. ..++.++|||||||++|||+++ .+||...+ .......+.....+..|
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~~~~~~~p 224 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKP 224 (263)
T ss_dssp -----------CTTSCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-HHHHHHHHHHTCCCCCC
T ss_pred CCceeecceecCcccCChHHhcC--------CCCCchhhhcchHHHHHHHHHCCCCCCCCCC-HHHHHHHHHhcCCCCCc
Confidence 32 2234578999999999864 6789999999999999999995 56665544 45556666677788888
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
..+++++.+|+.+||+.||.+|||+++++++|+.+..
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999988753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-57 Score=407.31 Aligned_cols=265 Identities=28% Similarity=0.427 Sum_probs=223.7
Q ss_pred cccccCCcceeecceeecccceEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
+.|.++.++|++++.||+|+||+||+|++.+ +.||||+++...... +.|.+|+.++++++|||||++++++.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~------~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH------HHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 4566788999999999999999999999854 689999997655443 358899999999999999999999988
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
+..++||||+++|+|..++.......+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+++.
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~ 162 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARL 162 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC-
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-cEEEcccchhhh
Confidence 8899999999999999998765556799999999999999999999999999999999999999654 599999999975
Q ss_pred cccc--cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 017046 210 ETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 287 (378)
Q Consensus 210 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 287 (378)
.... .......||+.|+|||++.. ..++.++|||||||++|||++|..||............+.....+.
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~ 234 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 234 (285)
T ss_dssp -------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccCCCceeeccccccccccChHHHhC--------CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 4322 22344578999999999865 6789999999999999999996665554455566666666777788
Q ss_pred CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 288 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 288 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
.+..+++++.+|+.+||+.||++|||+++|++.|+.++....|
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 8999999999999999999999999999999999998877654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=407.31 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=204.5
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec---CC
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PL 131 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~ 131 (378)
.++|++.+.||+|+||+||+|++. ++.||||++......... ...+.+|++++++++|||||++++++.+ ..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE---KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH---HHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH---HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence 467999999999999999999874 789999999876554332 2468899999999999999999998853 36
Q ss_pred eEEEEeccCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CeeecCCCCcEEEcCCCCceeEecc
Q 017046 132 MVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANG-----IIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~g-----ivH~dikp~Nill~~~~~~vkl~Df 204 (378)
+++||||++||+|.+++... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DF 158 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF 158 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CEEECCH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cEEEeec
Confidence 78999999999999998652 2457999999999999999999999976 99999999999999665 5999999
Q ss_pred ccccccccc-cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017046 205 GLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 205 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 283 (378)
|+++..... .......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+. ......+...
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-~~~~~~i~~~ 229 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIREG 229 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHT
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcC--------CCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-HHHHHHHHcC
Confidence 999865433 23345689999999999864 6789999999999999999999999998665 3445555566
Q ss_pred CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
..+.+|..+|+++.+||.+||+.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 230 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 667788899999999999999999999999999987
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=408.09 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=206.6
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
++|++++.||+|+||+||+|++. ++.||||++........ .+++.+|+.++++++||||+++++++.++ ..++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~----~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC----PENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH----HHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 57999999999999999999874 78999999976543322 23588999999999999999999999655 6889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 81 vmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhheeeccCC
Confidence 9999999999999864 45799999999999999999999999999999999999999665 5999999999864322
Q ss_pred --cccccCcCcccccccccccccccccccccc-CCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCCC
Q 017046 214 --EMMTAETGTYRWMAPELYSTVTLRQGEKKH-YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLP 289 (378)
Q Consensus 214 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~ 289 (378)
......+||+.|+|||++.+ .. ++.++|||||||++|+|++|+.||.........+....... .....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKR--------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHC--------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTG
T ss_pred ccccccceeeCcCccCHhHhcC--------CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 23455689999999999864 34 46789999999999999999999987665444443333322 22233
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
..+++++.+|+.+||+.||.+|||+.|+++ ++++.
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~--hpwf~ 264 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKK--DRWYN 264 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhC
Confidence 568999999999999999999999999988 45553
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-57 Score=406.28 Aligned_cols=257 Identities=27% Similarity=0.525 Sum_probs=213.7
Q ss_pred CCcceeec-ceeecccceEEEEEEEC----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC
Q 017046 56 DPKLLFIG-SKIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (378)
Q Consensus 56 ~~~~~~~~-~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 130 (378)
+.+.+.+. ++||+|+||+||+|.+. ++.||||+++....... ..++|.+|+.+|++++|||||++++++.++
T Consensus 4 d~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~g~~~~~ 80 (277)
T d1xbba_ 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA---LKDELLAEANVMQQLDNPYIVRMIGICEAE 80 (277)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH---HHHHHHHHHHHHHTCCCTTBCCEEEEEESS
T ss_pred chhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHH---HHHHHHHHHHHHHhCCCCCCceEEEEeccC
Confidence 34444544 47999999999999753 36899999976543322 235699999999999999999999999888
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 81 ~~~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~ 157 (277)
T d1xbba_ 81 SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKAL 157 (277)
T ss_dssp SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEEC
T ss_pred CEEEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhhc
Confidence 88999999999999999976 45699999999999999999999999999999999999999655 5999999999754
Q ss_pred ccc----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 017046 211 TVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 285 (378)
Q Consensus 211 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 285 (378)
... .......||+.|+|||++.. ..++.++|||||||++|||++ |..||.+.+.. .....+..+.+
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~~~~~i~~~~~ 228 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKGER 228 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTTCC
T ss_pred cccccccccccccCCCceecCchhhcC--------CCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-HHHHHHHcCCC
Confidence 322 12234578999999999865 668899999999999999998 89999987764 44555667778
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+..|..+|+++.+|+.+||+.||.+|||+.++++.|+.++..
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 889999999999999999999999999999999999887654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=402.22 Aligned_cols=248 Identities=29% Similarity=0.513 Sum_probs=209.7
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 129 (378)
.+.|++.++||+|+||+||+|++. ++.||+|++......... .+.|.+|+++|++++|||||++++++.+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH---HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH---HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 344577789999999999999874 678999999875544332 2468899999999999999999999853
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~g--ivH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
..+++||||++||+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+.+.+||+|||++
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 2578999999999999999763 57999999999999999999999999 9999999999999754456999999999
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC-C
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-P 286 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~ 286 (378)
+..... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+................ +
T Consensus 163 ~~~~~~-~~~~~~GT~~Y~aPE~~~---------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~ 232 (270)
T d1t4ha_ 163 TLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 232 (270)
T ss_dssp GGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred eeccCC-ccCCcccCccccCHHHhC---------CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc
Confidence 754332 334568999999999874 35899999999999999999999999887776666666554433 3
Q ss_pred CCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 287 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 287 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.++..+++++.+||.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 456678999999999999999999999999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-57 Score=415.09 Aligned_cols=263 Identities=32% Similarity=0.502 Sum_probs=220.4
Q ss_pred ccccccccCCcceeecceeecccceEEEEEEECC-------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCC
Q 017046 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDN 119 (378)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~ 119 (378)
..+..|.++.++|.+++.||+|+||+||+|++.+ ..||+|.+........ ...+.+|+.++.++ +|||
T Consensus 27 ~~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~Hpn 102 (325)
T d1rjba_ 27 EYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE----REALMSELKMMTQLGSHEN 102 (325)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTT
T ss_pred CCCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHH----HHHHHHHHHHHHHhcCCCc
Confidence 3445567788899999999999999999998632 3699999876443332 23588999999998 8999
Q ss_pred eeeEEeeEec-CCeEEEEeccCCCCHHHHHhhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 017046 120 LVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRP---------------------NKLDLHVALNFALDIARAMDCLHA 177 (378)
Q Consensus 120 iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~l~~lH~ 177 (378)
||++++++.+ +..++|||||++|+|.+++...+. ..+++..++.++.||+.||+|||+
T Consensus 103 Iv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~ 182 (325)
T d1rjba_ 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 182 (325)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999999965 478999999999999999976432 348999999999999999999999
Q ss_pred CCCeeecCCCCcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhh
Q 017046 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 254 (378)
Q Consensus 178 ~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG 254 (378)
+||+||||||+|||++.++ .+||+|||+|+...... ......||+.|+|||++.. ..++.++||||||
T Consensus 183 ~~IiHRDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~DiwS~G 253 (325)
T d1rjba_ 183 KSCVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWSYG 253 (325)
T ss_dssp TTEEETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHH
T ss_pred CCeeeccCchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--------CCCCcceeccchh
Confidence 9999999999999999664 59999999997644332 2234568999999999864 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 255 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 255 ~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
|++|||++ |..||.+...............++..|..+|+++.+||.+||+.||.+|||+++|+++|..
T Consensus 254 vil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 254 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 99999998 8999998777666677777777888899999999999999999999999999999999853
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-56 Score=409.15 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=213.5
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
.|.++++||+|+||+||+|++ +++.||||++.......... .+.+.+|+.+|++++|||||++++++.+ +..++|
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK--WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHH--HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHH--HHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 599999999999999999986 47899999998765544332 3468899999999999999999999965 478999
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccccc
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~~ 215 (378)
||||.+|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 94 ~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp EECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSSB--
T ss_pred EEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeecccccccCCC--
Confidence 999999999776654 35799999999999999999999999999999999999999654 5999999999764432
Q ss_pred cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChHH
Q 017046 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 295 (378)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (378)
...+||+.|+|||++.+. ....|+.++|||||||++|+|++|..||.+...................+..+|++
T Consensus 169 -~~~~GT~~Y~APE~~~~~-----~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 242 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTT-----TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHH
T ss_pred -CccccCccccCHHHHhcc-----CCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHH
Confidence 456899999999998642 12568999999999999999999999999877766555544444444445678999
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 296 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 296 l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+.+||.+||+.||.+|||+.++++ +.++..
T Consensus 243 ~~~li~~~L~~dP~~Rpt~~ell~--Hp~~~~ 272 (309)
T d1u5ra_ 243 FRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR 272 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTT--CHHHHS
T ss_pred HHHHHHHHCcCChhHCcCHHHHHh--CHHhcC
Confidence 999999999999999999999998 455543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-57 Score=408.38 Aligned_cols=255 Identities=29% Similarity=0.469 Sum_probs=212.6
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
+.|++++.||+|+||+||+|++ +++.||||++........ +.+.+|+++|++++|||||++++++.+ +..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL-----EDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGG-----GGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHH-----HHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence 4589999999999999999987 468999999986544332 347899999999999999999999865 57889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
||||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 87 vmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHH
T ss_pred EEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhccCCCc
Confidence 99999999999998653 45799999999999999999999999999999999999999665 5999999999754332
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--CCCCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPED 291 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~ 291 (378)
......+||+.|+|||++.... .....|+.++|||||||++|+|++|..||.+.+..+...... ....+ ..+..
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~---~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~ 240 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQPSR 240 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCS---TTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-HSCCCCCSSGGG
T ss_pred ccccccccccccCCHHHHhhcc---cCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH-cCCCCCCCcccc
Confidence 2344678999999999985421 123668999999999999999999999999877655544433 33332 34567
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
+|+++.+||.+||+.||.+|||+.|+++ +.++
T Consensus 241 ~s~~~~~li~~~L~~dp~~R~t~~ell~--hp~~ 272 (288)
T d2jfla1 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQ--HPFV 272 (288)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc--Cccc
Confidence 9999999999999999999999999988 4454
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-56 Score=405.78 Aligned_cols=258 Identities=29% Similarity=0.499 Sum_probs=210.2
Q ss_pred cCCcceeecceeecccceEEEEEEEC--C---eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--D---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 129 (378)
++.+.|.+.+.||+|+||+||+|++. + ..||||.+........ .+.|.+|+++|++++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ----RRDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHH----HHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 45577999999999999999999874 2 3588998876554433 2468999999999999999999999964
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
+..++||||+++|+|.+++.. ..+.+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~ 176 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSR 176 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC----
T ss_pred CCEEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC-cEEECCcccce
Confidence 478999999999999998875 345799999999999999999999999999999999999999665 59999999997
Q ss_pred ccccccc------cccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 017046 209 EETVTEM------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (378)
Q Consensus 209 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 281 (378)
....... .....||+.|+|||.+.. ..++.++|||||||++|||+| |..||.+.+.. .....+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-~~~~~i~ 247 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVINAIE 247 (299)
T ss_dssp -------------------CGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHH
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhc--------CCCCcccccccchHHHHHHHhCCCCCCCCCCHH-HHHHHHH
Confidence 5432221 122357899999999864 678999999999999999998 89999987764 4455556
Q ss_pred hcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 282 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
...++..|..+++++.+|+.+||+.||.+|||+.++++.|+.++..
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 6777788889999999999999999999999999999999988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-56 Score=409.94 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=195.7
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|.+++.||+|+||+||+|++. ++.||||++........ ...+.+|+.+|+.++|||||++++++.++ ..++
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK----EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45999999999999999999874 78999999986554332 23578999999999999999999999755 7889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC--CCCceeEecccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAREETV 212 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~--~~~~vkl~Dfg~a~~~~~ 212 (378)
|||||+||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+.. +++.+||+|||+++....
T Consensus 85 vmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999999975 467999999999999999999999999999999999999953 344699999999987666
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--CCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPE 290 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~ 290 (378)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+................ ...+.
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234 (307)
T ss_dssp ----------CTTSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT
T ss_pred CCeeeeeeeCccccCcHHHcC--------CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcccc
Confidence 665667789999999999864 67899999999999999999999999987664443333322222 23446
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.+|+++.+||.+||..||.+|||+.|+++ +.++.
T Consensus 235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~ 268 (307)
T d1a06a_ 235 DISDSAKDFIRHLMEKDPEKRFTCEQALQ--HPWIA 268 (307)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTTT
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhC
Confidence 79999999999999999999999999998 45554
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-56 Score=395.69 Aligned_cols=252 Identities=29% Similarity=0.542 Sum_probs=218.4
Q ss_pred cCCcceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 132 (378)
+++++|+++++||+|+||+||+|++. ++.||||+++...... ..|.+|+.++++++||||+++++++.+ +..
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~------~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE------DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH------HHHHHHHHHHHTCCCTTBCCEEEEECCSSSE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH------HHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Confidence 36788999999999999999999985 5689999998765543 248899999999999999999999965 578
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+.||+||||||+|||++.++ .+||+|||+++....
T Consensus 75 ~iv~Ey~~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEEEECCTTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSS
T ss_pred EEEEEccCCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-cEEECcchhheeccC
Confidence 999999999999998765 345789999999999999999999999999999999999999655 599999999975433
Q ss_pred cc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 213 TE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 213 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
.. ......||+.|+|||++.. ..++.++|||||||++|||+| |+.||.+.+.. .....+....++..|
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~p 223 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIAQGLRLYRP 223 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHHHHHHTTCCCCCC
T ss_pred CCceeecccCCCCCcCCcHHhcC--------CCCCcceeecccchhhHhHHhcCCCCCCCCCHH-HHHHHHHhCCCCCCc
Confidence 22 2234578999999999865 678999999999999999998 89999988764 455556677788889
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 323 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 323 (378)
..+++++.+|+.+||+.||.+|||+.+++++|..
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 9999999999999999999999999999998853
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-57 Score=407.72 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=207.9
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
.+++|++++.||+|+||+||+|++. ++.||||++......... ....+.+|++++++++||||+++++++.++ ..
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHH--HHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 3467999999999999999999874 789999999753321111 124588999999999999999999999765 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
++||||++||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSP 160 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC-
T ss_pred EEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccceeccc
Confidence 8999999999999998763 5799999999999999999999999999999999999999665 499999999986432
Q ss_pred c---cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 213 T---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 213 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.... ...+ ....+.+|
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i-~~~~~~~p 230 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-FQKI-IKLEYDFP 230 (288)
T ss_dssp ---------CCCCGGGCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH-HTTCCCCC
T ss_pred CCcccccccccCCccccCceeecc--------CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-HHHH-HcCCCCCC
Confidence 2 23345689999999999865 6789999999999999999999999998665433 3333 34456788
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
..+++++.+||.+||+.||.+|||++|+++
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 899999999999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7e-56 Score=411.22 Aligned_cols=255 Identities=26% Similarity=0.362 Sum_probs=214.3
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
++|.+++.||+|+||+||+|++. ++.||||++....... .+.+.+|+.+|++++|||||++++++.+ +..++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-----KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH-----HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 47999999999999999999874 7899999997644322 2458899999999999999999999965 47899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC-CCceeEeccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD-QKSLKLADFGLAREETVT 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~-~~~vkl~Dfg~a~~~~~~ 213 (378)
|||||+||+|.+++.. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+ ++.+||+|||+++.....
T Consensus 101 vmE~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 101 IYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp EECCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEEcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999999999865 34579999999999999999999999999999999999999643 346999999999876666
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--CCCCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPED 291 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~ 291 (378)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+............ .....
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 251 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHT--------CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGG
T ss_pred cccceecCcccccCHHHHcC--------CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 66667789999999999864 678899999999999999999999999876654444433322222 22346
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
+|+++.+||.+||..||.+|||+.|+++ +.++...
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~--hp~~~~~ 286 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTPG 286 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHH--STTTSCT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCCC
Confidence 8999999999999999999999999999 5555443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-56 Score=398.49 Aligned_cols=260 Identities=28% Similarity=0.527 Sum_probs=212.6
Q ss_pred cccCCcceeecceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeE
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 127 (378)
+.++.++|.+++.||+|+||+||+|++. +..||||.++....... .+.|.+|+.++++++||||+++++++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV----REKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHH----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3466788999999999999999999874 24688888865444332 34689999999999999999999999
Q ss_pred ecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
.++..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 78 ~~~~~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a 155 (273)
T d1mp8a_ 78 TENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLS 155 (273)
T ss_dssp CSSSCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC----
T ss_pred ecCeEEEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccchhh
Confidence 88899999999999999998765 446799999999999999999999999999999999999999655 5999999999
Q ss_pred ccccccc--ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 208 REETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 208 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
+...... ......||+.|+|||++.. ..++.++|||||||++|||++ |.+||.+.+..+ ....+..+.
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~--------~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-~~~~i~~~~ 226 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENGE 226 (273)
T ss_dssp ---------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHHTTC
T ss_pred eeccCCcceeccceecCcccchhhHhcc--------CCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCC
Confidence 7643322 2344578999999999864 678999999999999999998 899998876643 445556677
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.+.+|..+|+++.+||.+||+.||.+|||+.+|+++|..++..
T Consensus 227 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 7888999999999999999999999999999999999887643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-56 Score=409.08 Aligned_cols=250 Identities=23% Similarity=0.401 Sum_probs=205.3
Q ss_pred cCCcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-C
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 131 (378)
+..++|.++++||+|+||+||+|++ +++.||+|+++....... ..++.+|+.+|+.++|||||++++++.++ .
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 78 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI----RNQIIRELQVLHECNSPYIVGFYGAFYSDGE 78 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTH----HHHHHHHGGGGGGCCCTTBCCEEEEEECSSE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHH----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4567899999999999999999987 479999999987544332 23688999999999999999999999755 6
Q ss_pred eEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
.++||||++||+|.+++... +.+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+|...
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHH
T ss_pred EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCcccc
Confidence 89999999999999999763 5699999999999999999999975 999999999999999665 5999999999864
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHH--------------
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-------------- 276 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------------- 276 (378)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.....
T Consensus 156 ~~~-~~~~~~GT~~Y~APEvl~~--------~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
T d1s9ja_ 156 IDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226 (322)
T ss_dssp HHH-TC---CCSSCCCCHHHHHC--------SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred CCC-ccccccCCccccCchHHcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence 332 3345689999999999965 67999999999999999999999999765432110
Q ss_pred ---------------------------HHHHHhcCCCCCCC-CChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 277 ---------------------------YAAAFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 277 ---------------------------~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
.........+.++. .+|.++.+||.+||..||.+|||+.|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11111122223332 368899999999999999999999999993
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-55 Score=396.51 Aligned_cols=259 Identities=27% Similarity=0.465 Sum_probs=214.5
Q ss_pred cCCcceeecceeecccceEEEEEEECC------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
++++.|.+.+.||+|+||+||+|.+.+ ..||||++........ ...|.+|+.++++++|||||++++++.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ----RVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH----HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHH----HHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 566789999999999999999997642 4699999976554433 235889999999999999999999996
Q ss_pred c-CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 129 D-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 129 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
+ +..++||||+.+++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||||+.++ .+||+|||++
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla 157 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLS 157 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-
T ss_pred cCCceEEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-eEEEcccchh
Confidence 5 578999999999999998876 446799999999999999999999999999999999999999665 5999999999
Q ss_pred ccccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 017046 208 REETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 208 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 283 (378)
+...... ......||+.|+|||++.. ..++.++|||||||++|||++|..||............+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~ 229 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229 (283)
T ss_dssp ----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred hcccCCCccceEeccCCCCccccCHHHHcc--------CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc
Confidence 7543221 2233468999999999864 678999999999999999999665555444556667777778
Q ss_pred CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.++..|..++.++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 88889999999999999999999999999999999999887764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.2e-56 Score=411.47 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=214.2
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
+.|++++.||+|+||+||+|++ +++.||||++....... ...+.+|+.+|++++|||||++++++.++ ..++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-----KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH-----HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4699999999999999999987 47899999998654322 23578999999999999999999999755 7889
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC-CCCceeEeccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP-DQKSLKLADFGLAREETVT 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~-~~~~vkl~Dfg~a~~~~~~ 213 (378)
|||||+||+|.+++.. ....+++.+++.++.||+.||.|||++||+||||||+|||++. +.+.+||+|||++......
T Consensus 104 vmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999999988765 3457999999999999999999999999999999999999973 3346999999999877666
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC--CCCCCCC
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA--RPGLPED 291 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~ 291 (378)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+............. ....+..
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 254 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred CceeeccCcccccCHHHHcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 66667789999999999864 6789999999999999999999999998776554444333222 2234467
Q ss_pred ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
+|+++.+||.+||+.||.+|||+.|+++ +.++.
T Consensus 255 ~s~~~~~li~~~L~~dp~~R~s~~eil~--Hp~~~ 287 (352)
T d1koba_ 255 VSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLK 287 (352)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhC
Confidence 9999999999999999999999999998 44443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=400.35 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=214.9
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHH-HHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
+.|.+++.||+|+||+||+|++. ++.||||++.+....... ....+.+.+|+.+|++++|||||++++++.++ ..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46999999999999999999874 789999999765433211 11124588999999999999999999999765 688
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCC---ceeEecccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREE 210 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~---~vkl~Dfg~a~~~ 210 (378)
+|||||+||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++. .+||+|||++...
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999763 47999999999999999999999999999999999999986553 4999999999876
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--CCC
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--PGL 288 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~ 288 (378)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+........... ...
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred CCCccccccCCCCcccCHHHHcC--------CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence 66666667789999999999864 67899999999999999999999999987765443333222111 122
Q ss_pred CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 289 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 289 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+..+|+++.+||.+||..||.+|||+.++++ +.++..
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~~ 276 (293)
T d1jksa_ 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWIKP 276 (293)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTCC
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCC
Confidence 3578999999999999999999999999998 566643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=403.92 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=212.1
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeE
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 133 (378)
-++|.+++.||+|+||+||+|++ +++.||||++++....... ...++.+|+.+|+.++||||+++++++.++ .++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~--~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHH--HHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 35799999999999999999987 4789999999754322111 124578999999999999999999999765 788
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV- 212 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~- 212 (378)
+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 82 iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeecccccccccC
Confidence 99999999999999886 35799999999999999999999999999999999999999765 599999999986433
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+... .... .....+.+|..+
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~--------~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~-i~~~~~~~p~~~ 228 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFEL-ILMEEIRFPRTL 228 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH-HHHCCCCCCTTS
T ss_pred CcccccceeCHHHhhhhhccC--------CCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-HHHH-HhcCCCCCCccC
Confidence 344456789999999999865 678999999999999999999999999876533 3333 334557888999
Q ss_pred hHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPS-----FSQIIR 319 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps-----~~~ll~ 319 (378)
|+++.+||.+||++||.+|++ +.++++
T Consensus 229 s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 999999999999999999994 889988
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-54 Score=389.79 Aligned_cols=258 Identities=22% Similarity=0.329 Sum_probs=216.0
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCc----hHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTS----DERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~ 129 (378)
.++|++.+.||+|+||+||+|++ +++.||||++...... .......+++.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36799999999999999999987 5799999999875533 223334567899999999997 9999999999976
Q ss_pred C-CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 ~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
+ ..++||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-CeEEccchhee
Confidence 5 789999999999999999763 5799999999999999999999999999999999999999665 59999999998
Q ss_pred ccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC-
Q 017046 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG- 287 (378)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~- 287 (378)
............||+.|+|||.+.+... .....++.++||||+||++|+|++|+.||.+.+................
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~--~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMN--DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHC--TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred EccCCCceeeeeccCCCCCHHHhhcccc--ccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 7665555566789999999999865321 1234578899999999999999999999998776554433333333222
Q ss_pred -CCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 288 -LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 288 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
....+|+++.+|+.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 23479999999999999999999999999988
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=396.59 Aligned_cols=259 Identities=32% Similarity=0.527 Sum_probs=210.3
Q ss_pred ccCCcceeecceeecccceEEEEEEEC-----CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
+++.++|++.+.||+|+||+||+|++. ...||||+++........ ..+.|.+|+.+|+.++||||+++++++.
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE--AMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CH--HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHH--HHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 467789999999999999999999863 247999998765543322 2346899999999999999999999998
Q ss_pred cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
++..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 82 ~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~DfGl~~ 159 (273)
T d1u46a_ 82 TPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMR 159 (273)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCE
T ss_pred ecchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccchhhh
Confidence 88889999999999999988763 45699999999999999999999999999999999999999665 59999999998
Q ss_pred cccccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 017046 209 EETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 283 (378)
Q Consensus 209 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 283 (378)
...... ......|+..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~ 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhC--------CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC
Confidence 643222 2234467889999999865 678899999999999999998 899999888766666555566
Q ss_pred CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 017046 284 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 324 (378)
Q Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 324 (378)
..+..+..+|+++.+|+.+||..||.+|||+.+|++.|...
T Consensus 232 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 67788889999999999999999999999999999988753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=399.23 Aligned_cols=257 Identities=27% Similarity=0.498 Sum_probs=215.2
Q ss_pred cCCcceeecceeecccceEEEEEEEC--C----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEe
Q 017046 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--D----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (378)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 128 (378)
++..+|++++.||+|+||+||+|++. + .+||+|.++....... .+.|.+|+.++++++|||||++++++.
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCRLLGICL 81 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CT----HHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45578999999999999999999874 3 2689998865433322 246899999999999999999999999
Q ss_pred cCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
++..+++|||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 82 ~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~ 159 (317)
T d1xkka_ 82 TSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAK 159 (317)
T ss_dssp SSSEEEEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHH
T ss_pred cCCeeEEEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccccce
Confidence 9889999999999999998876 456799999999999999999999999999999999999999655 59999999997
Q ss_pred cccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 017046 209 EETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 209 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
...... ......||+.|+|||++.. ..++.++|||||||++|||+| |.+||.+.+.. ........+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~~~~~i~~~~ 230 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGE 230 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-GHHHHHHHTC
T ss_pred ecccccccccccccccCccccChHHHhc--------CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCC
Confidence 543322 2233468999999999865 678999999999999999998 89999876653 3455666677
Q ss_pred CCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 285 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 285 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
++..|..+++++.+|+.+||..||.+|||+.+++++|..+..
T Consensus 231 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 888889999999999999999999999999999999887653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-55 Score=390.33 Aligned_cols=254 Identities=33% Similarity=0.570 Sum_probs=213.7
Q ss_pred cccCCcceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec--C
Q 017046 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--P 130 (378)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~ 130 (378)
|.++.++|++++.||+|+||.||+|+++++.||||+++..... +.|.+|+.++++++||||+++++++.+ +
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA-------QAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHH-------HHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 5677788999999999999999999999999999999765432 348899999999999999999998843 4
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
.+++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+|+||||||+|||++.++ .+||+|||+++..
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~ 153 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA 153 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeecccccceec
Confidence 689999999999999999764444689999999999999999999999999999999999999665 5999999999864
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCC
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLP 289 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 289 (378)
... .....+++.|+|||++.. ..++.++|||||||++|||++ |++||..... ......+....++.+|
T Consensus 154 ~~~--~~~~~~~~~y~aPE~l~~--------~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-~~~~~~i~~~~~~~~~ 222 (262)
T d1byga_ 154 SST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYKMDAP 222 (262)
T ss_dssp ----------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GGHHHHHTTTCCCCCC
T ss_pred CCC--CccccccccCCChHHHhC--------CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCCCCCC
Confidence 433 334578899999999864 678999999999999999998 7888887654 3445556667888999
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
..+++++.+|+.+||..||.+|||+.+++++|+.+.
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999999999999998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=395.22 Aligned_cols=262 Identities=30% Similarity=0.535 Sum_probs=212.5
Q ss_pred ccccCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeE
Q 017046 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKF 123 (378)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l 123 (378)
.|.++.++|.++++||+|+||+||+|++. ++.||||+++........ ..+.+|..++.++ +|+||+.+
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~----~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHH----HHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHH----HHHHHHHHHHHhhcCCCeEEEe
Confidence 34566788999999999999999999862 368999999765544332 3577888888877 79999999
Q ss_pred EeeEec--CCeEEEEeccCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCC
Q 017046 124 LGACKD--PLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 187 (378)
Q Consensus 124 ~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp 187 (378)
++++.+ ...++|||||++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp 162 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCc
Confidence 998753 36899999999999999997532 23588999999999999999999999999999999
Q ss_pred CcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhC-
Q 017046 188 DNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN- 263 (378)
Q Consensus 188 ~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g- 263 (378)
+||||+.++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 163 ~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gvil~ellt~~ 233 (299)
T d1ywna1 163 RNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLG 233 (299)
T ss_dssp GGEEECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cceeECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhc--------CCCCcccceeehHHHHHHHHhCC
Confidence 999999655 59999999997543222 2334579999999999865 6789999999999999999986
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 264 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 264 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.+||.+.............+..+..|..+++++.+|+.+||+.||.+|||+.+++++|+.++.
T Consensus 234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 234 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 578988776666677777788888999999999999999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-54 Score=395.25 Aligned_cols=246 Identities=27% Similarity=0.405 Sum_probs=209.5
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
++|.+++.||+|+||+||+|++. ++.||||+++........ ..+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK--QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHH--HHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 57999999999999999999874 789999999753322111 124688999999999999999999999764 7899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 82 vmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSSC-
T ss_pred EeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccceEeccc-
Confidence 9999999999999876 45789999999999999999999999999999999999999665 5999999999865432
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.... +. .....+|..+++
T Consensus 158 -~~~~~Gt~~Y~APE~l~~--------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-i~-~~~~~~p~~~s~ 226 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK-IL-NAELRFPPFFNE 226 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HH-HCCCCCCTTSCH
T ss_pred -cccccCcccccCHHHHcC--------CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH-HH-cCCCCCCCCCCH
Confidence 345689999999999864 6789999999999999999999999998766443333 32 345677888999
Q ss_pred HHHHHHHHccccCCCCCC-----CHHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRP-----SFSQIIRM 320 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 320 (378)
++.+++.+||..||.+|+ |++++++|
T Consensus 227 ~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 227 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 999999999999999996 89999983
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.1e-54 Score=386.58 Aligned_cols=254 Identities=30% Similarity=0.435 Sum_probs=206.4
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-----
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 130 (378)
++|.+.+.||+|+||+||+|++ +++.||||+++........ ...+|.+|+++++.++||||+++++++.+.
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~--~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPS--FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHH--HHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 5699999999999999999987 4899999999876554332 234689999999999999999999988532
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..|+||||++|++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~-~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC-EEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc-ceeehhhhhhhh
Confidence 378999999999999988763 57999999999999999999999999999999999999996654 999999988643
Q ss_pred ccc----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017046 211 TVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 211 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...........+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233 (277)
T ss_dssp C----------------TTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred ccccccccccccccCcccccCHHHHcC--------CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC
Confidence 222 23345579999999999864 678999999999999999999999999877766555554433332
Q ss_pred --CCCCCChHHHHHHHHHccccCCCCCC-CHHHHHHHHHhh
Q 017046 287 --GLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAF 324 (378)
Q Consensus 287 --~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~~ 324 (378)
.....+|+++.+||.+||+.||.+|| |+++++..|..+
T Consensus 234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 23467999999999999999999999 899998877654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=387.89 Aligned_cols=264 Identities=31% Similarity=0.573 Sum_probs=220.0
Q ss_pred ccccccCCcceeecceeecccceEEEEEEECC---------eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCC
Q 017046 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD---------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDN 119 (378)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~ 119 (378)
+..|.++.+.|.+++.||+|+||.||+|+..+ ..||||+++........ ..+.+|...+.++ +|||
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~----~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL----SDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHH----HHHHHHHHHHHHHCCCTT
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHH----HHHHHHHHHHHHhcCCCe
Confidence 34567888999999999999999999997532 47999999876654432 3588999999888 7999
Q ss_pred eeeEEeeEec-CCeEEEEeccCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeec
Q 017046 120 LVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRD 184 (378)
Q Consensus 120 iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~d 184 (378)
||++++++.+ +..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.||+|||
T Consensus 81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD 160 (299)
T d1fgka_ 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 160 (299)
T ss_dssp BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeee
Confidence 9999999965 47899999999999999997643 23589999999999999999999999999999
Q ss_pred CCCCcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHH
Q 017046 185 LKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 261 (378)
Q Consensus 185 ikp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll 261 (378)
|||+|||++.++ .+||+|||++....... ......|++.|+|||.+.. ..|+.++|||||||++|+|+
T Consensus 161 iKp~NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--------~~y~~k~DiwS~Gvvl~ell 231 (299)
T d1fgka_ 161 LAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEIF 231 (299)
T ss_dssp CSGGGEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHH
T ss_pred ecccceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcC--------CCCCchhhhHHhHHHHHHhc
Confidence 999999999665 49999999998654332 2334578999999999864 68999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 262 T-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 262 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
+ |.+||.+.+. ......+..+..+..|..+++++.+||.+||+.||.+|||+.++++.|+.+++.
T Consensus 232 ~~g~~p~~~~~~-~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 232 TLGGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp TTSCCSSTTCCH-HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCH-HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 8 7899987665 455666677888889999999999999999999999999999999999887653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-54 Score=391.40 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=202.9
Q ss_pred cceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEEEecc
Q 017046 63 GSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELL 139 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~ 139 (378)
++.||+|+||+||+|++ +++.||||+++.............++.+|+.+++.++|||||++++++.+ +..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999987 47899999997655444333334568899999999999999999999965 4789999999
Q ss_pred CCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-ccccc
Q 017046 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTA 218 (378)
Q Consensus 140 ~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~~~~ 218 (378)
.++++..+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... .....
T Consensus 83 ~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 83 ETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp SEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCCCCCCC
T ss_pred cchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC-ccccccCccccccCCCcccccc
Confidence 8877766554 346799999999999999999999999999999999999999665 5999999999764433 23345
Q ss_pred CcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC-----------
Q 017046 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG----------- 287 (378)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 287 (378)
.+||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+...........+.
T Consensus 160 ~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp SCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred eecChhhccHHHHcc-------CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 689999999998854 24679999999999999999999999998877655444332111110
Q ss_pred ---------------CCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 017046 288 ---------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 333 (378)
Q Consensus 288 ---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 333 (378)
....+++++.+||.+||+.||.+|||+.|+++ +.++...+.|.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~--Hp~f~~~p~p~~ 291 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFSNRPGPTP 291 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTSSSCCCC
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC--CHhhCCCCCCCC
Confidence 01356889999999999999999999999998 677766554433
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=394.97 Aligned_cols=246 Identities=19% Similarity=0.324 Sum_probs=208.9
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 134 (378)
++|.+++.||+|+||+||+|++. ++.||||+++...... ..+.+|+++|+.++||||+++++++.+ +.+|+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~------~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ------VLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHH------HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccH------HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 56999999999999999999874 7899999997653221 247899999999999999999999975 57899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCC-CceeEeccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ-KSLKLADFGLAREETVT 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~-~~vkl~Dfg~a~~~~~~ 213 (378)
|||||+||+|.+++.. ....+++.+++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||++......
T Consensus 79 vmE~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 79 IFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999999975 334799999999999999999999999999999999999997543 36999999999876655
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCC----
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP---- 289 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 289 (378)
.......+|+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+......... . ....++
T Consensus 158 ~~~~~~~~t~~y~ape~~~~--------~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~-~-~~~~~~~~~~ 227 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM-N-AEYTFDEEAF 227 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-H-TCCCCCHHHH
T ss_pred CcccccccccccccchhccC--------CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH-h-CCCCCChhhc
Confidence 55566789999999998864 678899999999999999999999999877644433332 2 222232
Q ss_pred CCChHHHHHHHHHccccCCCCCCCHHHHHHH
Q 017046 290 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 320 (378)
Q Consensus 290 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 320 (378)
..+|+++.+||.+||..||.+|||+.|++++
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 228 KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3689999999999999999999999999983
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=388.37 Aligned_cols=274 Identities=32% Similarity=0.506 Sum_probs=232.8
Q ss_pred CccCCCcccccccccCCcceeecceeecccceEEEEEEE-------CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHh
Q 017046 41 SITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113 (378)
Q Consensus 41 ~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~ 113 (378)
.+.+.++..+..|.++.++|.+++.||+|+||.||+|++ .++.||||+++........ ..|.+|+.+++
T Consensus 6 ~~~~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~E~~~~~ 81 (311)
T d1t46a_ 6 YIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER----EALMSELKVLS 81 (311)
T ss_dssp CCCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHH----HHHHHHHHHHH
T ss_pred eeCcccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHH----HHHHHHHHHHH
Confidence 345566777778888999999999999999999999975 2368999999876544332 35889999999
Q ss_pred hc-cCCCeeeEEeeEecC-CeEEEEeccCCCCHHHHHhhhCC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 017046 114 RV-KHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRP----------------NKLDLHVALNFALDIARAMDCL 175 (378)
Q Consensus 114 ~l-~hp~iv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~----------------~~l~~~~~~~i~~qi~~~l~~l 175 (378)
.+ +|||||++++++.++ ..++||||+++|+|.+++..... ..+++..+..++.||+.||+||
T Consensus 82 ~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L 161 (311)
T d1t46a_ 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161 (311)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred hccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 99 699999999999754 68999999999999999976431 2589999999999999999999
Q ss_pred HhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc---cccccCcCccccccccccccccccccccccCCCcccchh
Q 017046 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 252 (378)
Q Consensus 176 H~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diws 252 (378)
|++|++||||||+|||++.++ .+||+|||+++..... .......||+.|+|||++.. ..++.++||||
T Consensus 162 H~~~ivHrDLKp~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DIwS 232 (311)
T d1t46a_ 162 ASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWS 232 (311)
T ss_dssp HHTTCCCSCCSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHHHH
T ss_pred HhCCeeecccccccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcC--------CCCCCcccccc
Confidence 999999999999999999655 5999999999854332 22334578999999999864 67899999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 253 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 253 lG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
|||++|||++ |.+||.+.............+.++..|..+++++.+||.+||+.||.+|||+.++++.|+..+.+
T Consensus 233 ~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 9999999998 67777777666666677777888888889999999999999999999999999999999887655
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-53 Score=388.12 Aligned_cols=258 Identities=30% Similarity=0.503 Sum_probs=216.2
Q ss_pred ccCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEee
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 126 (378)
.+..++|.+++.||+|+||+||+|++. ++.||||+++....... .++|.+|+.++++++||||++++++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM----QADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHH----HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHH----HHHHHHHHHHHHhcCCCCcccceee
Confidence 344567999999999999999999864 36899999976554332 3468999999999999999999999
Q ss_pred Eec-CCeEEEEeccCCCCHHHHHhhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeee
Q 017046 127 CKD-PLMVIVTELLPGMSLRKYLVSLR----------------------PNKLDLHVALNFALDIARAMDCLHANGIIHR 183 (378)
Q Consensus 127 ~~~-~~~~lv~e~~~~~sL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~ 183 (378)
+.+ ...+++|||+++|+|.+++.... ...+++..++.++.|++.||+|||++|++||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 865 47899999999999999996532 1248899999999999999999999999999
Q ss_pred cCCCCcEEEcCCCCceeEeccccccccccc---cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHH
Q 017046 184 DLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260 (378)
Q Consensus 184 dikp~Nill~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~l 260 (378)
||||+|||++.++ .+||+|||+++..... .......|++.|+|||.+.. ..++.++|||||||++|||
T Consensus 165 DlKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~t~ksDVwS~Gvvl~el 235 (301)
T d1lufa_ 165 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWEI 235 (301)
T ss_dssp CCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred EEcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc--------CCCChhhhhccchhhHHHH
Confidence 9999999999665 5999999999754322 22334578899999999865 6789999999999999999
Q ss_pred HhCC-CCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 017046 261 LTNR-LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 325 (378)
Q Consensus 261 l~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 325 (378)
++|. +||.+.... +....+.....+..|..+++++.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 236 l~~~~~p~~~~~~~-e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 236 FSYGLQPYYGMAHE-EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HTTTCCTTTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HccCCCCCCCCCHH-HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 9985 678776654 445556677788889999999999999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-54 Score=391.74 Aligned_cols=261 Identities=31% Similarity=0.526 Sum_probs=217.4
Q ss_pred ccCCcceeecceeecccceEEEEEEEC--Ce--eEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEe
Q 017046 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG--DR--IVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK 128 (378)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 128 (378)
.++.++|++.++||+|+||+||+|++. +. .||||.+........ .+.|.+|+++|+++ +|||||++++++.
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD----HRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHH----HHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 467789999999999999999999874 33 578888765443332 23588999999999 7999999999996
Q ss_pred cC-CeEEEEeccCCCCHHHHHhhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEc
Q 017046 129 DP-LMVIVTELLPGMSLRKYLVSL--------------RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 193 (378)
Q Consensus 129 ~~-~~~lv~e~~~~~sL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~ 193 (378)
++ ..++||||++||+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 54 789999999999999998642 235799999999999999999999999999999999999999
Q ss_pred CCCCceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCC-CCCCCCCh
Q 017046 194 PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR-LPFEGMSN 272 (378)
Q Consensus 194 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~ 272 (378)
.++ .+||+|||+++............||..|+|||.+.. ..++.++|||||||++|||++|. +||.+.+.
T Consensus 162 ~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~ 232 (309)
T d1fvra_ 162 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232 (309)
T ss_dssp GGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCC-ceEEccccccccccccccccceecCCcccchHHhcc--------CCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence 665 599999999987655555556679999999999864 67899999999999999999965 56776554
Q ss_pred HHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 273 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
......+..+.++..|..+++++.+||.+||+.||++|||+.+++++|..++...
T Consensus 233 -~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 233 -AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp -HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -HHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 5555666677788889999999999999999999999999999999999988654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-53 Score=396.03 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=208.7
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
++|.+++.||+|+||+||+|++. ++.||||++......... ....+.+|+.+|+.++|||||++++++.+. ..++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK--QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHH--HHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 57999999999999999999874 789999998753221111 123588999999999999999999999765 6789
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
||||+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 119 v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC-
T ss_pred ccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceeeeecccc-
Confidence 99999999999999763 4699999999999999999999999999999999999999665 5999999999865432
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCChH
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 294 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (378)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.... ...+ ....+.+|..+++
T Consensus 195 -~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i-~~~~~~~p~~~s~ 263 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-YEKI-VSGKVRFPSHFSS 263 (350)
T ss_dssp -BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH-HHCCCCCCTTCCH
T ss_pred -cccccCccccCCHHHHcC--------CCCCccccccchhHHHHHHHhCCCCCCCcCHHHH-HHHH-hcCCCCCCccCCH
Confidence 345689999999999865 6789999999999999999999999988765443 3332 3445667888999
Q ss_pred HHHHHHHHccccCCCCCC-----CHHHHHH
Q 017046 295 DLAFIVQSCWVEDPNLRP-----SFSQIIR 319 (378)
Q Consensus 295 ~l~~li~~~l~~dp~~Rp-----s~~~ll~ 319 (378)
++.+||.+||..||.+|+ |++++++
T Consensus 264 ~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 999999999999999994 8999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-53 Score=396.86 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=207.1
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHH-HHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-Ce
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 132 (378)
-++|.+++.||+|+||+||+|++ +++.||||++......... .....+...|+.+++.++|||||++++++.++ ..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 35799999999999999999987 4789999998753322111 11111233457777788899999999999764 78
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~ 212 (378)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-CEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-cEEEeeeceeeecCC
Confidence 9999999999999999763 5689999999999999999999999999999999999999665 599999999986544
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA-AYAAAFKHARPGLPED 291 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 291 (378)
.. ....+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+...... ..........+.+|..
T Consensus 160 ~~-~~~~~GT~~y~APE~~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (364)
T d1omwa3 160 KK-PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 231 (364)
T ss_dssp SC-CCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSS
T ss_pred Cc-ccccccccccchhHHhhc-------CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCC
Confidence 32 345689999999999853 25689999999999999999999999986543221 1222334556667888
Q ss_pred ChHHHHHHHHHccccCCCCCCC-----HHHHHHHHHhhh
Q 017046 292 ISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFL 325 (378)
Q Consensus 292 ~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~l~~~~ 325 (378)
+|+++.+||.+||..||.+||| ++++++ +.++
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~--Hp~f 268 (364)
T d1omwa3 232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFF 268 (364)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT--SGGG
T ss_pred CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc--Cccc
Confidence 9999999999999999999999 799998 4444
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-54 Score=394.99 Aligned_cols=249 Identities=25% Similarity=0.416 Sum_probs=202.7
Q ss_pred cceeecc-eeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc-cCCCeeeEEeeEec----
Q 017046 58 KLLFIGS-KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD---- 129 (378)
Q Consensus 58 ~~~~~~~-~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~---- 129 (378)
++|.+.. .||+|+||+||+|++ +++.||||+++.. ..+.+|+.++.++ +|||||++++++.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 4688765 599999999999987 4789999998642 1366899987655 89999999999864
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC--CCceeEecccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGL 206 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~--~~~vkl~Dfg~ 206 (378)
..+|+|||||+||+|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 468999999999999999986445679999999999999999999999999999999999999853 34599999999
Q ss_pred ccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHH--HhcC
Q 017046 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA--FKHA 284 (378)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~~~~ 284 (378)
++...........+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+......... ....
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~ 232 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCG--------GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC
T ss_pred eeeccCCCccccccCCcccCCcHHHcC--------CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC
Confidence 987666666677789999999999865 678999999999999999999999997655433222111 1122
Q ss_pred CCCCCC----CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 285 RPGLPE----DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 285 ~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
...+|. .+|+++.+||.+||+.||.+|||+.|++++ .++.
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h--p~~~ 276 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH--PWIM 276 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS--HHHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC--HHhh
Confidence 223332 478999999999999999999999999984 4443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=391.61 Aligned_cols=247 Identities=28% Similarity=0.465 Sum_probs=206.6
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHh-hccCCCeeeEEeeEecC-CeE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS-RVKHDNLVKFLGACKDP-LMV 133 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~l~~~~~~~-~~~ 133 (378)
++|.+++.||+|+||+||+|++ +++.||||++++........ .+.+..|..++. .++||||+++++++.++ ..|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~--~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD--VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTC--HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHH--HHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 4799999999999999999988 57999999997532211111 124566776665 68999999999999765 789
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccc-
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV- 212 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~- 212 (378)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 80 ivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-ceeccccchhhhcccc
Confidence 999999999999999763 5689999999999999999999999999999999999999655 599999999975443
Q ss_pred ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCCCC
Q 017046 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 292 (378)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (378)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.... ...+ ....+.+|..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i-~~~~~~~p~~~ 226 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-FHSI-RMDNPFYPRWL 226 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH-HHCCCCCCTTS
T ss_pred cccccccCCCCCcCCHHHHcC--------CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHH-HcCCCCCCccC
Confidence 233445689999999999965 6789999999999999999999999998765443 3333 34567888899
Q ss_pred hHHHHHHHHHccccCCCCCCCHH-HHHH
Q 017046 293 SPDLAFIVQSCWVEDPNLRPSFS-QIIR 319 (378)
Q Consensus 293 ~~~l~~li~~~l~~dp~~Rps~~-~ll~ 319 (378)
|+++.+||.+||..||.+|||+. ++++
T Consensus 227 s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 227 EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 99999999999999999999995 7876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=383.61 Aligned_cols=270 Identities=29% Similarity=0.507 Sum_probs=225.7
Q ss_pred cCCCcccccccccCCcceeecceeecccceEEEEEEEC-------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc
Q 017046 43 TAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV 115 (378)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l 115 (378)
+..++...+.|.++.++|.+++.||+|+||+||+|.+. ++.||||+++....... ...|.+|+.+++++
T Consensus 5 ~~~~~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~----~~~~~~E~~il~~l 80 (308)
T d1p4oa_ 5 SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE----RIEFLNEASVMKEF 80 (308)
T ss_dssp BCCSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHH----HHHHHHHHHHGGGC
T ss_pred CcccCcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHH----HHHHHHHHHHHHHc
Confidence 33445555678899999999999999999999999763 46899999976544332 23689999999999
Q ss_pred cCCCeeeEEeeEe-cCCeEEEEeccCCCCHHHHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCC
Q 017046 116 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 186 (378)
Q Consensus 116 ~hp~iv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dik 186 (378)
+||||+++++++. ++..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+|||||
T Consensus 81 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk 160 (308)
T d1p4oa_ 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLA 160 (308)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCS
T ss_pred CCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEc
Confidence 9999999999985 457899999999999999886432 1347899999999999999999999999999999
Q ss_pred CCcEEEcCCCCceeEecccccccccccc---ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhC
Q 017046 187 PDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 263 (378)
Q Consensus 187 p~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g 263 (378)
|+|||++.++ ++||+|||+++...... ......||+.|+|||.+.. ..++.++|||||||++|||++|
T Consensus 161 ~~NiLld~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~--------~~~~~~~Dv~S~G~il~El~t~ 231 (308)
T d1p4oa_ 161 ARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATL 231 (308)
T ss_dssp GGGEEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHT
T ss_pred CCceeecCCc-eEEEeecccceeccCCcceeeccceecccccCCHHHHcc--------CCCCcccccccHHHHHHHHHhC
Confidence 9999999654 59999999997543322 2344478999999999864 6788999999999999999997
Q ss_pred -CCCCCCCChHHHHHHHHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 017046 264 -RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 326 (378)
Q Consensus 264 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 326 (378)
.+||.+.+.. .....+.....+..|..+++.+.++|.+||+.||.+|||+.+|+++|+..+.
T Consensus 232 ~~~p~~~~~~~-~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 232 AEQPYQGLSNE-QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp SCCTTTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCCCCHH-HHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 5788876654 4455566777888889999999999999999999999999999999877643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=381.60 Aligned_cols=260 Identities=28% Similarity=0.459 Sum_probs=207.8
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
++|.++++||+|+||+||+|++. ++.||||+++....... ...++.+|+++|++++|||||++++++.++ ..++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChH---HHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence 47999999999999999999874 78999999965433221 224688999999999999999999999765 7899
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccccccc-
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~- 213 (378)
||||+.+ ++.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 79 v~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 79 VFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCS
T ss_pred EEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCcceeccCCc
Confidence 9999955 556666554567799999999999999999999999999999999999999665 5999999999765432
Q ss_pred cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC------
Q 017046 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG------ 287 (378)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------ 287 (378)
.......||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..............+.
T Consensus 157 ~~~~~~~gt~~y~apE~~~~-------~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccceeecccceeeehhhhcc-------ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccc
Confidence 33445689999999998754 24468899999999999999999999998776555444332111110
Q ss_pred ----------C-----------CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 288 ----------L-----------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 288 ----------~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
+ ...+++++.+|+.+||..||.+|||+.|+++ +.++..+..|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~--H~ff~~~~~p 292 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKP 292 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGTTCCCC
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC--CHhhccCCCC
Confidence 0 1246789999999999999999999999999 6777666544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=381.59 Aligned_cols=252 Identities=31% Similarity=0.489 Sum_probs=209.5
Q ss_pred cceeecccceEEEEEEECC-----eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec--CCeEEE
Q 017046 63 GSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--PLMVIV 135 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~lv 135 (378)
.++||+|+||+||+|++.+ ..||||+++....... .++|.+|+++|++++||||+++++++.+ +..++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHH----HHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHH----HHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 5789999999999998732 3689999875443332 2469999999999999999999998753 468899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+||+|||+++......
T Consensus 108 ~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSSGGGCCTTTTTC
T ss_pred EEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-CEEEecccchhhcccccc
Confidence 999999999998876 455788999999999999999999999999999999999999654 59999999997543322
Q ss_pred ----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 215 ----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 215 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
......||+.|+|||.+.. ..++.++||||||+++|||++|..||...............+.++..|.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~ 257 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 257 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCT
T ss_pred ccceecccccccccccChHHHhc--------CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 1223468999999999864 6789999999999999999998887766555555566667778888899
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
.+++++.+|+.+||..||.+|||+.||+++|+.++...
T Consensus 258 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 99999999999999999999999999999999987653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=382.43 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=205.0
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHH-HHHHHHHHHHHHHhhcc--CCCeeeEEeeEecC-C
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERA-LLEGRFIREVNMMSRVK--HDNLVKFLGACKDP-L 131 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~-~ 131 (378)
++|.+++.||+|+||+||+|++. ++.||||++.......... ....++.+|+.++++++ ||||+++++++.++ .
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 46999999999999999999874 7899999987643221100 00123568999999996 89999999999765 7
Q ss_pred eEEEEeccCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 132 MVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 132 ~~lv~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
.++||||+.+ +++.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 8899999976 578888875 3579999999999999999999999999999999999999866667999999999764
Q ss_pred ccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCCCC
Q 017046 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 290 (378)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (378)
... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+. .......++.
T Consensus 162 ~~~-~~~~~~GT~~y~aPE~~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------i~~~~~~~~~ 225 (273)
T d1xwsa_ 162 KDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIRGQVFFRQ 225 (273)
T ss_dssp CSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HHHCCCCCSS
T ss_pred ccc-cccccccCCCcCCHHHHcC-------CCCCCcccccccceeeehhHhhCCCCCCCchH--------HhhcccCCCC
Confidence 433 3356689999999999864 13346789999999999999999999976321 1234556778
Q ss_pred CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 291 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 291 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
.+|+++.+||.+||..||.+|||++|+++ +.++..
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~--hp~~~~ 260 (273)
T d1xwsa_ 226 RVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQD 260 (273)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGSS
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhCC
Confidence 89999999999999999999999999998 456654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-52 Score=378.20 Aligned_cols=257 Identities=26% Similarity=0.367 Sum_probs=206.7
Q ss_pred CcceeecceeecccceEEEEEEEC---CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhc---cCCCeeeEEeeEec-
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG---DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACKD- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~- 129 (378)
.++|+++++||+|+||+||+|++. ++.||||+++......... ..+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~---~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH---HHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 367999999999999999999873 5779999987543322111 1255777777666 79999999998842
Q ss_pred -----CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecc
Q 017046 130 -----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 130 -----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Df 204 (378)
...+++|||++++.+.... ......+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~~kl~df 160 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADF 160 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSC
T ss_pred ccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-Ceeecch
Confidence 3578999999876665443 33556799999999999999999999999999999999999999665 5999999
Q ss_pred ccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 017046 205 GLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 284 (378)
Q Consensus 205 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 284 (378)
|++.............||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+..........
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~--------~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 232 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcC--------CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhC
Confidence 99987766666677899999999999864 6789999999999999999999999998776554443322111
Q ss_pred C-------------------------CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 285 R-------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 285 ~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
. ..++..+++++.+||.+||+.||.+|||+.|+++ ++++..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~--Hpff~~i 299 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--HPYFQDL 299 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGTTC
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--ChhhcCc
Confidence 0 1134567899999999999999999999999998 5666554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-51 Score=379.29 Aligned_cols=256 Identities=26% Similarity=0.338 Sum_probs=207.7
Q ss_pred ceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-------
Q 017046 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------- 129 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------- 129 (378)
.|..+++||+|+||+||+|++ +++.||||++...... +.+|+.+|++++||||+++++++..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 588999999999999999998 4789999999875432 3479999999999999999998842
Q ss_pred CCeEEEEeccCCCCHHHHHhh-hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~-~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
.+.++||||++++.+..+... .....+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||++.
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 146899999976544433322 2345799999999999999999999999999999999999999777679999999998
Q ss_pred ccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC---
Q 017046 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--- 285 (378)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--- 285 (378)
............||+.|+|||.+.. ...++.++|||||||++|+|++|..||.+.+..+...........
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 172 QLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp ECCTTSCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred hccCCcccccccccccccChHHhhc-------ccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 7666666667789999999998754 256899999999999999999999999887765544433211000
Q ss_pred ------------C------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017046 286 ------------P------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 332 (378)
Q Consensus 286 ------------~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 332 (378)
. .....+++++.+||.+||..||.+|||+.|+++ +.++..+..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA--HSFFDELRDPN 313 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGGGGCTT
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhccccCCC
Confidence 0 112357899999999999999999999999998 67776665544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.4e-51 Score=370.75 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=200.4
Q ss_pred cceeecceeecccceEEEEEEEC-CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-CCeEEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 135 (378)
++|.++++||+|+||+||+|++. ++.||||++........ ...++.+|+.+|++++||||+++++++.+ +..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG---IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC---CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChH---HHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 47999999999999999999875 68999999976544322 12358899999999999999999999965 478899
Q ss_pred EeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc-
Q 017046 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (378)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~- 214 (378)
|||+.++.+..+.. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 79 ~e~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~-~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC-EEecccccceecccCcc
Confidence 99997766665544 3467999999999999999999999999999999999999997654 9999999997644332
Q ss_pred ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--------
Q 017046 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-------- 286 (378)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------- 286 (378)
......+++.|+|||.+.. ...++.++|||||||++|+|++|+.||.+.+..+...........+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~-------~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp ------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccceecccchhhhHHHHhC-------CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence 2344578999999999864 3567899999999999999999999999877655544432211111
Q ss_pred -------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHH
Q 017046 287 -------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 319 (378)
Q Consensus 287 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 319 (378)
.++..+++++.+||.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123457889999999999999999999999988
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=371.79 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=203.4
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 130 (378)
.+.|.++++||+|+||+||+|++. ++.||||+++....... ...++.+|+++|+.++|||||++++++.+.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL---FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH---HHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChH---HHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 467999999999999999999874 78999999986544332 234688999999999999999999998543
Q ss_pred ---CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccc
Q 017046 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (378)
Q Consensus 131 ---~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a 207 (378)
.+++||||+ +.+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a 168 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLA 168 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred ccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccce
Confidence 468999999 7788887764 5699999999999999999999999999999999999999665 4999999999
Q ss_pred cccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--
Q 017046 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-- 285 (378)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-- 285 (378)
..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..............
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 169 RQADS--EMTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp EECCS--SCCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eccCC--ccccccccccccCHHHHcC-------CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 76543 3356689999999999864 245789999999999999999999999887665443322211111
Q ss_pred ---------------------------CCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 286 ---------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 286 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
......+++++.+||.+||..||.+|||+.|+++ ++++..+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~--Hp~f~~~~~ 309 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA--HPYFESLHD 309 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTTC-
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc--ChhhCcCCC
Confidence 1123467899999999999999999999999999 677766543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=371.81 Aligned_cols=256 Identities=28% Similarity=0.375 Sum_probs=201.8
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-----
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 130 (378)
++|.++++||+|+||+||+|++ +++.||||++........ .+++.+|+.+|+.++||||+++++++...
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY----CQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHH----HHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHH----HHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 4699999999999999999987 478999999976443322 24688999999999999999999998543
Q ss_pred CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccc
Q 017046 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (378)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~ 210 (378)
..+++++|+.||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVA 159 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred ceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CEEEcccCceeec
Confidence 23556667779999999975 4699999999999999999999999999999999999999665 5999999999754
Q ss_pred cccc----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 017046 211 TVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 286 (378)
Q Consensus 211 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 286 (378)
.... .....+||+.|+|||++.. ...++.++||||+||++|+|++|..||.+.+..............+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTT-------BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCCCccceeeccccccceechHHHhhc-------CCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 3332 2345579999999999854 3567889999999999999999999998876544333322111111
Q ss_pred -----------------------------CCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCC
Q 017046 287 -----------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 330 (378)
Q Consensus 287 -----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 330 (378)
.....+++++.+|+.+||..||.+|||+.++++ +.++.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~--hpf~~~~~~ 303 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA--HPYLEQYYD 303 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGTTTCC
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhccCCC
Confidence 012357889999999999999999999999999 556554433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.8e-50 Score=370.90 Aligned_cols=250 Identities=20% Similarity=0.335 Sum_probs=204.8
Q ss_pred CCcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec---
Q 017046 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD--- 129 (378)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~--- 129 (378)
+.++|+++++||+|+||+||+|++. ++.||||+++.... .++.+|+.+|+.++ ||||+++++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--------~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--------KKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH--------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 3467999999999999999999874 79999999875331 24789999999995 9999999999863
Q ss_pred CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
...++||||+.+++|..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++..+||+|||++..
T Consensus 105 ~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence 3689999999999987653 46999999999999999999999999999999999999997776799999999987
Q ss_pred cccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHh-------
Q 017046 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK------- 282 (378)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------- 282 (378)
..........++|+.|+|||.+.. ...++.++|||||||++|+|++|..||...............
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred ccCCCcccccccCccccCcccccC-------CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence 665555667789999999999864 245789999999999999999999999765543222111100
Q ss_pred -----c------------------------CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 283 -----H------------------------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 283 -----~------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
. ........+++++.+||.+||..||.+|||++|+++ +.++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~--Hp~F~~ 324 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME--HPYFYT 324 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTT
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCC
Confidence 0 000111347889999999999999999999999998 666654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=369.06 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=196.9
Q ss_pred cceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-----Ce
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-----LM 132 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~ 132 (378)
+.|.+.+.||+|+||+||+|+++++.||||+++.... .. ..+..|+..+..++||||+++++++.+. .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~---~~---~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---RS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH---HH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch---hH---HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4688889999999999999999999999999864321 11 1123456666778999999999998542 47
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCeeecCCCCcEEEcCCCCceeEecc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA--------NGIIHRDLKPDNLLLTPDQKSLKLADF 204 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~--------~givH~dikp~Nill~~~~~~vkl~Df 204 (378)
++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+||||+.++ .+||+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DF 152 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCC
T ss_pred EEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEec
Confidence 899999999999999986 469999999999999999999996 5999999999999999665 5999999
Q ss_pred cccccccccc-----ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCC--------
Q 017046 205 GLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS-------- 271 (378)
Q Consensus 205 g~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------- 271 (378)
|+++...... ......||+.|+|||++.+... .....++.++|||||||+||||++|..||....
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSC--TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred CccccccCCCcceeccccceecccCcCChhhcccccc--ccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 9997543322 2334679999999999864211 011246778999999999999999988764211
Q ss_pred ------hHHHHHHHH-HhcCCCCCCCC-----ChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhc
Q 017046 272 ------NLQAAYAAA-FKHARPGLPED-----ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 327 (378)
Q Consensus 272 ------~~~~~~~~~-~~~~~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 327 (378)
......... ....++.++.. ....+.+|+.+||..||.+|||+.||++.|+.+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 112222222 22334444433 234689999999999999999999999999887643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=359.19 Aligned_cols=259 Identities=23% Similarity=0.383 Sum_probs=209.5
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEecC-CeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 134 (378)
++|+++++||+|+||+||+|++ +++.||||+++....... ...++.+|+.+|+.++||||+++++++.+. ..++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT---HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH---HHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence 4799999999999999999987 468899999976654332 234688999999999999999999999765 6789
Q ss_pred EEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccccccccc
Q 017046 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (378)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~~~~~~ 214 (378)
+++++.+++|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||.+.......
T Consensus 79 v~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCC
T ss_pred Eeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhcccCCC
Confidence 9999999888887764 46789999999999999999999999999999999999999665 59999999998654433
Q ss_pred -ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhc----------
Q 017046 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH---------- 283 (378)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---------- 283 (378)
......+++.|+|||++.. ...++.++|||||||++|+|++|+.||....+...........
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred ccceeeccccchhhhhHhcc-------CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence 3334467788999998864 2457899999999999999999999976555544444332211
Q ss_pred ------------------CCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 284 ------------------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 284 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
.....+..+++++.+|+.+||+.||.+|||++|+++ +.++..+.||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~--Hp~f~~~~~~ 292 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFCPP 292 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGSSCSCC
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc--ChhhcCCCCC
Confidence 111123457889999999999999999999999998 6677665543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=362.60 Aligned_cols=257 Identities=23% Similarity=0.316 Sum_probs=199.8
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 129 (378)
.++|.++++||+|+||+||+|++. ++.||||++......... ..++.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF---PITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSS---CHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHH---HHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 468999999999999999999874 789999998665433221 2357899999999999999999998743
Q ss_pred ----CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 130 ----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 130 ----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
...++||||+.++.+..... ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg 162 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFG 162 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred cccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeecc
Confidence 35789999997765554433 346799999999999999999999999999999999999999665 59999999
Q ss_pred cccccccc-----cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHH
Q 017046 206 LAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (378)
Q Consensus 206 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 280 (378)
++...... ......+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-------~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcC-------CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 99653322 22234579999999999864 2468899999999999999999999998877644433322
Q ss_pred HhcC--CCCCCC----------------------------CChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 281 FKHA--RPGLPE----------------------------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 281 ~~~~--~~~~~~----------------------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
.... .+.... ..++++.+||.+||+.||++|||+.|+++ +.++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~--Hpff~~~ 311 (318)
T d3blha1 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFWSD 311 (318)
T ss_dssp HHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGSSS
T ss_pred HhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc--ChhhccC
Confidence 2111 111100 12567889999999999999999999998 7777654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-49 Score=360.41 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=200.1
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeE-EeeEec-CCeE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF-LGACKD-PLMV 133 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l-~~~~~~-~~~~ 133 (378)
.+|++++.||+|+||+||+|++. ++.||||++....... ++..|+++++.++|+|++.. .+++.+ ...+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC-------CHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH-------HHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 46999999999999999999874 7899999987654432 36789999999987765554 444444 4678
Q ss_pred EEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcC--CCCceeEeccccccccc
Q 017046 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAREET 211 (378)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~--~~~~vkl~Dfg~a~~~~ 211 (378)
+||||+ +++|.+.+.. ....+++..+..++.|++.||+|||++||+||||||+|||++. .+..++|+|||+++...
T Consensus 80 ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 999999 6677777655 4567999999999999999999999999999999999999864 23469999999998543
Q ss_pred ccc--------ccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHH-----
Q 017046 212 VTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA----- 278 (378)
Q Consensus 212 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----- 278 (378)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~ 229 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--------BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhC--------CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh
Confidence 221 2234579999999999865 6789999999999999999999999987554332221
Q ss_pred -HHHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 279 -AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 279 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
.......+.++..+|+++.+++..||+.||.+||++.++.+.|+.++...
T Consensus 230 ~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 11112222345679999999999999999999999999999998876543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=368.15 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=204.3
Q ss_pred CcceeecceeecccceEEEEEEE-----CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccC-CCeeeEEeeEecC
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH-DNLVKFLGACKDP 130 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~ 130 (378)
-++|.+++.||+|+||+||+|+. +++.||||+++......+.. ..+++.+|++++++++| |||+++++++.+.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~-~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK-TTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES-SGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchH-HHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 36799999999999999999976 36899999986543211100 01247799999999966 8999999999654
Q ss_pred -CeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccccccc
Q 017046 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (378)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~~ 209 (378)
..+++|||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKE 178 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEE
T ss_pred CceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-CEEEeeccchhh
Confidence 788999999999999999874 4678999999999999999999999999999999999999765 599999999975
Q ss_pred ccc--ccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCC
Q 017046 210 ETV--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ--AAYAAAFKHAR 285 (378)
Q Consensus 210 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~ 285 (378)
... ........|++.|+|||.+.. ....++.++|||||||+||+|++|..||.+..... ...........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~------~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred hcccccccccccccccccchhHHhhc------CCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC
Confidence 432 223345689999999999864 23457889999999999999999999997654322 22222334556
Q ss_pred CCCCCCChHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 017046 286 PGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 319 (378)
Q Consensus 286 ~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~ 319 (378)
+.+|..+++++.+|+.+||..||.+|| |++|+++
T Consensus 253 ~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 677888999999999999999999999 4899988
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=367.04 Aligned_cols=257 Identities=30% Similarity=0.382 Sum_probs=205.6
Q ss_pred CcceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec-----
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 129 (378)
+++|.++++||+|+||+||+|++ +++.||||++......... ..++.+|+.+|+.++||||+++++++..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHH---HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHH---HHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence 56799999999999999999987 4799999999876544332 2468899999999999999999998842
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
...+++|+|+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|++|||++.
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~ 169 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR 169 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC----
T ss_pred cCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccchhc
Confidence 245677788889999999864 5799999999999999999999999999999999999999665 49999999987
Q ss_pred ccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--
Q 017046 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-- 286 (378)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-- 286 (378)
..... .....|++.|+|||.+.. ...++.++|||||||++|+|++|..||.+.+..............+
T Consensus 170 ~~~~~--~~~~~g~~~y~apE~~~~-------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 170 HTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp CCTGG--GSSSCHHHHTSCHHHHTT-------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccCcc--cccccccccccCchhhcC-------CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 54332 345689999999998754 2456889999999999999999999999877644433332211111
Q ss_pred -------------------CC--------CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccCCC
Q 017046 287 -------------------GL--------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 331 (378)
Q Consensus 287 -------------------~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 331 (378)
.. ...+++++.+||.+||..||.+|||+.|+++ +.++.....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~--Hp~f~~~~~~ 310 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYHDP 310 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTTCCT
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc--CHhhCCCCCC
Confidence 11 1357899999999999999999999999999 6777765443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-48 Score=352.86 Aligned_cols=256 Identities=20% Similarity=0.291 Sum_probs=206.5
Q ss_pred CcceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEec-CCe
Q 017046 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-PLM 132 (378)
Q Consensus 57 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~~ 132 (378)
.+.|++++.||+|+||+||+|++. ++.||||++....... .+.+|+++++.+. |+|++.+++++.+ ...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC-------CHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcH-------HHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 357999999999999999999874 7899999987654332 2668889999986 4899999998865 477
Q ss_pred EEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCC----CCceeEecccccc
Q 017046 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD----QKSLKLADFGLAR 208 (378)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~----~~~vkl~Dfg~a~ 208 (378)
++||||+ +++|.+++.. ....++...+..++.|++.||+|||++||+||||||+|||++.. .+.+||+|||+++
T Consensus 77 ~~vme~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 8999999 7899998876 44679999999999999999999999999999999999999742 3459999999997
Q ss_pred ccccc--------cccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH--HHHHH
Q 017046 209 EETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL--QAAYA 278 (378)
Q Consensus 209 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~ 278 (378)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~ 226 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC--------CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence 54321 12334579999999999864 67899999999999999999999999764431 11111
Q ss_pred H----HHhcCCCCCCCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhccC
Q 017046 279 A----AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 329 (378)
Q Consensus 279 ~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 329 (378)
. ........++..+|+++.+++..|+..+|++||+++.+.+.|+.++....
T Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 227 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 1 11112223456789999999999999999999999999999988876654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-49 Score=365.53 Aligned_cols=252 Identities=28% Similarity=0.389 Sum_probs=192.6
Q ss_pred cceeecceeecccceEEEEEEEC--CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCeeeEEeeEec------
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------ 129 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 129 (378)
++|+++++||+|+||+||+|++. ++.||||++......... ..++.+|+.++++++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~---~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH---AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHH---HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHH---HHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 56999999999999999999874 899999999876654332 2468899999999999999999999842
Q ss_pred -CCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
...|+||||+.++ +.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++++|||+++
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~-~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCCCC--
T ss_pred CceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc-eeeechhhhh
Confidence 3679999999665 444442 46899999999999999999999999999999999999997665 9999999998
Q ss_pred ccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC---
Q 017046 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--- 285 (378)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--- 285 (378)
...........++|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..............
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~--------~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp -------------CCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccccccccccccccccccChhhhcC--------CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence 7776666677789999999999865 67899999999999999999999999887654433322111100
Q ss_pred -----------------CCC--------------------CCCChHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhcc
Q 017046 286 -----------------PGL--------------------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 286 -----------------~~~--------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 328 (378)
+.. +...++++.+||++||..||.+|||++|+++ +.++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~--Hpw~~~~ 317 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ--HPYINVW 317 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTGGG
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--CcccCCC
Confidence 000 0124678899999999999999999999999 5676553
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-42 Score=320.72 Aligned_cols=253 Identities=19% Similarity=0.262 Sum_probs=189.0
Q ss_pred cceeecceeecccceEEEEEEE--CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-----------CCCeeeEE
Q 017046 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-----------HDNLVKFL 124 (378)
Q Consensus 58 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~iv~l~ 124 (378)
.+|+++++||+|+||+||+|++ +++.||||+++..... ...+.+|+.+++.++ |+||++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~------~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY------TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH------HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc------hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 4599999999999999999987 4799999999754321 234678888887775 57899998
Q ss_pred eeEec---CCeEEEEeccCCC-CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeecCCCCcEEEcCCCC--
Q 017046 125 GACKD---PLMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQK-- 197 (378)
Q Consensus 125 ~~~~~---~~~~lv~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~givH~dikp~Nill~~~~~-- 197 (378)
+++.. ...+++|+++..+ .............+++..+..++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 88743 3455666665444 34444444455779999999999999999999998 89999999999999975442
Q ss_pred ---ceeEeccccccccccccccccCcCccccccccccccccccccccccCCCcccchhhhHHHHHHHhCCCCCCCCChH-
Q 017046 198 ---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL- 273 (378)
Q Consensus 198 ---~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 273 (378)
.++++|||.+..... .....+||+.|+|||++.. ..++.++||||+||++++|++|+.||......
T Consensus 167 ~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG--------APWGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred ccceeeEeeccccccccc--ccccccccccccChhhccc--------cCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 389999999875433 2345689999999998865 66889999999999999999999999754321
Q ss_pred -----HHHHHHHHh-c---------------------------------------CCCCCCCCChHHHHHHHHHccccCC
Q 017046 274 -----QAAYAAAFK-H---------------------------------------ARPGLPEDISPDLAFIVQSCWVEDP 308 (378)
Q Consensus 274 -----~~~~~~~~~-~---------------------------------------~~~~~~~~~~~~l~~li~~~l~~dp 308 (378)
......... + ....++...++++.+||.+||..||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 111110000 0 0111223356789999999999999
Q ss_pred CCCCCHHHHHHHHHhhhhcc
Q 017046 309 NLRPSFSQIIRMLNAFLFTL 328 (378)
Q Consensus 309 ~~Rps~~~ll~~l~~~~~~~ 328 (378)
.+|||++|+++ +.++...
T Consensus 317 ~~Rpta~e~L~--Hp~f~~~ 334 (362)
T d1q8ya_ 317 RKRADAGGLVN--HPWLKDT 334 (362)
T ss_dssp TTCBCHHHHHT--CGGGTTC
T ss_pred hHCcCHHHHhc--CcccCCC
Confidence 99999999998 6777644
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=6.1e-27 Score=197.80 Aligned_cols=138 Identities=20% Similarity=0.172 Sum_probs=106.3
Q ss_pred eeecceeecccceEEEEEEE-CCeeEEEEEeecCCCch-------------HHHHHHHHHHHHHHHHhhccCCCeeeEEe
Q 017046 60 LFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSD-------------ERALLEGRFIREVNMMSRVKHDNLVKFLG 125 (378)
Q Consensus 60 ~~~~~~lG~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 125 (378)
+.++++||+|+||+||+|+. +++.||||+++...... ........+.+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35789999999999999986 57899999876432210 11122234567899999999999998876
Q ss_pred eEecCCeEEEEeccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeecCCCCcEEEcCCCCceeEeccc
Q 017046 126 ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (378)
Q Consensus 126 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~givH~dikp~Nill~~~~~~vkl~Dfg 205 (378)
.. ..+++|||+++..+.+ ++...+..++.|++.+|.|||++||+||||||+|||++. ++ ++|+|||
T Consensus 82 ~~---~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~~-~~liDFG 147 (191)
T d1zara2 82 WE---GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EG-IWIIDFP 147 (191)
T ss_dssp EE---TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-TE-EEECCCT
T ss_pred ec---CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-CC-EEEEECC
Confidence 53 2379999998765532 344556789999999999999999999999999999994 44 8999999
Q ss_pred cccccc
Q 017046 206 LAREET 211 (378)
Q Consensus 206 ~a~~~~ 211 (378)
+|....
T Consensus 148 ~a~~~~ 153 (191)
T d1zara2 148 QSVEVG 153 (191)
T ss_dssp TCEETT
T ss_pred CcccCC
Confidence 986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.50 E-value=2.1e-07 Score=80.19 Aligned_cols=137 Identities=15% Similarity=0.085 Sum_probs=87.4
Q ss_pred ceeecceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc-CCCeeeEEeeEe-cCCeEEEE
Q 017046 59 LLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVT 136 (378)
Q Consensus 59 ~~~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~-~~~~~lv~ 136 (378)
.|++.+..+.++.+.||+....++.+++|+......... ..+.+|...+..+. +--+.+++.+.. ++..++||
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~-----~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT-----YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTST-----TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccch-----hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 445555555555679999888888889998765432221 12557888877774 323456676664 45678999
Q ss_pred eccCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 017046 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-------------------------------------- 178 (378)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-------------------------------------- 178 (378)
++++|.++.+.... ... ...++.+++..++.||+.
T Consensus 90 ~~l~G~~~~~~~~~----~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 90 SEADGVLCSEEYED----EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp ECCSSEEHHHHTTT----CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred Eecccccccccccc----ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99999887654321 111 122334444444444421
Q ss_pred ---------------------CCeeecCCCCcEEEcCCCCceeEecccccc
Q 017046 179 ---------------------GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (378)
Q Consensus 179 ---------------------givH~dikp~Nill~~~~~~vkl~Dfg~a~ 208 (378)
.++|+|+.|.|||++. +..+-|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~-~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG 212 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecC-CceEEEeechhcc
Confidence 2799999999999984 4434699998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.94 E-value=2e-05 Score=66.90 Aligned_cols=71 Identities=14% Similarity=0.165 Sum_probs=46.7
Q ss_pred eecccc-eEEEEEEECC-eeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCC--eeeEEeeEec-CCeEEEEeccC
Q 017046 66 IGEGAH-GKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--LVKFLGACKD-PLMVIVTELLP 140 (378)
Q Consensus 66 lG~G~~-g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~~~~-~~~~lv~e~~~ 140 (378)
+..|.. +.||+....+ ..+++|......... +..|...++.+...+ +.+++.+..+ +..++||++++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~--------l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNE--------LQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSC--------HHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHhH--------HHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 344443 6789887754 568889876554322 557777777774323 4556766654 47789999998
Q ss_pred CCCH
Q 017046 141 GMSL 144 (378)
Q Consensus 141 ~~sL 144 (378)
|.++
T Consensus 90 G~~~ 93 (255)
T d1nd4a_ 90 GQDL 93 (255)
T ss_dssp SEET
T ss_pred cccc
Confidence 8655
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.89 E-value=8.6e-06 Score=74.26 Aligned_cols=80 Identities=21% Similarity=0.189 Sum_probs=46.0
Q ss_pred cceeecccceEEEEEEE--CCeeEEEEEeecCC--CchHHHHHHHHHHHHHHHHhhcc-C-C-CeeeEEeeEecCCeEEE
Q 017046 63 GSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGS--TSDERALLEGRFIREVNMMSRVK-H-D-NLVKFLGACKDPLMVIV 135 (378)
Q Consensus 63 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~~~~~E~~~l~~l~-h-p-~iv~l~~~~~~~~~~lv 135 (378)
.+.||.|....||+... .++.|+||.-.... ..........+...|...|+.+. + | .+.+++.+ .+...++|
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-d~~~~~lv 109 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV 109 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-cCCCCEEE
Confidence 35789999999999865 35688999643210 00000000113446777777663 2 3 34455544 34466899
Q ss_pred EeccCCCC
Q 017046 136 TELLPGMS 143 (378)
Q Consensus 136 ~e~~~~~s 143 (378)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.19 E-value=0.00073 Score=61.03 Aligned_cols=71 Identities=20% Similarity=0.303 Sum_probs=47.6
Q ss_pred ceeecccceEEEEEEEC---------CeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCe-eeEEeeEecCCeE
Q 017046 64 SKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMV 133 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~~ 133 (378)
+.|+.|-.-.+|+.... .+.|.+++........ ...+|..+++.+.-.++ .++++++.+ .
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~i-------dr~~E~~i~~~ls~~gl~Pkll~~~~~---g 117 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETES-------HLVAESVIFTLLSERHLGPKLYGIFSG---G 117 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHH-------HHHHHHHHHHHHHHTTSSSCEEEEETT---E
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhh-------HHHHHHHHHHHHHhCCCCCeEEEEcCC---c
Confidence 57888999999998753 2467777765322221 13478888888853344 467777653 6
Q ss_pred EEEeccCCCCH
Q 017046 134 IVTELLPGMSL 144 (378)
Q Consensus 134 lv~e~~~~~sL 144 (378)
+|+||++|.+|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 88999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.11 E-value=0.00062 Score=59.79 Aligned_cols=66 Identities=12% Similarity=0.175 Sum_probs=41.2
Q ss_pred ceEEEEEEE-CCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhccCCCe--eeEEe-----e-EecCCeEEEEeccCC
Q 017046 71 HGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL--VKFLG-----A-CKDPLMVIVTELLPG 141 (378)
Q Consensus 71 ~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i--v~l~~-----~-~~~~~~~lv~e~~~~ 141 (378)
--.||++.. .|+.|++|+.+....... .+..|+..+..|...+| +..+. . ..++..+.+++++.|
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~------~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTAD------QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHH------HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHH------HHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 358999986 467899999876544332 36678888777743222 11111 1 134567889999876
Q ss_pred C
Q 017046 142 M 142 (378)
Q Consensus 142 ~ 142 (378)
.
T Consensus 109 ~ 109 (325)
T d1zyla1 109 R 109 (325)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.50 E-value=0.0041 Score=53.87 Aligned_cols=46 Identities=9% Similarity=0.137 Sum_probs=28.8
Q ss_pred ceeecccceEEEEEEECCeeEEEEEeecCCCchHHHHHHHHHHHHHHHHhhcc
Q 017046 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116 (378)
Q Consensus 64 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 116 (378)
+.|..|---+.|+....+..+++|+........ .+..|+.++..|.
T Consensus 24 ~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~-------~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 24 KGIAEGVENSNFLLHTTKDPLILTLYEKRVEKN-------DLPFFLGLMQHLA 69 (316)
T ss_dssp EEECC---EEEEEEEESSCCEEEEEECC---CC-------HHHHHHHHHHHHH
T ss_pred ecCCCCcccCeEEEEECCCcEEEEEcCCCCCHH-------HHHHHHHHHHhhh
Confidence 456677778899998888889999986543222 1345677777774
|